Citrus Sinensis ID: 012039
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | 2.2.26 [Sep-21-2011] | |||||||
| Q38868 | 541 | Calcium-dependent protein | yes | no | 1.0 | 0.872 | 0.767 | 0.0 | |
| P53683 | 533 | Calcium-dependent protein | yes | no | 0.987 | 0.874 | 0.781 | 0.0 | |
| P49101 | 513 | Calcium-dependent protein | N/A | no | 0.925 | 0.851 | 0.806 | 0.0 | |
| Q9C6P3 | 521 | Calcium-dependent protein | no | no | 0.853 | 0.773 | 0.858 | 0.0 | |
| P28582 | 532 | Calcium-dependent protein | N/A | no | 0.989 | 0.877 | 0.76 | 0.0 | |
| Q9ZSA2 | 531 | Calcium-dependent protein | no | no | 0.911 | 0.809 | 0.785 | 0.0 | |
| O49717 | 554 | Calcium-dependent protein | no | no | 0.936 | 0.797 | 0.739 | 0.0 | |
| Q1PFH8 | 551 | Calcium-dependent protein | no | no | 0.932 | 0.798 | 0.715 | 0.0 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.974 | 0.871 | 0.647 | 0.0 | |
| Q3E9C0 | 523 | Calcium-dependent protein | no | no | 0.957 | 0.864 | 0.645 | 0.0 |
| >sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/482 (76%), Positives = 416/482 (86%), Gaps = 10/482 (2%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVAKAPAPA---QQQAHHRPEKPGPTPAAAPVSG 56
MG C K+ KP+ + RS V P+ Q + +PEKPG + P
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPSYTPQARTTQQPEKPGSVNSQPPPWR 60
Query: 57 LKQAV----PRPDT--NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
A P+ T N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++ACK
Sbjct: 61 AAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACK 120
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDR
Sbjct: 121 SISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDR 180
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHY+ERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDFGLS
Sbjct: 181 IIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLS 240
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEKGIF
Sbjct: 241 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIF 300
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP+ISSSAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASDKPI
Sbjct: 301 DAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPI 360
Query: 351 DSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAG 410
DSAVLSRMKQFRAMNKLKKLALKVIAEN+ TEEIQGLK MF NIDTDNSGTITYEELK G
Sbjct: 361 DSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEG 420
Query: 411 LARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDN 470
LA+LGSKLTEAEV+QLM+AADVDGNG+IDYIEFITATMHRH+LE +++LYKAFQHFDKD+
Sbjct: 421 LAKLGSKLTEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFDKDS 480
Query: 471 SG 472
SG
Sbjct: 481 SG 482
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/481 (78%), Positives = 427/481 (88%), Gaps = 15/481 (3%)
Query: 1 MGGCLTKSKDPKP-RHYAHGYRSSPNTVAKAPAPAQQQ-AHHRPEKPGP-----TPAA-- 51
MG C +++ P R A+GY S T PAQ +++ P+ P P TP+A
Sbjct: 1 MGSCCSRATSPDSGRGGANGYGYSHQT-----KPAQTTPSYNHPQPPPPAEVRYTPSAMN 55
Query: 52 APVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKS 111
PV A P+P +TILGKPY+DV+ YS GKELGRGQFGVTYLCTE ++G+Q+ACKS
Sbjct: 56 PPVVPPVVAPPKPTPDTILGKPYDDVRSVYSLGKELGRGQFGVTYLCTEIASGKQYACKS 115
Query: 112 ISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI 171
ISKRKLV+K DK+DI+REIQIMQHLSGQ NIVEF+GAYEDK +VHVVMELCAGGELFDRI
Sbjct: 116 ISKRKLVSKADKEDIRREIQIMQHLSGQQNIVEFRGAYEDKSNVHVVMELCAGGELFDRI 175
Query: 172 IAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231
IAKGHYSERAAA+ICR++VNVV+ICHFMGVMHRDLKPENFLL++K+ENA+LKATDFGLSV
Sbjct: 176 IAKGHYSERAAATICRAVVNVVNICHFMGVMHRDLKPENFLLATKEENAMLKATDFGLSV 235
Query: 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD 291
FIEEGK+YRDIVGSAYYVAPEVLRR YGKEID+WSAGVILYILLSGVPPFWAETEKGIFD
Sbjct: 236 FIEEGKMYRDIVGSAYYVAPEVLRRNYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 295
Query: 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
AILQG+IDFES PWP+IS SAKDLVR+MLTQDPKKRITSAQVL+HPW+++ GEASDKPID
Sbjct: 296 AILQGEIDFESQPWPSISESAKDLVRKMLTQDPKKRITSAQVLQHPWLRD-GEASDKPID 354
Query: 352 SAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL 411
SAVLSRMKQFRAMNKLKK+ALKVIA NL+ EEI+GLKQMFTN+DTDNSGTITYEELKAGL
Sbjct: 355 SAVLSRMKQFRAMNKLKKMALKVIASNLNEEEIKGLKQMFTNMDTDNSGTITYEELKAGL 414
Query: 412 ARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNS 471
A+LGSKL+EAEV+QLMEAADVDGNG+IDY+EFITATMHRHKLERD+HL+KAFQ+FDKDNS
Sbjct: 415 AKLGSKLSEAEVKQLMEAADVDGNGSIDYVEFITATMHRHKLERDEHLFKAFQYFDKDNS 474
Query: 472 G 472
G
Sbjct: 475 G 475
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 751 bits (1939), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/440 (80%), Positives = 400/440 (90%), Gaps = 3/440 (0%)
Query: 33 PAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQF 92
P QQ A R P+ + P+P +TILGK YEDV+ YSFGKELGRGQF
Sbjct: 20 PPQQAAEVRYT---PSATNSSAVPPVAVPPKPTADTILGKQYEDVRSVYSFGKELGRGQF 76
Query: 93 GVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152
GVTYLCTE ++GRQ+ACKSISKRKLV+K D++DI+REIQIMQHLSGQPNIVEF+GAYEDK
Sbjct: 77 GVTYLCTEIASGRQYACKSISKRKLVSKADREDIRREIQIMQHLSGQPNIVEFRGAYEDK 136
Query: 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212
+VHVVMELCAGGELFDRIIAKGHY+ERAAA+ICR++VNVV+ICHFMGVMHRDLKPENFL
Sbjct: 137 SNVHVVMELCAGGELFDRIIAKGHYTERAAATICRAVVNVVNICHFMGVMHRDLKPENFL 196
Query: 213 LSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILY 272
L++ +ENA+LKATDFGLSVFIEEGK+YRDIVGSAYYVAPEVLRR YGKEID+WSAGVILY
Sbjct: 197 LATMEENAMLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILY 256
Query: 273 ILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQ 332
ILLSGVPPFWAE EKGIFDAIL +IDFES PWP+IS SAKDLVR+MLT+DPKKR+TSAQ
Sbjct: 257 ILLSGVPPFWAEIEKGIFDAILHEEIDFESQPWPSISESAKDLVRKMLTRDPKKRLTSAQ 316
Query: 333 VLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFT 392
VL+H W++EGGEASDKPIDSAVLSRMKQFRAMNKLKK+ALKVIA NL+ EEI+GLKQMF
Sbjct: 317 VLQHQWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKMALKVIASNLNEEEIKGLKQMFM 376
Query: 393 NIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK 452
N+DTDNSGTITYEELKAGLA+LGSKL+EAEV+QLMEAADVDGNG+IDY+EFITATMHRHK
Sbjct: 377 NMDTDNSGTITYEELKAGLAKLGSKLSEAEVKQLMEAADVDGNGSIDYVEFITATMHRHK 436
Query: 453 LERDDHLYKAFQHFDKDNSG 472
LERD+HL+KAFQ+FDKDNSG
Sbjct: 437 LERDEHLFKAFQYFDKDNSG 456
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/404 (85%), Positives = 389/404 (96%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
IL KPYEDVKL Y+ KELGRGQFGVTYLCTE STG++FACKSISK+KLVTK DK+D++R
Sbjct: 61 ILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRR 120
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
EIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDRI+AKGHYSERAAAS+CR
Sbjct: 121 EIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQ 180
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
IVNVV+ICHFMGVMHRDLKPENFLLSSKDE AL+KATDFGLSVFIEEG+VY+DIVGSAYY
Sbjct: 181 IVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYY 240
Query: 249 VAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
VAPEVL+RRYGKEIDIWSAG+ILYILLSGVPPFWAETEKGIFDAIL+G+IDFES PWP+I
Sbjct: 241 VAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSI 300
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
S+SAKDLVRRMLTQDPK+RI++A+VL+HPW++EGGEASDKPIDSAVLSRMKQFRAMNKLK
Sbjct: 301 SNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLK 360
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
KLALKVIAEN+ TEEIQGLK MF NIDTDNSGTITYEELK GLA+LGS+LTEAEV+QLM+
Sbjct: 361 KLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSRLTEAEVKQLMD 420
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
AADVDGNG+IDYIEFITATMHRH+LE ++++YKAFQHFDKD SG
Sbjct: 421 AADVDGNGSIDYIEFITATMHRHRLESNENVYKAFQHFDKDGSG 464
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2 | Back alignment and function description |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/475 (76%), Positives = 411/475 (86%), Gaps = 8/475 (1%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP---NTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGL 57
MGGC +K + +GYRS+P +TV Q +P P S
Sbjct: 1 MGGCFSKKEYQAD---GNGYRSAPTAYHTVTDQSYEKSSQRSQPQAQPQPQVQQTGPSLK 57
Query: 58 KQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL 117
+ V RP++NTILGKP+ED++ Y+ GKELGRGQFG Y CTENS+G+ +ACKSI KRKL
Sbjct: 58 PRQVHRPESNTILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKL 117
Query: 118 VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY 177
V+KNDK+DIKREIQI+QHLSGQPNIVEFKG +ED+QSVH+VMELCAGGELFDRIIA+GHY
Sbjct: 118 VSKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHY 177
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
SERAAA+ICR IVNVVH+CHFMGVMHRDLKPENFLLSSKD++A+LKATDFGLSVFIEEGK
Sbjct: 178 SERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGK 237
Query: 238 VYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
VYR+IVGSAYYVAPEVLRR YGKEIDIWSAGVILYILLSGVPPFWAE EKGIFDAIL+G
Sbjct: 238 VYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGV 297
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
IDFES PWP++S+SAKDLVR+MLTQDP++RITSAQVL+HPW++EGGEASDKPIDSAVLSR
Sbjct: 298 IDFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKPIDSAVLSR 357
Query: 358 MKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK 417
MKQFRAMNKLK+LALKVIAE+LS EEI+GLK MF N+DTD SGTITYEELK+GLARLGSK
Sbjct: 358 MKQFRAMNKLKQLALKVIAESLSEEEIKGLKSMFANMDTDKSGTITYEELKSGLARLGSK 417
Query: 418 LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L+E EVQQLM+AADVDGNGTIDY+EFITATMHRHKLE +H +AFQ+FDKDNSG
Sbjct: 418 LSEVEVQQLMDAADVDGNGTIDYLEFITATMHRHKLESYEH--QAFQYFDKDNSG 470
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/442 (78%), Positives = 389/442 (88%), Gaps = 12/442 (2%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTN--------TILGKPYEDVKLHYSFGKELGRG 90
H +P+ P P P P+ Q + P +N TILGKP+ED++ YS GKELGRG
Sbjct: 33 HRKPQTPTPKPMTQPIH---QQISTPSSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRG 89
Query: 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
QFG+TY+C E TG +ACKSI KRKL++K DK+D+KREIQIMQ+LSGQPNIVE KGAYE
Sbjct: 90 QFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYE 149
Query: 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210
D+QS+H+VMELCAGGELFDRIIA+GHYSERAAA I RSIVNVV ICHFMGV+HRDLKPEN
Sbjct: 150 DRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPEN 209
Query: 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVI 270
FLLSSK+ENA+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YGKEIDIWSAGVI
Sbjct: 210 FLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVI 269
Query: 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS 330
LYILLSGVPPFWAE EKGIFD +++G+IDF S PWP+IS SAKDLVR+MLT+DPK+RIT+
Sbjct: 270 LYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITA 329
Query: 331 AQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQM 390
AQVLEHPWIK GGEA DKPIDSAVLSRMKQFRAMNKLKKLALKVIAE+LS EEI+GLK M
Sbjct: 330 AQVLEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLKTM 388
Query: 391 FTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450
F NIDTD SGTITYEELK GL RLGS+L+E EV+QLMEAADVDGNGTIDY EFI+ATMHR
Sbjct: 389 FANIDTDKSGTITYEELKTGLTRLGSRLSETEVKQLMEAADVDGNGTIDYYEFISATMHR 448
Query: 451 HKLERDDHLYKAFQHFDKDNSG 472
+KL+RD+H+YKAFQHFDKDNSG
Sbjct: 449 YKLDRDEHVYKAFQHFDKDNSG 470
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49717|CDPKF_ARATH Calcium-dependent protein kinase 15 OS=Arabidopsis thaliana GN=CPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 701 bits (1808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/453 (73%), Positives = 387/453 (85%), Gaps = 11/453 (2%)
Query: 29 KAPAP----AQQQAHHRPEKPGPTPAAAP-----VSGLKQAVPRPDTNTILGKPYEDVKL 79
K P+P Q HH ++ P LK V R +T TILGKP+E+++
Sbjct: 42 KPPSPQIPTTTQSNHHHQQESKPVNQQIEKKHVLTQPLKPIVFR-ETETILGKPFEEIRK 100
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y+ GKELGRGQFG+TY C ENSTG +ACKSI KRKL K D DD+KREIQIMQ+LSGQ
Sbjct: 101 LYTLGKELGRGQFGITYTCKENSTGNTYACKSILKRKLTRKQDIDDVKREIQIMQYLSGQ 160
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
NIVE KGAYED+QS+H+VMELC G ELFDRIIA+GHYSE+AAA + RS++NVV ICHFM
Sbjct: 161 ENIVEIKGAYEDRQSIHLVMELCGGSELFDRIIAQGHYSEKAAAGVIRSVLNVVQICHFM 220
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYG 259
GV+HRDLKPENFLL+S DENA+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YG
Sbjct: 221 GVIHRDLKPENFLLASTDENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYG 280
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
KEIDIWSAG+ILYILL GVPPFW+ETEKGIF+ I++G+IDF+S PWP+IS SAKDLVR++
Sbjct: 281 KEIDIWSAGIILYILLCGVPPFWSETEKGIFNEIIKGEIDFDSQPWPSISESAKDLVRKL 340
Query: 320 LTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENL 379
LT+DPK+RI++AQ LEHPWI+ GGEA DKPIDSAVLSRMKQFRAMNKLKKLALKVIAE+L
Sbjct: 341 LTKDPKQRISAAQALEHPWIR-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESL 399
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
S EEI+GLK MF N+DTD SGTITYEELK GLA+LGSKLTEAEV+QLMEAADVDGNGTID
Sbjct: 400 SEEEIKGLKTMFANMDTDKSGTITYEELKNGLAKLGSKLTEAEVKQLMEAADVDGNGTID 459
Query: 440 YIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
YIEFI+ATMHR++ +RD+H++KAFQ+FDKDNSG
Sbjct: 460 YIEFISATMHRYRFDRDEHVFKAFQYFDKDNSG 492
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PFH8|CDPKJ_ARATH Calcium-dependent protein kinase 19 OS=Arabidopsis thaliana GN=CPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/454 (71%), Positives = 381/454 (83%), Gaps = 14/454 (3%)
Query: 29 KAPAP-AQQQAHHRPEK-----PGPTPAAAPVSGLKQAV---PRPDTNTILGKPYEDVKL 79
+ PAP A+ Q +P K P P ++ KQ+ P P ILG+P+ED+K
Sbjct: 41 RQPAPRAKFQIVVQPHKLPLPLPQPQEKQKLINHQKQSTLQQPEP----ILGRPFEDIKE 96
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
YS G+ELGRGQFG+TY+CTE S+G+ FACKSI KRKL+ D++D++REIQIM +LSGQ
Sbjct: 97 KYSLGRELGRGQFGITYICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQ 156
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNIVE KGAYED+QSVH+VMELC GGELFD+I +GHYSE+AAA I RS+V VV ICHFM
Sbjct: 157 PNIVEIKGAYEDRQSVHLVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFM 216
Query: 200 GVMHRDLKPENFLLSSKDE-NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRY 258
GV+HRDLKPENFLLSSKDE +++LKATDFG+SVFIEEGKVY DIVGSAYYVAPEVL+R Y
Sbjct: 217 GVIHRDLKPENFLLSSKDEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNY 276
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
GK IDIWSAGVILYILL G PPFWAET+KGIF+ IL+G+IDFES PWP+IS SAKDLVR
Sbjct: 277 GKAIDIWSAGVILYILLCGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRN 336
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAEN 378
ML DPKKR T+AQVLEHPWI+EGGEASDKPIDSAVLSRMKQ RAMNKLKKLA K IA+N
Sbjct: 337 MLKYDPKKRFTAAQVLEHPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFKFIAQN 396
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
L EE++GLK MF N+DTD SGTITY+ELK+GL +LGS+LTE EV+QL+E ADVDGNGTI
Sbjct: 397 LKEEELKGLKTMFANMDTDKSGTITYDELKSGLEKLGSRLTETEVKQLLEDADVDGNGTI 456
Query: 439 DYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
DYIEFI+ATM+R ++ER+D+L+KAFQHFDKDNSG
Sbjct: 457 DYIEFISATMNRFRVEREDNLFKAFQHFDKDNSG 490
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/476 (64%), Positives = 373/476 (78%), Gaps = 16/476 (3%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQ----QAHHRPEKPGPTPAAAPVSG 56
MG C + +D A +S + A + P + Q+ H P P P P+
Sbjct: 1 MGNCCSHGRDSADNGDALENGASASNAANSTGPTAEASVPQSKHAPPSPPPATKQGPIG- 59
Query: 57 LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRK 116
+LG+P EDVK YS GKELGRGQFGVT+LCT+ +TG QFACK+I+KRK
Sbjct: 60 -----------PVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRK 108
Query: 117 LVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH 176
LV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+VMELCAGGELFDRIIAKGH
Sbjct: 109 LVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGH 168
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
YSERAAAS+ R+IV +VH CH MGV+HRDLKPENFLL +KDEN+ LKATDFGLSVF + G
Sbjct: 169 YSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPG 228
Query: 237 KVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296
+V++DIVGSAYY+APEVL+R+YG E DIWS GV+LYILL GVPPFWAE+E GIF+AIL+G
Sbjct: 229 EVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRG 288
Query: 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLS 356
+DF S PWP+IS AKDLV++ML DPK+R+T+AQVL HPWIKE GEA D P+D+AV+S
Sbjct: 289 HVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMS 348
Query: 357 RMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS 416
R+KQF+AMN KK+AL+VIA LS EEI GLK+MF +DTD+SGTIT EEL+ GLA+ G+
Sbjct: 349 RLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGT 408
Query: 417 KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+L+E EVQQLMEAAD DGNGTIDY EFI ATMH ++L+R++HLY AFQHFDKDNSG
Sbjct: 409 RLSEYEVQQLMEAADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSG 464
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/479 (64%), Positives = 372/479 (77%), Gaps = 27/479 (5%)
Query: 1 MGGCLTKSKD-------PKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAP 53
MG C + +D P+P + G ++ +V + + H P P P P
Sbjct: 1 MGNCCSHGRDSDDNKEEPRPENGGGGVGAAEASV--------RASKHPPASPPPATKQGP 52
Query: 54 VSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS 113
+ +LG+P EDVK Y+ GKELGRGQFGVT+LCT+ +TG QFACK+I+
Sbjct: 53 IG------------PVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIA 100
Query: 114 KRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA 173
KRKLV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+VMELCAGGELFDRIIA
Sbjct: 101 KRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIA 160
Query: 174 KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
KGHYSERAAAS+ R+IV ++H CH MGV+HRDLKPENFLL SKDEN+ LKATDFGLSVF
Sbjct: 161 KGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFY 220
Query: 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI 293
+ G+V++DIVGSAYY+APEVLRR+YG E DIWS GV+LYILL GVPPFWAE+E GIF+AI
Sbjct: 221 KPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAI 280
Query: 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
L G +DF S PWP IS AKDLVR+ML DPK+R+T+AQVL HPWIKE GEA D P+D+A
Sbjct: 281 LSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNA 340
Query: 354 VLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR 413
V+SR+KQF+AMN KK+AL+VIA LS EEI GLK+MF +DTDNSGTIT EEL+ GLA+
Sbjct: 341 VMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAK 400
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
G++L+E EVQQLMEAAD DGNGTIDY EFI ATMH ++L+R++HLY AFQHFDKDNSG
Sbjct: 401 QGTRLSEYEVQQLMEAADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSG 459
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | ||||||
| 225460973 | 536 | PREDICTED: calcium-dependent protein kin | 0.993 | 0.875 | 0.827 | 0.0 | |
| 255583607 | 533 | calcium-dependent protein kinase, putati | 0.980 | 0.868 | 0.808 | 0.0 | |
| 91992434 | 538 | calcium dependent protein kinase 3 [Medi | 0.983 | 0.862 | 0.798 | 0.0 | |
| 449470453 | 519 | PREDICTED: calcium-dependent protein kin | 0.978 | 0.890 | 0.803 | 0.0 | |
| 356569794 | 551 | PREDICTED: calcium-dependent protein kin | 0.980 | 0.840 | 0.776 | 0.0 | |
| 13561063 | 542 | protein kinase [Medicago sativa] | 0.983 | 0.856 | 0.792 | 0.0 | |
| 351727903 | 538 | calmodulin-like domain protein kinase is | 0.921 | 0.808 | 0.846 | 0.0 | |
| 267631890 | 549 | calcium-dependent protein kinase 1 [Pana | 0.993 | 0.854 | 0.761 | 0.0 | |
| 15231140 | 541 | calmodulin-domain protein kinase 9 [Arab | 1.0 | 0.872 | 0.767 | 0.0 | |
| 356501529 | 528 | PREDICTED: calcium-dependent protein kin | 0.983 | 0.878 | 0.789 | 0.0 |
| >gi|225460973|ref|XP_002278179.1| PREDICTED: calcium-dependent protein kinase 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/482 (82%), Positives = 426/482 (88%), Gaps = 13/482 (2%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP------NTVAKAPAPAQQQAHHRPEKPGPT---PAA 51
MG CL+K K Y +GY S + + + PA QQ H PEK P P
Sbjct: 1 MGICLSKGKRGSEPAY-NGYGSGAVAGGVYDRIQERPAAVQQPPHQLPEKRVPAAQPPMK 59
Query: 52 APVSGLK-QAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
P L + V RPDT ILGK +EDVKLHY+ GKELGRGQFGVTYLCTENSTG Q+ACK
Sbjct: 60 PPTVALSPKPVHRPDT--ILGKSFEDVKLHYTIGKELGRGQFGVTYLCTENSTGLQYACK 117
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISKRKLVTKNDK+DI+REIQIMQ LSGQPNIVEFKGAYED+ SVH+VMELCAGGELFDR
Sbjct: 118 SISKRKLVTKNDKEDIRREIQIMQDLSGQPNIVEFKGAYEDRLSVHLVMELCAGGELFDR 177
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHYSERAAASICR+IVNVVHICHFMGVMHRDLKPENFLLSSK ENALLKATDFGLS
Sbjct: 178 IIAKGHYSERAAASICRAIVNVVHICHFMGVMHRDLKPENFLLSSKGENALLKATDFGLS 237
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF
Sbjct: 238 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 297
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAILQG IDFE++PWP+ISSSAKDLVR+MLTQDP+KRITSAQVLEHPWIKE GEASDKPI
Sbjct: 298 DAILQGHIDFETSPWPSISSSAKDLVRKMLTQDPQKRITSAQVLEHPWIKEDGEASDKPI 357
Query: 351 DSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAG 410
DSAVLSRMKQFRAMNKLKKLALKVIAENLS EEIQGLK MFTN+DTD SGTITYEELK+G
Sbjct: 358 DSAVLSRMKQFRAMNKLKKLALKVIAENLSEEEIQGLKAMFTNMDTDKSGTITYEELKSG 417
Query: 411 LARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDN 470
LARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT++RHKLERD+HL+KAFQ+FDKD+
Sbjct: 418 LARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATVNRHKLERDEHLFKAFQYFDKDS 477
Query: 471 SG 472
SG
Sbjct: 478 SG 479
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583607|ref|XP_002532559.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223527714|gb|EEF29820.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/485 (80%), Positives = 424/485 (87%), Gaps = 22/485 (4%)
Query: 1 MGGCLTKSKDPKPRHY------AHGYRSSPNTVAKAPA------PAQQQAHHRPEKPG-P 47
MG CL+K K + HY H R +K+PA P+Q P KP P
Sbjct: 1 MGFCLSKEKRSQQHHYNGATGLQHQSREPVAYQSKSPAQPSYQFPSQTPGAQIPRKPVVP 60
Query: 48 TPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF 107
P+ PV +PDT IL KPYEDVKLHY+ GKELGRGQFGVTYLCTE STG+ +
Sbjct: 61 APSPKPVH-------KPDT--ILEKPYEDVKLHYTIGKELGRGQFGVTYLCTEISTGKLY 111
Query: 108 ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL 167
ACKSISKRKLVT+NDK+D+KREIQIMQHLSGQPNIVEFKGAYEDKQSVH+VMELCAGGEL
Sbjct: 112 ACKSISKRKLVTRNDKEDMKREIQIMQHLSGQPNIVEFKGAYEDKQSVHLVMELCAGGEL 171
Query: 168 FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227
FDRIIAKGHYSE+ AASICRSIVNVVH CHFMGVMHRDLKPENFLLSSKD+NALLKATDF
Sbjct: 172 FDRIIAKGHYSEKEAASICRSIVNVVHACHFMGVMHRDLKPENFLLSSKDQNALLKATDF 231
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
GLSVFIEEGK YRDIVGSAYYVAPEVLRRRYGKE+DIWSAGV+LYILLSGVPPFWAE+EK
Sbjct: 232 GLSVFIEEGKTYRDIVGSAYYVAPEVLRRRYGKEMDIWSAGVMLYILLSGVPPFWAESEK 291
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347
GIFDAILQGDIDFES PWPTISSSAKDLVRRMLTQDPKKRITS QVLEHPW+KEGG+ASD
Sbjct: 292 GIFDAILQGDIDFESPPWPTISSSAKDLVRRMLTQDPKKRITSTQVLEHPWLKEGGDASD 351
Query: 348 KPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEEL 407
KPIDSAVLSRMKQFRAMNKLKK+ALKVIAENLS++EIQGLK MF NIDTDNSGTITY+EL
Sbjct: 352 KPIDSAVLSRMKQFRAMNKLKKMALKVIAENLSSDEIQGLKSMFANIDTDNSGTITYDEL 411
Query: 408 KAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
KAGLARLGSKLTE EV+QLM+AADVDGNGTIDY+EFITATMHRH+LER++HLYKAFQ+FD
Sbjct: 412 KAGLARLGSKLTETEVKQLMDAADVDGNGTIDYLEFITATMHRHRLEREEHLYKAFQYFD 471
Query: 468 KDNSG 472
KDNSG
Sbjct: 472 KDNSG 476
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|91992434|gb|ABE72958.1| calcium dependent protein kinase 3 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/482 (79%), Positives = 415/482 (86%), Gaps = 18/482 (3%)
Query: 1 MGGCLTKSKDPKPRHYAHGYR----------SSPNTVAKAPAPAQQQAHHRPEKPGPTPA 50
MG L+K KD +P H GYR NT AP + Q P KP A
Sbjct: 1 MGCLLSKDKDSEPEHNNGGYRYGEHNHRNNHEQVNTSRTAPTSSYQP--QIPTKPSSISA 58
Query: 51 AAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
+P +KQ D+NTILGK EDVK Y+ GKELGRGQFGVT+LCTENSTG +ACK
Sbjct: 59 PSPKPLIKQ-----DSNTILGKGLEDVKQFYTLGKELGRGQFGVTFLCTENSTGLLYACK 113
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISKRKLV+K+D++DIKREIQIMQHLSGQPNIVEFKGAYED+ SVHVVMELCAGGELFDR
Sbjct: 114 SISKRKLVSKSDREDIKREIQIMQHLSGQPNIVEFKGAYEDRNSVHVVMELCAGGELFDR 173
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHYSE+AAASICR IVNVV+ICHFMGVMHRDLKPENFLL+SKDENALLKATDFGL+
Sbjct: 174 IIAKGHYSEKAAASICRQIVNVVNICHFMGVMHRDLKPENFLLASKDENALLKATDFGLA 233
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRR GKEIDIWSAGVILYILLSGVPPFWAETEKGIF
Sbjct: 234 VFIEEGKVYRDIVGSAYYVAPEVLRRRCGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 293
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP IS SAKDLVR+ML Q+PKKRIT+AQVLEHPWIK+G ASDKPI
Sbjct: 294 DAILEGHIDFESEPWPKISDSAKDLVRKMLIQEPKKRITAAQVLEHPWIKDGN-ASDKPI 352
Query: 351 DSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAG 410
DSAVLSRMKQFRAMNKLKKLALKVIAEN+S EEI+GLK MFTN+DTDNSGTITYEELKAG
Sbjct: 353 DSAVLSRMKQFRAMNKLKKLALKVIAENMSEEEIRGLKAMFTNMDTDNSGTITYEELKAG 412
Query: 411 LARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDN 470
L RLGSKL+EAEV+QLMEAADVDGNGTID IEFITATMHRHKLERDDHLYKAFQ+FDKD+
Sbjct: 413 LQRLGSKLSEAEVKQLMEAADVDGNGTIDCIEFITATMHRHKLERDDHLYKAFQYFDKDS 472
Query: 471 SG 472
SG
Sbjct: 473 SG 474
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470453|ref|XP_004152931.1| PREDICTED: calcium-dependent protein kinase-like [Cucumis sativus] gi|449532030|ref|XP_004172987.1| PREDICTED: calcium-dependent protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/473 (80%), Positives = 413/473 (87%), Gaps = 11/473 (2%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQA 60
MG C +K K R Y H Y P KAPA Q H PE A P K
Sbjct: 1 MGICTSKGK--YSRQYDH-YEQQP----KAPA---QHTHRSPEYRQTAGGAKPSGPPKSP 50
Query: 61 VPRP-DTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT 119
P ++TILGKP EDVKLHY+ GKELGRGQFGVTYLCTENS+G+Q+ACKSI KRKLVT
Sbjct: 51 KHTPFRSDTILGKPLEDVKLHYTIGKELGRGQFGVTYLCTENSSGKQYACKSILKRKLVT 110
Query: 120 KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE 179
KNDK+DI+REI IMQHLSGQPNIVEFKGAYEDK SVH++MELCAGGELFDRIIAKGHYSE
Sbjct: 111 KNDKEDIRREIHIMQHLSGQPNIVEFKGAYEDKLSVHLIMELCAGGELFDRIIAKGHYSE 170
Query: 180 RAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
+AAASICRSIVNVVHICHFMGVMHRDLKPENFLL+SK+E+A+LKATDFGLSVFIEEGKVY
Sbjct: 171 KAAASICRSIVNVVHICHFMGVMHRDLKPENFLLASKEEDAMLKATDFGLSVFIEEGKVY 230
Query: 240 RDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
RDIVGSAYYVAPEVLRR+YGKEID+WSAGV+LYILLSGVPPFWAETEKGIFD+ILQG ID
Sbjct: 231 RDIVGSAYYVAPEVLRRKYGKEIDVWSAGVMLYILLSGVPPFWAETEKGIFDSILQGHID 290
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMK 359
FES PWP IS SAKDLV+RMLTQDP RITSAQVLEHPW++EGGEASDKPIDSAV +R+K
Sbjct: 291 FESDPWPHISPSAKDLVKRMLTQDPANRITSAQVLEHPWMREGGEASDKPIDSAVFTRLK 350
Query: 360 QFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT 419
QFRAMNKLKKLALKVIAENLS EEIQGLK MFTN+DTD SGTITY ELK+GLARLGS L+
Sbjct: 351 QFRAMNKLKKLALKVIAENLSEEEIQGLKAMFTNMDTDKSGTITYAELKSGLARLGSTLS 410
Query: 420 EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
EAEV+QLMEAADVDGNGTIDYIEFITATMHR+KLE+++HLYKAFQHFDKDNSG
Sbjct: 411 EAEVKQLMEAADVDGNGTIDYIEFITATMHRYKLEKEEHLYKAFQHFDKDNSG 463
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569794|ref|XP_003553081.1| PREDICTED: calcium-dependent protein kinase 9-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/496 (77%), Positives = 419/496 (84%), Gaps = 33/496 (6%)
Query: 1 MGGCLTKSKDPKPRHYAHG-------YRSSPNTVAKAPAPAQQQAHHRPEK--------- 44
MG C++K +P+ Y HG ++ V ++ APA Q +H PEK
Sbjct: 1 MGCCVSKDSEPQHNGYRHGGTGGVHNQKTHEPLVNQSRAPANQ-PYHLPEKHAASTAQTV 59
Query: 45 --------PGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY 96
GP + PV ++Q +TILGK +EDVK Y+ GKELGRGQFGVTY
Sbjct: 60 PQNMPWKPSGPALSPKPVVSVRQ-------DTILGKQFEDVKQFYTLGKELGRGQFGVTY 112
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156
LCTENSTG Q+ACKSISKRKLV K+DK+DIKREIQIMQHLSGQPNIVEFKGAYED+ SVH
Sbjct: 113 LCTENSTGLQYACKSISKRKLVKKSDKEDIKREIQIMQHLSGQPNIVEFKGAYEDRNSVH 172
Query: 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
VVMELCAGGELFDRIIAKGHYSERAAASICR IVNVVHICHFMGVMHRDLKPENFLLSS+
Sbjct: 173 VVMELCAGGELFDRIIAKGHYSERAAASICRQIVNVVHICHFMGVMHRDLKPENFLLSSR 232
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLS 276
DE+ALLKATDFGLSVFIEEGK+YRDIVGSAYYVAPEVLRRR GKEIDIWSAGVILYILLS
Sbjct: 233 DESALLKATDFGLSVFIEEGKLYRDIVGSAYYVAPEVLRRRCGKEIDIWSAGVILYILLS 292
Query: 277 GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
GVPPFWAETEKGIFDAIL+G IDFES PWP IS++AKDLVR+ML QDPKKRITSAQVLEH
Sbjct: 293 GVPPFWAETEKGIFDAILEGHIDFESQPWPNISNNAKDLVRKMLIQDPKKRITSAQVLEH 352
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDT 396
PWIK+G ASD+PIDSAVLSRMKQFRAMNKLKKLALKVIAEN+S EEIQGLK MFTN+DT
Sbjct: 353 PWIKDGN-ASDRPIDSAVLSRMKQFRAMNKLKKLALKVIAENMSAEEIQGLKAMFTNMDT 411
Query: 397 DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456
D SG ITYEELKAGL RLGSKLTEAEV+QLMEAADVDGNG+IDYIEFITATMHRHKLERD
Sbjct: 412 DKSGAITYEELKAGLHRLGSKLTEAEVKQLMEAADVDGNGSIDYIEFITATMHRHKLERD 471
Query: 457 DHLYKAFQHFDKDNSG 472
D L+KAFQ+FDKDNSG
Sbjct: 472 DQLFKAFQYFDKDNSG 487
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13561063|emb|CAA65500.1| protein kinase [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/486 (79%), Positives = 414/486 (85%), Gaps = 22/486 (4%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP--------------NTVAKAPAPAQQQAHHRPEKPG 46
MG L+K KD + H GYR + NT AP + Q P KP
Sbjct: 1 MGCLLSKDKDSEQEHNNGGYRYAESSGMHNHRNNHEQVNTSRTAPTSSYQP--QIPTKPS 58
Query: 47 PTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQ 106
A +P +KQ DTNTILGK EDVK Y+ GKELGRGQFGVT+LCTENSTG
Sbjct: 59 SISAPSPKPLIKQ-----DTNTILGKGLEDVKQFYTLGKELGRGQFGVTFLCTENSTGLL 113
Query: 107 FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166
+ACKSISKRKLV+K+D++DIKREIQIMQHLSGQPNIVEFKGAYED+ SVHVVMELCAGGE
Sbjct: 114 YACKSISKRKLVSKSDREDIKREIQIMQHLSGQPNIVEFKGAYEDRNSVHVVMELCAGGE 173
Query: 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226
LFDRIIAKGHYSE+AAASICR IVNVV+ICHFMGVMHRDLKPENFLL+SKDENALLKATD
Sbjct: 174 LFDRIIAKGHYSEKAAASICRQIVNVVNICHFMGVMHRDLKPENFLLASKDENALLKATD 233
Query: 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETE 286
FGLSVFIEEG+VYRDIVGSAYYVAPEVLR R GKEIDIWSAGVILYILLSGVPPFWAETE
Sbjct: 234 FGLSVFIEEGRVYRDIVGSAYYVAPEVLRPRCGKEIDIWSAGVILYILLSGVPPFWAETE 293
Query: 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
KGIFDAIL+G IDFES PWP IS SAKDLVR+ML Q+PKKRIT+AQVLEHPWIK GG AS
Sbjct: 294 KGIFDAILEGHIDFESEPWPKISDSAKDLVRKMLIQEPKKRITAAQVLEHPWIK-GGNAS 352
Query: 347 DKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEE 406
DKPIDSAVLSRMKQFRAMNKLKKLALKVIAEN+S EEI+GLK MFTN+DTDNSGTITYEE
Sbjct: 353 DKPIDSAVLSRMKQFRAMNKLKKLALKVIAENMSEEEIRGLKAMFTNMDTDNSGTITYEE 412
Query: 407 LKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHF 466
LKAGL RLGSKL+EAEV+QLMEAADVDGNGTID IEFITATMHRHKLERDDHLYKAFQ+F
Sbjct: 413 LKAGLQRLGSKLSEAEVKQLMEAADVDGNGTIDCIEFITATMHRHKLERDDHLYKAFQYF 472
Query: 467 DKDNSG 472
DKD+SG
Sbjct: 473 DKDSSG 478
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727903|ref|NP_001235641.1| calmodulin-like domain protein kinase isoenzyme gamma [Glycine max] gi|2501766|gb|AAB80693.1| calmodulin-like domain protein kinase isoenzyme gamma [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/444 (84%), Positives = 402/444 (90%), Gaps = 9/444 (2%)
Query: 30 APAPAQQQAHHRPEKP-GPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELG 88
A + AQ + P KP GP + PV G++Q +TILGK +EDVK ++ GKELG
Sbjct: 39 AASTAQTVPQNMPWKPPGPALSPKPVVGVRQ-------DTILGKQFEDVKQFHTLGKELG 91
Query: 89 RGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148
RGQFGVTYLCTENSTG Q+ACKSISKRKL +K+DK+DIKREIQIMQHLSGQPNIVEFKGA
Sbjct: 92 RGQFGVTYLCTENSTGLQYACKSISKRKLASKSDKEDIKREIQIMQHLSGQPNIVEFKGA 151
Query: 149 YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKP 208
YED+ SVHVVMELCAGGELFDRIIAKGHYSE+AAASICR IVNVVHICHFMGVMHRDLKP
Sbjct: 152 YEDRSSVHVVMELCAGGELFDRIIAKGHYSEKAAASICRQIVNVVHICHFMGVMHRDLKP 211
Query: 209 ENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAG 268
ENFLLSS+DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR GKEIDIWSAG
Sbjct: 212 ENFLLSSRDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRCGKEIDIWSAG 271
Query: 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328
VILYILLSGVPPFWAETEKGIFDAIL+G IDFES PWP IS SAKDLVR+ML QDPKKRI
Sbjct: 272 VILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPNISDSAKDLVRKMLIQDPKKRI 331
Query: 329 TSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLK 388
TSAQVLEHPWIK+G ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAEN+S EEIQGLK
Sbjct: 332 TSAQVLEHPWIKDGN-ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENMSAEEIQGLK 390
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
MFTN+DTD SGTITYEELK+GL RLGSKLTEAEV+QLMEAADVDGNG+IDYIEFITATM
Sbjct: 391 AMFTNMDTDKSGTITYEELKSGLHRLGSKLTEAEVKQLMEAADVDGNGSIDYIEFITATM 450
Query: 449 HRHKLERDDHLYKAFQHFDKDNSG 472
HRHKLERDD L+KAFQ+FDKDNSG
Sbjct: 451 HRHKLERDDQLFKAFQYFDKDNSG 474
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|267631890|gb|ACY78680.1| calcium-dependent protein kinase 1 [Panax ginseng] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/494 (76%), Positives = 418/494 (84%), Gaps = 25/494 (5%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPE-KPGPTPAAAPVSGLK- 58
MGGC +K +D + +GYRS N Q + +P + PT P
Sbjct: 1 MGGCASKKQDYQAD--VNGYRSGRNG-GTGYQTVSGQGYEKPSTQYNPTQPQRPHQTQPQ 57
Query: 59 --------------------QAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
+ V +P+ NTILGK +ED++ HY+ GKELGRGQFGVTYLC
Sbjct: 58 PQPKQPAPAPLKPAAHNPSPRPVHKPEPNTILGKKFEDIRAHYTLGKELGRGQFGVTYLC 117
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
TE S+G +ACKSI KRKLV+KNDK+D+KREIQIMQHLSGQP+IVEFKGAYED+QSVH+V
Sbjct: 118 TEISSGHFYACKSILKRKLVSKNDKEDMKREIQIMQHLSGQPDIVEFKGAYEDRQSVHLV 177
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
MELCAGGELFDRIIA+GHYSERAAA+ICR IVNVVH+CHFMGVMHRDLKPENFLLSSK+E
Sbjct: 178 MELCAGGELFDRIIAQGHYSERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKNE 237
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
A+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YGKEIDIWSAGVILYILLSGV
Sbjct: 238 GAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGV 297
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPFWAE EKGIFDAIL+G IDFES PWP+IS+SAKDLVR+MLTQDP++RITSAQVLEHPW
Sbjct: 298 PPFWAENEKGIFDAILEGVIDFESQPWPSISNSAKDLVRKMLTQDPRRRITSAQVLEHPW 357
Query: 339 IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDN 398
++EGGEASDKPIDSAVLSRMKQFRAMNKLKKLALK IAE+LS EEI+GLK MFTNIDTDN
Sbjct: 358 MREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKGIAESLSEEEIKGLKAMFTNIDTDN 417
Query: 399 SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDH 458
SGTITYEELK+GLARLGSKL+EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD+H
Sbjct: 418 SGTITYEELKSGLARLGSKLSEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDEH 477
Query: 459 LYKAFQHFDKDNSG 472
LYKAFQ+FDKD+SG
Sbjct: 478 LYKAFQYFDKDSSG 491
|
Source: Panax ginseng Species: Panax ginseng Genus: Panax Family: Araliaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231140|ref|NP_188676.1| calmodulin-domain protein kinase 9 [Arabidopsis thaliana] gi|75319414|sp|Q38868.1|CDPK9_ARATH RecName: Full=Calcium-dependent protein kinase 9; AltName: Full=Calmodulin-domain protein kinase CDPK isoform 9 gi|1399265|gb|AAB03242.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|9294561|dbj|BAB02824.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|21539465|gb|AAM53285.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|31711962|gb|AAP68337.1| At3g20410 [Arabidopsis thaliana] gi|332642854|gb|AEE76375.1| calmodulin-domain protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/482 (76%), Positives = 416/482 (86%), Gaps = 10/482 (2%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVAKAPAPA---QQQAHHRPEKPGPTPAAAPVSG 56
MG C K+ KP+ + RS V P+ Q + +PEKPG + P
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPSYTPQARTTQQPEKPGSVNSQPPPWR 60
Query: 57 LKQAV----PRPDT--NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
A P+ T N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++ACK
Sbjct: 61 AAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACK 120
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDR
Sbjct: 121 SISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDR 180
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHY+ERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDFGLS
Sbjct: 181 IIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLS 240
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEKGIF
Sbjct: 241 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIF 300
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP+ISSSAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASDKPI
Sbjct: 301 DAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPI 360
Query: 351 DSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAG 410
DSAVLSRMKQFRAMNKLKKLALKVIAEN+ TEEIQGLK MF NIDTDNSGTITYEELK G
Sbjct: 361 DSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEG 420
Query: 411 LARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDN 470
LA+LGSKLTEAEV+QLM+AADVDGNG+IDYIEFITATMHRH+LE +++LYKAFQHFDKD+
Sbjct: 421 LAKLGSKLTEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFDKDS 480
Query: 471 SG 472
SG
Sbjct: 481 SG 482
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501529|ref|XP_003519577.1| PREDICTED: calcium-dependent protein kinase 33-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/479 (78%), Positives = 412/479 (86%), Gaps = 15/479 (3%)
Query: 1 MGGCLTKSKDPKP------RHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGP-TPAAAP 53
MG C++K K +P RH A + K+ P Q + PEK P P +P
Sbjct: 1 MGCCMSK-KGSEPEEHIVYRHVAGAGGAGVYNNHKSHEPPSHQPYPLPEKHAPWRPPPSP 59
Query: 54 VSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS 113
K +TI GKP+EDVK HY+ GKELGRGQFGVTYLCTENSTG Q+ACKSIS
Sbjct: 60 KHVHKH-------DTITGKPFEDVKQHYTLGKELGRGQFGVTYLCTENSTGFQYACKSIS 112
Query: 114 KRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA 173
KRKLV+++DK+D+KREIQIMQHLSGQ NIVEFKGA+EDKQSVHVVMELCAGGELFDRIIA
Sbjct: 113 KRKLVSRDDKEDMKREIQIMQHLSGQSNIVEFKGAFEDKQSVHVVMELCAGGELFDRIIA 172
Query: 174 KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
KGHYSERAAASICR +V VV+ CHFMGV+HRDLKPENFLLSSKD+ LLKATDFGLSVFI
Sbjct: 173 KGHYSERAAASICRQVVKVVNTCHFMGVIHRDLKPENFLLSSKDDKGLLKATDFGLSVFI 232
Query: 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI 293
EEGKVYRDIVGSAYYVAPEVLRR YGKE DIWSAGVILYILLSGVPPFWAETEKGIFD I
Sbjct: 233 EEGKVYRDIVGSAYYVAPEVLRRSYGKEADIWSAGVILYILLSGVPPFWAETEKGIFDVI 292
Query: 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
LQG IDFES+PWP+IS+SAKDLVR+ML +DPKKRIT+AQVLEHPW+KEGG ASDKPIDSA
Sbjct: 293 LQGHIDFESSPWPSISNSAKDLVRKMLIKDPKKRITAAQVLEHPWLKEGGNASDKPIDSA 352
Query: 354 VLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR 413
VLSRMKQFRAMNKLKKLALKVIAENLS EEIQGLK MFTNIDTDNSGTITYEEL+AGL R
Sbjct: 353 VLSRMKQFRAMNKLKKLALKVIAENLSEEEIQGLKAMFTNIDTDNSGTITYEELRAGLQR 412
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
LGSKLTEAEVQQLM+AADVDGNGTIDYIEFITATMHRH+LERD+HL+KAFQ+FDKD SG
Sbjct: 413 LGSKLTEAEVQQLMDAADVDGNGTIDYIEFITATMHRHRLERDEHLHKAFQYFDKDGSG 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | ||||||
| TAIR|locus:2092399 | 541 | CPK9 "calmodulin-domain protei | 0.993 | 0.866 | 0.769 | 8.1e-195 | |
| TAIR|locus:2015846 | 521 | CPK33 "calcium-dependent prote | 0.855 | 0.775 | 0.858 | 1.6e-191 | |
| TAIR|locus:2138897 | 531 | CPK21 "calcium-dependent prote | 0.917 | 0.815 | 0.788 | 1.3e-187 | |
| TAIR|locus:2036783 | 551 | CPK19 "calcium-dependent prote | 0.913 | 0.782 | 0.729 | 1.4e-172 | |
| TAIR|locus:2204340 | 561 | CPK29 "calcium-dependent prote | 0.968 | 0.814 | 0.660 | 2e-166 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.889 | 0.803 | 0.712 | 3e-165 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.902 | 0.806 | 0.702 | 3.8e-165 | |
| TAIR|locus:2128409 | 529 | CDPK6 "calcium-dependent prote | 0.978 | 0.873 | 0.638 | 3.2e-159 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.862 | 0.630 | 0.656 | 4e-151 | |
| TAIR|locus:2175503 | 610 | CPK1 "calcium dependent protei | 0.915 | 0.708 | 0.631 | 1.4e-149 |
| TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1887 (669.3 bits), Expect = 8.1e-195, P = 8.1e-195
Identities = 373/485 (76%), Positives = 416/485 (85%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVXXX---XXXXXXXXHHRPEKPG-----PTP-- 49
MG C K+ KP+ + RS V +PEKPG P P
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPSYTPQARTTQQPEKPGSVNSQPPPWR 60
Query: 50 AAAPVSGLKQAVPRPDT--NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF 107
AAA GL P+ T N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++
Sbjct: 61 AAAAAPGLS---PKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKY 117
Query: 108 ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL 167
ACKSISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGEL
Sbjct: 118 ACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGEL 177
Query: 168 FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227
FDRIIAKGHY+ERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDF
Sbjct: 178 FDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDF 237
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEK
Sbjct: 238 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEK 297
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347
GIFDAIL+G IDFES PWP+ISSSAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASD
Sbjct: 298 GIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASD 357
Query: 348 KPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEEL 407
KPIDSAVLSRMKQFRAMNKLKKLALKVIAEN+ TEEIQGLK MF NIDTDNSGTITYEEL
Sbjct: 358 KPIDSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEEL 417
Query: 408 KAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
K GLA+LGSKLTEAEV+QLM+AADVDGNG+IDYIEFITATMHRH+LE +++LYKAFQHFD
Sbjct: 418 KEGLAKLGSKLTEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFD 477
Query: 468 KDNSG 472
KD+SG
Sbjct: 478 KDSSG 482
|
|
| TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1856 (658.4 bits), Expect = 1.6e-191, P = 1.6e-191
Identities = 347/404 (85%), Positives = 389/404 (96%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
IL KPYEDVKL Y+ KELGRGQFGVTYLCTE STG++FACKSISK+KLVTK DK+D++R
Sbjct: 61 ILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRR 120
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
EIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDRI+AKGHYSERAAAS+CR
Sbjct: 121 EIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQ 180
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
IVNVV+ICHFMGVMHRDLKPENFLLSSKDE AL+KATDFGLSVFIEEG+VY+DIVGSAYY
Sbjct: 181 IVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYY 240
Query: 249 VAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
VAPEVL+RRYGKEIDIWSAG+ILYILLSGVPPFWAETEKGIFDAIL+G+IDFES PWP+I
Sbjct: 241 VAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSI 300
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
S+SAKDLVRRMLTQDPK+RI++A+VL+HPW++EGGEASDKPIDSAVLSRMKQFRAMNKLK
Sbjct: 301 SNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLK 360
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
KLALKVIAEN+ TEEIQGLK MF NIDTDNSGTITYEELK GLA+LGS+LTEAEV+QLM+
Sbjct: 361 KLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSRLTEAEVKQLMD 420
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
AADVDGNG+IDYIEFITATMHRH+LE ++++YKAFQHFDKD SG
Sbjct: 421 AADVDGNGSIDYIEFITATMHRHRLESNENVYKAFQHFDKDGSG 464
|
|
| TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1819 (645.4 bits), Expect = 1.3e-187, P = 1.3e-187
Identities = 346/439 (78%), Positives = 388/439 (88%)
Query: 39 HHRPEKPGPTPAAAPV-SGLKQAVPRP----DTNTILGKPYEDVKLHYSFGKELGRGQFG 93
H +P+ P P P P+ + P D +TILGKP+ED++ YS GKELGRGQFG
Sbjct: 33 HRKPQTPTPKPMTQPIHQQISTPSSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRGQFG 92
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153
+TY+C E TG +ACKSI KRKL++K DK+D+KREIQIMQ+LSGQPNIVE KGAYED+Q
Sbjct: 93 ITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQ 152
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
S+H+VMELCAGGELFDRIIA+GHYSERAAA I RSIVNVV ICHFMGV+HRDLKPENFLL
Sbjct: 153 SIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLL 212
Query: 214 SSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYI 273
SSK+ENA+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YGKEIDIWSAGVILYI
Sbjct: 213 SSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYI 272
Query: 274 LLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQV 333
LLSGVPPFWAE EKGIFD +++G+IDF S PWP+IS SAKDLVR+MLT+DPK+RIT+AQV
Sbjct: 273 LLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQV 332
Query: 334 LEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTN 393
LEHPWIK GGEA DKPIDSAVLSRMKQFRAMNKLKKLALKVIAE+LS EEI+GLK MF N
Sbjct: 333 LEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLKTMFAN 391
Query: 394 IDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL 453
IDTD SGTITYEELK GL RLGS+L+E EV+QLMEAADVDGNGTIDY EFI+ATMHR+KL
Sbjct: 392 IDTDKSGTITYEELKTGLTRLGSRLSETEVKQLMEAADVDGNGTIDYYEFISATMHRYKL 451
Query: 454 ERDDHLYKAFQHFDKDNSG 472
+RD+H+YKAFQHFDKDNSG
Sbjct: 452 DRDEHVYKAFQHFDKDNSG 470
|
|
| TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
Identities = 319/437 (72%), Positives = 376/437 (86%)
Query: 40 HRPEKPGPTPAAAP--VSGLKQA-VPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY 96
H+ P P P ++ KQ+ + +P+ ILG+P+ED+K YS G+ELGRGQFG+TY
Sbjct: 56 HKLPLPLPQPQEKQKLINHQKQSTLQQPEP--ILGRPFEDIKEKYSLGRELGRGQFGITY 113
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156
+CTE S+G+ FACKSI KRKL+ D++D++REIQIM +LSGQPNIVE KGAYED+QSVH
Sbjct: 114 ICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQPNIVEIKGAYEDRQSVH 173
Query: 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
+VMELC GGELFD+I +GHYSE+AAA I RS+V VV ICHFMGV+HRDLKPENFLLSSK
Sbjct: 174 LVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFMGVIHRDLKPENFLLSSK 233
Query: 217 DE-NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILL 275
DE +++LKATDFG+SVFIEEGKVY DIVGSAYYVAPEVL+R YGK IDIWSAGVILYILL
Sbjct: 234 DEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNYGKAIDIWSAGVILYILL 293
Query: 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
G PPFWAET+KGIF+ IL+G+IDFES PWP+IS SAKDLVR ML DPKKR T+AQVLE
Sbjct: 294 CGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRNMLKYDPKKRFTAAQVLE 353
Query: 336 HPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNID 395
HPWI+EGGEASDKPIDSAVLSRMKQ RAMNKLKKLA K IA+NL EE++GLK MF N+D
Sbjct: 354 HPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFKFIAQNLKEEELKGLKTMFANMD 413
Query: 396 TDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLER 455
TD SGTITY+ELK+GL +LGS+LTE EV+QL+E ADVDGNGTIDYIEFI+ATM+R ++ER
Sbjct: 414 TDKSGTITYDELKSGLEKLGSRLTETEVKQLLEDADVDGNGTIDYIEFISATMNRFRVER 473
Query: 456 DDHLYKAFQHFDKDNSG 472
+D+L+KAFQHFDKDNSG
Sbjct: 474 EDNLFKAFQHFDKDNSG 490
|
|
| TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1619 (575.0 bits), Expect = 2.0e-166, P = 2.0e-166
Identities = 310/469 (66%), Positives = 379/469 (80%)
Query: 5 LTKSKDPKPRHYAHGYRSSPNTVXXXXXXXXXXXHHRPE-KPGPTPAAAPVSGLKQAVPR 63
++ S D P H+ Y+ P + +P+ KP P P + SG Q P
Sbjct: 45 ISSSSDSSPPHH---YQPLPKPTVSQGQTSNPTSNPQPKPKPAPPPPPSTSSG-SQIGP- 99
Query: 64 PDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
IL +P D+ Y KELGRGQFG+TY CT+ S GR++ACKSISKRKL+ + D
Sbjct: 100 -----ILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDI 154
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA 183
+D++RE+ I+QHL+GQPNIVEF+GAYEDK ++H+VMELC+GGELFDRII KG YSE+ AA
Sbjct: 155 EDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAA 214
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+I R IVNVVH+CHFMGV+HRDLKPENFLL S +E++ +KATDFGLSVFIEEGKVYRDIV
Sbjct: 215 NIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIV 274
Query: 244 GSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303
GSAYYVAPEVL R YGKEID+WSAGV+LYILLSGVPPFW ETEK IF+AIL+G +D E++
Sbjct: 275 GSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETS 334
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRA 363
PWPTIS SAKDL+R+ML +DPKKRIT+A+ LEHPW+ + + SDKPI+SAVL RMKQFRA
Sbjct: 335 PWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMTDT-KISDKPINSAVLVRMKQFRA 393
Query: 364 MNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEV 423
MNKLKKLALKVIAENLS EEI+GLKQ F N+DTD SGTIT++EL+ GL RLGSKLTE+E+
Sbjct: 394 MNKLKKLALKVIAENLSEEEIKGLKQTFKNMDTDESGTITFDELRNGLHRLGSKLTESEI 453
Query: 424 QQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+QLMEAADVD +GTIDYIEF+TATMHRH+LE++++L +AF++FDKD SG
Sbjct: 454 KQLMEAADVDKSGTIDYIEFVTATMHRHRLEKEENLIEAFKYFDKDRSG 502
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1608 (571.1 bits), Expect = 3.0e-165, P = 3.0e-165
Identities = 302/424 (71%), Positives = 356/424 (83%)
Query: 49 PAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFA 108
P A+P KQ P +LG+P EDVK Y+ GKELGRGQFGVT+LCT+ +TG QFA
Sbjct: 40 PPASPPPATKQGPIGP----VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFA 95
Query: 109 CKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELF 168
CK+I+KRKLV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+VMELCAGGELF
Sbjct: 96 CKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELF 155
Query: 169 DRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228
DRIIAKGHYSERAAAS+ R+IV ++H CH MGV+HRDLKPENFLL SKDEN+ LKATDFG
Sbjct: 156 DRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFG 215
Query: 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG 288
LSVF + G+V++DIVGSAYY+APEVLRR+YG E DIWS GV+LYILL GVPPFWAE+E G
Sbjct: 216 LSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENG 275
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
IF+AIL G +DF S PWP IS AKDLVR+ML DPK+R+T+AQVL HPWIKE GEA D
Sbjct: 276 IFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDV 335
Query: 349 PIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELK 408
P+D+AV+SR+KQF+AMN KK+AL+VIA LS EEI GLK+MF +DTDNSGTIT EEL+
Sbjct: 336 PLDNAVMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELR 395
Query: 409 AGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDK 468
GLA+ G++L+E EVQQLMEAAD DGNGTIDY EFI ATMH ++L+R++HLY AFQHFDK
Sbjct: 396 QGLAKQGTRLSEYEVQQLMEAADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDK 455
Query: 469 DNSG 472
DNSG
Sbjct: 456 DNSG 459
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1607 (570.8 bits), Expect = 3.8e-165, P = 3.8e-165
Identities = 305/434 (70%), Positives = 362/434 (83%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNT-------ILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
GPT A A V K A P P T +LG+P EDVK YS GKELGRGQFGVT+LC
Sbjct: 32 GPT-AEASVPQSKHAPPSPPPATKQGPIGPVLGRPMEDVKASYSLGKELGRGQFGVTHLC 90
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
T+ +TG QFACK+I+KRKLV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+V
Sbjct: 91 TQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLV 150
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
MELCAGGELFDRIIAKGHYSERAAAS+ R+IV +VH CH MGV+HRDLKPENFLL +KDE
Sbjct: 151 MELCAGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDE 210
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
N+ LKATDFGLSVF + G+V++DIVGSAYY+APEVL+R+YG E DIWS GV+LYILL GV
Sbjct: 211 NSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGV 270
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPFWAE+E GIF+AIL+G +DF S PWP+IS AKDLV++ML DPK+R+T+AQVL HPW
Sbjct: 271 PPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPW 330
Query: 339 IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDN 398
IKE GEA D P+D+AV+SR+KQF+AMN KK+AL+VIA LS EEI GLK+MF +DTD+
Sbjct: 331 IKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDS 390
Query: 399 SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDH 458
SGTIT EEL+ GLA+ G++L+E EVQQLMEAAD DGNGTIDY EFI ATMH ++L+R++H
Sbjct: 391 SGTITLEELRQGLAKQGTRLSEYEVQQLMEAADADGNGTIDYGEFIAATMHINRLDREEH 450
Query: 459 LYKAFQHFDKDNSG 472
LY AFQHFDKDNSG
Sbjct: 451 LYSAFQHFDKDNSG 464
|
|
| TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1551 (551.0 bits), Expect = 3.2e-159, P = 3.2e-159
Identities = 298/467 (63%), Positives = 359/467 (76%)
Query: 6 TKSKDPKPRHYAHGYRSSPNTVXXXXXXXXXXXHHRPEKPGPTPAAAPVSGLKQAVPRPD 65
+KS DP P + SS N V G + + G +
Sbjct: 8 SKSSDPPP---SSSSSSSGNVVHHVKPAGERRGSSGSGTVGSSGSGT--GGSRSTTSTQQ 62
Query: 66 TNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
ILG+P E+V+ Y FG+ELGRGQFGVTYL T T +Q ACKSI R+LV K+D +D
Sbjct: 63 NGRILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIED 122
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
++RE+QIM HLSG NIV+ KGAYED+ SV+++MELC GGELFDRII+KG YSERAAA +
Sbjct: 123 VRREVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADL 182
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
CR +V VVH CH MGVMHRDLKPENFL SKDEN+ LKATDFGLSVF + G ++D+VGS
Sbjct: 183 CRQMVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGS 242
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305
AYYVAPEVL+R YG E DIWSAGVILYILLSGVPPFW E E GIFDAILQG +DF + PW
Sbjct: 243 AYYVAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPW 302
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMN 365
P +S AKDLVR+ML DPK R+T+A+VL HPWI+E GEASDKP+D+AVLSRMKQFRAMN
Sbjct: 303 PALSDGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRMKQFRAMN 362
Query: 366 KLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQ 425
KLKK+ALKVIAENLS EEI GLK+MF ++DTDN+G +T EEL+ GL +LGSK++EAE++Q
Sbjct: 363 KLKKMALKVIAENLSEEEIIGLKEMFKSLDTDNNGIVTLEELRTGLPKLGSKISEAEIRQ 422
Query: 426 LMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
LMEAAD+DG+G+IDY+EFI+ATMH +++ER+DHLY AFQ FD DNSG
Sbjct: 423 LMEAADMDGDGSIDYLEFISATMHMNRIEREDHLYTAFQFFDNDNSG 469
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1458 (518.3 bits), Expect = 4.0e-151, Sum P(2) = 4.0e-151
Identities = 267/407 (65%), Positives = 334/407 (82%)
Query: 66 TNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
T ++L + E+ K YS G++LG+GQFG T+LC E TG ++ACKSISKRKL+T D +D
Sbjct: 171 TESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKLLTDEDVED 230
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
++REIQIM HL+G PN++ KGAYED +VH+VMELC+GGELFDRII +GHY+ER AA +
Sbjct: 231 VRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAEL 290
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
R+IV V+ CH +GVMHRDLKPENFL S++E++LLK DFGLS+F + +V+ D+VGS
Sbjct: 291 ARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGS 350
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305
YYVAPEVLR+RYG E D+WSAGVI+YILLSGVPPFWAETE+GIF+ +L GD+DF S PW
Sbjct: 351 PYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPW 410
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMN 365
P+IS SAKDLVR+ML +DPK+R+T+ QVL HPW++ G A DKP+DSAVLSRMKQF AMN
Sbjct: 411 PSISESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMN 470
Query: 366 KLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQ 425
K KK+AL+VIAE+LS EEI GLKQMF ID DNSG IT+EELKAGL R+G+ L E+E+
Sbjct: 471 KFKKMALRVIAESLSEEEIAGLKQMFKMIDADNSGQITFEELKAGLKRVGANLKESEILD 530
Query: 426 LMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
LM+AADVD +GTIDY EFI AT+H +K+ER+DHL+ AF +FDKD SG
Sbjct: 531 LMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFSYFDKDESG 577
|
|
| TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 1.4e-149, P = 1.4e-149
Identities = 274/434 (63%), Positives = 341/434 (78%)
Query: 41 RPE-KPGPTPAAAPVSGLKQAVPRP-DTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
+PE KP P +K+ T ++L + E+ K YS G++LG+GQFG T+LC
Sbjct: 108 KPESKPDPPAKPKKPKHMKRVSSAGLRTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLC 167
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
E +TG++FACKSI+KRKL+T D +D++REIQIM HL+G PN++ KGAYED +VH+V
Sbjct: 168 VEKTTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLV 227
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
ME CAGGELFDRII +GHY+ER AA + R+IV VV CH +GVMHRDLKPENFL SK E
Sbjct: 228 MECCAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVMHRDLKPENFLFVSKHE 287
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
++LLK DFGLS+F + V+ D+VGS YYVAPEVLR+RYG E D+WSAGVI+YILLSGV
Sbjct: 288 DSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEADVWSAGVIVYILLSGV 347
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPFWAETE+GIF+ +L GD+DF S PWP+IS SAKDLVR+ML +DPKKR+T+ QVL HPW
Sbjct: 348 PPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKKRLTAHQVLCHPW 407
Query: 339 IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDN 398
++ G A DKP+DSAVLSRMKQF AMNK KK+AL+VIAE+LS EEI GLK+MF ID D
Sbjct: 408 VQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADK 467
Query: 399 SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDH 458
SG IT+EELKAGL R+G+ L E+E+ LM+AADVD +GTIDY EFI AT+H +K+ER+DH
Sbjct: 468 SGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDH 527
Query: 459 LYKAFQHFDKDNSG 472
L+ AF +FDKD SG
Sbjct: 528 LFAAFTYFDKDGSG 541
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P53683 | CDPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7817 | 0.9872 | 0.8742 | yes | no |
| P49101 | CDPK2_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.8068 | 0.9258 | 0.8518 | N/A | no |
| Q9ZSA2 | CDPKL_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7850 | 0.9110 | 0.8097 | no | no |
| A5A7I8 | CDPK5_SOLTU | 2, ., 7, ., 1, 1, ., 1 | 0.6055 | 0.9088 | 0.8018 | N/A | no |
| Q38868 | CDPK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7676 | 1.0 | 0.8724 | yes | no |
| P28582 | CDPK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.76 | 0.9894 | 0.8778 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 472 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-103 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-94 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-70 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-65 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-61 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-60 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-57 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-54 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-52 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-50 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-47 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-46 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-45 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-40 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-39 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-39 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-38 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-38 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-37 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-37 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-36 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-36 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-36 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-35 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-35 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-35 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-34 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-34 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-33 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-33 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-33 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-32 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-32 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-32 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-31 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-30 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-30 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-29 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-29 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-29 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-29 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-29 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-28 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-28 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-28 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-28 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-27 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-25 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-24 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-23 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-23 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-18 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 2e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-17 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 7e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-13 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 1e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 6e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| pfam13499 | 60 | pfam13499, EF_hand_5, EF-hand domain pair | 1e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| pfam13833 | 53 | pfam13833, EF_hand_6, EF-hand domain pair | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-09 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 8e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd00052 | 67 | cd00052, EH, Eps15 homology domain; found in prote | 7e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| pfam00036 | 29 | pfam00036, efhand, EF hand | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| smart00027 | 96 | smart00027, EH, Eps15 homology domain | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| smart00054 | 29 | smart00054, EFh, EF-hand, calcium binding motif | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| pfam13405 | 30 | pfam13405, EF_hand_4, EF-hand domain | 1e-04 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-04 | |
| pfam13833 | 53 | pfam13833, EF_hand_6, EF-hand domain pair | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.002 | |
| pfam00036 | 29 | pfam00036, efhand, EF hand | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-103
Identities = 110/261 (42%), Positives = 158/261 (60%), Gaps = 9/261 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y ++LG G FG YL + TG+ A K I K+K+ K D++ I REI+I++ L P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV +ED+ +++VME C GG+LFD + +G SE A R I++ + H G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YG 259
++HRDLKPEN LL DE+ +K DFGL+ ++ G+ VG+ Y+APEVL + YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 260 KEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
K +DIWS GVILY LL+G PPF + +F I + F P IS AKDL+R+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKDLIRK 233
Query: 319 MLTQDPKKRITSAQVLEHPWI 339
+L +DP+KR+T+ + L+HP+
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 4e-94
Identities = 105/265 (39%), Positives = 148/265 (55%), Gaps = 11/265 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y ++LG G FG Y TG+ A K + KR +K D+ REI+I++ LS P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSH-P 58
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV A+EDK +++VME C GG+LFD + G SE A I I+ + H G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR--RR 257
++HRDLKPEN LL +K DFGL+ ++ VG+ +Y+APEVL
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWPTISSSAKD 314
YG ++D+WS GVILY LL+G PPF E + IL ++F+ W + S AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
L+++ L +DP KR T+ ++L+HPW
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 1e-70
Identities = 93/257 (36%), Positives = 148/257 (57%), Gaps = 13/257 (5%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG L + TG+ +A K + K+K++ + + + E I+ ++ P IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
A++ ++ +++V+E GGELF + +G +SE A IV + H +G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 207 KPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
KPEN LL D + +K TDFGL+ EG G+ Y+APEVL + YGK +D
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
WS GV+LY +L+G PPF+AE K I++ IL+ + F P +S A+DL+ +L +DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQKDP 232
Query: 325 KKRITSA---QVLEHPW 338
KR+ S ++ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 2e-65
Identities = 91/255 (35%), Positives = 131/255 (51%), Gaps = 44/255 (17%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G FG YL + TG++ A K I K + + +++ REI+I++ L+ PNIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNH-PNIVKLY 57
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRD 205
G +ED+ +++VME C GG L D + G SE I I+ + H G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRRR--YGKEI 262
LKPEN LL S + L DFGLS + K + + IVG+ Y+APEVL + Y ++
Sbjct: 118 LKPENILLDSDNGKVKL--ADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
DIWS GVILY L KDL+R+ML +
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 323 DPKKRITSAQVLEHP 337
DP+KR ++ ++LEH
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 1e-61
Identities = 90/268 (33%), Positives = 139/268 (51%), Gaps = 19/268 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+ +G +G +L + STG +A K I K ++ KN D + E I+ P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLY 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
+++ K+++++VME GG+L + G E A IV + H G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVY---------RDIVGSAYYVAPEVLRRR 257
KP+N L+ D N LK TDFGLS + + IVG+ Y+APEV+ +
Sbjct: 120 KPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+ K +D WS G ILY L G+PPF ET + IF IL G I++ +S A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 317 RRMLTQDPKKRITSA---QVLEHPWIKE 341
++L DP+KR+ + ++ HP+ K
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 2e-60
Identities = 80/262 (30%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K++G+G FG YL S G+ + K I + ++ +++D E++I++ L+ PNI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIK 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRI----IAKGHYSERAAASICRSIVNVVHICHFMG 200
+ ++E+K + +VME GG+L +I + E + + H
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++HRD+KP+N L+S L+K DFG+S V + + +VG+ YY++PE+ + + Y
Sbjct: 124 ILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI-SSSAKDLVR 317
+ DIWS G +LY L + PF E + IL+G P P+ SS ++LV
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP----PIPSQYSSELRNLVS 236
Query: 318 RMLTQDPKKRITSAQVLEHPWI 339
+L +DP++R + AQ+L+ P+I
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 5e-59
Identities = 86/284 (30%), Positives = 138/284 (48%), Gaps = 33/284 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ FGK +G G F L E T +++A K + KR+L+ + +K E +++ L+G P
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
I++ ++D+++++ V+E GEL I G E+ I+ + H G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFG-------LSVFIEEGKVYRDI----------- 242
++HRDLKPEN LL D++ +K TDFG S +I
Sbjct: 123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 243 ---VGSAYYVAPEVLRRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298
VG+A YV+PE+L + GK D+W+ G I+Y +L+G PPF E F IL+ +
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLEHPW 338
F P AKDL+ ++L DP+ R+ ++ HP+
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 7e-57
Identities = 83/264 (31%), Positives = 135/264 (51%), Gaps = 16/264 (6%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
G+ LGRG FG YL + TG A KS+ + + ++REI+I+ L PNIV
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQ-HPNIV 62
Query: 144 EFKGAYEDKQSVH--VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHICHFMG 200
+ G+ D++ + +E +GG L + G E R I+ + ++ H G
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL-HSNG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR- 256
++HRD+K N L+ S +K DFG + + + + + G+ Y++APEV+R
Sbjct: 122 IVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKDL 315
YG+ DIWS G + + +G PP W+E A+ + E P +S AKD
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP-WSELGNP-MAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 316 VRRMLTQDPKKRITSAQVLEHPWI 339
+R+ L +DPKKR T+ ++L+HP++
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 4e-54
Identities = 87/267 (32%), Positives = 142/267 (53%), Gaps = 16/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ F K LG G FG L +G+ +A K +SK K+V + + E +I+Q + P
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V G+++D ++++VME GGELF + G + E A +V + H +
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YG 259
+++RDLKPEN LL D + +K TDFG + ++ Y + G+ Y+APE++ + YG
Sbjct: 122 IVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-TY-TLCGTPEYLAPEIILSKGYG 176
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
K +D W+ G+++Y +L+G PPF+ + I++ IL+G + F S S AKDL+R +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNL 232
Query: 320 LTQDPKKRI-----TSAQVLEHPWIKE 341
L D KR+ + HPW
Sbjct: 233 LQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 88/261 (33%), Positives = 144/261 (55%), Gaps = 16/261 (6%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G FG L S R FA K + KR +V ++ I E +I++ + P IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++DK+ ++++ME C GGEL+ + +G + E A +V H G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIW 265
KPEN LL D N +K DFG + ++ G+ G+ YVAPE+ L + Y +D W
Sbjct: 120 KPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 266 SAGVILYILLSGVPPFWAETEK--GIFDAILQGDIDFESAPWPT-ISSSAKDLVRRMLTQ 322
S G++LY LL+G PPF + E I++ IL+G+ E +P I +AKDL++++L +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRR 233
Query: 323 DPKKRITSAQ-----VLEHPW 338
+P++R+ + + + +H W
Sbjct: 234 NPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 6e-52
Identities = 87/263 (33%), Positives = 139/263 (52%), Gaps = 14/263 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +++G+G FG Y TG++ A K I KL +K K+ I EIQI++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-H 56
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHF 198
PNIV++ G+Y K + +VME C+GG L D + + +E A +C+ ++ + H
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-R 257
G++HRD+K N LL+S E +K DFGLS + + K +VG+ Y++APEV+
Sbjct: 117 NGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFESAPWPTISS-SAKDL 315
Y + DIWS G+ L G PP+ +E A+ P S KD
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230
Query: 316 VRRMLTQDPKKRITSAQVLEHPW 338
+++ L ++P+KR T+ Q+L+HP+
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 89/260 (34%), Positives = 129/260 (49%), Gaps = 10/260 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K + +G FG YL + STG FA K + K ++ KN ++K E IM P + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ K +++VME GG+ I G E A +V V H G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYG-KEID 263
D+KPEN L+ D+ LK TDFGLS G + VG+ Y+APE + K D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
WS G +++ L G PPF AET +FD IL I++ S A DL+ R+L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 324 PKKRITS---AQVLEHPWIK 340
P KR+ + ++ HP+ K
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 4e-50
Identities = 91/298 (30%), Positives = 139/298 (46%), Gaps = 28/298 (9%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y ++LG G FG YL + + A K ++K+ + + REIQI+ L+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRI---IAKGHYSERAAASICRSIVNVVHIC 196
PNIV+ ++D+ S+++VME GG L D + KG SE A I I++ +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-------YRDIVGSAYYV 249
H G++HRD+KPEN LL +K DFGL+ + + VG+ Y+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRV--VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 250 APEVLR----RRYGKEIDIWSAGVILYILLSGVPPF----WAETEKGIFDAILQGDIDFE 301
APEVL DIWS G+ LY LL+G+PPF + IL+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 302 SAPW-----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
++P IS +A DL++++L +DPK R++S+ L H + D
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-48
Identities = 89/286 (31%), Positives = 145/286 (50%), Gaps = 30/286 (10%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
D + Y +++G G G Y T+ +TG++ A K + + K +K+ I EI IM
Sbjct: 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIM 69
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNV 192
+ PNIV++ +Y + VVME GG L D I +E A +CR ++
Sbjct: 70 KDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAP 251
+ H V+HRD+K +N LLS +K DFG + + + K R+ +VG+ Y++AP
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 252 EVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFE 301
EV++R YG ++DIWS G++ + G PP+ E T KGI L+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LK-----N 238
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347
W S KD + + L +DP+KR ++ ++L+HP++K+ +
Sbjct: 239 PEKW---SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 86/266 (32%), Positives = 129/266 (48%), Gaps = 18/266 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+Y G +GRG FGV Y TG A K IS K+ + I +EI ++++L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNIV++ G+ E S+++++E G L I G + E A ++ + H
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDIVGSAYYVAPEVLRRRY 258
GV+HRD+K N L +KD K DFG++ + K +VG+ Y++APEV+
Sbjct: 119 GVIHRDIKAANILT-TKDGVV--KLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE--- 172
Query: 259 GKEI----DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAK 313
DIWS G + LL+G PP++ I+Q D P P IS K
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD----HPPLPEGISPELK 228
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWI 339
D + + +DP R T+ Q+L+HPWI
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 9e-46
Identities = 82/268 (30%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSI------SKRKLVTKNDKDDIKREIQIMQHLSG 138
K LG+G GV Y TG+ +A K I RK + RE++ +
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--------LLRELKTL-RSCE 57
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH- 197
P +V+ GA+ + + +V+E GG L D + G E A I R I+ + H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR- 255
++HRD+KP N L++SK E +K DFG+S +E + VG+ Y++PE ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP--TISSSAK 313
Y DIWS G+ L G PF + F+ ++Q D P S +
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-LMQAICDGPPPSLPAEEFSPEFR 233
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341
D + L +DPKKR ++A++L+HP+IK+
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 76/263 (28%), Positives = 132/263 (50%), Gaps = 8/263 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
H+ + +G+G FG + + T + FA K ++K+K V K ++ E +I+Q L+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-H 59
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P +V +++D++++++V++L GG+L + K +SE IV + H
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
G++HRD+KP+N LL DE + TDF ++ + + G+ Y+APEVL R+ Y
Sbjct: 120 GIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+D WS GV Y L G P+ + D I + T S+ A D + +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPATWSTEAIDAINK 235
Query: 319 MLTQDPKKRI--TSAQVLEHPWI 339
+L +DP+KR+ + HP+
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 51/296 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y ++LG G +GV Y + TG A K I +L N+++ I REI +++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RL--DNEEEGIPSTALREISLLKEL 55
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAK--GHYSERAAASICRSIVNV 192
PNIV+ ++ +++V E C D + + K G S SI ++
Sbjct: 56 K-HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAP 251
+ CH ++HRDLKP+N L++ +LK DFGL+ F + Y V + +Y AP
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDG---VLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAIL----------- 294
E+L + Y +DIWS G I +++G P F ++E IF IL
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGV 226
Query: 295 ----QGDIDF---ESAPW----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
F P + DL+ +ML +P KRI++ + L+HP+
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 89/292 (30%), Positives = 146/292 (50%), Gaps = 37/292 (12%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K +GRG FG +L + TG+ +A K + K ++ +N ++ E I+ + P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
IV+ +++D++ +++VME GG+L + +I K + E A +V + H +G
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK----------------------- 237
+HRD+KP+N L+ D + +K DFGL + + K
Sbjct: 122 FIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 238 ------VYRD-IVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
V + VG+ Y+APEVLR YG E D WS GVILY +L G PPF+++T +
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSA-QVLEHPWIK 340
++ I+ P P +S A DL+ R+L DP+ R+ S ++ HP+ K
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 81/289 (28%), Positives = 127/289 (43%), Gaps = 37/289 (12%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +G G G+ + + TG A K ++ R+L + REI+ +Q P
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFM 199
+V+ + +VME L + + + E S R ++ V H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSV--FIEEGKVYRDIVGSAYYVAPEVL--R 255
G+MHRDLKP N L+S+ +LK DFGL+ EE ++Y V + +Y APE+L
Sbjct: 119 GIMHRDLKPANLLISADG---VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI---------------LQG 296
R+Y +D+W+ G I LL+G P F E + +F +
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 297 DIDFESA---PW----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
I F + P P S A DL++ +L DP KR+++A+ L HP+
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y GK+LG G + V Y + TGR A K I + K KD I REI+++Q L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGER--KEAKDGINFTALREIKLLQEL 59
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG---GELFDRII--AKGHYSERAAASICRSIVN 191
PNI+ + K ++++V E + D+ I S +
Sbjct: 60 K-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK-----SYMLMTLR 113
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVA 250
+ H ++HRDLKP N L++S LK DFGL+ F + V + +Y A
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRA 170
Query: 251 PEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI----------- 293
PE+L R YG +D+WS G I LL VP +++ IF+A+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230
Query: 294 --LQGDIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
L ++F+ P +P S A DL++R+LT +P KRIT+ Q LEHP+
Sbjct: 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 85/271 (31%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 78 KLH-YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
KL + G+ LG G FG + TG +A K + KR+++ + +E I+ L
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
S P IV +++D+ V+ ++E GGELF + G + A +V
Sbjct: 76 S-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR 256
H +++RDLKPEN LL +K +K TDFG + + + + + + G+ Y+APEV++
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPD-RTF-TLCGTPEYLAPEVIQS 189
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ +GK +D W+ GV+LY ++G PPF+ +T I++ IL G + F + W A+DL
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245
Query: 316 VRRMLTQDPKKRITS-----AQVLEHPWIKE 341
V+ +L D KR+ + A V HP+
Sbjct: 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276
|
Length = 329 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y + +G+G FG S G+ K I + K +K + E+ I++ L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELK-H 58
Query: 140 PNIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNV 192
PNIV + D+ Q++++VME C GG+L ++I K + E I ++
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 193 VHICHF-----MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG----KVYRDIV 243
++ CH V+HRDLKP N L D N +K DFGL+ + K Y V
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTY---V 171
Query: 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302
G+ YY++PE L Y ++ DIWS G ++Y L + PPF A + + I +G
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--- 228
Query: 303 APWPTISSSA-KDLVRRMLTQDPKKRITSAQVLEHPWI 339
P SS ++++ ML DP KR ++ ++L+ P I
Sbjct: 229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 88/273 (32%), Positives = 144/273 (52%), Gaps = 29/273 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM---QHLSGQPN 141
++G G G+ + T+ STGRQ A K + RK + ++ + E+ IM QH PN
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQH----PN 77
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IVE +Y + VVME GG L D I+ +E A++C +++ + H GV
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRRR-YG 259
+HRD+K ++ LL+S + +K +DFG + +E + +VG+ Y++APEV+ R YG
Sbjct: 137 IHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT------ISSSAK 313
E+DIWS G+++ ++ G PP++ E LQ P +S +
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPKLKNLHKVSPRLR 246
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
+ RML +DP +R T+A++L HP++ + G S
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 76/266 (28%), Positives = 136/266 (51%), Gaps = 24/266 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G FG +L + + +A K ++ +++ + + E ++++ +S P I+
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIR 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
D++ ++++ME GGELF + G +S IV + H +++R
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLRRR-YG 259
DLKPEN LL D+ +K TDFG + K RD + G+ Y+APEV++ + +
Sbjct: 126 DLKPENILL---DKEGHIKLTDFGFA------KKLRDRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
K +D W+ G+++Y +L G PPF+ + GI++ IL G ++F + AKDL++++
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKL 232
Query: 320 LTQDPKKRI-----TSAQVLEHPWIK 340
L D +R+ + V H W K
Sbjct: 233 LVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 83/286 (29%), Positives = 126/286 (44%), Gaps = 38/286 (13%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
++G G +GV Y + TG A K I K + ++ REI++++ L+ PNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELN-HPNIIK 62
Query: 145 FKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
+ K +++V E +L + E S ++ + CH G++
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRRYG 259
HRDLKPEN L+ + +LK DFGL+ F + Y V + +Y APE+L + Y
Sbjct: 121 HRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--GDI------------------- 298
+DIWS G I LLS P F ++E I + G
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 299 -DFESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
P P + S A DL+ +ML DP KRIT+ Q L HP+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 90/294 (30%), Positives = 131/294 (44%), Gaps = 48/294 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K+LG G FG YL TG A K + K+K + + ++ RE++ ++ L+ P
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNL-REVKSLRKLNEHP 58
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHF 198
NIV+ K + + ++ V E G L+ + +SE SI I+ + H
Sbjct: 59 NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G HRDLKPEN L+S + ++K DFGL+ I Y D V + +Y APE+L R
Sbjct: 118 HGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 258 -YGKEIDIWSAGVILYILLSGVPPF-----------------------WAETEKGIFDAI 293
Y +DIW+ G I+ L + P F W E K
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK------ 228
Query: 294 LQGDIDF---------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
L + F P S A DL++ ML DPKKR T++Q L+HP+
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
G ++G G FG Y TG A K I + K K+ I E+++++ L PN+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLK-HPNLV 62
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
++ G ++ V++ ME C+GG L + + E ++ + H G++H
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEE-----GKVYRDIVGSAYYVAPEVLRRR- 257
RD+KP N L D N ++K DFG +V ++ G+ + + G+ Y+APEV+
Sbjct: 123 RDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 258 ---YGKEIDIWSAGVILYILLSGVPPFWAE--TEKGIFDAILQGDIDFESAPWPT---IS 309
+G+ DIWS G ++ + +G P W+E E I + G P P +S
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAG----HKPPIPDSLQLS 234
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
KD + R L DPKKR T++++L+HP++
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 95/326 (29%), Positives = 141/326 (43%), Gaps = 78/326 (23%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD--DIKREIQIMQHLS 137
Y K +G G +GV + TGR+ A K IS V + D I REI++++HL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHL- 56
Query: 138 GQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
NI+ + ED V++V EL +L ++I S + +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVI----KSPQP--------LTD 102
Query: 193 VHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
HI +F+ V+HRDLKP N L+ + N LK DFGL+ ++ +
Sbjct: 103 DHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDE 159
Query: 240 RDI----VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGI 289
+ V + +Y APE+L RY K IDIWS G I LL+ P F I
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219
Query: 290 FDAILQG-----DIDFES----------------APW----PTISSSAKDLVRRMLTQDP 324
+ + G D+ F + P P S A DL+ +ML DP
Sbjct: 220 VEVL--GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277
Query: 325 KKRITSAQVLEHPWIKEGGEASDKPI 350
KKRIT+ + L HP++ + + D+P+
Sbjct: 278 KKRITADEALAHPYLAQLHDPEDEPV 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 78/269 (28%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQP 140
+ LG G +G +L + G+ +A K + K +V K + + E Q+++ + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V A++ +H++++ GGELF + + H++E IV + H +G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLRRR- 257
+++RD+K EN LL D + TDFGLS + R G+ Y+APEV+R
Sbjct: 126 IIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 258 --YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-TISSSAKD 314
+ K +D WS GV+ + LL+G PF + E+ I + I P+P T+S+ A+D
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-RILKSKPPFPKTMSAEARD 241
Query: 315 LVRRMLTQDPKKRI---TSAQVLEHPWIK 340
++++L +DPKKR+ + ++ HP+ +
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 4e-38
Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G +G Y TG+ A K + + D +I +EI I++ P IV++
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CDSPYIVKYY 64
Query: 147 GAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
G+Y + +VME C G + D +I K +E A+I + + H +HR
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRR-RYGKEI 262
D+K N LL +E K DFG+S + + R+ ++G+ +++APEV++ Y +
Sbjct: 124 DIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 263 DIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISSSAK------D 314
DIWS G+ + G PP+ ++ + IF I P PT+S K D
Sbjct: 181 DIWSLGITAIEMAEGKPPY-SDIHPMRAIF-MIPN-------KPPPTLSDPEKWSPEFND 231
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
V++ L +DP++R ++ Q+L+HP+I
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 86/298 (28%), Positives = 129/298 (43%), Gaps = 58/298 (19%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDI----KREIQIMQHLSGQP 140
++G G +G Y TG A K K+ +N+K+ REI+++Q L P
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLR-HP 58
Query: 141 NIVEFKGAYEDKQ--SVHVVMELC----AGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV K K S+++V E G L D + ++E + ++ +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQ 114
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI--EEGKVYRDIVGSAYYVAPE 252
H G++HRD+K N L+++ LK DFGL+ Y + V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 253 VL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--GDIDFESAPWPT- 307
+L RYG E+D+WS G IL L G P F TE + I + G E+ WP
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN--WPGV 229
Query: 308 --------------------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
I SA DL+ ++LT DPKKRI++ Q L+H +
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-38
Identities = 93/268 (34%), Positives = 146/268 (54%), Gaps = 21/268 (7%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTKNDKDD--IKREIQIMQHLSGQ 139
K LG+G +G + T TG+ FA K + K +V +N KD K E I++ +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVK-H 59
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P IV+ A++ +++++E +GGELF + +G + E A I + H
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLKPEN LL D +K TDFGL I EG V G+ Y+APE+L R
Sbjct: 120 GIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
+GK +D WS G ++Y +L+G PPF AE K D IL+G + + P P ++ A+DL++
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLP-PYLTPEARDLLK 232
Query: 318 RMLTQDPKKRITS-----AQVLEHPWIK 340
++L ++P R+ + A+V HP+ +
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 81/266 (30%), Positives = 126/266 (47%), Gaps = 21/266 (7%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G+G +G +L + TG A K + K L N+ + E I+ + +V+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
A++D + +++ ME GG+ + G SE A + V H +G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 206 LKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEID 263
LKPENFL+ + +K TDFGLS + +VGS Y+APEVLR + Y +D
Sbjct: 127 LKPENFLIDASGH---IKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLRGKGYDFTVD 180
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-------TISSSAKDLV 316
WS G +LY L G PPF T ++ + E+ P +S A DL+
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK---ETLQRPVYDDPRFNLSDEAWDLI 237
Query: 317 RRMLTQDPKKRITS-AQVLEHPWIKE 341
+++ DP +R S + HP+ KE
Sbjct: 238 TKLIN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 85/281 (30%), Positives = 140/281 (49%), Gaps = 33/281 (11%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K + G +G YL T ++FA K I+K+ L+ +N + E I+ + P +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVS 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++E K+ + +VME GG+ + G A V + H G++HR
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLS--------VFIEEGKVYRD--------IVGSAYY 248
DLKP+N L++S +K TDFGLS + EG + +D + G+ Y
Sbjct: 126 DLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 249 VAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP- 306
+APEV LR+ YGK +D W+ G+ILY L G PF+ +T + +F ++ DI+ WP
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPE 237
Query: 307 ---TISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKE 341
+ + A+DL+ R+L Q+P +R+ + +V +H +
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 97/343 (28%), Positives = 167/343 (48%), Gaps = 35/343 (10%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDI--KREIQIMQHLSGQPNIVE 144
+G+G FG Y + T R +A K +SK+++V K + +R I + L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RAAASICRSIVNVVHICHFMGVMH 203
K +++ +++V + +GGELF + +G +SE RA I ++ + H+ H +++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL-HKYDIVY 119
Query: 204 RDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRRYGK 260
RDLKPEN LL D + DFGLS + + K G+ Y+APEVL + Y K
Sbjct: 120 RDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320
+D WS GV+++ + G PF+AE + ++ I G + F P +S + V+ +L
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGLL 233
Query: 321 TQDPKKRITS----AQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIA 376
++P+ R+ + ++ EHP+ + ID +LS+ K K I
Sbjct: 234 NRNPQHRLGAHRDAVELKEHPFFAD--------IDWDLLSK--------KQITPPFKPIV 277
Query: 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT 419
+ S E++ FTN N+G + +E++ + L+
Sbjct: 278 D--SDEDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANSTPLS 318
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 83/270 (30%), Positives = 139/270 (51%), Gaps = 27/270 (10%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPN 141
GK LG+G FG YLC + TGR+ A K + TK + + ++ EIQ++++L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HER 65
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IV++ G D +++ + ME GG + D++ A G +E R I+ V H +
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVAPEVLR-R 256
+HRD+K N L +D +K DFG S ++ G + + G+ Y+++PEV+
Sbjct: 126 VHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-------IS 309
YG++ D+WS G + +L+ PP WAE E AI F+ A PT +S
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP-WAEFEA--MAAI------FKIATQPTNPQLPSHVS 233
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
A++ +RR ++ KKR ++ ++L H ++
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TG+ +A K + K ++ K++ E +++Q+ + P +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K +++ + VME GGELF + + +SE A IV+ + H V++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEI 262
DLK EN +L D++ +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 323 DPKKRITSAQ-----VLEHPW 338
DPK+R+ ++EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-36
Identities = 80/269 (29%), Positives = 143/269 (53%), Gaps = 16/269 (5%)
Query: 85 KELGRGQFGVTYL---CTENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQP 140
K LG G +G +L T + TG+ +A K + K LV K + + E +++H+ P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V A++ + +H++++ +GGE+F + + ++SE I+ + H +G
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
+++RD+K EN LL S+ L TDFGLS EE + G+ Y+APE++R +
Sbjct: 126 IVYRDIKLENILLDSEGHVVL---TDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+GK +D WS G++++ LL+G PF E E+ + + + + I A+DL+
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLL 242
Query: 317 RRMLTQDPKKRITSA-----QVLEHPWIK 340
++L +DPKKR+ + ++ EHP+ K
Sbjct: 243 HKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 24/275 (8%)
Query: 80 HYSFGKELGRGQFGVTY--LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
Y + +G G V Y +C N + A K I K T D++++E+Q M
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQT--SVDELRKEVQAMS-QC 56
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFD---RIIAKGHYSERAAASICRSIVNVVH 194
PN+V++ ++ + +VM +GG L D +G E A++ + ++ +
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-----KVYRDIVGSAYYV 249
H G +HRD+K N LL E+ +K DFG+S + +G KV + VG+ ++
Sbjct: 117 YLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 250 APEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---IDFESAP 304
APEV+ Y + DIWS G+ L +G P+ + LQ D ++ A
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE-TGAD 232
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+ S S + ++ L +DP KR T+ ++L+H +
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 25/268 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
ELG G GV TG+ A K+I R + + + I RE+ I+ P IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHK-CNSPYIVG 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII--AKGHYSERAAASICRSIVN-VVHICHFMGV 201
F GA+ + + + ME GG L D+I+ +G ER I +++ + ++ +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI----VGSAYYVAPEVLR-R 256
+HRD+KP N L++S+ + +K DFG+S G++ + VG++ Y+APE ++
Sbjct: 123 IHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 257 RYGKEIDIWSAGVILYILLSG-VP-PFWAETEKGIFDAILQGDIDFESAPWPT--ISSSA 312
Y + DIWS G+ L L +G P P + GIF+ +LQ ++ P+ S
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEPPPRLPSGKFSPDF 233
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D V L +DP++R + ++LEHP+IK
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 82/248 (33%), Positives = 130/248 (52%), Gaps = 12/248 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K +GRG FG L S+ + +A K +SK +++ ++D E IM H +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSE 103
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
IV+ A++D + +++VME GG+L + +++ E+ A +V + H MG
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDI-VGSAYYVAPEVLRRR- 257
+HRD+KP+N LL D++ LK DFG + ++ G V D VG+ Y++PEVL+ +
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 258 ----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279
Query: 314 DLVRRMLT 321
DL+ LT
Sbjct: 280 DLICAFLT 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 81/266 (30%), Positives = 149/266 (56%), Gaps = 23/266 (8%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G G G+ + E +GRQ A K + RK + ++ + E+ IM+ Q N+VE
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQ-NVVEM 83
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
+Y + + V+ME GG L D I+++ +E A++C S++ + H GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVLRRR-YGKEID 263
+K ++ LL+ + +K +DFG I + R +VG+ Y++APEV+ R YG E+D
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK------DLVR 317
IWS G+++ ++ G PP+++++ +Q +P P + ++ K D +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGG 343
RMLT++P++R T+ ++L+HP++ + G
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTG 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 49/296 (16%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLSGQPN 141
K LG+G G +L TG+ FA K + K K + K +K +KR E +I+ L P
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDK-KEMIKRNK--VKRVLTEQEILATLD-HPF 62
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM 199
+ +++ + + +VM+ C GGELF + SE A ++ + H +
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS----------------------------- 230
G+++RDLKPEN LL E+ + +DF LS
Sbjct: 123 GIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 231 VFIEE-GKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKG 288
F EE VG+ Y+APEV+ +G +D W+ G++LY +L G PF
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLEHPWIK 340
F IL+ ++ F P +SSSA+DL+R++L +DP KR+ S A++ +HP+ +
Sbjct: 240 TFSNILKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 86/276 (31%), Positives = 147/276 (53%), Gaps = 27/276 (9%)
Query: 85 KELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKR-EIQIMQHLSGQP 140
K LG G +G +L + S +G+ +A K + K +V K + R E Q+++H+ P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V A++ +H++++ GGELF + + + E+ IV + H +G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG 125
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLR--- 255
+++RD+K EN LL D N + TDFGLS E +V R G+ Y+AP+++R
Sbjct: 126 IIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDFESAPWPT-ISS 310
+ K +D WS GV++Y LL+G PF + EK I IL+ + P+P +S+
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-----PPYPQEMSA 237
Query: 311 SAKDLVRRMLTQDPKKRITSA-----QVLEHPWIKE 341
AKD+++R+L +DPKKR+ ++ +HP+ ++
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 15/266 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+ +G+G FG Y + T + A K I + +++ +DI++EIQ + P I +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITK 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+ G++ + ++ME C GG D ++ G E A I R ++ + H G +HR
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRR-RYGKEI 262
D+K N LLS E +K DFG+S + R+ VG+ +++APEV+++ Y ++
Sbjct: 123 DIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 263 DIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320
DIWS G+ L G PP ++ + +F I + + S S KD V L
Sbjct: 180 DIWSLGITAIELAKGEPPL-SDLHPMRVLF-LIPKNNPP--SLEGNKFSKPFKDFVSLCL 235
Query: 321 TQDPKKRITSAQVLEHPWIKEGGEAS 346
+DPK+R ++ ++L+H +IK+ + S
Sbjct: 236 NKDPKERPSAKELLKHKFIKKAKKTS 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 82/268 (30%), Positives = 144/268 (53%), Gaps = 13/268 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G Y + +TG++ A K ++ L + K+ I EI +M+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 NK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL 254
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 255 -RRRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIF 245
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D + R L D +KR ++ ++L+HP++K
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 84/296 (28%), Positives = 131/296 (44%), Gaps = 49/296 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +G G +GV C +TG A K K D +D+K RE+++++ L
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQL 57
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV K A+ K +++V E EL + + G A S ++ +
Sbjct: 58 R-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPE 252
CH ++HRD+KPEN L+S E+ +LK DFG + + D V + +Y APE
Sbjct: 115 YCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 253 VL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE--------KGIFDAILQGDIDFES 302
+L YGK +D+W+ G I+ LL G P F +++ K + F S
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231
Query: 303 AP------WPTI--------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
P +P SS A D ++ L DPK+R+T ++L+HP+
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 12/261 (4%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACK--SISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
G+ LG G FG Y G FA K S++ + +++EI ++ L PN
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IV++ G ++ ++++ +EL GG L + G + E R I+ + H
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YG 259
+HRD+K N L+ D N ++K DFG++ + E + GS Y++APEV+ ++ YG
Sbjct: 124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-TISSSAKDLVRR 318
DIWS G + + +G PP W++ E A+ + E P P +S AKD + +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 319 MLTQDPKKRITSAQVLEHPWI 339
L +DP R T+A++LEHP++
Sbjct: 238 CLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 9e-34
Identities = 84/266 (31%), Positives = 139/266 (52%), Gaps = 20/266 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K+++ + + E QI++ ++ Q +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLA 66
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGH---YSERA---AASICRSIVNVVHICHFMG 200
AYE K ++ +V+ + GG+L I G+ ERA AA I + ++ H
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL----HREN 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYG 259
++RDLKPEN LL D+ ++ +D GL+V I EG+ R VG+ Y+APEVL +RY
Sbjct: 123 TVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
D W G ++Y ++ G PF EK + + + ++ E S AK + + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239
Query: 320 LTQDPKKRI-----TSAQVLEHPWIK 340
LT+DPK+R+ + +V HP+ +
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 84/259 (32%), Positives = 139/259 (53%), Gaps = 15/259 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TGR +A K + K ++ K++ E +++Q+ + P +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K A++ + VME GGELF + + ++E A IV+ + H V++R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEI 262
D+K EN +L D++ +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 323 DPKKRI-----TSAQVLEH 336
DPK+R+ + +V+EH
Sbjct: 233 DPKQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 89/291 (30%), Positives = 151/291 (51%), Gaps = 14/291 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G + + +TG++ A K I+ +K + K+ I EI +M+
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKE 72
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
L PNIV F ++ + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL 254
H V+HRD+K +N LL +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSPIF 245
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD-KPIDSAVLSRMKQFR 362
+D + R L D +KR ++ ++L+HP++K S P+ A MK R
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMKSNR 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 83/279 (29%), Positives = 149/279 (53%), Gaps = 17/279 (6%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G G G+ + TE TG+Q A K + RK + ++ + E+ IM+ N+V+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDM 84
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
+Y + VVME GG L D I+ +E A++C S++ + H GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRR-RYGKEID 263
+K ++ LL+S + +K +DFG + +E + +VG+ Y++APEV+ R YG E+D
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
IWS G+++ ++ G PP++ E I + ++ +SS + + ML ++
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 324 PKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
P +R T+ ++L+HP++K G S ++ M+Q+R
Sbjct: 260 PSQRATAQELLQHPFLKLAGPP------SCIVPLMRQYR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 81/279 (29%), Positives = 151/279 (54%), Gaps = 17/279 (6%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G G G+ + T S+G+ A K + RK + ++ + E+ IM+ + N+VE
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 82
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
+Y + VVME GG L D I+ +E A++C +++ + + H GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRR-RYGKEID 263
+K ++ LL+ + +K +DFG + +E + +VG+ Y++APE++ R YG E+D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
IWS G+++ ++ G PP++ E I + ++ + +S S K + R+L +D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 324 PKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
P +R T+A++L+HP++ + G S ++ M+Q R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPP------SCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 82/272 (30%), Positives = 139/272 (51%), Gaps = 21/272 (7%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCT-ENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
YED ++F + LG G FG L T +N A K K K++ + D + E +I
Sbjct: 29 YED----FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI 84
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
+ +++ P V G+++D+ +++V+E GGE F + + IV +
Sbjct: 85 LNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
+ +++RDLKPEN LL D++ +K TDFG + ++ + Y + G+ Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT-RTY-TLCGTPEYIAPE 198
Query: 253 VLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
+L +GK D W+ G+ +Y +L G PPF+A I+ IL+G I F + ++
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNN 254
Query: 312 AKDLVRRMLTQDPKKRITSAQ-----VLEHPW 338
K L++++L+ D KR + + V EHPW
Sbjct: 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 22/268 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L T +A K + K ++ +D + E +++ P + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K + VME GG+L I G + E A IV + H G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLR-RRYG 259
DLK +N LL D +K DFG+ +EG + G+ Y+APE+L + YG
Sbjct: 121 DLKLDNVLL---DSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKDLVRR 318
+D W+ GV+LY +L+G PF + E +F +IL+ ++ + P +S AK +++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILKS 229
Query: 319 MLTQDPKKRITS-----AQVLEHPWIKE 341
LT++P+KR+ + HP+ +E
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 82/272 (30%), Positives = 133/272 (48%), Gaps = 24/272 (8%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ Y + +G G +G Y + +TG A K I KL +D + I++EI +++
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHIC 196
PNIV + G+Y + + +VME C GG L D + +G SE A +CR + +
Sbjct: 59 -HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL- 254
H G +HRD+K N LL+ + +K DFG+S + R +G+ Y++APEV
Sbjct: 118 HETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 255 ---RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
+ Y + DIW+ G+ L PP + + A+ I + P P +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFL--ISKSNFPPPKLKDK 229
Query: 312 AK------DLVRRMLTQDPKKRITSAQVLEHP 337
K D +++ LT+DPKKR T+ ++L+HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 75/259 (28%), Positives = 130/259 (50%), Gaps = 16/259 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K+LG+G +G Y S + +A K + + ++ +++D EI+I+ ++ PNI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIIS 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-----YSERAAASICRSIVNVVHICHFM 199
+K A+ D + +VME G+L + I+K E+ I ++ + H
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++HRDLK N LL + N L+K D G+S +++ I G+ +Y+APEV + R Y
Sbjct: 123 KILHRDLKSANILLVA---NDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ DIWS G +LY + + PPF A + + + + +G + P P S ++ +R
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIP-PIYSQDLQNFIRS 235
Query: 319 MLTQDPKKRITSAQVLEHP 337
ML PK R ++L P
Sbjct: 236 MLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 84/247 (34%), Positives = 134/247 (54%), Gaps = 11/247 (4%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TGR +A K + K +V K++ E +++Q+ S P +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMH 203
K +++ + VME GGELF + + +SE A IV+ + H V++
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 204 RDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKE 261
RDLK EN +L D++ +K TDFGL I++G + G+ Y+APEVL YG+
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321
+D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+ +L
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232
Query: 322 QDPKKRI 328
+DPK+R+
Sbjct: 233 KDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 45/286 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + +G G +G Y TG+ A K + + ++++++IK E I++ S P
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNHP 63
Query: 141 NIVEFKGAYEDKQSVH--------VVMELCAGG---ELFDRIIAKGH-YSERAAASICRS 188
NI F GA+ + +VMELC GG +L + KG E A I R
Sbjct: 64 NIATFYGAF--IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAY 247
+ + H V+HRD+K +N LL+ +NA +K DFG+S ++ R+ +G+ Y
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 248 YVAPEV------LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDID 299
++APEV Y D+WS G+ L G PP + + +F I +
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALF-KIPRN--- 233
Query: 300 FESAPWPTISSSAK------DLVRRMLTQDPKKRITSAQVLEHPWI 339
P PT+ S D + L ++ ++R ++LEHP+I
Sbjct: 234 ----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 78/246 (31%), Positives = 132/246 (53%), Gaps = 10/246 (4%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E ++G+ +A K + K ++ K++ E +++++ + P +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K +++ K + VME GGELF + + +SE IV+ + H +++R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLK EN +L D++ +K TDFGL I + + G+ Y+APEVL YG+ +
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL DI F T+S+ AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232
Query: 323 DPKKRI 328
DP KR+
Sbjct: 233 DPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 79/262 (30%), Positives = 138/262 (52%), Gaps = 19/262 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK-DDIKREIQIMQHL--SGQPNIV 143
+GRG +G Y TGR A K I+ L T +D DI+RE+ ++ L S PNI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVM 202
++ G+Y + ++ME GG + R + K G +E+ + I R ++ + H +GV+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR--RRYG 259
HRD+K N L+++ +K DFG++ + + R VG+ Y++APEV+ + Y
Sbjct: 124 HRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFESAPWPTISSSAKDLVRR 318
+ DIWS G+ +Y + +G PP+ ++ + F A+ L S ++ V
Sbjct: 181 TKADIWSLGITIYEMATGNPPY-SDVDA--FRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237
Query: 319 MLTQDPKKRITSAQVLEHPWIK 340
L ++PK+R+++ ++L+ WIK
Sbjct: 238 CLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 15/263 (5%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG L +GR +A K + K ++ +D + E +I+ P + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + VME GG+L I + E A I + + H G+++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
K +N LL D K DFG+ I GK G+ Y+APE+L+ YG +D
Sbjct: 123 KLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
W+ GV+LY +L G PF AE E +F+AIL ++ + + W +S A D+++ +T++P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTKNP 235
Query: 325 KKRITS------AQVLEHPWIKE 341
R+ S +L HP+ KE
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 12/262 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY + LG+G FG L K ++ +L K ++ D EI I+ L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQ-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRII--AKGHYSERAAASICRSIVNVVHICH 197
PNI+ + + D ++ + ME GG L+D+I+ + E IV+ V H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR- 255
G++HRD+K N L+ L+K DFG+S + E + +VG+ YY++PE+ +
Sbjct: 119 KAGILHRDIKTLNIFLTKAG---LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+Y + DIW+ G +LY LL+ F A + I+QG+ + + SS L
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISL 232
Query: 316 VRRMLTQDPKKRITSAQVLEHP 337
V +L QDP+KR T+ +VL+ P
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 2e-31
Identities = 81/268 (30%), Positives = 144/268 (53%), Gaps = 13/268 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G Y + +TG++ A K ++ L + K+ I EI +M+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL 254
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--ERLSAVF 245
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D + R L D +R ++ ++L+HP++K
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 14/269 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K +GRG FG L S+ + +A K +SK +++ ++D E IM + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V+ A++D + +++VME GG+L + +++ E+ A +V + H MG
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI-VGSAYYVAPEVLRRR- 257
++HRD+KP+N LL D++ LK DFG + ++E G V D VG+ Y++PEVL+ +
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 258 ----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
YG+E D WS GV L+ +L G PF+A++ G + I+ IS AK
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279
Query: 314 DLVRRMLTQDPKK--RITSAQVLEHPWIK 340
+L+ LT + R ++ +HP+ K
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 76/248 (30%), Positives = 128/248 (51%), Gaps = 9/248 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L + G+ +A K + K+ ++ K ++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ ++ V++ GGELF + + + E A I + + H + +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLKPEN LL S+ L TDFGL IE K G+ Y+APEVLR++ Y + +
Sbjct: 121 DLKPENILLDSQGHVVL---TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W G +LY +L G+PPF++ ++D IL + + P IS SA+ L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQK 233
Query: 323 DPKKRITS 330
D KR+ +
Sbjct: 234 DRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 81/268 (30%), Positives = 143/268 (53%), Gaps = 13/268 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G Y + +TG++ A I + L + K+ I EI +M+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE 73
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVL 254
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIF 246
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D + R L D +KR ++ ++L+H ++K
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG FG + E +TG +A K + K L+ + + E I+ +S P I + +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
A++DK ++++VME GG+L + + + E A +V +H H MG +HRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDI-VGSAYYVAPEVL-------RR 256
+KPEN L+ D +K DFG + + V + VG+ Y+APEVL +
Sbjct: 128 IKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL--QGDIDFESAPWPTISSSAKD 314
YG E D WS GVI Y ++ G PF T ++ I+ Q + F P +SS D
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--PKVSSDFLD 242
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
L++ +L K+R+ + HP+ +
Sbjct: 243 LIQSLLC-GQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 82/304 (26%), Positives = 127/304 (41%), Gaps = 64/304 (21%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y E+G G +G Y + +TGR A K K+ ++ I REI +++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 137 --SGQPNIVE----FKGAYEDKQ-SVHVVMELC----AGGELFDRIIAKGHYSERAAASI 185
PNIV G D++ + +V E A + G +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT--YLSKCPKPG-LPPETIKDL 112
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD---- 241
R ++ V H ++HRDLKP+N L++S + +K DFGL+ ++Y
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLA------RIYSFEMAL 163
Query: 242 --IVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI- 293
+V + +Y APEVL + Y +D+WS G I L P F +E IFD I
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223
Query: 294 -------------------LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
F+S P I DL+++MLT +P KRI++ + L
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282
Query: 335 EHPW 338
+HP+
Sbjct: 283 QHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 25/267 (9%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVE 144
LGRG FG L TG +A K++ K ++ +++ + + E +I + + P +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ + V VME AGG+L I +SE A +V + H +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVL-RRRYG 259
DLK +N LL D +K DFGL +EG + D G+ ++APEVL Y
Sbjct: 126 DLKLDNLLL---DTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-TISSSAKDLVRR 318
+ +D W GV++Y +L G PF + E+ +FD+I+ ++ +P +S A ++RR
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREAISIMRR 234
Query: 319 MLTQDPKKRITSAQ-----VLEHPWIK 340
+L ++P++R+ S + V + P+ +
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 80/266 (30%), Positives = 137/266 (51%), Gaps = 20/266 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K+++ + + E QI++ ++ +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 66
Query: 147 GAYEDKQSVHVVMELCAGGEL---FDRIIAKGHYSERA---AASICRSIVNVVHICHFMG 200
AYE K ++ +V+ L GG+L + G ERA AA I + ++ H
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL----HRER 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYG 259
+++RDLKPEN LL D+ ++ +D GL+V I EG+ R VG+ Y+APEV++ RY
Sbjct: 123 IVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
D W G ++Y ++ G PF EK + + + + + S +A+ + R++
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239
Query: 320 LTQDPKKRI-----TSAQVLEHPWIK 340
LT+DP R+ + +V HP+ +
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++F LG+G FG L T +A K + K ++ +D + E +++ P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ + ++ ++ VME GG+L I G + E A I + H G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPE-VLRRRY 258
+++RDLK +N +L D +K DFG+ I GK R G+ Y+APE + + Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
GK +D W+ GV+LY +L+G PPF E E +F +I++ ++ + + +S A + +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKG 234
Query: 319 MLTQDPKKRITSA-----QVLEHPWIK 340
+LT+ P KR+ + EH + +
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 89/270 (32%), Positives = 140/270 (51%), Gaps = 16/270 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K +GRG FG L ST + +A K +SK +++ ++D E IM + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V+ A++D + +++VME GG+L + +++ E+ A +V + H MG
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDI-VGSAYYVAPEVLRRR- 257
+HRD+KP+N LL D++ LK DFG + + +EG V D VG+ Y++PEVL+ +
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 258 ----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 314 DLVRRMLTQDPKKRITSAQVLE---HPWIK 340
+L+ LT D + R+ V E H + K
Sbjct: 280 NLICAFLT-DREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 76/258 (29%), Positives = 134/258 (51%), Gaps = 15/258 (5%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FG + T R +A K+I K +V++++ E ++ ++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RAAASICRSIVNVVHICHFMGVMHRD 205
+++ + +++V+ GGELF + +G + RA + + ++ H V++RD
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENL-HKFNVIYRD 118
Query: 206 LKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEID 263
LKPEN LL + AL DFGL + +++ G+ Y+APE+L Y K +D
Sbjct: 119 LKPENILLDYQGHIAL---CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
W+ GV+LY +L+G+PPF+ E ++ ILQ + F AKDL+ +L++D
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRD 231
Query: 324 PKKRITSA---QVLEHPW 338
P +R+ ++ HP+
Sbjct: 232 PTRRLGYNGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 22/275 (8%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G FG Y TG A K I ++ ++ + +D EI I+ PNIV
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK-HPNIVGL 67
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHR 204
AY + + +++E C GG L ++ +E +CR ++ ++ H V+HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL------RRR 257
DLK N LL+ + +K DFG+S + RD +G+ Y++APEV+
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP--WPTISSSAKDL 315
Y + DIWS G+ L L PP + IL+ + P W SSS D
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW---SSSFNDF 241
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
++ L +DP R T+A++L+HP++ + +K I
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQS--DNKAI 274
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 16/266 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L T +A K + K ++ +D D E +I+ + P +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K + VME GG+L +I + E + + + H GV++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEI 262
DLK +N LL D K DFG+ I G G+ Y+APE+L+ YG +
Sbjct: 121 DLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W+ GV++Y +++G PPF A+ E +F++IL D+ + W +S A +++ +T+
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--W--LSKEAVSILKAFMTK 233
Query: 323 DPKKRI-------TSAQVLEHPWIKE 341
+P KR+ + +HP+ KE
Sbjct: 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 12/262 (4%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K++L + + E +I++ +S IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLA 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHR 204
A+E K + +VM L GG+L I G + E A I+ + H +++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEID 263
DLKPEN LL D++ ++ +D GL+V ++ GK + G+ Y+APEVL+ Y +D
Sbjct: 120 DLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
++ G LY +++G PF EK + + + ++ S AKDL +L +D
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 324 PKKRI-----TSAQVLEHPWIK 340
P+KR+ ++ +V EHP K
Sbjct: 237 PEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 80/302 (26%), Positives = 141/302 (46%), Gaps = 54/302 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L + TG +A K + K +++ K ++ E I+ + P +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++D+ ++++ME GG++ ++ K ++E + + H +G +HR
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGS---------------- 245
D+KP+N LL D +K +DFGL +++ YR + +
Sbjct: 126 DIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 246 -------------AY-------YVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAE 284
AY Y+APEV L+ Y KE D WS GVI+Y +L G PPF ++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 285 TEKGIFDAILQGDIDFESAPWPT---ISSSAKDLVRRMLTQDPKKRITSAQVLE---HPW 338
+ + I+ E+ +P +S AKDL++R+ + ++R+ + V E HP+
Sbjct: 243 NPQETYRKIINWK---ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298
Query: 339 IK 340
K
Sbjct: 299 FK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 37/273 (13%)
Query: 82 SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ GK+LG G FG Y T + + A K++ + ++ ++ RE +IM+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIVNVVHI 195
PNIV+ G +++ + +VME GG+L D + S S + I
Sbjct: 60 -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA------LQI 112
Query: 196 C------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA--Y 247
+HRDL N L+ EN ++K +DFGLS + + Y+ G
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
Query: 248 YVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
++APE L+ ++ + D+WS GV+L+ + + G P+ + + + + +G
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL------ 223
Query: 306 PTISSSAKDLVRRMLT---QDPKKRITSAQVLE 335
P + +L + ML +DP+ R T ++++E
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 80/274 (29%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY + LG+G FG C +TG+ +ACK + K+++ + + E +I++ ++ +
Sbjct: 4 HY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY---SERA---AASICRSIVNVV 193
+V AYE K ++ +V+ + GG+L I G+ +RA AA +C + ++
Sbjct: 61 -FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL- 118
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
+++RDLKPEN LL D+ ++ +D GL+V I EG+ R VG+ Y+APEV
Sbjct: 119 ---QRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 254 LR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
+ +Y D W G ++Y ++ G PF E+ + + + + + S A
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232
Query: 313 KDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
K + R +LT++PK+R+ +A V +HP K
Sbjct: 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 78/263 (29%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K+++ + + E QI++ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLA 66
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHR 204
AYE K ++ +V+ L GG+L I G + E A I + H +++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEID 263
DLKPEN LL D++ ++ +D GL+V + EG+ + VG+ Y+APEV++ RY D
Sbjct: 127 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
W+ G +LY +++G PF +K + + + + + S A+ L + +L +D
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243
Query: 324 PKKRI-----TSAQVLEHPWIKE 341
PK+R+ + +V EHP K+
Sbjct: 244 PKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 72/246 (29%), Positives = 125/246 (50%), Gaps = 9/246 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L + + +A K + K+ ++ K ++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ ++ V++ GGELF + + + E A I + + H + +++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLKPEN LL S+ L TDFGL IE G+ Y+APEVL ++ Y + +
Sbjct: 121 DLKPENILLDSQGHIVL---TDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W G +LY +L G+PPF++ ++D IL + + P I++SA+ L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQK 233
Query: 323 DPKKRI 328
D KR+
Sbjct: 234 DRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 3e-29
Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 82 SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ GK+LG G FG Y + A K++ + ++ ++ RE +IM+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHIC 196
PN+V+ G +++ +++VME GG+L + S S + I
Sbjct: 60 -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA------LQIA 112
Query: 197 ------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA--YY 248
+HRDL N L+ EN ++K +DFGLS + + YR G +
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 249 VAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306
+APE L+ ++ + D+WS GV+L+ + + G P+ + + + + + G P
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------LP 223
Query: 307 TISSSAKDLVRRMLT---QDPKKRITSAQVLE 335
+ +L ML +DP+ R T ++++E
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 79/304 (25%), Positives = 132/304 (43%), Gaps = 53/304 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G FG L + T +A K++ K ++ +N +K E I+ + +V+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++ VM+ GG++ +I G + E A + + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGL---------SVFIEEGKVYR--------------- 240
D+KP+N L+ D + +K TDFGL S + ++G +R
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 241 --------------------DIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVP 279
+VG+ Y+APEVL R Y + D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS---AQVLEH 336
PF A+T ++ + +S A DL+ R+ + R+ ++ H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH 301
Query: 337 PWIK 340
P+ K
Sbjct: 302 PFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 26/275 (9%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG+G +G Y TG A K I R + ++ + I E+ I+ H + P IV+F
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDIL-HKAVSPYIVDF 64
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHICHFM----G 200
GA+ + +V++ ME G L D++ A G +E + R I VV F+
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---- 256
++HRD+KP N L++ + +K DFG+S + +I G Y+APE ++
Sbjct: 124 IIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPN 179
Query: 257 ---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF---DAILQGDIDFESAPWPTISS 310
Y + D+WS G+ + + G P+ ET IF AI+ GD + P S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP--PTLP-SGYSD 236
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345
A+D V + L + P +R T AQ+LEHPW+ + A
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 71/267 (26%), Positives = 143/267 (53%), Gaps = 20/267 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K++G G FG L G+Q+ K I+ K+ K ++++ ++E+ ++ ++ P
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMK-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KG-HYSERAAAS----ICRSIVNVVH 194
NIV+++ ++E+ ++++VM+ C GG+L+ +I A +G + E IC ++ +V
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV-- 117
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
H ++HRD+K +N L+ ++ +K DFG++ V ++ R +G+ YY++PE+
Sbjct: 118 --HDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
R Y + DIW+ G +LY + + F A K + I++G + S
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339
++LV ++ ++P+ R + +LE +I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 45/296 (15%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L + TG +A K + K ++ K I+ E I+ G +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK++++++ME GG++ ++ K SE A V + H +G +HR
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEG---KVYRDI------------------- 242
D+KP+N LL +K +K +DFGL +++ + YR++
Sbjct: 126 DIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 243 --------------VGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
VG+ Y+APEV ++ Y K D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE---HPWIK 340
+ ++ P IS AKDL+ R T D + RI S V E HP+ +
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 86/279 (30%), Positives = 130/279 (46%), Gaps = 42/279 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQPNIVE 144
LG G G C +TG FA K+I N + I RE++I + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCK-SPYIVK 63
Query: 145 FKGAYEDKQS--VHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICH 197
+ GA+ D+ S + + ME C GG L D I K G E+ I S++ + H
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR- 255
++HRD+KP N LL+ K + +K DFG+S + + G+++Y+APE ++
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSGELVN--SLAGTFTGTSFYMAPERIQG 177
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES----APWPTI--- 308
+ Y D+WS G+ L + PF E E + G I+ S P P +
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL------GPIELLSYIVNMPNPELKDE 231
Query: 309 -------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
S KD +++ L +DP +R T +LEHPWIK
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 18/270 (6%)
Query: 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--KRKLVTKNDKDDIKREIQIMQHL 136
+++ GK LG+G FG YLC + TGR+ A K + T + ++ EIQ++++L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 137 SGQPNIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
+ IV++ G D+ +++ + ME GG + D++ A G +E R I+ +
Sbjct: 62 QHE-RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVA 250
H ++HRD+K N L +D +K DFG S ++ G R + G+ Y+++
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-I 308
PEV+ YG++ D+WS G + +L+ PP WAE E AI + + P+ I
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHI 234
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
S A+D + + + + R ++ ++L HP+
Sbjct: 235 SEHARDFLGCIFVE-ARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 84/292 (28%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G+ Y + ++G A K K+ N++D I REI ++ +L PNI
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK-----KVRMDNERDGIPISSLREITLLLNLR-HPNI 68
Query: 143 VEFKGAYEDKQ--SVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
VE K K S+ +VME C L D + +SE + ++ + H
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHE 126
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--R 255
++HRDLK N LL+ K LK DFGL+ + K V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------------------G 296
Y ID+W+ G IL LL+ P ++E D I+Q G
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 297 DIDFESAPW-------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P+ P +S + L+ +L DPKKR T+ + LE + KE
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 9/248 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L S G +A K + K+ ++ K +++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ + ++ V++ GGELF + + + E A + + + H + +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLKPEN LL S+ L TDFGL +E + G+ Y+APEVLR+ Y + +
Sbjct: 121 DLKPENILLDSQGHVVL---TDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W G +LY +L G+PPF++ ++D IL + + +A DL+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHK 233
Query: 323 DPKKRITS 330
D ++R+ +
Sbjct: 234 DQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 21/269 (7%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
YE +++ +GRG FG+ +LC + + K I ++ TK+++ + E Q++
Sbjct: 2 YEKIRV-------VGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVL 53
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVN 191
+ LS PNI+E+ + + +++ +VME GG L + I + + E I+
Sbjct: 54 KLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL 112
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVA 250
+H H ++HRDLK +N LL ++K DFG+S + + K Y +VG+ Y++
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKSKAY-TVVGTPCYIS 169
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-I 308
PE+ + Y ++ DIW+ G +LY L S F A + I+ G AP
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----APISDRY 225
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
S + L+ ML DP KR +Q++ P
Sbjct: 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 91/319 (28%), Positives = 144/319 (45%), Gaps = 46/319 (14%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
I G +E + Y + +G G FG+ + TG+ A K I K K R
Sbjct: 1 IFGTVFE-ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-TYR 58
Query: 129 EIQIMQHLSGQPNIVE----FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
E+++++HL + NI+ F ED ++ V EL G R++ ++
Sbjct: 59 ELKLLKHLRHE-NIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQY 112
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
I+ + H GV+HRDLKP N L+ +EN LK DFGL+ I++ ++ V
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLAR-IQDPQM-TGYVS 167
Query: 245 SAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL-------- 294
+ YY APE++ ++Y E+DIWSAG I +L G P F + F I
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 295 --------QGDIDF-------ESAP----WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + F E P + SA DL+ +ML DP+KRI++A+ L
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 336 HPWIKEGGEASDKPIDSAV 354
HP++ + +D+P+
Sbjct: 288 HPYLAPYHDPTDEPVAEEK 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-28
Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 24/273 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSI--SKRKLVTKNDKDDIKREIQIMQHLS 137
++ GK LG+G FG YLC + TGR+ A K + T + + ++ EIQ++++L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 138 GQPNIVEFKGAYEDKQ--SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ IV++ G D ++ + ME GG + D++ + G +E R I+ V
Sbjct: 63 HE-RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVAP 251
H ++HRD+K N L +D +K DFG S ++ G + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPW--P 306
EV+ YG++ DIWS G + +L+ PP WAE E IF Q + P P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPP 232
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S +D ++R+ + K R ++ ++L H ++
Sbjct: 233 HVSDHCRDFLKRIFVE-AKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 87/275 (31%), Positives = 131/275 (47%), Gaps = 23/275 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P ED +L + +G G +G Y +TG A K I KL D +++EI I
Sbjct: 7 PQEDFELI----QRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-I 58
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M NIV + G+Y + + + ME C GG L D G SE A + R +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAP 251
++ H G MHRD+K N LL+ +N +K DFG+S I R +G+ Y++AP
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 252 EV--LRRR--YGKEIDIWSAGVILYILLSGVPP-FWAETEKGIF---DAILQGDIDFESA 303
EV + R+ Y + DIW+ G+ L PP F + +F + Q +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W S+S V+ LT++PKKR T+ ++L+HP+
Sbjct: 236 KW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 73/263 (27%), Positives = 131/263 (49%), Gaps = 19/263 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L G+ +A K + K+ ++ + ++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ + ++ V++ GGELF + + + E A I + + H + +++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV----GSAYYVAPEVLRRR-YG 259
DLKPEN LL S+ L TDFGL +EG D G+ Y+APEV+R++ Y
Sbjct: 121 DLKPENILLDSQGHVVL---TDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
+D W G +LY +L G+PPF+ ++D IL + P S +A ++ +
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEEL 230
Query: 320 LTQDPKKRITSA----QVLEHPW 338
L +D ++R+ + ++ EHP+
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 36/269 (13%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG +TG+ +ACK + K++L K+ + E +I++ ++ P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLA 59
Query: 147 GAYEDKQSVHVVMELCAGGEL-------------FDRIIAKGHYSERAAASICRSIVNVV 193
A+E K + +VM L GG+L +R+I HYS + I +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI---HYSAQITCGI-------L 109
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H+ H M +++RD+KPEN LL D+ + +D GL+V +++GK G+ Y+APE+
Sbjct: 110 HL-HSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI----LQGDIDFESAPWPTI 308
L+ Y +D ++ G +Y +++G PF EK + + L+ ++ FE
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NF 222
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
+ +KD+ R L + P+ R+ S + + P
Sbjct: 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 63/255 (24%), Positives = 122/255 (47%), Gaps = 12/255 (4%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FGV + + R +A K I K+ + ++++ E +++ L I+ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLD-SSYIIRYY 65
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ DK +++VME G+L + E I+ + H ++HR
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RDIVGSAYYVAPEVLRRR-YGKEI 262
D+K N L + D +K D G++ + + + IVG+ YY++PE+ + Y ++
Sbjct: 126 DIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D+W+ GV+LY +G PF A + + I++G S + S L+ + LT+
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLIDQCLTK 239
Query: 323 DPKKRITSAQVLEHP 337
D ++R + Q+L +P
Sbjct: 240 DYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L T FA K++ K ++ +D + E +++ P +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K+ + VME GG+L I + G + E A I+ + H G+++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY-----YVAPEVLR-RRY 258
DLK +N LL D++ +K DFG+ + + + S + Y+APE+L+ ++Y
Sbjct: 121 DLKLDNVLL---DKDGHIKIADFGMC----KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW--PTISSSAKDLV 316
+ +D WS GV+LY +L G PF E E +FD+IL P IS AKD +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWISKEAKDCL 227
Query: 317 RRMLTQDPKKRITSA-QVLEHPWIKE 341
++ +DP KR+ + +HP+ +
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 9/250 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++F LG+G FG L T +A K + K ++ +D + E +++ P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ + ++ ++ VME GG+L I G + E A I + H G
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
+++RDLK +N +L S+ +K DFG+ + +G R G+ Y+APE++ + Y
Sbjct: 122 IIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
GK +D W+ GV+LY +L+G PPF E E +F +I++ ++ + ++S A + +
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 319 MLTQDPKKRI 328
++T+ P KR+
Sbjct: 235 LMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 88/312 (28%), Positives = 129/312 (41%), Gaps = 69/312 (22%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQH 135
+ ++G G +G Y + TG A K K+ N+K+ REI+I++
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62
Query: 136 LSGQPNIVEFKGAYEDKQSV------------------HVVMELCAGGELFDRIIAKGHY 177
L+ NIV K DKQ H +M L G + H+
Sbjct: 63 LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--------HF 113
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI--EE 235
SE S + ++ ++ CH +HRD+K N LL++K + +K DFGL+ EE
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEE 170
Query: 236 GKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI 293
+ Y + V + +Y PE+L RYG ID+WS G IL L + P F A E + I
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 294 LQGDIDFESAPWPT--------------------------ISSSAKDLVRRMLTQDPKKR 327
+ A WP I + A DL+ MLT DP KR
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290
Query: 328 ITSAQVLEHPWI 339
T+ + L PW+
Sbjct: 291 CTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 69/276 (25%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-------REIQIMQHL 136
G+ +G+G +G YL +TG A K + + K EI+ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
NIV++ G ++ + + +E GG + + G + E+ ++ +
Sbjct: 66 D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-----IVGSAYYVAP 251
H G++HRDLK +N L+ D + + K +DFG+S ++ +Y + + GS +++AP
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGISKKSDD--IYDNDQNMSMQGSVFWMAP 179
Query: 252 EVL---RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT- 307
EV+ + Y ++DIWS G ++ + +G P W++ E A+ + + P P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEE--AIAAMFKLGNKRSAPPIPPD 236
Query: 308 ----ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S A D + T +P R T+ ++L+HP+I
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 47/293 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-----REIQIMQH 135
Y ++G G F TG+ +A K + K ++ REIQ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRR 53
Query: 136 LSGQPNIVEFKGAYEDKQ--SVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNV 192
LS PNI+ D++ + +V EL L++ I + E+ S ++
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
+ H G+ HRD+KPEN L+ KD+ +LK DFG I Y + + + +Y APE
Sbjct: 113 LDHMHRNGIFHRDIKPENILI--KDD--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168
Query: 253 VLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFD-------AIL----- 294
L YG ++DIW+ G + + +LS P F E I D +L
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 295 --QGDIDFESA-----PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ +F S P S+ DL++++L DP +RIT+ Q L HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 81/276 (29%), Positives = 140/276 (50%), Gaps = 30/276 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSI--SKRKLVTKNDKDDIKREIQIMQHLS 137
++ GK LGRG FG YLC + TGR+ A K + T + + ++ EIQ++++L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 138 GQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
IV++ G D ++ + + +E GG + D++ A G +E R I+ V
Sbjct: 63 -HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVAP 251
H ++HRD+K N L +D +K DFG S I+ G + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT--- 307
EV+ YG++ D+WS + +L+ PP WAE E AI F+ A PT
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAI------FKIATQPTKPM 229
Query: 308 ----ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S + +D ++++ ++ K+R T+ +L HP++
Sbjct: 230 LPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 90/347 (25%), Positives = 145/347 (41%), Gaps = 65/347 (18%)
Query: 80 HYSFGKELGRGQFGVTYLC----TENSTGRQFACKSISK---RKLVTKNDKDDIKREIQI 132
Y KELG+G +G+ +C E S A K I+ +K++ K RE+++
Sbjct: 1 RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKR----ALRELKL 54
Query: 133 MQHLSGQPNIVE-------FKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAAS 184
++H G NI F G + + +++ EL +II G ++ S
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNE---LYLYEELMEAD--LHQIIRSGQPLTDAHFQS 109
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--- 241
I+ + H V+HRDLKP N L+++ E LK DFGL+ E
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFM 166
Query: 242 --IVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-- 295
V + +Y APE++ + Y K ID+WS G IL LL P F + + ILQ
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 296 -----------------------GDIDFESAPW--PTISSSAKDLVRRMLTQDPKKRITS 330
+I + P + A DL+ ++L DP KRI+
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286
Query: 331 AQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAE 377
+ LEHP++ + D+P+ F + + +++L +I E
Sbjct: 287 EEALEHPYLAIWHDPDDEPVCQKPFD--FSFESEDSMEELRDMIIEE 331
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 75/270 (27%), Positives = 131/270 (48%), Gaps = 21/270 (7%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK------DDIKREIQIMQHLS 137
G +G G FG YL S+G A K + + + D + REI +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
NIV++ G+ D +++ +E GG + + G + E + R I+ ++ H
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-------GKVYRDIVGSAYYVA 250
G++HRD+K N L+ +K +K +DFG+S +E + GS +++A
Sbjct: 124 NRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PEV+++ Y ++ DIWS G ++ +L+G PF T+ AI + + IS
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPSNIS 237
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
S A D + + D KR T+A++L+HP++
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 70/251 (27%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++F LG+G FG L T +A K + K ++ +D + E +++ LSG+P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKP 60
Query: 141 N-IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
+ + ++ ++ VME GG+L +I G + E A I + H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N +L D +K DFG+ + +G + G+ Y+APE++ +
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YGK +D W+ GV+LY +L+G PF E E +F +I++ ++ + ++S A + +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 233
Query: 318 RMLTQDPKKRI 328
++T+ P KR+
Sbjct: 234 GLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 78/263 (29%), Positives = 132/263 (50%), Gaps = 23/263 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y+ + +G G FG L ++ +++A K I R + + +D ++E ++ + P
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGH-YSERAA----ASICRSIVNVVH 194
NIV FK ++E +++VME C GG+L +I + +G + E +C + V H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC---LGVQH 115
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEV 253
I H V+HRD+K +N L+ +N +K DFG + + Y VG+ YYV PE+
Sbjct: 116 I-HEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSS 311
Y + DIWS G ILY L + PF A + K + + QG P P+ S
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYE 227
Query: 312 AKDLVRRMLTQDPKKRITSAQVL 334
+ L+++M ++P+ R ++ +L
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 56/292 (19%)
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK------REIQIMQHLSGQPNIV 143
G +GV Y + TG A K + K +K+ REI I+ L PNIV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINILLKLQ-HPNIV 67
Query: 144 EFK----GAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHICHF 198
K G+ DK +++VME +L + K + + + +++ V H
Sbjct: 68 TVKEVVVGSNLDK--IYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--R 255
++HRDLK N LL+++ LK DFGL+ + K Y +V + +Y APE+L
Sbjct: 125 NWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------------------G 296
+ Y ID+WS G I LL+ P F ++E + I +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 297 DIDFESAP-------WPTISSSAK--DLVRRMLTQDPKKRITSAQVLEHPWI 339
F P +P +S S DL+ R+LT DP KRI++ L+HP+
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 67/269 (24%), Positives = 129/269 (47%), Gaps = 15/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD----IKREIQIMQH 135
+ G++LG G F Y + TG A K ++ + T +++++ +++EI++M
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMAR 59
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
L+ P+I+ GA + ++ +E AGG + + G + E + ++ +
Sbjct: 60 LN-HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSY 118
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-----GKVYRDIVGSAYYVA 250
H ++HRD+K N L+ S + L+ DFG + + G+ ++G+ ++A
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-I 308
PEVLR +YG+ D+WS G ++ + + PP+ AE I + + P +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
S +D+ R L P+ R S ++L+HP
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 76/262 (29%), Positives = 127/262 (48%), Gaps = 16/262 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L G FA K++ K ++ +D + E +++ P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K+ + VME GG+L I KG + A IV + H G+++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL---SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGK 260
DLK +N +L D + +K DFG+ +VF + G+ Y+APE+L+ +Y
Sbjct: 121 DLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTF 175
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP-WPTISSSAKDLVRRM 319
+D WS GV+LY +L G PF + E +F++I D P W I+ +KD++ ++
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV---DTPHYPRW--ITKESKDILEKL 230
Query: 320 LTQDPKKRI-TSAQVLEHPWIK 340
+DP +R+ + HP+ K
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 41/271 (15%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L + TG +A K + K ++ K I+ E I+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++++ME GG++ ++ K +E V + H +G +HR
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEG---KVYRDI------------------- 242
D+KP+N LL SK +K +DFGL +++ + YR++
Sbjct: 126 DIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 243 --------------VGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
VG+ Y+APEV ++ Y K D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ ++ P IS AKDL+ R
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 72/266 (27%), Positives = 130/266 (48%), Gaps = 20/266 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K++G+GQF V Y GR A K + +++ + D +EI +++ L P
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HP 62
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHIC--- 196
N++++ ++ + +++V+EL G+L R+I H+ ++ R+I V +C
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDL-SRMIK--HFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 197 ---HFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPE 252
H +MHRD+KP N +++ ++K D GL F + +VG+ YY++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 253 VLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK--GIFDAILQGDIDFESAPWPTIS 309
+ Y + DIWS G +LY + + PF+ + + I + D+ P S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYS 234
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335
+DLV R + DP+KR + VL+
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 70/261 (26%), Positives = 130/261 (49%), Gaps = 12/261 (4%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG +L T + FA K++ K ++ +D + E +++ P +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K+++ VME GG+L I + + A I+ + H G+++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL--SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKE 261
DLK +N LL D + +K DFG+ + + K G+ Y+APE+L ++Y
Sbjct: 121 DLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQKYNTS 176
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321
+D WS GV+LY +L G PF E+ +F +I + + W ++ AKD++ ++
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFV 232
Query: 322 QDPKKRI-TSAQVLEHPWIKE 341
++P++R+ + +HP+ +E
Sbjct: 233 REPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 80/265 (30%), Positives = 129/265 (48%), Gaps = 15/265 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K++G G FG YL S K I K+ K +K+ K+E+ ++ + P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMK-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKG-HYSERAAASICRSI-VNVVHICH 197
NIV F ++++ + +VME C GG+L RI +G +SE S I + + HI H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI-H 118
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRR 256
++HRD+K +N LS A K DFG++ + ++ VG+ YY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW-PTISSSAKD 314
R Y + DIWS G +LY L + PF + I QG AP P S +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----APISPNFSRDLRS 232
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
L+ ++ P+ R + +L+ P++
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 25/271 (9%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSI---SKRKLVTKNDKDDIKREIQIMQHLSGQP 140
G+ LG+G +G Y C + G+ A K + + L + + + ++ E+ +++ L
Sbjct: 5 GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV++ G D ++ + ME GG + + G E + I++ V H
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFG-------LSVFIEEGKVYRDIVGSAYYVAPEV 253
V+HRD+K N +L N ++K DFG + + + + + G+ Y++APEV
Sbjct: 123 VVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI---- 308
+ YG++ DIWS G ++ + +G PP A ++ A+ I P +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDR--LAAMFY--IGAHRGLMPRLPDSF 234
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
S++A D V LT+D +R ++ Q+L H ++
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 16/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL--VTKNDKDDIKREIQIMQHLSG 138
Y + LG+G FG YL + + K + + + + N+ +E Q++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD- 60
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER-AAASICRSIVNV---VH 194
P IV+F ++ ++ + ++ E C G +L ++ H + + +C + + VH
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEV 253
H ++HRDLK +N L +N LLK DFG+S + + G+ YY++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
L+ + Y + DIWS G ILY + F + + I++G S P T S
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PSLP-ETYSRQL 233
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339
+++ ML +DP R ++A++L +P+I
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 92/335 (27%), Positives = 138/335 (41%), Gaps = 88/335 (26%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--------KRKLVTKNDKDDI 126
DV Y +G G +G+ T TG + A K IS +R L
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--------- 51
Query: 127 KREIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA 181
REI+I++ + NI+ ++E V++V EL +L+ ++I H S
Sbjct: 52 -REIKILRRFKHE-NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSND- 106
Query: 182 AASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFG 228
HI +F+ V+HRDLKP N LL++ N LK DFG
Sbjct: 107 ------------HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFG 151
Query: 229 LSVFIEEGKVYR----DIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFW 282
L+ + + + V + +Y APE++ + Y K IDIWS G IL +LS P F
Sbjct: 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211
Query: 283 AETEKGIFDAILQ-----GDIDFES------------------APW----PTISSSAKDL 315
+ + IL D PW P A DL
Sbjct: 212 GKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDL 271
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+ +MLT +P KRIT + L HP++++ + SD+P+
Sbjct: 272 LDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 71/267 (26%), Positives = 121/267 (45%), Gaps = 19/267 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQF-ACKSISKRKLVTKNDK-------DDIKREIQI 132
Y+ + LG G FG Y + + G+ A K I+ DK DI E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRS 188
++ PNIV + + + +++VM+L G L + + K ++E +I
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 189 IVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
+V + H ++HRDL P N +L D+ + TDFGL+ + +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306
Y PE+++ YG++ D+W+ G ILY + + PPF++ + I++ +E P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLPEG 236
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQV 333
S D++ LT D + R QV
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+E+G G FG Y + T A K +S + DI +E++ +Q L PN +E
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIE 79
Query: 145 FKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
+KG Y + + +VME C G ++ + + K E A+IC + + H +
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRY 258
HRD+K N LL+ E +K DFG + + + VG+ Y++APEV+ +Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA-----K 313
++D+WS G+ L PP + I Q D PT+SS+ +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-------PTLSSNDWSDYFR 244
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWI 339
+ V L + P+ R +S ++L+H ++
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 72/250 (28%), Positives = 134/250 (53%), Gaps = 22/250 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG + +TG+ +A K ++K +++ + + + E ++ + + I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW-ITN 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR----SIVNVVHICHFMG 200
A++D+ ++++VM+ GG+L +++K + +R + R +V + H +G
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDI-VGSAYYVAPEVLRR-- 256
+HRD+KP+N LL D+N ++ DFG + + +G V ++ VG+ Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 257 ----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL--QGDIDFESAPWPTISS 310
RYG E D WS GV +Y +L G PF+AE+ + I+ + F +S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSE 238
Query: 311 SAKDLVRRML 320
AKDL+RR++
Sbjct: 239 EAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 89/331 (26%), Positives = 139/331 (41%), Gaps = 82/331 (24%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
DV Y + +G G +GV + +G++ A K I V K + RE++I++H
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRH 60
Query: 136 LSGQPNIVE----FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
NI+ + D + V+VVM+L +L I + +E
Sbjct: 61 FK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEE----------- 107
Query: 192 VVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFG----LSVFIE 234
HI +F+ V+HRDLKP N L+ +E+ L+ DFG LS
Sbjct: 108 --HIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPT 162
Query: 235 EGKVY-RDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVI-------------------LY 272
E K + + V + +Y APE+L Y ID+WS G I L
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222
Query: 273 ILLS--GVPPFWAETEKGIFDAI--------LQGDIDFESAPW----PTISSSAKDLVRR 318
++LS G P + + + I +Q + PW P S A DL+ +
Sbjct: 223 LILSVLGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
ML DP++RIT Q L+HP++ + + D+P
Sbjct: 277 MLQFDPEERITVEQALQHPFLAQYHDPDDEP 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 82/298 (27%), Positives = 131/298 (43%), Gaps = 31/298 (10%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
E+G G FG Y T + T A K +S T DI +E++ +Q L PN +E+
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEY 86
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
KG Y + + +VME C G + K E A+I + + H ++HRD
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRYGKE 261
+K N LL+ E +K DFG + + VG+ Y++APEV+ +Y +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-DFESAPWPTISSSAKDLVRRML 320
+D+WS G+ L PP + I Q D +S W + S + V L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCL 257
Query: 321 TQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV--LSRMK---------QFRAMNKL 367
+ P++R SA++L H +++ D+P + + R K Q+R M K+
Sbjct: 258 QKIPQERPASAELLRHDFVRR-----DRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 84/289 (29%), Positives = 124/289 (42%), Gaps = 31/289 (10%)
Query: 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
TI G+ Y E+G G G Y TG A K + R+ K + I
Sbjct: 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRIL 61
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL---CAGGELFDRIIAKGHYSERAAAS 184
++ ++ P IV+ G + V + MEL C +L RI +G E
Sbjct: 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRI--QGPIPEDILGK 118
Query: 185 ICRSIVNVVHIC---HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+ +IV +H H GV+HRD+KP N LL D + +K DFG+S + + K
Sbjct: 119 MTVAIVKALHYLKEKH--GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTR 173
Query: 242 IVGSAYYVAPEVL-----RRRYGKEIDIWSAGVILYILLSGVPPF-WAETEKGIFDAILQ 295
G A Y+APE + +Y D+WS G+ L L +G P+ +TE + ILQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
Query: 296 GDIDFESAPWP----TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
E P S V LT+D +KR ++L+HP+I+
Sbjct: 234 -----EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 85/315 (26%), Positives = 134/315 (42%), Gaps = 57/315 (18%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG G FG L + T +A K++ K+ ++ +N +K E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-VVR 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++ VM+ GG++ +I G + E A + V H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSV---FIEEGKVYR--------------------- 240
D+KP+N L+ D + +K TDFGL + + K Y+
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 241 ------------------------DIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILL 275
+VG+ Y+APEVL R Y + D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
G PPF A+T ++ P +S A DL+ + L + P+ R+ E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 336 ---HPWIKEGGEASD 347
HP+ K +SD
Sbjct: 302 IKAHPFFKTIDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 55/230 (23%), Positives = 108/230 (46%), Gaps = 25/230 (10%)
Query: 85 KELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K+LG G FG Y ++ + A K++ + ++ ++ D +E ++M+ L G PN
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC----- 196
+V G +++ +++V+E GG+L D + S S+ +++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS-TLSLKDLLSFAIQIAK 116
Query: 197 -----HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-- 249
+HRDL N L+ E+ ++K +DFGLS + + YR G +
Sbjct: 117 GMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 250 -APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE L+ + + D+WS GV+L+ + + G P+ + + + + + +G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 43/286 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G+ C TG+ A K K + D +K REI++++ L + N+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLRHE-NL 62
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
V + K+ +++V E L D E I+ + CH ++
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIVGSAYYVAPEVL--RRRYG 259
HRD+KPEN L+S ++ ++K DFG + + G+VY D V + +Y APE+L +YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETE------------------KGIFD--AILQG--- 296
+ +DIW+ G ++ +L+G P F +++ + IF + G
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 297 ----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+I+ +P +S DL ++ L DP R +S+Q+L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 76/253 (30%), Positives = 128/253 (50%), Gaps = 16/253 (6%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K LG+G FG +L T G+ +A K + K L + D+ K E I+ + P
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPF 59
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IV+ A++ + ++++++ GG+LF R+ + ++E + + H +G+
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++RDLKPEN LL DE +K TDFGLS E K Y G+ Y+APEV+ RR +
Sbjct: 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGH 175
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ D WS GV+++ +L+G PF + K IL+ + +S A+ L+R
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRA 231
Query: 319 MLTQDPKKRITSA 331
+ ++P R+ +
Sbjct: 232 LFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 83 FGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
GK+LG G FG Y T T + A K++ ++ ++ ++++ E IM+ LS
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKLS- 59
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHIC- 196
PNIV G + +++V E GG+L D + G + + + I
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMAL------QIAK 113
Query: 197 -----HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-- 249
+HRDL N L+ EN ++K +DFGLS RDI YY
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLS---------RDIYEDDYYRKR 161
Query: 250 ----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFW 282
APE L+ ++ + D+WS GV+L+ + + G P+
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 89/310 (28%), Positives = 136/310 (43%), Gaps = 51/310 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSG 138
Y K +GRG +G+ + T + A K I+ N D + REI++++HL
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDH 63
Query: 139 QPNIVEFKG--------AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
+ N++ K A+ D V++V EL +L I + S+ ++
Sbjct: 64 E-NVIAIKDIMPPPHREAFND---VYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYV 249
+ H V+HRDLKP N LL + N LK DFGL+ E+G + V + +Y
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 250 APEVLRR--RYGKEIDIWSAGVILYILLSGVPPF----WAETEKGIFDAI---LQGDIDF 300
APE+L Y ID+WS G I LL P F + K I + + + D+ F
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235
Query: 301 ----------ESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
S P +P + A DL+ +ML DP KRIT + L HP++
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
Query: 341 EGGEASDKPI 350
+ SD+P+
Sbjct: 296 SLHDPSDEPV 305
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 74/256 (28%), Positives = 134/256 (52%), Gaps = 34/256 (13%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IV 143
K +GRG FG + + + FA K ++K +++ + + + E ++ ++G I
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWIT 64
Query: 144 EFKGAYEDKQSVHVVMELCAGGELF-------DRI---IAKGHYSERAAASICRSIVNVV 193
A++D+ ++++VM+ GG+L DR+ +A+ + +E A ++ V
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA------IDSV 118
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDI-VGSAYYVAP 251
H H++ HRD+KP+N L+ D N ++ DFG + +E+G V + VG+ Y++P
Sbjct: 119 HQLHYV---HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 252 EVL------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-SAP 304
E+L + +YG E D WS GV +Y +L G PF+AE+ + I+ F+ A
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQ 232
Query: 305 WPTISSSAKDLVRRML 320
+S AKDL+RR++
Sbjct: 233 VTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 19/268 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK ++K++L + + E +I+ + + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR-FIVSLA 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRII-----AKGHYSERAAASICRSIVNVVHICHFMGV 201
A++ K + +VM + GG+L I G RA + I + H+ H +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL-HQRRI 118
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-YRDIVGSAYYVAPEVLR-RRYG 259
++RDLKPEN LL D + ++ +D GL+V +++G+ + G+ ++APE+L+ Y
Sbjct: 119 IYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKDLVRR 318
+D ++ GV LY +++ PF A EK + + L+ I +S +P S ++K
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341
+L +DP+KR+ + HP ++
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 44/286 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQPNIVE 144
+G G +GV C T A I K K +N+ K+ RE+++++ L Q NIVE
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVA---IKKFKDSEENEEVKETTLRELKMLRTLK-QENIVE 64
Query: 145 FKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
K A+ + +++V E EL + + G E+ + I + ++ +H CH ++
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIV 122
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLR-RRYG 259
HRD+KPEN L+S D +LK DFG + + EG Y + V + +Y +PE+L YG
Sbjct: 123 HRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETE-------------------KGIFDAILQGDIDF 300
K +D+WS G IL L G P F E+E K + + F
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239
Query: 301 ESAPWPT---------ISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
+ P +S DL++ +L +P R + Q L HP
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
H F K+LG G FG LC ++TG Q A KS+ + + D +REI+I++
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRT 62
Query: 136 LSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
L NIV++KG E +S+ ++ME G L R + H R ++ R ++
Sbjct: 63 LD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLLFSS 116
Query: 194 HIC------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY------RD 241
IC +HRDL N L+ + L+K +DFGL+ + E K Y +
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 242 IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276
++ APE LR ++ D+WS GV LY L +
Sbjct: 174 S--PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 45/287 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +GV + C TG+ A K K V D IK REI++++ L PN+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPNL 62
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGV 201
V + K+ +H+V E C + + + E I + V+ CH
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL--RRRY 258
+HRD+KPEN L++ + + +K DFG + + G Y D V + +Y APE+L +Y
Sbjct: 122 IHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETE--------KGIFDAILQGDIDFES-------- 302
G +D+W+ G + LL+G P + +++ K + D I + F +
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238
Query: 303 -----------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ +P ISS A ++ L DP +R++ ++LEHP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 86/295 (29%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G Y + +TG+ A K K + D++ I REI ++Q LS I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 143 V-----EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER-----AAASICRSIVNV 192
V E K S+++V E +L + + G R S ++
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAP 251
V CH GVMHRDLKP+N L+ + LLK D GL F K Y + + +Y AP
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAP- 304
EVL Y +DIWS G I + P F ++E IF + G + P
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL--GTPTEQVWPG 238
Query: 305 ------W---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W P +S DL+++ML DP KRI++ L HP+
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 44/290 (15%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD--DIKREIQIMQHLSGQPNIV 143
ELG G FG Y TG A K I TK++++ D EI+I+ + P IV
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCN-HPYIV 72
Query: 144 EFKGAYEDKQSVHVVMELCAGGEL------FDRIIAKGHYSERAAASICRSIVNVVHICH 197
+ GA+ + +++E C GG + DR + +E ICR ++ + H
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVICRQMLEALQYLH 127
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR- 255
M ++HRDLK N LL+ + +K DFG+S + RD +G+ Y++APEV+
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 256 -----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
Y + DIWS G+ L + PP + I + + P PT+S
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE------P-PTLSQ 237
Query: 311 SAK------DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
+K D ++ L + P+ R ++AQ+LEHP++ S++P+ V
Sbjct: 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS--VTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 72/249 (28%), Positives = 131/249 (52%), Gaps = 20/249 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG + T R +A K ++K +++ + + + E ++ + Q I
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW-ITT 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR----SIVNVVHICHFMG 200
A++D+ +++VM+ GG+L +++K + +R + R +V +H H +
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDI-VGSAYYVAPEVLRR-- 256
+HRD+KP+N LL D N ++ DFG + ++G V + VG+ Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 257 ----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSS 311
+YG E D WS GV +Y +L G PF+AE+ + I+ + F+ T +S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 312 AKDLVRRML 320
AKDL++R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 80/314 (25%), Positives = 135/314 (42%), Gaps = 55/314 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG G FG L + T +A K++ K+ ++ +N +K E I+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW-VVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++ VM+ GG++ +I + E A + + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGL---------SVFIEEGKVYR--------------- 240
D+KP+N L+ D + +K TDFGL S + ++G R
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 241 ------------------------DIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILL 275
+VG+ Y+APEVL R+ Y + D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML--TQDPKKRITSAQV 333
G PPF A T ++ + P +S A DL+ ++ ++ R + +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 334 LEHPWIKEGGEASD 347
HP+ E +SD
Sbjct: 303 KAHPFFSEVDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 25/268 (9%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y + +G G +G Y TG A K I KL +D I++EI +++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HC 66
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV + G+Y ++ + + ME C GG L D G SE A +CR + + H G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVLRRR-- 257
MHRD+K N LL+ +N +K DFG++ I R +G+ Y++APEV
Sbjct: 127 KMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 258 --YGKEIDIWSAGVILYILLSGVPP-FWAETEKGIFDAILQGDIDF------ESAPWPTI 308
Y + DIW+ G+ L PP F + +F L +F + W
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKW--- 237
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336
SS+ + V+ LT++PKKR T+ ++L H
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-23
Identities = 78/288 (27%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQP 140
+++G G +GV Y TG+ A K K+ +++++ + REI +++ L P
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQ-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMEL--CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
NIV + + ++++ E + D + + S I+ + CH
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--R 255
V+HRDLKP+N L+ D ++K DFGL+ F +VY V + +Y APEVL
Sbjct: 120 RRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDID----FESAP--- 304
RY +DIWS G I + + P F ++E IF + D S P
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236
Query: 305 -----W---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W + DL+ +ML DP KRI++ + L HP+
Sbjct: 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 75/259 (28%), Positives = 129/259 (49%), Gaps = 20/259 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FG Y +N T A K I + +++ +DI++EI ++ P I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYY 68
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
G+Y + ++ME GG D ++ G E A+I R I+ + H +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDI 264
K N LLS E +K DFG++ + + ++ R+ VG+ +++APEV+++ Y + DI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI----SSSAKDLVRRML 320
WS G+ L G PP + I + ++P PT+ S K+ V L
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK------NSP-PTLEGQYSKPFKEFVEACL 237
Query: 321 TQDPKKRITSAQVLEHPWI 339
+DP+ R T+ ++L+H +I
Sbjct: 238 NKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 50/316 (15%)
Query: 42 PEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTEN 101
P + +++ S A K +++ +G G G Y
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAA-------KSLSELER----VNRIGSGAGGTVYKVIHR 96
Query: 102 STGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
TGR +A K I N +D ++ REI+I++ ++ PN+V+ ++ + V
Sbjct: 97 PTGRLYALKVI------YGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV 149
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217
++E GG L IA E+ A + R I++ + H ++HRD+KP N L++S
Sbjct: 150 LLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK 205
Query: 218 ENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRR-----RY-GKEIDIWSAGVI 270
+K DFG+S + + VG+ Y++PE + Y G DIWS GV
Sbjct: 206 N---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 271 LYILLSGVPPF-------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
+ G PF WA + AI T S + + L ++
Sbjct: 263 ILEFYLGRFPFGVGRQGDWA----SLMCAICMSQ---PPEAPATASREFRHFISCCLQRE 315
Query: 324 PKKRITSAQVLEHPWI 339
P KR ++ Q+L+HP+I
Sbjct: 316 PAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 78/269 (28%), Positives = 130/269 (48%), Gaps = 26/269 (9%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G G +G Y TG+ A K + VT +++++IK+EI +++ S NI +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 147 GAYEDKQ------SVHVVMELCAGGELFDRII-AKGH-YSERAAASICRSIVNVVHICHF 198
GA+ K + +VME C G + D I KG+ E A ICR I+ + H
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR-- 255
V+HRD+K +N LL+ ENA +K DFG+S ++ R+ +G+ Y++APEV+
Sbjct: 130 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 256 ----RRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPTISS 310
Y + D+WS G+ + G PP + +F +S W S
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SK 243
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+ + L ++ +R T+ Q+++HP+I
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 66/265 (24%), Positives = 134/265 (50%), Gaps = 15/265 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y F + +G+G +G L + G+Q+ K ++ R ++ ++ ++E Q++ L P
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLK-HP 59
Query: 141 NIVEFKGAYEDKQS-VHVVMELCAGGELFDRII-AKGHY-SERAAASICRSIVNVVHICH 197
NIV ++ ++E + +++VM C GG+L+ ++ KG E I + H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVLRR 256
++HRDLK +N L+ + ++K D G++ +E + + ++G+ YY++PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKD 314
+ Y + D+W+ G +Y + + F A+ + I++G + P P S +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPELGE 232
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
L+ ML++ P+KR + +L P+I
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 26/269 (9%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G G +G Y TG+ A K + VT++++++IK EI +++ S NI +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 147 GAYEDKQ------SVHVVMELCAGGELFDRII-AKGH-YSERAAASICRSIVNVVHICHF 198
GA+ K + +VME C G + D + KG+ E A ICR I+ + H
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR-- 255
V+HRD+K +N LL+ ENA +K DFG+S ++ R+ +G+ Y++APEV+
Sbjct: 140 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 256 ----RRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPTISS 310
Y DIWS G+ + G PP + +F +S W S
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW---SK 253
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
D + L ++ R ++ Q+L+HP+I
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 86/332 (25%), Positives = 129/332 (38%), Gaps = 92/332 (27%)
Query: 81 YSFGKELGRGQFGVTYLC--TENSTGRQFACKSISKRKLVTKNDKDDIK-------REIQ 131
Y +GRG +G Y G+++A K K DK+ REI
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-------KGDKEQYTGISQSACREIA 54
Query: 132 IMQHLSGQPNIVEFKGAYEDK--QSVHVVMELCAGGELFD--RIIAKGHYSERAAASICR 187
+++ L N+V + + +SV+++ + D +II + + SI
Sbjct: 55 LLRELK-HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIK--FHRQAKRVSIPP 107
Query: 188 SIV--------NVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGLS-------- 230
S+V N VH H V+HRDLKP N L+ + E ++K D GL+
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK- 287
+ V V + +Y APE+L R Y K IDIW+ G I LL+ P F K
Sbjct: 168 PLADLDPV----VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI 223
Query: 288 ------------GIFDAI-------------------LQGDIDFESAP----------WP 306
IF+ + L D ++ P
Sbjct: 224 KKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHK 283
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
S DL+R++L DP KRIT+ + LEHP+
Sbjct: 284 KPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG + L T R +A K + K + D D ++ E + + S P +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + + V+E GG+L + + E A I ++ H G+++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDI 264
K +N LL S+ +K TD+G+ + G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 265 WSAGVILYILLSGVPPF---------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
W+ GV+++ +++G PF TE +F IL+ I ++S A +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 235
Query: 316 VRRMLTQDPKKRITS------AQVLEHPWIK 340
++ L +DPK+R+ A + HP+ +
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 79/315 (25%), Positives = 122/315 (38%), Gaps = 69/315 (21%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-----------REIQI 132
G LG G +G + TG+ A K + ++ KD RE++I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M + NI+ Y + +++VM++ A +L + K +E I I+N
Sbjct: 74 MNEIK-HENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-------VFIEEGKV------- 238
+++ H MHRDL P N ++SK K DFGL+ K
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 239 -YRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
V + +Y APE+L +Y +D+WS G I LL+G P F E E I Q
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE------IDQ 242
Query: 296 -GDIDF-----ESAPWPTI------------------------SSSAKDLVRRMLTQDPK 325
G I WP S A DL++ +L +P
Sbjct: 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 326 KRITSAQVLEHPWIK 340
+RI++ + L+H + K
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 44/318 (13%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
L K +V Y +G G +G + TGR+ A K +S R + R
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYR 63
Query: 129 EIQIMQHLSGQPNIVEFKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
E+++++H+ N++ + ED Q V++V L G +L + I+ S+
Sbjct: 64 ELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHI 120
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ I+ + H G++HRDLKP N + +E+ LK DFGL+ ++
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDEMT--GY 175
Query: 243 VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ----- 295
V + +Y APE++ Y + +DIWS G I+ LL+G F I+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 296 -----GDIDFESA-------P----------WPTISSSAKDLVRRMLTQDPKKRITSAQV 333
I ESA P + + A DL+ +ML DP KRIT+A+
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 334 LEHPWIKEGGEASDKPID 351
L HP++ E + D+P+
Sbjct: 296 LAHPYLAEYHDPEDEPVA 313
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 7e-22
Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 20/261 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+++G+G FG + +N T + A K I + +++ +DI++EI ++ P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTK 66
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+ G+Y + ++ME GG D ++ G E A+I R I+ + H +HR
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEI 262
D+K N LLS E+ +K DFG++ + + ++ R+ VG+ +++APEV+++ Y +
Sbjct: 126 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI----SSSAKDLVRR 318
DIWS G+ L G PP + I + + PT+ S K+ V
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 235
Query: 319 MLTQDPKKRITSAQVLEHPWI 339
L ++P R T+ ++L+H +I
Sbjct: 236 CLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 8e-22
Identities = 85/285 (29%), Positives = 126/285 (44%), Gaps = 55/285 (19%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSI---SKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+LG G G TG A K + +K + + I RE+QIM P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV-----RKQILRELQIMHECR-SPY 64
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIV-------NVV 193
IV F GA+ ++ ++ + ME G L DRI K G I ++V NV
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI----VGSAYYV 249
I MHRD+KP N L++S+ + +K DFG+S G++ I VG++ Y+
Sbjct: 124 RI------MHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYM 169
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK--------GIFDAILQGDIDF 300
+PE ++ +Y + D+WS G+ + L G PF GI D + Q I
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ--IVQ 227
Query: 301 ESAPWPTISSS-----AKDLVRRMLTQDPKKRITSAQVLE-HPWI 339
E P P + SS +D V L +DP +R T Q+ P+I
Sbjct: 228 E--PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (245), Expect = 9e-22
Identities = 91/319 (28%), Positives = 144/319 (45%), Gaps = 51/319 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K++G G+FG +L T F K+IS R L + +K + E+ +M+ L
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HK 72
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVV 193
NIV + + +K Q ++++ME C G+L R I K G E A I R +++ +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 194 HICHFMG-------VMHRDLKPENFLLSSK--------------DENALLKATDFGLSVF 232
CH + V+HRDLKP+N LS+ + + K DFGLS
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 233 IEEGKVYRDIVGSAYYVAPEVL---RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
I + VG+ YY +PE+L + Y + D+W+ G I+Y L SG PF
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--- 248
Query: 290 FDAILQGDIDFESAPWPTISSSAKD---LVRRMLTQDPKKRITSAQVLEHPWIK------ 340
F ++ + + P I +K+ L++ +L K+R ++ Q L + IK
Sbjct: 249 FSQLIS---ELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPPV 305
Query: 341 --EGGEASDKPIDSAVLSR 357
GG A AV++R
Sbjct: 306 GAAGGGAGVAAAPGAVVAR 324
|
Length = 1021 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 15/260 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+E+G G FG Y + A K +S + DI +E++ +Q L PN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++G Y + + +VME C G + K E A++ + + H ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRYGK 260
D+K N LLS E L+K DFG + + + VG+ Y++APEV+ +Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-FESAPWPTISSSAKDLVRRM 319
++D+WS G+ L PP + I Q + +S W S ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 320 LTQDPKKRITSAQVLEHPWI 339
L + P+ R TS +L+H ++
Sbjct: 251 LQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 15/270 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
ED + ++ +E+G G FG Y + T A K +S + DI +E++ +Q
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
+ PN +E+KG Y + + +VME C G + K E A+I + +
Sbjct: 81 RIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRD+K N LL+ E +K DFG + + VG+ Y++APEV+
Sbjct: 140 YLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVI 193
Query: 255 ----RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-DFESAPWPTIS 309
+Y ++D+WS G+ L PP + I Q + +S W S
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---S 250
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
++ V L + P+ R TS ++L+H ++
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 81/317 (25%), Positives = 130/317 (41%), Gaps = 64/317 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----R 128
P+ D Y ++G+G FG + T + A K K++ +N+K+ R
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALR 60
Query: 129 EIQIMQHLSGQPNIVEF--------KGAYEDKQSVHVVMELC----AGGELFDRIIAKGH 176
EI+I+Q L N+V K S ++V E C AG L K
Sbjct: 61 EIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVK-- 115
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VF--- 232
++ + + ++N ++ H ++HRD+K N L++ ++ +LK DFGL+ F
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLS 172
Query: 233 -IEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
+ Y + V + +Y PE+L R YG ID+W AG I+ + + P TE+
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 290 FDAILQ--GDIDFESAP-------------------------WPTISS-SAKDLVRRMLT 321
I Q G I E P P + A DL+ ++L
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292
Query: 322 QDPKKRITSAQVLEHPW 338
DP KRI + L H +
Sbjct: 293 LDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 69/259 (26%), Positives = 128/259 (49%), Gaps = 20/259 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FG + +N T + A K I + +++ +DI++EI ++ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYY 68
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
G+Y + ++ME GG D ++ G + E A++ + I+ + H +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDI 264
K N LLS E +K DFG++ + + ++ R+ VG+ +++APEV+++ Y + DI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI----SSSAKDLVRRML 320
WS G+ L G PP + I + PT+ S K+ + L
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-------NPPTLTGEFSKPFKEFIDACL 237
Query: 321 TQDPKKRITSAQVLEHPWI 339
+DP R T+ ++L+H +I
Sbjct: 238 NKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 25/276 (9%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G FG Y TG A K I + ++ + +D EI I+ PNIV+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKL 67
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMH 203
A+ + ++ +++E CAGG + D ++ + +E +C+ + ++ H ++H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR------R 256
RDLK N L + + +K DFG+S RD +G+ Y++APEV+ R
Sbjct: 127 RDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP--WPTISSSAKD 314
Y + D+WS G+ L + PP + I + + + P W SS KD
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKD 240
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+++ L ++ R T+ Q+L+HP++ S+KPI
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFVT---VNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 16/251 (6%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG + L + +A K + K + D D ++ E + + S P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + +V+E GG+L + + E A I ++ H G+++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDI 264
K +N LL D + +K TD+G+ + G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 265 WSAGVILYILLSGVPPF-------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
W+ GV+++ +++G PF TE +F IL+ I +S A +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHVLK 235
Query: 318 RMLTQDPKKRI 328
L +DPK+R+
Sbjct: 236 GFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 7e-21
Identities = 63/180 (35%), Positives = 93/180 (51%), Gaps = 12/180 (6%)
Query: 166 ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225
E+ R + E A + ++ VH H ++HRD+K N LL S N L+K
Sbjct: 129 EIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLG 185
Query: 226 DFGLSVFIE---EGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPF 281
DFG S V R G+ YYVAPE+ RR+ Y K+ D++S GV+LY LL+ PF
Sbjct: 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245
Query: 282 WAETEKGIFDAILQGDIDFESAPWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
E + + L G D P P +IS +++V +L+ DPK+R +S+++L P K
Sbjct: 246 DGENMEEVMHKTLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 83/300 (27%), Positives = 134/300 (44%), Gaps = 47/300 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSG 138
Y ++LG+G +G+ + + T A K I +N D + REI +Q L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD---AFRNATDAQRTFREIMFLQELGD 65
Query: 139 QPNIVEFKGAY--EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
PNIV+ E+ + +++V E +L +I + I ++ +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFE-YMETDL-HAVIRANILEDVHKRYIMYQLLKALKYI 123
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR------DIVGSAYYVA 250
H V+HRDLKP N LL+S +K DFGL+ + E + D V + +Y A
Sbjct: 124 HSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 251 PEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-------DID-- 299
PE+L RY K +D+WS G IL +L G P F + + I++ DI+
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 300 --------FESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+S P P S A DL++++L +P KR+T+ + LEHP++ +
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 36/242 (14%)
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASI 185
REI +M+ L NIV + + +V E + D +G S
Sbjct: 47 REISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSF 105
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL--SVFIEEGKVYRDIV 243
++ + CH V+HRDLKP+N L++ + E LK DFGL + I ++V
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVV 162
Query: 244 GSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIF------- 290
+ +Y AP+VL R Y IDIWS G I+ +++G P F IF
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT 221
Query: 291 DAILQG-------DIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
++ G F P +P DL+ R+L +P+ RI++ L+H
Sbjct: 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
Query: 337 PW 338
PW
Sbjct: 282 PW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 69/305 (22%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND-KDDIKREIQIMQHLSGQPNIV 143
ELG G GV +G A K I L K ++ I RE++++ H P IV
Sbjct: 7 GELGAGNGGVVTKVLHRPSGLIMARKLI---HLEIKPAIRNQIIRELKVL-HECNSPYIV 62
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--- 200
F GA+ + + ME GG L D+++ K A I +I+ + I G
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPENILGKISIAVLRGLTY 114
Query: 201 ------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI----VGSAYYVA 250
+MHRD+KP N L++S+ E +K DFG+S G++ + VG+ Y++
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMS 166
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDID------- 299
PE L+ Y + DIWS G+ L + G P K +F +
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226
Query: 300 -------------FE------SAPWPTI-----SSSAKDLVRRMLTQDPKKRITSAQVLE 335
FE + P P + S +D V + L ++PK+R ++ +
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286
Query: 336 HPWIK 340
HP+IK
Sbjct: 287 HPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G +G Y T G A K + + ++I+ E I+Q L PN+V+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 147 GAY--EDKQS---VHVVMELCAGG---ELFDRIIAKGHYSERAAAS--ICRSIVNVVHIC 196
G + DK + +V+ELC GG EL ++ G + A S + +++ + H+
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL- 144
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI-VGSAYYVAPEVLR 255
H ++HRD+K N LL+++ +K DFG+S + ++ R+ VG+ +++APEV+
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 256 ------RRYGKEIDIWSAGVILYILLSGVPP-FWAETEKGIFDAILQGDIDFESAPWPTI 308
Y D+WS G+ L G PP F K +F P PT+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--------KIPRNPPPTL 253
Query: 309 SSSAK------DLVRRMLTQDPKKRITSAQVLEHPWIK 340
K + + L +D + R + +LEHP+IK
Sbjct: 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-20
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA--KGH--YSERAAASICRSIVNVVHICH 197
IV+ ++ + ++ME +GG+L +I K H + E + IV + H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV---------GSAYY 248
+MHRDLK N L ++K DFG S K Y D V G+ YY
Sbjct: 187 SRKMMHRDLKSANIFLMP---TGIIKLGDFGFS------KQYSDSVSLDVASSFCGTPYY 237
Query: 249 VAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
+APE+ R+RY K+ D+WS GVILY LL+ PF +++ I +L G D P+P
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----PFPC 293
Query: 308 -ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+SS K L+ +L+++P R T+ Q+L ++K
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 78/272 (28%), Positives = 130/272 (47%), Gaps = 30/272 (11%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVE 144
+GRG FG Y C + TG+ +A K + K+++ K + E ++ +S P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA----AASICRSIVNVVHICHFMG 200
A+ + +++L GG+L + G +SE AA I I+ + H+ H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEI---ILGLEHM-HNRF 117
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RY 258
V++RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++ Y
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAY 173
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWP-TISSSAKD 314
D +S G +L+ LL G PF K I L ++ P + S +
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----LPDSFSPELRS 228
Query: 315 LVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
L+ +L +D +R+ + +V EHP+ +
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 24/271 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG + L T R +A K I K + D D ++ E + + S P +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + + V+E +GG+L + + E A I ++ H G+++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDI 264
K +N LL D +K TD+G+ I G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 265 WSAGVILYILLSGVPPF---------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
W+ GV+++ +++G PF TE +F IL+ I ++S A +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKASSV 235
Query: 316 VRRMLTQDPKKRITS------AQVLEHPWIK 340
++ L +DPK+R+ + HP+ +
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 73/317 (23%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQH 135
Y +LG G FG Y + TGR A K K++ N+KD REI+I++
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63
Query: 136 LSGQPNIVEF--------KGAYEDKQSVHVVM-----ELCAGGELFDRIIAKGHYSERAA 182
L PN+V + + SV++V +L G L + + +E
Sbjct: 64 LK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQI 117
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---- 238
++ ++ H ++HRD+K N L+ D +LK DFGL+ +
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKG 174
Query: 239 --------YRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE-- 286
Y ++V + +Y PE+L RRY +DIW G + + + P +++
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234
Query: 287 --KGIFDAI----------------LQGDIDFESAPWPTISSSAK-------DLVRRMLT 321
IF +G F + P T+ DL+ ++L+
Sbjct: 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLS 293
Query: 322 QDPKKRITSAQVLEHPW 338
DP KR+T++ LEHP+
Sbjct: 294 LDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 40/296 (13%)
Query: 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
TI+ + D + + +G+G +G + G + A K + + ++I+
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIE 62
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVH-----VVMELCAGGELFDRIIAKG------H 176
E I++ LS PN+V+F G Y K + +V+ELC GG + D + KG
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGFLKRGER 120
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
E A I + + H +HRD+K N LL+++ +K DFG+S +
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTST 177
Query: 237 KVYRDI-VGSAYYVAPEV------LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
++ R+ VG+ +++APEV L Y D+WS G+ L G PP A+
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP-- 234
Query: 290 FDAILQGDIDFESAPWPTI------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
++ P PT+ S+ D +R+ LT+D +KR T + +L+H +I
Sbjct: 235 ----MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 82/298 (27%), Positives = 126/298 (42%), Gaps = 68/298 (22%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD-------IKREIQIMQHLSGQ 139
+G G +GV Y + TG A K I + + +D I REI +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAI-REISLLKELN-H 57
Query: 140 PNIVEFKGAYEDKQSVHVV-----------MELCAGGELFDRIIAKGHYSERAAASICRS 188
PNIV + +++V M+ L +I Y + +
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------LLQG 111
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAY 247
I CH V+HRDLKP+N L+ D LK DFGL+ F + Y V + +
Sbjct: 112 IA----YCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLW 164
Query: 248 YVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IF-------DAIL 294
Y APE+L R+Y +DIWS G I +++ P F ++E IF + +
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224
Query: 295 QGDI---DFESA-P-W---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
G D++ P W P + DL+ +ML DP KRI++ L+HP+
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 90/304 (29%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSI---------SKR-----KLVTKNDKDDIKREI 130
+ +G G FGV + T+ G++ A K + KR K++ D++ +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
I+Q P+I F + ++VV EL +L I++ S I+
Sbjct: 66 DILQ----PPHIDPF-------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE--EGKVYRDIVGSAYY 248
+ H G++HRD+KP N L++S N +LK DFGL+ E E K V + YY
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 249 VAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFE--- 301
APE+L R Y +DIWS G I LL F A++ D I L G E
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230
Query: 302 ------------SAPWP-------TISS----SAKDLVRRMLTQDPKKRITSAQVLEHPW 338
P T+SS A L+ RML DP KRI++A L HP+
Sbjct: 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
Query: 339 IKEG 342
+ EG
Sbjct: 291 LDEG 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 14/251 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K++GRGQF Y T + A K + +++ + D +EI +++ L+ PN+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIK 66
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICHFMG 200
+ ++ + +++V+EL G+L I K ER + + V H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRRR-Y 258
VMHRD+KP N +++ +K D GL F + +VG+ YY++PE + Y
Sbjct: 127 VMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT--ISSSAKDLV 316
+ DIWS G +LY + + PF+ +K ++ Q + P PT S ++LV
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241
Query: 317 RRMLTQDPKKR 327
+ DP +R
Sbjct: 242 SMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 69/259 (26%), Positives = 124/259 (47%), Gaps = 20/259 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++ K++GRGQF Y T G A K + L+ + D +EI +++ L+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 61
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHIC-- 196
PN++++ ++ + +++V+EL G+L R+I H+ ++ +++ V +C
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 197 ----HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAP 251
H VMHRD+KP N +++ ++K D GL F + +VG+ YY++P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK--GIFDAILQGDIDFESAPWPTI 308
E + Y + DIWS G +LY + + PF+ + + I Q D+ P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPPLPSDHY 233
Query: 309 SSSAKDLVRRMLTQDPKKR 327
S + LV + DP+KR
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 34/283 (12%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+++G G +GV Y TG A K I + T+ REI +++ L+ PNIV+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN-HPNIVK 63
Query: 145 FKGAYEDKQSVHVVME-LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
+ +++V E L + F S ++ + CH V+H
Sbjct: 64 LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 204 RDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR--RRYGK 260
RDLKP+N L+ + +K DFGL+ F + Y V + +Y APE+L + Y
Sbjct: 124 RDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGD----------IDFESA--P 304
+DIWS G I +++ F ++E IF + D D++ +
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 305 W---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W P + +DL+ +ML DP KRI++ L HP+
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 22/264 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G +G+ Y + ST + A K I +R + EI + +L NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYL 71
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMH 203
G+ + + ME GG L + +K +E+ + I+ + H ++H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIVGSAYYVAPEVL---RRRYG 259
RD+K +N L+++ + ++K +DFG S + G+ Y+APEV+ R YG
Sbjct: 132 RDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 260 KEIDIWSAGVILYILLSGVPPFW--AETEKGIFDAILQGDIDFESAP-WPT-ISSSAKDL 315
DIWS G + + +G PPF E + +F + F+ P P +S+ AK+
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-----FKIHPEIPESLSAEAKNF 244
Query: 316 VRRMLTQDPKKRITSAQVLEHPWI 339
+ R DP KR ++ +L+ P++
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ---PNIV 143
+GRG FG Y C + TG+ +A K + K+++ K + E +IM L P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
A+ + +++L GG+L + G +SE+ I+ + H V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKE 261
RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWPTISSSAKDLVRR 318
D +S G +L+ LL G PF K I L +++ + S K L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKSLLEG 232
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIK 340
+L +D KR+ + +V EH + K
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 81/335 (24%), Positives = 137/335 (40%), Gaps = 77/335 (22%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-- 127
LG Y D++ LG G G+ + ++ ++ A K I D +K
Sbjct: 3 LGSRYMDLR-------PLGCGSNGLVFSAVDSDCDKRVAVKKIVLT------DPQSVKHA 49
Query: 128 -REIQIMQHLSGQPNIVE-----FKGAYEDKQSVHVVMEL---CAGGELFD----RIIAK 174
REI+I++ L NIV+ + + V + EL E + ++ +
Sbjct: 50 LREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ 108
Query: 175 GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
G SE A ++ + H V+HRDLKP N +++ E+ +LK DFGL+ ++
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVD 166
Query: 235 -----EGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
+G + +V + +Y +P +L Y K ID+W+AG I +L+G P F E
Sbjct: 167 PHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
Query: 288 GIFDAILQGDIDFESAP--------------------------------WPTISSSAKDL 315
IL ES P P ++ A D
Sbjct: 226 EQMQLIL------ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+ ++LT +P R+T+ + L HP++ D+P+
Sbjct: 280 LEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 59/303 (19%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQHLSG 138
+++G G +GV Y + T A K I + +++D REI +++ +
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQ- 59
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--------SERAAASICRSIV 190
NIV + ++ +++V E + + K H + R + I+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFE-------YLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYV 249
+ CH V+HRDLKP+N LL + NA LK DFGL+ F + + V + +Y
Sbjct: 113 RGIAYCHSHRVLHRDLKPQN-LLIDRRTNA-LKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 250 APEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ------------ 295
APE+L R Y +DIWS G I +++ P F ++E I +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 296 --GDIDFESA--PW---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
D++SA W PT+ + DL+ +ML DP KRIT+ LEH + K+
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
Query: 343 GEA 345
G+A
Sbjct: 291 GDA 293
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 61/316 (19%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN--DKDDIKREIQIMQHLSG 138
Y + +G+G +GV + TG + A K I+ V ++ D I REI++++ L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND---VFEHVSDATRILREIKLLRLLR- 57
Query: 139 QPNIVEFKG-----AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
P+IVE K + + + ++VV EL +L I A + ++ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKV--YRDIVGSAYYV 249
H V HRDLKP+N L ++ + LK DFGL+ F + + D V + +Y
Sbjct: 117 KYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 250 APEV---LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI--DFESAP 304
APE+ +Y IDIWS G I +L+G P F + + + Q D+ D P
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------NVVHQLDLITDLLGTP 227
Query: 305 -------------------------------WPTISSSAKDLVRRMLTQDPKKRITSAQV 333
+P A L+ R+L DPK R T+ +
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287
Query: 334 LEHPWIKEGGEASDKP 349
L P+ K + +P
Sbjct: 288 LADPYFKGLAKVEREP 303
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 41/100 (41%), Positives = 61/100 (61%), Gaps = 3/100 (3%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+A+ L+ E+I K+ F+ D D GTIT +EL + LG TEAE+Q ++ D DG
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 435 NGTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
NGTID+ EF+T M R + D + + +AF+ FD+D +G
Sbjct: 61 NGTIDFPEFLT-LMARKMKDTDSEEEIKEAFKVFDRDGNG 99
|
Length = 149 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 77/327 (23%), Positives = 144/327 (44%), Gaps = 57/327 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L + TG+ +A K++ K ++ K+ +K E ++ S P +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVS 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++D Q ++++ME GG+L +I +SE V + H +G +HR
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 205 DL-------------KPENFLLSS----KDENA----LLKATDFGLSVFIEEGKVYRDI- 242
D+ K +F LS+ + ++A LL+ + I
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 243 -----------------------VGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGV 278
VG+ Y+APE+ L++ YG+E D WS G I++ L G
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGW 245
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWP---TISSSAKDLVRRMLTQDPKKRI---TSAQ 332
PPF +E + I+ E+ +P +S A+DL+RR++T + + R+ + +
Sbjct: 246 PPFCSENSHETYRKIINWR---ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301
Query: 333 VLEHPWIKEGGEASDKPIDSAVLSRMK 359
+ HP+ + + + I + + ++K
Sbjct: 302 IKSHPFFRGVDWDTIRQIRAPFIPQLK 328
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 37/264 (14%)
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKG 147
G+FG + T + F K I K I+ M H + PN ++
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKII----------KAKNFNAIEPMVHQLMKDNPNFIKLYY 76
Query: 148 AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLK 207
+ + ++M+ G+LFD + +G SE I R +V ++ H ++H D+K
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136
Query: 208 PENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWS 266
EN L + L D+GL I Y G+ Y +PE ++ Y D W+
Sbjct: 137 LENVLYDRAKDRIYL--CDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSFDWWA 191
Query: 267 AGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES---------APWPTISSSAKDLVR 317
GV+ Y LL+G PF + ++ ++D ES +S +A D V+
Sbjct: 192 VGVLTYELLTGKHPFKEDEDE---------ELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242
Query: 318 RMLTQDPKKRITS-AQVLEHPWIK 340
ML + R+T+ ++++HP++K
Sbjct: 243 SMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 75/270 (27%), Positives = 122/270 (45%), Gaps = 24/270 (8%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
E+GRG FG +G A K I R V + ++ + ++ ++ S P IV+F
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 146 KGAYEDKQSVHVVMELCAGG-ELFDRII---AKGHYSERAAASICRSIVNVV-HICHFMG 200
GA + + MEL + F + + K E I + V + ++ +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRY 258
++HRD+KP N LL D N +K DFG+S + + G Y+APE + R
Sbjct: 129 IIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARD 185
Query: 259 GKEI--DIWSAGVILYILLSGVPPF--WAETEKGIFDAILQ---GDID-FESAPWPTISS 310
G ++ D+WS G+ LY + +G P+ W +FD + Q GD ++ S
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQLTQVVKGDPPILSNSEEREFSP 241
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
S + + L +D KR ++LEHP+IK
Sbjct: 242 SFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 4e-17
Identities = 25/60 (41%), Positives = 37/60 (61%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L++ F D D GTI+ +ELKA L LG L+E E+ +++ D DG+G ID+ EF+
Sbjct: 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLEL 61
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSG--Q 139
E+G G +G Y + +G A KS+ + ++D + RE+ +++ L
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVR-----VQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 140 PNIVEF----KGAYEDKQSV------HVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
PNIV + D+++ HV +L D++ G +E + R
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRT---YLDKVPPPGLPAETIK-DLMRQF 117
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
+ + H ++HRDLKPEN L++S + +K DFGL+ +V + +Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 250 APEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAI-------LQGD 297
APEV L+ Y +D+WS G I + P F +E IFD I D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 298 IDFESAPW------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+ + P I S L+ MLT +P KRI++ + L+HP+
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 7e-17
Identities = 39/97 (40%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT 437
L+ E+IQ LK+ F D D+ G I EL L LG +EAE+ +L E D GN T
Sbjct: 13 QLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEID-AGNET 71
Query: 438 IDYIEFITATMHRHKLERDDH--LYKAFQHFDKDNSG 472
+D+ EF+T M D L +AF+ FDKD+ G
Sbjct: 72 VDFPEFLTV-MSVKLKRGDKEEELREAFKLFDKDHDG 107
|
Length = 160 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 54/292 (18%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPN 141
++G G +G + T A K + +D + + REI +++ L N
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK-HKN 60
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA--ASICRSIVNV----VHI 195
IV + + +V E C D+ + K S I +S + +
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL 254
CH V+HRDLKP+N L+ ++N LK DFGL+ F + Y V + +Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETE-----KGIFDAI-------------L 294
+ Y ID+WSAG I L + P + + K IF + L
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 295 QGDIDFESAP----W----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ P P ++S+ +DL++ +L +P +RI++ + L+HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 59/222 (26%), Positives = 111/222 (50%), Gaps = 16/222 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+F KELG GQFGV +L + + A K+I++ + ++D E ++M LS P
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPK 60
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMG 200
+V+ G ++ +++V E G L + + + G S+ S+C+ + +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-R 256
+HRDL N L+SS ++K +DFG++ ++ + + Y G+ + V PEV
Sbjct: 121 FIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFS 176
Query: 257 RYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGD 297
+Y + D+WS GV+++ + G PF ++ + + I +G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 16/225 (7%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+F KELG GQFGV +L A K I + + +DD E ++M LS
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAM----SEDDFIEEAKVMMKLS 57
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
PN+V+ G ++ + +V E A G L + + KG +C + +
Sbjct: 58 -HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEV 253
G +HRDL N L+ E+ ++K +DFGL+ ++ + + Y G+ + V PEV
Sbjct: 117 ESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEV 172
Query: 254 L-RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
R+ + D+WS GV+++ + S G P+ + + +++ G
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 16/221 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ +E+G GQFG+ +L R+ A K+I + + ++D E Q+M LS P
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPK 60
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMG 200
+V+ G ++ + +V E G L D + A +G +S+ +C + +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-R 256
V+HRDL N L+ EN ++K +DFG++ F+ + + Y G+ + V +PEV
Sbjct: 121 VIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+Y + D+WS GV+++ + S G P+ + + + I G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 55/183 (30%), Positives = 78/183 (42%), Gaps = 51/183 (27%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGL----SVFIEEGKVYRDIVGSAYYVAP 251
CH V+HRDLKP+N L+S + E LK DFGL SV K Y + V + +Y P
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRPP 172
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------A 303
+VL Y +D+W G I Y + +G P F G D Q F
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF-----PGSTDVEDQLHKIFRVLGTPTEE 227
Query: 304 PWPTISS----------------------------SAKDLVRRMLTQDPKKRITSAQVLE 335
WP +SS ++L + L +PKKRI++A+ ++
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 336 HPW 338
HP+
Sbjct: 288 HPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 21/268 (7%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELGRG +GV TG A K I R V ++ + ++ I P V F
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 146 KGAYEDKQSVHVVMELCAGG--ELFDRIIAKG-HYSERAAASICRSIVNVVHICHF-MGV 201
GA + V + ME+ + + ++ KG E I SIV + H + V
Sbjct: 66 YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL-----RR 256
+HRD+KP N L+ + N +K DFG+S ++ + G Y+APE + ++
Sbjct: 126 IHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP-WP--TISSSAK 313
Y + D+WS G+ + L +G P+ ++ K F + Q + E +P P S +
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQ--VVEEPSPQLPAEKFSPEFQ 238
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341
D V + L ++ K+R ++L+HP+ +
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 77/301 (25%), Positives = 135/301 (44%), Gaps = 53/301 (17%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G GV + + +G A K I + ++ I RE+Q++ H P IV F
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 68
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVN-VVHICHFMGVMH 203
GA+ + + ME GG L D+++ K G E+ + +++ + ++ +MH
Sbjct: 69 YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 127
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEI 262
RD+KP N L++S+ E +K DFG+S + + + VG+ Y++PE L+ Y +
Sbjct: 128 RDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 263 DIWSAGVILYILLSG---VPPFWAETEKGIFDAILQGD-IDFESAPWP------------ 306
DIWS G+ L + G +PP A+ + +F ++GD + E++P P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243
Query: 307 --------------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ +D V + L ++P +R Q++ H +IK
Sbjct: 244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303
Query: 341 E 341
Sbjct: 304 R 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 74/276 (26%), Positives = 106/276 (38%), Gaps = 48/276 (17%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKR--- 128
ED+ L G+ +G GQFG Y + A K KN R
Sbjct: 6 EDITL----GRCIGEGQFGDVYQGVYMSPENEKIAVAVK-------TCKNCTSPSVREKF 54
Query: 129 --EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI- 185
E IM+ P+IV+ G + V +VMEL GEL Y + S+
Sbjct: 55 LQEAYIMRQFD-HPHIVKLIGVITE-NPVWIVMELAPLGEL-------RSYLQVNKYSLD 105
Query: 186 -------CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
+ + +HRD+ N L+SS D +K DFGLS ++E+
Sbjct: 106 LASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESY 162
Query: 239 YRDIVGS--AYYVAPEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAIL 294
Y+ G ++APE + RR+ D+W GV ++ IL+ GV PF + I
Sbjct: 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222
Query: 295 QGDIDFESAPWPTISSSA-KDLVRRMLTQDPKKRIT 329
G E P P L+ + DP KR
Sbjct: 223 NG----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPR 254
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 70/317 (22%), Positives = 123/317 (38%), Gaps = 60/317 (18%)
Query: 82 SFGKELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHL 136
+G+ + +L T A K I+ + K+D+K EI + L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN----LDSCSKEDLKLLQQEIITSRQL 56
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY----SERAAASICRSIVNV 192
PNI+ + ++ ++VV L A G D + K H+ E A A I + ++N
Sbjct: 57 Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA------ 246
+ H G +HR +K + LLS D +L + +S I+ GK R +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKSSVKN 171
Query: 247 -YYVAPEVLR---RRYGKEIDIWSAGVILYILLSGVPPFWAETE---------KGIFDAI 293
+++PEVL+ + Y ++ DI+S G+ L +G PF + +G +
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTVPCL 230
Query: 294 L--------QGDI--DFESAPWPTISSSAKDLVRRM------------LTQDPKKRITSA 331
L + + S P S R L +DP+ R +++
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290
Query: 332 QVLEHPWIKEGGEASDK 348
Q+L H + K+ +
Sbjct: 291 QLLNHSFFKQCKRRNTS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+++G+G FG Y + A K+ R + + K +E +I++ PNIV+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNT-EVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
G KQ +++VMEL GG L + K + + + + +H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY------YVAPEVLRR- 256
RDL N L+ EN +LK +DFG+S EEG +Y V + APE L
Sbjct: 117 RDLAARNCLV---GENNVLKISDFGMSR-EEEGGIY--TVSDGLKQIPIKWTAPEALNYG 170
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPF 281
RY E D+WS G++L+ S G P+
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G G+ + G A K +S R + RE+ +++ ++ NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVN-HKNIIS 84
Query: 145 FKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
+ E+ Q V++VMEL ++I ER + + + + + H+ H
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHL-HS 141
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRR 257
G++HRDLKP N ++ S + LK DFGL+ + V + YY APEV L
Sbjct: 142 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ----GDIDFESAPWPTI----- 308
Y + +DIWS G I+ L+ G F ++ +++ +F + PT+
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258
Query: 309 -----------------------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S A+DL+ +ML DP KRI+ + L HP+I
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 80/289 (27%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLS 137
Y + +G+G G YL + R+ A K I R+ +++N K RE +I L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI--REDLSENPLLKKRFLREAKIAADLI 60
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--------RIIAKGHY---SERAAASIC 186
P IV D V+ M G L ++K S A SI
Sbjct: 61 -HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE------------ 234
I + H GV+HRDLKP+N LL E +L D+G ++F +
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVD 176
Query: 235 -EGKVYRD------IVGSAYYVAPEVLRRRYGKE-IDIWSAGVILYILLSGVPPFWAETE 286
Y IVG+ Y+APE L E DI++ GVILY +L+ P+ +
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
Query: 287 KGI-FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+ I + ++ I E AP+ I + + L DP +R +S Q L
Sbjct: 237 RKISYRDVILSPI--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 74/258 (28%), Positives = 113/258 (43%), Gaps = 33/258 (12%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+ +GRG FG + + A KS R+ + + K +E +I++ S PNIV
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYS-HPNIVR 57
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG---------HYSERAAASICRSIVNVVHI 195
G KQ +++VMEL GG+ + +G E AAA + + H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGM--EYLESKH- 114
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG----SAYYVAP 251
+HRDL N L++ K+ +LK +DFG+S E+G VY G + AP
Sbjct: 115 -----CIHRDLAARNCLVTEKN---VLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAP 165
Query: 252 EVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
E L RY E D+WS G++L+ S G P+ + + +AI QG
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPCPELCP 222
Query: 310 SSAKDLVRRMLTQDPKKR 327
+ L+ R DP +R
Sbjct: 223 DAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 85 KELGRGQFGVTYLC----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++LG G FG LC ++TG Q A KS+ N D+K+EI+I+++L +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE- 66
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAKGHYSERAAASI-CRSIVN-VVHIC 196
NIV++KG + + ++ME G L + Y R I + + V IC
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119
Query: 197 HFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR----DIVGSA 246
M + HRDL N L+ S+ + +K DFGL+ IE K Y D+
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 247 YYVAPEVL-RRRYGKEIDIWSAGVILYILLS 276
++ APE L + ++ D+WS GV LY LL+
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 4/146 (2%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K + RG FG YL + + + +A K + K ++ KN ++ E + LS P IV
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVH 68
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+ + +V++VME GG++ + G++ E A + + H G++HR
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 205 DLKPENFLLSSKDENALLKATDFGLS 230
DLKP+N L+S++ +K TDFGLS
Sbjct: 129 DLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 21/284 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G G Y T R A K I +T + I E++I+ + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEIL-YKCDSPYIIGFY 65
Query: 147 GAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
GA+ + + + E GG L + +I E I ++V + + ++HR
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKI------PEHVLGRIAVAVVKGLTYLWSLKILHR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE-VLRRRYGKEID 263
D+KP N L++++ + +K DFG+S + + + VG+ Y+APE + +YG D
Sbjct: 120 DVKPSNMLVNTRGQ---VKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 264 IWSAGVILYILLSGVPPF-WAETEKGIFDAI--LQGDIDFESAPWPT--ISSSAKDLVRR 318
+WS G+ L G P+ + +G + LQ +D + P S + +
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
+ + PK+R +++HP+I + + + + + V +++ R
Sbjct: 236 CMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEERR 279
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 16/223 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+F KELG GQFGV A K I + + +D+ E ++M LS
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA-ASICRSIVNVVHICHF 198
+V+ G ++ +++V E + G L + + G + + +C+ + +
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR 255
+HRDL N L+ D+ +K +DFGLS ++ + + Y VGS + V PEVL
Sbjct: 119 KQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLL 174
Query: 256 R-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
++ + D+W+ GV+++ + S G P+ + + QG
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 72/271 (26%), Positives = 105/271 (38%), Gaps = 38/271 (14%)
Query: 85 KELGRGQFGVTYLCT-ENSTGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K+LG G FGV S G+ A K + KL + DD +E IM L N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD-HEN 57
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRI--IAKGHYSERAAASICRSIVNVVHICHFM 199
++ G + +V EL G L DR+ A GH+ I N +
Sbjct: 58 LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---------- 249
+HRDL N LL+S D +K DFGL + + + +YV
Sbjct: 117 RFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNE--------DHYVMEEHLKVPFA 165
Query: 250 --APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
APE LR R + D+W GV L+ + + G P+ + I I D + E
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---DKEGERLER 222
Query: 306 PTISSS-AKDLVRRMLTQDPKKRITSAQVLE 335
P +++ + +P R T A + E
Sbjct: 223 PEACPQDIYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 65/259 (25%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEF 145
+G G+FG G++ +I K T+ + D E IM PNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70
Query: 146 KGAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
+G + V ++ E G L F R G ++ + R I + M +H
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAY---YVAPEVLR-R 256
RDL N L++S N + K +DFGLS F+E+ Y +G + APE + R
Sbjct: 130 RDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
++ D+WS G++++ ++S G P+W + + + +AI Q D+ P ++ L
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQL 243
Query: 316 VRRMLTQDPKKRITSAQVL 334
+ +D R Q++
Sbjct: 244 MLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 85 KELGRGQFG-VTYLC---TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG G FG V+ C + TG A K++ KR+ +N K+EI I++ L +
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQN-TSGWKKEINILKTLYHE- 66
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
NIV++KG ++ + + ++ME G L D Y + ++ + ++ IC
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 199 MGVMH------RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY----RDIVGSAYY 248
M +H RDL N LL D + L+K DFGL+ + EG Y D ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 249 VAPEVLRR-RYGKEIDIWSAGVILYILLS 276
A E L+ ++ D+WS GV LY LL+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 42/315 (13%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
L K +V Y +G G +G + TG + A K +S R + RE
Sbjct: 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 66
Query: 130 IQIMQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+++++H+ G ++ + E+ V++V L G +L + I+ ++
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQF 124
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ I+ + H ++HRDLKP N + +E+ LK DFGL+ ++ V
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMT--GYVA 179
Query: 245 SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302
+ +Y APE++ Y + +DIWS G I+ LL+G F IL+ +
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 303 APWPTISSS---------------------------AKDLVRRMLTQDPKKRITSAQVLE 335
ISS A DL+ +ML D KRIT+AQ L
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299
Query: 336 HPWIKEGGEASDKPI 350
H + + + D+P+
Sbjct: 300 HAYFAQYHDPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 53/300 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G G+ + R A K +S R + RE+ +M+ ++ NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVN-HKNIIS 80
Query: 145 FKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
+ E+ Q V++VMEL ++I ER + + + + + H+ H
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 137
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRR 257
G++HRDLKP N ++ S + LK DFGL+ + V + YY APEV L
Sbjct: 138 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 258 YGKEIDIWSAGVIL------YILLSG-----------------VPPFWAETEKGIFDAI- 293
Y + +DIWS G I+ IL G P F + + + + +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 294 -------LQGDIDFESAPWPTIS-------SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
L F + +P S S A+DL+ +ML DP KRI+ + L+HP+I
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 80 HYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
H F ++LG+G FG LC +++TG A K K + T D +REI+I++
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKS 61
Query: 136 LSGQPNIVEFKG-AYE-DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
L NIV++KG Y ++++ +VME G L D + + ER + ++
Sbjct: 62 LQHD-NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ---KHRERLDHR--KLLLYAS 115
Query: 194 HICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV---- 243
IC M + HRDL N L+ S+ +K DFGL+ + + K Y +
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 244 GSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLS 276
++ APE L ++ D+WS GV+LY L +
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 75/312 (24%), Positives = 131/312 (41%), Gaps = 50/312 (16%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISK---RKLVTKNDKDDIKREIQI 132
+V Y K++G G +G + TG + A K + + +L K RE+++
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR----AYRELRL 67
Query: 133 MQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR 187
++H+ G ++ + + ++VM G +++ SE +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVY 125
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
++ + H G++HRDLKP N + +E+ LK DFGL+ + V + +
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRW 180
Query: 248 YVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAE--------------TEKGIFD 291
Y APEV+ Y + +DIWS G I+ +L+G P F T F
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240
Query: 292 AILQGD--------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
LQ + DF S P + A +++ +ML D + RIT+A+ L HP
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299
Query: 338 WIKEGGEASDKP 349
+ +E + D+
Sbjct: 300 YFEEFHDPEDET 311
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 90/326 (27%), Positives = 140/326 (42%), Gaps = 72/326 (22%)
Query: 66 TNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
T T+L K Y+++K +G G G+ + TG+ A K +S R
Sbjct: 11 TFTVL-KRYQNLKP-------IGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKR 61
Query: 126 IKREIQIMQHLSGQPNIVEFKGAY------EDKQSVHVVME-----LCAGGELFDRIIAK 174
RE+ +M+ L NI+ + E+ Q V++VME LC ++I
Sbjct: 62 AYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQM 113
Query: 175 GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
ER + + + + + H+ H G++HRDLKP N ++ S + LK DFGL+
Sbjct: 114 DLDHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAG 169
Query: 235 EGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPF--------WAE- 284
+ V + YY APEV L Y + +DIWS G I+ ++ G F W +
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
Query: 285 -----TEKGIFDAILQGDID--FESAP---------------WPTISSS--------AKD 314
T F + LQ + E+ P +P S S A+D
Sbjct: 230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIK 340
L+ +ML DP+KRI+ L+HP+I
Sbjct: 290 LLSKMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ-----HLSGQ 139
K +G G G+ + R A K +S R + RE+ +M+ ++ G
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+ + + E+ Q V++VMEL ++I ER + + + + + H+ H
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRRY 258
G++HRDLKP N ++ S + LK DFGL+ + V + YY APEV L Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 259 GKEIDIWSAGVILYILLSGVPPF--------WAETEKGI------FDAILQGDID--FES 302
+ +DIWS G I+ ++ G F W + + + F LQ + E+
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 303 AP----------WPTI------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
P +P + +S A+DL+ +ML D KRI+ + L+HP+I
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 42/177 (23%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGL----SVFIEEGKVYRDIVGSAYYVAP 251
CH ++HRDLKP+N L++ K E LK DFGL SV K Y + V + +Y P
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNEVVTLWYRPP 172
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAPWPT 307
+VL Y ID+W G ILY + +G P F T K I L G E+ WP
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET--WPG 230
Query: 308 ISSSAK--------------------------DLVRRMLTQDPKKRITSAQVLEHPW 338
I+S+ + DL+ +L + K RI++ L H +
Sbjct: 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 77/314 (24%), Positives = 135/314 (42%), Gaps = 55/314 (17%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
++ Y+ K++G G +G + TG + A K +S R ++ RE+ +++H
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKH 70
Query: 136 L-----SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI----IAKGHYSERAAASIC 186
+ G ++ + ++ Q ++VM + + I SE +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMP-------YMQTDLQKIMGHPLSEDKVQYLV 123
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGS 245
++ + H G++HRDLKP N + +E+ LK DFGL+ + E Y V +
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGY---VVT 177
Query: 246 AYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-----GDI 298
+Y APEV+ Y + +DIWS G I+ +L+G F + IL+ G
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP- 236
Query: 299 DF-------------ESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+F +S P +P S A DL+ +ML D KR+T+ + LE
Sbjct: 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296
Query: 336 HPWIKEGGEASDKP 349
HP+ +A ++
Sbjct: 297 HPYFDSFRDADEET 310
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 32/178 (17%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL 254
CH V+HRDLKP+N L++ + E LK DFGL+ K Y + V + +Y P++L
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--------------GDI 298
Y +ID+W G I Y + +G P F T + I + +
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236
Query: 299 DFESAPWPT------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+F+S +P + S +L+ ++L + +KRI++ + ++HP+ GE
Sbjct: 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIV 143
K +G G+FG G++ +I K T+ + D E IM PNI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNII 68
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGV 201
+G + V +V E G L D + K G ++ + R I + + MG
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG--KVYRDIVGS--AYYVAPEVLR-R 256
+HRDL N L++S N + K +DFGLS +E+ Y G + APE + R
Sbjct: 128 VHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
++ D+WS G++++ ++S G P+W + + + AI +G
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 10/101 (9%)
Query: 242 IVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300
I+G+ Y+APE+L + +G +D W+ GV L+ L+G+PPF ET + +F IL DI
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597
Query: 301 ESAPWP----TISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
PWP +S +A++ + +LT DP KR ++ +HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 73/279 (26%), Positives = 109/279 (39%), Gaps = 58/279 (20%)
Query: 87 LGRGQFGVTYLCT-----ENSTGRQ-FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
LG G FG Y T +G A K++ RK T +K + +E +M + + P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFN-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS--------------IC 186
NIV+ G + +++MEL GG+L Y A IC
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDIC 112
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA--LLKATDFGLSVFIEEGKVYRDIVG 244
+ M +HRDL N L+S K +A ++K DFGL+ RDI
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYK 163
Query: 245 SAYY------------VAPEVLRR-RYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIF 290
S YY +APE L ++ + D+WS GV+++ IL G P+ A + +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
+ G L+ QDP +R T
Sbjct: 224 QHVTAGG---RLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G GV +G A K I + ++ I RE+Q++ H P IV F
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 68
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG----- 200
GA+ + + ME GG L D+++ + A I I+ V I G
Sbjct: 69 YGAFYSDGEISICMEHMDGGSL-DQVL-------KEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 201 ----VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR- 255
+MHRD+KP N L++S+ E +K DFG+S + + + VG+ Y++PE L+
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 176
Query: 256 RRYGKEIDIWSAGVILYILLSG---VPPFWAETEKGIF 290
Y + DIWS G+ L L G +PP A+ + IF
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 54/245 (22%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KDDIKRE 129
P V+ F +ELG G FG Y + + S++ + L + + + ++E
Sbjct: 3 PLSAVR----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
++M L PNIV G +Q ++ E A G+L + ++ +S+ A S ++
Sbjct: 59 AELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 190 VN------VVHIC------------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231
+ +HI H +HRDL N L+ E +K +DFGLS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG---EGLTVKISDFGLS- 171
Query: 232 FIEEGKVYRDIVGSAYY------------VAPE-VLRRRYGKEIDIWSAGVILYILLS-G 277
RDI + YY + PE +L ++ E DIWS GV+L+ + S G
Sbjct: 172 --------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYG 223
Query: 278 VPPFW 282
+ P++
Sbjct: 224 LQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 21/222 (9%)
Query: 127 KREIQIMQHLSGQPNIVEF--KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+RE + L PNIV G + V E G L + + A G
Sbjct: 26 RRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALPAGETGR 83
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI---EEGKVYR- 240
+ +++ + H G++HRDLKP+N ++S K DFG+ + + V
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 241 ----DIVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFWAETEKGIFDA 292
+++G+ Y APE LR G+ + D+++ G+I L+G + I
Sbjct: 144 TRTTEVLGTPTYCAPEQLR---GEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
L +D PW ++R+ L +DP++R SA L
Sbjct: 201 QL-SPVDVSLPPW-IAGHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL 254
CH V+HRDLKP+N L++ + E LK DFGL+ K Y + V + +Y P+VL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
Y +ID+W G I + + SG P F T + I + WP ISS+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 313 K--------------------------DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
+ +L+ + L + KKRI++ + ++H + + G
Sbjct: 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 9e-13
Identities = 83/324 (25%), Positives = 128/324 (39%), Gaps = 82/324 (25%)
Query: 84 GKELGRGQFGVTYLC--TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
G ++GRG +G Y + +++A K I + REI +++ L PN
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-----ACREIALLRELK-HPN 59
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRI------IAKGHYSERA-----------AAS 184
++ + + V + LFD I K H + +A S
Sbjct: 60 VIALQKVFLSHSDRKVWL-------LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFL-LSSKDENALLKATDFGLS-VFIEEGKVYRD- 241
+ I++ +H H V+HRDLKP N L + E +K D G + +F K D
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 242 --IVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVP-------------PFWAE 284
+V + +Y APE+L R Y K IDIW+ G I LL+ P PF +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 285 TEKGIFDAI-LQGDIDFES----APWPTISSSAKD------------------------- 314
IF + D D+E +PT+ +
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292
Query: 315 LVRRMLTQDPKKRITSAQVLEHPW 338
L++++LT DP KRITS Q L+ P+
Sbjct: 293 LLQKLLTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR------EIQIM 133
G +G+G+FG L +K+ K KDD E +M
Sbjct: 7 ELKLGATIGKGEFGDVMLGD------------YRGQKVAVKCLKDDSTAAQAFLAEASVM 54
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
L PN+V+ G +++V E A G L D + ++G RA ++ + + +
Sbjct: 55 TTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFAL 109
Query: 194 HICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGL----SVFIEEGKVYRDIV 243
+C M +HRDL N L+S E+ + K +DFGL S + GK+
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQGQDSGKL----- 161
Query: 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276
+ APE LR +++ + D+WS G++L+ + S
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 1/95 (1%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
L+ ++ + +++ F DTD SGTI +ELK + LG + + E++Q++ D DG+G I
Sbjct: 11 LTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKI 70
Query: 439 DYIEFI-TATMHRHKLERDDHLYKAFQHFDKDNSG 472
D+ EF+ T + + + + KAF+ FD D +G
Sbjct: 71 DFEEFLDIMTKKLGERDPREEILKAFRLFDDDKTG 105
|
Length = 158 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 72/309 (23%), Positives = 120/309 (38%), Gaps = 68/309 (22%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y G +G G FGV Y T + A K + + D RE+ IM++L+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-------DPQYKNRELLIMKNLN-HI 119
Query: 141 NIVEFKGAY--------EDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAA------- 183
NI+ K Y E ++VVME + + K HY+ A
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHALPLFLVK 173
Query: 184 ----SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
+CR++ + H + HRDLKP+N L+ LK DFG + + G+
Sbjct: 174 LYSYQLCRALAYI----HSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRS 227
Query: 240 RDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-- 295
+ S +Y APE++ Y ID+WS G I+ ++ G P F ++ I+Q
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287
Query: 296 ----------GDIDFESAPWPTISS-------------SAKDLVRRMLTQDPKKRITSAQ 332
+ ++ +P + A + + + L +P KR+ +
Sbjct: 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347
Query: 333 VLEHPWIKE 341
L P+ +
Sbjct: 348 ALADPFFDD 356
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 72/314 (22%), Positives = 134/314 (42%), Gaps = 42/314 (13%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
L K +V Y +G G +G + ++ A K +S R + RE
Sbjct: 6 LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRE 64
Query: 130 IQIMQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+++++H+ G ++ + E+ V++V L G +L + I+ S+
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQF 122
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ ++ + H G++HRDLKP N + +E+ L+ DFGL+ ++ V
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDEMT--GYVA 177
Query: 245 SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPF----WAETEKGIFDAILQGDI 298
+ +Y APE++ Y + +DIWS G I+ LL G F + + K I + +
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 299 DF-------------ESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ +S P + + A DL+ +ML D KRI++++ L
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297
Query: 336 HPWIKEGGEASDKP 349
HP+ + + D+P
Sbjct: 298 HPYFSQYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 48/246 (19%)
Query: 82 SFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ + LG G FG Y ++ Q A K++ + ++ D+ D E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKF 66
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVH 194
+ NIV G ++ +++EL AGG+L F R R ++ +++
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR-----ENRPRPERPSSLTMKDLLF 120
Query: 195 I-------CHFM---GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
C ++ +HRD+ N LL+ K + K DFG++ RDI
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYR 171
Query: 245 SAYY------------VAPEV-LRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF 290
++YY + PE L + + D+WS GV+L+ + S G P+ T + +
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 291 DAILQG 296
+ + G
Sbjct: 232 EFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 50/177 (28%), Positives = 69/177 (38%), Gaps = 41/177 (23%)
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL- 254
H ++HRDLKP+N L+S E LK DFGL+ + Y V + +Y P+VL
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 255 -RRRYGKEIDIWSAGVILYILLSGVPPF-------------WA-------ETEKGIFDAI 293
Y +DIW AG I +L G P F W +T G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL- 235
Query: 294 LQGDIDFESAPWPTISS------------SAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ E A+DL +ML PK RI++ L HP+
Sbjct: 236 --PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 85/324 (26%), Positives = 127/324 (39%), Gaps = 82/324 (25%)
Query: 84 GKELGRGQFGVTYLCT--ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
G ++GRG +G Y + R +A K I + REI +++ L PN
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-----ACREIALLRELK-HPN 59
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRI------IAKGHYSERA-----------AAS 184
++ + + V + LFD I K H + +A S
Sbjct: 60 VISLQKVFLSHADRKVWL-------LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFL-LSSKDENALLKATDFGLS-VFIEEGKVYRD- 241
+ I++ +H H V+HRDLKP N L + E +K D G + +F K D
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 242 --IVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----------- 286
+V + +Y APE+L R Y K IDIW+ G I LL+ P F E
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 287 --KGIFDAI-LQGDIDFES-APWPTISSSAKD---------------------------- 314
IF+ + D D+E P S+ KD
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292
Query: 315 LVRRMLTQDPKKRITSAQVLEHPW 338
L++++LT DP KRITS Q ++ P+
Sbjct: 293 LLQKLLTMDPIKRITSEQAMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 31/219 (14%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHLSG 138
SFGK LG G FG T + A ++ + L + + E++IM HL
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHIC 196
NIV GA + V+ E C G+L + + K + S + +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------- 249
+HRDL N LL+ ++K DFGL+ RDI+ + YV
Sbjct: 158 ASKNCIHRDLAARNVLLT---HGKIVKICDFGLA---------RDIMNDSNYVVKGNARL 205
Query: 250 -----APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + Y E D+WS G++L+ + S G P+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 55/277 (19%)
Query: 86 ELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
ELG G FG +L C + ++ K +++ + D +RE +++ L Q +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ-HIV 70
Query: 144 EFKGAYEDKQSVHVVMELCAGGEL--FDR-------IIAKGHYSE----------RAAAS 184
F G + + + +V E G+L F R I+A G A+
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
I +V + + HF+ HRDL N L+ + ++K DFG+S RDI
Sbjct: 131 IASGMVYLASL-HFV---HRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYS 174
Query: 245 SAYY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIF 290
+ YY + PE +L R++ E DIWS GV+L+ I G P++ +
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327
+ I QG E T +++ ++P++R
Sbjct: 235 ECITQGR---ELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL---VTKNDKDDIKREIQIMQHLSGQPN 141
K +G G+FG G++ ++ + L + + D E IM PN
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPN 66
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFM 199
I+ +G + V ++ E G L D+ + + G ++ + R I + + M
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG---SAYYVAPEVLR- 255
+HRDL N L++S N + K +DFGLS +E+ + G + APE +
Sbjct: 126 NYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
R++ D+WS G++++ ++S G P+W + + + A+ G
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 83 FGKELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKND-KDDIKREIQIMQHLSGQ 139
+ELG G FG +L C ++ K ND + D +RE +++ +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QH 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA--SICR--SIVNVVHI 195
NIV+F G + +V E G+L + + G + + S ++ ++ I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 196 C-------------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
HF+ HRDL N L+ + ++K DFG+S RD+
Sbjct: 128 AVQIASGMVYLASQHFV---HRDLATRNCLVG---YDLVVKIGDFGMS---------RDV 172
Query: 243 VGSAYY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKG 288
+ YY + PE ++ R++ E D+WS GV+L+ I G P++ + +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + I QG T S D++ +DP++RI + E
Sbjct: 233 VIECITQG---RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--------G 138
LG+G FG + T K + K K+D+ +E++I + LS
Sbjct: 3 LGKGNFGEVFKGTLKD-----------KTPVAVKTCKEDLPQELKI-KFLSEARILKQYD 50
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
PNIV+ G +Q +++VMEL GG+ + K E + + ++ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAY 108
Query: 199 M---GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-----RDIVGSAYYVA 250
+ +HRDL N L+ EN +LK +DFG+S E+ +Y + I + A
Sbjct: 109 LESKNCIHRDLAARNCLVG---ENNVLKISDFGMSR-QEDDGIYSSSGLKQI--PIKWTA 162
Query: 251 PEVLRR-RYGKEIDIWSAGVILYILLS-GVPPF 281
PE L RY E D+WS G++L+ S GV P+
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 26/232 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSG 138
H + K +G G+FG + GR+ +I K T+ + D E IM S
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHIC 196
NI+ +G + ++ E G L D+ + G +S + R I +
Sbjct: 66 H-NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE----------GKVYRDIVGSA 246
M +HRDL N L++S N K +DFGLS +E+ GK+
Sbjct: 124 SDMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLEDDPEGTYTTSGGKI------PI 174
Query: 247 YYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ APE + R++ D+WS G++++ ++S G P+W + + AI G
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSG--QPN 141
E+G G +G + + G +F ++ + ++ T + + RE+ +++HL PN
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 142 IVEF-------KGAYEDKQSV---HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
+V + E K ++ HV +L D++ G +E + ++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTE-TIKDMMFQLLR 121
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
+ H V+HRDLKP+N L++S + +K DFGL+ +V + +Y AP
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 252 EV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI-LQGDID------ 299
EV L+ Y +D+WS G I + P F ++ I D I L G+ D
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238
Query: 300 -----FESAPW-------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
F S I KDL+ + LT +P KRI++ L HP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 85 KELGRGQFGVT---YLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
KELG G FG ++ + A K++ + + K + RE +M L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLD-HPC 57
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI---VNVVHICHF 198
IV G + + + +VMEL G L + + + + + + HF
Sbjct: 58 IVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY---------- 248
+ HRDL N LL ++ + K +DFG+S + GS YY
Sbjct: 117 V---HRDLAARNVLLVNRHQ---AKISDFGMS------RALG--AGSDYYRATTAGRWPL 162
Query: 249 --VAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + ++ + D+WS GV L+ S G P+
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
+ED+K F +G G FG G + ++ ++ND D E++++
Sbjct: 1 WEDIK----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVL 56
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-----RII------AKGHYSERAA 182
L PNI+ GA E++ +++ +E G L D R++ AK H +
Sbjct: 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 183 AS--ICRSIVNVVHICHFMG---VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
S + + +V ++ +HRDL N L+ EN K DFGLS +
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS---RGEE 170
Query: 238 VY-RDIVGS--AYYVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292
VY + +G ++A E L Y + D+WS GV+L+ ++S G P+ T +++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230
Query: 293 ILQG 296
+ QG
Sbjct: 231 LPQG 234
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 42/283 (14%)
Query: 83 FGKELGRGQFGVTYLCTENS------------TGRQFACKSISKRKLVTKNDKDDIKREI 130
++LG GQFG +LC G+ R VTK ++D +EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS--ICRS 188
+IM L PNI+ G + ++ E G+L + + S A+ S
Sbjct: 69 KIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 189 IVNVVHIC----------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
I N++++ + +HRDL N L+ + +K DFG+S + G
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDY 184
Query: 239 YRDIVGSAY----YVAPE-VLRRRYGKEIDIWSAGVILY--ILLSGVPPFWAETEKGIFD 291
YR I G A ++A E +L ++ D+W+ GV L+ L P+ +++ + +
Sbjct: 185 YR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243
Query: 292 AI-----LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
QG + S P S L+ R ++D K R T
Sbjct: 244 NTGEFFRNQGRQIYLSQT-PLCPSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 372 LKVIAENLS-TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
L V++ L ++ + L++ F D D+ G I+ EL+ L LG +L++ EV++L++
Sbjct: 78 LTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEY 137
Query: 431 DVDGNGTIDYIEFITATMH 449
D DG+G IDY EF
Sbjct: 138 DEDGDGEIDYEEFKKLIKD 156
|
Length = 160 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 48/246 (19%)
Query: 85 KELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
+ELG G FG +L C + ++ K + N + D RE +++ +L + +I
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE-HI 69
Query: 143 VEFKGAYEDKQSVHVVMELCAGGEL--FDR-------IIAKGH----YSERAAASICRSI 189
V+F G + + +V E G+L F R ++A+G+ ++ I + I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 190 V-NVVHIC--HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
+V++ HF+ HRDL N L+ EN L+K DFG+S RD+ +
Sbjct: 130 AAGMVYLASQHFV---HRDLATRNCLVG---ENLLVKIGDFGMS---------RDVYSTD 174
Query: 247 YY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDA 292
YY + PE ++ R++ E D+WS GV+L+ I G P++ + + +
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 293 ILQGDI 298
I QG +
Sbjct: 235 ITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 45/227 (19%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYL-----CTENSTGRQFACKSISKRKLVTKNDKDDIK 127
P E + L +ELG+G FG+ Y + + A K++++ + ++ +
Sbjct: 4 PREKITL----IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFL 57
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-------- 179
E +M+ + ++V G Q VVMEL A G+L + + E
Sbjct: 58 NEASVMKEFN-CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLG 114
Query: 180 --------RAAASICR--SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229
+ AA I + + HRDL N +++ E+ +K DFG+
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAKKFV------HRDLAARNCMVA---EDLTVKIGDFGM 165
Query: 230 SVFIEEGKVYRDIVGSAYYV---APEVLRR-RYGKEIDIWSAGVILY 272
+ I E YR V APE L+ + + D+WS GV+L+
Sbjct: 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-10
Identities = 23/57 (40%), Positives = 31/57 (54%), Gaps = 4/57 (7%)
Query: 394 IDTDNSGTITYEELKAGLARLGSKLTEAEVQQ----LMEAADVDGNGTIDYIEFITA 446
+D D G I EEL+ L LG KLT+ EV++ D DG+G I + EF+ A
Sbjct: 3 LDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLEA 59
|
Length = 60 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 37/260 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G+ +G G+FG TG++ A K+I + VT + + + H
Sbjct: 7 KLTLGEIIGEGEFGAVL--QGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHH---- 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V G +++VMEL + G L + + +G RA S+ + + + + M
Sbjct: 59 KNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGM 113
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY----YV 249
++HRDL N L+S E+ + K +DFGL+ +V V ++ +
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLA------RVGSMGVDNSKLPVKWT 164
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
APE L+ +++ + D+WS GV+L+ + S G P+ + K + + + +G + P
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEG 221
Query: 308 ISSSAKDLVRRMLTQDPKKR 327
+ L+ +PKKR
Sbjct: 222 CPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
V++ Y+ L G G ++CT+ + ++ K+++ K REI I++
Sbjct: 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILK 141
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMEL--CAGGELFDRIIAKGHYSERAAASICRSIVNV 192
+S I+ AY K +V +VM C +LF + G A +I R ++
Sbjct: 142 TIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQRRLLEA 197
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG----LSVFIEEGKVYRDIVGSAYY 248
+ H G++HRD+K EN L + ENA+L DFG L + + Y G+
Sbjct: 198 LAYLHGRGIIHRDVKTENIFL-DEPENAVLG--DFGAACKLDAHPDTPQCY-GWSGTLET 253
Query: 249 VAPEVLR-RRYGKEIDIWSAGVILY 272
+PE+L Y + DIWSAG++L+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 25/146 (17%)
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM-- 364
TI++ V R L Q+P T A++ + I E + ID +F +
Sbjct: 27 TITTKELGTVMRSLGQNP----TEAELQD--MINEVDADGNGTID------FPEFLTLMA 74
Query: 365 NKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQ 424
K+K + S EEI K+ F D D +G I+ EL+ + LG KLT+ EV
Sbjct: 75 RKMK--------DTDSEEEI---KEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVD 123
Query: 425 QLMEAADVDGNGTIDYIEFITATMHR 450
+++ ADVDG+G I+Y EF+ M +
Sbjct: 124 EMIREADVDGDGQINYEEFVKMMMSK 149
|
Length = 149 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 68/249 (27%), Positives = 109/249 (43%), Gaps = 51/249 (20%)
Query: 85 KELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
+ELG G FG +L C S + ++ K T + D +RE +++ +L +I
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHI 69
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELF--------DRII--------AKGHYSERAAASIC 186
V+F G D + +V E G+L D +I AKG I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 187 RSIVN-VVHIC--HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
I + +V++ HF+ HRDL N L+ + N L+K DFG+S RD+
Sbjct: 130 SQIASGMVYLASQHFV---HRDLATRNCLVGA---NLLVKIGDFGMS---------RDVY 174
Query: 244 GSAYY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGI 289
+ YY + PE ++ R++ E D+WS GVIL+ I G P++ + +
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
Query: 290 FDAILQGDI 298
+ I QG +
Sbjct: 235 IECITQGRV 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E ++L +LG+G FG ++ T N T + A K++ + + +E Q+
Sbjct: 4 PRESLRLEV----KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQV 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER----AAASICRS 188
M+ L + + + A ++ +++V E + G L D + KG + +
Sbjct: 55 MKKLRHEKLVQLY--AVVSEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQ 110
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY- 247
I + + M +HRDL+ N L+ EN + K DFGL+ IE+ + Y G+ +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFP 166
Query: 248 --YVAPE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303
+ APE L R+ + D+WS G++L L + G P+ + + D + +G +
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMP 223
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRIT 329
P S DL+ + ++P++R T
Sbjct: 224 CPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 58/292 (19%)
Query: 82 SFGKELGRGQFG----VTYLCTENSTGRQ-FACKSISKRKLVTKNDKD--DIKREIQIMQ 134
+ GK LG G FG + +N A K + +KD D+ E+++M+
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD----DATEKDLSDLVSEMEMMK 70
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
+ NI+ G + ++VV+E A G L D + A+ E A+ R +
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 195 ICHFMG----------------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
+ +HRDL N L++ E+ ++K DFGL+
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA-------- 179
Query: 239 YRDIVGSAYY------------VAPEVLRRR-YGKEIDIWSAGVILY--ILLSGVPPFWA 283
RDI YY +APE L R Y + D+WS GV+L+ L G P
Sbjct: 180 -RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
Query: 284 ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
E+ +F + +G + + L+R + P +R T Q++E
Sbjct: 239 PVEE-LFKLLKEG---YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 32/274 (11%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
F +G G FG G + ++ +K+D D E++++ L PNI
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER----AAASICRSIVNVVHICHF 198
+ GA E + +++ +E G L D + K E A A+ S ++ + HF
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 199 MG-------------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RDIVG 244
+HRDL N L+ EN + K DFGLS +VY + +G
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMG 183
Query: 245 S--AYYVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300
++A E L Y D+WS GV+L+ ++S G P+ T +++ + QG +
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y 240
Query: 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
DL+R+ + P +R + AQ+L
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 61/274 (22%), Positives = 116/274 (42%), Gaps = 38/274 (13%)
Query: 85 KELGRGQFGVTYLC-----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
LGRG+FG +L E K++ K K +N + + +RE+ + + LS
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVHICH 197
N+V G + + ++++E G+L F R + S V +C
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL---STKQKVALCT 124
Query: 198 FMG----------VMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGS 245
+ +HRDL N L+SS+ E +K + LS V+ E R+ +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 246 AYYVAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDIDFESA 303
++APE V + + D+WS GV+++ + G PF+ +++ + + + G ++
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE---- 237
Query: 304 PWPTISSSAKDLVRRMLT---QDPKKRITSAQVL 334
P L + M +PK R + ++++
Sbjct: 238 -LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 180 RAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
A I + I+ + H ++HRD+K EN ++ D+ + D G + F +
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCI---GDLGAAQFPVVAPAF 213
Query: 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS 276
+ G+ APEVL R +Y + DIWSAG++L+ +L+
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 80 HYSFGKELGRGQFGVTYLCTENS--------------TGRQFACKSISKRKLVTKNDKDD 125
H F ++LG GQFG +LC + GR R KN ++D
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
+E++I+ L PNI+ G D+ + ++ E G+L ++ ++ H ++
Sbjct: 66 FLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGN 123
Query: 186 C-------------RSIVNV-VHICHFM------GVMHRDLKPENFLLSSKDENALLKAT 225
S+++V + I M +HRDL N L+ EN +K
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIA 180
Query: 226 DFGLSVFIEEGKVYRDIVGSAY----YVAPE-VLRRRYGKEIDIWSAGVILYILLS 276
DFG+S + G YR I G A ++A E +L ++ D+W+ GV L+ +L
Sbjct: 181 DFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K +S + G G + C +N T K+ + T E I++ ++
Sbjct: 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTAT---------EAHILRAIN 141
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
P+I++ KG + + +++ +L+ + AK + + +I RS++ + H
Sbjct: 142 -HPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLH 199
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF---IEEGKVYRDIVGSAYYVAPEVL 254
++HRD+K EN ++ + L DFG + F I K Y G+ APE+L
Sbjct: 200 ENRIIHRDIKAENIFINHPGDVCL---GDFGAACFPVDINANKYY-GWAGTIATNAPELL 255
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFESAPWPTISSSA 312
R YG +DIWSAG++L+ + + +F+ L GD D +
Sbjct: 256 ARDPYGPAVDIWSAGIVLFEMATC--------HDSLFEKDGLDGDCDSD--------RQI 299
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
K ++RR T + I + L+ +I ++S KP
Sbjct: 300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKP 336
|
Length = 391 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 47/233 (20%)
Query: 80 HYSFGKELGRGQFGVTYLC-TENSTG---------------RQFACKSISKRKLVTKNDK 123
+F ++LG GQFG +LC + A K + R + N +
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL--RPDASDNAR 63
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL---FDRIIAKGHYSER 180
+D +E++I+ LS PNI G + ++ME G+L + +A+
Sbjct: 64 EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 181 AAASICRSIVNVVHIC----------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
+ S+ S ++++ + +HRDL N L+ N +K DFG+S
Sbjct: 123 NSKSLSFS--TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGMS 177
Query: 231 VFIEEGKVYRDIVGSAYYVAP-------EVLRRRYGKEIDIWSAGVILYILLS 276
+ YR + G A P VL ++ + D+W+ GV L+ +L+
Sbjct: 178 RNLYSSDYYR-VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 30/268 (11%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G G FG G + ++ +K+D D E++++ L PNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 147 GAYEDKQSVHVVMELCAGGELFD-----RII------AKGH-----YSERAAASICRSIV 190
GA E + +++ +E G L D R++ A + S + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RDIVGS--AY 247
+ +HRDL N L+ EN + K DFGLS +VY + +G
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 176
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
++A E L Y D+WS GV+L+ ++S G P+ T +++ + QG +
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKP 233
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQV 333
DL+R+ + P +R + AQ+
Sbjct: 234 LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-09
Identities = 23/47 (48%), Positives = 26/47 (55%)
Query: 399 SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
G IT EELK LA LG L+E EV L D DG+G I + EF
Sbjct: 2 KGLITREELKRALALLGISLSEEEVDILFREFDTDGDGKISFEEFCV 48
|
Length = 53 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G FG +Q + K+ +D++ RE +IM L P IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRM 60
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH--FMGV-- 201
G E +++ +VME+ +GG L + K + S NVV + H MG+
Sbjct: 61 IGVCE-AEALMLVMEMASGGPLNKFLSGK---KDEITVS------NVVELMHQVSMGMKY 110
Query: 202 ------MHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAY---YVAP 251
+HRDL N LL ++ K +DFGLS + Y+ + + AP
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 252 E-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
E + R++ D+WS G+ ++ S G P+
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--DDIKREIQI 132
+++KL + GK G+FG L + G + A K I KND E +
Sbjct: 6 KELKLLQTIGK----GEFGDVML--GDYRGNKVAVKCI-------KNDATAQAFLAEASV 52
Query: 133 MQHLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
M L N+V+ G E+K +++V E A G L D + ++G R+ +
Sbjct: 53 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKF 107
Query: 192 VVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG- 244
+ +C M +HRDL N L+S E+ + K +DFGL+ +E +D
Sbjct: 108 SLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKL 161
Query: 245 SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276
+ APE LR +++ + D+WS G++L+ + S
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 65/266 (24%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E ++L +LG+G FG ++ T N T + A K++ ++ + +E QI
Sbjct: 4 PRESLRLDV----KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMM----PEAFLQEAQI 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSI 189
M+ L + + A ++ +++V E G L D + +G + + I
Sbjct: 55 MKKLRHDKLVPLY--AVVSEEPIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQI 111
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY-- 247
+ + M +HRDL+ N L+ +N + K DFGL+ IE+ + Y G+ +
Sbjct: 112 ADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPI 167
Query: 248 -YVAPE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304
+ APE L R+ + D+WS G++L L++ G P+ + + + + +G P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMP 223
Query: 305 WPT-ISSSAKDLVRRMLTQDPKKRIT 329
P S +L++ +DP +R T
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 60/282 (21%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL ++LG GQFG ++ T N T + A K++ + + +E QI
Sbjct: 4 PRESLKL----ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTM----SPEAFLQEAQI 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-------------------IA 173
M+ L +V+ +++ +++V E + G L D + IA
Sbjct: 55 MKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 174 KG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
+G Y E +HRDL N L+ EN + K DFGL+
Sbjct: 114 EGMAYLES------------------RNYIHRDLAARNILVG---ENLVCKIADFGLARL 152
Query: 233 IEEGKVYRDIVGSAY---YVAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEK 287
IE+ Y G+ + + APE R+ + D+WS G++L I+ G P+ T +
Sbjct: 153 IED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
+ + + +G + P DL+ + +DP++R T
Sbjct: 212 EVLEQVERG---YRMPRPPNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 3/76 (3%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ K + E EEI + F D D +G I+ + LK LG +T+ E+Q++++
Sbjct: 78 IMTKKLGERDPREEIL---KAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDE 134
Query: 430 ADVDGNGTIDYIEFIT 445
AD +G+G I EF
Sbjct: 135 ADRNGDGEISEEEFYR 150
|
Length = 158 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
++LG GQFG + N+T A K++ + D D E QIM+ L P +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQ 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
++ +++V EL G L + + A + + + + +
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY---YVAPEVLR-RRY 258
HRDL N L+ EN + K DFGL+ I+E +Y G+ + + APE R+
Sbjct: 126 HRDLAARNVLVG---ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRF 181
Query: 259 GKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
+ D+WS G++L I+ G P+ T + + QG
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 45/230 (19%)
Query: 82 SFGKELGRGQFGVTYLC----TENSTGRQFACKSISK----------RKLVTKNDKDDIK 127
+F ++LG GQFG +LC E + F+ R+ KN ++D
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR 187
+EI+IM L PNI+ + ++ E G+L ++ +++ H + AA
Sbjct: 68 KEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEKADV 124
Query: 188 SIVNVVHICHFMGV--------------MHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
++ + FM +HRDL N L+ +N +K DFG+S +
Sbjct: 125 VTISYSTLI-FMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNL 180
Query: 234 EEGKVYRDIVGSAYYVAP-------EVLRRRYGKEIDIWSAGVILYILLS 276
G YR I G A V P +L ++ D+W+ GV L+ +L+
Sbjct: 181 YSGDYYR-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
+LG GQ+G Y A K++ + + ++ +E +M+ + PN+V+
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIK-HPNLVQL 67
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA-----ASICRSIVNVVHICHFMG 200
G + +++ E G L D + A A+ S + + +F+
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI- 126
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY---YVAPEVLR-R 256
HRDL N L+ EN L+K DFGLS + G Y G+ + + APE L
Sbjct: 127 --HRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 257 RYGKEIDIWSAGVILY-ILLSGVPPF 281
++ + D+W+ GV+L+ I G+ P+
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE--------- 252
+HRDL N L+ EN ++K DFGLS R+I + YY A E
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLS---------RNIYSADYYKASENDAIPIRWM 199
Query: 253 ----VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
+ RY E D+W+ GV+L+ + S G+ P++ + + + G++ S P
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV--LSCP-DN 256
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQV 333
+L+R ++ P R + A +
Sbjct: 257 CPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156
L + T + F K + K ++ I PN+V + SV
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRERLTIIPH---------CVPNMVCLHKYIVSEDSVF 61
Query: 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
+V++ GG+L+ I + E +V + H G++ RDL P N LL
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--- 118
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE-IDIWSAGVILYILL 275
D+ ++ T F +E+ + V Y APEV E D WS G IL+ LL
Sbjct: 119 DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAILFELL 176
Query: 276 SG 277
+G
Sbjct: 177 TG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISK-----RKLVTKNDKDDIKREIQIMQHL 136
+ GK LG G FG + + ++++ + T+ D D+ E+++M+ +
Sbjct: 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR------SIV 190
NI+ GA ++V++E + G L + + A+ + I R +
Sbjct: 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 191 NVVHICHFMG----------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
++V + + +HRDL N L++ EN ++K DFGL+ + Y+
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYK 194
Query: 241 DIVGS---AYYVAPEVL-RRRYGKEIDIWSAGVILY-ILLSGVPPF 281
++APE L R Y + D+WS GV+++ I G P+
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 55/234 (23%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KD--DIKR 128
+E + + GK LG G FG + + K ++ + K+D KD D+
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVS 66
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR- 187
E+++M+ + NI+ GA ++V++E + G L + + A+ + C+
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 188 -----SIVNVVHICHFMG----------VMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
+ ++V + + +HRDL N L++ E+ ++K DFGL+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARD 183
Query: 233 IEEGKVYRDIVGS---AYYVAPEVL-RRRYGKEIDIWSAGVILY-ILLSGVPPF 281
+ Y+ ++APE L R Y + D+WS GV+L+ I G P+
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD---DIKREIQIMQHLSGQ 139
F +ELG FG Y G A + ++ + L N+ + ++E +M L
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELH-H 66
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV-------NV 192
PNIV G +Q V ++ E G+L + +I + +S+ +S V +
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 193 VHIC------------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+HI HF +H+DL N L+ E +K +D GLS I YR
Sbjct: 127 LHIAIQIAAGMEYLSSHFF--VHKDLAARNILIG---EQLHVKISDLGLSREIYSADYYR 181
Query: 241 ---DIVGSAYYVAPE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293
+ ++ PE ++ ++ + DIWS GV+L+ + S G+ P++ + + + + +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 33/237 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL K+LG GQFG ++ N++ + A K++ + + E +
Sbjct: 4 PRESIKLV----KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQA----FLEEANL 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M+ L +V ++ ++++ E A G L D + + E + + I
Sbjct: 55 MKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFS 109
Query: 193 VHICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I M + HRDL+ N L+S E+ + K DFGL+ IE+ + Y G+
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAK 165
Query: 247 Y---YVAPEVLRRRYGK---EIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
+ + APE + +G + D+WS G++LY I+ G P+ + + A+ +G
Sbjct: 166 FPIKWTAPEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 60/267 (22%), Positives = 114/267 (42%), Gaps = 28/267 (10%)
Query: 81 YSFGKELGRGQFGV---TYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
++ G+ LG+G+FG L +E+ + ++ A K + K + + +D ++ RE M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 138 GQPNIVEFKGAYEDKQSVH------VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
PN+++ G ++ V++ G+L ++ E + +
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 192 VVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
++ I M +HRDL N +L +EN + DFGLS I G YR S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 246 AY---YVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDIDF 300
++A E L Y D+W+ GV ++ I+ G P+ I++ +++G+
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN--- 232
Query: 301 ESAPWPTISSSAKDLVRRMLTQDPKKR 327
P +L+ + + +PK R
Sbjct: 233 RLKQPPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 33/238 (13%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQ 131
+E + ++ ++LG G FG + E + A K + L+ + D ++E+Q
Sbjct: 1 WERPREEFTLERKLGSGYFGEVW---EGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQ 54
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY---SERAAASICRS 188
++ L +++ + V+++ EL G L + E +
Sbjct: 55 ALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASL 106
Query: 189 IVNVVHICHFMG------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--R 240
I + M +HRDL N L+ E+ + K DFGL+ I+E VY
Sbjct: 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE-DVYLSS 162
Query: 241 DIVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
D + APE + + D+WS G++LY + + G P+ ++D I G
Sbjct: 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE---EGKVY 239
++ R +++ + H G++HRD+K EN L++ ++ L DFG + F +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICL---GDFGAACFARGSWSTPFH 319
Query: 240 RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILY 272
I G+ APEVL Y +DIWSAG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 31/241 (12%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISK------RKLVTKNDKDDIKREIQIMQHL 136
GK LG G FG + ++ + ++K + T+ D D+ E+++M+ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNR-VTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSER 180
NI+ GA ++V++E + G L + + A+ S +
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
S + + +HRDL N L++ E+ ++K DFGL+ I Y+
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYYK 197
Query: 241 DIVGS---AYYVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQ 295
++APE L R Y + D+WS GV+L+ I G P+ + +F + +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
Query: 296 G 296
G
Sbjct: 258 G 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 87 LGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
+G+G FG Y L + A KS+++ + + + +E IM+ S PN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 144 EFKG-AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
G + S VV+ G+L + I SE ++ I + + M +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 203 ------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY-------- 248
HRDL N +L DE+ +K DFGL+ RDI YY
Sbjct: 115 ASKKFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGA 162
Query: 249 ------VAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPF 281
+A E L+ +++ + D+WS GV+L+ L++ G PP+
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 36/279 (12%)
Query: 82 SFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
GK LG G+FG L ++ + + A K++ K + T ++ ++ E M+
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59
Query: 139 QPNIVEFKGA---YEDKQSVH---VVMELCAGGELFDRIIAKGHYSERAAAS-------I 185
PN+++ G Q + V++ G+L ++ YS +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTL 115
Query: 186 CRSIVNVVHICHFMG---VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ +V++ ++ +HRDL N +L E+ + DFGLS I G YR
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 243 VGSAY---YVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGD 297
+ ++A E L R Y + D+W+ GV ++ I G P+ I+D + G+
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ DL+ DPK R T ++ E
Sbjct: 233 RLKQPEDCL---DELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 31/257 (12%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K+LG GQFG ++ T N + A K++ + + E QIM+ L +V+
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQ 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSE-----RAAASICRSIVNVVHICHF 198
A ++ +++V E + G L D + +G + AA + + +
Sbjct: 66 LY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---- 120
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY---YVAPE-VL 254
M +HRDL+ N L+ + + K DFGL+ IE+ + Y G+ + + APE L
Sbjct: 121 MNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL 176
Query: 255 RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS-SSA 312
R+ + D+WS G++L L++ G P+ + + + + +G P P S
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPISL 232
Query: 313 KDLVRRMLTQDPKKRIT 329
+L+ + +DP++R T
Sbjct: 233 HELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 45/178 (25%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL--RRR 257
++HRDLKP+N L+S E LK DFGL+ Y + V + +Y P+VL
Sbjct: 124 ILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF------ESAPWPTISS- 310
Y +D+W G I ++ GV F G+ D Q + F WP + S
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF-----PGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 311 ---------------------------SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
A+DL ++L PK R+++ L H + +
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|238009 cd00052, EH, Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 7e-07
Identities = 21/62 (33%), Positives = 34/62 (54%), Gaps = 3/62 (4%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
Q+F ++D D G I+ +E + L + S L + + Q+ + AD D +G +D EF A
Sbjct: 2 DQIFRSLDPDGDGLISGDEARPFLGK--SGLPRSVLAQIWDLADTDKDGKLDKEEFAIA- 58
Query: 448 MH 449
MH
Sbjct: 59 MH 60
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. Length = 67 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 24/235 (10%)
Query: 82 SFGKELGRGQFGVTY--LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ GK LG G+FG ++ + + A K++ K + T+++ +D E M+
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFD-H 59
Query: 140 PNIVEFKGA------YEDKQSVHVVMELCAGGEL-----FDRIIAKGHY-SERAAASICR 187
PN++ G E S V++ G+L + R+ Y +
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
I + + +HRDL N +L +EN + DFGLS I G YR +
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 248 ---YVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGD 297
++A E L R Y + D+WS GV ++ I G P+ I+D + QG+
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 55/246 (22%), Positives = 108/246 (43%), Gaps = 50/246 (20%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KDDIKREIQIMQHLSGQ 139
F +ELG +FG Y T ++++ + L K + +++ K E + L
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI------VNVV 193
PNIV G +Q + ++ C+ +L + ++ + +S+ + +++ + V
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 194 HIC-------HFMG---VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
HI F+ V+H+DL N L+ K L+V I + ++R++
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK------------LNVKISDLGLFREVY 175
Query: 244 GSAYY------------VAPEVLRRRYGK---EIDIWSAGVILYILLS-GVPPFWAETEK 287
+ YY ++PE + YGK + DIWS GV+L+ + S G+ P+ + +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233
Query: 288 GIFDAI 293
+ + I
Sbjct: 234 DVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212
+V +V +L G L D + K + + C I + + ++HRDL N L
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141
Query: 213 LSSKDENALLKATDFGLSVF--IEEGKVYRD--IVGSAYYVAPEVLRRRYGKEIDIWSAG 268
+ S + +K TDFGL+ I+E + + D V + +L RR+ + D+WS G
Sbjct: 142 VKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 269 VILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
V ++ L++ G P+ + I D + +G E P P I +
Sbjct: 199 VTVWELMTFGAKPYDGIPAREIPDLLEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSIS-KRKLVTKN--DKD--DIKREIQIMQHLS 137
GK LG G FG + ++++ K++ N DKD D+ E+++M+ +
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERA 181
NI+ G + ++V++E A G L + + A+ S +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 182 AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
S + + +HRDL N L++ E+ ++K DFGL+ + + Y+
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKK 192
Query: 242 IVGS---AYYVAPEVL-RRRYGKEIDIWSAGVILY-ILLSGVPPF 281
++APE L R Y + D+WS G++++ I G P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL K+LG GQFG ++ N + A KS+ + + + E +
Sbjct: 4 PRETLKLV----KKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANL 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M+ L P +V A ++ ++++ E G L D + E +I + I
Sbjct: 55 MKQLQ-HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMA 108
Query: 193 VHICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I M + HRDL+ N L+S E K DFGL+ IE+ + Y G+
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAK 164
Query: 247 Y---YVAPEVLRRRYGK---EIDIWSAGVIL 271
+ + APE + YG + D+WS G++L
Sbjct: 165 FPIKWTAPEAI--NYGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI- 242
+I + ++ V H ++HRD+K EN L+ + L DFG ++ E+ + D
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVL---GDFGTAMPFEKEREAFDYG 327
Query: 243 -VGSAYYVAPEVLRRRYGKEI-DIWSAGVILYILLS 276
VG+ +PE+L EI DIWS G+IL +LS
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 22/171 (12%)
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
+E ++C + +HR K N LL+ + LLK G F +
Sbjct: 15 NEEEIWAVCLQC------LGALRELHRQAKSGNILLT---WDGLLKL--DGSVAFKTPEQ 63
Query: 238 VYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQ 295
Y++APEV++ + Y ++ DI+S G+ LY L P+ E E I + +L
Sbjct: 64 ---SRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119
Query: 296 GDIDFESAPWPTISS-----SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
G + + S +D +R ++ P++R + L H
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALF 170
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 51/289 (17%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD----DIKREIQIMQHLSG 138
GK LG G+FG T + +++ K++ +N D+ E +++ ++
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAV-KMLKENASSSELRDLLSEFNLLKQVN- 61
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGEL--FDRIIAK-----------------GHYSE 179
P++++ GA + +++E G L F R K + E
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 180 RA---------AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
RA A I R + + M ++HRDL N L++ E +K +DFGLS
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAE----MKLVHRDLAARNVLVA---EGRKMKISDFGLS 174
Query: 231 VFIEEGKVY----RDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAE 284
+ E Y + + ++A E L Y + D+WS GV+L+ +++ G P+
Sbjct: 175 RDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233
Query: 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQV 333
+ +F+ + G + S +L+ Q+P KR T A +
Sbjct: 234 APERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|200946 pfam00036, efhand, EF hand | Back alignment and domain information |
|---|
Score = 40.9 bits (97), Expect = 2e-05
Identities = 12/28 (42%), Positives = 16/28 (57%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARL 414
LK+ F D D G I++EE K L +L
Sbjct: 2 LKEAFKEFDKDGDGKISFEEFKELLKKL 29
|
The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LLS EN ++K DFGL+ RDI YV
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + + Y + D+WS GV+L+ + S G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+ RG+ G +Y G QF K I+ + ++ D+ + +QH PNIV+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK----LQH----PNIVKLI 749
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---GVMH 203
G ++ +++ E G L + + + ER I I + H V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 204 RDLKPENFLLSSKDENAL------LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR 257
+L PE ++ KDE L L TD FI S+ YVAPE R
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDT--KCFI-----------SSAYVAPET---R 850
Query: 258 YGKEI----DIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
K+I DI+ G+IL LL+G P A+ E G+ +I++
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVE 890
|
Length = 968 |
| >gnl|CDD|197477 smart00027, EH, Eps15 homology domain | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-05
Identities = 22/71 (30%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+S E+ +Q+F ++D + GT+T + K L + S L + + ++ AD+D +G +
Sbjct: 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLK--SGLPQTLLAKIWNLADIDNDGEL 61
Query: 439 DYIEFITATMH 449
D EF A MH
Sbjct: 62 DKDEFALA-MH 71
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. Length = 96 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LLS EN ++K DFGL+ RDI YV
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGSARLPLKWM 243
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + + Y + D+WS GV+L+ + S G P+
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif | Back alignment and domain information |
|---|
Score = 39.7 bits (94), Expect = 6e-05
Identities = 12/28 (42%), Positives = 14/28 (50%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARL 414
LK+ F D D G I +EE K L L
Sbjct: 2 LKEAFRLFDKDGDGKIDFEEFKDLLKAL 29
|
EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 34/94 (36%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LLS EN ++K DFGL+ RDI YV
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 248
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + R Y + D+WS GV+L+ + S G P+
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 23/239 (9%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK---DDIKREIQIMQHLSGQ 139
K LG G FG Y G + ++ + L + +I E +M +
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMASV-DH 68
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI---CRSIVNVVHIC 196
P++V G Q V ++ +L G L D + + H + + C I +
Sbjct: 69 PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSA--YYVAPE- 252
++HRDL N L+ + +K TDFGL+ ++ K Y G ++A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 253 VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
+L R Y + D+WS GV ++ L++ G P+ I D + +G E P P I +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 1e-04
Identities = 12/29 (41%), Positives = 16/29 (55%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLG 415
L++ F D D G I+ EEL+ L LG
Sbjct: 2 LREAFKLFDKDGDGYISAEELRKALRSLG 30
|
Length = 30 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 2e-04
Identities = 18/44 (40%), Positives = 23/44 (52%), Gaps = 3/44 (6%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLA 412
K ALK + E LS EEI +M +D D G I +EE +A
Sbjct: 23 KAALKSLGEGLSEEEID---EMIREVDKDGDGKIDFEEFLELMA 63
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY----SERAAASICRSIVN 191
L PNIV ++ + + VV A G D I H+ SE A A I + ++
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYILQGVLK 112
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG---KVYRDI----VG 244
+ H MG +HR +K + L+S D L LS+ I G +V D V
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNLSM-INHGQRLRVVHDFPKYSVK 170
Query: 245 SAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPF 281
+++PEVL++ Y + DI+S G+ L +G PF
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 69/329 (20%), Positives = 131/329 (39%), Gaps = 71/329 (21%)
Query: 86 ELGRGQFGVT--YLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
E+GRG +T YL TG + I+ + T+ ++ E+ ++ H PNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRHPNIM 62
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI----VNVVHICHFM 199
+ + V+ A G + K ++ E + ++ +I + ++ H
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI------EEGKVYRDI----VGSAYYV 249
G +HR++K + L+S + L+ + GLS ++ KV D ++
Sbjct: 121 GYIHRNIKASHILIS---GDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 250 APEVLRRR---YGKEIDIWSAGVILYILLSGVPPF--------------------WAET- 285
+PE+LR+ Y + DI+S G+ L +G PF T
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235
Query: 286 ---------------EKGIFDAILQGDI------DFESAPWP-TISSSAKDLVRRMLTQD 323
+ GI ++++ + + P T S + ++LV L QD
Sbjct: 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295
Query: 324 PKKRITSAQVLEHPWIKEGGEASDKPIDS 352
P+KR +++ +L H + K+ E + I S
Sbjct: 296 PEKRPSASSLLSHAFFKQVKEQTQGSILS 324
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 59/237 (24%), Positives = 107/237 (45%), Gaps = 34/237 (14%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL K+LG GQFG ++ T N + A K++ + + E +
Sbjct: 4 PRESLKLE----KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA----EANV 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M+ L Q + + A K+ ++++ E A G L D + + E + + + I
Sbjct: 55 MKTL--QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFS 108
Query: 193 VHICHFMG------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I M +HRDL+ N L+S+ + K DFGL+ IE+ + Y G+
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE-YTAREGAK 164
Query: 247 Y---YVAPEVLRRRYGK---EIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ + APE + +G + D+WS G++L +++ G P+ + + A+ +G
Sbjct: 165 FPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 59/233 (25%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQP--- 140
KE+G G FG L NS + ++V K + + Q M+ L QP
Sbjct: 1 KEIGNGWFGKVILGEVNS--------GYTPAQVVVKELRVSASVQEQ-MKFLEEAQPYRS 51
Query: 141 ----NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASI---------- 185
N+++ G + +VME C G+L KG+ S R A +
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL------KGYLRSCRKAELMTPDPTTLQRM 105
Query: 186 -CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-------VFIEEGK 237
C + ++H+ H +H DL N LL++ + +K D+GLS ++ +
Sbjct: 106 ACEIALGLLHL-HKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQ 161
Query: 238 VYRDIVGSAYYVAPEVLRRRYG--------KEIDIWSAGVILYILLS-GVPPF 281
++ + ++APE++ +G KE ++WS GV ++ L G P+
Sbjct: 162 LWVPL----RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 52/234 (22%), Positives = 103/234 (44%), Gaps = 26/234 (11%)
Query: 85 KELGRGQFGVTYL-----CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ELG+G FG+ Y ++ + A K++++ + ++ + E +M+ +
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCH 69
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE----RAAASICRSIVNVVHI 195
++V G Q V+MEL G+L + + E +A S+ + I I
Sbjct: 70 -HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 196 CHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR---DIVGSA 246
M + HRDL N +++ E+ +K DFG++ I E YR +
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 247 YYVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDI 298
+++PE L+ + D+WS GV+L+ I P+ + + + +++G +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 17/126 (13%)
Query: 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKD-------- 217
L D I+ G +S R A I + H + +MH DLKPEN L+ + D
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277
Query: 218 -----ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVIL 271
+ ++ D G +E IV + +Y +PEV L + D+WS G I+
Sbjct: 278 RALPPDPCRVRICDLGGCC--DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335
Query: 272 YILLSG 277
Y L +G
Sbjct: 336 YELYTG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK------NDKDDIKREIQIMQHLSG 138
+ELG+G FG+ Y + + I K + T+ N+ ++ I+ + S
Sbjct: 12 RELGQGSFGMVY---------EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62
Query: 139 QP-----NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE----RAAASICRSI 189
++V G Q VVMEL A G+L + + +E R ++ I
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 190 VNVVHICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--- 240
I M + HRDL N +++ + +K DFG++ I E YR
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 241 DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILY 272
+ ++APE L+ + D+WS GV+L+
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 28/98 (28%), Positives = 42/98 (42%), Gaps = 3/98 (3%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHLSGQ 139
FGK LG G FG T G++ ++ + L D+ + E++I+ HL
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY 177
NIV GA V V+ E C G+L + + K
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 34/162 (20%), Positives = 70/162 (43%), Gaps = 10/162 (6%)
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHF 198
NIV +G ++ +V E + G L D + K G + + + +
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS--AYYVAPEVLR- 255
MG +H+ L L++S + + K + F + +Y + G + APE ++
Sbjct: 126 MGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ D+WS G++++ ++S G P+W + + + A+ G
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 32/134 (23%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212
S+ +V +L G L D + + + + C I ++ ++HR+L N L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 213 LSSKDENALLKATDFGLSVFI---EEGKVYRDIVGSAYYVAPE-VLRRRYGKEIDIWSAG 268
L S +++++ DFG++ + ++ Y + ++A E +L RY + D+WS G
Sbjct: 142 LKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 269 VILYILLS-GVPPF 281
V ++ ++S G P+
Sbjct: 199 VTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 8e-04
Identities = 18/46 (39%), Positives = 25/46 (54%), Gaps = 3/46 (6%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL 414
K AL ++ +LS EE+ +F DTD G I++EE L RL
Sbjct: 11 KRALALLGISLSEEEVD---ILFREFDTDGDGKISFEEFCVLLQRL 53
|
Length = 53 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL---VTKNDKDDIKREIQIMQHLSGQ 139
GK LGRG FG + + +C++++ + L T ++ + E++I+ H+
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 140 PNIVEFKGAYEDKQS-VHVVMELCAGGEL 167
N+V GA + V++E C G L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/115 (30%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSA--YYVAPEVLR-R 256
++HRDL N L+ S + +K TDFGL+ +E + K Y G ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
++ + D+WS GV ++ L++ G P+ + I D + +G E P P I +
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|200946 pfam00036, efhand, EF hand | Back alignment and domain information |
|---|
Score = 34.7 bits (81), Expect = 0.003
Identities = 8/28 (28%), Positives = 14/28 (50%)
Query: 422 EVQQLMEAADVDGNGTIDYIEFITATMH 449
E+++ + D DG+G I + EF
Sbjct: 1 ELKEAFKEFDKDGDGKISFEEFKELLKK 28
|
The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 34/151 (22%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LL+ + K DFGL+ RDI + YV
Sbjct: 236 IHRDLAARNILLT---HGRITKICDFGLA---------RDIRNDSNYVVKGNARLPVKWM 283
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFES---AP 304
APE + Y E D+WS G++L+ + S G P+ F +++ S AP
Sbjct: 284 APESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP 343
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
S D+++ DP KR T Q+++
Sbjct: 344 -----SEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 20/113 (17%)
Query: 125 DIKREIQIMQHLSGQ----PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
D +RE+ I+Q L+ + P ++ E +++ME G L SE
Sbjct: 37 DREREVAILQLLARKGLPVPKVLAS---GESDGWSYLLMEWIEGETL-------DEVSEE 86
Query: 181 AAASICRSIVNVVHICH---FMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
I + ++ H + + H DL P N L+ ++ D+ +
Sbjct: 87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII---DWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 17/234 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISK--RKLVTKNDKDDIKREIQIMQHLSGQPNI 142
K LG G FG Y G + K R+ + +I E +M + P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHV 71
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGV 201
G +V ++ +L G L D + K + + + C I ++ +
Sbjct: 72 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSA---YYVAPEVLRRR 257
+HRDL N L+ + +K TDFGL+ + + K Y G + +L R
Sbjct: 131 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 258 YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
Y + D+WS GV ++ L++ G P+ I + +G E P P I +
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 48/220 (21%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD--DIKREIQIMQHLS----- 137
E+G G FG L + +SK ++V K + ++ +Q +
Sbjct: 1 DEIGNGWFGKVLLGEAHR--------GMSKARVVVKELRASATPDEQLLFLQEVQPYREL 52
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASI----------- 185
PN+++ G + +V+E C G+L K + S R +
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDL------KNYLRSNRGMVAQMAQKDVLQRMA 106
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL--SVFIEEGKVYRD-I 242
C ++ + H +H DL N L++ + +K D+GL + E+ + +D
Sbjct: 107 CEVASGLLWL-HQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 243 VGSAYYVAPEVLRRRYG--------KEIDIWSAGVILYIL 274
++APE++ R K+ +IWS GV ++ L
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.63 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.38 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| PTZ00183 | 158 | centrin; Provisional | 99.29 | |
| PTZ00184 | 149 | calmodulin; Provisional | 99.27 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.25 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 99.24 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 99.23 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 99.22 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 99.12 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.11 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 99.08 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 99.07 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 99.07 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.99 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.98 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 98.98 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.94 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 98.88 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 98.86 | |
| KOG0041 | 244 | consensus Predicted Ca2+-binding protein, EF-Hand | 98.84 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 98.8 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| PTZ00183 | 158 | centrin; Provisional | 98.72 | |
| cd00051 | 63 | EFh EF-hand, calcium binding motif; A diverse supe | 98.71 | |
| cd05030 | 88 | calgranulins Calgranulins: S-100 domain found in p | 98.68 | |
| cd00252 | 116 | SPARC_EC SPARC_EC; extracellular Ca2+ binding doma | 98.66 | |
| KOG0036 | 463 | consensus Predicted mitochondrial carrier protein | 98.63 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.61 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.61 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.58 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-65 Score=468.38 Aligned_cols=268 Identities=40% Similarity=0.698 Sum_probs=247.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc----cHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN----DKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
+.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+....... ....+.+|+++|++|+ |||||+++++|+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence 34677899999999999999999999999999999999987664422 3345789999999995 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
..+..||||||++||+|++.+..++.+.+...+.+++|++.||.|||++||+||||||+|||+..+.++..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999998888899999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhcc----cCCccchhhHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCccCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPW 305 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 305 (472)
+...+...+.+.||||.|.|||++... +..++|+|||||+||-+|+|.+||.+..... ..+.|.++.+.+....|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 999988889999999999999999642 5569999999999999999999998775554 88999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..+|+++.+||.+||..||++|||++|+|+||||+...
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999999999998643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-62 Score=420.50 Aligned_cols=299 Identities=39% Similarity=0.746 Sum_probs=277.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.+.|.+-+.||+|.|+.||+|.+..||+.+|+|+|....+. ....+.+.+|++|-+.|+ |||||++++.+...+..|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcC-CCcEeehhhhhcccceeE
Confidence 456899999999999999999999999999999999876653 447889999999999996 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||+|++.|++|..-|...-.++|..+..+++||+.||.|||.+||||||+||+|+++.+.+...-+||+|||++..+..+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999999887877777999999999999999999999999999999999999999888889999999999999877
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+|||.|||||+++. +|+..+|||+.|||||-||.|.+||++.+...+++.|+++.++++.+.|+++++++++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 77778899999999999975 69999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHh
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAE 377 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 377 (472)
|++||..||.+|+|+.|+|+|||+.+...........+++..|++|....+|+-+++..+..
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998766555556688899999999999999999877654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-59 Score=451.19 Aligned_cols=258 Identities=36% Similarity=0.623 Sum_probs=243.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|..++.||+|||+.||++++..+|..||+|+|++..+......+.+.+||+|.++|. |||||+++++|+|.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 57999999999999999999999999999999999988888888999999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-c
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~ 237 (472)
+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|+++ +++..+||+|||+|..+... +
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence 9999999999999988999999999999999999999999999999999999999 67788999999999998744 6
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
...+.||||.|.|||++.+ .++..+||||+|||+|.||.|++||...+.++++..|....+.++. .+|.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 6778999999999999874 6999999999999999999999999999999999999999988876 6899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.+||+.||.+|||++++|.|+||+....
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 9999999999999999999999965443
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-58 Score=441.31 Aligned_cols=322 Identities=63% Similarity=1.046 Sum_probs=295.4
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
...+...|.+.+.||+|.||.||+|+++.+|+.+|+|++.+...........+.+|+.+|++|.+|||||.+++.|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 35677899999999999999999999999999999999998887666677899999999999977999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC-CCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~~~kl~Dfg~~~~ 232 (472)
.+++|||+|.||.|++.+... .+++..+..+++|++.++.|||+.||+||||||+|+|+...+. ...+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999877 4999999999999999999999999999999999999986654 45899999999999
Q ss_pred ccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
...+......+||+.|+|||++. ..|+..+||||+||++|.|++|.+||++.+..+....|..+.+.|....|+.+|..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 98877788899999999999998 68999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHhhchhhHHhhhhhhh
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMF 391 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F 391 (472)
+++||++||..||.+|+|+.++|+|||++........+....+...++++..++++++..+.......+ +..++.+|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 345 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEMF 345 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHHH
Confidence 999999999999999999999999999998766666666677777888899999998887777666555 67788889
Q ss_pred ccccCCCC
Q 012039 392 TNIDTDNS 399 (472)
Q Consensus 392 ~~~D~~~~ 399 (472)
..+|.+++
T Consensus 346 ~~~~~~~~ 353 (382)
T KOG0032|consen 346 KLMDTDNN 353 (382)
T ss_pred Hhhccccc
Confidence 99988777
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=425.59 Aligned_cols=257 Identities=35% Similarity=0.649 Sum_probs=239.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|.+++.||+|+|++|++|+++.+++.||||++.|..+..+...+.+.+|-.+|.+|.+||.|++++-.|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 47999999999999999999999999999999999988877777888999999999998899999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||.|||.|+.+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence 9999999999999999999999999999999999999999999999999999999 7888999999999998754221
Q ss_pred e--------------eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 239 Y--------------RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 239 ~--------------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
. .+.+||..|++||++.. ..+..+|||+||||||+|+.|.+||.+.++..++++|+.-.+.|+.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~- 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE- 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence 1 34789999999999975 5789999999999999999999999999999999999999888875
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++++.+++||+++|..||.+|+|+++|.+||||...
T Consensus 309 ---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 309 ---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ---CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 688999999999999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-57 Score=411.24 Aligned_cols=257 Identities=35% Similarity=0.665 Sum_probs=238.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+++.+.+++.||+|+++|...........+.+|..||.++. ||.||+++..|++.+.+|+|
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence 47999999999999999999999999999999999998877778889999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee-ccCCc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-IEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~-~~~~~ 237 (472)
+||+.||.|+.+|.+.+.++|..++.++..|+.||.|||++||+||||||+|||+ +..++++|+|||+++. ...+.
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC
Confidence 9999999999999999999999999999999999999999999999999999999 7888899999999984 44445
Q ss_pred ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
...+.+||+.|||||++. ..|+..+|+||||+++|+|++|.+||.+.+...++++|..++...... .++.++++||
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardll 257 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDLL 257 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHHH
Confidence 666789999999999886 579999999999999999999999999999999999999988544432 4789999999
Q ss_pred HHhcccCCCCCC----CHHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRI----TSAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rp----s~~~~l~h~~~~~~ 342 (472)
+++|+.||++|. ++.++-+||||...
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999999996 78899999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-56 Score=411.54 Aligned_cols=264 Identities=35% Similarity=0.640 Sum_probs=240.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|.+.+.||+|+||+||+|+++.++..||||.|.+..+ .....+.+..|+.+|+.|+ |||||.++++..+++.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEE
Confidence 45689999999999999999999999999999999988765 4556788999999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC---CcEEEeecCCceec
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN---ALLKATDFGLSVFI 233 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~---~~~kl~Dfg~~~~~ 233 (472)
+|||||.||+|.+++.+.+.+++..++.++.||+.||++||+++||||||||.|||++....+ ..+||.|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999865333 68999999999999
Q ss_pred cCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.++....+.+|+|.|||||+++ ++|+.|+|+||+|+|+|+|++|+.||...+..+++..+.++....+... ..++..+
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCch
Confidence 9888888899999999999995 6799999999999999999999999999999999998888765544432 3567778
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+++...|+.+|.+|.+..+-+.|+++....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8999999999999999999999999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=401.57 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=227.0
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe-EE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS-VH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-~~ 156 (472)
..+.+.++.||+|..|+||+|+|+.|++.+|+|+|... .......++.+|+++++.. +||+||.+|+.|.+++. ++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEE
Confidence 34567788999999999999999999999999999432 2345578899999999999 59999999999999994 99
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|+||||+||||.+.+...++++|.....|+.+++.||.|||+ ++|+||||||+|||+ +..+.|||||||.+..+..
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhh
Confidence 999999999999999988999999999999999999999996 999999999999999 5677799999999998876
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC-----ChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-----TEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
. ...+.+||..|||||.+.+ .|+.++||||||+.++|+++|+.||... ..-+++..|..+..+-... ..+|
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS 308 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFS 308 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCC
Confidence 6 5567899999999999886 6999999999999999999999999774 4567777887754332221 2489
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+++++||..||++||.+|||+.|+++|||+++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999999999754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-56 Score=390.18 Aligned_cols=255 Identities=35% Similarity=0.649 Sum_probs=239.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
-++|++.+.||.|+||+|.+++++.+|..||+|++.+..+..-...+...+|.++|+.+. ||+++++++.+.+...+|+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEE
Confidence 457999999999999999999999999999999999888777677788999999999996 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||.+||.|+.++.+.+++++..++.++.||+.||+|||+++|++|||||+|||+ +.++.+||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999999999999999 78889999999999987654
Q ss_pred ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
..+.||||.|+|||++. .+|+.++|+|||||++|||+.|.+||...+...++++|..+++.|+. .+++++++||
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 56789999999999886 56999999999999999999999999999999999999999999885 5899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+++|+.|-.+|. ...+|..||||+..
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 999999999993 66899999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=424.78 Aligned_cols=257 Identities=39% Similarity=0.683 Sum_probs=241.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
+-|++++.||.|+.|.|.+|+|..||+.+|||+|.+...........+.+|+-||+.|. ||||+++|++|++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence 46999999999999999999999999999999999875555666788999999999996 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
+||++||.|++++..++++++.+++++++||+.|+.|||..+|+||||||+|+|+ +....+||+|||.|..-.++..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999 5555599999999998888888
Q ss_pred eeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
..+.||+|+|.|||++++. | +.++||||+|||||.||+|++||.+.+-..++.++.+|.+..+ ..+|.++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence 8899999999999999864 4 7899999999999999999999999999999999999998877 46999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
++||..||.+|+|.+||++|||+..+.
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=391.47 Aligned_cols=296 Identities=34% Similarity=0.640 Sum_probs=257.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--C---cccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--T---KNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
.+...|.-.+.||.|..++|.+|.++.+|+.+|+|+|....-. . ....+....|+.||+++.+||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788889999999999999999999999999998643221 1 1224556789999999999999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
.+..+++|+|.|+.|.|+++|.+.-.+++...+.|++||+.++.|||.++||||||||+|||+ +++..+||+|||++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 999999999999999999999998899999999999999999999999999999999999999 67888999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh-------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
+.+.+++.....||||+|.|||.+. ..|+..+|+|++|||+|.||.|.+|||.....-++..|.+|++.|..+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999874 248999999999999999999999999998888999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCC----CCchHHHHHHHHHHhhhHhHHHHHHH
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK----PIDSAVLSRMKQFRAMNKLKKLALKV 374 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~~ 374 (472)
.|.++|...++||.+||+.||.+|.|++|+|.||||......... ......+...-.+++..+++-+++..
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~~~~~~~k~qt~~~aRkrFk~ail~v 325 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPVVEVELVKDQTSERARKRFKVAILTV 325 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCCcchhhhhhhhhHHhhhheeeeeehH
Confidence 999999999999999999999999999999999999654322211 12233344444556666666655443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-54 Score=417.14 Aligned_cols=259 Identities=41% Similarity=0.724 Sum_probs=235.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc--ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK--NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
....+|.+++.||+|+||+|+.|.+..++..||+|++.+...... ...+.+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999999999999999998877533212 345677799999999977999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC-CcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN-ALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~-~~~kl~Dfg~~~~ 232 (472)
.+|+|||||.||+|++++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++ .+ +.+||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999994 44 7899999999998
Q ss_pred c-cCCcceeeccCCCCCCchhhhhc-c-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 233 I-EEGKVYRDIVGSAYYVAPEVLRR-R-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 233 ~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
. .......+.+||+.|+|||++.+ . | +.++||||+||+||.|++|..||...+...++..|..+.+.++.. +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----L 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----c
Confidence 8 46667788999999999999975 3 5 689999999999999999999999999899999999998887764 4
Q ss_pred -CHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 309 -SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 309 -s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
|+++++||.+||..||.+|+|+.++++||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999997
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=382.18 Aligned_cols=269 Identities=38% Similarity=0.686 Sum_probs=241.2
Q ss_pred cccccceEEcc-eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--
Q 012039 75 EDVKLHYSFGK-ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-- 151 (472)
Q Consensus 75 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 151 (472)
-.+.++|.+.. +||-|-.|.|..|.++.|++.+|+|++. +.....+|+++--....|||||.++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--------DSPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 34667888864 6999999999999999999999999874 235567888887777789999999999864
Q ss_pred --CCeEEEEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 152 --KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
...+.+|||.++||.|++++...+. |+|.++..|++||..|+.|||+.+|.||||||+|+|+.....+..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4678899999999999999998765 999999999999999999999999999999999999999889999999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCccCCC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFES 302 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 302 (472)
|+|+.........+.+-||+|.|||++. .+|+..+|+||+||++|.||+|.+||+... ..++...|..+.+.|+.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9999877666777888999999999997 469999999999999999999999998753 35678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~ 351 (472)
+.|..+|++++++|+++|..+|.+|.|++++++|||+.......+.++.
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 9999999999999999999999999999999999999987666555553
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-54 Score=408.13 Aligned_cols=260 Identities=32% Similarity=0.567 Sum_probs=236.0
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|.+++.||+|+||.||+|+.+.||..+|+|+++|+..........+..|-++|... ++|+||++|..|++..++||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence 45799999999999999999999999999999999999887778888999999999996 69999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC--
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-- 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-- 235 (472)
||||++||++..+|.+.+.|++..++.++.+++.||+-+|+.|++||||||+|+|| +..+++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999 7888999999999853211
Q ss_pred --------------------C--cc------------------------eeeccCCCCCCchhhhhc-ccCCccchhhHH
Q 012039 236 --------------------G--KV------------------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAG 268 (472)
Q Consensus 236 --------------------~--~~------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG 268 (472)
. .. ..+.+|||.|+|||++.+ +|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 00 013579999999999875 599999999999
Q ss_pred HHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccccC
Q 012039 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (472)
Q Consensus 269 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps---~~~~l~h~~~~~~ 342 (472)
||+||||.|.+||.+.++.+++.+|.+....+..+.-..++++++|||.+||. ||++|.. ++||.+||||+..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999999999999988655555556789999999999999 9999985 8999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=382.07 Aligned_cols=257 Identities=28% Similarity=0.553 Sum_probs=221.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
+.|+.+.++|+|+||+||+|+++.||+.||||.+..+.. ++.-.+-..+|+++|++|. |||+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence 468889999999999999999999999999998854332 2333556789999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CC
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~ 236 (472)
+|||+. ++.+.+... ..+++..+..++.|++.|+.|||+++++||||||+|||+ ..++.+||||||+|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence 999965 666666553 459999999999999999999999999999999999999 567789999999999988 77
Q ss_pred cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--------------C---
Q 012039 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--------------D--- 297 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------------~--- 297 (472)
..++.++.|.+|+|||.+.+ +|+..+||||+||++.||++|.+.|.+.++-+++-.|... .
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 78889999999999998865 6999999999999999999999999999887766665430 0
Q ss_pred --ccCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 298 --IDFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 298 --~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+.++. ..++.++.-+.+|+++||..||++|++.+++|.|+||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11111 124567888999999999999999999999999999953
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=396.84 Aligned_cols=261 Identities=32% Similarity=0.509 Sum_probs=227.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-e
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-S 154 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~ 154 (472)
.+..+|.++++||.|+||.||+|+.+.+|..||||.+++... ...+ -.=.||+..|++|..|||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456799999999999999999999999999999999876432 2222 223589999999966999999999998887 9
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+|+||||| ...|+++++.. +.|++..++.|+.||+.||+|+|.+|+.||||||+|||+. ....+||+|||+|+.+
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccccc
Confidence 99999999 57999999765 4599999999999999999999999999999999999994 4667999999999999
Q ss_pred cCCcceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---------------
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--------------- 296 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------------- 296 (472)
.....++.++.|.+|+|||++- +-|+.+.||||+|||++|+++-++.|.|.++-+.+.+|.+-
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 9999999999999999999874 45999999999999999999999999999998888777641
Q ss_pred ----CccCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 297 ----DIDFESA-------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 297 ----~~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+.++.. ..+..+.++.++|.+||.+||++||||.++|+||||+..
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1111111 124678999999999999999999999999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=384.17 Aligned_cols=259 Identities=39% Similarity=0.678 Sum_probs=243.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
...+-+|++.+.||+|.||.|-+|++...|+.||||.|.+..+.+..+.-.+.+|++||..| +||||+.+|++|+..+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDK 127 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCce
Confidence 45677999999999999999999999999999999999999988888888899999999999 59999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+.|||||..+|.|++++.+.+.+++.+++.+++||++|+.|||.++++|||||.+|||+ +.++.+||.|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999 778889999999999999
Q ss_pred CCcceeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
..+...++||+|.|.+||++++. | ++.+|-|||||+||.|+.|.+||.+.+...++..|..+.+..+. -+.++
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA 279 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDA 279 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchH
Confidence 88888999999999999999874 4 78999999999999999999999999999999999999876554 35788
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.-||+.||..||++|.|+++|-.|-|++..
T Consensus 280 ~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 280 SGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 999999999999999999999999999854
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=399.71 Aligned_cols=257 Identities=30% Similarity=0.540 Sum_probs=238.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.+.||+|+||+|+++..+.+++.||||+++|..+....+.+.+..|.+|+....+||.++.++.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 45899999999999999999999999999999999999988888999999999999999889999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~ 236 (472)
||||+.||++. ++...+.+++..++.++..|+.||.|||++||||||||.+|||+ |..+.+||+|||+++..- .+
T Consensus 447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCC
Confidence 99999999954 44556789999999999999999999999999999999999999 778889999999998643 56
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
+...+.+|||.|+|||++.+ .|+..+|+|||||+||+||.|..||.+.+++++++.|......++. .+|.++.++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~i 598 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAI 598 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHH
Confidence 67778999999999999975 5999999999999999999999999999999999999999887775 589999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITS-----AQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~-----~~~l~h~~~~~~ 342 (472)
++++|.+||++|..+ ++|..||||+..
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 999999999999965 789999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=397.51 Aligned_cols=254 Identities=32% Similarity=0.563 Sum_probs=234.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.|... .......+.+|++|++.|+ |||||.++++|+...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence 478999999999999999999999999999999988664 4456788999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
+|||.| +|+.++...+.++|+.+..|+.+++.||.|||+++|.|||+||.|||+ +..+.+|+||||+|+.+.....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 999976 999999999999999999999999999999999999999999999999 7788899999999998876543
Q ss_pred -eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 239 -YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 239 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....-|||.|||||++.+ .|+..+|+||||||+||+++|++||...+-..+...|......++. .+|..+..|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence 345679999999999875 5999999999999999999999999999999999999887766554 6899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+|.+||.+|.|+.+++.|||.+..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=385.84 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=224.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 155 (472)
.+.|+.+++||+|+||.||+|++..+|+.||+|.+...... .....-..+||.||++| +||||+++.+...+. ..+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceE
Confidence 45788999999999999999999999999999999765532 33455677999999999 599999999998776 789
Q ss_pred EEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|+|+|||+ .+|.-++... -+|++.+++.+|+||+.||+|||.+||+|||||.+|||| +.++.+||+|||+|+++.
T Consensus 194 YlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 99999995 4888777664 369999999999999999999999999999999999999 778889999999999876
Q ss_pred CCc--ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC-----
Q 012039 235 EGK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW----- 305 (472)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 305 (472)
... .++..+.|.+|+|||++.+ .|+.++|+||+||||.||++|++.|.+.++-+++..|....-......|
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 544 4677789999999998865 5999999999999999999999999999999998888652222222222
Q ss_pred --------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 306 --------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 306 --------------------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..++..+.+|+..||..||.+|.||.++|+|+||....
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 34688899999999999999999999999999996543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=379.33 Aligned_cols=260 Identities=33% Similarity=0.620 Sum_probs=226.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----------ccHHHHHHHHHHHHhccCCCCeeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----------NDKDDIKREIQIMQHLSGQPNIVE 144 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~hp~iv~ 144 (472)
..-.+|++++.||+|.||.|.+|++..+++.||||++.+...... ...+.+.+||.||++|. |||||+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVK 172 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeE
Confidence 344689999999999999999999999999999999986543211 12468899999999995 999999
Q ss_pred EEEEEEeC--CeEEEEEeccCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCc
Q 012039 145 FKGAYEDK--QSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 145 ~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~ 221 (472)
++++..+. +.+|||+|||..|.+.+ ....+. +++.+++.+++.++.||+|||.+||+||||||+|+|+ +.++.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCc
Confidence 99999864 68999999999998854 333344 9999999999999999999999999999999999999 56688
Q ss_pred EEEeecCCceeccCC------cceeeccCCCCCCchhhhhc---c--cCCccchhhHHHHHHHHhhCCCCCCCCChHHHH
Q 012039 222 LKATDFGLSVFIEEG------KVYRDIVGSAYYVAPEVLRR---R--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~------~~~~~~~gt~~y~aPE~~~~---~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 290 (472)
+||+|||.+.....+ ......+|||.|+|||.+.. . .+.+.||||+||+||.|+.|+.||.+....+++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999999876322 23345789999999998754 2 478899999999999999999999999999999
Q ss_pred HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+|.+..+.|+.. +.+.+++++||.+||.+||++|++..+|..|||....
T Consensus 329 ~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999998888876 4788999999999999999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-53 Score=369.59 Aligned_cols=247 Identities=30% Similarity=0.533 Sum_probs=216.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE-EEEeCC-e
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG-AYEDKQ-S 154 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~-~~~~~~-~ 154 (472)
....|.+.++||+|+||+||++.+..+|..||.|.+.-... +....+.+..|+.+|++|+ |||||++++ .|..++ .
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchh
Confidence 34579999999999999999999999999999999874443 4556788999999999995 999999998 454444 4
Q ss_pred EEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--cEeecCCCCceeeccCCCCCcEEEee
Q 012039 155 VHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHF--MG--VMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~--~~--i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
++||||||.+|+|.+.++. ++.++|..+|.++.|++.||..||+ .. |+||||||.||++ +.++.+||+|
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGD 171 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGD 171 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeecc
Confidence 9999999999999988863 4569999999999999999999999 44 9999999999999 6778899999
Q ss_pred cCCceeccCCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 227 FGLSVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 227 fg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
||+++++..... ..+.+|||+||+||.+.+ +|+.+|||||+||++|||+.-.+||.+.+-.++-.+|.++.+..-.
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-- 249 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-- 249 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--
Confidence 999999876544 346899999999998874 6999999999999999999999999999999999999999664221
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCH
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITS 330 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~ 330 (472)
-..+|.++..+|..|+..||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 14689999999999999999999997
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=356.52 Aligned_cols=255 Identities=33% Similarity=0.653 Sum_probs=236.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|.||.||+|+.++++..||+|++.++++.......++.+|++|...|+ ||||.++|++|.+...+|++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence 47999999999999999999999999999999999988776677788999999999996 99999999999999999999
Q ss_pred EeccCCcchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRII--AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||..+|+|+..|. ...++++..++.++.|++.||.|||.++|+||||||+|+|+ +..+.+||+|||.+.... .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-C
Confidence 99999999999998 56779999999999999999999999999999999999999 455669999999998765 4
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
+.-.+.+||..|.+||+..+ .++..+|+|++|++.||++.|.+||...+..+.++.|..-.+.++ ..+|.+++|+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence 45567899999999999876 589999999999999999999999999999999999999888877 4799999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
|.+||.++|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=353.46 Aligned_cols=260 Identities=33% Similarity=0.507 Sum_probs=224.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|...++||+|.||+||+|++..||+.||||.|+....... ..-...+|+.+|+.++ |+||+.++++|.+...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence 478889999999999999999999999999999987654322 2345679999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
+||++ .+|...++.. ..++..+++.++.+++.||+|||++.|+||||||+|+|+ +.++.+||+|||+++.+...+
T Consensus 80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence 99995 5898888754 458999999999999999999999999999999999999 567789999999999887655
Q ss_pred ce-eeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC---------
Q 012039 238 VY-RDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW--------- 305 (472)
Q Consensus 238 ~~-~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 305 (472)
.. ...+-|.+|+|||.+-+ .|+..+|+||.|||+.||+-|.+.|.+.++-+++..|.+.--......|
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 43 33478999999998754 6999999999999999999999999999998888888763333333333
Q ss_pred ---------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 306 ---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 306 ---------------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
+..+.++.+|+.+||..||.+|+|+.|+|+|+||+....
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 345778899999999999999999999999999997543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=370.91 Aligned_cols=260 Identities=32% Similarity=0.567 Sum_probs=233.6
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
-.+|++++.||.|.-|+||+|+.+.++..+|+|++.+..+.......+++.|-.||..+ +||.++.+|..|+.++..|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEE
Confidence 35789999999999999999999999999999999998876666677888999999999 69999999999999999999
Q ss_pred EEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 158 VMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||+||+|..+.+++ +.+++..++.++..++.||+|||-.|||+|||||+|||| .++++|.|+||.++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence 99999999999887654 469999999999999999999999999999999999999 6778899999998753210
Q ss_pred ---------------------------------C-c-----------------------ceeeccCCCCCCchhhhhc-c
Q 012039 236 ---------------------------------G-K-----------------------VYRDIVGSAYYVAPEVLRR-R 257 (472)
Q Consensus 236 ---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~-~ 257 (472)
. . .....+||-.|.|||++++ .
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0113579999999999986 5
Q ss_pred cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHH
Q 012039 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT----SAQV 333 (472)
Q Consensus 258 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps----~~~~ 333 (472)
++.++|+|+|||++||||.|..||.+.+.++++.+|......|+.. +.+|..++|||+++|.+||.+|.. ++||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 9999999999999999999999999999999999999999888876 488999999999999999999998 9999
Q ss_pred hcCCccccCC
Q 012039 334 LEHPWIKEGG 343 (472)
Q Consensus 334 l~h~~~~~~~ 343 (472)
.+||||+...
T Consensus 390 K~HpFF~gVn 399 (459)
T KOG0610|consen 390 KRHPFFEGVN 399 (459)
T ss_pred hcCccccCCC
Confidence 9999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=390.59 Aligned_cols=256 Identities=34% Similarity=0.582 Sum_probs=224.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+....|....+||+|+.|.||.|+...+++.||+|.+.... ....+-+.+|+.+|+.++ |+|||.+++.|...+.+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDEL 345 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhccccee
Confidence 45667999999999999999999999999999999997654 344677899999999995 99999999999988999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||++||+|.+.+.. ..++|.+++.|++.++.||+|||.+||+|||||.+|||+ +.++.+||+|||++..+..
T Consensus 346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecccc
Confidence 999999999999887754 469999999999999999999999999999999999999 5566699999999998876
Q ss_pred Cc-ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc-CCccCCCCCCCCCCHHH
Q 012039 236 GK-VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-GDIDFESAPWPTISSSA 312 (472)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~ 312 (472)
.. .-.+.+|||+|||||++. ..|++++||||||+++.||+-|.+||..+++-..+..|.. +...+. .+..+|+++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk--~~~klS~~~ 499 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK--NPEKLSPEL 499 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC--CccccCHHH
Confidence 54 445679999999999986 5799999999999999999999999997766555555544 433333 346899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
++|+.+||+.|+++|+++.++|+||||+.
T Consensus 500 kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 500 KDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999999999954
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=362.44 Aligned_cols=264 Identities=28% Similarity=0.397 Sum_probs=223.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCe
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQS 154 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 154 (472)
..+.|..+.+|++|+||.||+|+++.|++.||+|.++..... ..-.-.-.+||.+|.+++ |||||.+-++... -+.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccce
Confidence 345799999999999999999999999999999999765521 111223468999999996 9999999998764 467
Q ss_pred EEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+|||||||+ -+|..++..-+ +|...+++.++.|++.||+|||.+.|+||||||+|+|+ ...+.+||+|||+|+.+
T Consensus 152 iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhh
Confidence 999999996 48888887654 89999999999999999999999999999999999999 57788999999999998
Q ss_pred cCC-cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC-----
Q 012039 234 EEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW----- 305 (472)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 305 (472)
... ..+...+-|.+|+|||.+-+ .|+++.|+||+|||+.||+++++.|.+.++-+.++.|.+.--......|
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 765 45667789999999998864 5999999999999999999999999999998888888752211111111
Q ss_pred -----------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 306 -----------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 306 -----------------------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
..+++...+|+..+|.+||.+|.||.++|+|+||.+...+.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 12568889999999999999999999999999999864433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=369.99 Aligned_cols=268 Identities=31% Similarity=0.525 Sum_probs=227.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 151 (472)
.+..+|...+.||.|+||.|+.+.++.+|+.||+|.+... +......++..+|+.+|+.++ |+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRD 96 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccc
Confidence 4556777789999999999999999999999999988632 334556788899999999996 9999999998864
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
-+.+|+|+|+| +.+|.+.++.+..+++..+..++.||+.||+|+|+.+|+||||||+|+++ +.+..+||+|||+|
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLA 172 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccce
Confidence 46899999999 67899888888789999999999999999999999999999999999999 56677999999999
Q ss_pred eeccC---CcceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc----------
Q 012039 231 VFIEE---GKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ---------- 295 (472)
Q Consensus 231 ~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---------- 295 (472)
+.... ....+.++.|.+|+|||++. ..|+...||||+|||+.||++|++.|.|.+.-..+..|..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98864 44557788999999999874 4699999999999999999999999988776555555432
Q ss_pred -------------CCccCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCC
Q 012039 296 -------------GDIDFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349 (472)
Q Consensus 296 -------------~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 349 (472)
.....+. ..+++.++.+.+|+.+||..||.+|+|++|+|+||||.....+.+.+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 1111111 12468899999999999999999999999999999999876655554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=364.58 Aligned_cols=266 Identities=35% Similarity=0.645 Sum_probs=237.8
Q ss_pred cccceEE-cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 77 VKLHYSF-GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 77 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+.+-|++ .+.||+|+|+.|-.|+...+|.+||||+|.+. ....+.++.+|++++.+.++|+||++++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4455666 45799999999999999999999999999876 3456788999999999999999999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||.+.||+|..+|.+...+++.++..+.+.|+.||.+||.+||.||||||+|||....+.-.-+|||||.+..-+..
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998777778899999998754332
Q ss_pred C--------cceeeccCCCCCCchhhhh---c---ccCCccchhhHHHHHHHHhhCCCCCCCCC---------------h
Q 012039 236 G--------KVYRDIVGSAYYVAPEVLR---R---RYGKEIDIWSAGVILYILLSGVPPFWAET---------------E 286 (472)
Q Consensus 236 ~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------~ 286 (472)
. ....+.+|+..|||||+.. + .|+.++|.||||||||.||+|.+||.+.. .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 1234568999999999763 2 48999999999999999999999997642 3
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
+.++..|..|.+.|+...|..+|.+++++|..+|..|+.+|.++.++++|||++.....
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 67899999999999999999999999999999999999999999999999999865443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=368.55 Aligned_cols=261 Identities=30% Similarity=0.466 Sum_probs=228.2
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
-...|++.+.||.|..++||+|++..++..||||++.-.... .....+.+|+..|+.+ +||||++++..|..+..+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeE
Confidence 345899999999999999999999999999999999866643 3478999999999999 5999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||.||.+||+++++... ..+.|..++.|+++++.||.|||++|.+|||||+.|||| +.++.|||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeec
Confidence 999999999999999864 349999999999999999999999999999999999999 678889999999887654
Q ss_pred CCc-c----eeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC-----
Q 012039 235 EGK-V----YRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE----- 301 (472)
Q Consensus 235 ~~~-~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 301 (472)
... . +...+||++|||||++.+ .|+.|+||||||++..||.+|..||..-.+.+++..-+++.....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 322 1 144689999999999753 599999999999999999999999998888777777777665422
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 302 -SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 302 -~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
......++..++++|..||++||++|||+.++|+|+||+...
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 222345788999999999999999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=375.31 Aligned_cols=258 Identities=34% Similarity=0.558 Sum_probs=215.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--eEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--SVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~ 156 (472)
.+|..++.||+|+||.||++.+..+|...|||.+..... ...+.+.+|+.+|.+|+ |||||++++...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence 368889999999999999999999999999999865421 11677999999999997 999999999755444 699
Q ss_pred EEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|.|||++||+|.+++.+.+ ++++..++.+.+||+.||.|||++||+||||||+|||+... ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence 9999999999999999877 79999999999999999999999999999999999999421 57899999999987663
Q ss_pred ----CcceeeccCCCCCCchhhhhccc--CCccchhhHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCccCCCCCCCCC
Q 012039 236 ----GKVYRDIVGSAYYVAPEVLRRRY--GKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 236 ----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
........||+.|||||++.... ..++|||||||++.||+||+.||.. ......+-.+....... .....+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--~ip~~l 248 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--EIPDSL 248 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--CCCccc
Confidence 12233578999999999998543 3499999999999999999999987 33333334444433222 223469
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
|+++++||.+||..||.+||||.++|+|||.+....
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999986543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=378.54 Aligned_cols=264 Identities=34% Similarity=0.605 Sum_probs=242.1
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.+-|.+.+.||+|.|.+|-+|+|.-||..||||+|.+..+. ......+..|++.|+.++ |||||++|++......
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTK 91 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccce
Confidence 34667899999999999999999999999999999999988764 344667889999999996 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+|||+|+-.||+|+++|.+. ..+.|..+..++.||+.|+.|||+..+|||||||+||.+. ..-+.+||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence 99999999999999999765 4599999999999999999999999999999999999886 46688999999999999
Q ss_pred cCCcceeeccCCCCCCchhhhhc-cc-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
.++....+.+|+..|.|||++.+ .| .+++||||||||||.|++|++||...++.+.+-.|+..++..+. .+|.+
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~e 245 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKE 245 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHH
Confidence 99999999999999999998865 45 57899999999999999999999999999999999999988775 68999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
+++||..||..||++|.+.++|..|+|++......
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 99999999999999999999999999999765543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=382.82 Aligned_cols=254 Identities=32% Similarity=0.621 Sum_probs=227.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+++.+|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEE
Confidence 357999999999999999999999999999999997654433445677889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc
Confidence 99999999999999988899999999999999999999999999999999999999 566779999999998765432
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+...++. .++..+++||
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 246 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLV 246 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHH
Confidence 34579999999999864 5889999999999999999999999998888888888887655442 4789999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
++||+.||.+||+ ++++++||||..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 799999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=377.52 Aligned_cols=252 Identities=29% Similarity=0.570 Sum_probs=224.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence 6899999999999999999999999999999987544333334567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--c
Confidence 999999999999988899999999999999999999999999999999999999 45667999999999876432 2
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++. .++..+++||++
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 231 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKK 231 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHH
Confidence 34579999999998864 5889999999999999999999999998888888888887765543 468999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCcccc
Q 012039 319 MLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 319 ~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
||+.||.+||+ +.++++||||+.
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=379.84 Aligned_cols=250 Identities=33% Similarity=0.592 Sum_probs=220.5
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++++. ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654433444567789999999995 99999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CCcceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 243 (472)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ........+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence 9999999888899999999999999999999999999999999999999 556679999999987532 222334567
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+..+...++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999864 589999999999999999999999999888888888877765544 35899999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccccC
Q 012039 323 DPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 323 dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=383.51 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=221.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++. ||||+++++.+.+...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999997654433444567889999999994 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999 456779999999987543211
Q ss_pred -----------------------------------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCC
Q 012039 238 -----------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPF 281 (472)
Q Consensus 238 -----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 281 (472)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0123579999999999864 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCCccccC
Q 012039 282 WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPK---KRITSAQVLEHPWIKEG 342 (472)
Q Consensus 282 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~Rps~~~~l~h~~~~~~ 342 (472)
.+.+..+.+..+.........+....+++++++||.+|+. +|. .||+++++++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9988888888888754333333334689999999999875 444 45899999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=371.21 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=217.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++++. |+||+++++++.+++.+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEE
Confidence 3788999999999999999999999999999987654433334456789999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999999998877543 358999999999999999999999999999999999999 556679999999998876555
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+..............++.++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 5556689999999999864 689999999999999999999999987654332222222211122223346899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
++||+.||++||+ ++++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=383.37 Aligned_cols=258 Identities=28% Similarity=0.549 Sum_probs=224.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.+. ||||+++++++.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence 6999999999999999999999999999999997654333344567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
|||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccccc
Confidence 999999999999888889999999999999999999999999999999999999 5677899999999875432110
Q ss_pred --------------------------------------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCC
Q 012039 239 --------------------------------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVP 279 (472)
Q Consensus 239 --------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 279 (472)
....+||+.|+|||++.. .++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 012469999999998864 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccccC
Q 012039 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (472)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps---~~~~l~h~~~~~~ 342 (472)
||.+.+..+.+..+......+..+....+++++++||.+||. +|.+|++ +.++|+||||+..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999988888887777655444443334689999999999997 9999998 9999999999863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=378.46 Aligned_cols=256 Identities=30% Similarity=0.504 Sum_probs=225.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence 6999999999999999999999999999999997654433344567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--cc
Confidence 999999999999888889999999999999999999999999999999999999 5567799999999986544 23
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC----CCCCHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW----PTISSSAKD 314 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~ 314 (472)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+..+.+ ..+++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 45679999999998864 5899999999999999999999999988888877777654433332222 257899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
||.+||..+|.+||++.++++||||..
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=382.11 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=220.5
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|.+++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999997655444445677899999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 456779999999975321000
Q ss_pred ----------------------------------------------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHH
Q 012039 238 ----------------------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVI 270 (472)
Q Consensus 238 ----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i 270 (472)
.....+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123479999999998864 58999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCCccccC
Q 012039 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT--QDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 271 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+|+|++|..||...+..+....+.........+.+..+++++.+||.+||. .++..|+++.++++||||...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999999887777666666544444444445789999999999664 455569999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=376.73 Aligned_cols=254 Identities=30% Similarity=0.587 Sum_probs=225.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCC-CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTG-RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..+|.+.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence 457999999999999999999877655 689999987654434445667889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC
Confidence 999999999999999988899999999999999999999999999999999999999 56678999999999876432
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+...++ ..+++.+.++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence 235679999999999865 589999999999999999999999999888888888888766544 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 316 i~~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
|++||+.||++|+ +++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999995 8999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=372.08 Aligned_cols=248 Identities=30% Similarity=0.569 Sum_probs=218.7
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999997654434445667889999999995 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-CcceeeccCC
Q 012039 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIVGS 245 (472)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~gt 245 (472)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence 99999888889999999999999999999999999999999999999 5667799999999875432 2223446799
Q ss_pred CCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 012039 246 AYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324 (472)
Q Consensus 246 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 324 (472)
+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..+++++++||.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence 99999998865 589999999999999999999999999888888888887665544 3588999999999999999
Q ss_pred CCCC---CHHHHhcCCccccC
Q 012039 325 KKRI---TSAQVLEHPWIKEG 342 (472)
Q Consensus 325 ~~Rp---s~~~~l~h~~~~~~ 342 (472)
.+|| ++.++|+||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=374.05 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=208.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|+++++||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.+. |+||+++++++.+.+.+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence 457888999999999999999999999999999986432 2233567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+.+++|.+. ....+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence 9999999998643 346788889999999999999999999999999999999 456779999999998765332
Q ss_pred -ceeeccCCCCCCchhhhhc------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 238 -VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
......||..|+|||++.. ..+.++|||||||++|+|++|+.||......+....+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 2234579999999998742 235689999999999999999999974433222222111111112222346889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
++++||.+||..||++|||+.|+|+||||....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999999999999999999999998753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=382.58 Aligned_cols=257 Identities=29% Similarity=0.527 Sum_probs=219.5
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++++ +||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEE
Confidence 699999999999999999999999999999998765433334456788999999999 4999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 4567799999999863211000
Q ss_pred -----------------------------------------------eeeccCCCCCCchhhhhc-ccCCccchhhHHHH
Q 012039 239 -----------------------------------------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVI 270 (472)
Q Consensus 239 -----------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i 270 (472)
....+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 012469999999998864 58999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCcccc
Q 012039 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR---ITSAQVLEHPWIKE 341 (472)
Q Consensus 271 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---ps~~~~l~h~~~~~ 341 (472)
+|+|++|.+||.+.+..+.+..+.........+....++.++++||.+||. +|.+| +++.++++||||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999888877777777644333333334689999999999998 77765 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=382.05 Aligned_cols=257 Identities=31% Similarity=0.533 Sum_probs=222.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|.+++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++++. ||||+++++.+.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999997654333444667889999999994 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC---
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG--- 236 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~--- 236 (472)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 56678999999997532100
Q ss_pred ---------------------------------------------cceeeccCCCCCCchhhhhc-ccCCccchhhHHHH
Q 012039 237 ---------------------------------------------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVI 270 (472)
Q Consensus 237 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i 270 (472)
......+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00113469999999998864 68999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCcccc
Q 012039 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKE 341 (472)
Q Consensus 271 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps---~~~~l~h~~~~~ 341 (472)
+|+|++|..||.+.+..+....+.........+.+..+++++.++|.+|+ .+|.+|++ +.++++||||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999999988887777777765555555555678999999999987 59999997 999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=382.43 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=221.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++. ||||+++++.+.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence 6999999999999999999999999999999987654333344567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC---
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG--- 236 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~--- 236 (472)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 56677999999997532100
Q ss_pred -----------------------------------------cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHH
Q 012039 237 -----------------------------------------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYIL 274 (472)
Q Consensus 237 -----------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 274 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00113479999999999864 589999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCcccc
Q 012039 275 LSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKE 341 (472)
Q Consensus 275 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~~~l~h~~~~~ 341 (472)
++|+.||.+....+....+.........+.+..+++++.+||.+|+ .+|.+|+ ++.++++||||+.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999999988877777777665544444445678999999999987 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=369.28 Aligned_cols=261 Identities=36% Similarity=0.660 Sum_probs=237.4
Q ss_pred cccceEE--cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 77 VKLHYSF--GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 77 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+..-|.| .+.||+|.||+||-|+++++|+.||||+|.+..+..+ ....+.+|+.||+.+. ||.||.+.-.|+..+.
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETPER 637 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence 3344555 5689999999999999999999999999998887544 4588999999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRII--AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+++|||.+. |++.+.|. +.+++++...+.++.||+.||.|||.++|+|+||||+|||+.+.+....+||||||+|+.
T Consensus 638 vFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 999999994 57766664 467899999999999999999999999999999999999999888888999999999999
Q ss_pred ccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 233 IEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
+.+.....+.+|||.|.|||+++. .|...-|+||+|||+|--|+|..||.. ++++-+.|.+..+.++..+|..+|++
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHH
Confidence 998887788999999999999974 699999999999999999999999953 45678889999999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+||..+|+..-.+|.|.++.|.|||++.+
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999874
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.90 Aligned_cols=260 Identities=32% Similarity=0.526 Sum_probs=225.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+++.+|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEE
Confidence 458999999999999999999999999999999997654333344556788999999994 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999999999988754 468999999999999999999999999999999999999 567789999999998765432
Q ss_pred c--eeeccCCCCCCchhhhhc-----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 238 V--YRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 238 ~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
. ....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+....+..+.........+....+|.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 1 234579999999998853 378899999999999999999999999988888888877654444444456899
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~~ 342 (472)
++++||++||+.+|++ |+|++++++||||+..
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 9999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=378.71 Aligned_cols=258 Identities=34% Similarity=0.628 Sum_probs=226.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|.+.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+. ||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence 36999999999999999999999999999999997655444455677889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999999999999999999999 566779999999998665433
Q ss_pred -----------------------------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH
Q 012039 238 -----------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (472)
Q Consensus 238 -----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 287 (472)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2234579999999999865 5899999999999999999999999988887
Q ss_pred HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCcccc
Q 012039 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT-SAQVLEHPWIKE 341 (472)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps-~~~~l~h~~~~~ 341 (472)
.....+......+..+....+++++.+||.+||. ||.+||+ ++++|+||||+.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 7777877733333333334589999999999997 9999999 999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=371.48 Aligned_cols=250 Identities=31% Similarity=0.571 Sum_probs=220.3
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433445667788999998876799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CCcceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 243 (472)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 556679999999987542 222334457
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++..+..+...++ ..++.++.+||++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence 9999999999864 589999999999999999999999999998888888887765543 34789999999999999
Q ss_pred CCCCCCCH------HHHhcCCcccc
Q 012039 323 DPKKRITS------AQVLEHPWIKE 341 (472)
Q Consensus 323 dp~~Rps~------~~~l~h~~~~~ 341 (472)
||++||++ +++++||||..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 99999998 89999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=372.37 Aligned_cols=249 Identities=31% Similarity=0.583 Sum_probs=219.3
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997655444445667889999999995 99999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence 9999999888889999999999999999999999999999999999999 5567799999999875432 22334467
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+......++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence 9999999999864 589999999999999999999999998888777777776655544 35899999999999999
Q ss_pred CCCCCC-----CHHHHhcCCcccc
Q 012039 323 DPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 323 dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
||++|+ ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=370.05 Aligned_cols=255 Identities=29% Similarity=0.547 Sum_probs=224.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48899999999999999999999999999999976544344456778889999999975567999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CCcc
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~~~ 238 (472)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 456679999999987532 2233
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..++.++.++|+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 445679999999999864 589999999999999999999999999888888888887665544 357899999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCCcccc
Q 012039 318 RMLTQDPKKRITS-----AQVLEHPWIKE 341 (472)
Q Consensus 318 ~~L~~dp~~Rps~-----~~~l~h~~~~~ 341 (472)
+||..||.+|+++ +++++||||..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999986 89999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=375.67 Aligned_cols=261 Identities=31% Similarity=0.530 Sum_probs=223.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.++..+|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence 3468999999999999999999999999999999997644333344566889999999994 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence 99999999999998865 468999999999999999999999999999999999999 56677999999999876543
Q ss_pred cc--eeeccCCCCCCchhhhhc-----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 KV--YRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.. ....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+....+..+......+..+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 234579999999999863 27889999999999999999999999988888888887755444433334689
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~~ 342 (472)
..++++|.+||..++.+ |+++.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=370.13 Aligned_cols=254 Identities=29% Similarity=0.503 Sum_probs=223.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.++.|+.+|.++. ++||.++|+.|..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHH
Confidence 46888899999999999999999999999999997654 3455788999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||||.||++.+.+.....+.+..+..++++++.||.|||..+.+|||||+.|||+. ..+.+||+|||.+..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 99999999999998887789999999999999999999999999999999999995 447799999999998876543
Q ss_pred e-eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 239 Y-RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 239 ~-~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
. .+.+|||.|||||++.+ .|+.|+||||||++++||++|.+||....+...+..|-+...+... ..+|+.+++||
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV 243 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFV 243 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHH
Confidence 3 56899999999999986 6999999999999999999999999877664444344333222111 36889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..||.+||+.||+|.++|+|+|++.
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999999987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=371.53 Aligned_cols=250 Identities=33% Similarity=0.592 Sum_probs=219.5
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654433445567788999999995 99999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 5566799999999875322 22334467
Q ss_pred CCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 999999999886 4589999999999999999999999998888888888777665544 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccccC
Q 012039 323 DPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 323 dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
||++|+ ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=363.74 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=211.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|.+.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence 46999999999999999999999999999999986543 2223456779999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence 999975 8988886544 47899999999999999999999999999999999999 556679999999987654322
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID--------------- 299 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------------- 299 (472)
......|++.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2334578999999998853 5899999999999999999999999887776665554331110
Q ss_pred ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 ----FES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 ----~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
++. ...+.++.++.+||++||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=355.98 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=219.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
...-.|.-.+.+|+|+||.||+|....+++.||||.+-... ..-.+|+++|+.+ +|||||++.-+|...
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKL-DHPNIVRLLYFFSSSTES 92 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence 34557999999999999999999999999999999874322 2334799999999 599999998887642
Q ss_pred --CeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 153 --QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
-...+||||++ .+|.+.+.. +.+++.-.++-++.||+.||.|||+.||+||||||.|+|++ ...+.+||||
T Consensus 93 d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicD 169 (364)
T KOG0658|consen 93 DEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICD 169 (364)
T ss_pred chhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEecc
Confidence 24568999996 599888874 56799999999999999999999999999999999999996 4568899999
Q ss_pred cCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc---------
Q 012039 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--------- 295 (472)
Q Consensus 227 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------- 295 (472)
||.|+.+..++...++..|..|+|||.+-+ .|+.+.||||.||++.||+-|++-|.|.+..+++..|.+
T Consensus 170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999999988888888999999999998764 699999999999999999999999999988777776653
Q ss_pred -----CC------ccCCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 296 -----GD------IDFESAP-----WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 296 -----~~------~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
.. ..+.... ...+++++.+|+.++|..+|.+|.++.|+|.||||.+....
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00 1111112 24578999999999999999999999999999999976554
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=374.50 Aligned_cols=259 Identities=30% Similarity=0.477 Sum_probs=217.9
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-----CCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-----PNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----p~iv~~~~~~~ 150 (472)
.+..+|.+.+.||+|+||.|.+|.+..|++.||||+++... .-..+...|+.+|..|+.| -|||+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 44568999999999999999999999999999999997532 3345667899999999733 38999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
..+++|||+|.+ +.+|+++++.++ .++...++.++.||+.||.+||+++|||+||||+|||+...+. ..|||+|||
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVIDFG 336 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVIDFG 336 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEecc
Confidence 999999999999 679999998764 4889999999999999999999999999999999999986544 489999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc------------
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ------------ 295 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------------ 295 (472)
+|.+....- ..++.+..|+|||++- .+|+.+.||||||||++||++|.+.|.+.++.+++..|.+
T Consensus 337 SSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 337 SSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 999865433 3788999999999876 4799999999999999999999999999998888877753
Q ss_pred --CCcc-CCC-----------------------------------C----CC----C-CCCHHHHHHHHHhcccCCCCCC
Q 012039 296 --GDID-FES-----------------------------------A----PW----P-TISSSAKDLVRRMLTQDPKKRI 328 (472)
Q Consensus 296 --~~~~-~~~-----------------------------------~----~~----~-~~s~~~~~li~~~L~~dp~~Rp 328 (472)
.... |.. + .+ . .-...+.+||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0000 000 0 00 0 1124578999999999999999
Q ss_pred CHHHHhcCCccccC
Q 012039 329 TSAQVLEHPWIKEG 342 (472)
Q Consensus 329 s~~~~l~h~~~~~~ 342 (472)
|+.++|+||||...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999854
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=368.89 Aligned_cols=250 Identities=30% Similarity=0.547 Sum_probs=220.4
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654434445566788999998876799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence 9999999888889999999999999999999999999999999999999 5667799999999876432 22233457
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+..+...++. .++.++.+||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence 9999999999864 5899999999999999999999999999988888888887655442 4789999999999999
Q ss_pred CCCCCC-------CHHHHhcCCcccc
Q 012039 323 DPKKRI-------TSAQVLEHPWIKE 341 (472)
Q Consensus 323 dp~~Rp-------s~~~~l~h~~~~~ 341 (472)
||++|+ ++.++++||||..
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=365.33 Aligned_cols=247 Identities=29% Similarity=0.449 Sum_probs=212.6
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCE-EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-eEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQ-FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-SVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~l 157 (472)
...+.+.||+|+||+||++.++ |.. ||+|++......... ...|.+|+.+|.+|+ |||||+++|++.+.. .++|
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEE
Confidence 3455667999999999999988 556 999999765543333 779999999999995 999999999999887 7999
Q ss_pred EEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-cEeecCCCCceeeccCCCCC-cEEEeecCCceec
Q 012039 158 VMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMG-VMHRDLKPENFLLSSKDENA-LLKATDFGLSVFI 233 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~-~~kl~Dfg~~~~~ 233 (472)
||||+++|+|.+++.. ++.++...+..++.||+.||.|||+++ ||||||||+|||+ +... ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceee
Confidence 9999999999999987 678999999999999999999999999 9999999999999 5564 8999999999887
Q ss_pred cCC-cceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 234 EEG-KVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
... .......||+.|||||++++ .|+.|+||||||+++|||+||+.||.+.........+.........+ ..++
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~ 272 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECP 272 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCC
Confidence 654 33344789999999999984 49999999999999999999999999988766666665544433332 2388
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.+..|+.+||..||.+||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999998865
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=372.12 Aligned_cols=258 Identities=31% Similarity=0.504 Sum_probs=223.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|.+.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEE
Confidence 699999999999999999999999999999999865443344566788999999998 5999999999999999999999
Q ss_pred eccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||++|++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876 679999999999999999999999999999999999999 5667799999999987654332
Q ss_pred e--eeccCCCCCCchhhhh-------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 239 Y--RDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 239 ~--~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
. ....||+.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+.........+..+.++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 2 2347899999999875 247889999999999999999999999888877788777654333333335689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.++.+||++||. +|.+|||++++++||||...
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=367.56 Aligned_cols=256 Identities=27% Similarity=0.510 Sum_probs=224.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999999976544333445567788899988877899999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccc
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~ 238 (472)
||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 5667799999999875432 223
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+......++ ..++.++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence 345679999999998864 589999999999999999999999999888888888887766544 357899999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCCccccC
Q 012039 318 RMLTQDPKKRITS-----AQVLEHPWIKEG 342 (472)
Q Consensus 318 ~~L~~dp~~Rps~-----~~~l~h~~~~~~ 342 (472)
+||+.||.+|+++ .++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999984 899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=348.77 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=221.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC-eeEEEEEEEeCC---
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IVEFKGAYEDKQ--- 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-iv~~~~~~~~~~--- 153 (472)
...|..+++||+|+||+||+|+++.+|+.||+|.+.-.... +.......+|+.+++.|+ |+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence 44688889999999999999999999999999999754321 223456789999999996 999 999999998877
Q ss_pred ---eEEEEEeccCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 154 ---SVHVVMELCAGGELFDRIIAKG----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 154 ---~~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
.+++|+||+ ..+|..++.... .++...++.+++||+.||+|||+++|+||||||.|||+ +..+.+||+|
T Consensus 88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence 899999999 569999887654 47888999999999999999999999999999999999 5578899999
Q ss_pred cCCceecc-CCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 227 FGLSVFIE-EGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 227 fg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
||+|+... +...+...++|.+|+|||++-+ .|+...||||+|||++||+++++.|.+.++.+++..|.+---.....
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999776 4455777889999999998864 49999999999999999999999999999988888876522222112
Q ss_pred CC--------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 304 PW--------------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 304 ~~--------------------------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.| +..+++..+++.+||+.+|.+|.|++.+|.||||.....
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 22 233468899999999999999999999999999997643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=368.61 Aligned_cols=250 Identities=28% Similarity=0.522 Sum_probs=213.7
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|++++...........+.+|..+++.+.+||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998655434445567889999999997799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec-cCCcceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~-~~~~~~~~~~ 243 (472)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence 9999999888899999999999999999999999999999999999999 55677999999998753 2233344568
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ......+.+......++ ..++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 9999999999864 5889999999999999999999999532 11224455555544433 35789999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCCcccc
Q 012039 314 DLVRRMLTQDPKKRIT------SAQVLEHPWIKE 341 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps------~~~~l~h~~~~~ 341 (472)
++|++||+.||.+|++ ++++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999997 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=374.70 Aligned_cols=258 Identities=31% Similarity=0.543 Sum_probs=221.6
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+. ||||+++++.+.+.+.+|+||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999997654333445677889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
|||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 556789999999987543210
Q ss_pred ----------------------------------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCC
Q 012039 238 ----------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFW 282 (472)
Q Consensus 238 ----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 282 (472)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0113479999999999864 58999999999999999999999999
Q ss_pred CCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccccC
Q 012039 283 AETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKEG 342 (472)
Q Consensus 283 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~~~l~h~~~~~~ 342 (472)
+.+....+..+.........+....+++++++||.+|+. ||.+|+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 988888888887644333333334578999999999874 999998 47999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=369.62 Aligned_cols=249 Identities=33% Similarity=0.600 Sum_probs=218.9
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998655434444567788999999995 99999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CCcceeec
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDI 242 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~ 242 (472)
++|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 799999999999999 566779999999987543 22233446
Q ss_pred cCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 243 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ ..+++++.+||.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 79999999999864 589999999999999999999999998888888888777665544 3578999999999999
Q ss_pred cCCCCCC-----CHHHHhcCCcccc
Q 012039 322 QDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 322 ~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
.||++|+ ++.++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999997 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=361.47 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=211.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+. ||||+++++++..++.+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence 69999999999999999999999999999999875432 2334567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
||++++++..+......+++..++.++.||+.||.|||+.+|+||||||+||++ +.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence 999987776555455679999999999999999999999999999999999999 456679999999998764332
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-------------------
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------------- 297 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------------- 297 (472)
......|++.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 2234578999999998864 58999999999999999999999998776544433332210
Q ss_pred ccCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 298 IDFES---------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 298 ~~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..++. ..+..+|.++.+||++||+.||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000 0112478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=364.52 Aligned_cols=251 Identities=28% Similarity=0.510 Sum_probs=217.1
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997654333344566778888888765799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999 5566799999999875322 22334567
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++ ..++.++++||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999864 589999999999999999999999998888888887776544333 24789999999999999
Q ss_pred CCCCCCCH-HHHhcCCccccC
Q 012039 323 DPKKRITS-AQVLEHPWIKEG 342 (472)
Q Consensus 323 dp~~Rps~-~~~l~h~~~~~~ 342 (472)
||++||++ +++++||||...
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999998 588899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=364.30 Aligned_cols=251 Identities=31% Similarity=0.544 Sum_probs=216.7
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333444566677888887765799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-cceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 243 (472)
++|.+++...+.+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++...... ......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 55667999999999864332 2334467
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++ ..++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999864 589999999999999999999999999888888888776544333 35789999999999999
Q ss_pred CCCCCCCH-HHHhcCCccccC
Q 012039 323 DPKKRITS-AQVLEHPWIKEG 342 (472)
Q Consensus 323 dp~~Rps~-~~~l~h~~~~~~ 342 (472)
||++||++ .++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 488899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=365.38 Aligned_cols=251 Identities=30% Similarity=0.550 Sum_probs=220.2
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998654433445667788999999886799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
++|..++...+.+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++..... .......+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 5566799999999875322 22233457
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ ..++.++.+||++||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence 8999999999864 589999999999999999999999998888888888877665443 35789999999999999
Q ss_pred CCCCCCCH-----HHHhcCCccccC
Q 012039 323 DPKKRITS-----AQVLEHPWIKEG 342 (472)
Q Consensus 323 dp~~Rps~-----~~~l~h~~~~~~ 342 (472)
||.+|||+ .++++||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.74 Aligned_cols=261 Identities=31% Similarity=0.509 Sum_probs=223.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+.++..+|
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence 3468999999999999999999999999999999987644333334556788999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence 99999999999988865 468999999999999999999999999999999999999 45677999999999876543
Q ss_pred cc--eeeccCCCCCCchhhhhc-----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 KV--YRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.. ....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+....+..+......+..+....++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 22 234579999999999863 27899999999999999999999999988888888888765444444446789
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~~ 342 (472)
.++++||.+||..++.+ |++++++++|+||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999844443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=368.46 Aligned_cols=255 Identities=31% Similarity=0.579 Sum_probs=214.1
Q ss_pred ceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .......+.+|+.+++++.+||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998864 47899999998754322 1223456788999999997799999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4566799999999876533
Q ss_pred Cc--ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCCC
Q 012039 236 GK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 236 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+......+ ...
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCC
Confidence 22 2234579999999999864 37889999999999999999999996432 233334444433222 246
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
+++.+.+||.+||+.||++|| +++++++||||+.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 899999999999999999999 8889999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=379.12 Aligned_cols=261 Identities=24% Similarity=0.329 Sum_probs=206.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc-----CCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-----GQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~ 150 (472)
....+|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.+. +|++|+++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999986421 22344567888887774 2456899999887
Q ss_pred eC-CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCC----------
Q 012039 151 DK-QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDE---------- 218 (472)
Q Consensus 151 ~~-~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~---------- 218 (472)
.. ..+|+|||++ |++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||+...+.
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 64 5789999998 78999999888889999999999999999999998 59999999999999964331
Q ss_pred ---CCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 012039 219 ---NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 219 ---~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 294 (472)
...+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 23599999998764322 2335689999999998865 58999999999999999999999998877655444432
Q ss_pred cCCccCCC-----------------------C-------------CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 295 QGDIDFES-----------------------A-------------PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 295 ~~~~~~~~-----------------------~-------------~~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.....++. . .+ ...++.+.+||.+||++||++|||++|+|+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 21100000 0 00 0124567899999999999999999999999
Q ss_pred CccccCC
Q 012039 337 PWIKEGG 343 (472)
Q Consensus 337 ~~~~~~~ 343 (472)
|||....
T Consensus 439 p~~~~~~ 445 (467)
T PTZ00284 439 PYVLKYY 445 (467)
T ss_pred ccccccC
Confidence 9998753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=360.39 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=207.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865432 223456778999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~- 236 (472)
|||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC
Confidence 99995 6787777653 568999999999999999999999999999999999999 45667999999998764322
Q ss_pred cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCcc--------------
Q 012039 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDID-------------- 299 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~-------------- 299 (472)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22334578999999998853 478899999999999999999999987533 2223222110000
Q ss_pred CCCCC------------C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 FESAP------------W--PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ~~~~~------------~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.... | ...++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 0 1245789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=356.92 Aligned_cols=258 Identities=30% Similarity=0.515 Sum_probs=217.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++.+..++.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence 4889999999999999999999999999999987544333333456778999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+.|++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999999999887653 458999999999999999999999999999999999999 556779999999998765544
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+..............++..+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 4445679999999998864 588999999999999999999999987665444333332222222222346899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
.+||..||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=362.72 Aligned_cols=256 Identities=27% Similarity=0.524 Sum_probs=223.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999999999999999999976543334445677889999998876788999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-c
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~ 238 (472)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999 556679999999987543222 2
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+......++ ..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence 334579999999998864 589999999999999999999999999888888888887665544 357899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCccccC
Q 012039 318 RMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 318 ~~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
+||+.+|.+|++ .+++++||||...
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 4789999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=365.32 Aligned_cols=259 Identities=30% Similarity=0.468 Sum_probs=211.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-----Ce
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-----QS 154 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~ 154 (472)
+|++.+.||+|+||.||+|++..++..||||.+..... .......+.+|+.++++++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 58999999999999999999999999999999864321 2233456889999999995 99999999987543 35
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||| +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence 89999999 56899999888889999999999999999999999999999999999999 566789999999997643
Q ss_pred CCc----ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc------------
Q 012039 235 EGK----VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ------------ 295 (472)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------------ 295 (472)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 1234579999999998753 588999999999999999999999977654332222111
Q ss_pred ---------------CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 296 ---------------GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 296 ---------------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.........++.+++++.++|.+||+.||++|||+.++|+||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0001111223567889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=363.67 Aligned_cols=252 Identities=29% Similarity=0.553 Sum_probs=217.6
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHH---hccCCCCeeEEEEEEEeCCeEEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ---HLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~---~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|++++. .+ +||||+++++++.+.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 778999999999999999999999999999997654333344566777877664 45 49999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-C
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-G 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~ 236 (472)
||||++|++|..++.. +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999999999877754 579999999999999999999999999999999999999 5567799999999875432 2
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++ ..++.++.+|
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 22344679999999998864 588999999999999999999999999888888888877765543 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 316 i~~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
|.+||+.||.+|| ++.++++||||+.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=361.12 Aligned_cols=251 Identities=27% Similarity=0.491 Sum_probs=216.7
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654333344566778888888765799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999887889999999999999999999999999999999999999 4566799999999875432 22334567
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence 9999999999864 589999999999999999999999998888888777766544332 24789999999999999
Q ss_pred CCCCCCCHH-HHhcCCccccC
Q 012039 323 DPKKRITSA-QVLEHPWIKEG 342 (472)
Q Consensus 323 dp~~Rps~~-~~l~h~~~~~~ 342 (472)
||++||++. ++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 89999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=363.78 Aligned_cols=250 Identities=28% Similarity=0.516 Sum_probs=212.6
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765434445567888999998886799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CCcceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 243 (472)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 566779999999987532 222334567
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++ ..++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence 9999999999864 5889999999999999999999999521 12234444555544433 35789999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCCcccc
Q 012039 314 DLVRRMLTQDPKKRIT------SAQVLEHPWIKE 341 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps------~~~~l~h~~~~~ 341 (472)
+||++||+.||++||+ ++++++||||+.
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=363.29 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=231.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe-EEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS-VHV 157 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-~~l 157 (472)
++|.+++.+|+|+||.+++++++..++.|++|.|...... ........+|+.+++++. |||||.+.+.|..++. ++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence 5799999999999999999999999999999999766543 334457889999999996 9999999999998887 999
Q ss_pred EEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 158 VMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||+||+||+|.+.+.+.+ .++++.+..++.|++.|+.|||+++|+|||||+.||+++ .+..|||+|||+|+.+.+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCC
Confidence 999999999999997654 489999999999999999999999999999999999995 555689999999999988
Q ss_pred Cc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. ...+.+|||.|++||++.+ +|+.|+|||||||++|||++-+++|.+.+...++.+|.++.+.... ...|.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence 76 5677899999999999975 6999999999999999999999999999999999999998744333 46899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+|+.||..+|..||++.++|.+|.+..+
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999999999988743
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=361.59 Aligned_cols=249 Identities=35% Similarity=0.626 Sum_probs=216.3
Q ss_pred ceeeecCCeEEEEEEEC---CCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 85 KELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
+.||+|+||.||++++. .+++.||+|++.+.... .......+.+|+.+++.+. ||||+++++++..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence 67999999999999864 47889999998764332 1223456788999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-cce
Q 012039 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVY 239 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~~~ 239 (472)
|++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence 99999999999888889999999999999999999999999999999999999 55678999999998754322 223
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+....+..+..+...++ +.+++++.+||++
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 34579999999998864 588999999999999999999999999888888888887765443 3578999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCcccc
Q 012039 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 319 ~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
||+.||++|| +++++++||||..
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=360.60 Aligned_cols=259 Identities=28% Similarity=0.514 Sum_probs=218.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.+ +|+||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 3699999999999999999999999999999999764433334456688999999999 599999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||++|++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 999999999999976 4579999999999999999999999999999999999999 556679999999987665433
Q ss_pred ce--eeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCC
Q 012039 238 VY--RDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APWPTI 308 (472)
Q Consensus 238 ~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 308 (472)
.. ....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+.. .....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 22 2246999999999985 24788999999999999999999999988877777777654332221 223458
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCCcccc
Q 012039 309 SSSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKE 341 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~ 341 (472)
+.++++||++||..++++ |+++.++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999999764444 789999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=364.04 Aligned_cols=258 Identities=36% Similarity=0.614 Sum_probs=238.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
....|.+.+.||+|.|++|.++++..++..||+|+|++..... .....+.+|+++|+.|. |||||+++.+.+....+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeE
Confidence 4567999999999999999999999999999999999887643 34455899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+.||.+++++.+.+++.+..+..++.|+++|++|||+++|+|||||++|||+ +.+..+||+|||++.++..+
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeeccc
Confidence 999999999999999999999999999999999999999999999999999999999 66777999999999999988
Q ss_pred cceeeccCCCCCCchhhhhcc--cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
....+.+|++.|.|||++.+. -++.+|+||+|+++|.|+.|.+||.+.+-.+.-...+.+++..+. .++.++++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~ 284 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCED 284 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHH
Confidence 888899999999999999763 588999999999999999999999999998888888888887775 47899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+|+++|.++|.+|++.+++.+|.|.....
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccchhh
Confidence 99999999999999999999999998543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=362.57 Aligned_cols=249 Identities=30% Similarity=0.588 Sum_probs=214.2
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.+ +||||+++++.+.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999997654333333445556655 45667 59999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeec
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 242 (472)
|++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 5567799999999875432 2223345
Q ss_pred cCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 243 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+........ +.++.++.++|++||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 79999999998864 589999999999999999999999999888888888877655433 4679999999999999
Q ss_pred cCCCCCCCH----HHHhcCCcccc
Q 012039 322 QDPKKRITS----AQVLEHPWIKE 341 (472)
Q Consensus 322 ~dp~~Rps~----~~~l~h~~~~~ 341 (472)
.||.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999988 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=354.28 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=208.9
Q ss_pred ceEEcceeeecCCeEEEEEEECC-CCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEE-----e
Q 012039 80 HYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYE-----D 151 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~-----~ 151 (472)
+|++.+.||+|+||.||+|++.. +++.||+|.+..... .......+.+|+.+++.+. +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 79999999999999999999865 467899998865432 2223445667888887764 4999999999875 3
Q ss_pred CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccc
Confidence 456899999996 5898888653 358999999999999999999999999999999999999 4566799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------ 302 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 302 (472)
+.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 98765544444567899999999885 46899999999999999999999999988877777666542111000
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 303 -----------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 303 -----------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
...+.++..+++||.+||+.||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=366.75 Aligned_cols=249 Identities=31% Similarity=0.566 Sum_probs=215.7
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
||+|+||+||+|++..+++.||+|++.+..............|..++..+. +||||+++++++.....+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997654333333445566777777664 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 243 (472)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999888889999999999999999999999999999999999999 4566799999999875432 22334567
Q ss_pred CCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 244 GSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 244 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..+...++. ..+++++.+||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 9999999998864 4789999999999999999999999998888888888877665543 2578999999999999
Q ss_pred cCCCCCC----CHHHHhcCCcccc
Q 012039 322 QDPKKRI----TSAQVLEHPWIKE 341 (472)
Q Consensus 322 ~dp~~Rp----s~~~~l~h~~~~~ 341 (472)
.||.+|| ++.++++||||..
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccC
Confidence 9999998 7899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=360.09 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=215.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.+.||+|+||.||++++..++..||+|++.... .......+.+|+++++++. ||||+++++++.+++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999986532 2233567899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||++|++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 69999999999999 45667999999998765433
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc----------------
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID---------------- 299 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 299 (472)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......++...+......
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2234579999999999864 5899999999999999999999999766554433222110000
Q ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 ----------------------------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+......+++++++||.+||++||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0011112468899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=359.78 Aligned_cols=251 Identities=26% Similarity=0.489 Sum_probs=213.5
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998755444445667889999999997799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CCcceeecc
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 243 (472)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence 9999999888889999999999999999999999999999999999999 556679999999987532 233344567
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC-------ChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-------TEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++ ..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 9999999998864 5899999999999999999999999542 12234444444433332 3578999999
Q ss_pred HHHhcccCCCCCCC------HHHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRIT------SAQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps------~~~~l~h~~~~~~ 342 (472)
|++||+.||++|++ +.++++||||+..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999999998 5799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=351.86 Aligned_cols=251 Identities=28% Similarity=0.489 Sum_probs=206.8
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||+|+||+||+|.+..+++.||+|.+.+...........+..|+.+++.+ +||||+++++++..+..+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 69999999999999999999999998765443333446678899999999 59999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-eee
Q 012039 167 LFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-YRD 241 (472)
Q Consensus 167 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 241 (472)
|.+.+.. ...+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence 9877743 3468999999999999999999999999999999999999 4566799999999987654332 234
Q ss_pred ccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhc
Q 012039 242 IVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320 (472)
Q Consensus 242 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 320 (472)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+..............++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 578999999999864 5889999999999999999999999765432222222221111122222468999999999999
Q ss_pred ccCCCCCC-----CHHHHhcCCcccc
Q 012039 321 TQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 321 ~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
+.||++|| +++++++||||+.
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 99999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=357.32 Aligned_cols=259 Identities=26% Similarity=0.486 Sum_probs=220.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+.+|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 37999999999999999999999999999999987643323334556788999999994 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 999999999999976 4679999999999999999999999999999999999999 456679999999998765433
Q ss_pred ce--eeccCCCCCCchhhhhc------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC-CCCCCCC
Q 012039 238 VY--RDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-SAPWPTI 308 (472)
Q Consensus 238 ~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 308 (472)
.. ....||+.|+|||++.. .++.++|||||||++|+|++|+.||...+..+.+..+......+. ...+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 22 23579999999998863 478899999999999999999999998888777777776543332 1223567
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCCcccc
Q 012039 309 SSSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKE 341 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~ 341 (472)
++++++||.+||..++++ |++++++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999999876654 569999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=356.92 Aligned_cols=258 Identities=27% Similarity=0.497 Sum_probs=219.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.++||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..+ +|+||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEE
Confidence 699999999999999999999999999999998654332333445678899999998 4999999999999999999999
Q ss_pred eccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCCc
Confidence 99999999999976 4679999999999999999999999999999999999999 5567799999999876543322
Q ss_pred --eeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCC
Q 012039 239 --YRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APWPTIS 309 (472)
Q Consensus 239 --~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s 309 (472)
....+||+.|+|||++. ..++.++|||||||++|+|++|+.||...+..+.+..+......+.. ..+..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 22357999999999875 24789999999999999999999999998888888888765433322 2234689
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCCcccc
Q 012039 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKE 341 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~ 341 (472)
+++++||++||..++.+ |++++++++||||..
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999999999765554 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=372.38 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=207.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
...+|++++.||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++ |||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcC-CCCCcceeeeEeeccccc
Confidence 345899999999999999999999999999999987532 123457999999995 99999999876432
Q ss_pred ----CeEEEEEeccCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 153 ----QSVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 153 ----~~~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++. ....+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceee
Confidence 257799999965 7766654 3457999999999999999999999999999999999999952 3346999
Q ss_pred eecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----
Q 012039 225 TDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----- 297 (472)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----- 297 (472)
+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.+..
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987765555556688999999998754 58999999999999999999999999887666555544311
Q ss_pred ------------ccCCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 298 ------------IDFESAP--------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 298 ------------~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..++... ....|+++.+||.+||++||.+|||+.++|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 1111100 12467899999999999999999999999999999764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=359.67 Aligned_cols=249 Identities=28% Similarity=0.564 Sum_probs=213.9
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHH-HHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-MQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~-l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|..+ ++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999976543333344556666654 5667 59999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeec
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 242 (472)
|++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence 99999999888899999999999999999999999999999999999999 5566799999999875322 2233456
Q ss_pred cCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 243 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+++..+........ +.++..+.++|++||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence 79999999999865 589999999999999999999999999888888888877654433 4578999999999999
Q ss_pred cCCCCCCCH----HHHhcCCcccc
Q 012039 322 QDPKKRITS----AQVLEHPWIKE 341 (472)
Q Consensus 322 ~dp~~Rps~----~~~l~h~~~~~ 341 (472)
.+|.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999977 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.62 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=207.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|.+.+.||+|+||.||+|++..+++.||+|... ...+.+|++++++|+ ||||++++++|..+...++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence 457999999999999999999999999999999643 234678999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~- 236 (472)
|||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++......
T Consensus 161 v~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence 99999 57899988888889999999999999999999999999999999999999 45667999999999754322
Q ss_pred -cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHcC-----------
Q 012039 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-------EKGIFDAILQG----------- 296 (472)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~----------- 296 (472)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+..+...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22334679999999998864 58999999999999999999998875432 11111111110
Q ss_pred ---------------Ccc--CCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 297 ---------------DID--FESAPW---PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 297 ---------------~~~--~~~~~~---~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
... .....| ..++.++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000 001111 1356789999999999999999999999999999875433
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=359.25 Aligned_cols=248 Identities=30% Similarity=0.548 Sum_probs=216.2
Q ss_pred ceeeecCCeEEEEEEE---CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 012039 85 KELGRGQFGVTYLCTE---NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~---~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 161 (472)
+.||+|+||.||++++ ..+|+.||+|++.+... .......+.+|+.+++++. ||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999886 35789999999976443 1223456778999999995 99999999999999999999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-ccee
Q 012039 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYR 240 (472)
Q Consensus 162 ~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~~~~ 240 (472)
++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999 45667999999998865443 2334
Q ss_pred eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 012039 241 DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319 (472)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 319 (472)
...||+.|+|||++.. .++.++|||||||++|+|++|+.||...+..+.+..+......++ ..+++++.+||++|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 5679999999999864 588999999999999999999999998888888888877665544 35789999999999
Q ss_pred cccCCCCCCC-----HHHHhcCCcccc
Q 012039 320 LTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 320 L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
|+.||++||+ +.++++||||..
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 9999999999 778999999985
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=354.15 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=217.1
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
..+++.-+..+++++.||+|.||.||+|.+..+ ..||+|.++... ...+.|.+|+++|++|+ |+|||++++++.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS----MSPEAFLREAQIMKKLR-HEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccc----cChhHHHHHHHHHHhCc-ccCeEEEEEEEe
Confidence 445566667788899999999999999998743 479999987542 33577889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.++.+||||||++.|+|.++|.. ...+.......++.||+.|++||+++++|||||-..|||| +++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccc
Confidence 98999999999999999999987 4568999999999999999999999999999999999999 677789999999
Q ss_pred CceeccCCcceeeccC---CCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 229 LSVFIEEGKVYRDIVG---SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
+|+...+. .+....| ...|.|||++. +.++.|||||||||+||||+| |+.||.+.+..+.++.+.+|..-..
T Consensus 349 LAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-- 425 (468)
T KOG0197|consen 349 LARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-- 425 (468)
T ss_pred cccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC--
Confidence 99954433 3333333 24699999987 579999999999999999999 9999999999999999998854332
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l 334 (472)
...+|+++.++++.||..+|++|||++.+.
T Consensus 426 -P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 257999999999999999999999998654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=337.98 Aligned_cols=257 Identities=33% Similarity=0.607 Sum_probs=237.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|.+++.||+|.||+|.+|+.+.+++.||+|++++..+........-..|-++|+..+ ||.+..+-..|+..+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence 457899999999999999999999999999999999887766666777788999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee-ccCC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-IEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~-~~~~ 236 (472)
||||..||.|+-+|.+.+.+++..++.+-..|+.||.|||+++||+||||.+|.|+ +.++++||.|||+++. +..+
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc
Confidence 99999999999999998899999999999999999999999999999999999999 7888999999999975 3456
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
....+.||||.|.|||++.. .|+..+|+|.+||++|||++|++||+..+...++..|.-+.+.|+. .+|++++.|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL 398 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL 398 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence 67788999999999999974 6999999999999999999999999999999999999999998886 589999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+..+|.+||.+|. .+.+|.+|+||...
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999997 57899999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=349.76 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=208.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe-----C
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYED-----K 152 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~-----~ 152 (472)
+|++.+.||+|+||+||+|+++.+++.||+|.+..... .......+.+|+.+++.++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875432 1222345667888887764 59999999998864 3
Q ss_pred CeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
..+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence 46899999996 4888888653 348999999999999999999999999999999999999 45667999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc-----------
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------- 298 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------- 298 (472)
.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765544444567899999999885 4589999999999999999999999988776665555443110
Q ss_pred c-----CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 D-----FE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 ~-----~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
. +. ....+.++.++.+||.+||+.||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00 01124578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=349.31 Aligned_cols=255 Identities=30% Similarity=0.547 Sum_probs=213.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.++++++ |++|+.+++.+.+.+.+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence 3778889999999999999999999999999987654433333456778999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||++|++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999999999888643 358999999999999999999999999999999999999 456679999999998765544
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH---HHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---GIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||...... +....+... ........+++++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHH
Confidence 4445679999999999864 5899999999999999999999999765432 122222111 11122346889999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCcccc
Q 012039 314 DLVRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
+||.+||+.||++||| ++++++||||++
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=357.40 Aligned_cols=249 Identities=29% Similarity=0.566 Sum_probs=212.3
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999997644322233344555554 45667 59999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeec
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 242 (472)
|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 4566799999999875432 2233456
Q ss_pred cCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 243 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+. +.+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence 79999999998865 588999999999999999999999999888888888876544332 4689999999999999
Q ss_pred cCCCCCCCHH----HHhcCCcccc
Q 012039 322 QDPKKRITSA----QVLEHPWIKE 341 (472)
Q Consensus 322 ~dp~~Rps~~----~~l~h~~~~~ 341 (472)
.||.+|+++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=355.75 Aligned_cols=249 Identities=29% Similarity=0.555 Sum_probs=212.7
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999997654333333445556655 56777 59999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Ccceeec
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 242 (472)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence 99999998888889999999999999999999999999999999999999 5566799999999875322 2223445
Q ss_pred cCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 243 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++ +..+.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 79999999999864 589999999999999999999999999888888888877654433 3578999999999999
Q ss_pred cCCCCCCCH----HHHhcCCcccc
Q 012039 322 QDPKKRITS----AQVLEHPWIKE 341 (472)
Q Consensus 322 ~dp~~Rps~----~~~l~h~~~~~ 341 (472)
.||.+||++ .++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999976 49999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=349.31 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=205.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|+++++||+||.+.||+++.-. .+.||+|.+.... .+......+.+|+.+|.+|++|.+||++++|-..++.+|+||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 69999999999999999998653 4567776654322 244567889999999999999999999999999999999999
Q ss_pred eccCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||= ..+|..+|..... .+.-.++.+..|++.|+.++|+.||||.||||.|+|+. .+.+||+|||.|..+.....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCcccc
Confidence 985 5799988877654 34458889999999999999999999999999999994 67799999999998866542
Q ss_pred ---eeeccCCCCCCchhhhhc------------ccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCccCCC
Q 012039 239 ---YRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFES 302 (472)
Q Consensus 239 ---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~ 302 (472)
....+||+.||+||.+.. ..++++||||||||||+|+.|++||..-. ...-+..|......++.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 235799999999998731 15789999999999999999999995432 23334445444332222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+..+. ..++.++++.||.+||++|||+.++|+|||++-
T Consensus 595 p~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 595 PDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 22221 234999999999999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=345.60 Aligned_cols=248 Identities=29% Similarity=0.528 Sum_probs=208.3
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||+|+||.||+++++.+|+.||+|.+.+...........+..|+++++++ +||||+++++++.++..+|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999999999999999998765443333345566799999999 59999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccC
Q 012039 167 LFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244 (472)
Q Consensus 167 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 244 (472)
|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +.+..++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence 988876543 48899999999999999999999999999999999999 4566799999999987765554455679
Q ss_pred CCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 012039 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319 (472)
Q Consensus 245 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 319 (472)
++.|+|||++.+ .++.++|||||||++|+|++|..||..... .+....+......+. ...+++++++||++|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 999999998864 589999999999999999999999976433 233344444333322 236899999999999
Q ss_pred cccCCCCCCCH----HHHhcCCcccc
Q 012039 320 LTQDPKKRITS----AQVLEHPWIKE 341 (472)
Q Consensus 320 L~~dp~~Rps~----~~~l~h~~~~~ 341 (472)
|+.||++||++ ++++.||||+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=345.59 Aligned_cols=259 Identities=31% Similarity=0.527 Sum_probs=218.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|+..+.||+|+||+||++.+..+++.||+|.+.+...........+.+|+.+++.++ |+||+.+++.+..++.+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEE
Confidence 3778889999999999999999999999999987654433334456788999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.+..+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999999998887653 369999999999999999999999999999999999999 455679999999997765444
Q ss_pred ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......|++.|+|||++. ..++.++||||||+++|+|++|..||.+.........+..............++.++.+|+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 444567999999999885 4589999999999999999999999987766544444433222222233356889999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
.+||+.||++||+ +.+++.|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.15 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=212.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.++||+|+||.||++.+..++..+|+|++.... .......+.+|+++++++. ||||+++++++.+++.+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence 468999999999999999999999999999999886532 2233567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||+.|++|.+++...+.+++..+..++.|++.||.|||+. +|+|+||||+|||+ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 79999999999999 45567999999998765332
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHH---------------------
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL--------------------- 294 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--------------------- 294 (472)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234578999999999865 58899999999999999999999997655433322110
Q ss_pred -----------------------cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 295 -----------------------QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 295 -----------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+... +......++.++++||.+||++||++|||+.+++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 000012367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=356.61 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=208.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.+. ||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence 356789999999999999999999999999999999865432 2334567789999999995 99999999998654
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence 357999999965 6666653 358899999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc-------------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ------------- 295 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------------- 295 (472)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 986544444445678999999998864 589999999999999999999999987655433322211
Q ss_pred ---------CCccCCC----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 296 ---------GDIDFES----------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 296 ---------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
....+.. ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111100 001124678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=344.42 Aligned_cols=254 Identities=37% Similarity=0.681 Sum_probs=213.8
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|++++.||+|+||+||++++..+++.||+|++...... ........+|+.+++++ +||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence 88999999999999999999999999999999765432 11223345699999999 59999999999999999999999
Q ss_pred ccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec-cCCcce
Q 012039 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVY 239 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~-~~~~~~ 239 (472)
++.+++|.+++...+.+++..+..++.||+.||.+||+++|+|+||||+||++ +.++.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999878889999999999999999999999999999999999999 56777999999999864 233344
Q ss_pred eeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 240 RDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
....+++.|+|||++. ..++.++||||||+++|+|++|..||.... ....+..................+.++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5567899999999987 468999999999999999999999998873 33334434333332222222233489999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+|.+||+.||++|||+.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=350.04 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=212.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|.+.+.||+|+||.||+|+++.+++.||+|.+..... ......+.+|+.++++++ ||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence 479999999999999999999999999999999865432 223446778999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence 999965 888877654 358999999999999999999999999999999999999 456679999999987654322
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------------- 297 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------------- 297 (472)
......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2234568899999998753 47899999999999999999999998877655544443210
Q ss_pred --ccCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 298 --IDFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 298 --~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..++. ...+.++.++++||.+||+.||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00110 11235789999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=364.80 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=218.7
Q ss_pred ccceEEcceeeecCCeEEEEEEECCC-CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENST-GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...|.+.+.||+|++|.||+|.+..+ +..||+|.+... .......+.+|+.+++.+. |||||++++++..++.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEE
Confidence 34599999999999999999998887 788999976432 2233456788999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 157 VVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
|||||++||+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence 99999999999887753 3468999999999999999999999999999999999999 4567799999999987
Q ss_pred ccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 233 IEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 233 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++..+..+..... ...+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccC
Confidence 654321 234579999999999864 589999999999999999999999998888888888877655422 2357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+.++.+||.+||..||++||++.+++.|+|++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999974
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=366.31 Aligned_cols=258 Identities=31% Similarity=0.489 Sum_probs=220.2
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--- 153 (472)
...+|.+.+.||+|+||+||+|++..+++.||||++..... .......+.+|+.++..+. |+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence 34699999999999999999999999999999999876543 2344567889999999995 999999988775332
Q ss_pred -----eEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 154 -----SVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 154 -----~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 37899999999999998864 2468999999999999999999999999999999999999 45667999
Q ss_pred eecCCceeccCC---cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC
Q 012039 225 TDFGLSVFIEEG---KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 225 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+..+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999865432 12234679999999999874 58999999999999999999999999988888888887765542
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
. .+.+++++.+||.+||+.||.+||++.++++|||++..
T Consensus 265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 2 24689999999999999999999999999999998753
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=378.13 Aligned_cols=264 Identities=31% Similarity=0.513 Sum_probs=217.5
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-- 151 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 151 (472)
.+....+|.+++.||+|+||+||+|++..++..||+|++..... .......+..|+.++++|. |||||+++++|.+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence 34456789999999999999999999999999999999875443 2334567889999999995 9999999998854
Q ss_pred CCeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CcEeecCCCCceeeccC----
Q 012039 152 KQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFM-------GVMHRDLKPENFLLSSK---- 216 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-------~i~H~dlkp~Nili~~~---- 216 (472)
...+||||||+++++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+|||+...
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4679999999999999998865 35699999999999999999999985 49999999999999642
Q ss_pred ----------CCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCC
Q 012039 217 ----------DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWA 283 (472)
Q Consensus 217 ----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 283 (472)
+....+||+|||++..+..........||+.|+|||++.. .++.++||||||||||+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2234689999999987655444445689999999998853 478999999999999999999999976
Q ss_pred CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 284 ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 284 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
......+........ .......+.++.+||..||..+|.+||++.++|.|+|++..
T Consensus 246 ~~~~~qli~~lk~~p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHHHHHHHHhcCC---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 554433333333222 22234678999999999999999999999999999999754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=381.50 Aligned_cols=258 Identities=30% Similarity=0.514 Sum_probs=230.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
+++|.+++.||+|+||.|.+++++.|++.||+|++.+...........|..|-.+|-.- +.+-|+.++..|+|++++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEE
Confidence 46899999999999999999999999999999999886554444566788888888776 58999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++||+|..++.+..++++..++.++..|+.||.-||+.|+|||||||+|||+ +..+++||.|||.+..+....
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence 99999999999999998899999999999999999999999999999999999999 788899999999998877443
Q ss_pred c--eeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CccCCCCCCCC
Q 012039 238 V--YRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--DIDFESAPWPT 307 (472)
Q Consensus 238 ~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 307 (472)
. ....+|||.|.+||++. +.|++.+|+||+||++|||+.|..||+..+.-+++.+|.+- .+.|| .-..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~ 307 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD 307 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence 2 34568999999999984 35999999999999999999999999999999999999987 45555 3346
Q ss_pred CCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccccC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps---~~~~l~h~~~~~~ 342 (472)
+|.++++||.++|. +|+.|.. ++++..||||...
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 99999999999997 6999998 9999999999754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=358.29 Aligned_cols=257 Identities=29% Similarity=0.437 Sum_probs=213.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----e
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----S 154 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----~ 154 (472)
+|.+++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence 37788999999999999999999999999998864321 2233567889999999995 999999999998776 7
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence 999999995 6888888888889999999999999999999999999999999999999 566789999999998654
Q ss_pred CCc--ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--------------
Q 012039 235 EGK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-------------- 296 (472)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------- 296 (472)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2233468899999998864 4789999999999999999999999887766555544321
Q ss_pred ---------CccCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 297 ---------DIDFES-----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 297 ---------~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
....+. ......++++.+||.+||+.||++|||+.++|+||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 011100 1123468899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.53 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=210.7
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|.+.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.+. ||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence 346789999999999999999999999999999999865332 2334567789999999995 99999999987543
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCC
Confidence 457999999964 77776643 58899999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc----------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------- 298 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 298 (472)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 987655444455679999999998864 589999999999999999999999988776655555432100
Q ss_pred ------------cCC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 299 ------------DFE----------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 299 ------------~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.+. .......+.++++||.+||+.||.+|||+.++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 0011123568899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=344.39 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=213.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|.+.+.||+|+||.||+|++..+++.||+|.+..... ......+.+|+.+++.+. ||||+++++++..++.+++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence 479999999999999999999999999999999865432 223456778999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence 99996 5888887653 468999999999999999999999999999999999999 456679999999987644322
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc----------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------------- 298 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 298 (472)
......+++.|+|||++.+ .++.++|||||||++|+|++|++||...+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2233467899999998754 478899999999999999999999988776555444332110
Q ss_pred ---cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 299 ---DFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 299 ---~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.++. .....+++++++||.+||+.||.+|||++++|+||||+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0000 012357889999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.67 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=209.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence 356799999999999999999999999999999999865432 2334567788999999995 99999999988643
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence 357999999965 67666643 58899999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC------------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG------------ 296 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------ 296 (472)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987655444455689999999998864 5899999999999999999999999876654433322110
Q ss_pred ----------CccC----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 297 ----------DIDF----------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 297 ----------~~~~----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...+ ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000 000112346788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=317.62 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=220.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
..+++..||.|+.|.||+++.+.+|...|||.+.+.. +....+++...++++..-.++|+||+.+++|..+..++|.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455778999999999999999999999999998655 34456778888888877667899999999999999999999
Q ss_pred eccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|.|. ..+..++.+ .++++|.-+..+...++.||.||.. ++|+|||+||+|||+ ++.+.+||||||++.++.+..
T Consensus 171 elMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccc
Confidence 9984 344444433 5679999999999999999999986 589999999999999 788889999999999998888
Q ss_pred ceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 238 VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
......|-+.|||||-+. ..|+..+||||||+.++||.||..||.+. ++.+.+..+.+...+.. +.-..+|+.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L-~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL-PGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC-CcccCcCHHH
Confidence 777789999999999875 35899999999999999999999999874 56778888888544222 2224599999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
++|+..||++|+.+||...++|+|||+..+..
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 99999999999999999999999999987654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=340.56 Aligned_cols=252 Identities=34% Similarity=0.674 Sum_probs=222.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||++.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence 6999999999999999999999999999999987654433444677889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--C
Confidence 999999999999888889999999999999999999999999999999999999 45667999999999876544 2
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..+...++ ..++..++++|.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~ 231 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHHH
Confidence 34578999999998754 578899999999999999999999988877777777776655443 3468999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCcccc
Q 012039 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 319 ~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
||..||.+|+ +++++++||||..
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCccccc
Confidence 9999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=335.07 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=215.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC--cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.|.+.+.||+|++|.||+|.+..+++.||+|.+....... ......+.+|+.+++++. ||||+++++++.++..+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEE
Confidence 6889999999999999999999999999999987543221 122456889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|+||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccccc
Confidence 99999999999999888889999999999999999999999999999999999999 455679999999987654322
Q ss_pred ce----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 238 VY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 238 ~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.. ....|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+........ ....++..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHVSPDA 236 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCccCCHHH
Confidence 11 23467889999998864 488999999999999999999999987665555545444332222 224688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.++|.+||..+|.+|||+.++++||||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.31 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=215.1
Q ss_pred ccccccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 68 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
...|..+..-.-+++|.+.|.+|||+.||+|.+...|..||+|++-.. ++.....+.+|+++|++|++|+|||.+++
T Consensus 26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 344455555567899999999999999999999988899999987533 45678889999999999999999999999
Q ss_pred -EEEe------CCeEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccC
Q 012039 148 -AYED------KQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSK 216 (472)
Q Consensus 148 -~~~~------~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~ 216 (472)
.... .-.++|.||||.||+|.+++.. ..+|++.++..|+.+++.|+.+||... |||||||-+|||+
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--- 179 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--- 179 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---
Confidence 3321 1357899999999999999974 356999999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCceeccCCcce-e---------eccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCC
Q 012039 217 DENALLKATDFGLSVFIEEGKVY-R---------DIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFW 282 (472)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~-~---------~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~ 282 (472)
..++.+||||||.+...-..... . ....|+.|+|||++. ..++.|+|||+|||+||-|+....||.
T Consensus 180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 45667999999998753222110 0 134689999999984 358999999999999999999999997
Q ss_pred CCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 283 AETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 283 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.... -.|+++.+.++.. +.+|..+++||+.||+.||++||++.+++.+
T Consensus 260 ~sg~----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 260 ESGK----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cCcc----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 6533 4678888887765 6899999999999999999999999998854
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=334.13 Aligned_cols=254 Identities=26% Similarity=0.474 Sum_probs=217.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.-|.++.+||+|+||.||+|.|+.+|..+|+|.++. ..+.+++..|+.|++++ +.|++|++|+.|-....++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence 358899999999999999999999999999998863 45689999999999999 499999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||..||+.+.+.. ++.+++.++..+++..+.||+|||...-+|||||..|||+ +..+..||.|||.+..+.+..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhH
Confidence 999999999998864 5679999999999999999999999999999999999999 567789999999998876543
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CccCCCCCCCCCCHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-DIDFESAPWPTISSSAKD 314 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~ 314 (472)
. ..+.+|||.|||||++.. .|..++||||||++..||..|++||..-.+...+-.|-.. ...|.. ....|.++.+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~K--PE~WS~~F~D 261 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKK--PEEWSSEFND 261 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCC--hHhhhhHHHH
Confidence 2 345789999999999976 6999999999999999999999999665443222222111 111221 1346889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||++||.++|++|-|+.++++|||++...
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999999998653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=347.79 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=202.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++++.+||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 34568999999999999999999752 345689999986432 22345678899999999966999999999887
Q ss_pred eC-CeEEEEEeccCCcchHHHHHhc-------------------------------------------------------
Q 012039 151 DK-QSVHVVMELCAGGELFDRIIAK------------------------------------------------------- 174 (472)
Q Consensus 151 ~~-~~~~lv~e~~~g~sL~~~l~~~------------------------------------------------------- 174 (472)
.. +.+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999988642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce---eeccC
Q 012039 175 -------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVG 244 (472)
Q Consensus 175 -------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~g 244 (472)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......... ....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCC
Confidence 237788889999999999999999999999999999999 45667999999999865432211 12345
Q ss_pred CCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 245 SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 245 t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+ ....+..+.. .. ....+++++.+||.+||.
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-MR--APENATPEIYRIMLACWQ 315 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-CC--CCCCCCHHHHHHHHHHcc
Confidence 67899999875 458999999999999999997 999998755433 3344443322 11 124678999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 012039 322 QDPKKRITSAQVLE 335 (472)
Q Consensus 322 ~dp~~Rps~~~~l~ 335 (472)
.||++|||+.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=344.87 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=193.8
Q ss_pred cceeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEEEEE
Q 012039 84 GKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHVVM 159 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~ 159 (472)
+++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+++++. ||||+++++++.. +..+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999976 467899999886432 2345778999999995 9999999999854 46789999
Q ss_pred eccCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC-CCCCcEEEeecCC
Q 012039 160 ELCAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGL 229 (472)
Q Consensus 160 e~~~g~sL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~~~kl~Dfg~ 229 (472)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9994 5887776532 248999999999999999999999999999999999999643 3456899999999
Q ss_pred ceeccCCc----ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCCh---------HHHHHHHH
Q 012039 230 SVFIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE---------KGIFDAIL 294 (472)
Q Consensus 230 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~ 294 (472)
+....... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||..... ...+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98764322 2234578999999998864 489999999999999999999999965432 11122221
Q ss_pred cCCc--------------------------cCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 295 QGDI--------------------------DFE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 295 ~~~~--------------------------~~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
...- .+. .......+.++.+||++||+.||.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 000 00011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=349.65 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=206.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+..+|.+++.||+|+||.||+|... .+++.||+|.+... ....+|+.++++|. ||||+++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 345678999999999999999999764 35678999987532 23568999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccc
Confidence 99999999994 6898988777889999999999999999999999999999999999999 5566799999999976
Q ss_pred ccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH---HHHHHHHcC----CccCC
Q 012039 233 IEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---GIFDAILQG----DIDFE 301 (472)
Q Consensus 233 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~----~~~~~ 301 (472)
...... .....||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.... ..+..+... ...++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 554322 234579999999999864 5899999999999999999999999765321 222222110 00000
Q ss_pred C-----------------------C---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 302 S-----------------------A---PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 302 ~-----------------------~---~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
. + ....++.++++||++||..||++|||+.++|.||||++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 0 002356789999999999999999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=350.77 Aligned_cols=260 Identities=24% Similarity=0.420 Sum_probs=211.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+.++|.+.+.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+.+++++. ||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence 456789999999999999999999999999999999865322 2223456778999999995 99999999987543
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+|++++++ |++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence 4579999998 788977664 4579999999999999999999999999999999999999 4567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc--------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-------- 299 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 299 (472)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9876443 234578999999998864 4889999999999999999999999876654444433221000
Q ss_pred ---------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 300 ---------------FES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 300 ---------------~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.+. ..+...++.+.+||.+||..||.+|||+.++|+||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 000 012346778999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=346.52 Aligned_cols=255 Identities=23% Similarity=0.388 Sum_probs=217.9
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..++...+...++..||+|.||+||+|++..+ ||||++..... +....+.|.+|+.++++-+ |.||+-+.|++..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMN 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcC
Confidence 45666667788899999999999999998754 99999987665 3447889999999999997 9999999999988
Q ss_pred CCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
... .||+.+|+|.+|+.++.- ..+|.....+.|++||+.|+.|||.++|||+|||..||++ .++..|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccce
Confidence 876 999999999999998864 4568999999999999999999999999999999999999 45578999999998
Q ss_pred eecc---CCcceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 231 VFIE---EGKVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 231 ~~~~---~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
.... .........|...|||||+++. +|+..+||||||+++|||++|..||...+.+.++-.+-+|.......
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 7533 2233344568889999999863 59999999999999999999999999888887777777775543332
Q ss_pred -CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 304 -PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 304 -~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+.+.++++|+..||..++++||.+.+||.
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 23567889999999999999999999999887
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=333.03 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=211.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
..+.|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++++.+||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 456899999999999999999999999999999998643 233567889999999996699999999998753
Q ss_pred --CeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 153 --QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||++ +.+..++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCC
Confidence 4689999999999999988763 358999999999999999999999999999999999999 456679999999
Q ss_pred CceeccCCc-ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC
Q 012039 229 LSVFIEEGK-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 229 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 234 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP 234 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence 998654322 223457899999999874 247889999999999999999999997665544444333321 22
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
......++.++.+||.+||..||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.13 Aligned_cols=256 Identities=28% Similarity=0.520 Sum_probs=213.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|++|.||+|+++.+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++.....+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence 379999999999999999999999999999998865432 2223456789999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
|||+++++|..++.....+++..+..++.||+.+|.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 9999998888777776789999999999999999999999999999999999999 455679999999998765543
Q ss_pred ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 012039 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------------- 298 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------------- 298 (472)
......++..|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567889999998754 478899999999999999999999987765544433322100
Q ss_pred --cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 --DFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 --~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..+. ..++.++..+.+||.+||+.+|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.42 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=213.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.+. ||||+++++.+...+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence 458999999999999999999999999999999986432 233456788999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence 99999999999999888899999999999999999999999999999999999999 456679999999987654322
Q ss_pred -ceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-CCCCCCHH
Q 012039 238 -VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTISSS 311 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 311 (472)
......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.......+.. ....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999873 348889999999999999999999997665544443333333222211 11246789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPW 338 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~ 338 (472)
+.+||.+||..+|++||+++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.40 Aligned_cols=257 Identities=30% Similarity=0.553 Sum_probs=220.5
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||++.+..+++.|++|.+.+...........+.+|+++++.+. ||||+++++.+..++.+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999987654333344567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
||++|++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++ +..+.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence 999999999999888889999999999999999999999999999999999999 456779999999886421100
Q ss_pred --------------ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC
Q 012039 238 --------------VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (472)
Q Consensus 238 --------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (472)
......|+..|+|||.+. ..++.++||||||+++|+|++|..||.+....+....+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 001235788999999875 45899999999999999999999999988888878777776554444
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCcccc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKE 341 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps---~~~~l~h~~~~~ 341 (472)
.. ..++.++.++|.+||+.||++||+ +.++|+||||..
T Consensus 238 ~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 238 GD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 33 268899999999999999999998 789999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.19 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=199.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|++++.||+|+||.||+|++..+++.||+|+..+. ....|+.+++++. ||||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999975322 2346999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||++. ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||+ +....+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence 99995 588888765 4569999999999999999999999999999999999999 556679999999997654443
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh----------HHHHHHHHcC-Cc---cCC-
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE----------KGIFDAILQG-DI---DFE- 301 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~~i~~~-~~---~~~- 301 (472)
......||+.|+|||++.+ .++.++|||||||++|+|+++..|+..... ...+..+... .. .++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4445679999999998864 689999999999999999986555432211 0111111110 00 000
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 302 -------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 302 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
......++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0011246778889999999999999999999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=329.41 Aligned_cols=267 Identities=27% Similarity=0.442 Sum_probs=217.6
Q ss_pred cccccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC-CC----Cee
Q 012039 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-QP----NIV 143 (472)
Q Consensus 69 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp----~iv 143 (472)
.+....+.+..+|.+...+|+|.||.|-.|.+..++..||+|+++.- ....+...-|+++|+++.. .| -+|
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 44556667789999999999999999999999999999999998642 2335566779999999942 23 389
Q ss_pred EEEEEEEeCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC----
Q 012039 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD---- 217 (472)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---- 217 (472)
.+.+||+..++.|||+|.+ |.|+++++.+++ +++..+++.+.+||+.++++||+++++|.||||+|||+.+.+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 9999999999999999999 889999998754 588999999999999999999999999999999999996432
Q ss_pred -------------CCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCC
Q 012039 218 -------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA 283 (472)
Q Consensus 218 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 283 (472)
.+..|+|+|||.|++..... ...+.|..|+|||++.+ +|+.++||||+||||+|+++|...|++
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 24569999999999866544 56788999999998765 899999999999999999999999988
Q ss_pred CChHH---HHHHHHc------------------CCccCCCCCCC---------------------CCCHHHHHHHHHhcc
Q 012039 284 ETEKG---IFDAILQ------------------GDIDFESAPWP---------------------TISSSAKDLVRRMLT 321 (472)
Q Consensus 284 ~~~~~---~~~~i~~------------------~~~~~~~~~~~---------------------~~s~~~~~li~~~L~ 321 (472)
....+ +++.|.. +.++++..... ..-.++.|||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 77555 3344432 11111111000 012357799999999
Q ss_pred cCCCCCCCHHHHhcCCccccC
Q 012039 322 QDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 322 ~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.||.+|+|+.|+|.||||+..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFARL 412 (415)
T ss_pred cCccccccHHHHhcCHHhhcC
Confidence 999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=332.48 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=218.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||.|++|.||+|++..++..||+|++.... .......+.+|+++++.+. ||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence 36889999999999999999999999999999986543 2334567889999999996 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-c
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~ 237 (472)
+||+++++|.+++... ++++..++.++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence 9999999999988765 89999999999999999999999999999999999999 55677999999999877644 2
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+......... ...++.++.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence 2334578899999998864 5899999999999999999999999876665555555544222111 123789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+||..+|++|||++++++||||+...
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=330.79 Aligned_cols=252 Identities=35% Similarity=0.548 Sum_probs=214.5
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|++|.||+|.+..+++.||+|++.+...........+..|..++....+||||+++++++..++.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999999999999987544322223344556666655554699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccC
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 244 (472)
++|.+++...+.+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence 9999999888889999999999999999999999999999999999999 4566799999999876443 223468
Q ss_pred CCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 012039 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (472)
Q Consensus 245 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (472)
+..|+|||.+.+ .++.++||||||+++|+|++|..||...+....+..+......+.......++.++.++|.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 899999998764 4789999999999999999999999988888888877776666555555578999999999999999
Q ss_pred CCCCCC---HHHHhcCCccccC
Q 012039 324 PKKRIT---SAQVLEHPWIKEG 342 (472)
Q Consensus 324 p~~Rps---~~~~l~h~~~~~~ 342 (472)
|++||+ ++|+|+||||+..
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 999995 4799999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.14 Aligned_cols=257 Identities=32% Similarity=0.612 Sum_probs=220.6
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|.+..+++.||+|.+.+...........+.+|+.+++.+. ||||+++++.+.+....|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence 6999999999999999999999999999999997654433335567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+.|++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||++. .++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhcccccc
Confidence 999999999988754 4689999999999999999999999999999999999994 56679999999987543211
Q ss_pred c------------------------------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh
Q 012039 238 V------------------------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE 286 (472)
Q Consensus 238 ~------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 286 (472)
. .....|+..|+|||++.+ .++.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 112468889999998864 588999999999999999999999988887
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCccccC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT----SAQVLEHPWIKEG 342 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps----~~~~l~h~~~~~~ 342 (472)
...+..+......++.. ..++.++.++|.+||..||++||| ++++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 77777776655444332 337899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=338.33 Aligned_cols=256 Identities=34% Similarity=0.570 Sum_probs=227.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|+.-++||+|+||.||-|+.+.||+-||+|.+.+..+..........+|-.||.++. .+.||.+-..|+..+.+|+|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence 45778889999999999999999999999999998777665566677889999999995 89999999999999999999
Q ss_pred EeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|..|+||+|.-+|.+.+ .++++.+..++.+|+.||++||+.+||+|||||+|||+ |+.++++|+|+|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence 99999999988887765 69999999999999999999999999999999999999 78889999999999999999
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCccCCCCCCCCCCHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK----GIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
......+||.+|||||++.+ .|+...|+|||||++|+|+.|+.||...... ++-+.+++....++ ..+|++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~e 416 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEE 416 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHH
Confidence 88888899999999999974 5999999999999999999999999765433 44444555444444 578999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+++|.+.+|++||.+|. +++++.+||||+..
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999999998 56799999999864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=334.17 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=207.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|++..++..||+|.+..... .......+.+|+.+++++. ||||+++++++.++..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence 48899999999999999999999999999999865432 2233467889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 160 ELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 160 e~~~g~sL~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+|+||+|+||++ +.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence 9997 5888877542 468999999999999999999999999999999999999 45667999999998765432
Q ss_pred c-ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc---------------
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI--------------- 298 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------- 298 (472)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|++||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 2233467899999998754 478899999999999999999999987655433322211100
Q ss_pred ----------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 ----------DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 ----------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
......+..+++++.+||++||..||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00011134578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=348.78 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=203.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++|. |||||++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence 447999999999999999999999999999999532 223568999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|||++. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +....+||+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence 999994 6888887654 469999999999999999999999999999999999999 45667999999999875432
Q ss_pred cc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC--------hHHHHHHHHcCCcc---C-
Q 012039 237 KV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--------EKGIFDAILQGDID---F- 300 (472)
Q Consensus 237 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~---~- 300 (472)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+.... ...+...+...... +
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 223579999999998864 58999999999999999999887654321 22333333332211 0
Q ss_pred -----------------------CCCCCC---CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 301 -----------------------ESAPWP---TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 301 -----------------------~~~~~~---~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
....|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 111122 45678999999999999999999999999999974
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.89 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=222.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+....|.-++.||+|+||.||-|++..+...||||.+..+.-.....-..+..|+.+|++|. |||+|.+.++|-.+.+.
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTA 101 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchH
Confidence 34456777889999999999999999999999999987655444444567899999999996 99999999999999999
Q ss_pred EEEEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||||||- ||-.+++. .++++.+.++..|+.+.+.||.|||+.+.||||||..|||+ .+.+.|||+|||.+....
T Consensus 102 WLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcC
Confidence 99999995 57777775 35679999999999999999999999999999999999999 577889999999998876
Q ss_pred CCcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc-CCCCCCCCCC
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-FESAPWPTIS 309 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s 309 (472)
+.+ +++|||+|||||++- ++|+-++||||||++..+|.-.++|+...+....+--|.+...+ ... ...|
T Consensus 178 PAn---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS 251 (948)
T KOG0577|consen 178 PAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWS 251 (948)
T ss_pred chh---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhH
Confidence 654 569999999999873 67999999999999999999999999888777666666665443 333 3458
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..++.||..||++-|.+|||++++|.|+|+...
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 899999999999999999999999999999763
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.23 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=211.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++++++ ||||+++++.+.+++.+++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence 6899999999999999999999999999999886432 2233456889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+||++ +.++.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-
Confidence 999999999999888889999999999999999999997 599999999999999 456679999999987653322
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-----------------
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----------------- 300 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------- 300 (472)
.....|++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 234578999999998864 48899999999999999999999997655433322221110000
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 301 -----------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 301 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+......++.++.+||.+||..+|++|||+.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001112367899999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=328.94 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=216.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||.|++|+||+|.+..++..+++|++..... ......+.+|+.+++.+. |+||+++++.+...+.+++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEEE
Confidence 69999999999999999999988999999999865432 225677899999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 160 ELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 160 e~~~g~sL~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|+++|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHhccC
Confidence 999999999998764 4589999999999999999999999999999999999994 5567999999998766543
Q ss_pred cce-----eeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC--CCCC
Q 012039 237 KVY-----RDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA--PWPT 307 (472)
Q Consensus 237 ~~~-----~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~ 307 (472)
... ....|+..|+|||++.. .++.++|+||||+++|+|++|+.||...+....+..+.......... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 221 23468899999998864 48899999999999999999999998777666666655543221111 1246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+++.+.+|+.+||..||++||++.++++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 88999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.04 Aligned_cols=252 Identities=25% Similarity=0.468 Sum_probs=218.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++ ||||+++++++.+.+.+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence 47888999999999999999999999999999865433 2345677889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||++|++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence 999999999998764 5689999999999999999999999999999999999994 55679999999988765433
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+...... ..++..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2 234568899999998864 5789999999999999999999999888877777777665433221 2578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
|.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.93 Aligned_cols=254 Identities=26% Similarity=0.471 Sum_probs=206.5
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|++..+|+.||+|.+..... .......+.+|+.+++++. ||||+++++++.+.+.+++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence 58899999999999999999999999999999865432 2223456778999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence 9996 578877764 5679999999999999999999999999999999999999 456679999999988654332
Q ss_pred ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCC-CCChHHHHHHHHcCCc--------------c-
Q 012039 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDI--------------D- 299 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~--------------~- 299 (472)
......+++.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+..... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567899999998864 37899999999999999999988864 3443444433321100 0
Q ss_pred --CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 --FE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 --~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+. ....+.+++++.+||++||..||.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.69 Aligned_cols=259 Identities=26% Similarity=0.465 Sum_probs=222.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..+.|.|+..||.|+||.||+|.++.++...|.|+|... .....+.+.-||.||..+ +||+||++++.|..++.++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceE
Confidence 456789999999999999999999999988899988532 345678889999999999 5999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|+.|||.||-+...+..- +.+++.++..+++|++.||.|||+++|+|||||..|||++ .++.++|.|||.+.....
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchh
Confidence 999999999988777654 5699999999999999999999999999999999999995 556699999998765432
Q ss_pred -CcceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 236 -GKVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 236 -~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
.....+++|||+|||||+.. .+|+.++||||||++|.+|..+.+|....++...+-+|.....+... .....
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-qPS~W 261 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-QPSHW 261 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-Ccchh
Confidence 22334679999999999864 36999999999999999999999999988888777777665443222 12456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+..+.||+++||.+||..||+++++|+||||+...
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 88999999999999999999999999999998643
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=333.26 Aligned_cols=252 Identities=32% Similarity=0.537 Sum_probs=210.6
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.++++++ ||||+++++.+...+.+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999999999999999987654433334556778999999995 9999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccC
Q 012039 167 LFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244 (472)
Q Consensus 167 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 244 (472)
|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence 999987765 69999999999999999999999999999999999999 4566799999999887654444445578
Q ss_pred CCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 012039 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (472)
Q Consensus 245 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (472)
+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+..............+++.+.++|.+||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 889999998754 5888999999999999999999999765442222233332222233333467999999999999999
Q ss_pred CCCCC-----CHHHHhcCCccccC
Q 012039 324 PKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 324 p~~Rp-----s~~~~l~h~~~~~~ 342 (472)
|.+|| ++.++++||||...
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.55 Aligned_cols=252 Identities=25% Similarity=0.534 Sum_probs=213.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQSVHVV 158 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv 158 (472)
.|++.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+.++++++ |||++++++.+.. +..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999865332 2234566889999999995 9999999998864 4568999
Q ss_pred EeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|||+++++|.+++... ..+++.+++.++.|++.+|.+||++|++||||+|+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence 9999999999988753 458999999999999999999999999999999999999 45677999999999876432
Q ss_pred c-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||...+.......+..+.... ....+++++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 2 2234568899999998764 57889999999999999999999998877766666666654422 22468899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
||.+||+.||++|||+.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=330.24 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=211.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++++. ||||+++++++...+.+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence 457999999999999999999999999999999986432 233456789999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+++++|.+++...+.+++..+..++.|++.||.|||+++|+||||+|+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccc
Confidence 99999999999999888889999999999999999999999999999999999999 456679999999998664322
Q ss_pred -ceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-CCCCCCHH
Q 012039 238 -VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTISSS 311 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 311 (472)
......|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+.......+.. ....++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 123456889999999873 347889999999999999999999997654433333332222221111 11356899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPW 338 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~ 338 (472)
+.+||++||..+|++|||++++|+|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.58 Aligned_cols=259 Identities=31% Similarity=0.518 Sum_probs=216.6
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.....+|++.+.||+|++|.||+|++..+++.|++|.+..... .....+.+|+.+++.+. ||||+++++.+.....
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCE
Confidence 3455689999999999999999999999999999998865432 23567889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
.|+||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcc
Confidence 9999999999999998754 468999999999999999999999999999999999999 456679999999987654
Q ss_pred CCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||...........+..... ........++..+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 246 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF 246 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHH
Confidence 3322 233578899999998864 478999999999999999999999987765443333332221 1111224688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.++|.+||..+|++|||+.++++||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=331.93 Aligned_cols=241 Identities=20% Similarity=0.230 Sum_probs=206.3
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CCeEEEEEe
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQSVHVVME 160 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~~~lv~e 160 (472)
..||+|++|.||+|.. +|+.||+|.+.+.........+.+.+|+.+|++++ ||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 4689999999999987 58899999987654322223567889999999995 9999999999877 457899999
Q ss_pred ccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
|++||+|.+++...+.+++.....++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 999999999998888899999999999999999999984 99999999999999 556789999999988654332
Q ss_pred eeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....|+..|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......+..+ ..+++++++|+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 23468899999999864 68999999999999999999999999888888888876655443322 35789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 012039 317 RRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~ 335 (472)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=331.36 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=217.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|+++++++. ||||+++++.+.....+++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence 4899999999999999999999999999999997655434345678899999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
||+.|++|.+++.....+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999 45667999999998876554444
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
....|+..|+|||++.. .++.++|+||||+++|+|++|..||...+. ............ .....++..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV----LYPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc----cCcccCcHHHHHH
Confidence 45678899999998864 479999999999999999999999987763 333332222211 2224578999999
Q ss_pred HHHhcccCCCCCCCH--HHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITS--AQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~--~~~l~h~~~ 339 (472)
|.+||..||.+||++ .++++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=332.16 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=217.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.+.||.|++|.||++.+..++..+|+|++... .......+.+|+.+++++. ||||+++++.+..+..+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence 45799999999999999999999989999999998543 2334567889999999996 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||+++++|.+++... ..+++..++.++.|++.+|.|||+++|+|+||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence 99999999999988764 569999999999999999999999999999999999999 55677999999998765332
Q ss_pred c-ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 K-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
. ......|++.|+|||++. ..++.++||||||+++|+|++|+.||........+..+......... ....++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCC
Confidence 2 223456899999999874 23678999999999999999999999887766666666554332111 123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.++.++|.+||..+|.+||++.++|+||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.82 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=213.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc------ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK------NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~------~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
+|.+...||+|++|.||+|.+..+++.||+|.+........ ...+.+.+|+.+++++. ||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 47888999999999999999998999999998865433211 12356789999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++ +.+..++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence 999999999999999999888889999999999999999999999999999999999999 56677999999998876
Q ss_pred cCCc-------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 234 EEGK-------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 234 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
.... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||...+....+..+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCC
Confidence 5211 1123458889999998864 578899999999999999999999987665555444444221 1122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..++..+.++|++||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 4578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=330.50 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=207.5
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++++ +||||+++++.+...+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEE
Confidence 5788899999999999999999999999999986532 223356788999999999 5999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cc
Confidence 99999998643 357899999999999999999999999999999999999 55677999999999865433 22
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh-------HHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-------KGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
....|+..|+|||++.+ .++.++||||||+++|+|++|..||..... ......+..... ........+++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK 228 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence 34578999999998764 589999999999999999999999965321 122222222211 11122457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+||.+||+.+|++||+++++++||||...
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=348.20 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=215.3
Q ss_pred eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCc
Q 012039 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 165 (472)
.||+|.||+||.|+++.|....|||.|.... ....+-+..|+.+.++|+ |.|||+++|.+..++.+-|.||.++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 5999999999999999999999999986543 334567889999999996 999999999999999999999999999
Q ss_pred chHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce-ee
Q 012039 166 ELFDRIIA-KGHY--SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RD 241 (472)
Q Consensus 166 sL~~~l~~-~~~~--~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 241 (472)
||.+++.. .+++ .|..+..+.+||+.||.|||++.|||||||-+|||++ .-.+.+||+|||-++.+..-+.. .+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence 99999976 4677 7889999999999999999999999999999999996 45678999999999987665443 45
Q ss_pred ccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 242 IVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 242 ~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
..||..|||||++.. +|+.++|||||||++.||.||++||....... .....-|-++...+....+|.+++.||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-HhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 789999999999963 59999999999999999999999997543321 12233344444444446789999999999
Q ss_pred hcccCCCCCCCHHHHhcCCccccCC
Q 012039 319 MLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 319 ~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
|+.++|.+||++.++|.+||++...
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCC
Confidence 9999999999999999999998763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=327.30 Aligned_cols=250 Identities=34% Similarity=0.624 Sum_probs=214.9
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||.|++|.||+|++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+.++..+++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 689999999999999999999999997655433445677999999999994 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCC
Q 012039 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246 (472)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~ 246 (472)
|.+++.+...+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||++.............|++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence 99999888789999999999999999999999999999999999999 456679999999998776543334457899
Q ss_pred CCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 012039 247 YYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (472)
Q Consensus 247 ~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (472)
.|+|||.+.. .++.++|+||||+++|+|++|..||.... ....+..+..+......+ ...++++.++|.+||..+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence 9999998754 58899999999999999999999998776 555666666322222222 234899999999999999
Q ss_pred CCCCCC-----HHHHhcCCccccC
Q 012039 324 PKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 324 p~~Rps-----~~~~l~h~~~~~~ 342 (472)
|++||+ ++|+++||||+..
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=339.39 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=204.0
Q ss_pred Ecceeeec--CCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 83 FGKELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 83 ~~~~lg~G--~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
++++||+| +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 788999999999999999999865432 2233567888999999994 9999999999999999999999
Q ss_pred ccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 161 LCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 161 ~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
|+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||++ +.++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence 99999999988653 458999999999999999999999999999999999999 455679999998654332111
Q ss_pred -------ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC------
Q 012039 238 -------VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------ 301 (472)
Q Consensus 238 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 301 (472)
......++..|+|||++.+ .++.++|||||||++|+|++|..||..............+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0112346778999999864 488999999999999999999999976655443333332221100
Q ss_pred ------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 302 ------------------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 302 ------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
......+++++.+||.+||+.||++|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112357789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=334.50 Aligned_cols=262 Identities=31% Similarity=0.475 Sum_probs=216.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC--cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
+|++.+.||+|++|.||+|.+..+++.||+|.+....... ......+.+|+.+++++. |+||+++++++.+.+.+++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 4888999999999999999999999999999997654321 122455778999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence 99999 899999998766 79999999999999999999999999999999999999 45667999999999876543
Q ss_pred c-ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC------------
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------------ 301 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------ 301 (472)
. ......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+....+.+..+........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 2233457888999998853 478999999999999999999888887766555544432110000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 302 ------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 302 ------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
...+...+.++.+||.+||.+||++|||+.++|+|+||.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 001235678999999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.61 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=218.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|.+..++..+|+|.+..... .......+.+|+.+++.+. ||||+++++.+...+.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence 58999999999999999999999999999999876543 2334677889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||++|++|.+++... ..+++..+..++.|++.+|.|||++|++|+||+|+||++.. ....+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence 999999999999764 34899999999999999999999999999999999999952 34568999999998776554
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......|+..|+|||.+.. .++.++||||||+++|+|++|..||...+.......+....... ....++.++.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHH
Confidence 4445678999999998864 47889999999999999999999998877776666666543321 1235789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCcc
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.+||..+|++|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.20 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=216.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..+.|++.++||+|+||.||+|++..+++.|++|.+... .......+.+|+.+++.+. ||||+++++.+..++.++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence 346799999999999999999999999999999998643 2334567888999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||++|++|..++.+ ...+++..+..++.||+.+|.|||+++++||||+|+||++ +.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence 99999999999887754 4568999999999999999999999999999999999999 4566799999999875433
Q ss_pred C-cceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 236 G-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
. .......+++.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+....... ......+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCccc
Confidence 2 1223456889999999873 236789999999999999999999998776666555555433221 1122457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.++.++|.+||..||++||++.++++||||...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 8899999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.63 Aligned_cols=258 Identities=32% Similarity=0.541 Sum_probs=218.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||.|++|.||+|.+..+++.|++|.+.... ......+.+|+.+++.++ ||||+++++++...+.+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELF 92 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEE
Confidence 4467999999999999999999999999999999886432 234567889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||++ +.++.+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccc
Confidence 99999999999987754 468999999999999999999999999999999999999 45667999999998765443
Q ss_pred cc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.. .....|++.|+|||.+.. .++.++|||||||++|+|++|..||...+.......+...... .......+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 247 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFRD 247 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHHH
Confidence 22 223468899999998864 5889999999999999999999999887765554444433221 12223568899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||.+||..||++||++.++++||||+...
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=329.87 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=210.9
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE-
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE- 150 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 150 (472)
........+|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 444556779999999999999999999999999999999875422 224567889999999966999999999873
Q ss_pred ----eCCeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcE
Q 012039 151 ----DKQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 151 ----~~~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
.+..+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||++. .++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCE
Confidence 45679999999999999887753 34688999999999999999999999999999999999994 45669
Q ss_pred EEeecCCceeccCCc-ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc
Q 012039 223 KATDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295 (472)
Q Consensus 223 kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 295 (472)
||+|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+..+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999988764332 223346899999999874 2378899999999999999999999987655444333322
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
... ........++.++.+||.+||+.||++|||+.++++|+||
T Consensus 244 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 211 1111112467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=322.73 Aligned_cols=252 Identities=31% Similarity=0.540 Sum_probs=219.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||.|+||.||.+++..+++.+++|.+..... .......+.+|+.+++++. |+||+++++++.+.+.++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence 58999999999999999999999999999999865433 2334567889999999994 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||++. .+..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEccccc
Confidence 999999999998764 4589999999999999999999999999999999999994 55679999999998764433
Q ss_pred -ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2234578999999998764 4788999999999999999999999988888888888776554322 4678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
|.+||..+|.+||++.++|+|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.59 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=208.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe----
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS---- 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~---- 154 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999998865432 223346788899999999768999999999887665
Q ss_pred -EEEEEeccCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 155 -VHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 155 -~~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++. .++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence 8999999975 888877643 34799999999999999999999999999999999999952 26679999999
Q ss_pred CceeccCC-cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC----
Q 012039 229 LSVFIEEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE---- 301 (472)
Q Consensus 229 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 301 (472)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+....+..+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765332 22233467889999998753 478999999999999999999999988766554444432110000
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 302 --------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 302 --------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
....+.++.++.+||.+||..||.+||++.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001245789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=328.72 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=212.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-- 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 152 (472)
....++|.+.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++.+||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 345678999999999999999999999999999999986432 23456788999999996699999999998643
Q ss_pred ---CeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 153 ---QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
..+++||||++|++|.+++.. ...+++..++.++.|++.||.|||+.+++|+||||+||++ +.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence 468999999999999988753 4568999999999999999999999999999999999999 455679999
Q ss_pred ecCCceeccCCc-ceeeccCCCCCCchhhhhc------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc
Q 012039 226 DFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 226 Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 298 (472)
|||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|++||........+..+.....
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999988654332 1233568899999998753 268899999999999999999999987766555555544322
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
... ......+..+.+||.+||+.+|++||++.++++||||+
T Consensus 251 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 111 11134678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.44 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=216.6
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+...+|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDE 90 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCE
Confidence 445678999999999999999999999999999999986433 22346688999999999 59999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||++|++|.+++.+ ..+++..+..++.|++.+|.|||+.|++||||||+||++ +.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEcc
Confidence 9999999999999998754 468999999999999999999999999999999999999 456679999999988764
Q ss_pred CCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...+.......+..... ........++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPERLSAVF 245 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCCccccCHHH
Confidence 4332 223568899999998864 588999999999999999999999977655333222222111 1111224578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
++||.+||..+|++||++.++++||||+....
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.99 Aligned_cols=246 Identities=37% Similarity=0.573 Sum_probs=215.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..+.|.+...+|.|+||.|-.|.+..+++.+++|++.+.. ....+|+.++....+||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4678999999999999999999999999999999997652 233468888888889999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|||.+.|+.|.+.+...+.+. ..+..|+.+|+.|+.|||.+|++||||||+|||+. +..+.++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh
Confidence 9999999999999888776666 88889999999999999999999999999999995 45667999999999887655
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
....+-|..|.|||++.. .|+.+|||||||++||+||+|+.||...... ++...|..+.+. ..+|+++++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKd 541 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKD 541 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHH
Confidence 334466889999999874 5999999999999999999999999876665 556666555443 579999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
||++||+.||.+|+++.+++.||||.
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcchh
Confidence 99999999999999999999999993
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=328.68 Aligned_cols=256 Identities=27% Similarity=0.466 Sum_probs=215.4
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
+.|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence 34788999999999999999999999999999885432 234567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence 999999999887764 4569999999999999999999999999999999999999 456679999999987653322
Q ss_pred -ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 238 -VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
......|++.|+|||++. ..++.++|||||||++|+|++|.+||...+..+....+....... ......++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCH
Confidence 223456899999999873 236789999999999999999999998877766666665543221 112245789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++.+||.+||..||.+||++.++++||||+..
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.05 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=210.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC---CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV---TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+|++.+.||+|+||.||+|.. .+++.+|+|.+...... .......+.+|+++++++. |+||+++++++.+...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence 478899999999999999986 47889999988643211 1122456889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++.+...+++..+..++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence 999999999999999887889999999999999999999999999999999999999 45677999999998764321
Q ss_pred -------cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 237 -------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 237 -------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
.......|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+.......+ .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCC
Confidence 11233568899999999864 478999999999999999999999987655444434333222111 123468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+.++.+||++||..+|++||++.++|+||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.79 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=209.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE------
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE------ 150 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~------ 150 (472)
..+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++++.+||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 345899999999999999999999999999999988543 2234568889999999977999999999985
Q ss_pred eCCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
....+|++|||+++++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||+|+||++ +.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence 356789999999999999988653 358899999999999999999999999999999999999 456679999999
Q ss_pred CceeccCC-cceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC
Q 012039 229 LSVFIEEG-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 229 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||........+..+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence 98765422 1223456899999999874 2478899999999999999999999977655444433333211 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
......++.++.+||.+||..||.+|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 12224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=331.47 Aligned_cols=255 Identities=29% Similarity=0.536 Sum_probs=212.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|.+..+|..||+|++..... .......+.+|+.+++++. ||||+++++++.+...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence 58999999999999999999999999999999875432 2234567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence 999 9999998865 4568999999999999999999999999999999999999 456779999999988765433
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc----------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------------- 298 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 298 (472)
......|+..|+|||++.+ .++.++||||||+++|+|++|.+||.+......+..+....-
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2334578999999998753 368999999999999999999988877766555544432110
Q ss_pred ---cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 299 ---DFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 299 ---~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.+.. ..++..+.++.+||++||..+|.+|||++++|+||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 11235678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.17 Aligned_cols=254 Identities=28% Similarity=0.497 Sum_probs=208.6
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC--cccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSV 155 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 155 (472)
+|++.+.||+|+||.||+|.+..+++.|++|.+....... ......+.+|+.++++++ ||||+++++++.+ +..+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence 6889999999999999999999999999999886543211 123456889999999995 9999999998875 4678
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+++|+||||+|+||++ +.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4566799999999876532
Q ss_pred C----cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 236 G----KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 236 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
. .......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+..+....... .....+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP--QLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC--CCchhcCH
Confidence 1 11223468889999998864 58899999999999999999999998765544444333222111 11135688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.++++| +||..+|++||+++++++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=324.51 Aligned_cols=254 Identities=30% Similarity=0.517 Sum_probs=215.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... ......+.+|+.+++++. ||||+++++.+.+.+.+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence 358999999999999999999999999999999987543 224678899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||++ +.++.+||+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence 99999999999988776 789999999999999999999999999999999999999 45667999999998765543
Q ss_pred c-ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCH
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APWPTISS 310 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~ 310 (472)
. ......++..|+|||.+.. .++.++||||||+++|+|++|..||...+.......+....+.... .....++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 2234578889999998753 5788999999999999999999999887665555555444322211 11234678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~ 338 (472)
++.+||.+||..+|.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.53 Aligned_cols=247 Identities=25% Similarity=0.441 Sum_probs=201.5
Q ss_pred cceEEccee--eecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 79 LHYSFGKEL--GRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 79 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..|.+.+.+ |+|+||.||++.++.++..+|+|++...... . .|+.....+.+||||+++++.+..++.++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 467776766 9999999999999999999999998654321 1 13333333336999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC-cEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~-~~kl~Dfg~~~~~~~ 235 (472)
+||||++|++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+||++. .+. .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCC
Confidence 9999999999999998877899999999999999999999999999999999999995 333 799999999886643
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHH-HHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. ...|+..|+|||++.+ .++.++||||||+++|+|++|..||........ ...+.... ......++.+++.+.
T Consensus 163 ~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 PS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred Cc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 32 3468899999999864 588999999999999999999999976544332 11222211 222233457899999
Q ss_pred HHHHHhcccCCCCCCC-HHHHhcCCccc
Q 012039 314 DLVRRMLTQDPKKRIT-SAQVLEHPWIK 340 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps-~~~~l~h~~~~ 340 (472)
+||.+||+.+|.+||+ ++++|+||||+
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999999996 59999999996
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.79 Aligned_cols=252 Identities=26% Similarity=0.552 Sum_probs=217.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||++++..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++...+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence 58999999999999999999999999999999865432 2234567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+.+++|.+.+.... .+++..+..++.|++.||.|||+++++|+||+|+||++ +.+..++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence 9999999999887543 57899999999999999999999999999999999999 455679999999998664432
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||......+.+..+..+..... ...++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence 2 223468889999998764 578899999999999999999999988887777777776654322 23678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
|.+||+.+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.47 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=212.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||++++..++..||+|.+.... .......+.+|+.+++++. ||||+++++.+..++.+|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEEE
Confidence 6889999999999999999999999999999886432 2233567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 160 ELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 160 e~~~g~sL~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||++|++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++ .++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccC
Confidence 999999998887653 378999999999999999999997 5999999999999994 466799999999876543
Q ss_pred CcceeeccCCCCCCchhhhhc-------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
. ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+............+.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2 2233468889999998743 2578999999999999999999999766554444333221111122223458
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+.++.+||.+||..+|++||++.++++||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.61 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=202.3
Q ss_pred eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhc--cCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL--SGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l--~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++.+ .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765433222233344555444433 259999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeecc
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (472)
|++|.+++...+.+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++........ ....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc-cCcC
Confidence 99999999888889999999999999999999999999999999999999 5566799999999876543322 2346
Q ss_pred CCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 012039 244 GSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (472)
Q Consensus 244 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (472)
|++.|+|||.+.. .++.++||||+||++|+|++|..||........ ..+..............++.++.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 8999999998753 478999999999999999999999975432111 1111111122222335688999999999999
Q ss_pred cCCCCCC-----CHHHHhcCCccccC
Q 012039 322 QDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 322 ~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
.||.+|| |++++++||||+..
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCC
Confidence 9999999 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.66 Aligned_cols=256 Identities=26% Similarity=0.475 Sum_probs=216.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|+..+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++++. ||||+++++.+.+++.+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence 346888999999999999999999999999999986543 2234567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++|++|.+++.. +++++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCc
Confidence 9999999999998864 5789999999999999999999999999999999999994 55679999999997765433
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....++..|+|||++.+ .++.++|+||||+++|+|++|..||...........+..... ......++..+.++
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 232 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEF 232 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHH
Confidence 2 223467889999998864 578999999999999999999999987766655554433322 12224578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
|.+||..+|++||++.++++|+||....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=329.03 Aligned_cols=252 Identities=30% Similarity=0.508 Sum_probs=207.6
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEEEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHVV 158 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv 158 (472)
|++.+.||+|+||.||+|.+..+++.||+|.+.+... ........+|+.+++++.+||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865431 122234457999999997799999999999987 899999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+. ++|.+.+... ..+++..+..++.||+.||.|||++|++||||+|+||+++ . +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence 99996 5888877653 5689999999999999999999999999999999999995 3 789999999998765544
Q ss_pred ceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------
Q 012039 238 VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------------ 297 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------------ 297 (472)
......++..|+|||.+. +.++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444567899999999764 346889999999999999999999998877655544443210
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 298 IDFESA-------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 298 ~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..++.. ..+.++.++.+||.+||.++|++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 011110 013568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.59 Aligned_cols=261 Identities=29% Similarity=0.413 Sum_probs=213.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 155 (472)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++++++ |+||+++++++.+. +.+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence 45799999999999999999999999999999998654321 222335668999999995 99999999998765 578
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||++ +..+.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence 99999996 488887765 3568999999999999999999999999999999999999 456679999999998765
Q ss_pred CCc-ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc-------------
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI------------- 298 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------------- 298 (472)
... ......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+.+..+.+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 432 2233456788999998753 478999999999999999999999998887777666654211
Q ss_pred ------cCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 299 ------DFESA-------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 299 ------~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
..... ....+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 11101 01236889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=326.22 Aligned_cols=258 Identities=25% Similarity=0.467 Sum_probs=211.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC---cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT---KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+|+..+.||+|++|.||++.+..+++.||+|++....... ......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999986543211 113467889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||++.. ....+||+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999942 2346999999998776532
Q ss_pred cc-----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-ccCCCCCCCCCC
Q 012039 237 KV-----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD-IDFESAPWPTIS 309 (472)
Q Consensus 237 ~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s 309 (472)
.. .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.+.. ..........++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 123467889999998764 57899999999999999999999996544322222222111 111112223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
+++.+++.+||..+|++||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.00 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=205.1
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCC-----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTG-----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++|.+++.||+|+||.||+|++..++ ..||+|++..... ......+.+|+.+++.+.+|||||++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 34568999999999999999999875443 5799999865432 2335678899999999956999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhc--------------------------------------------------------
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAK-------------------------------------------------------- 174 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~-------------------------------------------------------- 174 (472)
..+.+++|||||++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999988542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCccee
Q 012039 175 --------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240 (472)
Q Consensus 175 --------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (472)
.++++..++.++.||+.||.|||++||+||||||+|||+ +.+..+||+|||++..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCccee
Confidence 247788899999999999999999999999999999999 456679999999998654432211
Q ss_pred ---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 241 ---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 241 ---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
...+++.|+|||++. ..++.++|||||||++|+|++ |+.||........+..+.......... ..+++++.++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 347 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSI 347 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHH
Confidence 223456799999875 468999999999999999997 999998765544444444433332222 3468999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 012039 316 VRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~ 335 (472)
|.+||+.||++|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=324.54 Aligned_cols=256 Identities=25% Similarity=0.467 Sum_probs=212.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc-------cHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-------DKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~-------~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
+|.+.+.||+|++|.||+|.+..+++.||+|.+......... ..+.+.+|+.+++++. ||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 588999999999999999999999999999988542211111 2346788999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+.+++||||++|++|.+++...+.+++..+..++.||+.||.|||+++++||||+|+||++ +.++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence 9999999999999999999888889999999999999999999999999999999999999 5567899999999876
Q ss_pred ccCCc---ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CccCCCCC
Q 012039 233 IEEGK---VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--DIDFESAP 304 (472)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~ 304 (472)
..... ......|+..|+|||.+.. .++.++|+||||+++|++++|..||........+..+... ...++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 53221 1223468889999998763 3789999999999999999999999765544433333222 22233333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
...++.++.++|.+||..+|++|||++++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 45679999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=341.28 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=204.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEE-----CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
....+|++++.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+.+||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3456899999999999999999974 3456789999986433 22345678899999999966999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC-------------------------------------------------------
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG------------------------------------------------------- 175 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~------------------------------------------------------- 175 (472)
+.+..++|||||+||+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999886422
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 176 --------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 176 --------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
.+++..+..++.||+.||.|||+++|+||||||+|||++ .+..+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccC
Confidence 367888999999999999999999999999999999994 566799999999987644
Q ss_pred Cccee---eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCC
Q 012039 236 GKVYR---DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG-IFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 236 ~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 309 (472)
..... ...++..|+|||++.+ .++.++|||||||++|+|++ |..||....... ....+..+ ..... ....+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~ 343 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-YRMLS--PECAP 343 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-ccCCC--CCCCC
Confidence 32211 1234567999998864 58999999999999999998 899997765443 33444333 22221 23568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.++.+||.+||+.||++|||+.++++.
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=327.02 Aligned_cols=258 Identities=29% Similarity=0.556 Sum_probs=234.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|.++..||+|+||.|.++..+.+.+.||||++++..+....+.+.-..|-++|.....-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35799999999999999999999999999999999988776666777778899998877667889999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee-ccCC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-IEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~-~~~~ 236 (472)
||||+.||+|.-.+..-+++.|..+..++..|+.||-+||++||++||||.+|||+ +..+.+||.|||+++. +-.+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999 6778899999999875 3345
Q ss_pred cceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
....+.+|||.|+|||++. ++|+..+|+||+||+||||+.|.+||.+.++.+++++|......++. .+|.++.++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~i 580 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAI 580 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHH
Confidence 5667889999999999876 67999999999999999999999999999999999999998888775 689999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITS-----AQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~-----~~~l~h~~~~~~ 342 (472)
++.+|.+.|.+|... .+|-.||||+..
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999999865 588899999863
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=325.69 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=211.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--- 153 (472)
..++|++.+.||+|++|.||+|.+..+++.+++|++.... .....+.+|+.+++++.+|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3468999999999999999999999899999999986532 234678899999999966999999999997644
Q ss_pred ---eEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 154 ---SVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 154 ---~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++++|+||+|+||++ +.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence 58999999999999988764 3579999999999999999999999999999999999999 4566799999
Q ss_pred cCCceeccCCc-ceeeccCCCCCCchhhhhc------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc
Q 012039 227 FGLSVFIEEGK-VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299 (472)
Q Consensus 227 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 299 (472)
||++....... ......|++.|+|||++.. .++.++||||||+++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 99987654322 2234568899999998742 3678999999999999999999999876655555555443221
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
. ......++.++++||.+||..||++|||+.++++|||+
T Consensus 237 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 T-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1 11112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=322.39 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=212.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|++|.||+|++..+++.|++|.+.... ....+.+|+.+++++ +||||+++++++.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence 47999999999999999999999889999999986432 267899999999999 599999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence 999999999999865 4568999999999999999999999999999999999999 456679999999998765443
Q ss_pred -ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...... .......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence 2233468899999998864 5889999999999999999999999876654444333322111 111123577899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
|.+||+.||++|||+.++|+||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.96 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=192.0
Q ss_pred cceeeecCCeEEEEEEECC--CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE--eCCeEEEEE
Q 012039 84 GKELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--DKQSVHVVM 159 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~lv~ 159 (472)
+.+||+|+||.||+|+++. ++..||+|.+.... ....+.+|+.+++.+. ||||+++++++. .+..+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999999654 56789999886432 2346788999999995 999999999885 456789999
Q ss_pred eccCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC-CCCCcEEEeecCC
Q 012039 160 ELCAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGL 229 (472)
Q Consensus 160 e~~~g~sL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~~~kl~Dfg~ 229 (472)
||+. ++|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+||++..+ +.++.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 9995 5777776421 248899999999999999999999999999999999999643 3556899999999
Q ss_pred ceeccCCc----ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChH---------HHHHHHH
Q 012039 230 SVFIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------GIFDAIL 294 (472)
Q Consensus 230 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~ 294 (472)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98764332 1234578999999998864 4789999999999999999999999654321 1111111
Q ss_pred cCCc---------------------cC-----C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 295 QGDI---------------------DF-----E--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 295 ~~~~---------------------~~-----~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.... .+ . .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00 0 00011245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.20 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=211.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.+. ||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEE
Confidence 68999999999999999999998999999998865432 2233566889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-c
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~ 238 (472)
||+++++|..+......+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccc
Confidence 999998888777666679999999999999999999999999999999999999 556779999999988754432 2
Q ss_pred eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc------------------
Q 012039 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI------------------ 298 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------ 298 (472)
.....++..|+|||++.+ .++.++||||||+++|+|++|.+||......+....+.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 334568899999998764 478899999999999999999999976655443333221000
Q ss_pred -cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 -DFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 -~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..+. ..++.++..+.+|+.+||..+|++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 1134678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=321.62 Aligned_cols=255 Identities=28% Similarity=0.521 Sum_probs=209.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--Ce
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 154 (472)
.+|++.+.||+|+||.||++.+..+++.||+|.+...... .......+.+|+.+++++. ||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 3689999999999999999999999999999987543211 1223467889999999995 99999999998763 57
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+++||||++|++|.+++.+...+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 88999999999999999887789999999999999999999999999999999999999 456679999999987653
Q ss_pred CC----cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EG----KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.. .......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+...... ......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhC
Confidence 21 11233468899999998754 5889999999999999999999999876555444444332211 11224578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
..+.++|.+||. +|++||+++++++|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=321.32 Aligned_cols=254 Identities=28% Similarity=0.503 Sum_probs=214.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++++. |+||+++++.+...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence 589999999999999999999989999999998755432 335678899999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
||+++++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCc
Confidence 9999999999998877799999999999999999999999999999999999994 566799999999887654322
Q ss_pred ----eeeccCCCCCCchhhhhc-c---cCCccchhhHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCC
Q 012039 239 ----YRDIVGSAYYVAPEVLRR-R---YGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 239 ----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 309 (472)
.....+++.|+|||++.. . ++.++||||||+++|++++|..||....... ....+.. ......+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence 123467889999998863 2 7889999999999999999999997653332 2223332 2222233344568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..+.+||++||+.+|.+|||+.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=325.66 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=205.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||++++..+|+.||+|.+..... ......+..|+.++.+..+||||+++++++..++.+|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 68999999999999999999999999999999875432 1223456667776444447999999999999999999999
Q ss_pred eccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 160 ELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 160 e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
||++ ++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+||++ +.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 9996 677776653 34689999999999999999999997 99999999999999 556779999999998765
Q ss_pred CCcceeeccCCCCCCchhhhh-----cccCCccchhhHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCCCC
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR-----RRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
.........|+..|+|||++. ..++.++|+||||+++|+|++|..||... ...+.+..+...... ......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 233 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP--QLPAEKF 233 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC--CCCcccc
Confidence 433333356889999999874 24688999999999999999999999643 222333333332111 1111357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
|.++.+||.+||..+|++||++.++++||||....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=349.64 Aligned_cols=263 Identities=21% Similarity=0.297 Sum_probs=195.3
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCC-EEEEE--------------EecccccCCcccHHHHHHHHHHHHhccCC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGR-QFACK--------------SISKRKLVTKNDKDDIKREIQIMQHLSGQ 139 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~va~K--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~h 139 (472)
..+..+|++++.||+|+||+||+|..+.... .++.| .+.+...........+.+|+.+++++. |
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence 3456789999999999999999987654322 12222 111111112223456789999999995 9
Q ss_pred CCeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeec
Q 012039 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLS 214 (472)
Q Consensus 140 p~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 214 (472)
||||++++++.+.+..|+|+|++ +++|.+++... .......++.|+.||+.||.|||++||+||||||+|||+
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl- 300 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL- 300 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 99999999999999999999999 56777776542 224466788999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCceeccCCcc--eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHH
Q 012039 215 SKDENALLKATDFGLSVFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKG 288 (472)
Q Consensus 215 ~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~ 288 (472)
+.++.+||+|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..++.... ...
T Consensus 301 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 --NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred --CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 5567799999999987654332 224579999999999864 58999999999999999999886544321 112
Q ss_pred HHHHHHcC-C---ccCCC------------------C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 289 IFDAILQG-D---IDFES------------------A------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 289 ~~~~i~~~-~---~~~~~------------------~------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.+..+... . ..++. . ....++.++.++|.+||+.||.+|||+.|+|+||||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 22222110 0 00000 0 0113567888999999999999999999999999997
Q ss_pred cC
Q 012039 341 EG 342 (472)
Q Consensus 341 ~~ 342 (472)
..
T Consensus 459 ~~ 460 (501)
T PHA03210 459 AE 460 (501)
T ss_pred cC
Confidence 64
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.15 Aligned_cols=255 Identities=30% Similarity=0.445 Sum_probs=209.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 156 (472)
..|++.+.||+|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++++. ||||+++++++... +.+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence 4799999999999999999999999999999998754332 223345678999999996 99999999998877 8999
Q ss_pred EEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++++|+||+|+||++ +.++.+||+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 9999996 48988887643 58999999999999999999999999999999999999 5567799999999987655
Q ss_pred C-cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc-------------
Q 012039 236 G-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID------------- 299 (472)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------------- 299 (472)
. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+..+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23334567889999998864 3688999999999999999999999877665555544321100
Q ss_pred -------------CCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 -------------FESAPWPT--ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 -------------~~~~~~~~--~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.....++. +++.+.+||++||+.+|++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00011222 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.55 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=213.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||++.++.+++.+|+|.+..... ......+.+|+.+++++. ||||+++++.+...+.+++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence 57888999999999999999999999999999875432 234567889999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHH
Confidence 999999999998775 789999999999999999999999 9999999999999994 56679999999987664332
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC-----hHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-----EKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
.. ...++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+...... ......++.+
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSPD 232 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCHH
Confidence 22 2678899999998764 58899999999999999999999996542 22333444333211 1111127899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+||.+||..||++|||+.+++.||||+.+
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=323.92 Aligned_cols=256 Identities=29% Similarity=0.535 Sum_probs=214.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~~~~~~l 157 (472)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .||||+++++++.+...+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999986432 2334567889999999995 49999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++|++|.+++.. +.+++..+..++.|++.+|.|||+.||+|+||+|+||+++ ..+.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCc
Confidence 9999999999988755 4799999999999999999999999999999999999994 56679999999998765433
Q ss_pred c-eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. .....|+..|+|||.+.. .++.++|+||||+++|+|++|..||.+.........+... ..+......++.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2 233568999999998854 3688999999999999999999999876654444333222 1122222247899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
++.+||+.||++||++.++++|+||++..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=326.41 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=210.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++.+...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence 479999999999999999999999999999999865432 2233467889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|||++ ++|.+.+..... +++..++.++.||+.||.|||+++++|+||+|+||+++. .+..+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence 99995 588887765433 578889999999999999999999999999999999953 3456899999999765332
Q ss_pred -cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC-----------
Q 012039 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES----------- 302 (472)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 302 (472)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|.+||......+.+..+.........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22234567899999998764 4788999999999999999999999877665555444321000000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 303 --------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 303 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...+.+++++.++|.+||+.+|++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0124578999999999999999999999999999999864
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=319.36 Aligned_cols=254 Identities=30% Similarity=0.489 Sum_probs=214.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
+|+..+.||+|++|.||+|.+..++..|++|.+...... .......+.+|+.+++.+. ||||+++++++.+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence 477889999999999999999989999999998654321 1234567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|+||+++++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence 99999999999999888789999999999999999999999999999999999999 456679999999988765544
Q ss_pred ceeeccCCCCCCchhhhhc-c-cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......|+..|+|||.+.. . ++.++|+||||+++|+|++|..||...........+.... ........+++.+.+|
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHH
Confidence 3345678999999998753 3 7899999999999999999999997766544444443311 1111224678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+.+||..+|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.42 Aligned_cols=256 Identities=21% Similarity=0.471 Sum_probs=222.3
Q ss_pred ce-EEcceeeecCCeEEEEEEECCCCCEEEEEEeccccc-CCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--eE
Q 012039 80 HY-SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--SV 155 (472)
Q Consensus 80 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~ 155 (472)
+| ++..+||+|+|-+||+|.|..+|.+||.-.++-..+ ......++|..|+.+|+.|+ |||||++|++|.+.. .+
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCcee
Confidence 44 456789999999999999999999998755443322 23445689999999999995 999999999998765 48
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+|+|++..|+|..++.+.++++...++.|++||+.||.|||++. |+|||||.+||+|+ +..+.|||+|+|+|...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHh
Confidence 899999999999999999999999999999999999999999985 99999999999997 66788999999999987
Q ss_pred cCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
..... ...+|||.|||||+....|+..+||||||+.+.||+|+..||.. .+...++.++..|..+--... --.+++
T Consensus 197 r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPev 273 (632)
T KOG0584|consen 197 RKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEV 273 (632)
T ss_pred hcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHH
Confidence 65443 44799999999999999999999999999999999999999965 566788999988865433222 226899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++||.+||.. .+.|+|+.|+|+||||...
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999999 9999999999999999975
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=325.50 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=203.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|++|.||+|.++.+++.||+|.+..... ......+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865331 222345678999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||+++|+|+||||+||++ +.++.+||+|||++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence 999975 898888654 468999999999999999999999999999999999999 556679999999987543221
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCC----------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGD---------------- 297 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~---------------- 297 (472)
......++..|+|||++.+ .++.++||||+|+++|+|++|..||.+.. ..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1223356889999998753 47899999999999999999999997654 222222221100
Q ss_pred ---ccCC-------CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 298 ---IDFE-------SAPWPTIS--SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 298 ---~~~~-------~~~~~~~s--~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..+. ...++.++ .++.++|.+||+.+|++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00112344 888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.49 Aligned_cols=236 Identities=26% Similarity=0.466 Sum_probs=207.6
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
++-||.|+.|.||+|+.. ++.||||.++. .-..+|.-|++|+ ||||+.|.++|...-.+|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence 456899999999999966 78999997742 1234788899995 9999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeecc
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (472)
.|.|...|+..+.++......|..+|+.|++|||.+.|||||||.-||||.. +..|||+|||-++...+....-.++
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~---~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY---DDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec---cceEEeccccchHhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999954 4469999999999887766666789
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||..|||||++++ +.+.|+|||||||||||||||..||..-+...++--+-...+..+.+ ..+++.++=||+.||+-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhc
Confidence 9999999999985 58999999999999999999999998776665555555555554443 57899999999999999
Q ss_pred CCCCCCCHHHHhcCC
Q 012039 323 DPKKRITSAQVLEHP 337 (472)
Q Consensus 323 dp~~Rps~~~~l~h~ 337 (472)
.|..||++.++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 999999999999983
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.32 Aligned_cols=252 Identities=32% Similarity=0.551 Sum_probs=215.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~l 157 (472)
+|++.+.||.|+||.||++.+..++..||+|++..... .....+.+.+|+.+++.+. ||||+++++.+.. ...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence 48899999999999999999999999999999865433 2334567889999999995 9999999997753 467899
Q ss_pred EEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICH-----FMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-----~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
+|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence 9999999999998865 357899999999999999999999 8899999999999999 456779999999
Q ss_pred CceeccCCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 229 LSVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 229 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
++........ .....|++.|+|||++.. .++.++|+||||+++|+|++|..||...........+..+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI---PY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC---cc
Confidence 9987765443 344578999999998864 578899999999999999999999988877777777766543221 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.++..+.+++.+||..+|++||++.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.12 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=211.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+++++++. |+||+++++++..++.+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence 79999999999999999999999999999998865432 2334577899999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
||++++.+..+......+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999887776666666679999999999999999999999999999999999999 457779999999988765543
Q ss_pred ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----------------c-
Q 012039 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------------I- 298 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------------~- 298 (472)
......++..|+|||++.. .++.++||||||+++|+|++|.+||.+....+.+..+.... .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 3344678899999998753 57899999999999999999999998765544333322100 0
Q ss_pred --cCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 --DFESA---------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 --~~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.+... ....++.++.+||++||..+|++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 011348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=327.60 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=207.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||.|++|.||+|++..+++.||+|.+..... .......+.+|++++++++ ||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999998864432 2233467889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+. ++|.+++.. ...+++..++.++.|++.||.|||+++++|+||+|+||++ +.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence 9995 588888765 3568999999999999999999999999999999999999 556679999999987654322
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc----------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------------- 298 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 298 (472)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+.......+....-
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999998754 368899999999999999999999987765444333322100
Q ss_pred --cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 --DFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 --~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.+.. ...+.++++++++|.+||+.||++|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=324.62 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=214.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||+||++.+..+++.||+|++.... .......+.+|+++++.+. ||||+++++.+.....+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999886432 2334567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||++ +.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence 9999999999998887889999999999999999999997 589999999999999 456679999999987543222
Q ss_pred ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChH-----------HHHHHHHcCCccCCCCCC
Q 012039 238 VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK-----------GIFDAILQGDIDFESAPW 305 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~ 305 (472)
.....|+..|+|||++. ..++.++|||||||++|+|++|..||...... +....+..... .....
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPS 235 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCc
Confidence 22457899999999875 46889999999999999999999999765432 22233332211 11111
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
..++.++.+||.+||..||++|||+.++++|+||.+....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 2378899999999999999999999999999999775443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.51 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=208.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++++. ||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence 356789999999999999999999999999999999864322 2233456778999999995 99999999988643
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
...|+||||+. ++|.+.+... +++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence 35799999995 5888877543 8999999999999999999999999999999999999 5566799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------- 297 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 297 (472)
+.............+++.|+|||++.+ .++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 987655443344568899999998764 58999999999999999999999998766544443332100
Q ss_pred -----------ccC---------CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 298 -----------IDF---------ESAP--------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 298 -----------~~~---------~~~~--------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
... +... ....++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 0000 1134667899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.26 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=207.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|...+.||+|+||.||++.+..+++.||+|.+.+... ......+.+|+.++.++.+||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 356778899999999999999999999999999875432 234567889999999996699999999999999999999
Q ss_pred EeccCCcchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 159 MELCAGGELFDRI---I--AKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 159 ~e~~~g~sL~~~l---~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
|||+. ++|.++. . ....+++..+..++.|++.||+|||+. +++||||||+||++ +.++.+||+|||++..
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQ 157 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHH
Confidence 99985 4554432 2 235799999999999999999999975 99999999999999 4566799999999976
Q ss_pred ccCCcceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCc-cCCCCCCC
Q 012039 233 IEEGKVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDI-DFESAPWP 306 (472)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~-~~~~~~~~ 306 (472)
...........|++.|+|||++.. .++.++|||||||++|+|++|+.||..... .+.+..+..+.. ......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 654433344578899999998864 488999999999999999999999975442 122222222221 22222234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.++.++.+||.+||+.+|++|||++++++||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 589999999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.55 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=202.0
Q ss_pred ccceEEcceeeecCCeEEEEEEECC----------------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS----------------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 141 (472)
..+|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 4689999999999999999998542 34479999886532 2334567889999999995 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-------------------HYSERAAASICRSIVNVVHICHFMGVM 202 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~ 202 (472)
|+++++++.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886432 367788999999999999999999999
Q ss_pred eecCCCCceeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh--
Q 012039 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-- 276 (472)
Q Consensus 203 H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-- 276 (472)
||||||+|||+ +.++.+||+|||++......... ....++..|+|||++. +.++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 45677999999999876443321 1234577899999875 468999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHcC----CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 277 GVPPFWAETEKGIFDAILQG----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 277 g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..||...+..+.+..+... .........+.++..+.+|+.+||..||++|||+.++.+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 66788776666555444321 111111122467899999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=329.13 Aligned_cols=262 Identities=30% Similarity=0.553 Sum_probs=217.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
...+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++ ||||+++++.+...+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL 94 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence 34556777788999999999999999999999999885432 234567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||+++++|.+++.. +.+++..+..++.||+.||.|||+++|+||||||+||++ +.++.++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhccc
Confidence 999999999999887754 568999999999999999999999999999999999999 4556799999999875432
Q ss_pred Cc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||........+..+.... .........++..+.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHH
Confidence 22 2234568999999998864 58899999999999999999999998877666555554322 111112235788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
++|.+||..||.+|||++++++||||.....+.
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 999999999999999999999999999654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.93 Aligned_cols=257 Identities=28% Similarity=0.490 Sum_probs=214.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+...+|.+.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeE
Confidence 34567999999999999999999999999999999986544333344567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+.+|+|+||+|+||++ +.++.++|+|||++....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVS 166 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecC
Confidence 99999996 577676653 4569999999999999999999999999999999999999 456679999999987654
Q ss_pred CCcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.. ....+++.|+|||++. +.++.++||||||+++|+|++|..||...........+...... ......++.
T Consensus 167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (307)
T cd06607 167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWSD 241 (307)
T ss_pred CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhCH
Confidence 33 2346888999999863 35889999999999999999999999887765555444433221 111134678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+.++|.+||..+|++||++.+++.||||...
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.35 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=201.7
Q ss_pred eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHH---HHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 012039 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI---MQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~---l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 162 (472)
.||+|+||.||+|.+..+++.||+|.+.+..............|..+ ++.. +||+|+++++.+.+.+.+++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999999999999999999876543322222233444443 3344 5999999999999999999999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeec
Q 012039 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242 (472)
Q Consensus 163 ~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 242 (472)
.|++|.+++...+.+++..++.++.|++.||.|||+++|+||||||+||++ +.++.+||+|||++....... ....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCc
Confidence 999999999888889999999999999999999999999999999999999 456679999999987654322 2345
Q ss_pred cCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 243 VGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 243 ~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.|+..|+|||++.+ .++.++||||+|+++|+|++|..||.... .......+...... ....+|.++.++|.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~ 231 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLE 231 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHH
Confidence 78999999999863 47899999999999999999999997663 22222222222221 22357899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 318 RMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 318 ~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+||..+|.+|| ++.++++||||+..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=317.04 Aligned_cols=248 Identities=29% Similarity=0.519 Sum_probs=213.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+.+|+.+++.+. ||||+++++.+.+.+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence 5889999999999999999999999999999986433 2234567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence 999999999988643 358999999999999999999999999999999999999 456679999999998765432
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+..+...... ..++..+.+|
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence 2 234578999999999864 5889999999999999999999999988877777777666543222 3578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 012039 316 VRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h 336 (472)
|.+||+.||++|||+.++++-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.99 Aligned_cols=249 Identities=16% Similarity=0.290 Sum_probs=207.9
Q ss_pred ccceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+++++. ||||+++++++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence 347999999999999999999865 345689999886532 2233457889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||++ +.+..++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 99999999999999988764 578999999999999999999999999999999999999 45677999999987654
Q ss_pred cCCccee--eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 234 EEGKVYR--DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 234 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
....... ...++..|+|||.+. ..++.++|||||||++|++++ |..||...+..+....+..+... +....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCC
Confidence 3222211 223467899999875 468999999999999999775 99999988888877777665322 2235688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.49 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=204.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATP 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence 345689999999999999999999999999999998864332 2222345678999999995 999999999886543
Q ss_pred ------eEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 154 ------SVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 154 ------~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
..++||||+. ++|.+.+.... .+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECc
Confidence 4699999995 58877776543 68999999999999999999999999999999999999 5567799999
Q ss_pred cCCceeccCCc-----ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc
Q 012039 227 FGLSVFIEEGK-----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299 (472)
Q Consensus 227 fg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 299 (472)
||++....... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+..-.-.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99997654322 1123457889999998754 3688999999999999999999999877655444333321100
Q ss_pred C-------------------CCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 F-------------------ESAP---------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 ~-------------------~~~~---------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+ +... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 0000 01235778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.79 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=208.5
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||.|++|.||+|++..+|..||+|.+..... ......+.+|+.+++++. ||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence 48899999999999999999999999999999875432 233466778999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 160 ELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 160 e~~~g~sL~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||+++ +|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence 99975 888887654 358999999999999999999999999999999999999 45667999999998765432
Q ss_pred -cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-------------
Q 012039 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF------------- 300 (472)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------- 300 (472)
.......+++.|++||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.......
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12233467889999998754 36889999999999999999999998877665555443211000
Q ss_pred -----CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 301 -----ES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 301 -----~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+. ...+.++..+.++|.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=324.30 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=210.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCC-----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTG-----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++++. ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 47899999999999999999976554 679999886432 2234567889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 154 SVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
..+++|||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 999999999999999998754 457889999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.+..++|+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 566799999999986543322 12345678899999875 568999999999999999998 9999999888888887
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+..+..... ...++.++.+|+.+||+.||.+||++.+++++
T Consensus 239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776544322 24689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.86 Aligned_cols=261 Identities=31% Similarity=0.477 Sum_probs=207.9
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
+.++|++.+.||+|+||.||+|++..+|+.||+|.+.... .......+.+|+.++++++ ||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence 4568999999999999999999999999999999985322 2233456788999999996 99999999886543
Q ss_pred -CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 -~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
...|+|+||+. ++|.+.+. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence 45899999995 58877664 4579999999999999999999999999999999999999 566779999999987
Q ss_pred eccCCcc----eeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc----------
Q 012039 232 FIEEGKV----YRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ---------- 295 (472)
Q Consensus 232 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---------- 295 (472)
....... .....|++.|+|||.+. ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6543221 12356899999999864 3588999999999999999999999977654332222211
Q ss_pred -----CC-------ccC-CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 296 -----GD-------IDF-ES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 296 -----~~-------~~~-~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
.. ... .. ...+.+++++.+||.+||+.+|++|||+.++++||||+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00 000 00 0124568899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=333.44 Aligned_cols=260 Identities=30% Similarity=0.445 Sum_probs=211.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
+..+|.+.+.||+|+||+||+|++..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence 34589999999999999999999999999999999865422 2333556778999999995 99999999987644
Q ss_pred -CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 -~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
..+|+|+||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence 35899999995 6899998888889999999999999999999999999999999999999 456679999999998
Q ss_pred eccCC-cceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------
Q 012039 232 FIEEG-KVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------- 297 (472)
Q Consensus 232 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 297 (472)
..... .......++..|+|||.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76443 2223456889999999875 358899999999999999999999997765433222221100
Q ss_pred -----------cc-----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 298 -----------ID-----FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 298 -----------~~-----~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.. .....++.+++++.+||++||+.+|++|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0011234688999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.99 Aligned_cols=254 Identities=30% Similarity=0.487 Sum_probs=217.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.++.+++ ||||+++++++...+.+++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence 68899999999999999999999999999999865432 134677899999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||+++++|.+++.....+++..+..++.|++.+|.|||+ ++++|+||+|+||++ +.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 999999999999888889999999999999999999999 999999999999999 5567799999999987654333
Q ss_pred e-eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCccCCCCCCCC-CCHHH
Q 012039 239 Y-RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---TEKGIFDAILQGDIDFESAPWPT-ISSSA 312 (472)
Q Consensus 239 ~-~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~s~~~ 312 (472)
. ....++..|+|||.+.. .++.++|+||||+++|+|++|..||... ...+....+........ ... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---PAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---CcccCCHHH
Confidence 2 24568899999998764 5788999999999999999999999776 33444555543322111 123 78999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.++|.+||..+|++||++.++++||||+..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.96 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=204.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCE--EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
.+|.+.+.||+|+||.||+|.++.++.. +++|.+... ........+.+|+.++.++.+||||+++++++..++.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4789999999999999999999887765 466655421 123345678899999999966999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 157 VVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence 9999999999999986542 47899999999999999999999999999999999999 4566
Q ss_pred cEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCc
Q 012039 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 298 (472)
.+||+|||++.............++..|+|||.+.. .++.++|||||||++|+|++ |..||...+..+....+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence 799999999864322111111234567999998764 47899999999999999998 999998877777666664432
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.......+++++.+||.+||+.+|++||+++++|.+
T Consensus 241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=325.05 Aligned_cols=253 Identities=33% Similarity=0.654 Sum_probs=220.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|.+.+.||+|++|.||+|.+..++..||+|++.+...........+.+|+.+++++.+||||+++++++.+.+.+++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 69999999999999999999999999999999876544344445678899999999955999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
||+.+++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcccc
Confidence 999999999999888889999999999999999999999999999999999999 4566799999999886543221
Q ss_pred --------------------eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 012039 239 --------------------YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297 (472)
Q Consensus 239 --------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 297 (472)
.....++..|+|||++. ..++.++||||||+++|++++|..||........+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 12245788999999875 457889999999999999999999998887766666666554
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCcc
Q 012039 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLEHPWI 339 (472)
Q Consensus 298 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~----~~~l~h~~~ 339 (472)
..++ ..+++.+.+||.+||+.+|++||++ .++++||||
T Consensus 239 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4433 3568999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=320.01 Aligned_cols=254 Identities=26% Similarity=0.470 Sum_probs=214.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
+-|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++++. ||||+++++++..++.+++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence 458889999999999999999998999999998764332 234567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
|||+++++|.+++.. ..+++..+..++.|++.++.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence 999999999988754 578999999999999999999999999999999999999 4556799999999876644321
Q ss_pred -eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 239 -YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 239 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
.....++..|+|||.+.. .++.++|+|||||++|+|++|..||...........+...... .....++.++.++|
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHHH
Confidence 223468889999998764 5788999999999999999999999877666555555443221 11235789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+||..+|.+||++.++++||||.+.
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.63 Aligned_cols=253 Identities=28% Similarity=0.530 Sum_probs=215.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|.+.+.||+|+||.||++.+..+|..+|+|.+..... .......+.+|+.+++.++ |+||+++++.+.+...+++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence 58899999999999999999999999999999866432 2234567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 160 ELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++. ....+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence 9999999999887643 4789999999999999999999999999999999999953 22457999999987665432
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....|++.|+|||++.. .++.++|+||||+++|+|++|..||...+..+....+........ .+.++.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI---SPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC---CCCCCHHHHHH
Confidence 2 223468899999998764 588999999999999999999999988777666666665543322 24678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
|.+||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=319.82 Aligned_cols=256 Identities=31% Similarity=0.582 Sum_probs=215.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|...+.||+|++|.||++.+..+++.+++|.+... .......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEE
Confidence 3566667999999999999999999999999987532 2233556889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
+||+.|++|.+++.. +++++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence 999999999998876 679999999999999999999999999999999999999 556779999999877554322
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+....+..+........ .....++..+.+||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHH
Confidence 2233568999999998864 588999999999999999999999988777666666665532221 11234789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+||..+|++||++.++++||||++..
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=284.67 Aligned_cols=256 Identities=27% Similarity=0.492 Sum_probs=216.6
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|.-.++||+|.||+||+|+++.+++.||+|.+..... ++.......+|+-+++.|. |.|||++++....++.+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence 56677899999999999999999999999999875443 2334567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 160 e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
||| ..+|..+..+ ++.+..+.++.++.|++.+|.+||++++.||||||.|.|| +.++.+||.|||+++.+.-+-
T Consensus 81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE
Confidence 999 4578777754 5779999999999999999999999999999999999999 678889999999999776543
Q ss_pred ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC---------
Q 012039 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW--------- 305 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 305 (472)
.++..+.|.+|++|.++-+ -|++..|+||.|||+.|+.. |.+.|.+.+..+.+..|..---......|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 4555678999999998864 38999999999999999987 77778888888888777642222222222
Q ss_pred ----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 306 ----------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 306 ----------------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+.++..-+++++++|.-+|.+|++++.+|+||||..
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 234556789999999999999999999999999975
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.55 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=209.4
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+.+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence 47999999999999999999999999999999886544333444567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 159 MELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||+++++|.+++.. ...+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 999999999887753 3458999999999999999999999999999999999999 456679999999988765
Q ss_pred CCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... ......+.... ++......++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 4322 223568899999998764 588899999999999999999999965532 34444444432 22222245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+.++|.+||..+|++||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=320.49 Aligned_cols=249 Identities=36% Similarity=0.629 Sum_probs=215.9
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||.|+||.||++++..+++.+++|++.............+.+|+++++++. ||||+++++.+..+..+|+||||+.|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999999999999987654433445678899999999996 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc---------
Q 012039 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--------- 237 (472)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~--------- 237 (472)
|.+++.+.+.+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence 99999887789999999999999999999999999999999999999 456679999999987643321
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
......++..|+|||.+.. .++.++||||||+++|+|++|..||......+....+..+...++.. ..++..+.+||
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 1223467889999998754 47889999999999999999999999888888887877755544332 23589999999
Q ss_pred HHhcccCCCCCCCH---HHHhcCCcccc
Q 012039 317 RRMLTQDPKKRITS---AQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps~---~~~l~h~~~~~ 341 (472)
.+||+.+|++|||+ .++|+||||+.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=319.73 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=209.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+|.+.+.||+|++|.||+|.+.. ++..|++|.+.... .......+.+|+.+++.+. |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 4579999999999999999999987 67889999875432 2223456889999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG-------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
+..++||||++|++|.+++...+ .+++..+..++.||+.||.|||+++++|+||||+||++..++....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999987653 48899999999999999999999999999999999999765555679999
Q ss_pred ecCCceeccCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccC
Q 012039 226 DFGLSVFIEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 226 Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
|||++.......... ....+..|+|||++. ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL- 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 999998764322211 122346799999886 458999999999999999997 99999888777766666543221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
. ....++..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 D--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 124678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=326.48 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=213.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|+..+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++++. ||||+++++.+..++.+|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence 346888899999999999999999999999999886433 1234567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+++++|.+++.. +.+++..+..++.||+.||.|||+++++|+||+|+||++. .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcc
Confidence 9999999999987754 5789999999999999999999999999999999999994 56679999999987665432
Q ss_pred c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+...... .....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHH
Confidence 2 223468889999998864 5788999999999999999999999766555544444333221 1113578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
|.+||..+|++||++.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=324.09 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=208.1
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|++.+.||.|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence 6778899999999999999999999999999875432 2233456788999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-c
Q 012039 161 LCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~ 237 (472)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++ .++.++|+|||++...... .
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc
Confidence 994 68999887665 689999999999999999999999999999999999994 4677999999998765322 1
Q ss_pred ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 012039 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------------- 298 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------------- 298 (472)
......+++.|+|||++.+ .++.++||||||+++|+|++|++||...+....+..+.+...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233456889999998753 468899999999999999999999987665444333322100
Q ss_pred --------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 --------DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.......+.++..+.++|.+||+.+|.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00011134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.10 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=204.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.++||+|+||.||+|++..+++.||+|++.............+.+|+.+++++. ||||+++++++.+++..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999987544333334567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 159 MELCAGGELFDRIIAK-----------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
|||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999999999988641 234566788999999999999999999999999999999 55667999999
Q ss_pred CCceeccCCc-------------------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH
Q 012039 228 GLSVFIEEGK-------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (472)
Q Consensus 228 g~~~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 287 (472)
|++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998652110 0112469999999998864 5899999999999999999999999875544
Q ss_pred HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
......... .......+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332221111 111112335788999999999999999999887766543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=319.55 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=207.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~ 79 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 456789999999999999999998653 35679999875432 1223456889999999995 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
.....++||||+++++|.+++.+.. .++...+..++.|++.||.|||+++++|+||||+||++ +.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCC
Confidence 9999999999999999999886532 25678889999999999999999999999999999999 4566
Q ss_pred cEEEeecCCceeccCCccee---eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 012039 221 LLKATDFGLSVFIEEGKVYR---DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQ 295 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 295 (472)
.++|+|||++.......... ...+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 79999999987654332211 1245678999998864 58999999999999999999 7899988887777777666
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...... ...++..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543222 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=332.10 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=212.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE----eCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE----DKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----~~~ 153 (472)
..+|.+.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++++. ||||+++++++. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence 4689999999999999999999999999999999875432 2234567788999999995 999999998875 345
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 7899999995 6899988877889999999999999999999999999999999999999 56677999999998765
Q ss_pred cCCcc-----eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC----------
Q 012039 234 EEGKV-----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG---------- 296 (472)
Q Consensus 234 ~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---------- 296 (472)
..... .....|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.+.+....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 43221 123478899999998753 4889999999999999999999999776544333222210
Q ss_pred -------------CccCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 297 -------------DIDFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 297 -------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
....... .++..+.++.++|++||+.+|++|||+.+++.||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000011 12457899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.99 Aligned_cols=256 Identities=30% Similarity=0.583 Sum_probs=212.7
Q ss_pred ceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++++.+|+||++++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 47899999998654321 1223466788999999997799999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||+|+||++ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4567799999999987544
Q ss_pred Cc--ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCC
Q 012039 236 GK--VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 236 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 306 (472)
.. ......|+..|+|||.+.. .++.++||||||+++|+|++|..||..... ..+...+......+ ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence 32 2224568999999998753 467899999999999999999999964332 33333333332222 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
.+++.+.+++.+||..||++|| +++++++||||+..
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 5789999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=324.35 Aligned_cols=258 Identities=29% Similarity=0.571 Sum_probs=216.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|.....||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.+. ||||+++++.+..++.+++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence 344566678999999999999999999999999986432 233567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccc
Confidence 9999999999886644 578999999999999999999999999999999999999 566779999999987554322
Q ss_pred -ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......|+..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+...... ....+..++..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHH
Confidence 2234578999999998864 5889999999999999999999999877766666555443222 222345678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
|.+||+.+|++||++.++++||||.+...
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 99999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=320.88 Aligned_cols=249 Identities=23% Similarity=0.407 Sum_probs=210.6
Q ss_pred ccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... .......+.+|+++++.+. ||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 3478999999999999999998753 35789999986432 2224578899999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG--------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 218 (472)
...++||||++|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||++ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 99999999999999999987542 37888999999999999999999999999999999999 55
Q ss_pred CCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 012039 219 NALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293 (472)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 293 (472)
++.+||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 67899999999976533221 12234567899999886 458999999999999999998 99999888888888888
Q ss_pred HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+...... ..++..+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 766554332 468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.04 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=204.0
Q ss_pred ceEEcceeeecCCeEEEEEEECC--CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 155 (472)
+|++.+.||+|++|.||+|.+.. +++.||+|.+.............+.+|+.+++.+. ||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 89999999987643222334567788999999995 99999999999988 889
Q ss_pred EEEEeccCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeecc-CCCCCcEEEeecCC
Q 012039 156 HVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS-KDENALLKATDFGL 229 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~~~kl~Dfg~ 229 (472)
++||||+++ +|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+||+++. .+.++.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999964 676666432 26899999999999999999999999999999999999954 22278899999999
Q ss_pred ceeccCCcc----eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHH---------HHHHHH
Q 012039 230 SVFIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKG---------IFDAIL 294 (472)
Q Consensus 230 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~ 294 (472)
+........ .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+..... .+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886543221 223467889999998754 47899999999999999999999997654321 111110
Q ss_pred c------------------------C--CccCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 295 Q------------------------G--DIDFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 295 ~------------------------~--~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
. . ...+.. ..+...+.++.++|.+||+.||++|||+.++++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0 000000 0011567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.55 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=213.5
Q ss_pred cccceEE-cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc-----------cHHHHHHHHHHHHhccCCCCeeE
Q 012039 77 VKLHYSF-GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----------DKDDIKREIQIMQHLSGQPNIVE 144 (472)
Q Consensus 77 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~hp~iv~ 144 (472)
+..+|.. .+.||+|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++++. ||||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence 4567865 56799999999999999999999999998654321100 1124678999999995 999999
Q ss_pred EEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
+++++..++..++||||+. ++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||++ +.++.++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI 160 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence 9999999999999999996 6999999888889999999999999999999999999999999999999 45667999
Q ss_pred eecCCceeccCC---------------cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChH
Q 012039 225 TDFGLSVFIEEG---------------KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (472)
Q Consensus 225 ~Dfg~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 287 (472)
+|||++...... .......+++.|+|||.+.+ .++.++||||||+++|+|++|.+||.+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998765411 11122356889999998864 3689999999999999999999999888776
Q ss_pred HHHHHHHcCCccCCCC------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 288 GIFDAILQGDIDFESA------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 288 ~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+.+..+.......... .....+.++.++|.+||..+|++|||++++|.||||+...
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 6655544311100000 1134578899999999999999999999999999999764
Q ss_pred C
Q 012039 344 E 344 (472)
Q Consensus 344 ~ 344 (472)
.
T Consensus 321 ~ 321 (335)
T PTZ00024 321 L 321 (335)
T ss_pred C
Confidence 4
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=320.83 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=202.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. |+||+++++++.+++..|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865432 223346678999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence 99995 677766654 3568889999999999999999999999999999999999 456679999999987543221
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCC--------------cc
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGD--------------ID 299 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~--------------~~ 299 (472)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.... +.+..+.... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 2233467899999998754 4788999999999999999999999765432 2222211100 00
Q ss_pred CCC------------CCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 FES------------APWP--TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 ~~~------------~~~~--~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+.. ..|. ..+.++.+++.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0011 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=318.27 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=207.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~l 157 (472)
+|...+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++++. ||||+++++++.+ .+.+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence 68899999999999999999999999999999865422 234567889999999995 9999999998865 347899
Q ss_pred EEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++. .+..++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeeccccccc
Confidence 9999999999887643 34589999999999999999999999999999999999994 5567999999998765
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC-----ChHHHHHHHHcCCcc-CCCCCC-
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-----TEKGIFDAILQGDID-FESAPW- 305 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~-~~~~~~- 305 (472)
..... ....++..|+|||.+.+ .++.++||||||+++|+|++|..||... ...+....+...... ......
T Consensus 156 ~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 156 VNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 43221 23467889999998764 5899999999999999999999999765 223344444332211 111110
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 306 -PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 306 -~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...++.+.+||.+||..+|.+|||+.|+++||||+..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1346789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=334.82 Aligned_cols=257 Identities=30% Similarity=0.539 Sum_probs=237.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+.+++..||-|+||.|=++........+|+|++++..+......+.+..|-+||...+ .|.||++|-.|.++..+|+.|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhH
Confidence 4567788999999999999877666669999999988887777888999999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
|-|-||.|...+...+.|.+..++.++.-++.|++|||++|||+|||||+|.++ +.++.+||.|||+|+.+..+...
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCce
Confidence 999999999999999999999999999999999999999999999999999999 78889999999999999999988
Q ss_pred eeccCCCCCCchhhh-hcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
.+.+|||.|+|||++ +..++.++|.||||+++||||+|.+||.+.++..+++.|+.+.-.+..+ ..++..+.+||++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKK 654 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHH
Confidence 999999999999975 5679999999999999999999999999999999999999986555444 4689999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCccccC
Q 012039 319 MLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 319 ~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
+...+|.+|.. +.+|-+|.||..-
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999986 7899999999753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=329.47 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=209.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
+..+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence 3568999999999999999999999999999999986543 234567889999999995 99999999876543
Q ss_pred ----------CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcE
Q 012039 153 ----------QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 153 ----------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
...|+||||+. ++|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+||+++. .+..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCceE
Confidence 35899999996 58887775 357999999999999999999999999999999999999953 34568
Q ss_pred EEeecCCceeccCCcc----eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 012039 223 KATDFGLSVFIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (472)
Q Consensus 223 kl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 296 (472)
||+|||++........ .....++..|+|||.+.. .++.++|||||||++|+|++|..||.+....+....+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976543211 122357889999998643 4788999999999999999999999877655544443321
Q ss_pred Ccc----------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 297 DID----------------------FES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 297 ~~~----------------------~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
... ... ...+.++.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence 100 000 012357889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=329.84 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=203.1
Q ss_pred cccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++++.+|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 344568999999999999999999754 345789999886432 2233456788999999996699999999987
Q ss_pred Ee-CCeEEEEEeccCCcchHHHHHhc------------------------------------------------------
Q 012039 150 ED-KQSVHVVMELCAGGELFDRIIAK------------------------------------------------------ 174 (472)
Q Consensus 150 ~~-~~~~~lv~e~~~g~sL~~~l~~~------------------------------------------------------ 174 (472)
.. +..++++|||+++++|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 46789999999999999888542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc---eeeccC
Q 012039 175 -------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVG 244 (472)
Q Consensus 175 -------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g 244 (472)
..+++..+..++.||+.||.|||++||+||||||+||++. .++.++|+|||++..+..... .....+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCC
Confidence 2578899999999999999999999999999999999994 566799999999987643221 122345
Q ss_pred CCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 245 SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 245 t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
+..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+............. ...++++.+++.+||+.
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHN 315 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccC
Confidence 67899999875 468999999999999999998 999998755444333333322222211 35789999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 012039 323 DPKKRITSAQVLEH 336 (472)
Q Consensus 323 dp~~Rps~~~~l~h 336 (472)
+|++||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.25 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=204.6
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCC-----CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++...++|.+++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++++..||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 344567899999999999999999987533 3469999986432 233456789999999999559999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhc------------------------------------------------------
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAK------------------------------------------------------ 174 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~------------------------------------------------------ 174 (472)
+.+...+|||||||++|+|.+++...
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999999887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCcee
Q 012039 175 ------------------------------------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212 (472)
Q Consensus 175 ------------------------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 212 (472)
..+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 13677888999999999999999999999999999999
Q ss_pred eccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChH
Q 012039 213 LSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEK 287 (472)
Q Consensus 213 i~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 287 (472)
+ +.+..+||+|||++......... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 270 l---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 L---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred E---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9 45667999999999865433221 2234677899999875 458999999999999999997 99999775443
Q ss_pred H-HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 288 G-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 288 ~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
. ....+..+ .... ....++.++.+++.+||+.||++|||+.++.+
T Consensus 347 ~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3 33444433 2222 22467899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=315.56 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=202.0
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
...||+|+||.||+|++..++..|++|.+.... ....+.+.+|+.++++++ |+||+++++++..++.+++|+||++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCC
Confidence 357999999999999999999999999886432 234567889999999995 9999999999999999999999999
Q ss_pred CcchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-e
Q 012039 164 GGELFDRIIAK-GHY--SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-Y 239 (472)
Q Consensus 164 g~sL~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~-~ 239 (472)
+++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ....++|+|||++........ .
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCCcc
Confidence 99999988764 445 88889999999999999999999999999999999952 245799999999876543222 2
Q ss_pred eeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
....|++.|+|||.+.. .++.++||||||+++|+|++|..||....... ....+.. ..........+++++.+|
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHHH
Confidence 33468899999998753 37889999999999999999999997543221 1111111 111111224578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+++||..+|++|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.47 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=213.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.+.|...+.||+|+||+||+|++..++..|++|.+.............+.+|+.+++.++ |||++++++++.+....|
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 3445777889999999999999999999999999987554333344567889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||+. ++|.+.+.. ...+++..+..++.||+.+|.|||++|++|+||+|+||++ +.++.+||+|||++.....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence 9999995 577777654 4568999999999999999999999999999999999999 4556799999999865432
Q ss_pred CcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
. ....|+..|+|||++. +.++.++||||||+++|+|++|..||...........+...... ......++..
T Consensus 174 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 248 (313)
T cd06633 174 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDS 248 (313)
T ss_pred C---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHH
Confidence 2 2457889999999873 35788999999999999999999999887665555555443322 2222457788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+++|+.+||+.+|.+||++.++++||||...
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.32 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=210.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEeccccc--CCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--Ce
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL--VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 154 (472)
.+|++.+.||+|++|.||+|.+..++..||+|.+..... ........+.+|+.++++++ ||||+++++++.+. +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 479999999999999999999999999999998754221 12234567889999999995 99999999998764 56
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+++++||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 89999999999999999887789999999999999999999999999999999999999 456679999999997653
Q ss_pred CC----cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EG----KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.. .......|+..|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence 21 12234568899999998864 478999999999999999999999987665554444433221 122235688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+.+.++|.+||. +|..||++.+++.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=312.16 Aligned_cols=252 Identities=31% Similarity=0.593 Sum_probs=218.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||.|++|.||++.+..++..|++|++..... .......+.+|+++++.++ |||++++++.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999865432 2345667889999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 160 ELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 160 e~~~g~sL~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.+..++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence 999999999988764 679999999999999999999999999999999999999 4566799999999987655
Q ss_pred Cc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. ......|++.|+|||.+.. .++.++|+||+|+++|+|++|..||......+....+......... ..++.++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 43 2234578899999998754 5889999999999999999999999887777777776665433221 36789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+++.+||..+|++|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=320.31 Aligned_cols=253 Identities=32% Similarity=0.507 Sum_probs=210.2
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEEEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHVV 158 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv 158 (472)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+. |||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999999999999997654 22334566889999999995 99999999999988 899999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||++ ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence 99996 4888888665 579999999999999999999999999999999999999 556779999999998765443
Q ss_pred --ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC--------
Q 012039 238 --VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW-------- 305 (472)
Q Consensus 238 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 305 (472)
......++..|+|||.+.+ .++.++||||||+++|+|++|+.||...+....+..+...........|
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334467889999997653 4789999999999999999999999887766655555432111111111
Q ss_pred ------------------CC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 306 ------------------PT-ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 306 ------------------~~-~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.. ++..+.++|++||..+|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=318.28 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=208.8
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCe----
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQS---- 154 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~~~~---- 154 (472)
|++.+.||+|+||.||+|+++.+++.||+|.+..... .......+.+|+.++++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999998899999999865432 2222445667888887774 49999999999988776
Q ss_pred -EEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 155 -VHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 155 -~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
++++|||+. ++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||++ +.++.+||+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence 999999996 48888886643 58999999999999999999999999999999999999 455779999999998
Q ss_pred eccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc-----CC----
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-----FE---- 301 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~---- 301 (472)
............++..|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+.+..+...... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 7755444445568889999998864 5889999999999999999999999888777666665432110 00
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 302 --------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 302 --------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
....+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112456888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=300.75 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=206.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----C
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-----K 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 152 (472)
..||++.+.||+|||+-||++....+++.||+|.+.... ..+.+...+|++..+++. |||+++++++... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence 569999999999999999999999999999999987543 456788999999999995 9999999876543 3
Q ss_pred CeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEee
Q 012039 153 QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
...||++.|+..|||.+.+.. ...+++.++..|+.+|+.||++||+.. ++||||||.|||++ +.+.++|+|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEe
Confidence 459999999999999998864 236999999999999999999999998 99999999999995 467799999
Q ss_pred cCCceeccCCc----------ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCC--hHHHH
Q 012039 227 FGLSVFIEEGK----------VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIF 290 (472)
Q Consensus 227 fg~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~ 290 (472)
||.+....-.- .......|..|+|||.+.- ..+.++|||||||+||.|+.|..||...- ...+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 99987643211 1112457899999999863 37899999999999999999999994211 11122
Q ss_pred HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
-.+.++.+.++... .+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 23445566666653 489999999999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=313.79 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=209.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
....|.+.+.||+|++|.||+|.+..+++.||+|++... ......+.+|+.+++++. ||||+++++++..+..++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY 78 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcE
Confidence 345689999999999999999999999999999988643 223567889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||||+++++|.+++... ..+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccc
Confidence 999999999999988653 358899999999999999999999999999999999999 456779999999998765
Q ss_pred CCccee--eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVYR--DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
...... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+..... ......++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPP 232 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCH
Confidence 432211 123456799999876 458899999999999999998 9999988877777777665421 122246889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.++|.+||..||++|||+.++++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=326.88 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=212.5
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
...+.++|++.+.||+|+||.||++.+..++..||+|++.+... .......+.+|+.+++++. ||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL 87 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence 34567789999999999999999999999999999999864321 2223456889999999995 999999999987653
Q ss_pred ------eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 154 ------SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 154 ------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
.+++||||+ |++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++ .++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~df 162 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDF 162 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeec
Confidence 468999999 778887765 45799999999999999999999999999999999999994 5667999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-----
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----- 300 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----- 300 (472)
|++...... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.+....+..+.......
T Consensus 163 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 163 GLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999865432 233467899999998864 47889999999999999999999998776544444433211100
Q ss_pred ------------------C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 301 ------------------E----SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 301 ------------------~----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
. ...++.+++++.++|.+||..||++|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 011346788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.99 Aligned_cols=262 Identities=27% Similarity=0.466 Sum_probs=214.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe-
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS- 154 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~- 154 (472)
.+.++|.+.+.||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++++. ||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccccc
Confidence 456789999999999999999999999999999998865322 2233456778999999995 9999999988766554
Q ss_pred -----EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 155 -----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 155 -----~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.++|+||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||+|+||++ +.++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccc
Confidence 89999999 6799888765 579999999999999999999999999999999999999 4566799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------ 301 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 301 (472)
+...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+......+..+.+......
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 9876433 334578899999998754 478899999999999999999999987776655555443211000
Q ss_pred -----------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 302 -----------------S----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 302 -----------------~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
. ..+..++.++.+||.+||..||++|||+.++++||||.......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 0 01134689999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=321.14 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=214.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|.+.+.||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.+. ||||+++++.+...+..|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELW 92 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEE
Confidence 3468999999999999999999998899999999885432 223567889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccc
Confidence 99999999999998865 358899999999999999999999999999999999999 45667999999988765433
Q ss_pred cc-eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KV-YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.. .....|++.|+|||.+. ..++.++||||||+++|++++|..||...+....+..+..... .....+..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 247 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHH
Confidence 22 23346888999999875 4588999999999999999999999987655443333322211 111223457889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+|.+||..+|++||++.+++.|+||+...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.60 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=210.0
Q ss_pred cccccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
+...++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.+. ||||+++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 78 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVV 78 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Confidence 3456789999999999999999997652 34579999876432 2223456788999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKG----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 219 (472)
.+.+..++||||+++|+|.+++.... .++...+..++.||+.||.|||+++|+||||||+||++ +.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCC
Confidence 99999999999999999999996532 24567888999999999999999999999999999999 456
Q ss_pred CcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 012039 220 ALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 294 (472)
+.++|+|||+++........ ....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 67999999998765432211 1224567899999876 458999999999999999998 789998887777777766
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCcccc
Q 012039 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE------HPWIKE 341 (472)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~------h~~~~~ 341 (472)
.+..... ...+++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 236 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 DGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred cCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 5533221 1356899999999999999999999999986 888874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.74 Aligned_cols=261 Identities=32% Similarity=0.475 Sum_probs=218.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----e
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----S 154 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----~ 154 (472)
+|++.+.||.|++|.||+|++..+++.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 58999999999999999999999999999999865321 2344567889999999995 999999999988765 7
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence 899999996 5899988887789999999999999999999999999999999999999 455789999999998765
Q ss_pred CCc----ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-----
Q 012039 235 EGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA----- 303 (472)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 303 (472)
... ......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+.+..+....-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 543 2344568899999998753 57899999999999999999999998887766665554421111100
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 304 ----------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 304 ----------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
..+.++.++.+||.+||+++|.+|||++++++||||+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 1134688999999999999999999999999999998654443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=317.24 Aligned_cols=251 Identities=27% Similarity=0.499 Sum_probs=208.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|++|.||+|.+..+++.+|||.+.............+.+|+.+++.+. ||||+++++++..++.++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence 36889999999999999999999999999999886544333344567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 159 MELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 999999999988763 3458999999999999999999999999999999999999 456679999999987664
Q ss_pred CCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.... .....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.+... ......+.... ++...+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence 4322 234568899999998864 588899999999999999999999976543 23333333322 22223346889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+.++|.+||..||++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.85 Aligned_cols=248 Identities=24% Similarity=0.433 Sum_probs=208.2
Q ss_pred ccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
+.+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++++. ||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 357999999999999999999853 34567899987543 2234567889999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG-------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 219 (472)
+.+++||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||++ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999987543 38999999999999999999999999999999999999 556
Q ss_pred CcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 012039 220 ALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 294 (472)
+.+||+|||++......... ....++..|+|||++.. .++.++||||||+++|+|++ |..||......+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 77999999999865433221 12335678999998864 58999999999999999998 999998888888888887
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+...... ..++.++.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 76543221 357899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.97 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=215.7
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+...|...+.||+|+||.||++++..++..||+|.+.............+.+|+.+++++. |||++++++++.+++..
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeE
Confidence 44556889999999999999999999999999999987554333344567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+.| +|.+.+.. ..++++..+..++.|++.||.|||+++|+||||+|+||++ +.++.++|+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccC
Confidence 999999965 77776654 5568999999999999999999999999999999999999 456679999999987554
Q ss_pred CCcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+........ ....+++
T Consensus 177 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 251 (317)
T cd06635 177 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSD 251 (317)
T ss_pred Cc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccH
Confidence 32 2346889999999863 3588999999999999999999999988776666666655433222 1235788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+++||.+||+.+|.+||++.++++|+|+...
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 99999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=309.65 Aligned_cols=252 Identities=32% Similarity=0.555 Sum_probs=216.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||++++..+++.|++|.+...... ......+.+|+++++++. |||++++++++.+.+.+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence 588999999999999999999999999999998765432 234678899999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
||+++++|.+++.....+++..+..++.|++.+|.|||++||+||||+|+||+++ .++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 9999999999998888899999999999999999999999999999999999994 466799999999987765433
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....++..|+|||.+.. .++.++||||||+++|+|++|..||...........+...... .....++..+.++|.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence 233568899999998754 4788999999999999999999999876655544444433221 222467899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCcc
Q 012039 318 RMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 318 ~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+||..+|++|||+.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.05 Aligned_cols=258 Identities=30% Similarity=0.500 Sum_probs=226.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
-|..++.||-|+||.|.+++...|...||+|.+.+..+...+....+..|-.||..- +.+-||++|..|++.+.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEE
Confidence 367788999999999999999999999999999888777777778888999999998 5899999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-----
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----- 234 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~----- 234 (472)
+|++||++..+|.+.+-|.|..++.++..+..|+++.|..|+|||||||+|||| |.++.|||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecccc
Confidence 999999999999999999999999999999999999999999999999999999 788889999999986321
Q ss_pred ----CCcc----------------------------------eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHh
Q 012039 235 ----EGKV----------------------------------YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILL 275 (472)
Q Consensus 235 ----~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 275 (472)
+++. ....+||+.|+|||++. ..|+.-||+||.|||||+|+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 1100 01367999999999885 57999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccccC
Q 012039 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKEG 342 (472)
Q Consensus 276 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~~~l~h~~~~~~ 342 (472)
.|.+||...+..+...++++..-.+......++|+++.++|.++.. +++.|. .++++..||||+..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 9999999998887777777766555566667899999999999875 688887 45779999999863
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.84 Aligned_cols=253 Identities=31% Similarity=0.560 Sum_probs=214.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~l 157 (472)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.+++++. ||||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence 478889999999999999999999999999998654321 234678899999999995 99999999999988 89999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|+||+++++|.+++.+...+++..++.++.|++.+|.|||+.+++|+||+|+||++. .++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 999999999999998877899999999999999999999999999999999999994 46679999999998876554
Q ss_pred c---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 238 V---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 238 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
. .....++..|+|||.+.. .++.++||||||+++|+|++|..||.... .......+...... ......++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--PEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC--cCCCcccCHHH
Confidence 3 344578899999998865 48899999999999999999999997765 22222233221111 11223568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.+||.+||..||++||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.97 Aligned_cols=245 Identities=24% Similarity=0.445 Sum_probs=206.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||.||++..+. +..+|+|.+.... .....+.+|+.+++++. ||||+++++++.....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence 468899999999999999998764 5689999875432 23467889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+|+||+|+||++ +.+..+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence 999999999998865 3468999999999999999999999999999999999999 456679999999988654332
Q ss_pred cee--eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 VYR--DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
... ...++..|+|||++. ..++.++||||||+++|+|++ |+.||...+..+.+..+.++...... ...+.++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence 221 223456799999886 458899999999999999999 99999988888888888776433222 24678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+++.+||..+|++||+++++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=324.89 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=208.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCC--CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CC
Q 012039 80 HYSFGKELGRGQFGVTYLCTENST--GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQ 153 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~ 153 (472)
+|++.+.||+|+||.||++++..+ +..||+|.+..... .......+.+|+.+++++.+||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999988 89999999864321 222356678899999999779999999986432 35
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+|+++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence 6889999984 6899999888889999999999999999999999999999999999999 45667999999999865
Q ss_pred cCCcc-----eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC---------
Q 012039 234 EEGKV-----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--------- 297 (472)
Q Consensus 234 ~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 297 (472)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|.+||...+....+..+....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43221 223478999999998753 57899999999999999999999998765444333322210
Q ss_pred ------------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 298 ------------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 298 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.......++.++..+.+|+.+||+.||++|||+.+++.||||.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0000112345688999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=306.54 Aligned_cols=265 Identities=30% Similarity=0.459 Sum_probs=208.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCC----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-C
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-K 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~ 152 (472)
...|+++..||+|.||.||+|..+.++. .+|+|.++.....+ .-.....+|+.+++.|+ ||||+.+..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3479999999999999999997665543 68999887554322 22355679999999996 9999999998876 8
Q ss_pred CeEEEEEeccCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC-CCCCcEEEee
Q 012039 153 QSVHVVMELCAGGELFDRIIA-----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATD 226 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~~~kl~D 226 (472)
..+++++||.+ -+|.+.|.- .+.++...++.|++||+.|++|||++-|+||||||.|||+..+ .+.+.|||+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 89999999995 488887753 2358999999999999999999999999999999999999754 3458899999
Q ss_pred cCCceeccCCc----ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCCh---------HHHHH
Q 012039 227 FGLSVFIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE---------KGIFD 291 (472)
Q Consensus 227 fg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~ 291 (472)
||+++.+...- .....+.|.+|+|||.+-+ .|+++.||||+|||+.||++-.+.|.+... .+.++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999875432 2234577999999998864 599999999999999999999988865421 23344
Q ss_pred HHHcCCccCCCCCC---------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 012039 292 AILQGDIDFESAPW---------------------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (472)
Q Consensus 292 ~i~~~~~~~~~~~~---------------------------------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~ 338 (472)
.|..---......| ..-++...+|+.+||+.||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 44321111111111 123556889999999999999999999999999
Q ss_pred cccCCCC
Q 012039 339 IKEGGEA 345 (472)
Q Consensus 339 ~~~~~~~ 345 (472)
|.+...+
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9987544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.95 Aligned_cols=251 Identities=32% Similarity=0.567 Sum_probs=212.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|.+.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.+. ||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence 47888999999999999999998999999999865432 34678899999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||++|++|.+++... ..+++..+..++.|++.+|.+||++|++||||+|+||+++ .++.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc
Confidence 999999999988775 5799999999999999999999999999999999999994 566799999999987765443
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....++..|+|||.+.. .++.++||||||+++|+|++|..||...+.......+........ .....++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHH
Confidence 344578899999998864 478899999999999999999999987755444444443222111 111234899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCc
Q 012039 318 RMLTQDPKKRITSAQVLEHPW 338 (472)
Q Consensus 318 ~~L~~dp~~Rps~~~~l~h~~ 338 (472)
+||+.||++|||+.++|+|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.50 Aligned_cols=257 Identities=33% Similarity=0.565 Sum_probs=218.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.....|.+.+.||+|++|.||+|.+..++..|++|++..... ....+.+|+.+++.+. |+||+++++.+......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence 355679999999999999999999998999999999864321 4667889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence 99999999999999998776 89999999999999999999999999999999999999 456679999999987654
Q ss_pred CCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+...... .......++.++
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence 322 1223457889999998764 5889999999999999999999999877665555555443322 111223478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.+||.+||+.+|.+|||+.++++|+||+.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=319.82 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=204.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCC--EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
++|++.+.||+|+||.||+|+...++. .+++|.++... .....+.+.+|+.++.++.+||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 479999999999999999999887765 46888765321 22345678899999999966999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 157 VVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.+.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence 9999999999999986532 47889999999999999999999999999999999999 4566
Q ss_pred cEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCc
Q 012039 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 298 (472)
.+||+|||++..............+..|+|||++.. .++.++|||||||++|+|++ |..||...........+..+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 799999999864322111111223457999998754 58999999999999999997 9999998888777777765432
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
. .....++.++.+||.+||..+|.+|||++++++.
T Consensus 237 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1224688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=319.52 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=211.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
....+.|++.+.||+|++|.||+|.+..+++.||+|.+.+... ......+.+|+.++.++.+||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3345679999999999999999999999999999999875432 22345567788877777679999999999999999
Q ss_pred EEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||+|+||++ +.++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence 999999984 567666654 4578999999999999999999997 599999999999999 4567799999999887
Q ss_pred ccCCcceeeccCCCCCCchhhhhc-----ccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCccCCCCCCC
Q 012039 233 IEEGKVYRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 306 (472)
...........++..|+|||.+.. .++.++||||||+++|+|++|+.||.... ..+.+..+........ ....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 243 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNE 243 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCC
Confidence 654443344467889999998853 37889999999999999999999996532 2344445544432211 1112
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.++.++.+||.+||..||++||+++++++||||...
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 478999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.36 Aligned_cols=250 Identities=24% Similarity=0.453 Sum_probs=216.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
..+.+-.+.+.||+|.||+||+|+... ....||||.++... +.....+|++|+.++..|+ |||||+++|++.
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCR 559 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEc
Confidence 344566778899999999999998543 23569999886543 3446789999999999995 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAK--------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~ 216 (472)
.++.+|+|+|||..|+|.++|... ..++..+...|+.||+.|+.||-++.+|||||-..|.||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV--- 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV--- 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---
Confidence 999999999999999999999642 127888999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCceeccCCcceeec---cCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHH
Q 012039 217 DENALLKATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFD 291 (472)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 291 (472)
+++..|||+|||+++.+-..+.++.. .-...|||||.+. ++|+++|||||+||+|||+++ |+.||.+.+.++.++
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 67889999999999987655544322 2245899999664 789999999999999999998 999999999999999
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012039 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (472)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l 334 (472)
.|.++.. ...+ .++|.++.+|+..||+.+|++||++.||-
T Consensus 717 ~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9999988 4444 58999999999999999999999999873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=311.75 Aligned_cols=245 Identities=36% Similarity=0.690 Sum_probs=214.4
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||+|++|.||++.+..+++.+|+|++.+...........+.+|+.+++++. ||||+++++.++.+..+++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 689999999999999899999999997765544445678899999999995 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-cceeeccCC
Q 012039 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGS 245 (472)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt 245 (472)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++ ..+.++|+|||++...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccCCcCC
Confidence 999998888899999999999999999999999999999999999994 5567999999999876543 223445788
Q ss_pred CCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 012039 246 AYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324 (472)
Q Consensus 246 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 324 (472)
..|+|||.+.+ .++.++|+||||+++|++++|..||...........+......++ ..++..+.++|++||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence 99999998764 478899999999999999999999988777677777766444333 3458999999999999999
Q ss_pred CCCCCH---HHHhcCCcc
Q 012039 325 KKRITS---AQVLEHPWI 339 (472)
Q Consensus 325 ~~Rps~---~~~l~h~~~ 339 (472)
++||++ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=320.56 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=209.1
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
...++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh
Confidence 345689999999999999999999999999999999865432 2233456778999999995 999999999987654
Q ss_pred --------eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 154 --------SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 154 --------~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
.+++|+||+++ +|...+... ..+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl 157 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKL 157 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEe
Confidence 79999999976 676766543 468999999999999999999999999999999999999 56677999
Q ss_pred eecCCceeccCCc--ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC
Q 012039 225 TDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 225 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
+|||++....... ......++..|+|||.+.+ .++.++|||||||++|+|++|++||......+.+..+.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998764432 2223356788999998753 47889999999999999999999998766655544443311000
Q ss_pred C--------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 301 E--------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 301 ~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
. ...+..++..+.++|.+||..||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0 01133578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.42 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=207.4
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||+||++.+.. +..+|+|.+.... .....+.+|+.+++++. ||||+++++++.....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence 469999999999999999998754 4569999886432 23467889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||++ +.++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence 9999999999998764 468999999999999999999999999999999999999 456679999999988654432
Q ss_pred cee--eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 VYR--DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.++...... ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 211 123456799999986 468899999999999999998 99999887777777777776443322 34689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+++.+||..||.+||++.+++++
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.34 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=207.9
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++.++||+|++|.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+. |+||+++++.+.+.+..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcE
Confidence 3568999999999999999999865 56789999875422 23567889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||++ +.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIE 154 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecC
Confidence 999999999999988653 458899999999999999999999999999999999999 556779999999998765
Q ss_pred CCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..... .+....++.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPD 231 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence 43221 1223566899999876 458889999999999999998 9999988877777777665422 223356889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.+++.+||..+|++||+++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=302.80 Aligned_cols=260 Identities=26% Similarity=0.491 Sum_probs=232.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.....+|++++.||+|+|++|.++++++|.+.||+|++++..+....+..-++.|-.+..+-++||.+|-++.+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 33456899999999999999999999999999999999998887788888899999999999999999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee-c
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-I 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~-~ 233 (472)
+++|.||++||+|.-++.++++++++.++.+...|+.||+|||++||++||||.+|+|+ +..+.+||.|+|.++. +
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCC
Confidence 99999999999999889999999999999999999999999999999999999999999 6677899999999875 4
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCC--------CChHHHHHHHHcCCccCCCCC
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA--------ETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~~~~~ 304 (472)
.++...++.+|||.|.|||++++ .|+..+|+|+|||+++||+.|+.||.- +++.-+++-|+...+.++.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr-- 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR-- 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence 56777788999999999999986 599999999999999999999999952 2233456667776666554
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCCcccc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRI------TSAQVLEHPWIKE 341 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rp------s~~~~l~h~~~~~ 341 (472)
.+|-.+..+++..|++||++|. ...++..|+||+.
T Consensus 481 --slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 481 --SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred --eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 4677888999999999999997 4578999999984
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.48 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=206.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++|.+.+.||+|+||.||++.+. .++..||+|.+.... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 44568999999999999999999752 345689999886432 22335678899999999956999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
..+.+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||++ +.+..++|+|||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg 186 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFG 186 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCc
Confidence 9999999999999999999987543 38999999999999999999999999999999999999 456679999999
Q ss_pred CceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 229 LSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 229 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
++......... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+.+...........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-- 264 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA-- 264 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--
Confidence 99865433221 1234567899999876 458899999999999999998 9999987665544444433322222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.....++++.+|+.+||..+|++|||+.++++
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 22457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=328.22 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=216.2
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCC---E-EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGR---Q-FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
.+|+...++-.+.++||+|+||.||+|..+..+. . ||+|...............+.+|+++|+++ +|||||++||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEE
Confidence 3445555666778999999999999998776432 3 899988754444566788899999999999 5999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
+..+...++||||+|.||+|.++|...+. ++..+...++.+.+.||+|||+++++||||-..|+|+ .....+||+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISD 305 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISD 305 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCc
Confidence 99999999999999999999999998774 9999999999999999999999999999999999999 4556689999
Q ss_pred cCCceeccCCccee-eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 227 FGLSVFIEEGKVYR-DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 227 fg~~~~~~~~~~~~-~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
||+++.-....... ..--...|+|||.+.. -|+.++|||||||++||+++ |..||.+....++...|....+..+.+
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 99987654111111 1112457999999874 59999999999999999999 889999999999999996655544443
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+.++..++.+|+..+|++||++.++.+
T Consensus 386 --~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 --SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 367899999999999999999999998865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.22 Aligned_cols=256 Identities=29% Similarity=0.488 Sum_probs=207.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE-------
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY------- 149 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~------- 149 (472)
...+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+.+|.+| +|||||++|..|
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcc
Confidence 3456788899999999999999999999999999997543 344567789999999999 599999998765
Q ss_pred --------------------------------------------------E---------------------eC------
Q 012039 150 --------------------------------------------------E---------------------DK------ 152 (472)
Q Consensus 150 --------------------------------------------------~---------------------~~------ 152 (472)
. +.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 00
Q ss_pred -----------------------------------CeEEEEEeccCCcchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 012039 153 -----------------------------------QSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHIC 196 (472)
Q Consensus 153 -----------------------------------~~~~lv~e~~~g~sL~~~l~~~~~~-~~~~~~~i~~qi~~~l~~l 196 (472)
..+||-||||+..+|.+++.++... ....+|.++++|+.||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 2378999999887777766665544 4778999999999999999
Q ss_pred HHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-------------------CCcceeeccCCCCCCchhhhhc-
Q 012039 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-------------------EGKVYRDIVGSAYYVAPEVLRR- 256 (472)
Q Consensus 197 H~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~- 256 (472)
|++|||||||||.||++ +....|||+|||++.... +....+..+||..|+|||++.+
T Consensus 714 H~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999 566679999999998721 0112345789999999999852
Q ss_pred ---ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 012039 257 ---RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQ 332 (472)
Q Consensus 257 ---~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~ 332 (472)
.|+.|+|+|||||||+||+. ||....+ ..++..+..+.++++...+..--+.-..+|+.||+.||.+||||.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 59999999999999999995 5755443 3466777777777664444444456677999999999999999999
Q ss_pred HhcCCcccc
Q 012039 333 VLEHPWIKE 341 (472)
Q Consensus 333 ~l~h~~~~~ 341 (472)
+|++.||--
T Consensus 868 LL~s~llpp 876 (1351)
T KOG1035|consen 868 LLNSELLPP 876 (1351)
T ss_pred HhhccCCCc
Confidence 999999963
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.24 Aligned_cols=251 Identities=27% Similarity=0.512 Sum_probs=209.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++.+.||+|++|.||+|.+..+|+.||+|.+.............+.+|+.+++++. |+||+++++.+.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence 47999999999999999999999999999999987544434444678899999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 159 MELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 999999999988864 3458999999999999999999999999999999999999 456679999999987654
Q ss_pred CCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+..+... ......++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence 332 2233568899999998764 58899999999999999999999996543 22344444443322 222236788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.43 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=199.9
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|++..+++.||+|.+.... .......+.+|+++++.+. ||||+++++++.....+++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999999999999999875432 2334567889999999995 99999999999999999999999999
Q ss_pred cchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCccee---
Q 012039 165 GELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--- 240 (472)
Q Consensus 165 ~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~--- 240 (472)
++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence 99999987644 58999999999999999999999999999999999999 455679999999987654321111
Q ss_pred eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 241 DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 241 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... .....++..+.+|+.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHH
Confidence 112245699999876 458899999999999999997 99999777766665555543221 2224678999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 012039 319 MLTQDPKKRITSAQVLE 335 (472)
Q Consensus 319 ~L~~dp~~Rps~~~~l~ 335 (472)
||+.+|++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.61 Aligned_cols=251 Identities=28% Similarity=0.506 Sum_probs=216.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++ |+||+++++++.+....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence 58899999999999999999999999999999875443 2234567788999999996 999999999999999999999
Q ss_pred eccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 160 ELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 160 e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++ ....+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence 99999999988865 35689999999999999999999999999999999999995 456799999999987655
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...+.......+......... ..++.++++
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence 4 3334568899999998864 4788999999999999999999999888877776666665443222 367899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+|.+||..+|++||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=316.59 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=210.2
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCC-----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTG-----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
+....+|++.+.||+|+||.||++.+.... ..+|+|.+.... .......+.+|+.+++++.+||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 334568999999999999999999876433 679999886432 2233456889999999995699999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceee
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIA----------------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili 213 (472)
..++.+++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999999854 2458899999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEeecCCceeccCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHH
Q 012039 214 SSKDENALLKATDFGLSVFIEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKG 288 (472)
Q Consensus 214 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 288 (472)
+.++.+||+|||++.......... ...++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+
T Consensus 166 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 ---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred ---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 456779999999998765433211 123456799999875 458999999999999999997 999998888777
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
....+..+... . ....++..+.+|+.+||..||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYRM-E--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77776655322 1 224678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.59 Aligned_cols=149 Identities=28% Similarity=0.476 Sum_probs=135.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|.+.++||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+. ||||+++++++.....+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999997655444444577889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
|||+.|++|.+++...+.+++..++.|+.||+.||.|||.++|+||||||+|||+ +.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999 456679999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.42 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=206.1
Q ss_pred cceEEcceeeecCCeEEEEEEEC----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTEN----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..|++.+.||+|+||+||+|... .++..|++|.+.... .......+.+|+.+++++. ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 46899999999999999999853 456789999886432 2233467889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 155 VHVVMELCAGGELFDRIIAK-----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 99999999999999988532 237888899999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.+..+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 566799999999986543321 12234567799999875 458999999999999999998 9999988777666666
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+...... .....+++.+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6654432 1234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=318.46 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=208.5
Q ss_pred cccccceEEcceeeecCCeEEEEEEECC-------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
+...++|.+++.||+|+||.||++++.. +...+|+|.+.... .......+.+|+.+++.+.+||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3345689999999999999999998643 23469999886532 23345678889999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
++...+.+|+||||+++++|.+++...+ .++...+..++.|++.||.|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997542 478889999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 286 (472)
++ +.++.+||+|||++......... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus 172 ll---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99 45667999999998765432211 11234568999998864 58999999999999999998 8999988777
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+....+...... .....++.++.+||.+||..+|++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7777666554321 1224678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=312.95 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=208.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCC-----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTG-----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++|++.+.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.+. ||||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~ 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc
Confidence 44678999999999999999999986443 789999975432 1233457889999999995 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
.....++||||+++++|.+++.... .+++..+..++.||+.||.|||+++++|+||||+||++ +.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCC
Confidence 9999999999999999999886432 36788899999999999999999999999999999999 4567
Q ss_pred cEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 012039 221 LLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQ 295 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 295 (472)
.+||+|||++......... ....++..|+|||.+. +.++.++|||||||++|++++ |..||.+.+..+....+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 7999999998765443221 2234678899999876 458999999999999999998 9999988887777777764
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..... ...++.++.++|.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 432211 1346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=318.19 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=213.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
....|...+.||+|++|.||+|++..++..+|+|.+.............+.+|+.+++.+. |+|++++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence 3456888899999999999999999999999999886543323334567788999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence 9999996 578776653 4568999999999999999999999999999999999999 4566799999999876544
Q ss_pred CcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+........ ....++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHH
Confidence 3 2346889999999874 3578899999999999999999999987665555555544333211 12357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+||.+||..+|++||++.++++|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=316.16 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=207.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCC----------------CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTG----------------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 141 (472)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+++++++. |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 458999999999999999999876543 458999886543 2234677889999999995 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
|+++++++..+..+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++|+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987655 68999999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh--CCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS--GVPPFWAE 284 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~--g~~pf~~~ 284 (472)
|++ +.++.++|+|||++........ .....+++.|+|||.+.. .++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 4557799999999886543322 123346778999998764 68999999999999999998 78888777
Q ss_pred ChHHHHHHHHcC----CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 285 TEKGIFDAILQG----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 285 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+....+..+... ...........++.++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 666666665443 111111122457899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=310.73 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=208.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 4799999999999999999998654 4579999886432 2334567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 556679999999998775
Q ss_pred CCc-cee--eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EGK-VYR--DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~~-~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
... ... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+.... ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---PPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 221 111 123457899999886 458999999999999999998 999998887777777776543221 124678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.31 Aligned_cols=256 Identities=29% Similarity=0.553 Sum_probs=213.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.|....+||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.+. |+||+++++.+...+..++||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEE
Confidence 455557899999999999999999999999987532 2234567889999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-c
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~ 238 (472)
||+++++|.+++. .+.+++..+..++.|++.+|.|||++|++||||+|+||++ +.++.++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceeccccccc
Confidence 9999999988764 4578999999999999999999999999999999999999 456679999999987654322 2
Q ss_pred eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.........+..... ........++..+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHH
Confidence 23456889999999875 4578999999999999999999999988776665555543322 122223467899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 318 RMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 318 ~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
+||..+|.+||++.++++||||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=317.29 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=207.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECC-------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
.....+|.+++.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++++.+||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3445789999999999999999998642 34568999876432 22345678899999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
++.+.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999998653 2478889999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 286 (472)
++ +.++.+||+|||+++........ ....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+...
T Consensus 166 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99 45567999999999865432211 11234467999998764 58899999999999999999 8999988887
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+.+..+..+... .....++.++.++|.+||..+|++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7777777665321 112467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.94 Aligned_cols=253 Identities=34% Similarity=0.534 Sum_probs=209.2
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|++.+.||+|++|+||+|+...+++.|++|.+..... ........+|+..++++.+||||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998999999998865432 12233455799999999659999999999999999999999
Q ss_pred ccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 161 LCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||+++++|+||+|+||++ +.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence 99 789999887764 78999999999999999999999999999999999999 5577899999999987765544
Q ss_pred eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc-----------------
Q 012039 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID----------------- 299 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----------------- 299 (472)
.....++..|+|||++.. .++.++|+||||+++|+|++|++||......+.+..+....-.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 455678999999998743 4789999999999999999999999877655544433321000
Q ss_pred --CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 --FE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 --~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
++ ....+..+..+.+||++||+.+|++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 00112346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.15 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=203.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCE----EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+|++.+.||+|+||.||+|++..++.. ||+|++.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 4799999999999999999998766654 8999885422 2334567889999999995 99999999998765 4
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++|+||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.+..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 67999999999999998764 458899999999999999999999999999999999999 45667999999999876
Q ss_pred cCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 234 EEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 234 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
....... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....++...+..+ ...+.. +.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCCCC--CCC
Confidence 5433221 123456799999876 458999999999999999997 99999877666554444333 322222 457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+.++.+++.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=309.46 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=209.2
Q ss_pred ceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 012039 85 KELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 161 (472)
+.||+|+||.||+|.+... +..|++|++..... ......+.+|+.+++.++ |+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999866 88999999875432 124678899999999996 99999999999999999999999
Q ss_pred cCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 162 CAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 162 ~~g~sL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+++++|.+++... ..+++..++.++.|++.||.|||+++++|+||+|+||++ +.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999 4557799999999987
Q ss_pred ccCCc---ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 233 IEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
..... ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||...........+..+... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 75532 1233457889999998864 68999999999999999999 69999888887787777764322 12246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+|.++.+++.+||..+|++|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.23 Aligned_cols=263 Identities=30% Similarity=0.476 Sum_probs=212.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--C
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--Q 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 153 (472)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.+... .......+.+|+.+++++.+||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 356789999999999999999999998999999998864321 2233456778999999995599999999988643 4
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence 6899999996 5998888665 78999999999999999999999999999999999999 56778999999998865
Q ss_pred cCCc------ceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--------
Q 012039 234 EEGK------VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD-------- 297 (472)
Q Consensus 234 ~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-------- 297 (472)
.... ......|++.|+|||.+. ..++.++||||||+++|+|++|+.||.+.........+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4322 223356899999999774 347889999999999999999999998765544333322211
Q ss_pred -------------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 298 -------------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 298 -------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
........+.++.++.+||.+||+.||++|||+.++++||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 11111223457899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=323.91 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=200.7
Q ss_pred ceeeec--CCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 012039 85 KELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (472)
Q Consensus 85 ~~lg~G--~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 162 (472)
..||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++..++.+++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999999865432 2233567889999999995 999999999999999999999999
Q ss_pred CCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-ce
Q 012039 163 AGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VY 239 (472)
Q Consensus 163 ~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~~ 239 (472)
.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++. .++.++++||+.+....... ..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence 999999988764 3489999999999999999999999999999999999994 55679999997654322111 00
Q ss_pred -------eeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC--------
Q 012039 240 -------RDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-------- 301 (472)
Q Consensus 240 -------~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 301 (472)
....++..|+|||++.+ .++.++|||||||++|+|++|..||........+..+.......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01234567999999864 378999999999999999999999987665444433332211000
Q ss_pred -----------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 302 -----------------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 302 -----------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
......+++.+.+||++||+.||++|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 011123577899999999999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.98 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=204.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-----
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK----- 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----- 152 (472)
.++|++.+.||+|++|.||+|.++.+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence 4689999999999999999999999999999998865432 1222345678999999995 99999999887543
Q ss_pred ---CeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
..+++||||+. ++|...+.. ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence 35799999995 467666654 4579999999999999999999999999999999999999 566779999999
Q ss_pred CceeccCCcc------------eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 012039 229 LSVFIEEGKV------------YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 229 ~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 294 (472)
++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976543221 122356888999998753 47899999999999999999999998877665555443
Q ss_pred cCCccCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 295 QGDIDFES--------------------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 295 ~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
........ ..+..+++.+.+||.+||+.||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 21110000 0123455788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=308.18 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=207.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|++.+.||+|++|.||+|.+. +++.||+|.+.... .....+.+|+.++++++ ||||+++++++...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCe
Confidence 34568999999999999999999875 45789999986432 23567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEc
Confidence 99999999999999987644 68999999999999999999999999999999999999 45667999999999876
Q ss_pred cCCcceeeccC---CCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 234 EEGKVYRDIVG---SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 234 ~~~~~~~~~~g---t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
..... ....| +..|+|||.+.. .++.++||||||+++|+|++ |+.||.+......+..+..... .+ ....+
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 229 (261)
T cd05068 154 KEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MP--CPPGC 229 (261)
T ss_pred cCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCCcC
Confidence 53221 11222 357999998764 58999999999999999999 9999988877777777655422 22 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=323.24 Aligned_cols=263 Identities=25% Similarity=0.422 Sum_probs=211.0
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-- 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 152 (472)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 90 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccc
Confidence 4466799999999999999999999999999999999865321 2223456788999999995 99999999988643
Q ss_pred ----CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 153 ----QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 153 ----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
..+|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg 165 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 165 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccc
Confidence 3478889887 7899876654 469999999999999999999999999999999999999 456679999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc--------
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-------- 298 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 298 (472)
++...... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 166 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 98765332 234578899999998754 478899999999999999999999977665444433322110
Q ss_pred ---------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 299 ---------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 299 ---------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
..+. ..+...++++.+||.+||+.||.+||++.++++||||++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 0000 11224688999999999999999999999999999999755433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.46 Aligned_cols=256 Identities=29% Similarity=0.541 Sum_probs=209.2
Q ss_pred ceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+|++.+.||+|++|.||++++. .+++.||+|++.+.... .......+.+|+.++.++++||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46788999998654321 1223456789999999997799999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||+.+++|.+++.....+++..+..++.|++.+|.|||+.+++||||+|+||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence 9999999999999999877789999999999999999999999999999999999999 4566799999999876543
Q ss_pred Ccc--eeeccCCCCCCchhhhhcc---cCCccchhhHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCC
Q 012039 236 GKV--YRDIVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 236 ~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 306 (472)
... .....|+..|+|||.+.+. ++.++||||||+++|+|++|..||..... .+....+...... ...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----FPK 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----CCc
Confidence 322 1234688999999987542 68899999999999999999999964322 2333333333222 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps---~~~~l~h~~~~~~ 342 (472)
.++.++.++|.+||+.||++||| +.++|+||||+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 57899999999999999999998 5677999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=308.28 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=204.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|++.++||+|+||.||+|.+..+ ..||+|++.... .....+.+|+++++++. ||||+++++.+.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~ 75 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI 75 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc----cCHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCc
Confidence 3456899999999999999999988765 469999986432 23467889999999995 9999999998754 557
Q ss_pred EEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||++ +.++.++|+|||.+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLI 152 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeec
Confidence 9999999999999999753 358899999999999999999999999999999999999 45667999999999876
Q ss_pred cCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 234 EEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 234 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
...... ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.. .. ....++
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 229 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPECP 229 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CC--CccccC
Confidence 543321 1234567899999875 468999999999999999999 8889988877777776655432 11 124678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+.++|.+||+.||++||++.++++
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.91 Aligned_cols=245 Identities=31% Similarity=0.499 Sum_probs=200.5
Q ss_pred EEcceeeecCCeEEEEEEEC----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 82 SFGKELGRGQFGVTYLCTEN----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
++.+.||.|.||.||+|... ..+..|+||.+... ........+.+|+++++++ +||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 45688999999999999988 34568999998432 1333468899999999999 59999999999998888999
Q ss_pred EEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 158 VMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||++|+|.+++... ..+++.....|+.||+.||.|||+++++|++|+++||++ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999886 679999999999999999999999999999999999999 4567899999999987733
Q ss_pred Ccce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 236 GKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 236 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.... ....+...|+|||.+.. .++.++||||||+++|||++ |+.||...+..++...+.++..... ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence 2222 12346678999999864 58999999999999999999 7899988888888888866544222 246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+.++|.+||..||++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.47 Aligned_cols=253 Identities=33% Similarity=0.536 Sum_probs=210.0
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|++.+.||+|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++. ||||+++++++.++..+++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence 6678899999999999999998999999999865432 2234567889999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-c
Q 012039 161 LCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (472)
Q Consensus 161 ~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~ 238 (472)
|+++ +|.+.+.. ...+++..+..++.||+.||.|||+++|+|+||+|+||++ +.++.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence 9965 88887766 3579999999999999999999999999999999999999 456679999999998775543 3
Q ss_pred eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc-----------------
Q 012039 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID----------------- 299 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----------------- 299 (472)
.....++..|+|||.+.+ .++.++||||||+++|+|++|+.||...+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334568889999998754 4789999999999999999999999877665544444321000
Q ss_pred --CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 300 --FE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 300 --~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
++ ...++.++.++.+||.+||.+||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.38 Aligned_cols=249 Identities=20% Similarity=0.341 Sum_probs=207.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCC-----CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+|++.+.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+.++..+. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 3688899999999999999987543 5789999986432 1223466889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 154 SVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988531 347888899999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.+..+||+|||++......... ....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.+..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 5567999999998865433221 2334577899999875 568999999999999999998 8899988888888888
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+........ ...++.++.+|+.+||+.+|.+||++.+++..
T Consensus 239 i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 877654322 24688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=359.46 Aligned_cols=258 Identities=30% Similarity=0.497 Sum_probs=221.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.-+|.-+..||.|.||.||.|.+..+|...|+|-|.-.... ....+.+.+|+.++..+ +|||+|++|++=.+++..
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHHH
Confidence 4556788889999999999999999999999999988755443 44567788999999999 599999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+|.||||+||+|.+.+...+..++.....+..|++.|+.|||+.|||||||||+||++ +.++.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecC
Confidence 9999999999999999888888888899999999999999999999999999999999 6777999999999998765
Q ss_pred Cc-----ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccCCCCCC
Q 012039 236 GK-----VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 236 ~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 305 (472)
.. ......||+.|||||++.+ +...+.||||||||+.||+||+.||...+. -.++-.+..+..+...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P--- 1463 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP--- 1463 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc---
Confidence 42 2345789999999999863 467899999999999999999999976544 3445555555433222
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..+|.+.++||..||..||++|+++.|+|+|-|-+.
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 249999999999999999999999999999988764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=315.28 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=209.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEEC-------CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTEN-------STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
....+|.+.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+.+||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34668999999999999999999753 234579999876432 233456788999999999669999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCcee
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 212 (472)
+......|+||||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999998753 24677889999999999999999999999999999999
Q ss_pred eccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChH
Q 012039 213 LSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEK 287 (472)
Q Consensus 213 i~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 287 (472)
+ +.++.+||+|||++......... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..
T Consensus 170 i---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 170 V---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred E---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9 45667999999999876543221 12345678999998864 58999999999999999998 88999888888
Q ss_pred HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
++...+..+.... ....++.++.+||.+||..+|++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8877776553221 124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=307.36 Aligned_cols=241 Identities=26% Similarity=0.347 Sum_probs=200.6
Q ss_pred eeeecCCeEEEEEEE--CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 86 ELGRGQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
+||+|+||.||+|.+ ..++..+|+|++..... .....+.+.+|+.+++.+. ||||+++++++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLD-NPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCcEEEEecCC
Confidence 689999999999965 45678999998864321 2334567889999999995 9999999998764 46789999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce----
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---- 239 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~---- 239 (472)
+++|.+++.....+++..+..++.|++.||.|||++||+||||||.||++ +.+..+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence 99999999887889999999999999999999999999999999999999 45667999999999876543321
Q ss_pred eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
....++..|+|||.+.. .++.++||||||+++|+|++ |..||......+....+.++... . ....+++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~--~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-E--CPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHHHH
Confidence 11234578999998864 57889999999999999998 99999888787777777765432 1 12468999999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 012039 318 RMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 318 ~~L~~dp~~Rps~~~~l~ 335 (472)
+||+.||++||++.+|..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=306.63 Aligned_cols=246 Identities=24% Similarity=0.433 Sum_probs=205.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||.||++.++ ++..+|+|++.+.. .....+.+|+.+++++. ||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA----MSEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEE
Confidence 36889999999999999999886 46689999886432 23456888999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||++|++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence 9999999999998753 468999999999999999999999999999999999999 456679999999987654332
Q ss_pred cee--eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 VYR--DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+..+.. .. ....++.++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LY--RPKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCHHHH
Confidence 211 112345799999886 468899999999999999999 8999988777777777665422 11 1245799999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+++.+||..+|++|||+.++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.26 Aligned_cols=249 Identities=19% Similarity=0.330 Sum_probs=210.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|+++++||.|+||.||+|.+.. +..+++|++.... ......+.+|+.+++.++ ||||+++++++.+...+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCe
Confidence 345689999999999999999999987 8899999986543 223567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||++ +.+..+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhc
Confidence 9999999999999998753 458999999999999999999999999999999999999 45667999999999766
Q ss_pred cCCcc-eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 234 EEGKV-YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 234 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
..... .....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+.+..+..+.. .+ ....+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 231 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-MP--CPAKCPQ 231 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-CC--CCCCCCH
Confidence 43321 11234567899999875 458899999999999999998 8999988887777777765422 22 2246889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=309.66 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=203.7
Q ss_pred eEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe---
Q 012039 81 YSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS--- 154 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--- 154 (472)
|++++.||+|+||.||+|....+ +..||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 57889999999999999987653 47899999865332 2334567889999999995 9999999998765443
Q ss_pred ---EEEEEeccCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 155 ---VHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 155 ---~~lv~e~~~g~sL~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
.++||||+++++|..++... ..+++..+..++.|++.||.|||+++++||||||+||++ +.+..+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999999999887432 358999999999999999999999999999999999999 556779999
Q ss_pred ecCCceeccCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccC
Q 012039 226 DFGLSVFIEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 226 Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
|||++.......... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+.++.+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999998765433211 123467899999876 458999999999999999999 999998888777777776654321
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
....++.++.+++.+||+.||++|||+.+++++
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 124678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.25 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=208.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.+. ||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSG 89 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccccC
Confidence 345689999999999999999999999999999999865432 2233456789999999995 99999999998754
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+++|+||+. .+|.+++ ...+++..+..++.|++.||.|||+++|+||||||+||++ +.++.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~ 163 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGL 163 (342)
T ss_pred CCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCC
Confidence 35799999995 4676554 3468999999999999999999999999999999999999 4567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---------- 297 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 297 (472)
+...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8765332 234567889999998754 47899999999999999999999998876554444433210
Q ss_pred -------------ccCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 298 -------------IDFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 298 -------------~~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..... ..++..+.++.+||.+||+.||++||++.+++.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00011 01245788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.14 Aligned_cols=261 Identities=31% Similarity=0.480 Sum_probs=210.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQSV 155 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~ 155 (472)
+.++|.+.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++++. ||||+++++++.. ....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCcE
Confidence 56789999999999999999999999999999998865432 2234567789999999995 9999999999875 5678
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++|+||+ +++|.+++. ...+++..+..++.||+.||.|||+++|+|+||+|+||++ +.++.++|+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC
Confidence 9999999 668877665 4568899999999999999999999999999999999999 5567799999999876533
Q ss_pred CcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc---------------C--
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ---------------G-- 296 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---------------~-- 296 (472)
. .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.+ .
T Consensus 161 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 Q--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred C--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2 234567889999998754 588999999999999999999999976654322211111 0
Q ss_pred ----------CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 297 ----------DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 297 ----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
.........+.++.++.++|++||+.+|++|||+++++.||||.....+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 00000011245789999999999999999999999999999998654443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=312.53 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=206.3
Q ss_pred cceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ......+.+|+.+++++. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 468999999999999999998643 45568888875322 223467889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 154 SVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence 9999999999999999986532 37899999999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.++.++|+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 567899999999976543321 12235678899999876 458899999999999999998 9999988887777777
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..+..... ...++..+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 766544322 2357899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=318.46 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=208.7
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCC-------CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENST-------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 146 (472)
++....+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++.+||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 344556899999999999999999986432 2368999876432 2234567889999999996699999999
Q ss_pred EEEEeCCeEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 147 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
+++...+.++++|||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999987532 36778889999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
|++ +.+..+||+|||+++........ ....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+
T Consensus 165 ill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 165 VLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 45567999999999876543221 11234567999998864 58899999999999999998 899998888
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+....+..+... .....++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 87777777654322 1124678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=308.62 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=198.2
Q ss_pred ceeeecCCeEEEEEEECCCCCE--EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 012039 85 KELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~--va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 162 (472)
+.||+|+||.||+|++..++.. +++|.+.... .......+.+|+.++.++.+||||+++++++...+.+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999887764 5778765321 23345678899999999977999999999999999999999999
Q ss_pred CCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 163 AGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 163 ~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||++ +.+..+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence 9999999987543 47889999999999999999999999999999999999 5667799999
Q ss_pred cCCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 227 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
||++..............+..|+|||++. ..++.++||||||+++|+|++ |..||.+.+..+....+..+.. . ..
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~--~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-L--EK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-C--CC
Confidence 99986332111111123356799999875 458899999999999999997 9999988777777766655421 1 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...++.++.+++.+||..||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2357899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=324.43 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=205.6
Q ss_pred ccccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++...++|.+++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.++.++..|||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3445668999999999999999999864 345689999996532 222345788999999999559999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhcC-----------------------------------------------------
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAKG----------------------------------------------------- 175 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------------------------------------------- 175 (472)
+...+.+++|||||.+|+|.+++...+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999886432
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 176 ---------------------------------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 176 ---------------------------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
.+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
||+ +....+||+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||....
T Consensus 270 iLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999 4566799999999986533221 12235678899999886 458899999999999999998 899997765
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+............. ....++.++.+|+.+||..+|.+||++.++++.
T Consensus 347 ~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5554444333332222 224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=313.29 Aligned_cols=253 Identities=30% Similarity=0.526 Sum_probs=210.4
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|++.+.||+|++|.||+|++..+++.||+|++.... ........+.+|+.+++++. |+||+++++++.+...+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence 677889999999999999999999999999987653 12333567788999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-c
Q 012039 161 LCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (472)
Q Consensus 161 ~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~ 238 (472)
|++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence 997 5999998876 579999999999999999999999999999999999999 456779999999988765432 2
Q ss_pred eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------c
Q 012039 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------------I 298 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------------~ 298 (472)
.....++..|+|||.+.. .++.++||||||+++|+|++|..||.+.+..+.+..+.+.. .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 333456788999998753 57899999999999999999999998877655554443210 0
Q ss_pred cCC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 299 DFE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 299 ~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
.++ ...++.++..+.++|.+||..||++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 01223567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.05 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=206.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+...++|+++++||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++. ||||+++++++.+ +.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ-EP 74 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcC-CcCeeeEEEEEcc-CC
Confidence 445678999999999999999999865 57889999886433 23567889999999995 9999999998754 56
Q ss_pred EEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceee
Confidence 89999999999999988653 358999999999999999999999999999999999999 4566799999999987
Q ss_pred ccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 233 IEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 233 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
...... .....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+.+..+....+..+.. .......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNC 228 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCC
Confidence 653221 11234567899999886 457899999999999999999 9999988877777776655422 1223467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++.++|.+||..+|++|||++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=308.86 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=202.2
Q ss_pred eEEcceeeecCCeEEEEEEECCCCC--EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe------C
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------K 152 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~--~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------~ 152 (472)
|.+++.||+|+||.||+|.+..++. .||+|.+..... .......+.+|+.+++.++ ||||+++++++.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence 3567899999999999999887765 689998865422 3344677889999999995 9999999997642 2
Q ss_pred CeEEEEEeccCCcchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 153 QSVHVVMELCAGGELFDRIIA------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
...++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.+..+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence 357899999999999887742 2348899999999999999999999999999999999999 5567799999
Q ss_pred cCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCC
Q 012039 227 FGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 227 fg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
||++......... ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+..+....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9999876543321 12245678999998864 58999999999999999999 899998877777777777654322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+.++..+.++|.+||+.||++|||+.+++++
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 124678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=321.46 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=200.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEE-----CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++|++++.||+|+||.||+|++ ..+++.||||++.... .......+.+|+.++.++.+||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3456899999999999999999985 3467889999986432 22334678899999999977999999999876
Q ss_pred e-CCeEEEEEeccCCcchHHHHHhc-------------------------------------------------------
Q 012039 151 D-KQSVHVVMELCAGGELFDRIIAK------------------------------------------------------- 174 (472)
Q Consensus 151 ~-~~~~~lv~e~~~g~sL~~~l~~~------------------------------------------------------- 174 (472)
. +..+++|||||++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45689999999999999988642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce---
Q 012039 175 ------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--- 239 (472)
Q Consensus 175 ------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 239 (472)
..++...+..++.||+.||.|||+++|+||||||+||++ +.+..+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhc
Confidence 135777888999999999999999999999999999999 45667999999998765332211
Q ss_pred eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 240 RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....++..|+|||++. ..++.++||||||+++|+|++ |..||...... .....+..+.. ...+ ..+++++.+++
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~ 315 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAP--DYTTPEMYQTM 315 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCCC--CCCCHHHHHHH
Confidence 1223567799999875 458999999999999999997 99999765433 33333333322 2222 24678999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 012039 317 RRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h 336 (472)
.+||+.||++|||+.++++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.73 Aligned_cols=248 Identities=24% Similarity=0.424 Sum_probs=207.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++++. ||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 479999999999999999999875543 69999886432 2234567899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||++ +.+..++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 456679999999998765
Q ss_pred CCccee----eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 235 EGKVYR----DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 235 ~~~~~~----~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
...... ...++..|+|||.+. ..++.++|+||||+++|++++ |..||......+....+.++. ..+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCC
Confidence 432211 112346799999886 468999999999999999886 999998887777777776652 222 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=304.85 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=204.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
...++|++.++||+|++|.||+|.+. .+..+|+|.+.... .....+.+|+.+++++. ||||+++++++.. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~ 75 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT----MSPESFLEEAQIMKKLR-HDKLVQLYAVVSE-EPI 75 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC----CCHHHHHHHHHHHHhcC-CCceEEEEeEECC-CCc
Confidence 34568999999999999999999876 56679999886533 23467899999999995 9999999998754 568
Q ss_pred EEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||++ +.+..++|+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeec
Confidence 8999999999999988753 358999999999999999999999999999999999999 45667999999999876
Q ss_pred cCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 234 EEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 234 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
...... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+..+....+..... . ......+
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 229 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M--PCPQDCP 229 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCC
Confidence 443211 1223556799999875 458899999999999999999 9999988777777777765421 1 1224678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+.+|+.+||..+|++|||+.++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.57 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=203.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCC----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+|++.+.||+|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence 479999999999999999999877776 47999875432 2334567889999999995 99999999988754 4
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++++||+++|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+||++. .+..+||+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceeec
Confidence 78999999999999998764 5689999999999999999999999999999999999994 4556999999999876
Q ss_pred cCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 234 EEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 234 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
....... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||...........+..+... + ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-P--QPPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C--CCccC
Confidence 5433221 123467899999875 458999999999999999998 99999877666666655554322 1 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++.++|.+||..||++||++.++++
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=312.43 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCC--------------CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCee
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTG--------------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 143 (472)
..+|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|++++++++ ||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 458999999999999999999875432 358999886432 2334567889999999995 99999
Q ss_pred EEEEEEEeCCeEEEEEeccCCcchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
++++++...+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886432 367888999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh--CCCCCCCCC
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS--GVPPFWAET 285 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~pf~~~~ 285 (472)
+++ .+..+||+|||++......... ....++..|+|||++. +.++.++||||||+++|+|++ |..||...+
T Consensus 161 ll~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 994 5567999999998765433221 1223467899999875 468999999999999999988 778888777
Q ss_pred hHHHHHHHHcC----CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 286 EKGIFDAILQG----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 286 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+.+..+... .........+.+++.+.+|+.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655554321 111111223457899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.75 Aligned_cols=248 Identities=24% Similarity=0.440 Sum_probs=206.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
..|++.+.||+|+||.||+|.++.+++ .||+|.+.... .......+.+|+.+++.+. ||||+++++++.++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 468999999999999999999887665 59999886432 2334567899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||++ +.+..+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 9999999999999988753 568999999999999999999999999999999999999 556679999999987654
Q ss_pred CCcce---eecc---CCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 235 EGKVY---RDIV---GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 235 ~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
..... .... .+..|+|||.+. ..++.++||||||+++|++++ |..||......+....+... ... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~--~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRL--PPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcC--CCcc
Confidence 33211 1111 134799999886 468999999999999999886 99999988877777777543 222 2224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.88 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=206.1
Q ss_pred ccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 347888999999999999999743 35668999987543 2334567899999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG---------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
...++||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||++ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999987643 47889999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.+..+||+|||++......... ....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 5677999999998765433221 1223467899999876 458999999999999999998 9999988777777777
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..+.... ....+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 76654321 12468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.52 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=203.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... .....+.+|+++++++. ||||+++++++.. +..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcE
Confidence 346799999999999999999987654 469999875432 23467889999999995 9999999998754 5688
Q ss_pred EEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEcc
Confidence 999999999999998753 347899999999999999999999999999999999999 566779999999998764
Q ss_pred CCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+..... ......++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPE 230 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCH
Confidence 33211 1234567899999875 458899999999999999999 9999988877777776655421 122346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+.+++.+||.+||++||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.78 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=208.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+...++|++.+.||+|++|.||+|.+. .+..||+|.+.... .....+.+|+.+++++. ||||+++++++.....
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEP 75 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCc
Confidence 345678999999999999999999976 45789999886432 23567899999999995 9999999999999899
Q ss_pred EEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.+||+|||++..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARL 152 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECcccccee
Confidence 99999999999999998764 368999999999999999999999999999999999999 4567799999999887
Q ss_pred ccCCcce--eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 233 IEEGKVY--RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 233 ~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
....... ....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+......+..+..+... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNC 229 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence 6532211 12234568999998864 58899999999999999998 99999888877777777654221 112356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++.+++.+||..+|++||+++++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.44 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=200.6
Q ss_pred ceeeecCCeEEEEEEECCCC---CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 012039 85 KELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 161 (472)
++||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.+ +||||+++++++.. ..+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence 46999999999999876554 78999998754432 3456788999999999 49999999998764 468999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCccee-
Q 012039 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR- 240 (472)
Q Consensus 162 ~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~- 240 (472)
+++++|.+++.....+++..+..++.|++.+|.|||.++++|+||||+||++ +.++.+||+|||++..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence 9999999999888889999999999999999999999999999999999999 456679999999998764433211
Q ss_pred e---ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 241 D---IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 241 ~---~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. ..++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+...... .....++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence 1 12346799999876 458899999999999999998 99999887777777766655322 2224678999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 012039 316 VRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~ 335 (472)
|.+||..+|++||++.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.14 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=208.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
+|.+.+.||+|+||.||++++..++..+++|+++..... .......+.+|+.+++.+. ||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 589999999999999999999888777777776543221 1223445778999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++.. ..++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence 9999999999888753 356899999999999999999999999999999999999942 35999999998776
Q ss_pred cCCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 234 EEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 234 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
.... ......|++.|+|||.+.. .++.++|+||||+++|+|++|..||...........+..+..... ...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence 4332 2234568899999998754 578899999999999999999999987776666666655432221 2367899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
+.++|.+||..+|++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=296.42 Aligned_cols=265 Identities=27% Similarity=0.465 Sum_probs=217.8
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE--
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE-- 150 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 150 (472)
|+-+..+.|.-..+||+|.||.||+|+++.+|+.||+|++-...-. ..-.....+|+.+|..|. |+|++.+++.+.
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lk-Henv~nliEic~tk 88 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTK 88 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhc
Confidence 4445566788889999999999999999999999999876432211 122345678999999995 999999988763
Q ss_pred ------eCCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEE
Q 012039 151 ------DKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 151 ------~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
+...+|+||.+|+ .+|.-++.+. -+++..++..++++++.||.|+|++.|+|||+|++|+|| +.++++|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilk 164 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILK 164 (376)
T ss_pred cCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEE
Confidence 3456999999995 4888888664 579999999999999999999999999999999999999 6778999
Q ss_pred EeecCCceeccCC-----cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 012039 224 ATDFGLSVFIEEG-----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (472)
Q Consensus 224 l~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 296 (472)
|.|||+++.+... ..+...+.|.+|++||.+-+ .|+++.|||..|||+.+|+++.+-+.+.++...+..|.+-
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999999765432 23455677999999998754 5999999999999999999999999999998888887653
Q ss_pred CccCCCCCCCCC-------------------------------CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 297 DIDFESAPWPTI-------------------------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 297 ~~~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.-.+....|+++ .+++.+|+.+||..||.+|+++.++|+|.||....
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 333344444322 34778999999999999999999999999998753
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.20 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=194.9
Q ss_pred cce-EEcceeeecCCeEEEEEE----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--
Q 012039 79 LHY-SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-- 151 (472)
Q Consensus 79 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 151 (472)
++| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.+. ||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 899999999999998865 34567899999986532 2234567889999999995 9999999998765
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
...+++||||+++++|.+++... .+++..++.++.|++.||.|||+++|+||||||+||++ +.+..++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 34689999999999999988654 69999999999999999999999999999999999999 455679999999998
Q ss_pred eccCCcce----eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChH--HHH------------HH
Q 012039 232 FIEEGKVY----RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK--GIF------------DA 292 (472)
Q Consensus 232 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~------------~~ 292 (472)
........ ....++..|+|||.+. ..++.++||||||+++|+|++|..||...... +.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 76543221 1224566799999876 45899999999999999999999998543221 000 00
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
........+ ....++.++.+++.+||+.+|++|||++++++
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011111111 12357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.96 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=202.3
Q ss_pred ceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 80 HYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 47889999999999999998753 23568888876432 2233567889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 155 VHVVMELCAGGELFDRIIAK------------------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
.++|+||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 247788999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
|++ +.++.+||+|||++......... ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 45667999999998765332211 12345678999998754 58999999999999999998 999998887
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+.+.+.... ... ....++.++.+|+.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 777766655442 222 22467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=306.98 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=200.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCE----EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+|++.+.||+|+||+||+|.+..++.. +++|.+.... .......+..|+.+++++. ||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCC-CCCcceEEEEECC-Cc
Confidence 4789999999999999999999877764 6666654211 1223456778888999995 9999999998764 45
Q ss_pred EEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++++|+||||+||++ +.+..+||+|||++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 7889999999999999975 4568999999999999999999999999999999999999 55677999999999876
Q ss_pred cCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 234 EEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 234 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
..... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+.......+.+..+..... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCC
Confidence 43321 22345677899999885 468999999999999999998 9999988776665555554433221 1346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 788999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.10 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=197.2
Q ss_pred eeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 86 ELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++++. ||||+++++++.. ..+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 4899999999999765 345579999886432 2334567889999999995 9999999998864 46899999999
Q ss_pred CcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce-ee
Q 012039 164 GGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RD 241 (472)
Q Consensus 164 g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 241 (472)
+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||++ +.+..+||+|||++......... ..
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence 9999998875 4568999999999999999999999999999999999999 45667999999999865443221 11
Q ss_pred ---ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 242 ---IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 242 ---~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
..++..|+|||++. ..++.++||||||+++|++++ |..||......+....+..+.... .....++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHH
Confidence 12356899999876 458899999999999999996 999998888777777776654321 1246789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 012039 317 RRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~ 335 (472)
.+||..+|++||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=304.11 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=207.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+|+..+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++++. ||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence 3478899999999999999999876665 69999886432 2234567889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||++ +.+..+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 99999999999999988754 568999999999999999999999999999999999999 45667999999998866
Q ss_pred cCCcc--eee--ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKV--YRD--IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~--~~~--~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
..... ... ...+..|+|||++. ..++.++||||||+++|+|++ |..||...+..+....+..... .+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCC
Confidence 43221 111 12345799999876 458899999999999999997 9999988888777777765422 122235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.++.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=315.91 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=196.2
Q ss_pred CCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcchHHH
Q 012039 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170 (472)
Q Consensus 91 ~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~ 170 (472)
++|.||.+++..+++.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..+++|||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 445667777777899999999875422 3345678999999999995 99999999999999999999999999999998
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc--------ee
Q 012039 171 IIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV--------YR 240 (472)
Q Consensus 171 l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~ 240 (472)
+... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||.+........ ..
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccccccccccccccc
Confidence 8753 4589999999999999999999999999999999999994 556799999998875532211 12
Q ss_pred eccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-----------------
Q 012039 241 DIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----------------- 300 (472)
Q Consensus 241 ~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------- 300 (472)
...++..|+|||++.. .++.++||||+||++|+|++|..||..............+....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence 2356778999999864 47899999999999999999999998665443322222111100
Q ss_pred -------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 301 -------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 301 -------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.......++.++.+|+.+||..||++|||+.++|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000112356889999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=302.62 Aligned_cols=245 Identities=27% Similarity=0.462 Sum_probs=209.0
Q ss_pred EEcceeeecCCeEEEEEEECCCC----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 82 SFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.+.+.||.|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.+ +|+||+++++++.+.+..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEE
Confidence 56789999999999999998766 889999986432 122467889999999999 59999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 158 VMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+|||+++++|.+++..... +++..+..++.|++.||.+||+++++|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccc
Confidence 9999999999999876544 9999999999999999999999999999999999999 4566799999999987665
Q ss_pred Ccceee--ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 236 GKVYRD--IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 236 ~~~~~~--~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
...... ..+++.|+|||.+. ..++.++||||||+++|+|++ |..||...+.......+..+...... ..++.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPE 232 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHH
Confidence 432222 23678999999885 458999999999999999998 88999888777777777766543222 358999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.+++.+||..||++|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=311.73 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=201.0
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.....++|.-...||+|+||.||+|.... |..||||.+...... . ..+|.+|+.++.+++ |||+|+++|||.+.+
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLR-HPNLVKLLGYCLEGG 144 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCC-CcCcccEEEEEecCC
Confidence 34445688888999999999999998764 489999977643321 1 455999999999996 999999999999988
Q ss_pred -eEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---cEeecCCCCceeeccCCCCCcEEEeec
Q 012039 154 -SVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMG---VMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 154 -~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
..+||+||+++|+|.++|.... .++|.....|+..++.||+|||... |+|||||++|||+ |.+...||+||
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDF 221 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDF 221 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCc
Confidence 5999999999999999997655 8999999999999999999999854 9999999999999 78889999999
Q ss_pred CCceeccC-Ccceeec-cCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHH----HHHcCC
Q 012039 228 GLSVFIEE-GKVYRDI-VGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFD----AILQGD 297 (472)
Q Consensus 228 g~~~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~----~i~~~~ 297 (472)
|+|+.... ....... .||.+|+|||.+. +..+.|+|||||||+|.||++|+.+..... ...+.. .+..+.
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 99977654 4433344 8999999999886 578999999999999999999998876432 111121 222221
Q ss_pred cc-CCCCCC--CCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 298 ID-FESAPW--PTIS-----SSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 298 ~~-~~~~~~--~~~s-----~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.. +..+.. ...+ ..+..+..+|++.+|..||++.++++
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11 111111 1222 22557889999999999999998754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.64 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=206.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++++. ||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 4579999999999999999998753 67889999886432 2233567889999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG----------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
..+++||||+++++|.+++.... .+++..++.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 36788899999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
|++ +.++.++|+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 4566799999999876543221 11223466799999875 468999999999999999997 888998888
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+....+..+..... ...++.++.+||.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8777777776554211 1357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=301.68 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=202.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE-EeCCeEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY-EDKQSVHV 157 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~~~l 157 (472)
.+|.+.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++++. |+|++++++++ ..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence 47999999999999999999865 778999987532 23567889999999995 99999999975 45567999
Q ss_pred EEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 158 VMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence 999999999999987643 37899999999999999999999999999999999999 5566799999999876543
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. ....++..|+|||++.. .++.++||||||+++|+|++ |+.||......+....+..+.. ......+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence 22 22344568999998864 58899999999999999997 9999988777777777665422 122356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++|.+||..+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=301.54 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=206.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||.|++|.||+|... |+.||+|.+.... .....+.+|+.+++.+. |+||+++++++.+....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEE
Confidence 347899999999999999999865 7899999986432 14677889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 158 VMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++ +.++.+||+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccc
Confidence 999999999999987665 68999999999999999999999999999999999999 5567799999999987643
Q ss_pred CcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||...+.......+..+.. . .....+++.+.
T Consensus 155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~ 229 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPPEVY 229 (256)
T ss_pred ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCHHHH
Confidence 222 234456799999875 468889999999999999997 9999988877776666655422 1 11245789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++|.+||..+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.54 Aligned_cols=250 Identities=21% Similarity=0.398 Sum_probs=209.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCC-----CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+|++.+.||+|+||.||+|+.+.+ .+.|++|.+.... .......+.+|+++++++. ||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 5799999999999999999997643 4678999875432 1223567899999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 154 SVHVVMELCAGGELFDRIIAKG---------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+||++ +..+.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999997655 68999999999999999999999999999999999999 45567999
Q ss_pred eecCCceeccCCc--ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccC
Q 012039 225 TDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 225 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
+|||++....... ......++..|+|||.+. ..++.++||||||+++|+|++ |..||........+..+..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543222 122335677899999875 457889999999999999998 889998777777777777665544
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
... ..++..+.+++.+||+.+|++|||+.++++.
T Consensus 239 ~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 332 4678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=285.70 Aligned_cols=254 Identities=27% Similarity=0.524 Sum_probs=212.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--Ce
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QS 154 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 154 (472)
..++|++.+++|+|.++.||.|++..++..++||+++. -..+.+.+|+.||+.|++||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35689999999999999999999999999999999864 33678999999999999999999999998764 56
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
..+|+||+++.+...+. ..++.-.++.++.+|+.||.|||+.||+|||+||.|++++. ....++|+|+|+|.+..
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhcC
Confidence 88999999886665433 45888899999999999999999999999999999999964 34468999999999999
Q ss_pred CCcceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCC-CCChHHHHHHHHc-------------CCc
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQ-------------GDI 298 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~-------------~~~ 298 (472)
++..+...+.+..|.-||.+. ..|+..-|+|||||+|..|+..+-||. +.+..+++-+|.. -..
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 998888889999999999885 458999999999999999999888874 4554444444321 000
Q ss_pred c-----------CCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 299 D-----------FESAPW---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 299 ~-----------~~~~~~---------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
. .....| .-+++++.||+.++|..|-.+|+|+.|++.||||..
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 0 011112 235799999999999999999999999999999974
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=301.85 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=201.9
Q ss_pred ceeeecCCeEEEEEEECC-CCC--EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 012039 85 KELGRGQFGVTYLCTENS-TGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-~~~--~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 161 (472)
+.||+|++|.||+|.+.. .++ .||+|.+...... .....+.+|+.+++++. ||||+++++.+.+ ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 333 6899998765432 45678889999999995 9999999999988 889999999
Q ss_pred cCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce
Q 012039 162 CAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (472)
Q Consensus 162 ~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~ 239 (472)
+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999997754 68999999999999999999999999999999999999 45578999999999876542211
Q ss_pred ----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 240 ----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 240 ----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
....++..|+|||.+.. .++.++||||||+++|+|++ |..||...+..+....+......... ...++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 12356788999998864 68999999999999999998 99999887777777666643222222 135789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=307.60 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=200.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECC----------------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS----------------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 141 (472)
..+|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.+. |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 4579999999999999999986432 34468999886432 2334567889999999995 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
|+++++++...+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 36678899999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh--CCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS--GVPPFWAE 284 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~pf~~~ 284 (472)
|++ +.++.++|+|||++..+...... ....+++.|++||+.. +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 45667999999998865433211 1223457899999764 568999999999999999998 78899777
Q ss_pred ChHHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 285 TEKGIFDAILQ----GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 285 ~~~~~~~~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..+.+..... .......+....+++.+.+|+.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555543321 0011111112457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=302.86 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=205.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+|.+.+.||+|+||.||+|.+... ...|++|.+.... .....+.+.+|+.+++++. ||||+++++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITEN-P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcCC-C
Confidence 45799999999999999999987644 3468999875432 1234567889999999995 99999999988764 5
Q ss_pred EEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++ ..+.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence 789999999999999997644 589999999999999999999999999999999999994 5567999999999876
Q ss_pred cCCcceee--ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 234 EEGKVYRD--IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 234 ~~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
........ ..++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+.++... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 54432221 23446799999876 458899999999999999986 99999888877777777665432 2235688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.++.++|.+||..+|++|||+.++++.
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=299.74 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=205.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+...++|++.++||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++++. |+||+++++.+.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EP 74 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CC
Confidence 345678999999999999999999865 4567999987642 223567889999999995 9999999999887 77
Q ss_pred EEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++ +....+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARV 151 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceee
Confidence 89999999999999998763 357888999999999999999999999999999999999 5567899999999976
Q ss_pred ccCCcce--eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 233 IEEGKVY--RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 233 ~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
....... ....++..|+|||++.. .++.++|+||||+++|++++ |..||.+.+.......+.++.. .......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENC 228 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccC
Confidence 6433221 12235567999998864 57889999999999999998 9999988877777776665432 2223568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++.+++.+||..+|++||++.++++
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=298.84 Aligned_cols=246 Identities=26% Similarity=0.473 Sum_probs=206.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+++++++. ||||+++++++......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA----MSEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC----CCHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEE
Confidence 36889999999999999999875 46789999886432 23457889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+++++|.+++... +.+++..++.++.|++.+|.|||+++++|+||||+||++ +.+..++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence 9999999999988754 468999999999999999999999999999999999999 456679999999987654322
Q ss_pred c--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 V--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
. .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+...+.. ...+..+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence 1 11223456899999886 468899999999999999998 99999888877777777655332221 34689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+|+.+||+.+|++|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=297.83 Aligned_cols=241 Identities=25% Similarity=0.383 Sum_probs=199.2
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence 36899999999999865 67899999876432 2233456889999999995 99999999999999999999999999
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCccee--e
Q 012039 165 GELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--D 241 (472)
Q Consensus 165 ~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~--~ 241 (472)
++|.+++... ..+++..+..++.|++.+|.|+|++|++||||+|+||++ +.+..+||+|||++.......... .
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence 9999988653 458899999999999999999999999999999999999 456679999999987654322111 1
Q ss_pred ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 012039 242 IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319 (472)
Q Consensus 242 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 319 (472)
..++..|+|||++. ..++.++||||||+++|++++ |..||...........+..+... .....++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence 23456799999886 458899999999999999998 99999887776666666554221 22246789999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 012039 320 LTQDPKKRITSAQVLE 335 (472)
Q Consensus 320 L~~dp~~Rps~~~~l~ 335 (472)
|..+|++||++.++++
T Consensus 231 l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 231 WDYKPENRPKFSELQK 246 (250)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=309.77 Aligned_cols=263 Identities=30% Similarity=0.481 Sum_probs=218.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC----cccHHHHHHHHHHHHhccCCCCeeEEEEEEE-
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT----KNDKDDIKREIQIMQHLSGQPNIVEFKGAYE- 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~----~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 150 (472)
.+.++|-++..||+|||+.||+|.+....+.||||+-.....-. .+..+...+|.+|-+.| +||.||++|++|.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee
Confidence 34578999999999999999999999999999999865332111 11234467899999999 6999999999986
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--GVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
+.+.+|-|+|||+|.+|.-+|+.++.+++.+++.|+.||+.||.||... .|+|-||||.|||+.+....+.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5678999999999999999999999999999999999999999999986 59999999999999887778899999999
Q ss_pred CceeccCCcc--------eeeccCCCCCCchhhhh-c----ccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHH--
Q 012039 229 LSVFIEEGKV--------YRDIVGSAYYVAPEVLR-R----RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDA-- 292 (472)
Q Consensus 229 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~-- 292 (472)
+++.+..... .....||.+|++||.+. + ..+.++||||+|||+|.++.|+.||.... ..++++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9998865421 23357999999999763 2 37899999999999999999999996543 2333322
Q ss_pred HH-cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 293 IL-QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 293 i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
|+ ...+.|+.. +.++.++++||++||++.-++|....++-.||||.-
T Consensus 699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 22 234455544 679999999999999999999999999999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.36 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=205.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCC----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... .......+.+|+.+++++. ||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 3579999999999999999999877665 58899876443 1234567889999999995 9999999999887 7
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||++ +.+..+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 889999999999999998764 468999999999999999999999999999999999999 4566799999999987
Q ss_pred ccCCcceee---ccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 233 IEEGKVYRD---IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 233 ~~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
......... ..++..|+|||.+. ..++.++||||||+++|++++ |..||.+....++...+..+... ..+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQP--PI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CCC--CC
Confidence 654332111 12356799999875 468899999999999999998 99999888877777777654322 211 34
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+..+.+++.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.93 Aligned_cols=247 Identities=30% Similarity=0.508 Sum_probs=199.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ----- 153 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 153 (472)
..|...+.||+|+||.||+++++.+|+.||||.+.+.. .....+...+|+++|++|. |||||+++++=+...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence 34667789999999999999999999999999987644 3345778889999999995 999999998765433
Q ss_pred -eEEEEEeccCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeecc-CCCCCcEEEeecC
Q 012039 154 -SVHVVMELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS-KDENALLKATDFG 228 (472)
Q Consensus 154 -~~~lv~e~~~g~sL~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~~~kl~Dfg 228 (472)
...+|||||.||||...+.+. ..+++.+...++..+..||.|||++||+||||||.||++.. .+.....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 467999999999999999753 45999999999999999999999999999999999999864 3366788999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCC-----
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGD----- 297 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~----- 297 (472)
.|+.++++....+.+||+.|.+||+.. +.|+..+|.|||||++|++.||..||.... ..++...+..++
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 999999999999999999999999987 468999999999999999999999995321 222333332211
Q ss_pred ----------ccCCC--CCCCCCCH----HHHHHHHHhcccCCCCCC
Q 012039 298 ----------IDFES--APWPTISS----SAKDLVRRMLTQDPKKRI 328 (472)
Q Consensus 298 ----------~~~~~--~~~~~~s~----~~~~li~~~L~~dp~~Rp 328 (472)
+.+.. +..-.++. .+...+..+|..+|.+|.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11000 00012222 345678889999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.60 Aligned_cols=344 Identities=19% Similarity=0.263 Sum_probs=220.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCC----CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENST----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA---- 148 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~---- 148 (472)
..++|.+.+.||+|+||.||+|++..+ +..||+|.+.... ..+...+| . ++.. .+.+++.+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e-~-l~~~-~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE-R-VRRA-CPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH-H-HHhh-chhhHHHHHHhhhcc
Confidence 346899999999999999999999988 8999999875321 11111111 1 1121 12222222211
Q ss_pred --EEeCCeEEEEEeccCCcchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecC
Q 012039 149 --YEDKQSVHVVMELCAGGELFDRIIAKGH--------------------YSERAAASICRSIVNVVHICHFMGVMHRDL 206 (472)
Q Consensus 149 --~~~~~~~~lv~e~~~g~sL~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 206 (472)
...+..+++||||+.+++|.+++..... .....+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999998865321 123446789999999999999999999999
Q ss_pred CCCceeeccCCCCCcEEEeecCCceeccCCc--ceeeccCCCCCCchhhhhc-----------------------ccCCc
Q 012039 207 KPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRR-----------------------RYGKE 261 (472)
Q Consensus 207 kp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~ 261 (472)
||+|||++. ....+||+|||++..+.... ......+++.|+|||.+.. .++.+
T Consensus 282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999952 34579999999998654332 2235678999999996531 13446
Q ss_pred cchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-------CC----------CCCCCCCHHHHHHHHHhcccCC
Q 012039 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF-------ES----------APWPTISSSAKDLVRRMLTQDP 324 (472)
Q Consensus 262 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~s~~~~~li~~~L~~dp 324 (472)
+|||||||+||+|+++..++... .......+....... .. ..+...+....+||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 79999999999999977664321 111111111111100 00 0011123445689999999999
Q ss_pred CCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHhhchhhHHhhhhhhhccccCCCCCcccH
Q 012039 325 KKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITY 404 (472)
Q Consensus 325 ~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~ 404 (472)
++|||+.++|+||||+..............+. .+... . ....+-...+...+..-..+.+|..+.
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~~~~~~~~~~~~~---~~~~~-----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~e 503 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGLLGLSVMQNLRLQ---LFRAT-----------Q-QDYGEAAAWVVFLMAKSGTEKEGGFTE 503 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCccccccccccccc---cchhh-----------H-HHHHHHHHHHHHHHHhcCCCCCCCccH
Confidence 99999999999999987543211111000000 00000 0 000011122333344456677889999
Q ss_pred HHHHHHHHHcCCCCCHHHHH--HHHHHhcCCCCcceeHHHHHHHHh
Q 012039 405 EELKAGLARLGSKLTEAEVQ--QLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 405 ~el~~~l~~~~~~~~~~~~~--~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.||+.+...- ...+++.+ .|....+....|..++.+++.-..
T Consensus 504 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (566)
T PLN03225 504 AQLQELREKE--PKKKGSAQRNALASALRLQRKGVKTVARTVDEIP 547 (566)
T ss_pred HHHHHhhhhc--CcchhhhhhhhHHHHHhhhhhhhhhhhhhhhccc
Confidence 9997666553 22333333 488888999999999999987543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=301.52 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=208.9
Q ss_pred ceEEcceeeecCCeEEEEEEECC-CCCEEEEEEecccccC-------CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 80 HYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLV-------TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+...... .......+.+|+.++.+..+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999987 6789999988643221 122345577899988764469999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 152 KQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
++..++||||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .+++|+||+|+||++ +.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 9999999999999999887743 3468999999999999999999996 789999999999999 4566799999
Q ss_pred cCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 227 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
||++.............|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+........ ..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence 999987665544455678999999998864 588999999999999999999999987777666666665544322 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+++++.++|.+||+.||++||++.++..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=302.89 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=205.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECC----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-C
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-K 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~ 152 (472)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.+ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 4689999999999999999999876 35789999875322 233466788999999999 59999999998665 5
Q ss_pred CeEEEEEeccCCcchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 153 QSVHVVMELCAGGELFDRIIAK--------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
...++++||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||++ +.+..+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 7789999999999999988653 358899999999999999999999999999999999999 45577999
Q ss_pred eecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCcc
Q 012039 225 TDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDID 299 (472)
Q Consensus 225 ~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 299 (472)
+|||+++.+...... ....++..|+|||++.+ .++.++||||||+++|++++ |+.||...+..++...+..+. .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 999999865433221 12345677999998764 58999999999999999999 999998877766666555542 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+. ....+++++.+++.+||..||++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 22457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=304.90 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=197.6
Q ss_pred ceEEcceeeecCCeEEEEEEE----CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--C
Q 012039 80 HYSFGKELGRGQFGVTYLCTE----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--Q 153 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 153 (472)
.|++.+.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence 578899999999999999974 4578899999986432 2333567899999999995 99999999998775 6
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+++||||++|++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++ .++.++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccc
Confidence 789999999999999998664 3589999999999999999999999999999999999994 556799999999987
Q ss_pred ccCCcce----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC---------------hHHHHHH
Q 012039 233 IEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---------------EKGIFDA 292 (472)
Q Consensus 233 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------~~~~~~~ 292 (472)
....... ....++..|+|||++.+ .++.++||||||+++|+|+++..|+.... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543221 23456778999998754 58899999999999999999876653211 0111122
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+..+. ....+..++..+.+||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22221 112235689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.47 Aligned_cols=241 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
++||+|++|.||+|.+.. ++.||+|.+..... ......+.+|+++++++. ||||+++++++.+....++||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999887 99999998865432 234567889999999995 99999999999999999999999999
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCccee---
Q 012039 165 GELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--- 240 (472)
Q Consensus 165 ~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~--- 240 (472)
++|.+++... ..+++..+..++.+++.+|.|||+++++||||+|+||++ +.+..+||+|||++..........
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence 9999998653 468999999999999999999999999999999999999 456679999999987654322111
Q ss_pred eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 012039 241 DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (472)
Q Consensus 241 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (472)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.... ... ....++.++.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHHHHH
Confidence 122356799999876 458999999999999999999 899998877666666665432 111 224678999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 012039 319 MLTQDPKKRITSAQVLE 335 (472)
Q Consensus 319 ~L~~dp~~Rps~~~~l~ 335 (472)
||..+|++|||+.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=293.86 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=214.9
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
.+-+..||.|+||+|++..++.+|+..|||.|..... .....++..|.....+-.++||||++||..-.++..+|.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3345679999999999999999999999999976543 44567888999988888889999999999999999999999
Q ss_pred ccCCcchHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 161 LCAGGELFDRI-----IAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 161 ~~~g~sL~~~l-----~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+| ..||..+. ..+..++|.-+..|.--.+.||.||.. ..|+|||+||+|||+ +..+.+||||||.+..+.
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHH
Confidence 99 45664332 235679999999999999999999975 589999999999999 677889999999998876
Q ss_pred CCcceeeccCCCCCCchhhhh---cccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCccCCCCC--CCCC
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR---RRYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAP--WPTI 308 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~--~~~~ 308 (472)
++-..+..+|-..|||||-+. ..|+.+|||||||++|||+.||+.|+.+-+ .-+.+..+..+..+..... .-.+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 655555568889999999885 359999999999999999999999997643 3455566666655433322 1357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
+..+..||..||.+|-..||...+++++||++.+...
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 8999999999999999999999999999999876543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=302.80 Aligned_cols=240 Identities=18% Similarity=0.276 Sum_probs=191.9
Q ss_pred ceeeecCCeEEEEEEECCCCC-------EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 85 KELGRGQFGVTYLCTENSTGR-------QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~-------~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
+.||+|+||.||+|.++.++. .+++|.+.... ....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 369999999999999865543 38888764322 233457888999999995 9999999999999899999
Q ss_pred EEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC-----CCcEEEeecCCce
Q 012039 158 VMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-----NALLKATDFGLSV 231 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-----~~~~kl~Dfg~~~ 231 (472)
||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999987644 5899999999999999999999999999999999999975432 2348999999987
Q ss_pred eccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCC-CCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
..... ....++..|+|||++.+ .++.++||||||+++|+|++|. .||.......... +......++ ...
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~----~~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP----APK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC----CCC
Confidence 65432 23467889999999864 4789999999999999999984 6665544433322 223222222 235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+.++.+||.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=298.33 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=191.8
Q ss_pred ceeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 012039 85 KELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 162 (472)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.++++++ ||||+++++++.+...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence 36899999999999854 345679999876433 1223456888999999995 999999999999999999999999
Q ss_pred CCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 163 AGGELFDRIIAKG-----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 163 ~g~sL~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
++++|.+++.... ..++..+..++.|++.||.|||+++++|+||||+||++ +....+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence 9999999886432 35667888999999999999999999999999999999 456679999999987543332
Q ss_pred ce---eeccCCCCCCchhhhhc--------ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHH-cCCccCCCCC
Q 012039 238 VY---RDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL-QGDIDFESAP 304 (472)
Q Consensus 238 ~~---~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~-~~~~~~~~~~ 304 (472)
.. ....++..|+|||++.. .++.++||||||+++|+|++ |..||......+...... ........+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 21 12356788999998753 25789999999999999996 999997766555443332 2223233222
Q ss_pred C-CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 305 W-PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 305 ~-~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
. ...++.+.+++.+|+ .+|++|||+++++.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2 246788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=296.60 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=201.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.+|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.++++++ ||||+++++++..+. .++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence 579999999999999999986 46888999988532 23467889999999995 999999999987654 7999
Q ss_pred EeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence 99999999999987643 47899999999999999999999999999999999999 45667999999998764332
Q ss_pred cceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
......+..|+|||.+. ..++.++|+||||+++|+|++ |..||......+....+..+.. . .....++..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M--EPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C--CCCCcCCHHHHH
Confidence 12234456799999876 468899999999999999997 9999988887777776665422 1 123468899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 012039 315 LVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.+||+.+|++||++++++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.76 Aligned_cols=245 Identities=26% Similarity=0.424 Sum_probs=199.3
Q ss_pred ceeeecCCeEEEEEEECCCC------CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 85 KELGRGQFGVTYLCTENSTG------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~------~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
+.||+|+||.||+|++.... ..+|+|.+.+.. .......+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36899999999999976543 679999875432 1234567889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC--CCCcEEEeecCC
Q 012039 159 MELCAGGELFDRIIAK-------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGL 229 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~~~kl~Dfg~ 229 (472)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999988642 2378899999999999999999999999999999999996533 233799999999
Q ss_pred ceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 230 SVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 230 ~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
+......... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...+..+....+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence 8765433211 1234567899999886 458999999999999999998 99999877776666665543221 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+|..+.+||.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=297.33 Aligned_cols=228 Identities=25% Similarity=0.378 Sum_probs=188.1
Q ss_pred cCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcchHH
Q 012039 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD 169 (472)
Q Consensus 90 G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~sL~~ 169 (472)
|.+|.||++++..+++.||+|.+.+.. ...+|...+... .||||+++++++.+.+.+++||||++|++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999986532 223445555555 49999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCC
Q 012039 170 RIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249 (472)
Q Consensus 170 ~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~ 249 (472)
++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence 99887789999999999999999999999999999999999999 45667999999987665432 22345677899
Q ss_pred chhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 012039 250 APEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328 (472)
Q Consensus 250 aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 328 (472)
|||.+. ..++.++||||+|+++|+|++|..|+...... + .....+..+ ..+++.+++||.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNIP--EWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCCc--ccCCHHHHHHHHHHccCCHHHhc
Confidence 999876 45889999999999999999999887543221 0 111111111 35789999999999999999999
Q ss_pred CH-----HHHhcCCcc
Q 012039 329 TS-----AQVLEHPWI 339 (472)
Q Consensus 329 s~-----~~~l~h~~~ 339 (472)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=297.40 Aligned_cols=244 Identities=20% Similarity=0.329 Sum_probs=191.8
Q ss_pred ceeeecCCeEEEEEEECC--CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 012039 85 KELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 162 (472)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.+. ||||+++++.+.....+++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence 369999999999996432 34568888765322 2233456789999999995 999999999999999999999999
Q ss_pred CCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 163 AGGELFDRIIAKG-----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 163 ~g~sL~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
++|+|.+++.... ..++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence 9999999987643 24677889999999999999999999999999999999 556679999999987543322
Q ss_pred ce---eeccCCCCCCchhhhhc--------ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHc-CCccCCCCC
Q 012039 238 VY---RDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQ-GDIDFESAP 304 (472)
Q Consensus 238 ~~---~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 304 (472)
.. ....+++.|+|||++.. .++.++|||||||++|+|++ |..||......+.+..+.. .....+.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 11 22345677999998742 36789999999999999999 7888877766665555443 333333322
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 305 -WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 305 -~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...++..+.+++..|+ .||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2357889999999998 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.21 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=210.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+..++...++++||+|.||.|.+|.-.. +..||+|+++... .......|.+|+.+|.+|+ |||||+++++|..++.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDP 609 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCc
Confidence 3456678899999999999999998543 6899999987544 3445689999999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+++|+||++.|+|.+++..+. .+.......|+.||++|++||.+.++|||||.+.|+|+ +.++++||+|||.++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccc
Confidence 999999999999999998763 23455667799999999999999999999999999999 7888999999999997
Q ss_pred ccCCcceee---ccCCCCCCchhh-hhcccCCccchhhHHHHHHHHhh--CCCCCCCCChHHHHHHHHcCCccC----CC
Q 012039 233 IEEGKVYRD---IVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLS--GVPPFWAETEKGIFDAILQGDIDF----ES 302 (472)
Q Consensus 233 ~~~~~~~~~---~~gt~~y~aPE~-~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~----~~ 302 (472)
+-.++.+.. .+-...|||||. +.+++++++|+|+||+++||+++ ...||...++++..++...-.... -.
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 766655433 234578999995 46899999999999999999765 788998888877776654311111 11
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+-++..+.+++.+|+..+.++||+++++-.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 112467899999999999999999999999854
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.90 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=195.3
Q ss_pred cceEEcceeeecCCeEEEEEE----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--C
Q 012039 79 LHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--K 152 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 152 (472)
.+|++.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+++++++. ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 479999999999999999997 34578899999986432 234567889999999995 9999999997643 4
Q ss_pred CeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 5789999999999999998764 468999999999999999999999999999999999999 456679999999998
Q ss_pred eccCCccee----eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHH---------------HHH
Q 012039 232 FIEEGKVYR----DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG---------------IFD 291 (472)
Q Consensus 232 ~~~~~~~~~----~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------------~~~ 291 (472)
......... ...++..|+|||++.+ .++.++||||||+++|+|++|..|+......- .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 765433211 1123446999998864 58899999999999999999877754322110 011
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+......++ ....++.++.+||.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111111111 22467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.99 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=212.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCC-----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGR-----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
...-++.+.||+|.||.||.|....... .||+|.+.+.. +......|.+|..+|+.+ +|||||+++|++-+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCC
Confidence 4466788899999999999998764332 38888876543 456678899999999999 599999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 153 QSVHVVMELCAGGELFDRIIAK-------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
...+|++|||+||+|..+|.+. ..++......++.+|+.|++||+++++|||||...|+|+ +....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999875 348899999999999999999999999999999999999 556889999
Q ss_pred ecCCceeccCCcceeecc---CCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccC
Q 012039 226 DFGLSVFIEEGKVYRDIV---GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~---gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
|||+|+.+.....+.... -...|||||.+. +.++.|+|||||||++||++| |..||.+.+..+++.-...+. ..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 999999665544333211 124799999987 679999999999999999999 999999999988888666554 22
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+. .+.+++.+.+++..||+.+|++||++..|++
T Consensus 924 ~~--P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DP--PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC--CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 32 2579999999999999999999999999987
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=299.63 Aligned_cols=239 Identities=17% Similarity=0.204 Sum_probs=190.1
Q ss_pred eeeecCCeEEEEEEECCC------------------------CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC
Q 012039 86 ELGRGQFGVTYLCTENST------------------------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~------------------------~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 141 (472)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.+. |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999975321 2358888875432 123456788999999995 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC---
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--- 217 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--- 217 (472)
|+++++++.+....++||||+++++|..++.. .+.+++..+..++.||+.||.|||+++|+||||||+||++...+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888865 45689999999999999999999999999999999999996422
Q ss_pred -CCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHh-hCCCCCCCCChHHHHHHH
Q 012039 218 -ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILL-SGVPPFWAETEKGIFDAI 293 (472)
Q Consensus 218 -~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i 293 (472)
....+|++|||++...... ....++..|+|||.+.+ .++.++||||||+++|+|+ +|..||......+....+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 2345899999987654322 22357888999998854 4789999999999999984 799999876655443322
Q ss_pred HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
......+ ...++.+.++|.+||+.+|++|||+.++|++
T Consensus 235 -~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 -EKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2222222 2345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.95 Aligned_cols=263 Identities=28% Similarity=0.508 Sum_probs=202.5
Q ss_pred cccc-cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-------CCeeEEE
Q 012039 75 EDVK-LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-------PNIVEFK 146 (472)
Q Consensus 75 ~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------p~iv~~~ 146 (472)
+.+. .+|.+.++||.|.|++||+|.+..+.+.||+|+++..+ ...+....||.+|++++.+ .+||+++
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 4455 79999999999999999999999999999999986433 2356678899999999732 3699999
Q ss_pred EEEEe----CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCC--
Q 012039 147 GAYED----KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKD-- 217 (472)
Q Consensus 147 ~~~~~----~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-- 217 (472)
+.|.. +.++|+|+|++ |..|+.+|... +.++...++.|++||+.||.|||. .||+|-||||+|||+...+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~ 227 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEID 227 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccc
Confidence 99964 56899999999 88999998753 459999999999999999999997 5999999999999983220
Q ss_pred --------------------------------------------------------------------------------
Q 012039 218 -------------------------------------------------------------------------------- 217 (472)
Q Consensus 218 -------------------------------------------------------------------------------- 217 (472)
T Consensus 228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~ 307 (590)
T KOG1290|consen 228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP 307 (590)
T ss_pred hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence
Q ss_pred -----------------------------C--------------------------------------------------
Q 012039 218 -----------------------------E-------------------------------------------------- 218 (472)
Q Consensus 218 -----------------------------~-------------------------------------------------- 218 (472)
.
T Consensus 308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~ 387 (590)
T KOG1290|consen 308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP 387 (590)
T ss_pred CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence 0
Q ss_pred --CCcEEEeecCCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCC------hHHH
Q 012039 219 --NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAET------EKGI 289 (472)
Q Consensus 219 --~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~ 289 (472)
...+||+|||-|+... +.+...+.|..|+|||++- ..|+..+||||++|++|||+||...|...+ +++-
T Consensus 388 ~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 388 ECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred ccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0125666666666542 2344556788999999876 579999999999999999999999885321 2222
Q ss_pred HHHHHc------------CCcc--CCC-----------CCCC---------CC----CHHHHHHHHHhcccCCCCCCCHH
Q 012039 290 FDAILQ------------GDID--FES-----------APWP---------TI----SSSAKDLVRRMLTQDPKKRITSA 331 (472)
Q Consensus 290 ~~~i~~------------~~~~--~~~-----------~~~~---------~~----s~~~~~li~~~L~~dp~~Rps~~ 331 (472)
+..|.. |++. |.. ..|+ .. ..++.+||.-||+.+|++||||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 333221 1111 000 1121 11 35678999999999999999999
Q ss_pred HHhcCCccccCCC
Q 012039 332 QVLEHPWIKEGGE 344 (472)
Q Consensus 332 ~~l~h~~~~~~~~ 344 (472)
++|+|||++....
T Consensus 546 ~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 546 QCLKHPWLNPVAG 558 (590)
T ss_pred HHhcCccccCCCC
Confidence 9999999986544
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.38 Aligned_cols=237 Identities=19% Similarity=0.233 Sum_probs=190.4
Q ss_pred ceeeecCCeEEEEEEECCCC----------CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 85 KELGRGQFGVTYLCTENSTG----------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~----------~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+++++. ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46899999999999998776 347777765332 12577889999999995 9999999999888 77
Q ss_pred EEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC----CCCcEEEeecCC
Q 012039 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD----ENALLKATDFGL 229 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~~~kl~Dfg~ 229 (472)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 789999999999999999999999999999999999996433 223699999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
+...... ....++..|+|||++.. .++.++||||||+++|+|++ |..||...+........... ...+.
T Consensus 155 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~--- 227 (259)
T cd05037 155 PITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM--- 227 (259)
T ss_pred ccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC---
Confidence 9875442 23456788999999864 47899999999999999999 57888665443333333221 11111
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+..+.++|.+||..+|++|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=295.03 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=193.2
Q ss_pred ceeeecCCeEEEEEEECC---CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE-eCCeEEEEEe
Q 012039 85 KELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE-DKQSVHVVME 160 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~~lv~e 160 (472)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.+. ||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998653 34579999875321 2234567889999999995 999999999765 5667899999
Q ss_pred ccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 161 LCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 161 ~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
|+.+++|.+++... ...++..+..++.||+.||.|||+.+++||||||+|||+ +.++.+||+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 99999999998764 346778888999999999999999999999999999999 4566799999999876543211
Q ss_pred ----eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 239 ----YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 239 ----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.....++..|+|||.+. ..++.++||||||+++|+|++ |.+||......+....+..+..... ...+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 11234567899999875 468899999999999999999 5667776666666666655432211 13468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+++.+||..+|++||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.21 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=218.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE-----e
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE-----D 151 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~ 151 (472)
..+.|.|.+.||.|.+|.||+++++.+++.+|+|+.... ....+++..|.+||+.+.+|||++.++++|. .
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 345789999999999999999999999999999997643 3456788899999999999999999999985 3
Q ss_pred CCeEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 KQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
++.++||||||.|||.-++++. ..++.|..++.|++.++.|+.+||++.++|||||-.|||++ .++.|||+|||.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeee
Confidence 5789999999999999998875 45699999999999999999999999999999999999994 566799999999
Q ss_pred ceeccCCcc-eeeccCCCCCCchhhhhc------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC
Q 012039 230 SVFIEEGKV-YRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (472)
Q Consensus 230 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (472)
+..+..... ..+.+|||.|||||++.. .|+..+|+||||++..||.-|.+|+....+...+-.|-.. .+...
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkL 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccc
Confidence 988765432 345689999999999852 3788999999999999999999999777665444333332 11122
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..|...+.++.+||..||.+|-.+||+..++|+|||+++.
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 2356678999999999999999999999999999999953
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=295.43 Aligned_cols=240 Identities=17% Similarity=0.231 Sum_probs=189.8
Q ss_pred ceeeecCCeEEEEEEECC------------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 85 KELGRGQFGVTYLCTENS------------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~------------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
+.||+|+||.||+|+... ....|++|.+.... ......+.+|+.+++.+. ||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 368999999999998532 22358888765432 233457788999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC----CCcEEEeec
Q 012039 153 QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE----NALLKATDF 227 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~~~~kl~Df 227 (472)
...++||||+++++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+..++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999887765 356899999999999999999999999999999999999964321 123899999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILL-SGVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
|++...... ....++..|+|||.+. ..++.++|||||||++|+|+ +|..||......+.. ..........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~--- 229 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLV--- 229 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCC---
Confidence 998765322 2346788999999875 35889999999999999998 588888765543332 2222222211
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...++++.+||.+||+.||.+||++.+++++
T Consensus 230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 2346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.58 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=200.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCC----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence 478899999999999999999887776 46888775432 1222346789999999994 99999999998764 4
Q ss_pred EEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||++. .+..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEccccccccc
Confidence 679999999999999987644 589999999999999999999999999999999999994 4567999999999876
Q ss_pred cCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 234 EEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 234 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
...... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.........+..+. .++. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCC
Confidence 433221 1234567899999876 458899999999999999997 999998776655554444332 2222 2457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+..+.+++.+||..+|++||++.++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=298.45 Aligned_cols=250 Identities=15% Similarity=0.154 Sum_probs=187.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCccc--------HHHHHHHHHHHHhccCCCCeeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKND--------KDDIKREIQIMQHLSGQPNIVE 144 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~hp~iv~ 144 (472)
....+|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...+..+ +|+||++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~ 87 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK 87 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence 3446899999999999999999998877 6677777643221100000 01112233344556 5999999
Q ss_pred EEEEEEeCC----eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 145 FKGAYEDKQ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 145 ~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+++++.... ..++++|++ ..++.+.+......++..+..++.|++.||.|||+++|+||||||+|||+ +...
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCC
Confidence 998765443 457888887 44676666665567889999999999999999999999999999999999 4566
Q ss_pred cEEEeecCCceeccCCc--------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HH--
Q 012039 221 LLKATDFGLSVFIEEGK--------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KG-- 288 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~-- 288 (472)
.++|+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 79999999998653211 1122469999999998864 589999999999999999999999987632 22
Q ss_pred ------HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 289 ------IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 289 ------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+..+..+... .+..++++.++++.|+..+|++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22233333222 2456899999999999999999999999875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=295.27 Aligned_cols=248 Identities=21% Similarity=0.370 Sum_probs=199.7
Q ss_pred eEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 012039 81 YSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~---- 153 (472)
|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+.+|+++++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 677889999999999999864 3578999999865432 2334567889999999995 999999999886532
Q ss_pred --eEEEEEeccCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 154 --SVHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 154 --~~~lv~e~~~g~sL~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
..++++||+.+++|.+++... ..++...+..++.||+.||.|||+++|+||||||+||++ +.+..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 347899999999998877532 247889999999999999999999999999999999999 456679999
Q ss_pred ecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccC
Q 012039 226 DFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 226 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
|||++......... ....+++.|++||.+.. .++.++||||||+++|+|++ |.+||.+....+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99998866433221 12234578999998764 57889999999999999999 899998877777666666543221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
. ....+..+.+++.+||..+|++|||+.+++++
T Consensus 236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 13578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.62 Aligned_cols=243 Identities=19% Similarity=0.308 Sum_probs=190.1
Q ss_pred eeeecCCeEEEEEEECCC--CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 86 ELGRGQFGVTYLCTENST--GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~--~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++ ||||+++++.+.+...+|+||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence 699999999999975432 2346667654332 1234567889999999995 9999999999999999999999999
Q ss_pred CcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 164 GGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 164 g~sL~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
+++|.+++.+. ...++..+..++.||+.||.|||+++++||||||+|||+ +.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence 99999998753 235677788999999999999999999999999999999 456779999999986432211
Q ss_pred -ceeeccCCCCCCchhhhhc--------ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC-ccCCCCC-C
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGD-IDFESAP-W 305 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~-~ 305 (472)
......++..|+|||++.. .++.++||||||+++|+|++ |..||......+.+..+..+. .....+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1123467889999998742 35789999999999999997 577887777766666654432 2222222 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+++.+.+++..|| .+|++||+++++++
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 357889999999999 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.78 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=199.5
Q ss_pred cceEEcceeeecCCeEEEEEEEC----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--C
Q 012039 79 LHYSFGKELGRGQFGVTYLCTEN----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--K 152 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 152 (472)
.+|++.+.||+|+||.||+|... .+++.||+|++...... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 46888899999999999999864 34789999998754321 24678899999999995 9999999999877 5
Q ss_pred CeEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 68999999999999999987654 58999999999999999999999999999999999999 455789999999998
Q ss_pred eccCCccee----eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHH--------------HHHH
Q 012039 232 FIEEGKVYR----DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG--------------IFDA 292 (472)
Q Consensus 232 ~~~~~~~~~----~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------------~~~~ 292 (472)
......... ...++..|+|||.+. ..++.++||||||+++|+|++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765332211 123456799999875 458899999999999999999999986542211 1112
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.......... ...++.++.+|+.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222222 2457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.79 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=213.9
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC-----CCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-----QPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----hp~iv~~~~~~~ 150 (472)
.+..+|.+....|+|-||+|..|.+...|..||||+|.... ...+.=++|++||++|.. .-|+++++-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34567888888999999999999999999999999997543 334555789999999962 348999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
..+++|||+|.+ ...|.+.|...+. |....+..++.|++.||..|-..||+|.||||+|||++ ....++|||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDf 581 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDF 581 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccC
Confidence 999999999998 5789999987654 88899999999999999999999999999999999996 45678999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC--
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP-- 304 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 304 (472)
|.|.+..+... ..+..+..|.|||++.+ .|+...|+||+||+||||+||+..|.+.+...++...+..+-.|+..-
T Consensus 582 GSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 582 GSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 99998766543 44566788999998765 799999999999999999999999999988777765543222221100
Q ss_pred --------C---------------------------------------CCCC-------HHHHHHHHHhcccCCCCCCCH
Q 012039 305 --------W---------------------------------------PTIS-------SSAKDLVRRMLTQDPKKRITS 330 (472)
Q Consensus 305 --------~---------------------------------------~~~s-------~~~~~li~~~L~~dp~~Rps~ 330 (472)
+ ..++ ..+++||.+||..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0 0111 357899999999999999999
Q ss_pred HHHhcCCcccc
Q 012039 331 AQVLEHPWIKE 341 (472)
Q Consensus 331 ~~~l~h~~~~~ 341 (472)
.++|.||||+.
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.01 Aligned_cols=242 Identities=42% Similarity=0.737 Sum_probs=207.2
Q ss_pred CCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcchHHH
Q 012039 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170 (472)
Q Consensus 91 ~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~ 170 (472)
+||.||+|.+..+++.+++|++....... ....+.+|++.++++ +|+||+++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999999899999999987543211 167899999999999 599999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCc
Q 012039 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250 (472)
Q Consensus 171 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~a 250 (472)
+.....++...+..++.+++.++.+||+.+++|+||+|+||+++ .++.++|+|||.+.............++..|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 88766689999999999999999999999999999999999994 456799999999998766544556678999999
Q ss_pred hhhhh-cccCCccchhhHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 012039 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328 (472)
Q Consensus 251 PE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 328 (472)
||.+. ..++.++||||||+++|++++|..||.. .......+.+.......... +..++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-cccCCHHHHHHHHHHccCCchhcc
Confidence 99886 4688899999999999999999999987 55555555555544433222 222789999999999999999999
Q ss_pred CHHHHhcCCcc
Q 012039 329 TSAQVLEHPWI 339 (472)
Q Consensus 329 s~~~~l~h~~~ 339 (472)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.64 Aligned_cols=252 Identities=26% Similarity=0.444 Sum_probs=211.7
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCC--C--CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENST--G--RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
.++.-+..-.+.++||.|.||.||+|..... | -.||||..+... +....+.|..|.-+|+.+ +|||||+++|+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv 459 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGV 459 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeee
Confidence 3444455566678899999999999986432 3 358888776543 455688999999999999 59999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
+.+. ..+||||+++-|.|..+|..+ ..++.....-++.||+.||.|||+.+.|||||-..|||+. ...-+||+||
T Consensus 460 ~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDF 535 (974)
T KOG4257|consen 460 CVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADF 535 (974)
T ss_pred eecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeeccc
Confidence 8765 589999999999999999865 4588999999999999999999999999999999999995 4445999999
Q ss_pred CCceeccCCcceeeccCC--CCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 228 GLSVFIEEGKVYRDIVGS--AYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt--~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
|+++.+.....+....|. .-|||||.++ .+++.++|||-|||.+||++. |..||.+-...+.+-.|.+|....-
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~-- 613 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC-- 613 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC--
Confidence 999998877666554443 4599999987 569999999999999999887 9999999888888888888764322
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l 334 (472)
.+++|+.+..|+.+||.++|.+||.+.++.
T Consensus 614 -P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 614 -PPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -CCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 258999999999999999999999997764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=297.87 Aligned_cols=251 Identities=21% Similarity=0.388 Sum_probs=215.3
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
.|+--+.+.....+||-|.||.||.|.++...-.||||.++.. ....++|+.|+.+|+.+. |||+|+++++|..+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeik-HpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHE 335 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhc-CccHHHHhhhhccC
Confidence 3444455667778999999999999999999999999988642 345789999999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 QSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
-.+|||+|||..|.|+++|.+..+ ++.-....++.||..|++||..+++|||||-..|.|+ +++..+|+.|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchh
Confidence 999999999999999999986443 6667778899999999999999999999999999999 78889999999999
Q ss_pred eeccCCcceeeccCC---CCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 231 VFIEEGKVYRDIVGS---AYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt---~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
+.+... .+....|. .-|.|||-+. ..++.|+|||+|||+|||+.| |-.||.+-+....+..+.++. .....
T Consensus 413 RlMtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy---RM~~P 488 (1157)
T KOG4278|consen 413 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY---RMDGP 488 (1157)
T ss_pred hhhcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---cccCC
Confidence 988654 44444444 4699999876 569999999999999999998 888999988888887776652 33333
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.++++.+.+|++.||+++|.+||+++|+-+
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 689999999999999999999999998743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.50 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=213.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCC-C--EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTG-R--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~--~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+..++.++||+|+||.|++|.+...+ + .||||.+...... .....|.+|+.+|.+|+ |||++++|++..+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence 35567789999999999999987643 2 5899998755432 25788999999999996 9999999999887 668
Q ss_pred EEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+|||+++.|||.+.|.. +..|.......++.||+.|+.||..+++|||||-..|+|+.+ ...|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceecc
Confidence 899999999999999987 345888889999999999999999999999999999999954 557999999999998
Q ss_pred cCCcceeeccC----CCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKVYRDIVG----SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~~~~~~g----t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
...+.+....+ ...|+|||.++. .++.++|||++||++|||++ |..||.+.....++++|..+.. .+.+ +.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpRP--k~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPRP--KY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCCC--CC
Confidence 77665543322 346999999984 69999999999999999999 8899999999999999985543 2222 56
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+|+++.++++.||..+|.+|||+..|.+.-+..+
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 8999999999999999999999998876555543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.01 Aligned_cols=259 Identities=21% Similarity=0.309 Sum_probs=187.5
Q ss_pred cccceEEcceeeecCCeEEEEEEEC----------------CCCCEEEEEEecccccCC-----------cccHHHHHHH
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTEN----------------STGRQFACKSISKRKLVT-----------KNDKDDIKRE 129 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~va~K~~~~~~~~~-----------~~~~~~~~~E 129 (472)
..++|.+.++||+|+||+||+|... ..++.||||.+....... ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 235679999985432100 0111223457
Q ss_pred HHHHHhccCCCC-----eeEEEEEEEe--------CCeEEEEEeccCCcchHHHHHhc----------------------
Q 012039 130 IQIMQHLSGQPN-----IVEFKGAYED--------KQSVHVVMELCAGGELFDRIIAK---------------------- 174 (472)
Q Consensus 130 ~~~l~~l~~hp~-----iv~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~---------------------- 174 (472)
+.++.+++ |.+ ++++++++.. .+..++||||+++++|.+++...
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77788885 443 3666776643 35689999999999999888532
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceee--ccCCCCCCc
Q 012039 175 --GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVA 250 (472)
Q Consensus 175 --~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~gt~~y~a 250 (472)
..+++..++.++.|++.+|.|||+++|+||||||+|||+ +.+..+||+|||++........... ..+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 123556788999999999999999999999999999999 4556799999999976544332222 234789999
Q ss_pred hhhhhcc---------------------c--CCccchhhHHHHHHHHhhCCC-CCCCCCh-----------HHHHHHHHc
Q 012039 251 PEVLRRR---------------------Y--GKEIDIWSAGVILYILLSGVP-PFWAETE-----------KGIFDAILQ 295 (472)
Q Consensus 251 PE~~~~~---------------------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~-----------~~~~~~i~~ 295 (472)
||++... + ..+.||||+|||+|+|++|.. ||..... ......+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9987421 1 134799999999999999886 6643211 111112222
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCcccc
Q 012039 296 GDIDFESAPWPTISSSAKDLVRRMLTQDP---KKRITSAQVLEHPWIKE 341 (472)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp---~~Rps~~~~l~h~~~~~ 341 (472)
..+.+ ..|..+++.+++|+.+||..+| .+|+|++|+|+||||..
T Consensus 459 ~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33333 3467789999999999999866 68999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.09 Aligned_cols=249 Identities=25% Similarity=0.458 Sum_probs=217.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
...-.|.+.||.|.||.|++|+.+..|+ .||||.++... ++..+..|+.|+.||-++ +||||+++.++....+.
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCce
Confidence 3456788999999999999999987775 59999987543 455677899999999999 59999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+.||.|||++|+|..+|..+ +.|+..+...+++-|+.|++||-+.++|||||...|||+ +.+..+|++|||+++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeec
Confidence 99999999999999999754 669999999999999999999999999999999999999 77889999999999988
Q ss_pred cCCc-c-eeeccC--CCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGK-V-YRDIVG--SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~-~-~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
.++. . +.+.-| ...|.|||.+. .+++.++||||+||++||.++ |..|||..+.++.+..|.++.. .+....
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR---LPpPmD 858 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR---LPPPMD 858 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC---CCCCCC
Confidence 6544 2 222223 25799999886 579999999999999999776 9999999999999999998743 233357
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+|..+.+|+..||++|-.+||.+.+|+.
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 9999999999999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=274.65 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=210.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|.-+..+|.|.- .|..+-+.-+++.||+|.+... .......++..+|+.++..+. |+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccH
Confidence 34558888899999988 7888888889999999988655 444556778889999999995 99999999998643
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
...|+|||++ ..+|.+.+. -.+....+..|+.|++.|++|||+.||+||||||+||++ .....+||.|||+
T Consensus 91 ~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 91 EEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGL 164 (369)
T ss_pred HHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchh
Confidence 4689999999 558877776 357888999999999999999999999999999999999 6777899999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc-------------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ------------- 295 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------------- 295 (472)
++.....-..+.++.|..|.|||++- -.+...+||||+||++.||++|+..|.+.+.-+.+.++.+
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 98766554567789999999999874 3599999999999999999999999988765544444332
Q ss_pred ---------------C---CccCCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 296 ---------------G---DIDFESAPWP-------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 296 ---------------~---~~~~~~~~~~-------~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
+ ...++...|+ .-+..+++++.+||..||++|.|++++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 0011111221 2245689999999999999999999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.15 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=208.9
Q ss_pred EEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----eEE
Q 012039 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----SVH 156 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----~~~ 156 (472)
+-.+.||.|+||+||.+.+..+|+.||+|.+..-. ..-...+.+.+|+.+|..++ |.|+...+++.+-.+ .+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHH
Confidence 34578999999999999999999999999875322 22334678889999999996 999999988876543 467
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|+|++ ..+|...+.+...++...++-++.||+.||+|||+.+|.||||||.|.|+ +.+..+||||||+++..+..
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchh
Confidence 889998 56888888888899999999999999999999999999999999999999 78889999999999976543
Q ss_pred c--ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHc-----------------
Q 012039 237 K--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ----------------- 295 (472)
Q Consensus 237 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----------------- 295 (472)
. .+...+.|.+|+|||++.+ .|+.+.||||+|||+.||+..+..|...++-+.++.|..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3 3444567899999999975 599999999999999999999999988887766666542
Q ss_pred ------CCccCCCC-CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 296 ------GDIDFESA-PW------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 296 ------~~~~~~~~-~~------~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+....+.. .+ ..-..+...++.++|..||++|.+.++++.|++..+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111110 00 1223467789999999999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.14 Aligned_cols=250 Identities=33% Similarity=0.485 Sum_probs=201.9
Q ss_pred eEEcceeeecCCe-EEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 81 YSFGKELGRGQFG-VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 81 y~~~~~lg~G~~g-~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
|.-.+.+|.|+.| .||+|... |+.||||.+-. .......+|+..|+.-..|||||++|+.-.++...||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4445678999988 46899855 88999998742 234567899999999988999999999999999999999
Q ss_pred eccCCcchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC--CCCCcEEEeecCCceec
Q 012039 160 ELCAGGELFDRIIAKGH----YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--DENALLKATDFGLSVFI 233 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~--~~~~~~kl~Dfg~~~~~ 233 (472)
|.| ..+|.+++...+. ......+.++.|++.||++||+.+||||||||.||||... +....++|+|||+++.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 6799999976411 1114568899999999999999999999999999999854 34467899999999988
Q ss_pred cCCcc----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
..+.. .....||-+|+|||++.. ..+.++||+||||++|+.++| ..||...- +.-.+|..+.+....... .
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~-~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEP-L 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeecc-C
Confidence 76543 334679999999999975 457799999999999999996 89995443 334567777665443321 1
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...++.+||.+||.++|..||+|.++|.||+|...
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11289999999999999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=248.76 Aligned_cols=217 Identities=25% Similarity=0.374 Sum_probs=181.3
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
++...+....+..||+|++|.|=+.++..+|...|+|.+...- ......++.+|+++..+..++|.+|.+|+.+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3444455566788999999999999999999999999997543 34456778899999888888999999999999999
Q ss_pred eEEEEEeccCCcchHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 154 SVHVVMELCAGGELFD----RIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~----~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.++|.||.|. .||.. .+...+.++|..+-.|+..++.||.|||++ .++|||+||+|||+ +..+.+|+||||
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFG 194 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccc
Confidence 9999999994 56643 334567799999999999999999999986 89999999999999 677889999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-----cccCCccchhhHHHHHHHHhhCCCCCCC-CChHHHHHHHHcC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-----RRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQG 296 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~ 296 (472)
.+..+.++-..+-..|-..|||||.+. ..|+.++||||||+++.||.+++.||.. .++.+++.++...
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 998877655444467889999999875 2589999999999999999999999964 4556666666554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.54 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=203.4
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECC---CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...+...|.++.+||+|+|++||++.+.. ..+.||+|.+... .....+.+|+++|..+.++.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34456689999999999999999999887 7889999988643 345679999999999999999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
.++...+|+||++..+..++.. .++...+..+++.++.||.++|.+|||||||||+|||++.. ...-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~--t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR--TQRGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc--cCCceEEechhH
Confidence 9999999999999877777664 46789999999999999999999999999999999999744 445678999998
Q ss_pred eecc-----------------C--C--------------c-c-----------eeeccCCCCCCchhhhh--cccCCccc
Q 012039 231 VFIE-----------------E--G--------------K-V-----------YRDIVGSAYYVAPEVLR--RRYGKEID 263 (472)
Q Consensus 231 ~~~~-----------------~--~--------------~-~-----------~~~~~gt~~y~aPE~~~--~~~~~~~D 263 (472)
.... . + . . .....||++|+|||++. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211 0 0 0 0 01246999999999985 35789999
Q ss_pred hhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHH--------------cCC-------------------cc----------
Q 012039 264 IWSAGVILYILLSGVPPFWAETE-KGIFDAIL--------------QGD-------------------ID---------- 299 (472)
Q Consensus 264 iwslG~il~~ll~g~~pf~~~~~-~~~~~~i~--------------~~~-------------------~~---------- 299 (472)
|||.|||+..++++..||....+ -+.+..|. -+. ..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999854321 11111110 011 00
Q ss_pred ---CCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 ---FESAPW-PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ---~~~~~~-~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.....| ...+..+.+|+.+||..||.+|.|++++|+||||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 000111 2345688999999999999999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.90 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=211.5
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECC-------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 146 (472)
++....+..+.+.||+|.||.|++|.-.. ....||||..+... .....+.+..|+.+|+.+..||||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 44445555777899999999999987431 14579999886544 2356788999999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 147 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
+++...+.+++|+||+..|+|.+++...+ .++......++.||+.|++||++..++||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998765 38889999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcceeec--cCCC--CCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDI--VGSA--YYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAE 284 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~--~gt~--~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~ 284 (472)
||+ ..+..+||+|||+++.......+... .|+. .|||||.+.. .|+.++||||+||+|||+++ |..||.+-
T Consensus 449 VLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 449 VLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred EEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999 56678999999999976655544322 2223 4999999875 69999999999999999999 88999875
Q ss_pred C-hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 285 T-EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 285 ~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
. ..++++.+..|...... ..+++++.++++.||+.+|++||++.++.+
T Consensus 526 ~~~~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CcHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 5 56667766666543222 467999999999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.69 Aligned_cols=260 Identities=28% Similarity=0.494 Sum_probs=219.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+.+++|.+...+|.|+||.||+++++.+++..|+|+++.. ...+...++.|+-+++..+ |||||.+++.|..+..+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence 4567899999999999999999999999999999999643 3456777889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+|.||||.||+|.+.-.-.+++++.++..+++..+.+|+|||+.|-+|||||-.||+++ +.+.+|+.|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhh
Confidence 99999999999998877888999999999999999999999999999999999999994 556699999999877654
Q ss_pred Cc-ceeeccCCCCCCchhhh----hcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-CCCCCC
Q 012039 236 GK-VYRDIVGSAYYVAPEVL----RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTIS 309 (472)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s 309 (472)
.- ...+..||++|||||+. .+.|...+|||++|+...|+---.+|-....+...+.......++.+.. .-...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 32 33467899999999975 2569999999999999999988777765554444443333333333222 223467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+.+|++.+|.++|++||+++.+|.|||....
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 889999999999999999999999999999753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=279.31 Aligned_cols=201 Identities=30% Similarity=0.530 Sum_probs=177.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----ccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLS--GQPNIVEFKGAYED 151 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~ 151 (472)
..|...+.+|+|+||.|++|.++.+...|++|.|.|...... .....+-.|++||..|. .|+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 359999999999999999999999999999999988765321 22334567999999994 38999999999999
Q ss_pred CCeEEEEEeccC-CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCA-GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~-g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
++.+||+||--. |.+|+++|..+.+++|.++..|++|++.|+++||+.||||||||-+|+++ +.++-+||+|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 999999999763 56899999999999999999999999999999999999999999999999 77888999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhcc--cCCccchhhHHHHHHHHhhCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWA 283 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~ 283 (472)
.....+ .+...+||..|.|||++.+. .+..-|||+||++||.++...-||+.
T Consensus 718 a~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 876655 45678999999999999864 48899999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=315.63 Aligned_cols=241 Identities=23% Similarity=0.264 Sum_probs=183.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|...+.||+|+||.||+|++..++..||+|.+..... ....|+.++++++ |||||++++++.+.+..|+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEE
Confidence 3456677889999999999999999999999998853221 1234688999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH---FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
||||+++|+|.+++. .+++..+..++.|++.||.||| +.+|+||||||+||++. .....++. ||......
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-eccccccc
Confidence 999999999999885 4889999999999999999999 66999999999999994 44445554 55544322
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh--HHHHHHHH---c---------CCcc
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAIL---Q---------GDID 299 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~---~---------~~~~ 299 (472)
.. ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ........ . ....
T Consensus 834 ~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 834 TD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred cC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 11 22368899999998864 589999999999999999999999854221 11111110 0 0000
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...........++.+++.+||+.||++|||+.++++.
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000112356789999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=254.82 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=204.6
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE-EEeCC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA-YEDKQ 153 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~-~~~~~ 153 (472)
-++.+.|.|.+.||+|.||.+-+|+|+.+...+++|.+++.. .....|.+|...--.|..|.||+.-|+. |+..+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 356678999999999999999999999999999999997644 3467899999988888889999998764 78888
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+++++||++.|+|.+-+.. ..+.|...+.++.|+++||.|+|++++||||||.+||||...+ ...+||||||+.+..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccccc
Confidence 99999999999999887655 3588999999999999999999999999999999999997544 348999999998765
Q ss_pred cCCcceeeccCCCCCCchhhhh----c--ccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCccCCCC
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLR----R--RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESA 303 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~ 303 (472)
+..- ...--+..|.+||++. + ...+.+|||.||+|+|.+|||++||+... ..-.+....++...-...
T Consensus 174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 4322 1222356799999763 2 25788999999999999999999997432 222334444444443344
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCcc
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKR---ITSAQVLEHPWI 339 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~R---ps~~~~l~h~~~ 339 (472)
.+..+|+.+..+.++-|.+++++| .++..-....|.
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 456789999999999999999999 444444444444
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.28 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=204.9
Q ss_pred EEcceeeecCCeEEEEEEECCCCC----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 82 SFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
+.+++||+|+||+||+|.+-..|+ +||+|++.... ....-.++..|+-+|.+| +|||++++++++.... +-|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHH
Confidence 346789999999999999876554 58888875433 334467889999999999 5999999999988766 789
Q ss_pred EEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|++|+++|+|.++++.+ .++..+....|+.||+.|+.|||.++++||||-..|||+ ..-..+||.|||+++.+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence 99999999999999864 568899999999999999999999999999999999999 45567999999999987654
Q ss_pred cce-eeccC--CCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 237 KVY-RDIVG--SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 237 ~~~-~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
... ....| .+.|||=|.+. ..|+.++||||+||++||++| |..|+.+...+++-+.+..+.. ...+ +.++-+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCtiD 928 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICTID 928 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCccHH
Confidence 432 22222 34688888776 469999999999999999999 9999999999888888887765 3333 578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.-++.+||..|+..||+++++..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 999999999999999999988753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=252.00 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=190.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhc-cCCCCeeEEEEEEEeC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL-SGQPNIVEFKGAYEDK-- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~~hp~iv~~~~~~~~~-- 152 (472)
.+..+-.+.+.||+|-||.||+|+++ |..||||++. ..+.....+|.+|.+.+ -.|+||..+++.-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~------srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS------SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEec------ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 45567889999999999999999998 8899999985 33466778888887763 1499999998765432
Q ss_pred --CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeecCCCCceeeccCCCCCcE
Q 012039 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------GVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
..++||++|.+.|||+|+|.+ ..++......++..++.||++||.. .|.|||||..|||+ ..++.+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C 355 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC 355 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcE
Confidence 368999999999999999987 5799999999999999999999953 49999999999999 678889
Q ss_pred EEeecCCceeccCCc-----ceeeccCCCCCCchhhhhccc-------CCccchhhHHHHHHHHhhC----------CCC
Q 012039 223 KATDFGLSVFIEEGK-----VYRDIVGSAYYVAPEVLRRRY-------GKEIDIWSAGVILYILLSG----------VPP 280 (472)
Q Consensus 223 kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~DiwslG~il~~ll~g----------~~p 280 (472)
-|+|+|+|....... .....+||..|||||++.... -..+||||||.|+||++.. .+|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999998765442 223468999999999996432 2468999999999998752 578
Q ss_pred CCCC-----ChHHHHHHHHcCCccCC-CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHh
Q 012039 281 FWAE-----TEKGIFDAILQGDIDFE-SAPWPTIS--SSAKDLVRRMLTQDPKKRITSAQVL 334 (472)
Q Consensus 281 f~~~-----~~~~~~~~i~~~~~~~~-~~~~~~~s--~~~~~li~~~L~~dp~~Rps~~~~l 334 (472)
|++- +.+++.+-+.-.++... ...|...+ ..+..+++.||..||..|.|+-.+.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 8653 22333333333333322 23343332 2456889999999999999986543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=253.89 Aligned_cols=240 Identities=25% Similarity=0.377 Sum_probs=187.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc-CCCCeeEEEEEEEeCC----e
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQPNIVEFKGAYEDKQ----S 154 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~~----~ 154 (472)
.-.+.+.||+|.||.||+|... ++.||||+++ ....+.+.+|-+|.+... .|+||+++++.-.... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4566788999999999999865 6899999985 345778888988887642 5999999998765443 8
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEeecCCCCceeeccCCCCCcEEEe
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---------GVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
++||+||.+.|+|.++|..+ .+++....+|+..++.||+|||+- .|+|||||..|||+ ..+.+.-|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEee
Confidence 99999999999999999765 689999999999999999999962 59999999999999 567789999
Q ss_pred ecCCceeccCCcce---eeccCCCCCCchhhhhcccC-------CccchhhHHHHHHHHhhCCCC------------CC-
Q 012039 226 DFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRRRYG-------KEIDIWSAGVILYILLSGVPP------------FW- 282 (472)
Q Consensus 226 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~~ll~g~~p------------f~- 282 (472)
|||+|..+..+... ...+||..|||||++.+... ...||||+|.|||||++...- |.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999988765432 23789999999999976422 358999999999999985433 32
Q ss_pred ----CCChHHHHHHHHcCCccC-CCCCCCC--CCHHHHHHHHHhcccCCCCCCCHH
Q 012039 283 ----AETEKGIFDAILQGDIDF-ESAPWPT--ISSSAKDLVRRMLTQDPKKRITSA 331 (472)
Q Consensus 283 ----~~~~~~~~~~i~~~~~~~-~~~~~~~--~s~~~~~li~~~L~~dp~~Rps~~ 331 (472)
..+.+++...+.+.+... ....|.. -...+++.+..||..|++.|.|+.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 112234444444433321 2222322 235688999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-30 Score=235.40 Aligned_cols=211 Identities=44% Similarity=0.740 Sum_probs=184.1
Q ss_pred eeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCcc
Q 012039 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (472)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~s 166 (472)
||+|++|.||++....+++.+++|++....... ....+.+|+++++.+. |++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999986543211 3577899999999996 8999999999999999999999999899
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-ceeeccC
Q 012039 167 LFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVG 244 (472)
Q Consensus 167 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g 244 (472)
|.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||++... ...++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99988765 478999999999999999999999999999999999999531 5679999999998765442 1233567
Q ss_pred CCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 245 SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 245 t~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+||..
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 889999999865 678999999999999999 5789999999999
Q ss_pred CCCCCCCHHHHhcCC
Q 012039 323 DPKKRITSAQVLEHP 337 (472)
Q Consensus 323 dp~~Rps~~~~l~h~ 337 (472)
+|++||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=235.44 Aligned_cols=211 Identities=43% Similarity=0.761 Sum_probs=181.6
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++++. |+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence 56788999999999999999988999999998754321 24678889999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc--
Q 012039 161 LCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-- 237 (472)
++.+++|.+++..... +++..+..++.+++.++.+||+++++|+||+|.||+++ ....++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc
Confidence 9999999999987766 89999999999999999999999999999999999994 45779999999998776543
Q ss_pred ceeeccCCCCCCchhhh-h-cccCCccchhhHHHHHHHHhhCCCCCCC--CChHHHHHHHHcCC
Q 012039 238 VYRDIVGSAYYVAPEVL-R-RRYGKEIDIWSAGVILYILLSGVPPFWA--ETEKGIFDAILQGD 297 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~ 297 (472)
......++..|++||.+ . ..++.++|+|+||+++|+|++|+.||.. .....+.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 33445788899999987 3 3477899999999999999999999977 34446677776664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=284.83 Aligned_cols=197 Identities=19% Similarity=0.231 Sum_probs=147.3
Q ss_pred CCeeEEEEEE-------EeCCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 140 PNIVEFKGAY-------EDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 140 p~iv~~~~~~-------~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
+||+++++++ .....+++++|++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4666677766 2334677889988 6799999965 34599999999999999999999999999999999999
Q ss_pred eeccC----------------CCCCcEEEeecCCceeccCCc-----------------ceeeccCCCCCCchhhhh-cc
Q 012039 212 LLSSK----------------DENALLKATDFGLSVFIEEGK-----------------VYRDIVGSAYYVAPEVLR-RR 257 (472)
Q Consensus 212 li~~~----------------~~~~~~kl~Dfg~~~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 257 (472)
|+... +....+|++|||+++...... .....+||+.|+|||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99531 234567888888876432100 011246899999999876 46
Q ss_pred cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 012039 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (472)
Q Consensus 258 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~ 337 (472)
++.++|||||||+||||++|.+|+.... ..+..+...... . .+....+...+++.+||.++|.+||++.++|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP--P-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC--h-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 8999999999999999999988875321 222223222111 1 1112245678899999999999999999999999
Q ss_pred ccccC
Q 012039 338 WIKEG 342 (472)
Q Consensus 338 ~~~~~ 342 (472)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=230.79 Aligned_cols=250 Identities=18% Similarity=0.228 Sum_probs=202.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCC-----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE-
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTG-----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE- 150 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 150 (472)
.+.++++...+-+|.||.||.|.++... +.|.+|.++... .+.....+..|--++..+. |||+..+.++..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEee
Confidence 3567888889999999999999876532 345566654322 3344566788888888885 999999998764
Q ss_pred eCCeEEEEEeccCCcchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcE
Q 012039 151 DKQSVHVVMELCAGGELFDRIIA--------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
+....++++.+..-|.|..++.. .+.++..+...++.|+..|++|||+.||+|.||-..|.+| ++...+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeE
Confidence 45678899999988999988862 1236777888999999999999999999999999999999 667889
Q ss_pred EEeecCCceeccCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 012039 223 KATDFGLSVFIEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGD 297 (472)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 297 (472)
||+|=.+++.+-+.+... .......||+||.+. ..|+.++|+|||||+||||+| |+.|+..-++.++..-++.|.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 999999998776544211 112345799999886 569999999999999999999 999999989988888887764
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 298 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.- ..+ -++|+++..++.-||...|++||+++|+..
T Consensus 516 Rl-aQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 RL-AQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ee-cCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 32 222 479999999999999999999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=225.36 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=206.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.-+|+++++||+|+||.++.|.+.-+++.||||.-+. .....++..|.+..+.|.+.++|..+|.+...+.+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3489999999999999999999999999999998653 34567899999999999989999999999999999999
Q ss_pred EEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC--CCCCcEEEeecCCceecc
Q 012039 158 VMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--DENALLKATDFGLSVFIE 234 (472)
Q Consensus 158 v~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~--~~~~~~kl~Dfg~~~~~~ 234 (472)
|+|++ |.||.|++. ..++|+..++..++.|++.-++|+|++.+|+|||||+|+||+.. .....|.|+|||+|+.+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999 899988875 45679999999999999999999999999999999999999742 344678999999999886
Q ss_pred CCcc--------eeeccCCCCCCchhhh-hcccCCccchhhHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCccCC-
Q 012039 235 EGKV--------YRDIVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAE---TEKGIFDAILQGDIDFE- 301 (472)
Q Consensus 235 ~~~~--------~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~- 301 (472)
+..+ ..+..||..||+-... ...-+...|+=|||-++.+.|.|.+||.+. +.++-+++|-..+...+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 6542 2356799999997743 345788999999999999999999999874 55677777766544322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSA 331 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~ 331 (472)
.....++|.++...++-.-..+-.+-|..+
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 223456788888777777777777777764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=210.79 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=207.1
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+...|+++++||+|+||.+|+|....+|..||||+-... .....+..|..+.+.|++...|+.+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 3567899999999999999999999999999999986432 23457888999999999888999999999999999
Q ss_pred EEEEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
.+||+++ |.||.+++. ..+.++..++..++-|++.-++|+|.++++||||||+|+|++-......+.|+|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 899988875 45679999999999999999999999999999999999999876677789999999998765
Q ss_pred CCcc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCccCCC
Q 012039 235 EGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFES 302 (472)
Q Consensus 235 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 302 (472)
+... .....||..|.+-...-+ ..+...|+-|+|.+|.++..|..||++.. ...-++.|...+...+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 4321 234679999998765443 46788999999999999999999998754 34556667666554432
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 012039 303 -APWPTISSSAKDLVRRMLTQDPKKRITSA 331 (472)
Q Consensus 303 -~~~~~~s~~~~~li~~~L~~dp~~Rps~~ 331 (472)
....++|.++.-.+.-|-..--++-|...
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 34578899999999999887777777654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=211.92 Aligned_cols=162 Identities=25% Similarity=0.341 Sum_probs=127.9
Q ss_pred cchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeecc
Q 012039 165 GELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (472)
Q Consensus 165 ~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (472)
|||.+++.. ...+++..++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 689999976 445999999999999999999999998 9999999 55667888 99998765432 26
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccCCC---CCCCCCCH--HHHHHH
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFES---APWPTISS--SAKDLV 316 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 316 (472)
||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8999999999864 589999999999999999999999976543 2333333332222111 11122334 699999
Q ss_pred HHhcccCCCCCCCHHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.+||..+|.+||++.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=222.12 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=195.9
Q ss_pred ceEEcceeeecCCeEEEEEEECCCC-CEEEEEEecccccCCcccHHHHHHHHHHHHhcc---CCCCeeEEEEEE-EeCCe
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTG-RQFACKSISKRKLVTKNDKDDIKREIQIMQHLS---GQPNIVEFKGAY-EDKQS 154 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~iv~~~~~~-~~~~~ 154 (472)
+|.+.++||+|+||.||.|.+..++ ..+|+|+...... .....+..|..++..+. +.+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~---~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG---SKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc---CCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988775 5788888754321 11126778999999986 246999999999 57888
Q ss_pred EEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC--CCCcEEEeecCCc
Q 012039 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLS 230 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~~~kl~Dfg~~ 230 (472)
.||||+.+ |.+|.++.... +.++..++..|+.|++.+|+++|+.|++||||||+|++++... ....+.|+|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 89999977543 5799999999999999999999999999999999999997543 2257999999999
Q ss_pred eecc---CCc-------c-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc
Q 012039 231 VFIE---EGK-------V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 231 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 298 (472)
+... ... . .....||..|.++.+..+ ..+.+.|+||++.++.+++.|..||.+.........+.+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 111 1 123459999999998764 589999999999999999999999977654333333333222
Q ss_pred cCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 299 DFESA-PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 299 ~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..... .....+.++..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 233456788888888888889999988776543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-25 Score=217.01 Aligned_cols=255 Identities=35% Similarity=0.581 Sum_probs=208.6
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCC-CeeEEEEEEEeCCeEEEEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-~iv~~~~~~~~~~~~~lv~ 159 (472)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+. |+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence 788899999999999999987 779999987665433335778999999999997 66 8999999998888889999
Q ss_pred eccCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC-cEEEeecCCceeccC
Q 012039 160 ELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIEE 235 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~-~~kl~Dfg~~~~~~~ 235 (472)
+++.++++.+.+.... .+++..+..++.|++.++.|+|+.+++|||+||+||++. ... .++++|||.+.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence 9999999997776654 799999999999999999999999999999999999994 444 699999999986554
Q ss_pred Cc-------ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCcc-
Q 012039 236 GK-------VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDID- 299 (472)
Q Consensus 236 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~- 299 (472)
.. ......||..|++||.+.. .+....|+||+|++++++++|..||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 33 2356789999999998864 578899999999999999999999877653 4455555544433
Q ss_pred CCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 FESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ~~~~~~~~~----s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
......... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 222211222 2578999999999999999999999988776643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=252.75 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=197.5
Q ss_pred EEcceeeecCCeEEEEEEECCCCCEEEEEEeccc---ccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKR---KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.....+|.|++|.|+.+......+.++.|..... ..........+..|+-+-..|. |||++..+..+.+...++-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcccchhh
Confidence 4567899999998888887776666666654321 1111111222666777888885 99998887777666666666
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC--
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-- 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-- 236 (472)
||||++ +|+.++...+.++...+-.+++||+.|+.|+|..||.|||||++|+++ ..++.+||+|||.+.....+
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence 999999 999999988899999999999999999999999999999999999999 56678999999998765432
Q ss_pred ---cceeeccCCCCCCchhhhhc-cc-CCccchhhHHHHHHHHhhCCCCCCCCChHHH--HHHHHcCCcc---CCCCCCC
Q 012039 237 ---KVYRDIVGSAYYVAPEVLRR-RY-GKEIDIWSAGVILYILLSGVPPFWAETEKGI--FDAILQGDID---FESAPWP 306 (472)
Q Consensus 237 ---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~---~~~~~~~ 306 (472)
......+|+..|+|||++.+ .| ....||||.|+++..|.+|+.||......+. .......... -+...|.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 22345789999999999865 45 4579999999999999999999965433322 1111111111 1222345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.++...+.+|.+||++||.+|.|+++|++.+||+...
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 6788999999999999999999999999999998754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=221.44 Aligned_cols=175 Identities=19% Similarity=0.210 Sum_probs=132.9
Q ss_pred ccccceEEcceeeecCCeEEEEEEECC-CCCEEEEEEeccccc--CCcccHHHHHHHHHHHHhccCCCCeeE-EEEEEEe
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKL--VTKNDKDDIKREIQIMQHLSGQPNIVE-FKGAYED 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~-~~~~~~~ 151 (472)
.+..+|.+.+.||+|+||+||+|+++. +++.||||++..... ........+.+|+.+|++|. |+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~--- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT--- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc---
Confidence 455689999999999999999999876 677789998753211 12223567899999999996 999885 5432
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecC-CCCceeeccCCCCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL-KPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl-kp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+..|+|||||+|++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||++ .++.+||+|||++
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECccc
Confidence 45799999999999963 21 111 1467899999999999999999999 99999994 4567999999999
Q ss_pred eeccCCcc---------eeeccCCCCCCchhhhhcc-------cCCccchh
Q 012039 231 VFIEEGKV---------YRDIVGSAYYVAPEVLRRR-------YGKEIDIW 265 (472)
Q Consensus 231 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-------~~~~~Diw 265 (472)
..+..... .....+++.|+|||.+... .+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 97654321 1235678889999988521 34457776
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-28 Score=235.57 Aligned_cols=240 Identities=27% Similarity=0.492 Sum_probs=207.2
Q ss_pred eeecCCeEEEEEEE---CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012039 87 LGRGQFGVTYLCTE---NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 87 lg~G~~g~V~~~~~---~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
+|+|+||.|++++. ...+..+|+|+..+......... ....|..++..+++||.+|+++..++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 79999999998653 23467799998877655433222 455688888888779999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeecc
Q 012039 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (472)
Q Consensus 164 g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (472)
||.|...+.....+.+.....+...++-++.++|+.+|+|||+|++||++ +.++.+++.|||+++..-..+.. +
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---C 154 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---c
Confidence 99999999888889999999999999999999999999999999999999 77888999999999876554433 8
Q ss_pred CCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 012039 244 GSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (472)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (472)
||..|||||+++ .+...+|.||+|+++++|++|..||.+ ++...|...++..+. .++..+++++..++..+
T Consensus 155 gt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 155 GTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRN 225 (612)
T ss_pred cchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhC
Confidence 999999999998 678899999999999999999999987 677788877776664 46789999999999999
Q ss_pred CCCCCCH-----HHHhcCCccccC
Q 012039 324 PKKRITS-----AQVLEHPWIKEG 342 (472)
Q Consensus 324 p~~Rps~-----~~~l~h~~~~~~ 342 (472)
|..|... .++++|+||+..
T Consensus 226 p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 226 PENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHHhccCcchhHHHhccchheee
Confidence 9999855 689999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.81 Aligned_cols=220 Identities=32% Similarity=0.609 Sum_probs=175.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|..++.|..|+||.||.++|+.+.+.+|+| +.+..+. +.+ ++... +.|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a-~npfvv--------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFA-GNPFVV--------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---ccccc-CCccee---------------
Confidence 46888999999999999999999999999995 4333221 111 33333 355555
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC---
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE--- 235 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~--- 235 (472)
|+-...++.-+.++... +.+++|||+.||+|||+||+|.+| ..-+.+|+.|||+++....
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence 34445555555666554 678999999999999999999999 5677899999999874321
Q ss_pred -----Cc--------ceeeccCCCCCCchhhh-hcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC
Q 012039 236 -----GK--------VYRDIVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 236 -----~~--------~~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
+. .-...+|||.|.|||++ +..|+..+|+|++|+|+|+.+.|+.||.+.+.++++..+......++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 10 01235899999999976 56799999999999999999999999999999999999999888888
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccccCC
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKEGG 343 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~~~l~h~~~~~~~ 343 (472)
... ..++++++++|.++|+.+|..|. .+-++.+|+||+...
T Consensus 279 E~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 279 EED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 774 46789999999999999999995 567888999998653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=196.90 Aligned_cols=234 Identities=24% Similarity=0.378 Sum_probs=153.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC---------CCCeeEEEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG---------QPNIVEFKGAYE 150 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------hp~iv~~~~~~~ 150 (472)
....++.||.|+++.||.+++..|++.+|+|+............+.+.+|......+.+ |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46678899999999999999999999999998865554344456777777655554432 212333333221
Q ss_pred ---------e---CC-----eEEEEEeccCCcchHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHcCcEeecC
Q 012039 151 ---------D---KQ-----SVHVVMELCAGGELFDRII---AKGHY----SERAAASICRSIVNVVHICHFMGVMHRDL 206 (472)
Q Consensus 151 ---------~---~~-----~~~lv~e~~~g~sL~~~l~---~~~~~----~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 206 (472)
. .. +.+++|+-+ -++|.+.+. ..... .......+..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 11 236788877 568876653 22222 12233456689999999999999999999
Q ss_pred CCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc---------ccCCccchhhHHHHHHHHhhC
Q 012039 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---------RYGKEIDIWSAGVILYILLSG 277 (472)
Q Consensus 207 kp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~~ll~g 277 (472)
+|+||++ +.++.+.|+||+.....+. .......+..|.+||.... .++.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999 6778899999988775443 2222345678999997632 378899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 012039 278 VPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327 (472)
Q Consensus 278 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 327 (472)
..||........... .|. .+.++|+.+++||+.+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 999976543211111 222 223789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=191.78 Aligned_cols=175 Identities=18% Similarity=0.155 Sum_probs=133.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHH------HHHHHHHHHhccCCCCeeEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~------~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
.+..+|++.+.||.|+||.||++.. ++..+|+|++.......+..... +.+|++.+.+|. ||+|+.+.+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence 4577999999999999999999654 46789999987554333322223 679999999995 99999999886
Q ss_pred EeC--------CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCc
Q 012039 150 EDK--------QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 150 ~~~--------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~ 221 (472)
... +..+|||||++|.+|.+.. .+++ ..+.+++.+|..+|+.|++|||++|+||+++ .++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~~g- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---KNG- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---CCC-
Confidence 643 3578999999999997763 2333 3466999999999999999999999999995 344
Q ss_pred EEEeecCCceeccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHh
Q 012039 222 LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILL 275 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll 275 (472)
++|+|||............. =++...|..++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 99999998875533221110 022345778999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=187.38 Aligned_cols=143 Identities=20% Similarity=0.202 Sum_probs=110.8
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCccc-----------------------HHHHHHHHHHHHhccCCC
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND-----------------------KDDIKREIQIMQHLSGQP 140 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~hp 140 (472)
...||+|++|.||+|.+. +|+.||+|+++......... .....+|+.++.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 467999999999999987 89999999997543211110 122345999999995 77
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEeecCCCCceeeccCCCC
Q 012039 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC-HFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 141 ~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~dlkp~Nili~~~~~~ 219 (472)
++.....+.... .+|||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+|||++ +
T Consensus 80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~ 153 (190)
T cd05147 80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D 153 (190)
T ss_pred CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence 664433332222 379999999887766555567899999999999999999999 799999999999999995 2
Q ss_pred CcEEEeecCCceecc
Q 012039 220 ALLKATDFGLSVFIE 234 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~ 234 (472)
+.++|+|||++....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 469999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-24 Score=194.98 Aligned_cols=189 Identities=29% Similarity=0.421 Sum_probs=143.5
Q ss_pred CCCCeeEEEEEEEe---------------------------CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHH
Q 012039 138 GQPNIVEFKGAYED---------------------------KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190 (472)
Q Consensus 138 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~ 190 (472)
.|||||+++..|.+ ...+|+||..+ ..+|.+++..+ ..+....+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999988732 35689999988 46999888654 467778889999999
Q ss_pred HHHHHHHHcCcEeecCCCCceeecc-CCCCCcEEEeecCCceeccCC-------cceeeccCCCCCCchhhhhccc----
Q 012039 191 NVVHICHFMGVMHRDLKPENFLLSS-KDENALLKATDFGLSVFIEEG-------KVYRDIVGSAYYVAPEVLRRRY---- 258 (472)
Q Consensus 191 ~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---- 258 (472)
+|+.|||++||.|||||.+|||+.- +|.-..+.|.|||++.-.+.. ......-|....||||+.....
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999974 344567889999987643321 1222345778899999986321
Q ss_pred ---CCccchhhHHHHHHHHhhCCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 012039 259 ---GKEIDIWSAGVILYILLSGVPPFWAETEKGIF-DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSA 331 (472)
Q Consensus 259 ---~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~ 331 (472)
-.++|.|+.|.+.||+++..-||++..+..+- ....+..++ .....+++.+++++..+|+.||.+|+++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 24899999999999999999999884432111 111222221 11246889999999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=179.57 Aligned_cols=188 Identities=20% Similarity=0.256 Sum_probs=139.8
Q ss_pred EcceeeecCCeEEEEEEECCCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 012039 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 161 (472)
+...|++|+||+||++.. .+.+++.+.+.....- .......+.+|+++|++|.++++|++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 457899999999998765 4677776655432210 011122578999999999767899999886 346999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecC-CCCceeeccCCCCCcEEEeecCCceeccCCcce-
Q 012039 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL-KPENFLLSSKDENALLKATDFGLSVFIEEGKVY- 239 (472)
Q Consensus 162 ~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl-kp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~- 239 (472)
+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++ .++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcchHH
Confidence 999998654321 1 2357889999999999999999999 79999994 4567999999999865543311
Q ss_pred -----e--------eccCCCCCCchhhhh--cccC-CccchhhHHHHHHHHhhCCCCCCCCCh
Q 012039 240 -----R--------DIVGSAYYVAPEVLR--RRYG-KEIDIWSAGVILYILLSGVPPFWAETE 286 (472)
Q Consensus 240 -----~--------~~~gt~~y~aPE~~~--~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~ 286 (472)
. -...++.|++|+.-. ...+ ...++++.|.-+|.++|+..++++..+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 122578888888532 2333 667899999999999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=179.08 Aligned_cols=144 Identities=17% Similarity=0.174 Sum_probs=113.1
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc------------------c-----HHHHHHHHHHHHhccCCC
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN------------------D-----KDDIKREIQIMQHLSGQP 140 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~------------------~-----~~~~~~E~~~l~~l~~hp 140 (472)
.+.||+|++|.||+|.+. +|+.||||++......... . ...+.+|...+.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 568999999999999987 8999999998765211000 0 123467999999995 88
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCC
Q 012039 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 141 ~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~ 219 (472)
+|.....+.... .+|||||++|+++.........++...+..++.|++.++.++|+ +||+||||||+||++. +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence 875444433332 47999999988665444445678899999999999999999999 9999999999999995 4
Q ss_pred CcEEEeecCCceeccC
Q 012039 220 ALLKATDFGLSVFIEE 235 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~ 235 (472)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 5699999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=173.00 Aligned_cols=138 Identities=20% Similarity=0.251 Sum_probs=108.9
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc----CCCCeeEEEEEEEeCC---eEE
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS----GQPNIVEFKGAYEDKQ---SVH 156 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~---~~~ 156 (472)
.+.||+|+||.||. ++.++.. +||++.... ......+.+|+.+++.|. +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999995 7777666 699886532 224567899999999994 3799999999999873 434
Q ss_pred -EEEec--cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCcEeecCCCCceeeccCC-CCCcEEEeecCCc
Q 012039 157 -VVMEL--CAGGELFDRIIAKGHYSERAAASICRSIVNVV-HICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLS 230 (472)
Q Consensus 157 -lv~e~--~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~i~H~dlkp~Nili~~~~-~~~~~kl~Dfg~~ 230 (472)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ .|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5579999999663 56666 35678888777 999999999999999999997533 3457999995443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-23 Score=211.01 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=178.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEeccccc-CCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.|...+.||.+.|=+|.+|++++ | .|+||++-+... ..-....+-..|++ .... ++||++.+.-+.+.+..-|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence 68888999999999999999874 4 489999866542 12222333444555 3334 599999998888888888999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec--cCC
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI--EEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~--~~~ 236 (472)
-+|. ..+|+|++.....+..-+.+-|+.||+.||.-||..||+|||||.+|||++ .-+.+.|.||...+.. .+.
T Consensus 100 Rqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 9999 459999998877788889999999999999999999999999999999995 4456889999876532 221
Q ss_pred c--cee----eccCCCCCCchhhhhc-----------c-cCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 012039 237 K--VYR----DIVGSAYYVAPEVLRR-----------R-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGD 297 (472)
Q Consensus 237 ~--~~~----~~~gt~~y~aPE~~~~-----------~-~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 297 (472)
+ .+. +-..-.+|.|||-+.. . .+++-||||+||+++||++ |.+||.- ..+-+...+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC
Confidence 1 111 1122347999997632 1 4678999999999999988 7888831 1111222221
Q ss_pred ccCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 298 IDFESAPWPT-ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 298 ~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...+...+.. -+..++.+|..|++.||++|.++++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111100111 12468999999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=175.39 Aligned_cols=240 Identities=19% Similarity=0.272 Sum_probs=186.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
...+..+|.+...|..|+|++. |..+++|++..... +......|..|.-.|+-+. ||||..+++.+...-++.+|.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEee
Confidence 4556778999999999999988 55678888865544 2333456888988898885 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEE--eecCCceec
Q 012039 160 ELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKA--TDFGLSVFI 233 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl--~Dfg~~~~~ 233 (472)
.|++.|||+..+..... ....++..++..++.++.|||+.. |.---|....+++ +++.+.+| .|--++...
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec
Confidence 99999999999987654 567889999999999999999975 4445578888888 44444443 333232211
Q ss_pred cCCcceeeccCCCCCCchhhhhcc----cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
....-+|.|++||.+... --.++|+|||++++|||.|...||..-++.+.-.+|.-..+....+ +++|
T Consensus 344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip--pgis 415 (448)
T KOG0195|consen 344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGIS 415 (448)
T ss_pred ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC--CCcc
Confidence 112346889999998643 3468999999999999999999998887777666665544443333 6899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHh
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVL 334 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l 334 (472)
..+..|+.-|+..||.+||.+..++
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=199.25 Aligned_cols=195 Identities=24% Similarity=0.380 Sum_probs=159.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~~~~~ 155 (472)
...|.|.+.||+|+||+||+|.+.. |+.||+|+-+.... . +|.--.+++.+|+ --+.|..+...+...+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--W----EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--e----eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 4579999999999999999999887 99999998654321 1 1112233444442 124566666666777788
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeecc----CCCCCcEEEeecCCce
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS----KDENALLKATDFGLSV 231 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~----~~~~~~~kl~Dfg~~~ 231 (472)
+||+||.+.|||.+++...+.+++..+..+..|++..|+.||..+||||||||+|+|+.. +....-++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998888999999999999999999999999999999999999963 2345679999999997
Q ss_pred ecc---CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCC
Q 012039 232 FIE---EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVP 279 (472)
Q Consensus 232 ~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 279 (472)
.+. ++..+...++|-.+-.+|+..+ .|+...|.|.|+.++|.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 653 4456777889999999999876 59999999999999999999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=171.56 Aligned_cols=147 Identities=19% Similarity=0.184 Sum_probs=115.0
Q ss_pred ceEEcceeeecCCeEEEEEE-ECCCCCEEEEEEecccccCCc-----------------c----cHHHHHHHHHHHHhcc
Q 012039 80 HYSFGKELGRGQFGVTYLCT-ENSTGRQFACKSISKRKLVTK-----------------N----DKDDIKREIQIMQHLS 137 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~va~K~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~ 137 (472)
-|.+.+.||+|++|.||+|. +..+|+.||+|++........ . ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 777899999999875432100 0 1123578999999995
Q ss_pred CC--CCeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-cEeecCCCCceeec
Q 012039 138 GQ--PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG-VMHRDLKPENFLLS 214 (472)
Q Consensus 138 ~h--p~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nili~ 214 (472)
+ ..+++++++ . ..++||||++|.+|.........+....+..++.||+.+|.+||+.| |+||||||+||++.
T Consensus 109 -~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 -EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred -hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 4 334455543 2 35899999999888766544556677778899999999999999999 99999999999995
Q ss_pred cCCCCCcEEEeecCCceeccC
Q 012039 215 SKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 215 ~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
...++|+|||.+.....
T Consensus 184 ----~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 ----DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ----CCCEEEEEChhhhccCC
Confidence 45699999999876543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-21 Score=182.60 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=164.2
Q ss_pred ceEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEE------EEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK------GAYE 150 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~------~~~~ 150 (472)
.+.+.+..+..+++.+....-... ...++-+..+.. .-.......+++-.+.....|+..+..- ..+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 345555566666666664432222 112222221111 1122344455666655554444433321 1111
Q ss_pred -----eCCeEEEEEeccCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcE
Q 012039 151 -----DKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 151 -----~~~~~~lv~e~~~g~sL~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
...++||.|++|.-.+|.++|.... ..+......++.|+..++.| ++.+|+|+||.||++.. +..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~---d~q~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD---DDQL 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccccc---chhh
Confidence 1246899999999999999997543 36677889999999999999 99999999999999953 4469
Q ss_pred EEeecCCceeccCCc-------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 012039 223 KATDFGLSVFIEEGK-------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293 (472)
Q Consensus 223 kl~Dfg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 293 (472)
||.|||+........ .....+||..||+||.+.+ .|+.++||||||+||+||+. -..+| .....+..+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhh
Confidence 999999998776555 4456789999999999985 69999999999999999998 22222 112234445
Q ss_pred HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..+.++ ...+... ++-..|+.+||...|.+||++.+.--|+|.
T Consensus 473 r~g~ip--~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIP--PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCC--hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 555443 1112222 445689999999999999988777777765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-21 Score=199.89 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=207.1
Q ss_pred ceEEcceeeecCCeEEEEEEECC-CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.|.+.+.||+|+|+.|-.+.... +...+|+|.+.... ........+..|..+-+.+.+|+|++.+++...+....+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 57777789999999999887643 33456667665432 12333455566888888886699999999999999999999
Q ss_pred EeccCCcchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCcEeecCCCCceeeccCCCCC-cEEEeecCCceecc
Q 012039 159 MELCAGGELFDRI-IAKG-HYSERAAASICRSIVNVVHICH-FMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIE 234 (472)
Q Consensus 159 ~e~~~g~sL~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~~-~~kl~Dfg~~~~~~ 234 (472)
++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++ ..+ .+++.|||+|....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcccc
Confidence 9999999999888 4444 5788889999999999999999 99999999999999995 444 79999999998765
Q ss_pred C-Cc---ceeeccC-CCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCccCCCCCCC
Q 012039 235 E-GK---VYRDIVG-SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWP 306 (472)
Q Consensus 235 ~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 306 (472)
. .. .....+| ++.|+|||...+ ...+..|+||+|+++..+++|..||....... .+.........+....|.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 5 22 2334678 999999998865 35788999999999999999999997654432 122222333334566788
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 99999999999999999999999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=175.31 Aligned_cols=198 Identities=28% Similarity=0.373 Sum_probs=157.8
Q ss_pred HhccCCCCeeEEEEEEEeCCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCc-EeecCCCCce
Q 012039 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGV-MHRDLKPENF 211 (472)
Q Consensus 134 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i-~H~dlkp~Ni 211 (472)
+.+. |.|+.++++.+.++...++|.+||..|+|.+.+.. .-.++.-....+++.|+.||.|+|...| .|+.|+..|.
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4564 99999999999999999999999999999999976 4568888889999999999999999876 9999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCC---cceeeccCCCCCCchhhhhcc--------cCCccchhhHHHHHHHHhhCCCC
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEG---KVYRDIVGSAYYVAPEVLRRR--------YGKEIDIWSAGVILYILLSGVPP 280 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~ll~g~~p 280 (472)
++ +..+.+||.|||+....... .......-...|.|||.++.. .+.+.||||+|++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 78899999999998776421 111112234579999998642 46789999999999999999999
Q ss_pred CCCC----ChHHHHHHHHc-CCccCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 281 FWAE----TEKGIFDAILQ-GDIDFESAPW--PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 281 f~~~----~~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
|... ...+++..+.. +...+....+ ..+.+++..+++.||..+|.+||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9753 22356666666 3222222222 145668999999999999999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-19 Score=158.85 Aligned_cols=137 Identities=26% Similarity=0.341 Sum_probs=112.0
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+. |++|+....++.+....++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 577899997653322111 11245778999999995 888877777777777889999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
||++|++|.+.+..... ....++.+++.+|.++|+.+++|+|++|.|||+. ...++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999988865322 7889999999999999999999999999999995 45689999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=170.32 Aligned_cols=261 Identities=22% Similarity=0.255 Sum_probs=204.1
Q ss_pred cccccceEEcceeee--cCCeEEEEEEE--CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 75 EDVKLHYSFGKELGR--GQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
+.+...+.+...+|. |.+|.||.+.. ..++..+|+|.-+.. .........=.+|+...+.+..|+|.++.+..++
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccc
Confidence 344567788889999 99999999988 888999999873221 1122233344578888888888999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVN----VVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~i~~qi~~----~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
..+..|+-+|+| |.+|..+...... +++..++..+.+... ||.++|..+++|-|+||.||+...+. ...+++
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~ 265 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLT 265 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecC
Confidence 999999999999 6788888876655 889999999999999 99999999999999999999995321 678999
Q ss_pred ecCCceeccCCccee------eccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc
Q 012039 226 DFGLSVFIEEGKVYR------DIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299 (472)
Q Consensus 226 Dfg~~~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 299 (472)
|||+...+.++.... ...|...|++||..++-++...||+++|.+..+..++..++...... ....+.+..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~-- 342 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY-- 342 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--
Confidence 999999887665221 22577889999999999999999999999999888876665333110 011111111
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+.......+.++...+..|+..+|..|++++.+++|+++...
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 2333345667788889999999999999999999999999743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=152.94 Aligned_cols=134 Identities=21% Similarity=0.278 Sum_probs=104.7
Q ss_pred eeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
.||+|++|.||++.. ++..+++|.......... .....+.+|+++++.+. |+++.....++.+....++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999984 578899998653322111 12356778999999996 7765544444555666789999
Q ss_pred ccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
|++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||++. ...++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 7899999999999999999999999999995 456999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=153.39 Aligned_cols=141 Identities=20% Similarity=0.248 Sum_probs=108.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-------------------ccHHHHHHHHHHHHhccCCC
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-------------------NDKDDIKREIQIMQHLSGQP 140 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~hp 140 (472)
.|.+.+.||+|+||.||++... +|+.||||++........ .......+|+.++..+. ++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence 3888899999999999999875 799999998764321000 01223678999999995 66
Q ss_pred --CeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC
Q 012039 141 --NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (472)
Q Consensus 141 --~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 218 (472)
.++..++ ....++||||++|++|..... ......++.+++.++.++|+.||+||||+|+||++ +.
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 4444443 234589999999998865432 13466788999999999999999999999999999 45
Q ss_pred CCcEEEeecCCceeccC
Q 012039 219 NALLKATDFGLSVFIEE 235 (472)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~ 235 (472)
+..++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 67799999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=171.91 Aligned_cols=141 Identities=19% Similarity=0.236 Sum_probs=110.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC-----cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
...|...+.||+|+||+||++.+.. ..+++|+........ ......+.+|+++++.++ |++|+....++.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeC
Confidence 3456778899999999999998754 344555432211111 112356889999999996 99998887777777
Q ss_pred CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+. +..++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCccccc
Confidence 77899999999999988775 3567899999999999999999999999999992 34689999999876
Q ss_pred c
Q 012039 233 I 233 (472)
Q Consensus 233 ~ 233 (472)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=147.12 Aligned_cols=142 Identities=18% Similarity=0.230 Sum_probs=100.4
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHH---------------------HHHHHHHHHHhccCC-CC
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD---------------------DIKREIQIMQHLSGQ-PN 141 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h-p~ 141 (472)
++.||+|+||+||+|.+. +++.||||++............ ....|...+.++.++ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 7999999998654321111111 114677777777422 23
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCC
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+.+.+++ ...++||||++|+++.......... ...+..++.+++.++.++|. .+|+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CC
Confidence 4555543 2358999999985443211111111 16788999999999999999 9999999999999995 56
Q ss_pred cEEEeecCCceeccC
Q 012039 221 LLKATDFGLSVFIEE 235 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~ 235 (472)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 799999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.2e-16 Score=143.03 Aligned_cols=138 Identities=19% Similarity=0.266 Sum_probs=103.2
Q ss_pred ceee-ecCCeEEEEEEECCCCCEEEEEEeccccc----------CCcccHHHHHHHHHHHHhccCCCCe--eEEEEEEEe
Q 012039 85 KELG-RGQFGVTYLCTENSTGRQFACKSISKRKL----------VTKNDKDDIKREIQIMQHLSGQPNI--VEFKGAYED 151 (472)
Q Consensus 85 ~~lg-~G~~g~V~~~~~~~~~~~va~K~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~i--v~~~~~~~~ 151 (472)
..|| .|+.|+||.+... +..+++|.+..... ........+.+|+.++.+|. |++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence 4577 8888999988764 77899998864321 01123456789999999996 7774 667766433
Q ss_pred C-Ce---EEEEEeccCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 152 K-QS---VHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 152 ~-~~---~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
. .. .++|||+++| .+|.+++.. ..+++. .+.||+.+|.+||++||+|+||||.|||++ .+..++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 2 22 3599999997 688877654 455554 367899999999999999999999999995 344799999
Q ss_pred cCCceec
Q 012039 227 FGLSVFI 233 (472)
Q Consensus 227 fg~~~~~ 233 (472)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9998763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-17 Score=169.45 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=205.4
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
.+.+.+-+.+|+++.++.+.-..+|...+.|+............+.+..+-+++-.. .+|.++...-.+......+|++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchhh
Confidence 455666788899999999888888876777765444333333444555555554434 2677777766667778899999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC----
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE---- 235 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~---- 235 (472)
+|+.|++|...+.+.+..+.+.++..+..+..+++|||...+.|+|++|.|++. ...+..++.|||.......
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccCc
Confidence 999999999999988888888999999999999999999999999999999999 5666788899984322110
Q ss_pred -----------------C-----------cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh
Q 012039 236 -----------------G-----------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE 286 (472)
Q Consensus 236 -----------------~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 286 (472)
. .......||+.|.+||.+.+ .....+|+|++|+++++.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 00113468999999998754 588899999999999999999999999999
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCccccC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSA---QVLEHPWIKEG 342 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~---~~l~h~~~~~~ 342 (472)
+.++++|..+...++... ...+.++++++.++|..+|.+|..+. ++-.|+||+..
T Consensus 1041 q~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999887766543 45789999999999999999999887 88899999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.1e-16 Score=131.26 Aligned_cols=133 Identities=23% Similarity=0.293 Sum_probs=110.4
Q ss_pred EcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-CCeeEEEEEEEeCCeEEEEEec
Q 012039 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~iv~~~~~~~~~~~~~lv~e~ 161 (472)
+++.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.++++ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35689999999999999753 6899998754321 46788999999999733 6899999988888889999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 162 ~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+.|+++..+ +......++.+++.+|.++|.. +++|+|++|+||++. ....++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 998877543 5566778899999999999985 699999999999995 356799999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=126.57 Aligned_cols=97 Identities=39% Similarity=0.594 Sum_probs=89.8
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-C
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-L 453 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~ 453 (472)
....++.+++++|+++|..+|+|++|.|++.||..+|+.+|..++++++.+|+..+|. +.|.|+|.+|+.++..... .
T Consensus 10 ~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~ 88 (160)
T COG5126 10 TFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLKRG 88 (160)
T ss_pred hcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhccC
Confidence 3456789999999999999999999999999999999999999999999999999999 9999999999999876653 5
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
..+++|+.||+.||+|+||
T Consensus 89 ~~~Eel~~aF~~fD~d~dG 107 (160)
T COG5126 89 DKEEELREAFKLFDKDHDG 107 (160)
T ss_pred CcHHHHHHHHHHhCCCCCc
Confidence 6689999999999999998
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.8e-15 Score=124.54 Aligned_cols=93 Identities=41% Similarity=0.623 Sum_probs=84.0
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC-C----
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL-E---- 454 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~-~---- 454 (472)
+.+++.+++++|..||+|++|+|+..||..+++.+|..++++++..++..+|.|++|.|+|+||+.++...... .
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~ 82 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEA 82 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccc
Confidence 45677889999999999999999999999999999999999999999999999999999999999988755331 1
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
..+.+++||+.||+|++|
T Consensus 83 ~~~el~eaF~~fD~d~~G 100 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDG 100 (151)
T ss_pred cHHHHHHHHHHHccCCCC
Confidence 345999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-13 Score=121.50 Aligned_cols=144 Identities=13% Similarity=0.120 Sum_probs=103.9
Q ss_pred cceeeecCCeEEEEEEECC------CCCEEEEEEeccccc---------------C----CcccHHHHH----HHHHHHH
Q 012039 84 GKELGRGQFGVTYLCTENS------TGRQFACKSISKRKL---------------V----TKNDKDDIK----REIQIMQ 134 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~------~~~~va~K~~~~~~~---------------~----~~~~~~~~~----~E~~~l~ 134 (472)
...||.|--+.||.|.... .+..+|+|+++.... . ..+....+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 357899998753211 0 011133333 8999999
Q ss_pred hccCC-CCeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEeecCCCCcee
Q 012039 135 HLSGQ-PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC-HFMGVMHRDLKPENFL 212 (472)
Q Consensus 135 ~l~~h-p~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~dlkp~Nil 212 (472)
++... -++++++++ ...+|||||+.+..+..-......+++..+..+..+++.+|..+ |+.||+||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99632 467777764 34679999997654432222333466677788899999999998 8999999999999999
Q ss_pred eccCCCCCcEEEeecCCceeccC
Q 012039 213 LSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 213 i~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+. .+.+.|+|||.+.....
T Consensus 158 ~~----~~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WH----DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EE----CCcEEEEECCCceeCCC
Confidence 94 24589999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.7e-15 Score=135.98 Aligned_cols=237 Identities=16% Similarity=0.214 Sum_probs=157.4
Q ss_pred EEEEEEECCCCCEEEEEEecccccCCcc-cHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----eEEEEEeccCCcch
Q 012039 94 VTYLCTENSTGRQFACKSISKRKLVTKN-DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----SVHVVMELCAGGEL 167 (472)
Q Consensus 94 ~V~~~~~~~~~~~va~K~~~~~~~~~~~-~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----~~~lv~e~~~g~sL 167 (472)
.||++.+...|.+|+.-.+......... ..+....-...|-++- |.|||+++.+|.+.. ...++.||+..|+|
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 5677777777777655444322211111 1222222334455553 999999999987643 47789999999999
Q ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEeecCCceeccC---C--
Q 012039 168 FDRIIAK----GHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE---G-- 236 (472)
Q Consensus 168 ~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~---~-- 236 (472)
.++|++. ..+....+.+|+.||+.||.|||+.. |+|+++..+.|++ ..++.+|+.---....-.. .
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence 9999754 34888999999999999999999975 9999999999999 5777787632111110000 0
Q ss_pred cceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCC-CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPF-WAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.......+-++|.+||.=. .+.+.++|||++|+...+|..+..-- .+.+....-..|.+-.+.... ..-++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-------~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-------GLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC-------ccccC
Confidence 0011234678899998643 34677899999999999998876532 222211111222222111111 22356
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
++.+||+..|..||++.++|.||.+-+
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceeee
Confidence 899999999999999999999998754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-14 Score=145.70 Aligned_cols=157 Identities=22% Similarity=0.304 Sum_probs=100.6
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--------------------C-------c---
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--------------------T-------K--- 120 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--------------------~-------~--- 120 (472)
+.+.+.+-..|.. +.||+|++|.||+|+.+.+|+.||||++.+.... . .
T Consensus 112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v 190 (537)
T PRK04750 112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV 190 (537)
T ss_pred CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence 3445555566776 7899999999999999888999999998754200 0 0
Q ss_pred -ccHHH------HHHHHHHHHhcc---CCCCeeEEEEEEEe-CCeEEEEEeccCCcchHHH--HHhcC----CCCHHHHH
Q 012039 121 -NDKDD------IKREIQIMQHLS---GQPNIVEFKGAYED-KQSVHVVMELCAGGELFDR--IIAKG----HYSERAAA 183 (472)
Q Consensus 121 -~~~~~------~~~E~~~l~~l~---~hp~iv~~~~~~~~-~~~~~lv~e~~~g~sL~~~--l~~~~----~~~~~~~~ 183 (472)
..... +.+|+..+.++. .+.+.+.+-.+|.+ ....+|||||+.|+.+.+. +...+ .+.+..+.
T Consensus 191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 01112 334444444443 12222332222222 3456799999999999764 33332 24444455
Q ss_pred HHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC-CCCcEEEeecCCceeccC
Q 012039 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEE 235 (472)
Q Consensus 184 ~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~~~kl~Dfg~~~~~~~ 235 (472)
.++.|++ ..|++|+|+||.||++..++ ..+.++++|||++..+++
T Consensus 271 ~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5555554 58999999999999996432 234799999999887643
|
|
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.8e-14 Score=113.53 Aligned_cols=94 Identities=28% Similarity=0.514 Sum_probs=86.1
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-C
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-L 453 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~ 453 (472)
+-..+.+.++++++++|..+|.|+||.|++++|+.+|..+|...++++++.|+.+. .|.|+|.-|+.++..+.. .
T Consensus 22 vFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea----~gPINft~FLTmfGekL~gt 97 (171)
T KOG0031|consen 22 VFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEA----PGPINFTVFLTMFGEKLNGT 97 (171)
T ss_pred HHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhC----CCCeeHHHHHHHHHHHhcCC
Confidence 34457888999999999999999999999999999999999999999999999876 889999999999987654 6
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
+.++.|..||+.||.+++|
T Consensus 98 dpe~~I~~AF~~FD~~~~G 116 (171)
T KOG0031|consen 98 DPEEVILNAFKTFDDEGSG 116 (171)
T ss_pred CHHHHHHHHHHhcCccCCC
Confidence 7789999999999999987
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-13 Score=136.38 Aligned_cols=143 Identities=18% Similarity=0.219 Sum_probs=95.5
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCC-------------------c----cc--------------HHHHH
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-------------------K----ND--------------KDDIK 127 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-------------------~----~~--------------~~~~~ 127 (472)
+.||.|++|.||+|+.+ +|+.||||+........ . .. .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 79999999975431000 0 00 00234
Q ss_pred HHHHHHHhcc----CCCCeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 012039 128 REIQIMQHLS----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVN-VVHICHFMGV 201 (472)
Q Consensus 128 ~E~~~l~~l~----~hp~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~lH~~~i 201 (472)
+|++.+.++. ++++|.-..-+.......+|||||++|++|.+..... .... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4565555553 3444332222222234568999999999998766432 1222 2345555555 4788899999
Q ss_pred EeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 202 ~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+|++|.||++ ..++.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999 455679999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.2e-12 Score=121.77 Aligned_cols=315 Identities=16% Similarity=0.216 Sum_probs=203.9
Q ss_pred CCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE----eCCeEEEEEeccCC-c
Q 012039 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE----DKQSVHVVMELCAG-G 165 (472)
Q Consensus 91 ~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----~~~~~~lv~e~~~g-~ 165 (472)
-..+.|+|....+|..|++|+++-.+.... .....-+++++++. |+|||++.++|. .+..+++|++|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 345789999999999999999843332221 12234588999995 999999999886 45689999999987 4
Q ss_pred chHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 166 ELFDRIIA---------------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 166 sL~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+|.++.-. +.+.+|..+|.++.||..||.++|+.|+.-+-|.|.+||+. .+..++|+..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccce
Confidence 77765522 23478899999999999999999999999999999999994 4447888888877
Q ss_pred eeccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCC-CChHHH-HHHHHcCCccCCCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGI-FDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~-~~~i~~~~~~~~~~~~~~~ 308 (472)
..+.... . |.+.+ -.+-|.=.||.+++.|.||..--+. ....+. +..|. ..+
T Consensus 441 Dvl~~d~-----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y 494 (655)
T KOG3741|consen 441 DVLQEDP-----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY 494 (655)
T ss_pred eeecCCC-----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence 6554432 0 11111 1356888999999999999543111 111111 22221 357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC---CccccCCCCCCCCCchHHH-HHHHHHHhhhHhHHHHHHHHH--hhc---
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH---PWIKEGGEASDKPIDSAVL-SRMKQFRAMNKLKKLALKVIA--ENL--- 379 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~--~~~--- 379 (472)
|.+++++|.-+...++++ -++.+++.+ .||........+ .+.. ..+.+--...+|.++..+... +..
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~---~d~mE~~Ls~emENGRLfRll~Kln~I~dR~e~~ 570 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLK---TDVMETELSREMENGRLFRLLLKLNFIDDRPEYV 570 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHH---HHHHHHHHHHHHhcchHHHHHHHHhhhccCcccc
Confidence 899999999999999987 788888864 455433211110 1111 111111112233333333221 110
Q ss_pred ---hhhH------Hhh-hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHh--cCCCCcceeHHHHHHHH
Q 012039 380 ---STEE------IQG-LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA--DVDGNGTIDYIEFITAT 447 (472)
Q Consensus 380 ---~~~~------~~~-~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~--d~d~~g~i~~~eF~~~~ 447 (472)
+..+ +.- -.-+|...|.|+.-.|+...+.++|.+|.... ++. +... |....=-|+|.|....+
T Consensus 571 ~D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLDAG~-~Ek----I~LvSrDE~t~IIvSY~ELK~~l 645 (655)
T KOG3741|consen 571 DDPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLDAGI-QEK----ILLVSRDELTCIIVSYKELKTIL 645 (655)
T ss_pred cCCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhccccc-hhh----eeEeccCCCcEEEEEHHHHHHHH
Confidence 0000 111 23578888999999999999999999986543 222 2233 33333447999887644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.4e-13 Score=111.62 Aligned_cols=148 Identities=21% Similarity=0.201 Sum_probs=110.8
Q ss_pred EcceeeecCCeEEEEEEECCCCCEEEEEEec-c----cccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 83 FGKELGRGQFGVTYLCTENSTGRQFACKSIS-K----RKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~-~----~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
....|-+|+-+.|+++... |+.+.||.=. + ..+...-...+..+|+++|.++. --.|.-..-++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 4567889999999999865 7777777422 1 11222233566778999999985 4455555556777777789
Q ss_pred EEeccCC-cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 158 VMELCAG-GELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 158 v~e~~~g-~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+|||++| .++.+++.... .........++++|-..+.-||.++|+||||..+||++.+++....+.++|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999987 36777775432 2333334789999999999999999999999999999998888888899999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.6e-14 Score=138.76 Aligned_cols=251 Identities=18% Similarity=0.208 Sum_probs=184.2
Q ss_pred ccceEEcceeeecCCeEEEEEEEC-CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN-STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..+|..+..||.|.|+.|+.+..+ .++..|++|...+..... .....-..|+.+...+.-|.+++.++..|......|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch-HhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346788899999999999987755 577889999876543322 222223467777777777999999888888877888
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+++ +..++.|||+...+.-.
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccccee
Confidence 9999999998876665555688889999999999999999999999999999999996533 67899999998642211
Q ss_pred cceeeccCCCCCC-chhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 237 KVYRDIVGSAYYV-APEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 237 ~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.....+.-.+. ..|++.. .+..+.|++|||.-+.+.+++...-.... ....|..+... ..+..+.++.
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p----~~~~~~~~~q 491 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTP----NLPGLKLQLQ 491 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeeccccc----CCCchHHhhh
Confidence 11122333444 3565543 47889999999999999998865422211 11223333222 1134457889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.+.+.++..++..||.+.++..|.=|.
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 999999999999999999998886554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.6e-13 Score=116.79 Aligned_cols=128 Identities=16% Similarity=0.149 Sum_probs=95.1
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+.|+.|.++.||++... +..|++|+...... ....+.+|+.+++.+.+...+++++.+.. ...++||||++|
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 56889999999999865 77899998754321 12346789999999863333456665543 334799999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----EeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV-----MHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-----~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ...++++|||.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 888543 11123467899999999999985 9999999999995 33589999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.5e-13 Score=107.86 Aligned_cols=95 Identities=31% Similarity=0.541 Sum_probs=87.1
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~~~ 456 (472)
.+..++.++++.+|..||.+++|+|+..||+.+++.+|..+..++|.+|+..+|.++.|.|+|++|+..+..+. ..++.
T Consensus 26 ~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~ 105 (172)
T KOG0028|consen 26 ELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTK 105 (172)
T ss_pred cccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcH
Confidence 44567778999999999999999999999999999999999999999999999999999999999999876553 35688
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
++++.+|+.||-|++|
T Consensus 106 eEi~~afrl~D~D~~G 121 (172)
T KOG0028|consen 106 EEIKKAFRLFDDDKTG 121 (172)
T ss_pred HHHHHHHHcccccCCC
Confidence 9999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.5e-12 Score=106.24 Aligned_cols=136 Identities=22% Similarity=0.274 Sum_probs=98.6
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
..+++|+-+.+|.+... |..+++|.=.+.....+ -......+|++++.++. --.|...+-+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 35789999999998654 55566764222221111 12345678999999986 445544444555666678999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
||++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++... .+.++|||++.+..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----~i~~IDfGLg~~s~ 142 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----RIYFIDFGLGEFSD 142 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----cEEEEECCcccccc
Confidence 999988888888654 25677888888899999999999999999999532 28899999987543
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-12 Score=96.32 Aligned_cols=68 Identities=19% Similarity=0.303 Sum_probs=62.6
Q ss_pred hHHhhhhhhhccccC-CCCCcccHHHHHHHHHH-cCCCCCH-HHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDT-DNSGTITYEELKAGLAR-LGSKLTE-AEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~-~~~G~i~~~el~~~l~~-~~~~~~~-~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+..+.++|+.||. +++|+|+.+||+.++++ +|..++. +++++||+.+|.|+||.|+|+||+.++..
T Consensus 5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~ 75 (89)
T cd05022 5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGE 75 (89)
T ss_pred HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 346678999999999 99999999999999999 9988888 99999999999999999999999998764
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=121.63 Aligned_cols=182 Identities=15% Similarity=0.205 Sum_probs=131.0
Q ss_pred eEEcceeeecCCeEEE-EEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 81 YSFGKELGRGQFGVTY-LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~-~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
|++ ...+-++.+ +| .|..+.++.+|.|.+++... ......+.+-+.-|+.|+ ||||+++++.++.++.+|||+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence 444 333334443 44 46667788899998876443 133556778888999996 999999999999999999999
Q ss_pred eccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH-FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 160 e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
|-+. .|..++.+. ....+.-.+.||+.||.+|| ..+++|++|..+.|++ +..+..||++|.++........
T Consensus 89 ErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~ 160 (690)
T KOG1243|consen 89 ERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA 160 (690)
T ss_pred eccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc
Confidence 9984 555566543 36777788999999999997 5789999999999999 5677799999988764432221
Q ss_pred -eeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhC
Q 012039 239 -YRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSG 277 (472)
Q Consensus 239 -~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 277 (472)
.....---.|..|+.+... .-..|.|-||+++++++.|
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 0011111235555543211 1346999999999999999
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.9e-11 Score=105.19 Aligned_cols=95 Identities=33% Similarity=0.611 Sum_probs=81.3
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc-ccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR-HKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~-~~~~~~ 456 (472)
.++++++.++..+|..+|.+++|.|+..||..++..+|...+..++..++..+|.+++|.|+|.||+.++... .....+
T Consensus 10 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 89 (158)
T PTZ00183 10 GLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPR 89 (158)
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcH
Confidence 4567778889999999999999999999999999999888888889999999999999999999999876543 223456
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.+|.|++|
T Consensus 90 ~~l~~~F~~~D~~~~G 105 (158)
T PTZ00183 90 EEILKAFRLFDDDKTG 105 (158)
T ss_pred HHHHHHHHHhCCCCCC
Confidence 7899999999999887
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=104.32 Aligned_cols=96 Identities=39% Similarity=0.677 Sum_probs=83.2
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCCc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLER 455 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~~ 455 (472)
..+++++.+.++..|..+|.+++|.|+..||..++..++..++.+++..++..+|.+++|.|+|+||+.++.... ....
T Consensus 3 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~ 82 (149)
T PTZ00184 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDS 82 (149)
T ss_pred CccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcH
Confidence 345677788899999999999999999999999999999888888999999999999999999999998876432 2345
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
++.+..+|+.+|.|++|
T Consensus 83 ~~~~~~~F~~~D~~~~g 99 (149)
T PTZ00184 83 EEEIKEAFKVFDRDGNG 99 (149)
T ss_pred HHHHHHHHHhhCCCCCC
Confidence 67889999999999987
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=101.69 Aligned_cols=69 Identities=35% Similarity=0.598 Sum_probs=64.7
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+..+++.++|+.||.|++|+|+..||+.+++.+|...++++++.|++.+|.|++|.|+|++|+..+..
T Consensus 88 ~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~ 156 (160)
T COG5126 88 GDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKD 156 (160)
T ss_pred CCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhc
Confidence 344678999999999999999999999999999999999999999999999999999999999998764
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2e-11 Score=96.38 Aligned_cols=94 Identities=20% Similarity=0.369 Sum_probs=83.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCC--CCcceeHHHHHHHHhccc---cC
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD--GNGTIDYIEFITATMHRH---KL 453 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d--~~g~i~~~eF~~~~~~~~---~~ 453 (472)
++.+++.+++++|..||..+||+|+..+...+|+.+|.++|++++.+.+.+.+.+ +--+|+|++|+.++.... ..
T Consensus 5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~q 84 (152)
T KOG0030|consen 5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKDQ 84 (152)
T ss_pred cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhcccc
Confidence 3456678999999999999999999999999999999999999999999999887 557899999999876432 34
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
.+.++..+.+++||++++|
T Consensus 85 ~t~edfvegLrvFDkeg~G 103 (152)
T KOG0030|consen 85 GTYEDFVEGLRVFDKEGNG 103 (152)
T ss_pred CcHHHHHHHHHhhcccCCc
Confidence 5678999999999999998
|
|
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.1e-11 Score=101.69 Aligned_cols=84 Identities=32% Similarity=0.490 Sum_probs=77.9
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
-++.|+++|+.+|+|++|.|+..||+++|..+|..++++-++.+++.+|.-++|.|.|++|+.+++.. ..+.++
T Consensus 122 ~i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L------~~lt~~ 195 (221)
T KOG0037|consen 122 YINQWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVL------QRLTEA 195 (221)
T ss_pred HHHHHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHH------HHHHHH
Confidence 46789999999999999999999999999999999999999999999998889999999999998765 567899
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.+.+|
T Consensus 196 Fr~~D~~q~G 205 (221)
T KOG0037|consen 196 FRRRDTAQQG 205 (221)
T ss_pred HHHhccccce
Confidence 9999999876
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.2e-11 Score=91.51 Aligned_cols=68 Identities=24% Similarity=0.396 Sum_probs=62.2
Q ss_pred hHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+..++++|..|| .|++| +|+.+||+.+|+. +|...++++++.+++.+|.|++|.|+|+||+.++..
T Consensus 5 ~~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~ 79 (88)
T cd05027 5 KAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM 79 (88)
T ss_pred HHHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 34677899999998 89999 6999999999999 898899999999999999999999999999987753
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.7e-11 Score=87.48 Aligned_cols=62 Identities=35% Similarity=0.671 Sum_probs=54.5
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHH----HHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE----VQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~----~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
+++++|..+|.|++|+|+.+||..++..++...+.++ ++.+++.+|.|+||.|+|+||+.++
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 3678999999999999999999999999997665544 5566999999999999999999764
|
... |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-10 Score=106.37 Aligned_cols=143 Identities=24% Similarity=0.414 Sum_probs=102.7
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-CCeeEEEEEEEeC---CeEEEEEe
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDK---QSVHVVME 160 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~iv~~~~~~~~~---~~~~lv~e 160 (472)
+.|+.|.++.||++.... |+.+++|+....... .....+.+|+.+++.+..+ .++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 468999999999998653 678999987543321 1345788999999999632 3467777776553 36789999
Q ss_pred ccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 012039 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF------------------------------------------ 198 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------------ 198 (472)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888664421 345666666667777777766663
Q ss_pred --------------cCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 199 --------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 199 --------------~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++|+|+.|.||+++.+ ....+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999532 145678999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.5e-10 Score=104.19 Aligned_cols=238 Identities=16% Similarity=0.191 Sum_probs=159.3
Q ss_pred EcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE------EEe-CCeE
Q 012039 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA------YED-KQSV 155 (472)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~------~~~-~~~~ 155 (472)
.++.||+|+.+.+|..-.. ...+.|++.+.... ... ..+..|.....||-+..=+.| .-+ ...+
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa---~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA---AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCch---HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 4567999999999965432 22456888654321 111 223444455456644331111 112 2337
Q ss_pred EEEEeccCCcch-HHHHH---hc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 156 HVVMELCAGGEL-FDRII---AK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 156 ~lv~e~~~g~sL-~~~l~---~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.+.|..++|..= ..++. +. ....+.....+.+.|+.+...||+.|.+-||+.++|||+ .++..+.|+|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEccc
Confidence 889999887532 22221 11 226678889999999999999999999999999999999 456678999876
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-c-----ccCCccchhhHHHHHHHHhhC-CCCCCCCCh----HHHHH-HHHcC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-R-----RYGKEIDIWSAGVILYILLSG-VPPFWAETE----KGIFD-AILQG 296 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwslG~il~~ll~g-~~pf~~~~~----~~~~~-~i~~~ 296 (472)
......++..+...+|...|.+||.-+ + .-+...|.|.||+++|++|.| +.||.+-.. ..-++ .|..+
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 655555666677789999999999754 2 246789999999999999987 999965211 01111 23222
Q ss_pred Cc------------cCCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 012039 297 DI------------DFESAPWPTISSSAKDLVRRMLTQ--DPKKRITSAQ 332 (472)
Q Consensus 297 ~~------------~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rps~~~ 332 (472)
.+ .....+|.-++++++.|..+|+.. ++.-|||++.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 21 122234567899999999999975 3568999853
|
|
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.1e-10 Score=116.73 Aligned_cols=90 Identities=18% Similarity=0.285 Sum_probs=79.7
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcC-CCCCHHH---HHHHHHHhcCCCCcceeHHHHHHHHhccccCC
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAE---VQQLMEAADVDGNGTIDYIEFITATMHRHKLE 454 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~---~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~ 454 (472)
+...++++++++|..+|.|++|+| +..+++.+| ..+++++ ++.+|..+|.|++|.|+|+||+.++.......
T Consensus 137 f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~~~ 212 (644)
T PLN02964 137 FVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGNLV 212 (644)
T ss_pred ccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhccCC
Confidence 455577889999999999999997 899999999 5888877 89999999999999999999999887654456
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
+++++..+|+.||+|++|
T Consensus 213 seEEL~eaFk~fDkDgdG 230 (644)
T PLN02964 213 AANKKEELFKAADLNGDG 230 (644)
T ss_pred CHHHHHHHHHHhCCCCCC
Confidence 788999999999999998
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-10 Score=98.90 Aligned_cols=67 Identities=36% Similarity=0.619 Sum_probs=63.4
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+.++++|+.||.|++|+|+..||+.+|..+|.+.+.++++.|++.+|.|+||.|+|+||+.++..
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~ 149 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSG 149 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhc
Confidence 4568999999999999999999999999999999999999999999999999999999999998753
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-10 Score=86.66 Aligned_cols=69 Identities=28% Similarity=0.457 Sum_probs=61.3
Q ss_pred hhHHhhhhhhhccccC-CC-CCcccHHHHHHHHHH---cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDT-DN-SGTITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~-~~-~G~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++.+..+..+|..||. |+ +|+|+.+||+.++++ +|..++++++++|++.+|.|++|.|+|+||+.++..
T Consensus 6 e~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~ 79 (88)
T cd05029 6 DQAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGA 79 (88)
T ss_pred HHHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHH
Confidence 3456678889999998 77 899999999999973 799999999999999999999999999999987753
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.8e-09 Score=98.96 Aligned_cols=137 Identities=18% Similarity=0.143 Sum_probs=94.9
Q ss_pred eEEEEEEECCCCCEEEEEEeccccc----CC----cccHHHHHHHHHHHHhccCCCCe--eEEEEEEEe-----CCeEEE
Q 012039 93 GVTYLCTENSTGRQFACKSISKRKL----VT----KNDKDDIKREIQIMQHLSGQPNI--VEFKGAYED-----KQSVHV 157 (472)
Q Consensus 93 g~V~~~~~~~~~~~va~K~~~~~~~----~~----~~~~~~~~~E~~~l~~l~~hp~i--v~~~~~~~~-----~~~~~l 157 (472)
..|+++.. .|+.|.||....... .. ......+.+|.+.+.+|. .-+| +.+..+++. ...-+|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence 34555543 467888886632210 00 011224778999988884 2233 334444433 235789
Q ss_pred EEeccCCc-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC----CCCCcEEEeecCCc
Q 012039 158 VMELCAGG-ELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK----DENALLKATDFGLS 230 (472)
Q Consensus 158 v~e~~~g~-sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~----~~~~~~kl~Dfg~~ 230 (472)
|||++++. +|.+++.. ....+......++.++...+.-||.+||+|+||++.|||+..+ ++...+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999876 78888754 3456677888999999999999999999999999999999641 33567999999987
Q ss_pred ee
Q 012039 231 VF 232 (472)
Q Consensus 231 ~~ 232 (472)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.7e-10 Score=96.84 Aligned_cols=131 Identities=19% Similarity=0.189 Sum_probs=82.1
Q ss_pred EEEEEEECCCCCEEEEEEeccccc-------------C--------C--cccHHHHHHHHHHHHhccCC-CCeeEEEEEE
Q 012039 94 VTYLCTENSTGRQFACKSISKRKL-------------V--------T--KNDKDDIKREIQIMQHLSGQ-PNIVEFKGAY 149 (472)
Q Consensus 94 ~V~~~~~~~~~~~va~K~~~~~~~-------------~--------~--~~~~~~~~~E~~~l~~l~~h-p~iv~~~~~~ 149 (472)
.||.|... .|..+|+|+...... . . ........+|.+.|.++... -++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 477999998753210 0 0 01134567899999999633 2577776553
Q ss_pred EeCCeEEEEEeccC--CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 150 EDKQSVHVVMELCA--GGELFDRIIAKGHYSERAAASICRSIVNVVHI-CHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 150 ~~~~~~~lv~e~~~--g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~-lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
. .+|||||++ |..+..+... .++......++.+++..+.. +|..||+||||++.||++.. . .+.++|
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~---~-~~~iID 149 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD---G-KVYIID 149 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET---T-CEEE--
T ss_pred --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec---c-eEEEEe
Confidence 3 369999998 6555443322 12245567788888885555 58999999999999999953 2 699999
Q ss_pred cCCceeccC
Q 012039 227 FGLSVFIEE 235 (472)
Q Consensus 227 fg~~~~~~~ 235 (472)
||.+.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-10 Score=88.31 Aligned_cols=69 Identities=29% Similarity=0.456 Sum_probs=63.2
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++.+++..++++|..+|.|++|.|+.+|++.+++.+| +++++++.|+..+|.+++|.|+|+||+.++..
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~ 72 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAMHL 72 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHH
Confidence 4567888999999999999999999999999999976 68899999999999999999999999998754
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.4e-10 Score=87.21 Aligned_cols=68 Identities=24% Similarity=0.391 Sum_probs=58.4
Q ss_pred hHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-c----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR-L----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-~----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.-+..+.++|..|| .|++| +|+..||+.++.. + +...++.++++|++.+|.|+||.|+|+||+.++..
T Consensus 7 ~a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~ 81 (93)
T cd05026 7 GAMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAA 81 (93)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 34567889999999 78998 5999999999977 3 33457789999999999999999999999998764
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.1e-10 Score=88.96 Aligned_cols=68 Identities=21% Similarity=0.383 Sum_probs=60.5
Q ss_pred HHhhhhhhhccccC-CC-CCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 383 EIQGLKQMFTNIDT-DN-SGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~-~~-~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
.+..++++|..||. |+ +|+|+.+||+.+++. +|..+++++++.++..+|.|++|.|+|+||+.++...
T Consensus 6 ~~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~ 80 (94)
T cd05031 6 AMESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGL 80 (94)
T ss_pred HHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 35678999999997 97 799999999999986 5667899999999999999999999999999887644
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.6e-10 Score=85.17 Aligned_cols=66 Identities=23% Similarity=0.443 Sum_probs=58.3
Q ss_pred Hhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-cC----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNID-TDNSG-TITYEELKAGLAR-LG----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++.++++|..|| .|++| +|+..||+.+|+. +| ..+++++++.|+..+|.|++|.|+|+||+.++..
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~ 80 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 467899999997 99999 5999999999986 54 3468899999999999999999999999987764
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.4e-10 Score=114.41 Aligned_cols=151 Identities=19% Similarity=0.272 Sum_probs=109.7
Q ss_pred HHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCccee----------eccCCCCCCchhhhhc
Q 012039 188 SIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR----------DIVGSAYYVAPEVLRR 256 (472)
Q Consensus 188 qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~gt~~y~aPE~~~~ 256 (472)
+...|+.|+|+. ++||++|.|++|.+ +..+..||+.|+++....++..+. -..-...|.|||.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344899999975 89999999999999 677789999999987665532211 1123457999998765
Q ss_pred -ccCCccchhhHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCccCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 012039 257 -RYGKEIDIWSAGVILYILL-SGVPPFWAETEKGIFDAILQGDIDFESA-PWPTISSSAKDLVRRMLTQDPKKRITSAQV 333 (472)
Q Consensus 257 -~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rps~~~~ 333 (472)
..+.++|++|+|+++|.+. .|+.-+....... .............. .-.+++.++++-+.++|..++..||++..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 4688999999999999999 4555554433222 22222211111111 114789999999999999999999999999
Q ss_pred hcCCccccC
Q 012039 334 LEHPWIKEG 342 (472)
Q Consensus 334 l~h~~~~~~ 342 (472)
+..|||...
T Consensus 263 ~~~~ff~D~ 271 (700)
T KOG2137|consen 263 LSIPFFSDP 271 (700)
T ss_pred hcccccCCc
Confidence 999999854
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-09 Score=88.19 Aligned_cols=67 Identities=33% Similarity=0.543 Sum_probs=63.5
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..++++.+|+.+|.|++|+|+..+|+.+...||.+++++|+++|+.++|.|++|.|+-+||+.++..
T Consensus 104 t~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk~ 170 (172)
T KOG0028|consen 104 TKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKK 170 (172)
T ss_pred cHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHhc
Confidence 5677889999999999999999999999999999999999999999999999999999999998754
|
|
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.98 E-value=1e-09 Score=84.14 Aligned_cols=70 Identities=24% Similarity=0.408 Sum_probs=61.7
Q ss_pred hhHHhhhhhhhccccC--CCCCcccHHHHHHHHHH-cCCCC----CHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNIDT--DNSGTITYEELKAGLAR-LGSKL----TEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~--~~~G~i~~~el~~~l~~-~~~~~----~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
++++..++++|..+|. |++|.|+.+||..+++. +|..+ ++++++.|+..+|.+++|.|+|+||+.++...
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~ 80 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKL 80 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHH
Confidence 4567889999999999 89999999999999986 56444 58999999999999999999999999987643
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.7e-09 Score=92.91 Aligned_cols=83 Identities=28% Similarity=0.426 Sum_probs=75.4
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
...+...|...|+|+.|.|+.+||..+|...+ ..++.+.++.|+..+|.|.+|+|+|+||..++... +.++.+
T Consensus 56 ~~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i------~~Wr~v 129 (221)
T KOG0037|consen 56 FPQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYI------NQWRNV 129 (221)
T ss_pred cHHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHH------HHHHHH
Confidence 34678899999999999999999999999664 67889999999999999999999999999988654 789999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.||+|++|
T Consensus 130 F~~~D~D~SG 139 (221)
T KOG0037|consen 130 FRTYDRDRSG 139 (221)
T ss_pred HHhcccCCCC
Confidence 9999999998
|
|
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-09 Score=78.38 Aligned_cols=59 Identities=31% Similarity=0.482 Sum_probs=54.9
Q ss_pred hhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 388 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+++|..+|.|++|.|+.+|++.+++.+|. ++++++.++..+|.+++|.|+|+||+.++.
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~ 60 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLADTDKDGKLDKEEFAIAMH 60 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhcCCCCCcCCHHHHHHHHH
Confidence 57899999999999999999999999874 888999999999999999999999998775
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-08 Score=91.70 Aligned_cols=111 Identities=21% Similarity=0.261 Sum_probs=87.1
Q ss_pred cHHHHHHHHHHHHhccCCC--CeeEEEEEEEeC----CeEEEEEeccCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 012039 122 DKDDIKREIQIMQHLSGQP--NIVEFKGAYEDK----QSVHVVMELCAGG-ELFDRIIAKGHYSERAAASICRSIVNVVH 194 (472)
Q Consensus 122 ~~~~~~~E~~~l~~l~~hp--~iv~~~~~~~~~----~~~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~i~~qi~~~l~ 194 (472)
......+|...+..|. .- .+++.+.+.+.. ...+||+|+++|. +|.+++......+......++.++...+.
T Consensus 54 ~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 3456778888888875 22 245555555542 3458999999884 78888876555778888999999999999
Q ss_pred HHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 195 ~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
-||.+||+|+|+++.|||+..++....+.|+||+.+...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999976655567999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.6e-09 Score=81.21 Aligned_cols=69 Identities=16% Similarity=0.315 Sum_probs=59.3
Q ss_pred hhHHhhhhhhhcc-ccCCCCC-cccHHHHHHHHHHc-----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTN-IDTDNSG-TITYEELKAGLARL-----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~-~D~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+..+..+|.. +|.|++| +|+.+||+..+... +....+.+++.+++.+|.|+||.|+|+||+.++..
T Consensus 5 e~~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~ 80 (89)
T cd05023 5 ERCIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGG 80 (89)
T ss_pred HHHHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH
Confidence 3456778899999 7898987 99999999999886 34556789999999999999999999999987754
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=3e-09 Score=73.15 Aligned_cols=52 Identities=42% Similarity=0.703 Sum_probs=48.7
Q ss_pred CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 398 NSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 398 ~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+|.|+.+||+.++..+|.. +++++++.+|..+|.|++|.|+|+||+.++..
T Consensus 1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~~ 53 (54)
T PF13833_consen 1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQR 53 (54)
T ss_dssp SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHHH
T ss_pred CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Confidence 47999999999999889999 99999999999999999999999999998753
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.1e-09 Score=93.30 Aligned_cols=140 Identities=23% Similarity=0.282 Sum_probs=103.2
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEeccccc------------C-----C--cccHHHHHHHHHHHHhccCC-C
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL------------V-----T--KNDKDDIKREIQIMQHLSGQ-P 140 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~------------~-----~--~~~~~~~~~E~~~l~~l~~h-p 140 (472)
+.++.+||-|--|.||.|.+. .|.++|+|+-..... . + .......++|..+|.+|..+ -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567889999999999999976 588999997531100 0 0 01234567899999999533 2
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 141 ~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
.+++.+++ +...+|||+++|-.|... ++....+..++..|+.-+..+-..||+|||+++=||++ ++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence 56666544 456799999999777532 23466677778888887777778999999999999999 4566
Q ss_pred cEEEeecCCceec
Q 012039 221 LLKATDFGLSVFI 233 (472)
Q Consensus 221 ~~kl~Dfg~~~~~ 233 (472)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 6999999766543
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.1e-09 Score=91.14 Aligned_cols=89 Identities=21% Similarity=0.340 Sum_probs=76.0
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-----------
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK----------- 452 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~----------- 452 (472)
......+|+.||.|++|.|+..|+..+|..+-....++.+.+.|+.+|.|++|.|+++|++.++.....
T Consensus 63 ~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~ 142 (193)
T KOG0044|consen 63 SKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTLEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDE 142 (193)
T ss_pred HHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcHHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCccc
Confidence 345678999999999999999999999998877777888999999999999999999999998754321
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
...++....+|+.+|.|+||
T Consensus 143 ~~~~~~v~~if~k~D~n~Dg 162 (193)
T KOG0044|consen 143 ETPEERVDKIFSKMDKNKDG 162 (193)
T ss_pred ccHHHHHHHHHHHcCCCCCC
Confidence 22356789999999999998
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=9.8e-09 Score=88.82 Aligned_cols=93 Identities=29% Similarity=0.382 Sum_probs=78.8
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCH-HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTE-AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++..++..+++-|.. ...+|.++.++++.++.......+. .-.+.+|+.+|.|+||.|+|.||+.++.-......+
T Consensus 22 ~f~~~ei~~~Yr~Fk~--~cP~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~e 99 (193)
T KOG0044|consen 22 KFSKKEIQQWYRGFKN--ECPSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTLE 99 (193)
T ss_pred CCCHHHHHHHHHHhcc--cCCCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcHH
Confidence 4566777777777765 4569999999999999998864444 447889999999999999999999998877777778
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|++||.||+|
T Consensus 100 ekl~w~F~lyD~dgdG 115 (193)
T KOG0044|consen 100 EKLKWAFRLYDLDGDG 115 (193)
T ss_pred HHhhhhheeecCCCCc
Confidence 9999999999999998
|
|
| >KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.7e-09 Score=86.98 Aligned_cols=72 Identities=26% Similarity=0.463 Sum_probs=67.1
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++..++..+..+|+.+|.+.||+|+..||+.+|.+||.+-|.--+..|+..+|.|.||+|+|.||+-++..
T Consensus 92 eFsrkqIk~~~~~Fk~yDe~rDgfIdl~ELK~mmEKLgapQTHL~lK~mikeVded~dgklSfreflLIfrk 163 (244)
T KOG0041|consen 92 EFSRKQIKDAESMFKQYDEDRDGFIDLMELKRMMEKLGAPQTHLGLKNMIKEVDEDFDGKLSFREFLLIFRK 163 (244)
T ss_pred HHHHHHHHHHHHHHHHhcccccccccHHHHHHHHHHhCCchhhHHHHHHHHHhhcccccchhHHHHHHHHHH
Confidence 467888999999999999999999999999999999999888888999999999999999999999987653
|
|
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-08 Score=70.01 Aligned_cols=62 Identities=23% Similarity=0.442 Sum_probs=58.1
Q ss_pred hhhccccCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCC-cceeHHHHHHHHhcc
Q 012039 389 QMFTNIDTDNSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGN-GTIDYIEFITATMHR 450 (472)
Q Consensus 389 ~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~-g~i~~~eF~~~~~~~ 450 (472)
.+|..||.++.|.|...+|+..|+.++. .+++++++.+.+++|.++. |.|+|+.|+.+|..|
T Consensus 2 ~~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elDP~g~~~~v~~d~F~~iM~~w 65 (66)
T PF14658_consen 2 TAFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELDPEGRDGSVNFDTFLAIMRDW 65 (66)
T ss_pred cchhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhCCCCCCceEeHHHHHHHHHHh
Confidence 3699999999999999999999999998 8999999999999999988 999999999998754
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-08 Score=79.66 Aligned_cols=73 Identities=34% Similarity=0.527 Sum_probs=63.8
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++++-.+-..+.+.+.++.||++++|.|...||+.+|..+|..++++|++.++.-. .|.+|.|+|++|+..++
T Consensus 78 vaknk~q~t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~-eD~nG~i~YE~fVk~i~ 150 (152)
T KOG0030|consen 78 VAKNKDQGTYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQ-EDSNGCINYEAFVKHIM 150 (152)
T ss_pred HHhccccCcHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccc-cccCCcCcHHHHHHHHh
Confidence 34444455667888999999999999999999999999999999999999999765 78899999999998765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-07 Score=81.70 Aligned_cols=141 Identities=15% Similarity=0.131 Sum_probs=99.4
Q ss_pred eecCCeEEEEEEECCCCCEEEEEEeccccc---CCcccHHHHHHHHHHHHhccCC-CCeeEEEEEEE---e--CCeEEEE
Q 012039 88 GRGQFGVTYLCTENSTGRQFACKSISKRKL---VTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYE---D--KQSVHVV 158 (472)
Q Consensus 88 g~G~~g~V~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~~~E~~~l~~l~~h-p~iv~~~~~~~---~--~~~~~lv 158 (472)
|+||-|-|+..... |+.+-+|.-..... ..+.....|.+|+..+.+|... -.++++. ++. . ...-+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56888888886644 44677886542111 1134678899999999998621 1244444 222 1 1246799
Q ss_pred EeccCC-cchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 159 MELCAG-GELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 159 ~e~~~g-~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+|-+.| .+|.+++.+. .+.+......++.++...+.-||+.|+.|+|+.+.||++..++ ...++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 998854 4787777553 3467777889999999999999999999999999999996433 34599999976653
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.8e-08 Score=82.94 Aligned_cols=65 Identities=29% Similarity=0.520 Sum_probs=52.2
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..++.+|..+|.+++|.|+..||..++..+|..++.+++..+|..+|.|++|.|+|+||+.++..
T Consensus 90 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~ 154 (158)
T PTZ00183 90 EEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMKK 154 (158)
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 45777888888888888888888888888887788888888888888888888888888776643
|
|
| >cd00051 EFh EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.1e-08 Score=68.91 Aligned_cols=61 Identities=41% Similarity=0.737 Sum_probs=57.1
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
+..+|..+|.+++|.|+..|+..+++.++...+.+++..++..+|.+++|.|+++||+..+
T Consensus 2 ~~~~f~~~d~~~~g~l~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ef~~~~ 62 (63)
T cd00051 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLELM 62 (63)
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 5678999999999999999999999999999999999999999999999999999998754
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. |
| >cd05030 calgranulins Calgranulins: S-100 domain found in proteins belonging to the Calgranulin subgroup of the S100 family of EF-hand calcium-modulated proteins, including S100A8, S100A9, and S100A12 | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.8e-08 Score=74.99 Aligned_cols=68 Identities=18% Similarity=0.390 Sum_probs=58.4
Q ss_pred hHHhhhhhhhccccCC--CCCcccHHHHHHHHH-HcCCCCC----HHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDTD--NSGTITYEELKAGLA-RLGSKLT----EAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~-~~~~~~~----~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.+..+..+|..++.. .+|+|+.+||+.+|. .+|..++ +++++.||..+|.|++|.|+|+||+.++..
T Consensus 5 ~~i~~~~~~f~~y~~~~~~~~~Is~~El~~ll~~~~g~~~t~~~~~~~v~~i~~~~D~d~dG~I~f~eF~~~~~~ 79 (88)
T cd05030 5 KAIETIINVFHQYSVRKGHPDTLYKKEFKQLVEKELPNFLKKEKNQKAIDKIFEDLDTNQDGQLSFEEFLVLVIK 79 (88)
T ss_pred HHHHHHHHHHHHHhccCCCcccCCHHHHHHHHHHHhhHhhccCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH
Confidence 3456778899999865 489999999999997 5666666 899999999999999999999999998763
|
Note that the S-100 hierarchy, to which this Calgranulin group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. These proteins are expressed mainly in granulocytes, and are involved in inflammation, allergy, and neuritogenesis, as well as in host-parasite response. Calgranulins are modulated not only by calcium, but also by other metals such as zinc and copper. Structural data suggested that calgranulins may exist in multiple structural forms, homodimers, as well as hetero-oligomers. For example, the S100A8/S100A9 complex called calprotectin plays important roles in the regulation of inflammatory processes, wound repair, and regulating zinc-dependent enzymes as well as microbial growth. |
| >cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP) | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.7e-08 Score=77.43 Aligned_cols=64 Identities=22% Similarity=0.326 Sum_probs=55.3
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
......+..+|..+|.|+||+|+.+||..+. + ...+..+..+|..+|.|+||.|+++||...+.
T Consensus 44 ~~~~~~l~w~F~~lD~d~DG~Ls~~EL~~~~--l--~~~e~~~~~f~~~~D~n~Dg~IS~~Ef~~cl~ 107 (116)
T cd00252 44 PMCKDPVGWMFNQLDGNYDGKLSHHELAPIR--L--DPNEHCIKPFFESCDLDKDGSISLDEWCYCFI 107 (116)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCHHHHHHHH--c--cchHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 3455678899999999999999999999776 2 34567789999999999999999999999883
|
SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules. |
| >KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-07 Score=89.03 Aligned_cols=86 Identities=27% Similarity=0.524 Sum_probs=74.4
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
+...+++.+|+.||.+++|.++..+|.+++..+..+ ...+-...++...|.|.||.+||.||.+.+.. .|..+.
T Consensus 11 er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~-----~E~~l~ 85 (463)
T KOG0036|consen 11 ERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDN-----KELELY 85 (463)
T ss_pred HHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHH-----hHHHHH
Confidence 334578899999999999999999999999999876 55666888999999999999999999988764 356788
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|..+|.|+||
T Consensus 86 ~~F~~iD~~hdG 97 (463)
T KOG0036|consen 86 RIFQSIDLEHDG 97 (463)
T ss_pred HHHhhhccccCC
Confidence 999999999987
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=5e-07 Score=79.95 Aligned_cols=142 Identities=20% Similarity=0.199 Sum_probs=88.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccH------HHHHHHHHHHHhcc--CCCCeeEEEEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK------DDIKREIQIMQHLS--GQPNIVEFKGA 148 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~------~~~~~E~~~l~~l~--~hp~iv~~~~~ 148 (472)
+..+|.+.+.+-......|.+.. -.|+.+++|.........+... ....+++..+.++. +...++.++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 35578888888777666666654 4578899997653221111111 11233444444443 12233333222
Q ss_pred E-----EeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEE
Q 012039 149 Y-----EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 149 ~-----~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
. .--...+++|||++|..|.+... +++ .+...|..++.-+|+.|++|+|.+|.|+++.. ..++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~----~~i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN----NGIR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC----CcEE
Confidence 2 22345678999999988865431 232 24466778899999999999999999999952 2389
Q ss_pred EeecCCcee
Q 012039 224 ATDFGLSVF 232 (472)
Q Consensus 224 l~Dfg~~~~ 232 (472)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-07 Score=81.82 Aligned_cols=91 Identities=26% Similarity=0.413 Sum_probs=76.3
Q ss_pred hchhhHHhhhhhhhccccCC-CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcc-eeHHHHHHHHhccccCCc
Q 012039 378 NLSTEEIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT-IDYIEFITATMHRHKLER 455 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~-i~~~eF~~~~~~~~~~~~ 455 (472)
.++.+++..+...|.++|.+ ++|+|+.+||..+... ..++ -.+.|+..++.+++|. |+|++|+..+........
T Consensus 26 ~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~~-~~Np---~~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~~ 101 (187)
T KOG0034|consen 26 QFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPEL-ALNP---LADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKAS 101 (187)
T ss_pred ccCHHHHHHHHHHHHHhccccccCccCHHHHHHHHHH-hcCc---HHHHHHHHHhccCCCCccCHHHHHHHHhhhcCCcc
Confidence 47788999999999999999 9999999999998833 2222 2567889999998988 999999999876665444
Q ss_pred -HHHHHHHHHhhcCCCCC
Q 012039 456 -DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 -~~~l~~~F~~~D~d~~G 472 (472)
+++++-||++||.|++|
T Consensus 102 ~~~Kl~faF~vYD~~~~G 119 (187)
T KOG0034|consen 102 KREKLRFAFRVYDLDGDG 119 (187)
T ss_pred HHHHHHHHHHHhcCCCCC
Confidence 45999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.2e-09 Score=104.49 Aligned_cols=242 Identities=17% Similarity=0.193 Sum_probs=166.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC-eeEEEEEEEeCCeEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-iv~~~~~~~~~~~~~lv 158 (472)
.|.....+++|+++++++.+...+...+ .+++... ....-++++|.++ +||| .+..++-++.+....++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchh
Confidence 3555567899999999998877665444 6665422 3445688999999 5999 77778888888899999
Q ss_pred EeccCCc-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGG-ELFDRI-IAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~-sL~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
++++.++ +..... ...-.+.+-+...+++.-+.+++++|+.-=+|+| ||+.. ....+..||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCcc
Confidence 9999887 222111 1111233444556667777889999988778888 88864 345788999998888776
Q ss_pred cceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--ccCCC-CCCCCCCHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--IDFES-APWPTISSSA 312 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~s~~~ 312 (472)
..-+...+++.++|||+.. +.+....|.|++|+-..++.-|-+|-.... .....+-.+. ..... ..|.... -
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~--~ 460 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVF--H 460 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCccc--c
Confidence 6566778999999999765 568899999999987777777776653311 0111111110 00000 1122111 1
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.++...|+..-|..|+....++-|.+|....
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 2588999999999999999999999998653
|
|
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.8e-07 Score=74.53 Aligned_cols=77 Identities=27% Similarity=0.501 Sum_probs=66.7
Q ss_pred HHHHhhch-hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 373 KVIAENLS-TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 373 ~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++.+.++ .+..+.+..+|..||.+++|+|+.+.|+.+|...|..++++||+.|++.+-.|..|.|+|.+|+.++..
T Consensus 88 TmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ith 165 (171)
T KOG0031|consen 88 TMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIITH 165 (171)
T ss_pred HHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHHc
Confidence 34444442 233456889999999999999999999999999999999999999999999999999999999998863
|
|
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.9e-07 Score=79.72 Aligned_cols=66 Identities=33% Similarity=0.510 Sum_probs=56.2
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHc-CCCCC--HHH----HHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARL-GSKLT--EAE----VQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~--~~~----~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
++++=+|+.||.+++|+|+.+|+..++..+ +...+ ++. ++.+|.++|.|+||.|+|+||..++...
T Consensus 104 ~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~ 176 (187)
T KOG0034|consen 104 EKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQ 176 (187)
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence 578889999999999999999999999987 43444 433 6778899999999999999999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=79.92 Aligned_cols=73 Identities=22% Similarity=0.250 Sum_probs=55.5
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCC-CeeEEEEEEEeCCeEEEEEeccC
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVVMELCA 163 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-~iv~~~~~~~~~~~~~lv~e~~~ 163 (472)
..||+|..+.||+. .+..+++|..... .....+.+|.++++.+.... .+++++++..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 2556788987532 23456789999999986332 35788888888888899999999
Q ss_pred Ccc
Q 012039 164 GGE 166 (472)
Q Consensus 164 g~s 166 (472)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.9e-07 Score=97.66 Aligned_cols=206 Identities=17% Similarity=0.219 Sum_probs=146.6
Q ss_pred HHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE----EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 012039 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH----VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198 (472)
Q Consensus 123 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~----lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~ 198 (472)
......|+..+..+. |+|++.++.|........ +..++|...++...+..-+..+....+.+..+++.+|.|+|+
T Consensus 226 i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344556788888886 999999998876543333 456889999999999988999999999999999999999999
Q ss_pred cCcEeecCCCCceeeccCCCCCcEEEe--ecCCceeccCCcceeeccCCCCCCchhhhhcc---cCCccchhhHHHHHHH
Q 012039 199 MGVMHRDLKPENFLLSSKDENALLKAT--DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYI 273 (472)
Q Consensus 199 ~~i~H~dlkp~Nili~~~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ 273 (472)
..+.|.-|..+-..-...+..+.+.+. ||+.+..............+..+.++|..... .....|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 866665554442222112344455555 88888777665554455566778888877644 3344699999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 274 LLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 274 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+..|..+-.- ......+.. . ....+..+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~~---~~~~~~~l~-------~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEK---SAVPVSLLD-------V---LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCccccc---ccchhhhhc-------c---ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 9887544210 011111111 0 111267889999999999999999999999999864
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.9e-07 Score=76.69 Aligned_cols=64 Identities=41% Similarity=0.725 Sum_probs=49.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+..+|..+|.+++|+|+.+|+..++..+|..++.++++.++..+|.+++|.|+|+||+.++.
T Consensus 84 ~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~ 147 (149)
T PTZ00184 84 EEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMM 147 (149)
T ss_pred HHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHh
Confidence 4567778888888888888888888887777777777788888888888888888888876654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.9e-07 Score=75.48 Aligned_cols=133 Identities=23% Similarity=0.284 Sum_probs=92.5
Q ss_pred EEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 012039 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 161 (472)
++.+.||+|.+|.||+|.+. |..+|+|+-. .+.....+..|+++|..+.+----.+++.+..+ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRR-----RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEec-----CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 45678999999999999977 6689999754 344578899999999999744444666665443 355999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCC-CC-ceeeccCCCCCcEEEeecCCceeccCC
Q 012039 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLK-PE-NFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 162 ~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk-p~-Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+.|..|.+..... .. .-+..++.+---|-..||-|+.|+ |. ||++. +..+.|+||..|.....+
T Consensus 94 i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 94 IDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhccCC
Confidence 9998886654321 12 223344555455667899999998 44 55552 225899999998854433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.9e-06 Score=73.44 Aligned_cols=129 Identities=22% Similarity=0.286 Sum_probs=91.8
Q ss_pred cceEEcceeeecCC-eEEEEEEECCCCCEEEEEEecc---ccc-------CC-c-------ccHHHHHHHHHHHHhcc--
Q 012039 79 LHYSFGKELGRGQF-GVTYLCTENSTGRQFACKSISK---RKL-------VT-K-------NDKDDIKREIQIMQHLS-- 137 (472)
Q Consensus 79 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~va~K~~~~---~~~-------~~-~-------~~~~~~~~E~~~l~~l~-- 137 (472)
..++.++.||.|.. |.||+++.. |+.||+|+... ... .. . ....-|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57889999999999 999999855 78999999321 110 00 0 11235778998888886
Q ss_pred CCCCe--eEEEEEEEeC------------------CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 012039 138 GQPNI--VEFKGAYEDK------------------QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197 (472)
Q Consensus 138 ~hp~i--v~~~~~~~~~------------------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH 197 (472)
++.++ |+.++|..-. -...||.||.+... .++. .-+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 24455 9999987311 12468888886543 1222 33566777888999
Q ss_pred HcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 198 ~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
..||+-+|+++.|..= -||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999973 488999865
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5e-07 Score=91.03 Aligned_cols=144 Identities=17% Similarity=0.177 Sum_probs=92.0
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEeccccc--------------------CC-------cccH----H------HHH
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL--------------------VT-------KNDK----D------DIK 127 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------------------~~-------~~~~----~------~~~ 127 (472)
..|+.++-|.||+|+.+. |+.||||+....-. .. .... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999765 99999999753210 00 0000 1 123
Q ss_pred HHHHHHHhcc----CCCCeeEEEEEEEeCCeEEEEEeccCCcchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 012039 128 REIQIMQHLS----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI--IAKGHYSERAAASICRSIVNVVHICHFMGV 201 (472)
Q Consensus 128 ~E~~~l~~l~----~hp~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 201 (472)
+|...+.+++ +.|+|.-..=+++-.+.-.|+|||+.|..+.+.. .. ..++...+.....++ .+.-+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 4555555543 4455443333444445567999999998887763 33 334433333322222 1233334899
Q ss_pred EeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 202 ~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+|.|.+|.||++ ..++.+.+.|||+...+.+
T Consensus 287 fHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 999999999999 4557799999999887654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 472 | ||||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-80 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-80 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-80 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-78 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-78 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-78 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-77 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-67 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-62 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-61 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-60 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-60 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-59 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-59 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-59 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-59 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-59 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-59 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-59 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-59 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-58 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-58 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-58 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-57 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-57 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-57 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-55 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-55 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-55 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-55 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-54 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-54 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-53 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-53 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-53 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-53 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-53 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-53 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-53 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-53 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-53 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-53 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-53 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-53 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-53 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-52 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-52 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-52 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-52 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-50 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-50 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-49 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-47 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-47 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-47 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-47 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-47 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-47 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-46 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-46 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-46 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-46 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-46 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-46 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-46 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-46 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-46 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-46 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-46 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-43 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-43 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-43 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-42 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-42 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-42 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-41 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-41 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-41 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-41 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-40 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-40 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-40 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-40 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-40 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-40 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-40 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-40 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-40 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-40 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-40 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-40 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-39 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-39 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-39 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-38 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-38 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-38 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-38 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-38 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-38 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-38 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-37 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-37 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-37 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-37 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-37 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-37 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-37 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-37 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-37 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-37 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-37 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-37 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-37 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-37 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-37 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-37 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-37 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-37 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-37 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-37 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-37 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-37 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-37 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-37 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-36 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-36 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-36 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-36 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 1e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-36 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-36 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-36 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-36 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-36 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-36 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-35 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-35 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-35 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-34 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-34 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-34 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-34 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-34 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-34 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-34 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-34 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-34 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-34 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-34 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-34 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-34 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-33 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-33 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-33 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-33 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-33 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-33 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-33 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-33 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-33 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-33 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-33 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-33 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-33 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-33 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-33 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-33 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-33 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-33 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-33 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-33 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-33 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-33 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-33 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-33 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-33 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-33 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-33 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-33 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-33 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-32 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-32 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-32 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-32 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-32 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-32 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-32 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-32 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-32 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-32 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-32 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-32 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-32 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-32 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-32 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-32 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-32 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-32 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-32 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-32 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-32 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-31 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-31 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-31 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-31 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-30 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-30 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-30 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-30 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-30 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-30 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-30 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-30 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-30 | ||
| 1s6i_A | 188 | Ca2+-Regulatory Region (Cld) From Soybean Calcium-D | 5e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-30 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-29 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-28 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-28 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-28 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-28 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-28 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-28 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-28 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-28 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-28 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-28 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-28 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-28 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-28 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-28 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-28 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-28 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-28 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-28 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-28 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-28 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-28 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-28 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-27 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-24 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-24 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-23 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-23 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 1s6j_A | 87 | N-Terminal Region Of The Ca2+-Saturated Calcium Reg | 2e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-22 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-17 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-17 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-17 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-17 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-16 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-16 | ||
| 3pm8_A | 197 | Cad Domain Of Pff0520w, Calcium Dependent Protein K | 6e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 3k21_A | 191 | Crystal Structure Of Carboxy-Terminus Of Pfc0420w L | 9e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 1ahr_A | 146 | Calmodulin Mutant With A Two Residue Deletion In Th | 1e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 2be6_A | 150 | 2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaC | 2e-14 | ||
| 2bkh_B | 149 | Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Struc | 2e-14 | ||
| 1iq5_A | 149 | CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE | 2e-14 | ||
| 1xfu_O | 149 | Crystal Structure Of Anthrax Edema Factor (ef) Trun | 2e-14 | ||
| 4djc_A | 152 | 1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCA | 2e-14 | ||
| 2ygg_B | 150 | Complex Of Cambr And Cam Length = 150 | 2e-14 | ||
| 2wel_D | 150 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-14 | ||
| 2vb6_B | 149 | Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigo | 2e-14 | ||
| 1ooj_A | 149 | Structural Genomics Of Caenorhabditis Elegans : Cal | 2e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-14 | ||
| 3o4y_A | 196 | Crystal Structure Of Cad Domain Of The Plasmodium V | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 2lv6_A | 148 | The Complex Between Ca-calmodulin And Skeletal Musc | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 1prw_A | 149 | Crystal Structure Of Bovine Brain Ca++ Calmodulin I | 2e-14 | ||
| 1up5_B | 148 | Chicken Calmodulin Length = 148 | 2e-14 | ||
| 1cdl_A | 147 | Target Enzyme Recognition By Calmodulin: 2.4 Angstr | 2e-14 | ||
| 1dmo_A | 148 | Calmodulin, Nmr, 30 Structures Length = 148 | 2e-14 | ||
| 2bbm_A | 148 | Solution Structure Of A Calmodulin-Target Peptide C | 2e-14 | ||
| 3ewt_A | 154 | Crystal Structure Of Calmodulin Complexed With A Pe | 2e-14 | ||
| 1cm1_A | 148 | Motions Of Calmodulin-Single-Conformer Refinement L | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 3l19_A | 214 | Crystal Structure Of Calcium Binding Domain Of Cpcd | 4e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-14 | ||
| 2f2o_A | 179 | Structure Of Calmodulin Bound To A Calcineurin Pept | 5e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1qtx_A | 148 | The 1.65 Angstrom Structure Of Calmodulin Rs20 Pept | 5e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-14 | ||
| 1vrk_A | 148 | The 1.9 Angstrom Structure Of E84k-Calmodulin Rs20 | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 2ix7_A | 145 | Structure Of Apo-Calmodulin Bound To Unconventional | 7e-14 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-14 | ||
| 1deg_A | 142 | The Linker Of Des-Glu84 Calmodulin Is Bent As Seen | 7e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-14 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-14 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-14 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-14 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-14 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-14 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-14 | ||
| 1cdm_A | 144 | Modulation Of Calmodulin Plasticity In Molecular Re | 1e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-13 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-13 | ||
| 2vay_A | 146 | Calmodulin Complexed With Cav1.1 Iq Peptide Length | 1e-13 | ||
| 4gow_D | 144 | Crystal Structure Of Ca2+CAM:KV7.4 (KCNQ4) B HELIX | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-13 | ||
| 1exr_A | 148 | The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Ca | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 3khe_A | 191 | Crystal Structure Of The Calcium-Loaded Calmodulin- | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 3sg2_A | 449 | Crystal Structure Of Gcamp2-T116v,D381y Length = 44 | 1e-13 | ||
| 3ek8_A | 449 | Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER L | 1e-13 | ||
| 3sg6_A | 450 | Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) L | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3o77_A | 415 | The Structure Of Ca2+ Sensor (Case-16) Length = 415 | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3evu_A | 449 | Crystal Structure Of Calcium Bound Dimeric Gcamp2, | 2e-13 | ||
| 3o78_A | 415 | The Structure Of Ca2+ Sensor (Case-12) Length = 415 | 2e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-13 | ||
| 3evr_A | 411 | Crystal Structure Of Calcium Bound Monomeric Gcamp2 | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 1qs7_A | 145 | The 1.8 Angstrom Structure Of Calmodulin Rs20 Pepti | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-13 | ||
| 1xfx_O | 149 | Crystal Structure Of Anthrax Edema Factor (Ef) In C | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 1niw_A | 148 | Crystal Structure Of Endothelial Nitric Oxide Synth | 2e-13 | ||
| 1rfj_A | 149 | Crystal Structure Of Potato Calmodulin Pcm6 Length | 2e-13 | ||
| 4aqr_A | 149 | Crystal Structure Of A Calmodulin In Complex With T | 3e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-13 | ||
| 1y0v_H | 146 | Crystal Structure Of Anthrax Edema Factor (Ef) In C | 3e-13 | ||
| 1k93_D | 144 | Crystal Structure Of The Adenylyl Cyclase Domain Of | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 1clm_A | 148 | Structure Of Paramecium Tetraurelia Calmodulin At 1 | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-13 | ||
| 3sg5_A | 448 | Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linke | 4e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 3sg4_A | 448 | Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Len | 4e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-13 | ||
| 2k0j_A | 148 | Solution Structure Of Cam Complexed To Drp1p Length | 5e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-13 | ||
| 3sg7_A | 448 | Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 4 | 5e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 3sg3_A | 449 | Crystal Structure Of Gcamp3-D380y Length = 449 | 6e-13 | ||
| 3ekh_A | 449 | Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER | 6e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 3u0k_A | 440 | Crystal Structure Of The Genetically Encoded Calciu | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1y6w_A | 148 | Trapped Intermediate Of Calmodulin Length = 148 | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 1ggz_A | 148 | Crystal Structure Of The Calmodulin-Like Protein (H | 3e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 3qrx_A | 169 | Chlamydomonas Reinhardtii Centrin Bound To Melittin | 4e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-12 | ||
| 4ds7_A | 147 | Crystal Structure Of Yeast Calmodulin Bound To The | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 1lkj_A | 146 | Nmr Structure Of Apo Calmodulin From Yeast Saccharo | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 2l1w_A | 149 | The Solution Structure Of Soybean Calmodulin Isofor | 2e-11 | ||
| 2lhh_A | 128 | Solution Structure Of Ca2+-Bound Ycam Length = 128 | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-11 | ||
| 3ifk_A | 90 | Crystal Structure Of Calcium-Saturated Calmodulin N | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 2lhi_A | 176 | Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam L | 3e-11 | ||
| 2lqc_A | 77 | Nmr Solution Structure Of A Ca2+-Calmodulin With A | 3e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 3uct_A | 79 | Structure Of Mn2+-Bound N-Terminal Domain Of Calmod | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 2llo_A | 80 | Solution Nmr-Derived Structure Of Calmodulin N-Lobe | 4e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-11 | ||
| 1f70_A | 76 | Refined Solution Structure Of Calmodulin N-Terminal | 5e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-11 | ||
| 3b32_A | 75 | Crystal Structure Of Calcium-Saturated Calmodulin N | 6e-11 | ||
| 1ak8_A | 76 | Nmr Solution Structure Of Cerium-Loaded Calmodulin | 6e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 1sw8_A | 79 | Solution Structure Of The N-Terminal Domain Of Huma | 1e-10 | ||
| 1j7o_A | 76 | Solution Structure Of Calcium-calmodulin N-terminal | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ekj_A | 449 | Calcium-Free Gcamp2 (Calcium Binding Deficient Muta | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 2i08_A | 78 | Solvation Effect In Conformational Changes Of Ef-Ha | 3e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-10 | ||
| 2ro8_A | 79 | Solution Structure Of Calcium Bound Soybean Calmodu | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 3kf9_A | 149 | Crystal Structure Of The SdcenSKMLCK COMPLEX Length | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 1f54_A | 77 | Solution Structure Of The Apo N-Terminal Domain Of | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 7e-09 | ||
| 2kn2_A | 92 | Solution Structure Of The C-Terminal Domain Of Soyb | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 3e3r_A | 204 | Crystal Structure And Biochemical Characterization | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 2rob_A | 70 | Solution Structure Of Calcium Bound Soybean Calmodu | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 2ksz_A | 76 | The Solution Structure Of The Magnesium Bound Soybe | 4e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-08 | ||
| 2roa_A | 79 | Solution Structure Of Calcium Bound Soybean Calmodu | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 2ro9_A | 69 | Solution Structure Of Calcium Bound Soybean Calmodu | 5e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-08 | ||
| 2lmt_A | 148 | Nmr Structure Of Androcam Length = 148 | 5e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-08 |
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3K21|A Chain A, Crystal Structure Of Carboxy-Terminus Of Pfc0420w Length = 191 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1AHR|A Chain A, Calmodulin Mutant With A Two Residue Deletion In The Central Helix Length = 146 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BE6|A Chain A, 2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaCAM COMPLEX Length = 150 | Back alignment and structure |
|
| >pdb|2BKH|B Chain B, Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Structure Length = 149 | Back alignment and structure |
|
| >pdb|1IQ5|A Chain A, CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE KINASE Fragment Length = 149 | Back alignment and structure |
|
| >pdb|1XFU|O Chain O, Crystal Structure Of Anthrax Edema Factor (ef) Truncation Mutant, Ef-delta 64 In Complex With Calmodulin Length = 149 | Back alignment and structure |
|
| >pdb|4DJC|A Chain A, 1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCAM COMPLEX Length = 152 | Back alignment and structure |
|
| >pdb|2YGG|B Chain B, Complex Of Cambr And Cam Length = 150 | Back alignment and structure |
|
| >pdb|2WEL|D Chain D, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 150 | Back alignment and structure |
|
| >pdb|2VB6|B Chain B, Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigor State ( Crystal Form 2) Length = 149 | Back alignment and structure |
|
| >pdb|1OOJ|A Chain A, Structural Genomics Of Caenorhabditis Elegans : Calmodulin Length = 149 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3O4Y|A Chain A, Crystal Structure Of Cad Domain Of The Plasmodium Vivax Cdpk, Pvx_11610 Length = 196 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LV6|A Chain A, The Complex Between Ca-calmodulin And Skeletal Muscle Myosin Light Chain Kinase From Combination Of Nmr And Aqueous And Contrast-matched Saxs Data Length = 148 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1PRW|A Chain A, Crystal Structure Of Bovine Brain Ca++ Calmodulin In A Compact Form Length = 149 | Back alignment and structure |
|
| >pdb|1UP5|B Chain B, Chicken Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|1CDL|A Chain A, Target Enzyme Recognition By Calmodulin: 2.4 Angstroms Structure Of A Calmodulin-Peptide Complex Length = 147 | Back alignment and structure |
|
| >pdb|1DMO|A Chain A, Calmodulin, Nmr, 30 Structures Length = 148 | Back alignment and structure |
|
| >pdb|2BBM|A Chain A, Solution Structure Of A Calmodulin-Target Peptide Complex By Multidimensional Nmr Length = 148 | Back alignment and structure |
|
| >pdb|3EWT|A Chain A, Crystal Structure Of Calmodulin Complexed With A Peptide Length = 154 | Back alignment and structure |
|
| >pdb|1CM1|A Chain A, Motions Of Calmodulin-Single-Conformer Refinement Length = 148 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3L19|A Chain A, Crystal Structure Of Calcium Binding Domain Of Cpcdpk3, Cgd5_820 Length = 214 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F2O|A Chain A, Structure Of Calmodulin Bound To A Calcineurin Peptide: A New Way Of Making An Old Binding Mode Length = 179 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QTX|A Chain A, The 1.65 Angstrom Structure Of Calmodulin Rs20 Peptide Complex Length = 148 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1VRK|A Chain A, The 1.9 Angstrom Structure Of E84k-Calmodulin Rs20 Peptide Complex Length = 148 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IX7|A Chain A, Structure Of Apo-Calmodulin Bound To Unconventional Myosin V Length = 145 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DEG|A Chain A, The Linker Of Des-Glu84 Calmodulin Is Bent As Seen In The Crystal Structure Length = 142 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1CDM|A Chain A, Modulation Of Calmodulin Plasticity In Molecular Recognition On The Basis Of X-Ray Structures Length = 144 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2VAY|A Chain A, Calmodulin Complexed With Cav1.1 Iq Peptide Length = 146 | Back alignment and structure |
|
| >pdb|4GOW|D Chain D, Crystal Structure Of Ca2+CAM:KV7.4 (KCNQ4) B HELIX COMPLEX Length = 144 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1EXR|A Chain A, The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KHE|A Chain A, Crystal Structure Of The Calcium-Loaded Calmodulin-Like Domain Of The Cdpk, 541.M00134 From Toxoplasma Gondii Length = 191 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SG2|A Chain A, Crystal Structure Of Gcamp2-T116v,D381y Length = 449 | Back alignment and structure |
|
| >pdb|3EK8|A Chain A, Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER Length = 449 | Back alignment and structure |
|
| >pdb|3SG6|A Chain A, Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) Length = 450 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3O77|A Chain A, The Structure Of Ca2+ Sensor (Case-16) Length = 415 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EVU|A Chain A, Crystal Structure Of Calcium Bound Dimeric Gcamp2, (#1) Length = 449 | Back alignment and structure |
|
| >pdb|3O78|A Chain A, The Structure Of Ca2+ Sensor (Case-12) Length = 415 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EVR|A Chain A, Crystal Structure Of Calcium Bound Monomeric Gcamp2 Length = 411 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QS7|A Chain A, The 1.8 Angstrom Structure Of Calmodulin Rs20 Peptide Complex Length = 145 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1XFX|O Chain O, Crystal Structure Of Anthrax Edema Factor (Ef) In Complex With Calmodulin In The Presence Of 10 Millimolar Exogenously Added Calcium Chloride Length = 149 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1NIW|A Chain A, Crystal Structure Of Endothelial Nitric Oxide Synthase Peptide Bound To Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|1RFJ|A Chain A, Crystal Structure Of Potato Calmodulin Pcm6 Length = 149 | Back alignment and structure |
|
| >pdb|4AQR|A Chain A, Crystal Structure Of A Calmodulin In Complex With The Regulatory Domain Of A Plasma-Membrane Ca2+-Atpase Length = 149 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y0V|H Chain H, Crystal Structure Of Anthrax Edema Factor (Ef) In Complex With Calmodulin And Pyrophosphate Length = 146 | Back alignment and structure |
|
| >pdb|1K93|D Chain D, Crystal Structure Of The Adenylyl Cyclase Domain Of Anthrax Edema Factor (Ef) In Complex With Calmodulin Length = 144 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1CLM|A Chain A, Structure Of Paramecium Tetraurelia Calmodulin At 1.8 Angstroms Resolution Length = 148 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SG5|A Chain A, Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linker 1), Lp(Linker 2) Length = 448 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SG4|A Chain A, Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Length = 448 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2K0J|A Chain A, Solution Structure Of Cam Complexed To Drp1p Length = 148 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SG7|A Chain A, Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 448 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3SG3|A Chain A, Crystal Structure Of Gcamp3-D380y Length = 449 | Back alignment and structure |
|
| >pdb|3EKH|A Chain A, Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER Length = 449 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3U0K|A Chain A, Crystal Structure Of The Genetically Encoded Calcium Indicator Rcamp Length = 440 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Y6W|A Chain A, Trapped Intermediate Of Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GGZ|A Chain A, Crystal Structure Of The Calmodulin-Like Protein (Hclp) From Human Epithelial Cells Length = 148 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QRX|A Chain A, Chlamydomonas Reinhardtii Centrin Bound To Melittin Length = 169 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4DS7|A Chain A, Crystal Structure Of Yeast Calmodulin Bound To The C-Terminal Fragment Of Spindle Pole Body Protein Spc110 Length = 147 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1LKJ|A Chain A, Nmr Structure Of Apo Calmodulin From Yeast Saccharomyces Cerevisiae Length = 146 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2L1W|A Chain A, The Solution Structure Of Soybean Calmodulin Isoform 4 Complexed With The Vacuolar Calcium Atpase Bca1 Peptide Length = 149 | Back alignment and structure |
|
| >pdb|2LHH|A Chain A, Solution Structure Of Ca2+-Bound Ycam Length = 128 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3IFK|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-90 Length = 90 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2LHI|A Chain A, Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam Length = 176 | Back alignment and structure |
|
| >pdb|2LQC|A Chain A, Nmr Solution Structure Of A Ca2+-Calmodulin With A Binding Motif (Nscate) Peptide From The N-Terminal Cytoplasmic Domain Of The L-Type Voltage-Cated Calcium Channel Alpha1c Subunit Length = 77 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UCT|A Chain A, Structure Of Mn2+-Bound N-Terminal Domain Of Calmodulin In The Presence Of Zn2+ Length = 79 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2LLO|A Chain A, Solution Nmr-Derived Structure Of Calmodulin N-Lobe Bound With Er Alpha Peptide Length = 80 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1F70|A Chain A, Refined Solution Structure Of Calmodulin N-Terminal Domain Length = 76 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3B32|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-75 Length = 75 | Back alignment and structure |
|
| >pdb|1AK8|A Chain A, Nmr Solution Structure Of Cerium-Loaded Calmodulin Amino- Terminal Domain (Ce2-Tr1c), 23 Structures Length = 76 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SW8|A Chain A, Solution Structure Of The N-Terminal Domain Of Human N60d Calmodulin Refined With Paramagnetism Based Strategy Length = 79 | Back alignment and structure |
|
| >pdb|1J7O|A Chain A, Solution Structure Of Calcium-calmodulin N-terminal Domain Length = 76 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKJ|A Chain A, Calcium-Free Gcamp2 (Calcium Binding Deficient Mutant) Length = 449 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2I08|A Chain A, Solvation Effect In Conformational Changes Of Ef-Hand Proteins: X-Ray Structure Of Ca2+-Saturated Double Mutant Q41l-K75i Of N-Domain Of Calmodulin Length = 78 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2RO8|A Chain A, Solution Structure Of Calcium Bound Soybean Calmodulin Isoform 1 N-Terminal Domain Length = 79 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KF9|A Chain A, Crystal Structure Of The SdcenSKMLCK COMPLEX Length = 149 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1F54|A Chain A, Solution Structure Of The Apo N-Terminal Domain Of Yeast Calmodulin Length = 77 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2KN2|A Chain A, Solution Structure Of The C-Terminal Domain Of Soybean Calmodulin Isoform 4 Fused With The Calmodulin-Binding Domain Of Ntmkp1 Length = 92 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3E3R|A Chain A, Crystal Structure And Biochemical Characterization Of Recombinant Human Calcyphosine Delineates A Novel Ef-hand-containing Protein Family Length = 204 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ROB|A Chain A, Solution Structure Of Calcium Bound Soybean Calmodulin Isoform 4 C-Terminal Domain Length = 70 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2KSZ|A Chain A, The Solution Structure Of The Magnesium Bound Soybean Calmod Isoform 4 N-Domain Length = 76 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2ROA|A Chain A, Solution Structure Of Calcium Bound Soybean Calmodulin Isoform 4 N-Terminal Domain Length = 79 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2RO9|A Chain A, Solution Structure Of Calcium Bound Soybean Calmodulin Isoform 1 C-Terminal Domain Length = 69 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2LMT|A Chain A, Nmr Structure Of Androcam Length = 148 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 677 bits (1748), Expect = 0.0
Identities = 164/435 (37%), Positives = 237/435 (54%), Gaps = 18/435 (4%)
Query: 53 PVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSI 112
P S + P + Y + LG+G FG LC + TG++ A K I
Sbjct: 2 PGSMMDHLHATPGM--FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI 59
Query: 113 SKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRII 172
SKR++ K DK+ + RE+Q+++ L PNI++ +EDK ++V E+ GGELFD II
Sbjct: 60 SKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 173 AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
++ +SE AA I R +++ + H ++HRDLKPEN LL SK ++A ++ DFGLS
Sbjct: 119 SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 233 IEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA 292
E K +D +G+AYY+APEVL Y ++ D+WS GVILYILLSG PPF E I
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK---EGGEASDKP 349
+ +G FE W +S SAKDL+R+MLT P RI++ L+H WI+ + + D P
Sbjct: 239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKVIAENL-STEEIQGLKQMFTNIDTDNSGTITYEELK 408
+ ++QF+ KL + AL + L S +E + L +F +D + G + EL
Sbjct: 299 SLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELI 358
Query: 409 AGLAR-----------LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457
G L + E EV Q+++A D D NG I+Y EF+T M R L +
Sbjct: 359 EGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRE 418
Query: 458 HLYKAFQHFDKDNSG 472
L +AF+ FD DNSG
Sbjct: 419 RLERAFRMFDSDNSG 433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L++ F D+DNSG I+ EL + + ++ D + +G +D+ EF
Sbjct: 420 LERAFRMFDSDNSGKISSTELATIFGVSD--VDSETWKSVLSEVDKNNDGEVDFDEFQQM 477
Query: 447 TMHR 450
+ +
Sbjct: 478 -LLK 480
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 676 bits (1747), Expect = 0.0
Identities = 149/456 (32%), Positives = 230/456 (50%), Gaps = 30/456 (6%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH G + + K + Y ++LG G +G LC
Sbjct: 3 HHHHHSSGRENLYFQGIAINP-------GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC 55
Query: 99 TENSTGRQFACKSISKRKLVT----------KNDKDDIKREIQIMQHLSGQPNIVEFKGA 148
E + + A K I K + + ++I EI +++ L PNI++
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDV 114
Query: 149 YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKP 208
+EDK+ ++V E GGELF++II + + E AA+I + I++ + H ++HRD+KP
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 209 ENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAG 268
EN LL +K+ +K DFGLS F + RD +G+AYY+APEVL+++Y ++ D+WS G
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG 234
Query: 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328
VI+YILL G PPF + ++ I + +G F+ W IS AK+L++ MLT D KR
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
Query: 329 TSAQVLEHPWIKEG---GEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLST-EEI 384
T+ + L WIK+ SD+ LS M++F KL + A+ I L+T EE
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEER 354
Query: 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGS--------KLTEAEVQQLMEAADVDGNG 436
+ L +F +D + G + +EL G L + K E EV +++ D D NG
Sbjct: 355 KELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNG 414
Query: 437 TIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I+Y EFI+ M + L ++ L +AF FD D SG
Sbjct: 415 YIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSG 450
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 21/64 (32%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L++ F DTD SG IT EEL ++E ++ AD + + ID+ EF++
Sbjct: 437 LRRAFNLFDTDKSGKITKEELANLFGLTS--ISEKTWNDVLGEADQNKDNMIDFDEFVSM 494
Query: 447 TMHR 450
MH+
Sbjct: 495 -MHK 497
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 672 bits (1735), Expect = 0.0
Identities = 161/417 (38%), Positives = 235/417 (56%), Gaps = 21/417 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
Y+ LG+G FG C + T +++A K I+K K D I RE+++++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNI++ ED S ++V EL GGELFD II + +SE AA I + + + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRDLKPEN LL SK+++ +K DFGLS ++ +D +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
R Y ++ D+WSAGVILYILLSG PPF+ + E I + G F+ W TIS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIK----EGGEASDKPIDSAVLSRMKQFRAMNKLKKL 370
L+R+MLT P RIT+ Q LEHPWI+ E SD P + ++ ++QF+A KL +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315
Query: 371 ALKVIAENLST-EEIQGLKQMFTNIDTDNSGTITYEELKAGLARL--------------G 415
AL +A L+T +E + L ++F +DT+N G + +EL G
Sbjct: 316 ALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNE 375
Query: 416 SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
E ++ LM D+DG+G+I+Y EFI + + R L + + +AF+ FDKD SG
Sbjct: 376 GSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDGSG 432
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 16/63 (25%), Positives = 34/63 (53%), Gaps = 1/63 (1%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+++ F D D SG I+ +EL ++ S + E++ ++E D + +G +D+ EF+
Sbjct: 419 MERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEM 478
Query: 447 TMH 449
+
Sbjct: 479 -LQ 480
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 668 bits (1726), Expect = 0.0
Identities = 160/447 (35%), Positives = 246/447 (55%), Gaps = 20/447 (4%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH L+ + + Y K+LG G +G LC
Sbjct: 2 HHHHHHSSGRENLYFQGDLQ-----ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLC 56
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
+ T + A K I K + + + + E+ +++ L PNI++ +EDK++ ++V
Sbjct: 57 RDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLV 114
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
ME GGELFD II + ++E AA I + +++ V H ++HRDLKPEN LL SK++
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
+AL+K DFGLS E K ++ +G+AYY+APEVLR++Y ++ D+WS GVIL+ILL+G
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPF +T++ I + +G F+S W +S AKDL+++ML D ++RI++ Q LEHPW
Sbjct: 235 PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 339 IKEGGEAS----DKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLST-EEIQGLKQMFTN 393
IKE + P + + M++F+ KL + AL +A L++ EE + L +F +
Sbjct: 295 IKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRH 354
Query: 394 IDTDNSGTITYEELKAGLARLGSK--------LTEAEVQQLMEAADVDGNGTIDYIEFIT 445
ID + G + +EL G ++L + E+EV ++ AAD D NG IDY EF+T
Sbjct: 355 IDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVT 414
Query: 446 ATMHRHKLERDDHLYKAFQHFDKDNSG 472
M R L D L AFQ FD+D +G
Sbjct: 415 VAMDRKSLLSKDKLESAFQKFDQDGNG 441
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L+ F D D +G I+ +EL + L ++++ D + +G +D+ EF
Sbjct: 428 LESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDSNNDGDVDFEEFCKM 485
Query: 447 TMHR 450
+ +
Sbjct: 486 -IQK 488
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 625 bits (1614), Expect = 0.0
Identities = 131/403 (32%), Positives = 207/403 (51%), Gaps = 17/403 (4%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
Y +ELG+G F V C + G+++A I+ +KL + D ++RE +I +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICR 65
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNIV + ++ +++ +L GGELF+ I+A+ +YSE A+ + I+ V
Sbjct: 66 LLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEV 253
CH MGV+HR+LKPEN LL+SK + A +K DFGL++ +E E + + G+ Y++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
LR+ YGK +D+W+ GVILYILL G PPFW E + ++ I G DF S W T++ A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
KDL+ +MLT +P KRIT+A+ L+HPWI + + +K+F A KLK L
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL 304
Query: 373 KVIAEN--LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
V+ S + + +K I+ ++G +K+ + + A
Sbjct: 305 TVMLATRNFSVRKQEIIKVTEQLIEAISNGDFE----------SYTKMCDPGMTAFEPEA 354
Query: 431 DVDGNGTIDYIEFITATM-HRHKLERDDHLYKAFQHFDKDNSG 472
+ +D+ F + R+ + H D S
Sbjct: 355 LGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESA 397
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 566 bits (1462), Expect = 0.0
Identities = 121/365 (33%), Positives = 190/365 (52%), Gaps = 11/365 (3%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGR 105
GP A+ + + +Y +ELG+G F V C +TG
Sbjct: 1 GPHMASMTGGQ-----QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGL 55
Query: 106 QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165
+FA K I+ +KL + D ++RE +I + L PNIV + +++ ++V +L GG
Sbjct: 56 EFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 166 ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225
ELF+ I+A+ YSE A+ + I+ + CH G++HR+LKPEN LL+SK + A +K
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 226 DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAE 284
DFGL++ + + + + G+ Y++PEVL++ Y K +DIW+ GVILYILL G PPFW E
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ ++ I G D+ S W T++ AK L+ MLT +PKKRIT+ Q L+ PWI
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
Query: 345 ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITY 404
+ + +K+F A KLK L + +T + L + N +
Sbjct: 294 VASAIHRQDTVDCLKKFNARRKLKGAILTTMI---ATRNLSNLGRNLLNKKEQGPPSTIK 350
Query: 405 EELKA 409
E ++
Sbjct: 351 ESSES 355
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 554 bits (1429), Expect = 0.0
Identities = 116/347 (33%), Positives = 175/347 (50%), Gaps = 12/347 (3%)
Query: 63 RPDTNTILGKPYEDVKL--HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK 120
IL +DV Y + +G+G F V C TG+QFA K + K +
Sbjct: 6 SGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65
Query: 121 N--DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-- 176
+D+KRE I L P+IVE Y +++V E G +L I+ +
Sbjct: 66 PGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 177 --YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV-FI 233
YSE A+ R I+ + CH ++HRD+KP LL+SK+ +A +K FG+++
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 234 EEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA 292
E G V VG+ +++APEV++R YGK +D+W GVIL+ILLSG PF+ E+ +F+
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEG 243
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
I++G W IS SAKDLVRRML DP +RIT + L HPW+KE + K
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLP 303
Query: 353 AVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNS 399
+ ++++F A KLK L ++ + + + D +
Sbjct: 304 ETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 536 bits (1383), Expect = 0.0
Identities = 125/350 (35%), Positives = 189/350 (54%), Gaps = 13/350 (3%)
Query: 31 PAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRG 90
+ + + + A+ G VP I G + + + ELGRG
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPD---YWIDGSNRDALSDFFEVESELGRG 64
Query: 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
+ Y C + T + +A K + K DK ++ EI ++ LS PNI++ K +E
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFE 118
Query: 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210
+ +V+EL GGELFDRI+ KG+YSER AA + I+ V H G++HRDLKPEN
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGV 269
L ++ +A LK DFGLS +E + + + G+ Y APE+LR YG E+D+WS G+
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 270 ILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328
I YILL G PF+ E ++ +F IL + F S W +S +AKDLVR+++ DPKKR+
Sbjct: 239 ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298
Query: 329 TSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAEN 378
T+ Q L+HPW+ G+A++ ++++F A KLK V+A +
Sbjct: 299 TTFQALQHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASS 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 532 bits (1373), Expect = 0.0
Identities = 121/329 (36%), Positives = 178/329 (54%), Gaps = 16/329 (4%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQ 131
E+V +Y G+ELG GQF V C E STG Q+A K I KR+ + ++DI+RE+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + PN++ YE+K V +++EL AGGELFD + K +E A + I+N
Sbjct: 67 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + + H DLKPEN +L ++ +K DFGL+ I+ G +++I G+ +VA
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ + + +FE + S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
+ AKD +RR+L +DPKKR+T L+HPWIK LSR M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT-------QQALSRKASAVNMEKFKK 298
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDN 398
A + + N S GL +F +
Sbjct: 299 FAARKKSNNGSGG---GLNDIFEAQKIEW 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 525 bits (1353), Expect = 0.0
Identities = 112/402 (27%), Positives = 178/402 (44%), Gaps = 24/402 (5%)
Query: 22 SSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPD-TNTILGKPYEDVKLH 80
+S P PA P P P A P Q P+ + + K + +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG G G T +FA K + +RE+++ S P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCP 115
Query: 141 NIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVH 194
+IV YE+ ++ + +VME GGELF RI +G ++ER A+ I +SI +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H + + HRD+KPEN L +SK NA+LK TDFG + + YYVAPEVL
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAE----TEKGIFDAILQGDIDFESAPWPTIS 309
Y K D+WS GVI+YILL G PPF++ G+ I G +F + W +S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
K L+R +L +P +R+T + + HPWI + + P+ ++ + + + R + ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 355
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL 411
+ + + E+I ++ D N + + L
Sbjct: 356 MTSALATMRVDYEQI----KIKKIEDASNPLLLKRRKKARAL 393
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 517 bits (1334), Expect = 0.0
Identities = 90/338 (26%), Positives = 160/338 (47%), Gaps = 20/338 (5%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSF-GKELGRGQFGVTYL 97
HH T + + E+ Y KELGRG+F V
Sbjct: 2 HHHHHHSSGVDLG--------------TENLYFQSMENFNNFYILTSKELGRGKFAVVRQ 47
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
C STG+++A K + KR+ ++ + +I EI +++ P ++ YE+ + +
Sbjct: 48 CISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106
Query: 158 VMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS 215
++E AGGE+F + + SE + + I+ V+ H ++H DLKP+N LLSS
Sbjct: 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166
Query: 216 KDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYIL 274
+K DFG+S I R+I+G+ Y+APE+L D+W+ G+I Y+L
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226
Query: 275 LSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
L+ PF E + + I Q ++D+ + ++S A D ++ +L ++P+KR T+ L
Sbjct: 227 LTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286
Query: 335 EHPWIKEGG-EASDKPIDSAVLSRMKQFRAMNKLKKLA 371
H W+++ E P +++ S+ + + K +
Sbjct: 287 SHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 81/321 (25%), Positives = 160/321 (49%), Gaps = 12/321 (3%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+++ Y ++LGRG+FG+ + C E S+ + + K + + D+ +K+EI I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILN 56
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVV 193
NI+ ++E + + ++ E +G ++F+RI +ER S + +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H + H D++PEN + ++ ++ +K +FG + ++ G +R + + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
+ D+WS G ++Y+LLSG+ PF AET + I + I+ + F+ + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
D V R+L ++ K R+T+++ L+HPW+K+ + + + V+ +K R + L K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ----KIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 373 KVIAENLSTEEIQGLKQMFTN 393
++ ++
Sbjct: 291 NMVVSAARISCGGAIRSQKGV 311
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 507 bits (1309), Expect = 0.0
Identities = 113/280 (40%), Positives = 165/280 (58%), Gaps = 4/280 (1%)
Query: 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREI 130
G D+ +Y+ +GRG +G + + T + A K I K + D D K+EI
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
+IM+ L PNI+ +ED +++VMELC GGELF+R++ K + E AA I + ++
Sbjct: 58 EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
+ V CH + V HRDLKPENFL + ++ LK DFGL+ + GK+ R VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 251 PEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
P+VL YG E D WSAGV++Y+LL G PPF A T+ + I +G F W +S
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
A+ L+RR+LT+ PK+RITS Q LEH W ++ +S + +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 508 bits (1311), Expect = 0.0
Identities = 112/348 (32%), Positives = 178/348 (51%), Gaps = 10/348 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQ 131
+ V+ Y G+ELG GQF + C E STG ++A K I KR+ +++I+RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + PNI+ YE++ V +++EL +GGELFD + K SE A S + I++
Sbjct: 68 ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + H DLKPEN +L K+ +K DFGL+ IE+G +++I G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ I DF+ + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG--EASDKPIDSAVLSRMKQFRAMNKL 367
AKD +R++L ++ +KR+T + L HPWI +A + L K+ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306
Query: 368 KKLALKVIAEN-LSTEEIQGLK-QMFTNIDTDNSGTITYEELKAGLAR 413
K V N L+ ++ + + ++ S T + L
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHP 354
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = e-180
Identities = 108/347 (31%), Positives = 169/347 (48%), Gaps = 20/347 (5%)
Query: 59 QAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV 118
Q V L + Y +++G G + V C +T +FA K I K K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR- 60
Query: 119 TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYS 178
D EI+I+ PNI+ K Y+D + V+VV EL GGEL D+I+ + +S
Sbjct: 61 ------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 179 ERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIE-EG 236
ER A+++ +I V H GV+HRDLKP N L + N ++ DFG + + E
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 237 KVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWA---ETEKGIFDA 292
+ +A +VAPEVL R+ Y DIWS GV+LY +L+G PF +T + I
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
I G W ++S +AKDLV +ML DP +R+T+A VL HPWI + ++
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNR 294
Query: 353 AVLSRMKQ------FRAMNKLKKLALKVIAENLSTEEIQGLKQMFTN 393
+ + + A+N+ + L+ + + + +G+K++ +
Sbjct: 295 QDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQR-RGIKKITST 340
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 501 bits (1292), Expect = e-178
Identities = 108/324 (33%), Positives = 164/324 (50%), Gaps = 25/324 (7%)
Query: 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
P+ K LG G F + C + + FA K ISKR + ++EI
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
++ G PNIV+ + D+ +VMEL GGELF+RI K H+SE A+ I R +V+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVA 250
V H +GV+HRDLKPEN L + +++N +K DFG + + + + + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK-------GIFDAILQGDIDFES 302
PE+L + Y + D+WS GVILY +LSG PF + I I +GD FE
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI---------DSA 353
W +S AKDL++ +LT DP KR+ + + + W+++G + S P+ +A
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
Query: 354 VLSRMK-QFRAMNKLKKLALKVIA 376
V + +K F A NK K+ +
Sbjct: 298 VHTCVKATFHAFNKYKREGFCLQN 321
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 494 bits (1273), Expect = e-176
Identities = 115/267 (43%), Positives = 161/267 (60%), Gaps = 2/267 (0%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
Y+ LG+G FG C + T +++A K I+K K D I RE+++++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNI++ ED S ++V EL GGELFD II + +SE AA I + + + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRDLKPEN LL SK+++ +K DFGLS ++ +D +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
R Y ++ D+WSAGVILYILLSG PPF+ + E I + G F+ W TIS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
L+R+MLT P RIT+ Q LEHPWI++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 495 bits (1277), Expect = e-176
Identities = 103/309 (33%), Positives = 167/309 (54%), Gaps = 9/309 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQ 131
+ V+ Y G+ELG GQF + C E STG ++A K I KR+ +++I+RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + N++ YE++ V +++EL +GGELFD + K SE A S + I++
Sbjct: 68 ILRQVLH-HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDEN-ALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + H DLKPEN +L K+ +K DFGL+ IE+G +++I G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ I DF+ + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG--GEASDKPIDSAVLSRMKQFRAMNKL 367
AKD +R++L ++ +KR+T + L HPWI +A + L ++ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
Query: 368 KKLALKVIA 376
K + +++
Sbjct: 307 KL-SFSIVS 314
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 496 bits (1278), Expect = e-175
Identities = 104/352 (29%), Positives = 166/352 (47%), Gaps = 21/352 (5%)
Query: 7 KSKDPKPRHYAHGYRSSPNTVAKAPA------PAQQQAHHRPEKPGPTPAAAPVSGLKQA 60
+ + R + +A P+Q K L
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 61 VPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK 120
P+ ++ Y +GRG V C +TG +FA K +
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 121 ND-----KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG 175
+ ++ +RE I++ ++G P+I+ +YE + +V +L GELFD + K
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV 195
Query: 176 HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
SE+ SI RS++ V H ++HRDLKPEN LL D+N ++ +DFG S +E
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEP 252
Query: 236 GKVYRDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG 288
G+ R++ G+ Y+APE+L+ YGKE+D+W+ GVIL+ LL+G PPFW +
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ I++G F S W SS+ KDL+ R+L DP+ R+T+ Q L+HP+ +
Sbjct: 313 MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 492 bits (1270), Expect = e-175
Identities = 110/283 (38%), Positives = 165/283 (58%), Gaps = 6/283 (2%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQI 132
V+ HY G+ELG GQF + C + TG+++A K I KR+L + +++I+RE+ I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
++ + PNI+ +E+K V +++EL +GGELFD + K +E A + I++
Sbjct: 62 LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 193 VHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
VH H + H DLKPEN +L K+ N +K DFG++ IE G +++I G+ +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
E++ G E D+WS GVI YILLSG PF ET++ I + DF+ + S
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
AKD +RR+L +DPK+R+T AQ LEH WIK + + DS
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 492 bits (1270), Expect = e-175
Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 3/275 (1%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+Y +ELG+G F V C +TG +FA K I+ +KL + D ++RE +I +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNIV + +++ ++V +L GGELF+ I+A+ YSE A+ + I+ +
Sbjct: 61 KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
CH G++HR+LKPEN LL+SK + A +K DFGL++ + + + + G+ Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
++ Y K +DIW+ GVILYILL G PPFW E + ++ I G D+ S W T++ AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
L+ MLT +PKKRIT+ Q L+ PWI +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 482 bits (1243), Expect = e-171
Identities = 89/272 (32%), Positives = 155/272 (56%), Gaps = 8/272 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ + F ++LG G FG +L E S+G + K+I+K + ++ + I+ EI++++
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLK 75
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK----GHYSERAAASICRSIV 190
L PNI++ +ED ++++VME C GGEL +RI++ SE A + + ++
Sbjct: 76 SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
N + H V+H+DLKPEN L ++ +K DFGL+ + + + G+A Y+A
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194
Query: 251 PEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
PEV +R + DIWSAGV++Y LL+G PF + + + + ++ P ++
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTP 253
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
A DL+++MLT+DP++R ++AQVL H W K+
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 483 bits (1245), Expect = e-171
Identities = 104/322 (32%), Positives = 163/322 (50%), Gaps = 18/322 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKRE 129
+ ++ Y K LG G G L E T ++ A K ISKRK + +++ E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
I+I++ L+ P I++ K ++ + ++V+EL GGELFD+++ E +
Sbjct: 66 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
+ V H G++HRDLKPEN LLSS++E+ L+K TDFG S + E + R + G+ Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 250 APEVL----RRRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAP 304
APEVL Y + +D WS GVIL+I LSG PPF T+ + D I G +F
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM 364
W +S A DLV+++L DPK R T+ + L HPW++ D+ + + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENES 297
Query: 365 NKLKKLALKVIAENLSTEEIQG 386
L ++ + E +
Sbjct: 298 TALPQVLAQPSTSRKRPREGEA 319
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-171
Identities = 96/288 (33%), Positives = 151/288 (52%), Gaps = 16/288 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT------KNDKDDIKR 128
+Y + LGRG V C T +++A K I + + ++ +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
E+ I++ +SG PNI++ K YE +V +L GELFD + K SE+ I R+
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
++ V+ H + ++HRDLKPEN LL D++ +K TDFG S ++ G+ R++ G+ Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 249 VAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
+APE++ YGKE+D+WS GVI+Y LL+G PPFW + + I+ G+ F
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
S W S + KDLV R L P+KR T+ + L HP+ ++ +
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 489 bits (1261), Expect = e-170
Identities = 109/399 (27%), Positives = 170/399 (42%), Gaps = 13/399 (3%)
Query: 29 KAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELG 88
+ G ++ + + + ++ V HY +ELG
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 89 RGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148
G FGV + TE +TG FA K + +DK+ +++EIQ M L P +V A
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR-HPTLVNLHDA 222
Query: 149 YEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLK 207
+ED + ++ E +GGELF+++ + SE A R + + H +H DLK
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 208 PENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWS 266
PEN + ++K N L K DFGL+ ++ + + G+A + APEV + G D+WS
Sbjct: 283 PENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 267 AGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKK 326
GV+ YILLSG+ PF E + + D + + + + IS KD +R++L DP
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401
Query: 327 RITSAQVLEHPWIKEG-GEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQ 385
R+T Q LEHPW+ G D I S SR + R K K I
Sbjct: 402 RMTIHQALEHPWLTPGNAPGRDSQIPS---SRYTKIRDSIKTKY--DAWPEPLPPLGRIS 456
Query: 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQ 424
+ + + S + + R K EV
Sbjct: 457 NYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVG 495
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 481 bits (1240), Expect = e-169
Identities = 101/377 (26%), Positives = 169/377 (44%), Gaps = 32/377 (8%)
Query: 36 QQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPY----EDVKLHYSFGKELGRGQ 91
HH P + +P V +Y +ELG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151
FGV + C E +TGR F K I+ + DK +K EI IM L P ++ A+ED
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-HPKLINLHDAFED 119
Query: 152 KQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210
K + +++E +GGELFDRI A+ + SE + R + H ++H D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGV 269
+ +K +++ K DFGL+ + ++ + +A + APE++ R G D+W+ GV
Sbjct: 180 IMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
+ Y+LLSG+ PF E + + + D +F+ + ++S AKD ++ +L ++P+KR+T
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298
Query: 330 SAQVLEHPWIKEGGEASDKPIDSAVLS---------------------RMKQFRAMNKLK 368
LEHPW+K I S+ + R+ F ++ K +
Sbjct: 299 VHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 358
Query: 369 KLALKVIAENLSTEEIQ 385
++ +E
Sbjct: 359 PQEYQIYDSYFDRKEAV 375
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 474 bits (1222), Expect = e-168
Identities = 94/309 (30%), Positives = 154/309 (49%), Gaps = 36/309 (11%)
Query: 80 HYSFGKE-LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
Y ++ LG G C T +++A K I K+ + + + RE++++ G
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
N++E +E++ ++V E GG + I + H++E A+ + + + + + H
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--------VGSAYYVA 250
G+ HRDLKPEN L ++ + +K DF L I+ I GSA Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 251 PEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAE---------------TEKGI 289
PEV+ Y K D+WS GVILYILLSG PPF + +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
F++I +G +F W IS +AKDL+ ++L +D K+R+++AQVL+HPW++ G A +
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCAPENT 307
Query: 350 IDSA-VLSR 357
+ + VL R
Sbjct: 308 LPTPMVLQR 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 474 bits (1222), Expect = e-167
Identities = 108/324 (33%), Positives = 161/324 (49%), Gaps = 25/324 (7%)
Query: 75 EDVKLHYSFGKE-LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
V Y K+ LG G G C TG++ A K + ++E+
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHH 75
Query: 134 QHLSGQPNIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICR 187
SG P+IV YE+ K+ + ++ME GGELF RI +G ++ER AA I R
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
I + H + HRD+KPEN L +SK+++A+LK TDFG + + + + Y
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPY 194
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK----GIFDAILQGDIDFES 302
YVAPEVL Y K D+WS GVI+YILL G PPF++ T + G+ I G F +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA-VLSRMKQF 361
W +S AK L+R +L DP +R+T Q + HPWI + P+ +A VL K
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314
Query: 362 RAMNKLKKLALKVIAEN-LSTEEI 384
+++K+ +A + +++
Sbjct: 315 --WDEVKEEMTSALATMRVDYDQV 336
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 468 bits (1205), Expect = e-164
Identities = 100/370 (27%), Positives = 172/370 (46%), Gaps = 15/370 (4%)
Query: 6 TKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPD 65
+++ + + + A P + + ++ A P P
Sbjct: 14 LGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPF 73
Query: 66 TNTILGKPYEDVKLHYSFGK--ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
+ I+ V Y+ K LG G+FG + C E +TG + A K I R + DK
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDK 130
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAA 182
+++K EI +M L N+++ A+E K + +VME GGELFDRII + + +E
Sbjct: 131 EEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ I + H M ++H DLKPEN L ++D + K DFGL+ + + +
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVN 248
Query: 243 VGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
G+ ++APEV+ D+WS GVI Y+LLSG+ PF + + + IL D E
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF 361
+ IS AK+ + ++L ++ RI++++ L+HPW+ D + S + ++ K+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS------DHKLHSRLSAQKKKN 362
Query: 362 RAMNKLKKLA 371
R + +
Sbjct: 363 RGSDAQDFVT 372
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 464 bits (1195), Expect = e-164
Identities = 92/315 (29%), Positives = 145/315 (46%), Gaps = 39/315 (12%)
Query: 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
K + + + LG G G T +FA K + +RE++
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 132 IMQHLSGQPNIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASI 185
+ S P+IV YE+ ++ + +VME GGELF RI +G ++ER A+ I
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
+SI + H + + HRD+KPEN L +SK NA+LK TDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAE----TEKGIFDAILQGDIDFE 301
A E +Y K D+WS GVI+YILL G PPF++ G+ I G +F
Sbjct: 167 ----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF 361
+ W +S K L+R +L +P +R+T + + HPWI + + P+ ++ + + +
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282
Query: 362 RAMNKLKKLALKVIA 376
R +K+ +A
Sbjct: 283 R-WEDVKEEMTSALA 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-154
Identities = 100/279 (35%), Positives = 153/279 (54%), Gaps = 12/279 (4%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKRE 129
+ ++ Y K LG G G L E T ++ A + ISKRK + +++ E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
I+I++ L+ P I++ K ++ + ++V+EL GGELFD+++ E +
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
+ V H G++HRDLKPEN LLSS++E+ L+K TDFG S + E + R + G+ Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 250 APEVL----RRRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAP 304
APEVL Y + +D WS GVIL+I LSG PPF T+ + D I G +F
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
W +S A DLV+++L DPK R T+ + L HPW+++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 436 bits (1122), Expect = e-152
Identities = 96/330 (29%), Positives = 152/330 (46%), Gaps = 52/330 (15%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL--VTKNDKDDI 126
G +++ Y +G+G +GV + EN T A K ++K K+ + D + I
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 127 KREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH---------- 176
K E+++M+ L PNI YED+Q + +VMELC GG L D++
Sbjct: 76 KTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 177 ------------------------------YSERAAASICRSIVNVVHICHFMGVMHRDL 206
E+ ++I R I + +H H G+ HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIE-----EGKVYRDIVGSAYYVAPEVLR---RRY 258
KPENFL S+ +++ +K DFGLS E G+ Y+VAPEVL Y
Sbjct: 195 KPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
G + D WSAGV+L++LL G PF + +L + FE+ + +S A+DL+
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
+L ++ +R + + L+HPWI + + K
Sbjct: 314 LLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-112
Identities = 79/416 (18%), Positives = 156/416 (37%), Gaps = 34/416 (8%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K+ + LG G G T + R A K I RE+Q+++
Sbjct: 23 KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHIC 196
PN++ + +D+Q ++ +ELC L + + K + ++ + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKA--TDFGLSVFIEEGKVY----RDIVGSAYYVA 250
H + ++HRDLKP N L+S + + +KA +DFGL + G+ + G+ ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 251 PEVLR----RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
PE+L +DI+SAG + Y ++S G PF ++ + +D P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PE 253
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMN 365
A++L+ +M+ DP+KR ++ VL+HP+ V R+++
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW--SLEKQLQFFQDVSDRIEKESLDG 311
Query: 366 KLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT---EAE 422
+ K + + + + + D T ++ L R
Sbjct: 312 PIVKQLERGGRAVVKMDWRENITVPLQT-DLRKFRTYKGGSVRD-LLRAMRNKKHHYREL 369
Query: 423 VQQLMEAADVDGNGTIDYIE--FITATMHRHKLER----DDHLYKAFQHFDKDNSG 472
++ E + + Y F H ++ + + H +
Sbjct: 370 PAEVRETLGTLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQP 425
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = e-105
Identities = 82/341 (24%), Positives = 140/341 (41%), Gaps = 46/341 (13%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ +K K LG G G + GR A K + D EI+++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA-------AASICR 187
PN++ + + + +++ +ELC L D + +K E S+ R
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKD----------ENALLKATDFGLSVFIEEGK 237
I + V H + ++HRDLKP+N L+S+ EN + +DFGL ++ G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 238 VY-----RDIVGSAYYVAPEVLR--------RRYGKEIDIWSAGVILYILLS-GVPPFWA 283
+ G++ + APE+L RR + IDI+S G + Y +LS G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 284 --ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
E I I D + + ++ + A DL+ +M+ DP KR T+ +VL HP
Sbjct: 243 KYSRESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301
Query: 342 GGEASDKPIDSA----VLSRMKQFRAMNKLKKLALKVIAEN 378
+ + + + + +R + K + VI
Sbjct: 302 KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 6e-95
Identities = 97/325 (29%), Positives = 149/325 (45%), Gaps = 21/325 (6%)
Query: 31 PAPAQQQAHHRPEKPGP-TPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGR 89
PAPA P P PAAAP + + +P + + Y G+ LG+
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPA---KEIPEVLVDPRSRRRYV-------RGRFLGK 51
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149
G F + ++ T FA K + K L+ + ++ + EI I + L+ ++V F G +
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFF 110
Query: 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209
ED V VV+ELC L + + +E A R IV H V+HRDLK
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDIWSA 267
N L +E+ +K DFGL+ +E + + G+ Y+APEVL ++ + E+D+WS
Sbjct: 171 NLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 268 GVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327
G I+Y LL G PPF K + I + + P I+ A L+++ML DP R
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKMLQTDPTAR 283
Query: 328 ITSAQVLEHPWIKEGGEASDKPIDS 352
T ++L + G + PI
Sbjct: 284 PTINELLNDEFFTSGYIPARLPITC 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 4e-93
Identities = 83/265 (31%), Positives = 129/265 (48%), Gaps = 10/265 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y G+ LG+G F + ++ T FA K + K L+ + ++ + EI I + L+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-H 74
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
++V F G +ED V VV+ELC L + + +E A R IV H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR- 257
V+HRDLK N L +E+ +K DFGL+ +E + + G+ Y+APEVL ++
Sbjct: 135 RVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
+ E+D+WS G I+Y LL G PPF K + I + + P I+ A L++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQ 247
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEG 342
+ML DP R T ++L + G
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSG 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 6e-91
Identities = 84/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ G+ LG+G+FG YL E + A K + K +L + ++RE++I HL P
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NI+ G + D V++++E G ++ + + E+ A+ + N + CH
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-Y 258
V+HRD+KPEN LL LK DFG SV + R + G+ Y+ PE++ R +
Sbjct: 130 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMH 184
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+++D+WS GV+ Y L G PPF A T + + I + + F P ++ A+DL+ R
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLISR 240
Query: 319 MLTQDPKKRITSAQVLEHPWIKEG 342
+L +P +R +VLEHPWI
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-90
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 11/266 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G LG+G F Y TG + A K I K+ + ++ E++I L
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-H 70
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHICHF 198
P+I+E +ED V++V+E+C GE+ + + SE A I+ + H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR 257
G++HRDL N LL N +K DFGL+ ++ + G+ Y++PE+ R
Sbjct: 131 HGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+G E D+WS G + Y LL G PPF +T K + ++ D + P +S AKDL+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDLI 243
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342
++L ++P R++ + VL+HP++
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRN 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 2e-90
Identities = 85/279 (30%), Positives = 147/279 (52%), Gaps = 12/279 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ G+ LG+G+FG YL E A K + K +L + + ++REI+I HL P
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NI+ + D++ +++++E GEL+ + G + E+ +A+ + + +H CH
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV-GSAYYVAPEVLRRR-Y 258
V+HRD+KPEN L+ LK DFG SV + R + G+ Y+ PE++ + +
Sbjct: 135 VIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLR--RRTMCGTLDYLPPEMIEGKTH 189
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+++D+W AGV+ Y L G+PPF + + I+ D+ F P P +S +KDL+ +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKDLISK 245
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
+L P +R+ V+EHPW+K P+ + S+
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 277 bits (709), Expect = 2e-90
Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 43/299 (14%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG+G + TG FA K + D RE ++++ L+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HK 67
Query: 141 NIVEFKGAYEDKQSVHV--VMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHI 195
NIV+ E+ + H +ME C G L+ + + E + R +V ++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 196 CHFMGVMHRDLKPENFLLS-SKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
G++HR++KP N + +D ++ K TDFG + +E+ + + + G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 255 RRR---------YGKEIDIWSAGVILYILLSGVPPFWA----ETEKGIFDAILQG----- 296
R YG +D+WS GV Y +G PF K + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 297 ------------DIDFESAPWPTISSSAKDLV----RRMLTQDPKKRITSAQVLEHPWI 339
D + ++S + L+ +L D +K Q
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-89
Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 41/295 (13%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG+G FG R +A K I T+ I E+ ++ L+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQ 62
Query: 141 NIVEFKGAYEDKQSVHV-------------VMELCAGGELFDRIIAKGHYSER-AAASIC 186
+V + A+ ++++ ME C G L+D I ++ +R +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI---- 242
R I+ + H G++HRDLKP N + DE+ +K DFGL+ + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 243 -----------VGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
+G+A YVA EVL Y ++ID++S G+I + ++ P I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ I+F K ++R ++ DP KR + +L W+ +
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 4e-89
Identities = 45/359 (12%), Positives = 97/359 (27%), Gaps = 44/359 (12%)
Query: 34 AQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFG 93
+++ + AA V + V + T + + + L G
Sbjct: 17 REEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRS 76
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL----------------- 136
V +L + FA K + ++++ + + L
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 137 ------SGQPNIVEFKGAYEDK--QSVHVVMELCAG------GELFDRIIAKGHYSERAA 182
QP + +D + ++M + L + +G A
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ ++ + G++H P+N + + L D + G
Sbjct: 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALW--KVGTRGPAS 251
Query: 243 VGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL----- 294
Y E L + ++ W G+ +Y + PF T
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
G + K L+ R L D ++R+ + +E P + + +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-87
Identities = 77/329 (23%), Positives = 139/329 (42%), Gaps = 33/329 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
YS K++G G + N + +A K ++ + D + EI + L
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 140 -PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
I+ Q +++VME C +L + K S ++++ VH H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRD-IVGSAYYVAPEVL- 254
G++H DLKP NFL+ + +LK DFG++ ++ V +D VG+ Y+ PE +
Sbjct: 127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 255 -----------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFES 302
+ + + D+WS G ILY + G PF + AI+ + + E
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA------VLS 356
+D+++ L +DPK+RI+ ++L HP+++ ++ VL
Sbjct: 243 --PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300
Query: 357 RMKQFRAMNKLKKLALKVIAENLSTEEIQ 385
++ + N + K A K + E+ S E
Sbjct: 301 QLVGLNSPNSILK-AAKTLYEHYSGGESH 328
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 3e-87
Identities = 79/389 (20%), Positives = 154/389 (39%), Gaps = 40/389 (10%)
Query: 18 HGYRSSPNTVAKAPAPAQQQAHHRPEKP-GPTPAAAPVSGLKQAVPRPDTNTILGKPYED 76
H + + + + ++ A + E+ +P K + + ++ G+ Y
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYS- 59
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
K++G G + N + +A K ++ + D + EI + L
Sbjct: 60 ------ILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL 111
Query: 137 SGQ-PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
I+ Q +++VME C +L + K S ++++ VH
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRD-IVGSAYYVAPE 252
H G++H DLKP NFL+ + +LK DFG++ ++ V +D VG+ Y+ PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 253 VL------------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDID 299
+ + + + D+WS G ILY + G PF + AI+ + +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA------ 353
E +D+++ L +DPK+RI+ ++L HP+++ ++
Sbjct: 287 IEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 344
Query: 354 VLSRMKQFRAMNKLKKLALKVIAENLSTE 382
VL ++ + N + K A + E
Sbjct: 345 VLGQLVGLNSPNSILKAAKTLYEHYSGGE 373
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 1e-86
Identities = 72/354 (20%), Positives = 140/354 (39%), Gaps = 52/354 (14%)
Query: 53 PVSGLKQAVPRPDTNTILGKPYEDVKLH---YSFGKELGRGQFGVTYLCTENSTGRQFAC 109
P+ +K + L K ++ + Y + L +G+F LC + + +A
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYAL 59
Query: 110 KSISKRKLV--------------TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155
K K L K+ DD K E+QI+ + + +G + V
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEV 118
Query: 156 HVVMELCAGGELFDRIIAKGH--------YSERAAASICRSIVNVVHICH-FMGVMHRDL 206
+++ E + + I +S++N H + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR---YGKEID 263
KP N L+ D+N +K +DFG S ++ + K+ + G+ ++ PE G ++D
Sbjct: 179 KPSNILM---DKNGRVKLSDFGESEYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 264 IWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDF---------------ESAPWPT 307
IWS G+ LY++ V PF + + +F+ I +I++ +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF 361
+S+ D ++ L ++P +RITS L+H W+ + + + + K+
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 2e-86
Identities = 81/276 (29%), Positives = 134/276 (48%), Gaps = 14/276 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G +G L T A K + ++ V + ++IK+EI I + L+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-H 64
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V+F G + ++ +E C+GGELFDRI E A ++ V H +
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLRR 256
G+ HRD+KPEN LL DE LK +DFGL+ R + G+ YVAPE+L+R
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 257 R-Y-GKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAK 313
R + + +D+WS G++L +L+G P+ ++ + + PW I S+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPL 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
L+ ++L ++P RIT + + W + + K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 4e-86
Identities = 101/265 (38%), Positives = 135/265 (50%), Gaps = 10/265 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY G LG G FG + TG + A K ++++K+ + + IKREIQ ++
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P+I++ +VME +GGELFD I G E A + + I++ V CH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
V+HRDLKPEN LL D + K DFGLS + +G+ R GS Y APEV+ R Y
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
G E+DIWS GVILY LL G PF E +F I G F + ++ S L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEG 342
ML DP KR T + EH W K+
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 5e-86
Identities = 70/333 (21%), Positives = 131/333 (39%), Gaps = 40/333 (12%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH + + ++ G+ Y K++G G +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQ-------SMSVKGRIYS-------ILKQIGSGGSSKVFQV 47
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQSVHV 157
N + +A K ++ + D + EI + L I+ Q +++
Sbjct: 48 L-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217
VME C +L + K S ++++ VH H G++H DLKP NFL+
Sbjct: 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--- 161
Query: 218 ENALLKATDFGLSVFIEEGK--VYRD-IVGSAYYVAPEVL------------RRRYGKEI 262
+ +LK DFG++ ++ V +D VG+ Y+ PE + + + +
Sbjct: 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 263 DIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321
D+WS G ILY + G PF + AI+ + + E +D+++ L
Sbjct: 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLK 278
Query: 322 QDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
+DPK+RI+ ++L HP+++ ++
Sbjct: 279 RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-85
Identities = 81/323 (25%), Positives = 131/323 (40%), Gaps = 25/323 (7%)
Query: 34 AQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFG 93
+ HH P + T GK E ++ Y G LG G FG
Sbjct: 3 SSHHHHHHSSGLVPRGSHMA-----PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHLS-GQPNIVEFKGAY 149
Y S A K + K ++ + + + E+ +++ +S G ++ +
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 150 EDKQSVHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKP 208
E S +++E +LFD I +G E A S ++ V CH GV+HRD+K
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 177
Query: 209 ENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY-GKEIDIWS 266
EN L+ LK DFG +++ Y D G+ Y PE +R RY G+ +WS
Sbjct: 178 ENILIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 267 AGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKK 326
G++LY ++ G PF E ++ I +SS + L+R L P
Sbjct: 235 LGILLYDMVCGDIPF--EHDEEIIRG------QVFFRQR--VSSECQHLIRWCLALRPSD 284
Query: 327 RITSAQVLEHPWIKEGGEASDKP 349
R T ++ HPW+++ +
Sbjct: 285 RPTFEEIQNHPWMQDVLLPQETA 307
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-85
Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 21/307 (6%)
Query: 67 NTILGKPYEDVKL-HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
N+I E + +Y K +G+G F L TGR+ A K I K +L
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQK 60
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
+ RE++IM+ L+ PNIV+ E +++++++ME +GGE+FD ++A G E+ A S
Sbjct: 61 LFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
R IV+ V CH ++HRDLK EN LL D + +K DFG S G G+
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGA 176
Query: 246 AYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303
Y APE+ + + Y G E+D+WS GVILY L+SG PF + K + + +L+G +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIP 234
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG---------GEASDKPIDSAV 354
+ +S+ ++L++R L +P KR T Q+++ WI G E D
Sbjct: 235 FY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKR 292
Query: 355 LSRMKQF 361
+ M
Sbjct: 293 IDIMVGM 299
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 3e-85
Identities = 53/377 (14%), Positives = 105/377 (27%), Gaps = 63/377 (16%)
Query: 13 PRHYAHG----YRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNT 68
H++ G Y P V + + +AA S + ++
Sbjct: 4 HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAAD-SLVSTSLWNTGQPF 62
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
+ + G LG+ T+ TG F + N +K
Sbjct: 63 RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122
Query: 129 EIQIMQHL------------------------SGQPNIVEFKGAYEDKQ--SVHVVMELC 162
E+ ++ L + ++ + D S +
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 163 A------GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
G L A + ++ ++ H G++H L+P + +L
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--- 239
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR------------YGKEIDI 264
D+ + T F V S + PE+ RR D
Sbjct: 240 DQRGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
W+ G+++Y + P + G + I + + I + L+ L
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPK 348
Query: 325 KKRITSAQVLEHPWIKE 341
+ R+ Q +E P ++
Sbjct: 349 EDRLLPLQAMETPEYEQ 365
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 1e-84
Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 14/276 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G +G L T A K + ++ V + IK+EI I + L+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN-H 64
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V+F G + ++ +E C+GGELFDRI E A ++ V H +
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLRR 256
G+ HRD+KPEN LL DE LK +DFGL+ R + G+ YVAPE+L+R
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 257 R-Y-GKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAK 313
R + + +D+WS G++L +L+G P+ ++ + + PW I S+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPL 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
L+ ++L ++P RIT + + W + + K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 2e-84
Identities = 68/358 (18%), Positives = 130/358 (36%), Gaps = 57/358 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG+G + TG FA K + + D RE ++++ L+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLN-HK 67
Query: 141 NIVEFKGAYEDKQSVHV--VMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHI 195
NIV+ E+ + H +ME C G L+ + + E + R +V ++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 196 CHFMGVMHRDLKPENFLLS-SKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
G++HR++KP N + +D ++ K TDFG + +E+ + + + G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 255 RRR---------YGKEIDIWSAGVILYILLSGVPPFWA----ETEKGIFDAILQG----- 296
R YG +D+WS GV Y +G PF K + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 297 ------------DIDFESAPWPTISSSAKDLV----RRMLTQDPKKRITSAQVLEHPWIK 340
D + ++S + L+ +L D +K Q
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS-- 305
Query: 341 EGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDN 398
+ + ++ ++ + + + N + L T I + N
Sbjct: 306 -----------DILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSN 351
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 2e-84
Identities = 96/340 (28%), Positives = 147/340 (43%), Gaps = 24/340 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y F K++G G FGV L + T A K I + + +N ++REI + L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLR-H 75
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNIV FK + ++ME +GGEL++RI G +SE A + +++ V CH M
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
+ HRDLK EN LL LK DFG S + VG+ Y+APEVL R+ Y
Sbjct: 136 QICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIF----DAILQGDIDFESAPWPTISSSAK 313
GK D+WS GV LY++L G PF E + IL IS
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECC 252
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG----------GEASDKPIDSAVLSRMKQFRA 363
L+ R+ DP RI+ ++ H W + + + + + S +
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQI 312
Query: 364 MNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTIT 403
+++ A++ + + L + D+++ I
Sbjct: 313 ISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDID 352
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 4e-84
Identities = 93/291 (31%), Positives = 146/291 (50%), Gaps = 19/291 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y + LG G FG L T T ++ A K IS++ L + ++REI ++ L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-H 68
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P+I++ + +V+E AGGELFD I+ K +E + I+ + CH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++HRDLKPEN LL D+N +K DFGLS + +G + GS Y APEV+ + Y
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
G E+D+WS G++LY++L G PF E +F + + + +S A+ L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKP--------IDSAVLSRMKQ 360
RM+ DP +RIT ++ PW +P DS ++S++ +
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 1e-83
Identities = 102/292 (34%), Positives = 146/292 (50%), Gaps = 19/292 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY G LG G FG + TG + A K ++++K+ + + I+REIQ ++
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-H 75
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P+I++ + +VME +GGELFD I G E+ + + + I++ V CH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
V+HRDLKPEN LL D + K DFGLS + +G+ R GS Y APEV+ R Y
Sbjct: 136 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
G E+DIWS+GVILY LL G PF + +F I G F + + ++ S L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGG---------EASDKPIDSAVLSRMKQ 360
ML DP KR T + EH W K+ S ID L + +
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCE 300
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-83
Identities = 77/309 (24%), Positives = 127/309 (41%), Gaps = 23/309 (7%)
Query: 50 AAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFAC 109
P+ G A P T GK E + Y G LG+G FG + + Q A
Sbjct: 3 LTKPLQG-PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI 61
Query: 110 KSISKRKLVTKNDKDD---IKREIQIMQHLSGQ---PNIVEFKGAYEDKQSVHVVMEL-C 162
K I + +++ + D E+ ++ + P ++ +E ++ +V+E
Sbjct: 62 KVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL 121
Query: 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222
+LFD I KG E + +V + CH GV+HRD+K EN L+ +
Sbjct: 122 PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--A 179
Query: 223 KATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY-GKEIDIWSAGVILYILLSGVPP 280
K DFG + + Y D G+ Y PE + +Y +WS G++LY ++ G P
Sbjct: 180 KLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
Query: 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
F E ++ I +A + +S L+RR L P R + ++L PW++
Sbjct: 239 F--ERDQEILEA------ELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
Query: 341 EGGEASDKP 349
E
Sbjct: 289 TPAEDVPLN 297
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 1e-81
Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 22/281 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD-----IKREIQIMQ 134
YS LG G FG + + ++ K I K K++ +D + EI I+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMEL-CAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
+ NI++ +E++ +VME +G +LF I E A+ I R +V+ V
Sbjct: 85 RVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
++HRD+K EN ++ E+ +K DFG + ++E GK++ G+ Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 254 LRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
L Y G E+++WS GV LY L+ PF + ++ I P+ +S
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHP---PYL-VSKE 250
Query: 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
LV +L P++R T +++ PW+ + +D +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-80
Identities = 78/291 (26%), Positives = 137/291 (47%), Gaps = 37/291 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--------------------- 118
Y+ E+G+G +GV L + +A K +SK+KL+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 119 --TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAK 174
+ + + +EI I++ L PN+V+ +D + +++V EL G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 175 GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFI 233
SE A + ++ + H+ ++HRD+KP N L+ E+ +K DFG+S F
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFK 188
Query: 234 EEGKVYRDIVGSAYYVAPEVL---RRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
+ + VG+ ++APE L R+ + GK +D+W+ GV LY + G PF E +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
I ++F P I+ KDL+ RML ++P+ RI ++ HPW+
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 6e-80
Identities = 71/349 (20%), Positives = 139/349 (39%), Gaps = 42/349 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G FG TG Q A K + + +++ EIQIM+ L+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-H 71
Query: 140 PNIVEFKGAYEDKQSVH------VVMELCAGGELFDRIIAKGH---YSERAAASICRSIV 190
PN+V + + Q + + ME C GG+L + + E ++ I
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
+ + H ++HRDLKPEN +L + + K D G + +++G++ + VG+ Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE+L ++ Y +D WS G + + ++G PF + + ++ + + ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 310 SS--------------------AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
+ + ++ ML ++R T Q + D
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL----DSI 307
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDN 398
+ +LS M ++ + EN + + ++ Q T I +
Sbjct: 308 LSLKLLSVMNMVSG-----RVHTYPVTENENLQNLKSWLQQDTGIPEEE 351
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 5e-79
Identities = 42/142 (29%), Positives = 76/142 (53%), Gaps = 1/142 (0%)
Query: 332 QVLEHPWIKE-GGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQM 390
H +E + S +L +K F+ N+LKK+AL +IA++L EI L+ +
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 391 FTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450
F +D DNSGT++ +E+ GL ++G + ++ Q++ D + +G I Y +F+ AT+ +
Sbjct: 63 FIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDK 122
Query: 451 HKLERDDHLYKAFQHFDKDNSG 472
+ + F+ FD D +G
Sbjct: 123 QTYLKKEVCLIPFKFFDIDGNG 144
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 8e-79
Identities = 71/330 (21%), Positives = 114/330 (34%), Gaps = 24/330 (7%)
Query: 14 RHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKP 73
H+ H T Q R G G + P
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----- 57
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
+ LG G +G + GR +A K S D+ E+
Sbjct: 58 ------SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSH 110
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNV 192
+ + P V + A+E+ +++ ELC G L A G E R +
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
+ H G++H D+KP N L K DFGL V + G Y+APE
Sbjct: 170 LAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 253 VLRRRYGKEIDIWSAGVILYILLSGVP-PFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
+L+ YG D++S G+ + + + P E + + L + +SS
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSE 280
Query: 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ ++ ML DPK R T+ +L P +++
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-76
Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y +G G +G S G+ K + + T+ +K + E+ +++ L
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-H 64
Query: 140 PNIVEFKGAYEDKQS--VHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVV 193
PNIV + D+ + +++VME C GG+L I + + E + + +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 194 HICH-----FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAY 247
CH V+HRDLKP N L D +K DFGL+ + + + VG+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306
Y++PE + R Y ++ DIWS G +LY L + +PPF A ++K + I +G P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----RIP 237
Query: 307 TI-SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
S +++ RML R + ++LE+P I E
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 4e-75
Identities = 78/303 (25%), Positives = 142/303 (46%), Gaps = 21/303 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSG 138
Y G LG G +G ++ T + A K + K+KL N + ++K+EIQ+++ L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64
Query: 139 QPNIVEFKG--AYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVH 194
N+++ E+KQ +++VME C G E+ D + + + A +++ +
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLE 123
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE---EGKVYRDIVGSAYYVAP 251
H G++H+D+KP N LL LK + G++ + R GS + P
Sbjct: 124 YLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 252 EVLR--RRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
E+ + G ++DIWSAGV LY + +G+ PF + +F+ I +G +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIPGD--C 236
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMK-QFRAMNKL 367
DL++ ML +P KR + Q+ +H W ++ ++ P+ K ++R+M +
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVV 296
Query: 368 KKL 370
L
Sbjct: 297 PYL 299
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-74
Identities = 48/139 (34%), Positives = 71/139 (51%), Gaps = 2/139 (1%)
Query: 334 LEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTN 393
+ H G + VL K + + K +KLA+ +IA+ + +++ LK F
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 394 IDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL 453
+D D G IT E+LK GL + G K L++ D DG+G IDY EFI A + R +L
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLK-LPYNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQL 119
Query: 454 ERDDHLYKAFQHFDKDNSG 472
+ +Y AF+ FD DN G
Sbjct: 120 SK-KLIYCAFRVFDVDNDG 137
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-74
Identities = 68/267 (25%), Positives = 133/267 (49%), Gaps = 14/267 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y +++G G FG L GRQ+ K I+ ++ + ++++ +RE+ ++ ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-H 82
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICH 197
PNIV+++ ++E+ S+++VM+ C GG+LF RI A + E I + H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRR 256
++HRD+K +N L ++ ++ DFG++ + +G+ YY++PE+
Sbjct: 143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKD 314
+ Y + DIW+ G +LY L + F A + K + I+ G P S +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYDLRS 255
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
LV ++ ++P+ R + +LE +I +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-68
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 17/301 (5%)
Query: 49 PAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFA 108
+ Q P+ +G ++ K++GRGQF Y G A
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLA---NFRIEKKIGRGQFSEVYRAACLLDGVPVA 61
Query: 109 CKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELF 168
K + L+ + D +EI +++ L+ PN++++ ++ + +++V+EL G+L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 169 DRI----IAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224
I K ER + + + H VMHRD+KP N +++ ++K
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKL 177
Query: 225 TDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFW 282
D GL F + +VG+ YY++PE + Y + DIWS G +LY + + PF+
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237
Query: 283 AETE--KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ + I Q D+ P S + LV + DP+KR V +
Sbjct: 238 GDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
Query: 341 E 341
Sbjct: 296 H 296
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 3e-67
Identities = 52/385 (13%), Positives = 108/385 (28%), Gaps = 71/385 (18%)
Query: 7 KSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPA----AAPVSGLKQAVP 62
+ Y G+R ++ + P+ T + +A S + ++
Sbjct: 6 HHSSGRENLYFQGFRG----TDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 63 RPDTN----TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV 118
+ LG+ G LG+ T+ TG F +
Sbjct: 62 NTGQPFRVESELGERP----RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 117
Query: 119 TKNDKDDIKREIQIMQHL------------------------SGQPNIVEFKGAYEDK-- 152
N +K E+ ++ L + ++ + D
Sbjct: 118 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 177
Query: 153 QSVHVVMELCAG------GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
S + L A + ++ ++ H G++H L
Sbjct: 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY----YVAPEVLRRR----- 257
+P + +L D+ + T F V +G +G + A +L
Sbjct: 238 RPVDIVL---DQRGGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPT 292
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
D W+ G+ +Y + P + G + I + + I + L+
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALL 344
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKE 341
L + R+ Q +E P ++
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-67
Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 38/280 (13%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + +G G FG + G+ + K + + + +RE++ + L
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAKLD-HV 64
Query: 141 NIVEFKGAYED----------------KQSVHVVMELCAGGELFDRIIAK--GHYSERAA 182
NIV + G ++ + + + ME C G L I + + A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ I V H +++RDLKP N L + +K DFGL ++
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRS 181
Query: 243 VGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
G+ Y++PE + + YGKE+D+++ G+IL LL F + G I
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS-- 237
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
K L++++L++ P+ R ++++L + +
Sbjct: 238 ----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-66
Identities = 62/302 (20%), Positives = 104/302 (34%), Gaps = 32/302 (10%)
Query: 64 PDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
+ G HY F ++LG G F L G +A K I + + D+
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDR 70
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQS----VHVVMELCAGGELFDRI----IAKG 175
++ +RE + + PNI+ ++ +++ G L++ I
Sbjct: 71 EEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 176 HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
+E + I + H G HRDLKP N LL + + D G
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACI 186
Query: 236 GKVYRD----------IVGSAYYVAPEVL----RRRYGKEIDIWSAGVILYILLSGVPPF 281
+ Y APE+ + D+WS G +LY ++ G P+
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246
Query: 282 WAETEKG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+KG +Q + P SS+ L+ M+T DP +R +L
Sbjct: 247 DMVFQKGDSVALAVQNQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
Query: 341 EG 342
+
Sbjct: 305 QP 306
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 7e-65
Identities = 78/309 (25%), Positives = 124/309 (40%), Gaps = 43/309 (13%)
Query: 60 AVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT 119
D + +G+ E +L + L G F Y + +GR++A K + +
Sbjct: 9 GASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--- 65
Query: 120 KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS--------VHVVMELCAGGELFDRI 171
+ I +E+ M+ LSG PNIV+F A + ++ ELC G+L + +
Sbjct: 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFL 124
Query: 172 I---AKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATD 226
++G S I V H ++HRDLK EN LL +K D
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD 181
Query: 227 FGLSVFI-----------EEGKVYRDI--VGSAYYVAPEVL----RRRYGKEIDIWSAGV 269
FG + I V +I + Y PE++ G++ DIW+ G
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241
Query: 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
ILY+L PF E G I+ G P T + L+R ML +P++R++
Sbjct: 242 ILYLLCFRQHPF----EDGAKLRIVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLS 295
Query: 330 SAQVLEHPW 338
A+V+
Sbjct: 296 IAEVVHQLQ 304
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-64
Identities = 46/137 (33%), Positives = 69/137 (50%), Gaps = 12/137 (8%)
Query: 348 KPIDSAVLSRMKQFRAMNKLKKLALKVIAENLST-EEIQGLKQMFTNIDTDNSGTITYEE 406
K + L MK+F++ KL + A+ + L+T EE + L Q+F +D + G + +E
Sbjct: 2 KHALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKE 61
Query: 407 LKAGLAR-----------LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLER 455
L G + L S EAEV ++++ D D NG I+Y EF+T M + L
Sbjct: 62 LIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLS 121
Query: 456 DDHLYKAFQHFDKDNSG 472
+ L AFQ FD D SG
Sbjct: 122 RERLLAAFQQFDSDGSG 138
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
L F D+D SG IT EEL +++ + Q+++ D + +G +D+ EF+
Sbjct: 125 LLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDKNNDGEVDFEEFVE 181
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-64
Identities = 96/307 (31%), Positives = 144/307 (46%), Gaps = 24/307 (7%)
Query: 45 PGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTG 104
G P +G Q P ED + FGK LG G F L E +T
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKR--PED----FKFGKILGEGSFSTVVLARELATS 55
Query: 105 RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164
R++A K + KR ++ +N + RE +M L P V+ ++D + ++ +
Sbjct: 56 REYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224
GEL I G + E IV+ + H G++HRDLKPEN LL +E+ ++
Sbjct: 115 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQI 171
Query: 225 TDFGLS-VFIEEGKVYRD--IVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPP 280
TDFG + V E K R VG+A YV+PE+L + K D+W+ G I+Y L++G+PP
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS------AQVL 334
F A E IF I++ + DF P A+DLV ++L D KR+ +
Sbjct: 232 FRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 335 EHPWIKE 341
HP+ +
Sbjct: 288 AHPFFES 294
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-63
Identities = 76/114 (66%), Positives = 93/114 (81%)
Query: 359 KQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKL 418
KQF AMNK KK+AL+VIAE+LS EEI GLK+MF ID D SG IT+EELKAGL R+G+ L
Sbjct: 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60
Query: 419 TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
E+E+ LM+AADVD +GTIDY EFI AT+H +K+ER+DHL+ AF +FDKD SG
Sbjct: 61 KESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSG 114
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 1e-13
Identities = 25/83 (30%), Positives = 36/83 (43%), Gaps = 13/83 (15%)
Query: 363 AMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
A L K+ + L FT D D SG IT +EL+ G + +
Sbjct: 88 ATLHLNKI--------EREDH---LFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVR 134
Query: 423 VQQLMEAADVDGNGTIDYIEFIT 445
+++LM D D +G IDY EF+
Sbjct: 135 IEELMRDVDQDNDGRIDYNEFVA 157
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-62
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 42/292 (14%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + LGRG FGV + +A K I + ++ + RE++ + L P
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HP 63
Query: 141 NIVEFKGAYEDKQS------------VHVVMELCAGGELFDRIIAKGHYS---ERAAASI 185
IV + A+ +K + +++ M+LC L D + + I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-------------VF 232
I V H G+MHRDLKP N + ++K DFGL
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IF 290
+ + VG+ Y++PE + Y ++DI+S G+IL+ LL PF + E+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
+ + +V+ ML+ P +R + ++E+ ++
Sbjct: 238 TDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-60
Identities = 57/288 (19%), Positives = 113/288 (39%), Gaps = 34/288 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +++G G+FG + C + G +A K SK+ L D+ + RE+ L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRI----IAKGHYSERAAASICRSIVNVVHI 195
++V + A+ + + + E C GG L D I ++ E + + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 196 CHFMGVMHRDLKPENFLLSSK----------------DENALLKATDFGLSVFIEEGKVY 239
H M ++H D+KP N +S + K D G I +V
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 240 RDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
G + ++A EVL+ + + DI++ + + P + + I QG
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGR 244
Query: 298 IDFESAPWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ P +S +L++ M+ DP++R ++ +++H +
Sbjct: 245 LP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-60
Identities = 32/125 (25%), Positives = 67/125 (53%), Gaps = 5/125 (4%)
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKVIAENLST--EEIQGLKQMFTNIDTDNSGTITYEEL 407
I VL+ MK + + ++ + + ++A LS I+ + ++F +DT+++G++++ E+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 408 KAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
LA +G + + ++ ++++A D++ G I Y EF+ +E L AF D
Sbjct: 62 YTVLASVG--IKKWDINRILQALDINDRGNITYTEFMAGCYRWKNIE-STFLKAAFNKID 118
Query: 468 KDNSG 472
KD G
Sbjct: 119 KDEDG 123
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 15/84 (17%), Positives = 28/84 (33%), Gaps = 13/84 (15%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+A +N+ + LK F ID D G I+ ++ + + L ++ +
Sbjct: 96 MAGCYRWKNIESTF---LKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLS 150
Query: 430 ADVDGNGT--------IDYIEFIT 445
G I + EF
Sbjct: 151 VHSIKKGIPREHIINKISFQEFKD 174
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-57
Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 24/271 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K LG G FG L +G +A K + K+K+V + E +I+Q ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V+ + +++D ++++VME AGGE+F + G +SE A IV H +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV----GSAYYVAPEVLRR 256
+++RDLKPEN L+ D+ ++ TDFG + K + G+ +APE++
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFA------KRVKGRTWTLCGTPEALAPEIILS 212
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ Y K +D W+ GV++Y + +G PPF+A+ I++ I+ G + F P SS KDL
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268
Query: 316 VRRMLTQDPKKRITSAQ-----VLEHPWIKE 341
+R +L D KR + + + H W
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-56
Identities = 74/277 (26%), Positives = 138/277 (49%), Gaps = 19/277 (6%)
Query: 75 EDVKL-HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
EDV H+ + +G+G FG + +N T + +A K ++K+K V +N+ ++ +E+QIM
Sbjct: 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RAAASICRSIVNV 192
Q L P +V +++D++ + +V++L GG+L + H+ E IC ++ +
Sbjct: 70 QGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
++ ++HRD+KP+N LL DE+ + TDF ++ + + G+ Y+APE
Sbjct: 129 DYL-QNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184
Query: 253 VLRRR----YGKEIDIWSAGVILYILLSGVPPFW---AETEKGIFDAILQGDIDFESAPW 305
+ R Y +D WS GV Y LL G P+ + + K I + + P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P- 240
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQ-VLEHPWIKE 341
S L++++L +P +R + V P++ +
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-56
Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 8/130 (6%)
Query: 343 GEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTI 402
G P+ S + M KL+ L A IQGL + F +D D S ++
Sbjct: 3 GLVPRGPLGSHMD---AVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSL 54
Query: 403 TYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462
+E + GLA+LG L +AE + + D +G+GT+D EF+ A R+ + A
Sbjct: 55 DADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAAA 114
Query: 463 FQHFDKDNSG 472
F D+ G
Sbjct: 115 FAKLDRSGDG 124
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 13/81 (16%), Positives = 31/81 (38%), Gaps = 8/81 (9%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL-------ARLGSKLTEAEVQ 424
L+ + +S + F +D G +T ++L+ R G + ++
Sbjct: 96 LRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLR 155
Query: 425 QLMEAAD-VDGNGTIDYIEFI 444
+ ++ D + +G + EF
Sbjct: 156 RFLDNFDSSEKDGQVTLAEFQ 176
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-55
Identities = 83/267 (31%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L ST + +A K +SK +++ ++D E IM + P +V+
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQ 133
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
A++D + +++VME GG+L +++ E+ A +V + H MG +HR
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLRR-----R 257
D+KP+N LL D++ LK DFG + + + + R VG+ Y++PEVL+
Sbjct: 193 DVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK+L+
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 318 RMLTQDPKKRITS---AQVLEHPWIKE 341
LT D + R+ ++ H + K
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKN 335
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-55
Identities = 83/275 (30%), Positives = 137/275 (49%), Gaps = 32/275 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + LG G FG +L GR +A K + K +V + E ++ ++ P
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHIC 196
I+ G ++D Q + ++M+ GGELF + + A AA +C ++ ++
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---YL- 122
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV----GSAYYVAPE 252
H +++RDLKPEN LL D+N +K TDFG + K D+ G+ Y+APE
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFA------KYVPDVTYTLCGTPDYIAPE 173
Query: 253 VLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
V+ + Y K ID WS G+++Y +L+G PF+ ++ IL ++ F P P +
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNED 229
Query: 312 AKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
KDL+ R++T+D +R+ + V HPW KE
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-53
Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 28/273 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNI 142
+ +GRG FG Y C + TG+ +A K + K+++ K + E ++ +S P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICHF 198
V A+ + +++L GG+L + G +SE AA I + H+ H
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL---EHM-HN 310
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-- 256
V++RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWPTISSSAK 313
Y D +S G +L+ LL G PF K I L ++ + S +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELR 422
Query: 314 DLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
L+ +L +D +R+ + +V E P+ +
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-53
Identities = 65/325 (20%), Positives = 119/325 (36%), Gaps = 19/325 (5%)
Query: 23 SPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYS 82
S + + A P + + V + + Y + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
+GRG FG + + TG Q A K + + E+ LS P I
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFRVEELVACAGLS-SPRI 112
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
V GA + V++ MEL GG L I G E A + + H ++
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR------DIVGSAYYVAPEVLRR 256
H D+K +N LLSS + DFG ++ ++ + + I G+ ++APEV+
Sbjct: 173 HGDVKADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ ++DIWS+ ++ +L+G P+ + I P P+ +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQA 289
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIK 340
++ L ++P R ++ ++
Sbjct: 290 IQEGLRKEPVHRASAMELRRKVGKA 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 61/267 (22%), Positives = 122/267 (45%), Gaps = 16/267 (5%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
F E+GRG F Y + T + A + RKL TK+++ K E ++++ L PNI
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87
Query: 143 VEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
V F ++E K+ + +V EL G L + + S CR I+ + H
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 199 MG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR 256
++HRDLK +N ++ +K D GL+ + ++G+ ++APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEE 204
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISSSAKD 314
+Y + +D+++ G+ + + + P ++E + I+ + G ++ K+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKE 261
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
++ + Q+ +R + +L H + +E
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 50/295 (16%), Positives = 103/295 (34%), Gaps = 39/295 (13%)
Query: 72 KPYEDVKL---HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDK 123
KP + +L LG G F Y T + ++F K +
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEF 111
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-----S 178
+ ++ ++ Q ++F A+ + +V EL + G L + I +
Sbjct: 112 YIGTQLMERLKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 179 ERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--------DENALLKATDFGLS 230
+ S ++ ++ H ++H D+KP+NF+L + D +A L D G S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 231 V---FIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWA-ET 285
+ +G ++ ++ + E+L + + +ID + +Y +L G E
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ + + + + W + ML + S +L K
Sbjct: 291 GECKPEGLFRRLPHLD--MW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 18/270 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG + + + FA K ++K +++ + + + E ++ + I
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITT 138
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMH 203
A++D ++++VM+ GG+L + + E A +V + H + +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 204 RDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRD-IVGSAYYVAPEVL------R 255
RD+KP+N L+ D N ++ DFG +E+G V VG+ Y++PE+L +
Sbjct: 199 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKD 314
RYG E D WS GV +Y +L G PF+AE+ + I+ F+ T +S +AKD
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 315 LVRRMLTQDPKKRITS---AQVLEHPWIKE 341
L+RR++ + R+ +HP+
Sbjct: 316 LIRRLIC-SREHRLGQNGIEDFKKHPFFSG 344
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 30/172 (17%), Positives = 62/172 (36%), Gaps = 15/172 (8%)
Query: 305 WPTISSSAKDLVRRMLTQDPK--KRITSAQVLEHPWIK--EGGEASDKPIDSAVLSRMKQ 360
I+ ++ ++ D K + + E A + + S +
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLEDD 102
Query: 361 FRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTE 420
N+L+ LS E+ L+Q+F + SG ++++LK LA+ + E
Sbjct: 103 ASGYNRLR-----PSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPE 157
Query: 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+++L + D G + YI + L F+ D +++G
Sbjct: 158 GPLKKLFVMVENDTKGRMSYITLVAVANDLAALV------ADFRKIDTNSNG 203
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 14/69 (20%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
L+ ++ D D SG ++ EE++ L + + + DVD + ++ Y EF+
Sbjct: 255 LRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVM 314
Query: 446 ATMHRHKLE 454
+ +
Sbjct: 315 LVLLMFHDD 323
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 15/116 (12%), Positives = 34/116 (29%), Gaps = 5/116 (4%)
Query: 357 RMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS 416
++ +K + L+ E+ L + + + E + AR +
Sbjct: 27 KLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAERERE-AARGDA 85
Query: 417 KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + L++ + D +G E + L + F SG
Sbjct: 86 AAEKQRLASLLKDLEDDASGYNRLRPSKPML----SEEDTNILRQLFLSSAVSGSG 137
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 17/102 (16%), Positives = 26/102 (25%), Gaps = 7/102 (6%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD 431
+ L ++ +F D D S + + E L L AD
Sbjct: 210 FREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVH-LGLCLLVLRILY-----AFAD 263
Query: 432 VDGNGTIDYIEFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
D +G + E F D D+S
Sbjct: 264 FDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSK 305
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 20/269 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG F + TG+ +A K ++K ++ + + + E ++ + + I +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQ 125
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMH 203
A++D+ +++VME GG+L + G A IV + H +G +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRD-IVGSAYYVAPEVLRR----- 256
RD+KP+N LL D ++ DFG + +G V VG+ Y++PE+L+
Sbjct: 186 RDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 257 ---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSA 312
YG E D W+ GV Y + G PF+A++ + I+ + A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 313 KDLVRRMLTQDPKKRITSAQVLE---HPW 338
+D ++R+L P+ R+ + HP+
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 70/258 (27%), Positives = 126/258 (48%), Gaps = 10/258 (3%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG +L T + FA K++ K ++ +D + E +++ P +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ K+++ VME GG+L I + + A I+ + H G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 207 KPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
K +N LL D++ +K DFG+ + G+ Y+APE+L + Y +D
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
WS GV+LY +L G PF + E+ +F +I + + P + AKDL+ ++ ++P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLFVREP 257
Query: 325 KKRITSAQ-VLEHPWIKE 341
+KR+ + +HP +E
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 7e-52
Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 15/270 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++ F + LG+G FG L TG +A K + K ++ +D + E +I+
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P + + ++ + VME GG+L I + E A I++ + H
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N LL D K DFG+ I G G+ Y+APE+L+
Sbjct: 144 GIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YG +D W+ GV+LY +L G PF AE E +F+AIL ++ + P + A +++
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGILK 256
Query: 318 RMLTQDPKKRITS------AQVLEHPWIKE 341
+T++P R+ S +L HP+ KE
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 70/269 (26%), Positives = 128/269 (47%), Gaps = 14/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++F LG+G FG L T +A K + K ++ +D + E +++
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P + + ++ ++ VME GG+L I G + E A I +
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N +L D +K DFG+ I +G + G+ Y+APE++ +
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 197
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YGK +D W+ GV+LY +L+G PF E E +F +I++ ++ + P ++S A + +
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICK 253
Query: 318 RMLTQDPKKRITSAQ-----VLEHPWIKE 341
++T+ P KR+ + EH + +
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 82/322 (25%), Positives = 151/322 (46%), Gaps = 32/322 (9%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGK-----PYEDVKLHYSFGKELGRGQFG 93
HH L D +L ++G G G
Sbjct: 2 HHHHHHSSGV--DLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTG 59
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153
+ L E +GRQ A K + L + ++ + E+ IM+ N+VE +Y +
Sbjct: 60 IVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGE 115
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
+ V+ME GG L D I+++ +E A++C +++ + H GV+HRD+K ++ LL
Sbjct: 116 ELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174
Query: 214 SSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDIWSAGVIL 271
+ + +K +DFG I + R +VG+ Y++APEV+ R Y E+DIWS G+++
Sbjct: 175 T---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 272 YILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTI------SSSAKDLVRRMLTQDP 324
++ G PP+++++ + + + +P P + S +D + RML +DP
Sbjct: 232 IEMVDGEPPYFSDSPVQAMK-RL-------RDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 325 KKRITSAQVLEHPWIKEGGEAS 346
++R T+ ++L+HP++ + G
Sbjct: 284 QERATAQELLDHPFLLQTGLPE 305
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 7e-51
Identities = 92/319 (28%), Positives = 153/319 (47%), Gaps = 23/319 (7%)
Query: 32 APAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKL-HYSFGKELGRG 90
A Q +K + L KP V + + + K LG+G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKG 159
Query: 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
FG L E +TGR +A K + K +V K++ E +++Q+ S P + K +++
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYSFQ 218
Query: 151 DKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICHFMGVMHRDL 206
+ VME GGELF + + +SE RA A I ++ ++ V++RDL
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD---YLHSEKNVVYRDL 275
Query: 207 KPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
K EN +L D++ +K TDFGL I++G + G+ Y+APEVL YG+ +D
Sbjct: 276 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
W GV++Y ++ G PF+ + + +F+ IL +I F P T+ AK L+ +L +DP
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAKSLLSGLLKKDP 388
Query: 325 KKRITSAQ-----VLEHPW 338
K+R+ +++H +
Sbjct: 389 KQRLGGGSEDAKEIMQHRF 407
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-50
Identities = 76/339 (22%), Positives = 141/339 (41%), Gaps = 17/339 (5%)
Query: 10 DPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTI 69
K G + + ++ AP + + D N
Sbjct: 275 WFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGN 334
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ ++F LG+G FG L T +A K + K ++ +D + E
Sbjct: 335 RDRMKLT---DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
+++ P + + ++ ++ VME GG+L I G + E A I
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYY 248
+ G+++RDLK +N +L D +K DFG+ I +G + G+ Y
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 508
Query: 249 VAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
+APE++ + YGK +D W+ GV+LY +L+G PF E E +F +I++ ++ + P +
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KS 564
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQ-----VLEHPWIKE 341
+S A + + ++T+ P KR+ + EH + +
Sbjct: 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 78/285 (27%), Positives = 140/285 (49%), Gaps = 23/285 (8%)
Query: 72 KPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
K E + + + LG+G FG C +TG+ +ACK + K+++ + +
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI--IAKGHYSERAAASIC 186
E QI++ ++ +V AYE K ++ +V+ L GG+L I + + + E A
Sbjct: 234 EKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I + H +++RDLKPEN LL D++ ++ +D GL+V + EG+ + VG+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 247 YYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDFE 301
Y+APEV++ RY D W+ G +LY +++G PF +K + + + ++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITS-----AQVLEHPWIKE 341
S A+ L ++L +DP +R+ +V EHP K+
Sbjct: 410 ----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 85/261 (32%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TGR +A K + K ++ K++ E +++Q+ P +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTA 69
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K A++ + VME GGELF + + ++E A IV+ + H V++R
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 205 DLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
D+K EN +L D++ +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL +I F P T+S AK L+ +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLAGLLKK 242
Query: 323 DPKKRITSAQ-----VLEHPW 338
DPK+R+ V+EH +
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-50
Identities = 82/279 (29%), Positives = 141/279 (50%), Gaps = 21/279 (7%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D K Y+ +++G+G G Y + +TG++ A + + L + K+ I EI +M+
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEV 253
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAP----WPT 307
+ R+ YG ++DIWS G++ ++ G PP+ E + ++ I P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPELQNPEK 241
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
+S+ +D + R L D +KR ++ ++L+H ++K S
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 4e-50
Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 34/292 (11%)
Query: 72 KPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
K E + + + LGRG FG + C +TG+ +ACK ++K++L +
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYS-----ERA-- 181
E +I+ + IV A+E K + +VM + GG++ I + RA
Sbjct: 235 EKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 182 -AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVY 239
A I + H+ H +++RDLKPEN LL D++ ++ +D GL+V
Sbjct: 294 YTAQIVSGL---EHL-HQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKT 346
Query: 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAIL 294
+ G+ ++APE+L Y +D ++ GV LY +++ PF A EK + +L
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS-----AQVLEHPWIKE 341
+ + + P S ++KD +L +DP+KR+ + HP ++
Sbjct: 407 EQAVTY---P-DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-50
Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 24/303 (7%)
Query: 49 PAAAPVSGLKQAVPRPDTNTILGKPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGR 105
P + A P + I P + + F K +G+G FG L +
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV 64
Query: 106 QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165
+A K + K+ ++ K ++ I E ++ P +V +++ ++ V++ GG
Sbjct: 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124
Query: 166 ELFDRIIAKGHYSE-RA---AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221
ELF + + + E RA AA I ++ ++ H + +++RDLKPEN LL D
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASAL---GYL-HSLNIVYRDLKPENILL---DSQGH 177
Query: 222 LKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVP 279
+ TDFGL IE G+ Y+APEVL ++ Y + +D W G +LY +L G+P
Sbjct: 178 IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
Query: 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLE 335
PF++ ++D IL + P I++SA+ L+ +L +D KR+ + ++
Sbjct: 238 PFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293
Query: 336 HPW 338
H +
Sbjct: 294 HVF 296
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-50
Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 22/272 (8%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
LG+G +G+ Y + S + A K I + EI + +HL NIV
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMG 200
++ G++ + + + ME GG L + +K +E+ + I+ + H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-- 257
++HRD+K +N L+++ + +LK +DFG S + + G+ Y+APE++ +
Sbjct: 143 IVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWP-TISSSA 312
YGK DIWS G + + +G PP + E + +F + P ++S+ A
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP-FYELGEPQAAMF-KVGMFK---VHPEIPESMSAEA 255
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
K + + DP KR + +L ++K +
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 81/265 (30%), Positives = 139/265 (52%), Gaps = 19/265 (7%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQP 140
+ LG+G +G + T +TG+ FA K + K +V D K E I++ + P
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HP 81
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
IV+ A++ +++++E +GGELF ++ +G + E A I + H G
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
+++RDLKPEN +L + +K TDFGL I +G V G+ Y+APE+L R +
Sbjct: 142 IIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ +D WS G ++Y +L+G PPF E K D IL+ ++ P P ++ A+DL+++
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKK 254
Query: 319 MLTQDPKKRITS-----AQVLEHPW 338
+L ++ R+ + +V HP+
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 62/97 (63%), Positives = 80/97 (82%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
AE LS EEI GLK++F IDTDNSGTIT++ELK GL R+GS+L E+E++ LM+AAD+D +
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60
Query: 436 GTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
GTIDY EFI AT+H +KLER+++L AF +FDKD SG
Sbjct: 61 GTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSG 97
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-19
Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 10/109 (9%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD 431
+ E + L F+ D D SG IT +E++ G L + + +++ D
Sbjct: 69 IAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEID 126
Query: 432 VDGNGTIDYIEFIT--------ATMHRHKLERDDHLYKAFQHFDKDNSG 472
D +G IDY EF + R + + +L A D ++
Sbjct: 127 QDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKTLNLRDALGLVDNGSNQ 175
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 71/279 (25%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + +GRG + L T R +A K + K + D D ++ E + + S
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P +V ++ + + V+E GG+L + + E A I ++ H
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N LL D +K TD+G+ + G G+ Y+APE+LR
Sbjct: 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 258 YGKEIDIWSAGVILYILLSGVPPFW---------AETEKGIFDAILQGDIDFESAPWPTI 308
YG +D W+ GV+++ +++G PF TE +F IL+ I P ++
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSL 242
Query: 309 SSSAKDLVRRMLTQDPKKRITS------AQVLEHPWIKE 341
S A +++ L +DPK+R+ A + HP+ +
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 74/327 (22%), Positives = 132/327 (40%), Gaps = 27/327 (8%)
Query: 35 QQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKL---HYSFGKELGRGQ 91
HH + P + + L + + +GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151
+ L T R +A + + K + D D ++ E + + S P +V ++
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124
Query: 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211
+ + V+E GG+L + + E A I ++ H G+++RDLK +N
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 212 LLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGV 269
LL D +K TD+G+ + G G+ Y+APE+LR YG +D W+ GV
Sbjct: 185 LL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 270 ILYILLSGVPPFW---------AETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320
+++ +++G PF TE +F IL+ I P ++S A +++ L
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVKAASVLKSFL 297
Query: 321 TQDPKKRITS------AQVLEHPWIKE 341
+DPK+R+ A + HP+ +
Sbjct: 298 NKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 27/137 (19%), Positives = 51/137 (37%), Gaps = 6/137 (4%)
Query: 336 HPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNID 395
P + + +PI + + ++ ++ + + ++ + Q F +D
Sbjct: 2 QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61
Query: 396 TDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLER 455
D SGT+ EL G G +L+ ++M D D NG I + EF+
Sbjct: 62 RDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHISFYEFMAMYKFM----- 116
Query: 456 DDHLYKAFQHFDKDNSG 472
+ Y F + SG
Sbjct: 117 -ELAYNLFVMNARARSG 132
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 7/92 (7%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
+ ++ +F SGT+ E+ L +LG + + L+ G D
Sbjct: 113 YKFMELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQ-RTSLLLHRLFARGMAFCDL 171
Query: 441 IEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+I + A+Q +
Sbjct: 172 NCWIAICA---FAAQ---TRSAYQMIFMNPYY 197
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 7/80 (8%), Positives = 18/80 (22%), Gaps = 7/80 (8%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
AL+ + ++ + + A A A M
Sbjct: 142 ALQQLGFYINQR----TSLLLHRLFARGMAFCDLNCWIAICAFAAQ-TRSAYQMIFMNPY 196
Query: 431 DVDGNG--TIDYIEFITATM 448
+++ +F+
Sbjct: 197 YGPMKPFNPMEFGKFLDVVT 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-49
Identities = 76/268 (28%), Positives = 136/268 (50%), Gaps = 27/268 (10%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K LG+G FG +L + + + +A K + K L ++ K E I+ ++ P
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN-HPF 87
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICH 197
IV+ A++ + ++++++ GG+LF R+ + ++E A + + + H+ H
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL---ALALDHL-H 143
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRR 256
+G+++RDLKPEN LL DE +K TDFGLS I+ K G+ Y+APEV+ R
Sbjct: 144 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
R + + D WS GV+++ +L+G PF + K IL+ + P +S A+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSL 256
Query: 316 VRRMLTQDPKKRITSAQ-----VLEHPW 338
+R + ++P R+ + + H +
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-49
Identities = 79/317 (24%), Positives = 132/317 (41%), Gaps = 28/317 (8%)
Query: 63 RPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND 122
+ TI G+ Y+ E+G G G + TG A K + R+ K +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEE 66
Query: 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
I ++ ++ P IV+ G + V + MEL + +G ER
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL 126
Query: 183 ASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+ +IV ++ GV+HRD+KP N LL + + +K DFG+S + + K
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDR 183
Query: 242 IVGSAYYVAPEVLRRR------YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
G A Y+APE + Y D+WS G+ L L +G P+ + K F+ + +
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTK 241
Query: 296 GDIDFESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ E P S + V+ LT+D +KR ++LEH +IK +D
Sbjct: 242 --VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK---RYETLEVD 296
Query: 352 SA-----VLSRMKQFRA 363
A V+++ + R+
Sbjct: 297 VASWFKDVMAKTESPRS 313
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 79/299 (26%), Positives = 148/299 (49%), Gaps = 24/299 (8%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D + ++ +++G+G FG + +N T + A K I + +++ +DI++EI ++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLS 75
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
P + ++ G+Y + ++ME GG D ++ G E A+I R I+ +
Sbjct: 76 QCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 133
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEV 253
H +HRD+K N LLS E+ +K DFG++ + + ++ R+ VG+ +++APEV
Sbjct: 134 YLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 254 LRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTI--- 308
+++ Y + DIWS G+ L G PP K +F I + + P PT+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPK------NNP-PTLEGN 242
Query: 309 -SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNK 366
S K+ V L ++P R T+ ++L+H +I A + ++ R K+++A
Sbjct: 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR--NAKKTSYLTELIDRYKRWKAEQS 299
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-48
Identities = 77/322 (23%), Positives = 131/322 (40%), Gaps = 22/322 (6%)
Query: 37 QAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKP-------YEDVKLHYSFGKELGR 89
HH + PT G +P L P +D + +S +E+G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149
G FG Y + A K +S + DI +E++ +Q L PN ++++G Y
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCY 123
Query: 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209
+ + +VME C G + K E A++ + + H ++HRD+K
Sbjct: 124 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 183
Query: 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRYGKEIDIW 265
N LLS E L+K DFG + + VG+ Y++APEV+ +Y ++D+W
Sbjct: 184 NILLS---EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 266 SAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
S G+ L PP + ++ +S W S ++ V L + P
Sbjct: 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIP 294
Query: 325 KKRITSAQVLEHPWIKEGGEAS 346
+ R TS +L+H ++ +
Sbjct: 295 QDRPTSEVLLKHRFVLRERPPT 316
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 90/335 (26%), Positives = 160/335 (47%), Gaps = 34/335 (10%)
Query: 27 VAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKL-HYSFGK 85
+A +++ G + V L E V + ++ K
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 86 ELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQPN 141
LG G +G +L + + TG+ +A K + K +V K + + E Q+++H+ P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICH 197
+V A++ + +H++++ GGELF + + ++E I ++ H+ H
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE---HL-H 176
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGSAYYVAPEVLR 255
+G+++RD+K EN LL D N + TDFGLS +E + D G+ Y+AP+++R
Sbjct: 177 KLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 256 RR---YGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDFESAPWPTI 308
+ K +D WS GV++Y LL+G PF + EK I IL+ + + P +
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEM 289
Query: 309 SSSAKDLVRRMLTQDPKKRITS-----AQVLEHPW 338
S+ AKDL++R+L +DPKKR+ ++ EH +
Sbjct: 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 78/307 (25%), Positives = 137/307 (44%), Gaps = 29/307 (9%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D + + +G G +G Y TG+ A K + VT +++++IK+EI +++
Sbjct: 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLK 75
Query: 135 HLSGQPNIVEFKGAYEDKQSVH------VVMELCAGGELFD--RIIAKGHYSERAAASIC 186
S NI + GA+ K +VME C G + D + E A IC
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGS 245
R I+ + H V+HRD+K +N LL+ ENA +K DFG+S ++ R+ +G+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 246 AYYVAPEVLRRR------YGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGD 297
Y++APEV+ Y + D+WS G+ + G PP + + +F
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-CDMHPMRALFLIPRNPA 251
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD-KPIDSAVLS 356
+S W S + + L ++ +R + Q+++HP+I++ + +
Sbjct: 252 PRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHID 308
Query: 357 RMKQFRA 363
R K+ R
Sbjct: 309 RTKKKRG 315
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D + ELG G FG Y TG A K I ++ + +D EI+I+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVV 193
P IV+ GAY + +++E C GG + + +E +CR ++ +
Sbjct: 72 TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPE 252
+ H ++HRDLK N L++ ++ DFG+S + RD +G+ Y++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 253 VLRRR------YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPW 305
V+ Y + DIWS G+ L + PP + + I + +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAK-------SDP 239
Query: 306 PTI------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
PT+ S +D ++ L ++P+ R ++AQ+LEHP++
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 29/283 (10%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ + + ++LG G +G Y TG+ A K + ++D +I +EI IMQ
Sbjct: 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQ 79
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVV 193
P++V++ G+Y + +VME C G + D I + +E A+I +S + +
Sbjct: 80 QCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPE 252
HFM +HRD+K N LL+ K DFG++ + + R+ ++G+ +++APE
Sbjct: 139 EYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 253 VLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAI-------LQGDIDFESA 303
V++ Y DIWS G+ + G PP+ + IF I + +
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELW--- 251
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
S + D V++ L + P++R T+ Q+L+HP+++ S
Sbjct: 252 -----SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 28/292 (9%)
Query: 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREI 130
P+ + Y + +G G V + A K I+ K + D++ +EI
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEI 64
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI--------IAKGHYSERAA 182
Q M PNIV + ++ K + +VM+L +GG + D I G E
Sbjct: 65 QAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD- 241
A+I R ++ + H G +HRD+K N LL E+ ++ DFG+S F+ G
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRN 180
Query: 242 -----IVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294
VG+ ++APEV+ + Y + DIWS G+ L +G P+ + L
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 295 QGD------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
Q D + S + ++ L +DP+KR T+A++L H + +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 28/283 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
E+GRG +G +G+ A K I R V + ++ + ++ ++ S P IV+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVN-VVHICH 197
F GA + + MEL + FD+ E I + V + H+
Sbjct: 86 FYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--- 254
+ ++HRD+KP N LL +K DFG+S + + G Y+APE +
Sbjct: 144 NLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA---ILQGDI-DFESAPWPTI 308
R+ Y D+WS G+ LY L +G P+ +FD +++GD ++
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREF 258
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
S S + V LT+D KR ++L+HP+I ++ ++
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFIL---MYEERAVE 298
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 30/282 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
ELGRG +GV +G+ A K I R V ++ + ++ I P V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 145 FKGAYEDKQSVHVVMELCAGG--ELFDRIIAK-GHYSERAAASICRSIVNVVHICHF-MG 200
F GA + V + MEL + + ++I K E I SIV + H +
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR----- 255
V+HRD+KP N L+++ + +K DFG+S ++ + G Y+APE +
Sbjct: 131 VIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP------WPTIS 309
+ Y + DIWS G+ + L P+ ++ F + Q + E +P + S
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQ--VVEEPSPQLPADKF---S 240
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ D + L ++ K+R T ++++HP+ K D
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFT---LHESKGTD 279
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 82/305 (26%), Positives = 129/305 (42%), Gaps = 47/305 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y ++G G +GV + C TG+ A K K + D IK REI++++ L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQL 59
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
PN+V + K+ +H+V E C DR + E SI + V+
Sbjct: 60 K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVN 116
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH +HRD+KPEN L++ +K DFG + + Y D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI-------------L 294
L +YG +D+W+ G + LLSGVP + +++ I +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 295 QGDIDFESAPW----------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
Q + P IS A L++ L DP +R+T Q+L HP+ + E
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 345 ASDKP 349
D
Sbjct: 294 IEDLA 298
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 100/419 (23%), Positives = 169/419 (40%), Gaps = 80/419 (19%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNTI-----LGKPYEDVKLHYSFGKELGRGQFGVTYLCTE 100
T + AP++G+K I GK E ++ Y+ K +G G FGV +
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 101 NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK------GAYEDKQS 154
+ + A K + DK RE+QIM+ + PN+V+ K G +D+
Sbjct: 62 VESD-EVAIKKV-------LQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVF 112
Query: 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI-------------CHFMGV 201
+++V+E E R HY++ + + ++ I H +G+
Sbjct: 113 LNLVLEYV--PETVYRASR--HYAKL------KQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYG 259
HRD+KP+N LL + +LK DFG + + G+ + S YY APE++ Y
Sbjct: 163 CHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAIL----QGDIDFESA-------- 303
IDIWS G ++ L+ G P F E+ I +L + I +
Sbjct: 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFP 279
Query: 304 -----PW-----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
P+ P A DL+ R+L P R+T+ + L HP+ E + +
Sbjct: 280 QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGR 339
Query: 354 VLSRMKQFRAMNKLKKLALKV-IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL 411
L + + ++L+++ + L + + + + ID N I E LK L
Sbjct: 340 ELPPLFNW----TKEELSVRPDLISRLVPQHAEA-ELLSRGIDVHNFQPIPLESLKVTL 393
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 74/304 (24%), Positives = 125/304 (41%), Gaps = 49/304 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +G G +G+ C TGR A K K + +D +K REI++++ L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
N+V + K+ ++V E + + + I+N +
Sbjct: 82 R-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIG 138
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH ++HRD+KPEN L+S +K DFG + G+VY D V + +Y APE+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE------------------------- 286
L +YGK +D+W+ G ++ + G P F +++
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 287 ---KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
G+ ++ E +P +S DL ++ L DP KR A++L H + + G
Sbjct: 256 PVFAGVRLPEIKEREPLERR-YPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 344 EASD 347
A
Sbjct: 315 FAER 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 76/329 (23%), Positives = 125/329 (37%), Gaps = 52/329 (15%)
Query: 65 DTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD 124
T K E + ELG G GV + + +G A K I + ++
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRN 76
Query: 125 DIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
I RE+Q++ H P IV F GA+ + + ME GG L + G E+
Sbjct: 77 QIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 135
Query: 185 ICRSIVNVVHICHFMG-VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ +++ + +MHRD+KP N L++S+ E +K DFG+S + + V
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFV 191
Query: 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL-------- 294
G+ Y++PE L+ Y + DIWS G+ L + G P K +
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 295 ------------QGDIDFESAPWPTI--------------------SSSAKDLVRRMLTQ 322
+S P I S +D V + L +
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311
Query: 323 DPKKRITSAQVLEHPWIKEGGEASDKPID 351
+P +R Q++ H +IK + + +D
Sbjct: 312 NPAERADLKQLMVHAFIK---RSDAEEVD 337
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-42
Identities = 56/261 (21%), Positives = 101/261 (38%), Gaps = 28/261 (10%)
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
+ + + L + + D +I+ M S N V K +++
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYI 138
Query: 158 VMELCAGGELFDRIIAKGHYSER---AAASICRSIVNVVHICHFMGVMHRDLKPENFLLS 214
M+LC L D + + +R I I V H G+MHRDLKP N +
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 215 SKDENALLKATDFGLSVFIEEGKVYRDI-------------VGSAYYVAPEVLR-RRYGK 260
D +K DFGL +++ + + + VG+ Y++PE + Y
Sbjct: 199 MDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
++DI+S G+IL+ LL F + E+ I + + +V+ M
Sbjct: 256 KVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKF---PLLFTQKYPQEHMMVQDM 309
Query: 320 LTQDPKKRITSAQVLEHPWIK 340
L+ P +R + ++E+ +
Sbjct: 310 LSPSPTERPEATDIIENAIFE 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 89/372 (23%), Positives = 140/372 (37%), Gaps = 67/372 (18%)
Query: 31 PAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGK-PYEDVKLHYSFGKELGR 89
P +P + + VS K G+ P ++ Y+ K +G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK--- 146
G FGV Y +G A K + DK RE+QIM+ L NIV +
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLRYFF 116
Query: 147 ---GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI-------- 195
G +D+ +++V++ E R+ HYS + + V+++
Sbjct: 117 YSSGEKKDEVYLNLVLDYV--PETVYRVAR--HYSRA------KQTLPVIYVKLYMYQLF 166
Query: 196 -----CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
H G+ HRD+KP+N LL + A+LK DFG + + G+ + S YY A
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 224
Query: 251 PEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------GDIDFE 301
PE++ Y ID+WSAG +L LL G P F ++ I++ I
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284
Query: 302 SA-------------PW-----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
+ PW P A L R+L P R+T + H + E
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344
Query: 344 EASDKPIDSAVL 355
+ + K +
Sbjct: 345 DPNVKLPNGRDT 356
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-42
Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 364 MNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAE 422
M+ + K E L+ E+ K F G+I+ +EL + LG T E
Sbjct: 1 MDDIYK----AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMH----RHKLERDDHLYKAFQHFDKDNSG 472
+Q++++ D DG+GT+D+ EF+ + K + ++ L F+ FDK+ G
Sbjct: 57 LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADG 110
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 22/76 (28%), Positives = 41/76 (53%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ ++ + ++ + + L +F D + G I EELK L G +TE ++++LM+
Sbjct: 80 MMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKD 139
Query: 430 ADVDGNGTIDYIEFIT 445
D + +G IDY EF+
Sbjct: 140 GDKNNDGRIDYDEFLE 155
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-42
Identities = 55/353 (15%), Positives = 117/353 (33%), Gaps = 63/353 (17%)
Query: 74 YEDVKLHYSFGKELGRGQ--FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
+ Y +G+G L TG + I+ + ++ E+
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELH 78
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSI 189
+ + + PNIV ++ + + VV A G D +E A A I + +
Sbjct: 79 VSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--------D 241
+ + H MG +HR +K + L+S + + + ++ + +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 242 IVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPF----------------- 281
V +++PEVL++ Y + DI+S G+ L +G PF
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 282 -------------------WAETEKGIFDAILQGDIDFESAPWPTI------SSSAKDLV 316
+ G+ D++ + P+ S V
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
+ L ++P R +++ +L H + K+ + + + +L + +
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE-LLRPVTPITNFEGSQS 366
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-42
Identities = 24/144 (16%), Positives = 51/144 (35%), Gaps = 14/144 (9%)
Query: 343 GEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQG----LKQMFTNIDTDN 398
G K S + K +K A + I + + E+ ++F D +
Sbjct: 2 GACGSKGSTSDKGLASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNE 61
Query: 399 SGTITYEELKAGLAR-LGSKLTEAEVQQLMEAA---------DVDGNGTIDYIEFITATM 448
+G + Y+E+ +G L + V+ + + A ++ G+ D++EF+ +
Sbjct: 62 TGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFLEFRL 121
Query: 449 HRHKLERDDHLYKAFQHFDKDNSG 472
+ L F D +
Sbjct: 122 MLCYIYDFFELTVMFDEIDASGNM 145
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 3e-15
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 4/89 (4%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLME 428
L +++ + L MF ID + + EE K + +L + + L +
Sbjct: 117 LEFRLMLCYIYDFFE--LTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFK 174
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERDD 457
D +G G++ + EF KL+ D
Sbjct: 175 ELDKNGTGSVTFDEFAAW-ASAVKLDADG 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 85/339 (25%), Positives = 133/339 (39%), Gaps = 51/339 (15%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
AHH G A G P +I Y ++ +LG G +G Y
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSI--DRYR--RI-----TKLGEGTYGEVYK 52
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNIVEFKGAYEDKQ 153
+ T A K I +L +++++ + RE+ +++ L NI+E K
Sbjct: 53 AIDTVTNETVAIKRI---RL--EHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH 106
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
+H++ E +L + S R S ++N V+ CH +HRDLKP+N LL
Sbjct: 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165
Query: 214 SSKD--ENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAG 268
S D E +LK DFGL+ F + + + + +Y PE+L R Y +DIWS
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA 225
Query: 269 VILYILLSGVPPFWAETEKG----IFDAI----------------------LQGDIDFES 302
I +L P F ++E IF+ + +
Sbjct: 226 CIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKR 285
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ DL+ ML DP KRI++ LEHP+
Sbjct: 286 VLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 2/111 (1%)
Query: 364 MNKLKK-LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
M+K + L + L E+ Q + + F+ D +N G + Y ELK + LG +L + E
Sbjct: 1 MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60
Query: 423 VQQLMEAADVDGNGTIDYIEFIT-ATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L++ D +G + Y +F K + D + +AFQ FD D++G
Sbjct: 61 ILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQLFDDDHTG 111
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 3/76 (3%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ + I + +EI K+ F D D++G I+ + L+ LG LT+ E++ ++E
Sbjct: 84 VMGEKILKRDPLDEI---KRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEE 140
Query: 430 ADVDGNGTIDYIEFIT 445
D+DG+G I+ EFI
Sbjct: 141 FDLDGDGEINENEFIA 156
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 40/100 (40%), Positives = 56/100 (56%), Gaps = 3/100 (3%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+++NL+ E+I K+ F D DNSG+I+ EL + LG +EAEV LM DVDG
Sbjct: 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDG 60
Query: 435 NGTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
N I++ EF+ M R D L +AF+ FDK+ G
Sbjct: 61 NHAIEFSEFLAL-MSRQLKCNDSEQELLEAFKVFDKNGDG 99
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 4e-14
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
L + + N S +E+ ++F D + G I+ ELK L +G KLT+AEV +++
Sbjct: 72 LMSRQLKCNDSEQELLEAFKVF---DKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLRE 128
Query: 430 ADVDGNGTIDYIEFIT 445
DG+G I+ +F
Sbjct: 129 VS-DGSGEINIKQFAA 143
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-41
Identities = 39/118 (33%), Positives = 65/118 (55%), Gaps = 5/118 (4%)
Query: 356 SRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG 415
+ K + + +K L+ E+ Q +++ F DTD SGTI +ELK + LG
Sbjct: 3 YKAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALG 58
Query: 416 SKLTEAEVQQLMEAADVDGNGTIDYIEFIT-ATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + E+++++ D DG+GTID+ EF+T T + + + + KAF+ FD DNSG
Sbjct: 59 FEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSG 116
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-15
Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ + E S EEI + F D DNSGTIT ++L+ LG LTE E+Q+++
Sbjct: 89 MMTAKMGERDSREEI---LKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAE 145
Query: 430 ADVDGNGTIDYIEFITATMHRHKL 453
AD + + ID EFI M + L
Sbjct: 146 ADRNDDNEIDEDEFI-RIMKKTSL 168
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 79/322 (24%), Positives = 132/322 (40%), Gaps = 60/322 (18%)
Query: 65 DTNTILGKPYEDVKLH---------YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKR 115
D NT + Y D + H Y ++LGRG++ + + + K +
Sbjct: 13 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--- 69
Query: 116 KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS---VHVVMELCAGGELFDRII 172
K V K IKREI+I+++L G PNI+ +D S V + F ++
Sbjct: 70 KPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV--NNTDFKQLY 124
Query: 173 AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
++ I+ + CH MG+MHRD+KP N ++ E+ L+ D+GL+ F
Sbjct: 125 QT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEF 180
Query: 233 IEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWA------- 283
G+ Y V S Y+ PE+L + Y +D+WS G +L ++ PF+
Sbjct: 181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240
Query: 284 ----------ETEKGIFDAI-LQGDIDFESA-------PW---------PTISSSAKDLV 316
E D ++ D F W +S A D +
Sbjct: 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300
Query: 317 RRMLTQDPKKRITSAQVLEHPW 338
++L D + R+T+ + +EHP+
Sbjct: 301 DKLLRYDHQSRLTAREAMEHPY 322
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 7e-40
Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 5/103 (4%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+ +L EEI+ L++ F D D G I +L + +G TE E+ +L + +++
Sbjct: 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNL 60
Query: 435 NGTIDYIEFITATMHRHKLERDD-----HLYKAFQHFDKDNSG 472
G +D+ +F+ + E D L AF+ FD + G
Sbjct: 61 GGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDG 103
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 5e-14
Identities = 20/74 (27%), Positives = 43/74 (58%), Gaps = 1/74 (1%)
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL-ARLGSKLTEAEVQQLMEAAD 431
K++AE ++ L+ F DT+ G I+ EL+ + A LG ++ ++++++ D
Sbjct: 76 KLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVD 135
Query: 432 VDGNGTIDYIEFIT 445
++G+G +D+ EF+
Sbjct: 136 LNGDGRVDFEEFVR 149
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 4e-04
Identities = 6/40 (15%), Positives = 20/40 (50%), Gaps = 3/40 (7%)
Query: 367 LKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEE 406
L++ ++ + +I+ ++ ++D + G + +EE
Sbjct: 110 LREAMRALLGHQVGHRDIE---EIIRDVDLNGDGRVDFEE 146
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-39
Identities = 50/77 (64%), Positives = 64/77 (83%)
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV 432
K +AE LS EEI GLK++F IDTDNSGTIT++ELK GL R+GS+L E+E++ LM+AAD+
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70
Query: 433 DGNGTIDYIEFITATMH 449
D +GTIDY EFI AT+H
Sbjct: 71 DKSGTIDYGEFIAATVH 87
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-06
Identities = 20/81 (24%), Positives = 33/81 (40%), Gaps = 12/81 (14%)
Query: 397 DNSGTITYEELKAGLARLGSKLTEAEVQQLMEA---ADVDGNGTIDYIEFITATMHR--H 451
+SG I ++ + +L+E E+ L E D D +GTI + E + R
Sbjct: 1 HSSGHIDDDDKH-----MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDG-LKRVGS 54
Query: 452 KLERDDHLYKAFQHFDKDNSG 472
+L + + D D SG
Sbjct: 55 EL-MESEIKDLMDAADIDKSG 74
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 69/307 (22%), Positives = 113/307 (36%), Gaps = 56/307 (18%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQHLSGQP 140
LG G + Y +TG A K + K D ++ I REI +M+ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAI-REISLMKELK-HE 63
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGG-----ELFDRIIAKGHYSERAAASICRSIVNVVHI 195
NIV + + +V E + ++ +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL 254
CH ++HRDLKP+N L++ + + LK DFGL+ F + V + +Y AP+VL
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IF-------DAILQGDID-- 299
R Y IDIWS G IL +++G P F ++ IF +++
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 300 -----------------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
+ + + D + +L +P R+++ Q L HPW E
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300
Query: 343 GEASDKP 349
+
Sbjct: 301 YHHASMG 307
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 42/100 (42%), Positives = 61/100 (61%), Gaps = 3/100 (3%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+A+ L+ E+I K+ F+ D D GTIT +EL + LG TEAE+Q ++ D DG
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 435 NGTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
NGTID+ EF+T M R + D + + +AF+ FDKD +G
Sbjct: 61 NGTIDFPEFLTM-MARKMKDTDSEEEIREAFRVFDKDGNG 99
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-23
Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ + + + S EE +++ F D D +G I+ EL+ + LG KLT+ EV +++
Sbjct: 72 MMARKMKDTDSEEE---IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 128
Query: 430 ADVDGNGTIDYIEFI---TATM-HRHKLERDDHLYKAFQHFDKDNSG 472
AD+DG+G ++Y EF+ TA R + + + K
Sbjct: 129 ADIDGDGQVNYEEFVQMMTAKGGGGGAAARKEVIRNKIRAIGKMARV 175
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ +F ID + G ++YEE+KA +++ + E +Q + ++ D DGNG ID EF
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61
Query: 447 TMHRHK---LERDDHLYKAFQHFDKDNSG 472
+ L ++ D D G
Sbjct: 62 YGSIQGQDLSDDKIGLKVLYKLMDVDGDG 90
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 2e-12
Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
+++ GLK ++ +D D G +T EE+ + + G +V + + AD +G+G I
Sbjct: 71 SDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHG----IEKVAEQVMKADANGDGYITL 126
Query: 441 IEFIT 445
EF+
Sbjct: 127 EEFLE 131
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 137 bits (349), Expect = 3e-39
Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
+++ K+ F D++ +G IT E L+ L + G ++ A ++ AD GNG I +
Sbjct: 3 DQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFP 62
Query: 442 EFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
EF++ M R + D L +AF+ FD + +G
Sbjct: 63 EFLSM-MGRRMKQTTSEDILRQAFRTFDPEGTG 94
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 4e-13
Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 4/76 (5%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ + + + S + + +Q F D + +G I L+ L LG +L E + +
Sbjct: 67 MMGRRMKQTTSEDIL---RQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGI 123
Query: 430 ADVDGNGTIDYIEFIT 445
+ + G I Y FI
Sbjct: 124 TETE-KGQIRYDNFIN 138
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 76/294 (25%), Positives = 119/294 (40%), Gaps = 41/294 (13%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y LG GQF Y + +T + A K I + KD I REI+++Q L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQEL 69
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
S PNI+ A+ K ++ +V + + + + + +
Sbjct: 70 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
H ++HRDLKP N LL LK DFGL+ F + Y V + +Y APE+
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI-------------L 294
L R YG +D+W+ G IL LL VP +++ IF+ + L
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243
Query: 295 QGDIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ F+S P + DL++ + +P RIT+ Q L+ +
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 46/290 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G + T A K + +L +D + + REI +++ L NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---RL--DDDDEGVPSSALREICLLKELK-HKNI 63
Query: 143 VEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
V + + +V E C + FD G S ++ + CH
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRR 257
V+HRDLKP+N L++ E LK +FGL+ F + Y V + +Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 258 YGKEIDIWSAGVILYILLS-GVPPFWAETEKG----IFDAI-------------LQGDID 299
Y ID+WSAG I L + G P F IF + L
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 300 FESAP--------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ P P ++++ +DL++ +L +P +RI++ + L+HP+ +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 88/297 (29%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +++G G +GV Y N+ G FA K I +L + + + I REI I++ L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKI---RL--EKEDEGIPSTTIREISILKEL 57
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV+ K+ + +V E +L D +G A S ++N +
Sbjct: 58 K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIA 114
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH V+HRDLKP+N L++ + E LK DFGL+ F + Y + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG----DI--DFE 301
L ++Y IDIWS G I +++G P F +E IF + G +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL--GTPNSKNWPNVT 229
Query: 302 SAPW-----------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P + S DL+ +ML DP +RIT+ Q LEH + KE
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 71/321 (22%), Positives = 125/321 (38%), Gaps = 66/321 (20%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQ 134
Y +LG G + Y T A K I + + ++ I RE+ +++
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAI-REVSLLK 55
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELC---------AGGELFDRIIAKGHYSERAAASI 185
L NIV ++S+ +V E G + + K
Sbjct: 56 DLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK---------LF 105
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVG 244
++ + CH V+HRDLKP+N L++ + E LK DFGL+ K Y + V
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVV 162
Query: 245 SAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAI----- 293
+ +Y P++L Y +ID+W G I Y + +G P F T + IF +
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 294 --------LQG--DIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ ++ P + S DL+ ++L + + RI++ ++H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 337 PWIKEGGEASDK-PIDSAVLS 356
P+ GE K P +++ +
Sbjct: 283 PFFLSLGERIHKLPDTTSIFA 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 38/277 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
Y++++ + +GRG FGV + A K ++ +++++ E++
Sbjct: 6 DYKEIE----VEEVVGRGAFGVVCKAKWR--AKDVAIK-----QIESESERKAFIVELRQ 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSI 189
+ ++ PNIV+ GA V +VME GG L++ + +Y+ A S C
Sbjct: 55 LSRVN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 190 ---VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
V +H ++HRDLKP N LL + LK DFG + I+ GSA
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQTHMTNN--KGSA 167
Query: 247 YYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFW--AETEKGIFDAILQGDIDFESA 303
++APEV Y ++ D++S G+IL+ +++ PF I A+ G
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------ 221
Query: 304 PWPTISSSA----KDLVRRMLTQDPKKRITSAQVLEH 336
P + + + L+ R ++DP +R + ++++
Sbjct: 222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-39
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNG 436
LS E I K F D D G I+ +EL + LG T+ E+ ++E D DG+G
Sbjct: 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 71
Query: 437 TIDYIEFITATMHRHKLE----RDDHLYKAFQHFDKDNSG 472
TID+ EF+ + + K + ++ L F+ FDK+ G
Sbjct: 72 TIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADG 111
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-16
Identities = 21/76 (27%), Positives = 39/76 (51%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ ++ + E+ + + L F D + G I EEL L G +TE +++ LM+
Sbjct: 81 MMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKD 140
Query: 430 ADVDGNGTIDYIEFIT 445
+D + +G ID+ EF+
Sbjct: 141 SDKNNDGRIDFDEFLK 156
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 27/94 (28%), Positives = 54/94 (57%), Gaps = 1/94 (1%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
+ E+ Q +++ F D D +GTI +ELK + LG + + E+++++ D +G G ++
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMN 60
Query: 440 YIEFIT-ATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ +F+T T + + + + KAF+ FD D +G
Sbjct: 61 FGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETG 94
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 2e-15
Identities = 24/77 (31%), Positives = 43/77 (55%), Gaps = 3/77 (3%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+ + ++E + EEI + F D D +G I+++ LK LG LT+ E+Q++++
Sbjct: 66 TVMTQKMSEKDTKEEI---LKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMID 122
Query: 429 AADVDGNGTIDYIEFIT 445
AD DG+G + EF+
Sbjct: 123 EADRDGDGEVSEQEFLR 139
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 26/103 (25%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 376 AENLSTEEIQGLKQMFTNIDT-DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
LS+ +++ L+ F + +T + SG ++ +++ L LG + T++ ++QL++ D G
Sbjct: 4 VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFG 63
Query: 435 NGTIDYIEFITATM-----HRHKLERDDHLYKAFQHFDKDNSG 472
NG ID+ F + + L +AF+ +DK+ +G
Sbjct: 64 NGDIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNG 106
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 20/75 (26%), Positives = 40/75 (53%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
A + E + Q L++ F D + +G I+ + ++ LA L L+ ++ +++
Sbjct: 77 ARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEI 136
Query: 431 DVDGNGTIDYIEFIT 445
D DG+GT+D+ EF+
Sbjct: 137 DADGSGTVDFEEFMG 151
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 4e-38
Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +++G G +GV Y +S GR A K I +L + + I REI +++ L
Sbjct: 23 YQKLEKVGEGTYGVVYKAK-DSQGRIVALKRI---RL--DAEDEGIPSTAIREISLLKEL 76
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
PNIV ++ + +V E ++ D K + ++ V
Sbjct: 77 H-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVA 133
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH ++HRDLKP+N L++S LK DFGL+ F + Y V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG----DI--DFE 301
L ++Y +DIWS G I +++G P F T+ IF + G +
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL--GTPNPREWPQVQ 248
Query: 302 SAPW------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P P DL+ ML DP KRI++ + HP+ K+
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 21/126 (16%)
Query: 368 KKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAG-----LARLGSKLTEAE 422
K A+K+ + + I+ K MF +D + +G IT +E+ + A+L + + +
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 423 VQQLMEAADVDGNGT-----IDYIEFIT-----ATMHRHKLERDDH------LYKAFQHF 466
Q+ A G G I + +F+ AT K R++ F F
Sbjct: 63 RHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIF 122
Query: 467 DKDNSG 472
DKD SG
Sbjct: 123 DKDGSG 128
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 9e-18
Identities = 25/95 (26%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 363 AMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
+L LK A N T + +F D D SGTIT +E KA G ++ +
Sbjct: 91 GWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQED 150
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457
+ D+D G +D E H D
Sbjct: 151 CEATFRHCDLDNAGDLDVDEMT--RQHLGFWYTLD 183
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 132 bits (336), Expect = 2e-37
Identities = 43/99 (43%), Positives = 60/99 (60%), Gaps = 3/99 (3%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
AE L+ E+I K+ F D D GTIT +EL + LG TEAE+Q ++ D DGN
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 436 GTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
GTID+ EF++ M R E+D + L +AF+ FD+D +G
Sbjct: 61 GTIDFPEFLSL-MARKMKEQDSEEELIEAFKVFDRDGNG 98
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 9e-16
Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 23/137 (16%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
+ K+L V R L Q+P + A++ + I E + ID +F ++ K
Sbjct: 28 TTKELGTVMRSLGQNPTE----AELQDM--INEVDADGNGTID------FPEFLSLMARK 75
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+ E S EE+ + F D D +G I+ EL+ + LG KLT+ EV +++
Sbjct: 76 ------MKEQDSEEEL---IEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIR 126
Query: 429 AADVDGNGTIDYIEFIT 445
AD+DG+G I+Y EF+
Sbjct: 127 EADIDGDGHINYEEFVR 143
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK----DDIKR 128
+++ + K++G+G FG+ + A KS+ + + + +R
Sbjct: 17 ADNEIE----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICR 187
E+ IM +L+ PNIV+ G +VME G+L+ R++ K H +
Sbjct: 73 EVFIMSNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 188 SI---VNVVHICHFMGVMHRDLKPENFLLSSKDENA--LLKATDFGLSVFIEEGKVYRDI 242
I + + + ++HRDL+ N L S DENA K DFGLS + +
Sbjct: 130 DIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGL 186
Query: 243 VGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
+G+ ++APE + Y ++ D +S +ILY +L+G PF E I
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---DEYSYGKIKFINMIR 243
Query: 300 FESAPWPTISSSA----KDLVRRMLTQDPKKRITSAQVLEH 336
E PTI ++++ + DPKKR + +++
Sbjct: 244 EEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-37
Identities = 75/303 (24%), Positives = 118/303 (38%), Gaps = 53/303 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-------REIQIM 133
Y E+G G +G Y + +G A KS+ ++ N RE+ ++
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RV--PNGGGGGGGLPISTVREVALL 65
Query: 134 QHLSGQ--PNIVEFK-----GAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAAS 184
+ L PN+V + + V +V E D+ G
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ R + + H ++HRDLKPEN L++S +K DFGL+ +V
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVV 181
Query: 245 SAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG--- 296
+ +Y APEVL + Y +D+WS G I + P F +E IFD I G
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPP 239
Query: 297 -DI--DFESAPW---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
D S P P + S L+ MLT +P KRI++ + L+H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 339 IKE 341
+ +
Sbjct: 300 LHK 302
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 29/130 (22%), Positives = 54/130 (41%), Gaps = 6/130 (4%)
Query: 348 KPIDSAVLS--RMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTD--NSGTIT 403
K + ++VL + ++ L L S EI+ L ++F I + + G I
Sbjct: 9 KHLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLIN 68
Query: 404 YEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA-TMHRHKLERDDHLYKA 462
EE + L + K + ++ + D NG + + EF A ++ DD ++ +
Sbjct: 69 KEEFQLALFKTNKKESL-FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFS 127
Query: 463 FQHFDKDNSG 472
FQ +D G
Sbjct: 128 FQLYDLKQQG 137
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 26/108 (24%), Positives = 40/108 (37%), Gaps = 17/108 (15%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLTEAEVQQL 426
AL V N ++ + F D G I +E+ A LA G L + ++ +
Sbjct: 110 ALSVFHPNAPIDD--KIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDI 167
Query: 427 ----MEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ-HFDKD 469
E AD +G ID E+ + + R L K + KD
Sbjct: 168 IDKTFEEADTKHDGKIDKEEWRSL------VLRHPSLLKNMTLQYLKD 209
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 50/319 (15%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTN-TILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
HH P L + I P+ D+ +++G G FG +
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDI---PWCDLN----IKEKIGAGSFGTVHR 55
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
+ G A K + ++ ++ RE+ IM+ L PNIV F GA ++ +
Sbjct: 56 AEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSI 111
Query: 158 VMELCAGGELFDRII---AKGHYSERAAASICRSI---VNVVHICHFMGVMHRDLKPENF 211
V E + G L+ + A+ ER S+ + +N +H + ++HR+LK N
Sbjct: 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNL 170
Query: 212 LLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVLR-RRYGKEIDIWSAGV 269
L+ D+ +K DFGLS + G+ ++APEVLR ++ D++S GV
Sbjct: 171 LV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW--------PTISSSA----KDLVR 317
IL+ L + P+ G+++ I + ++
Sbjct: 228 ILWELATLQQPW--------------GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 318 RMLTQDPKKRITSAQVLEH 336
T +P KR + A +++
Sbjct: 274 GCWTNEPWKRPSFATIMDL 292
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 78/339 (23%), Positives = 127/339 (37%), Gaps = 73/339 (21%)
Query: 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
+ + + G+G FG L E STG A K + D
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRN 64
Query: 128 REIQIMQHLSGQ--PNIVEFK-----GAYEDKQSV--HVVMELCAGGELFDRIIAKGHYS 178
RE+QIMQ L+ PNIV+ + D++ + +VVME + R +Y
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCR--NYY 120
Query: 179 ERAAASICRSIVNVVHICHFM---------------GVMHRDLKPENFLLSSKDENALLK 223
R + + I F+ V HRD+KP N L++ + LK
Sbjct: 121 RR------QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLK 172
Query: 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPF 281
DFG + + + + S YY APE++ + Y +DIWS G I ++ G P F
Sbjct: 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 282 WAETEKGIFDAILQ--G-----DIDF-------------ESAPW--------PTISSSAK 313
+ G I++ G + + PW + A
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
DL+ +L P++R+ + L HP+ E + + K ++
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNN 331
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 55/313 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTE-NSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQH 135
Y E+G G +G + + + GR A K + ++ + ++ + RE+ +++H
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RV--QTGEEGMPLSTIREVAVLRH 67
Query: 136 LSGQ--PNIVEFK-----GAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASIC 186
L PN+V + + + +V E D++ + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMM 126
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
++ + H V+HRDLKP+N L++S + +K DFGL+ +V +
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTL 183
Query: 247 YYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG----D 297
+Y APEVL + Y +D+WS G I + P F ++ I D I G +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI--GLPGEE 241
Query: 298 I--DFESAPW---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ P I KDL+ + LT +P KRI++ L HP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 341 EGGEASDKPIDSA 353
+ ++ ++
Sbjct: 302 D----LERCKENL 310
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 26/125 (20%), Positives = 56/125 (44%), Gaps = 6/125 (4%)
Query: 353 AVLSRMKQFRAMNKLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTD--NSGTITYEELK 408
+S+ K+ AM +++A + EE++ L ++F + + + G I EE +
Sbjct: 3 CSVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQ 62
Query: 409 AGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA-TMHRHKLERDDHLYKAFQHFD 467
L R ++ ++ + DV NG I++ EF+ + + + + AF+ +D
Sbjct: 63 LALFRNRNR-RNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYD 121
Query: 468 KDNSG 472
+G
Sbjct: 122 LRQTG 126
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 23/102 (22%), Positives = 35/102 (34%), Gaps = 16/102 (15%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLTEAEVQQL 426
+L V + E +K F D +G I EEL A L L+E ++ +
Sbjct: 99 SLGVFHPSAPVHE--KVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVM 156
Query: 427 ----MEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
AD +G ID E+ + + L K
Sbjct: 157 VDKAFVQADRKNDGKIDIDEWKDF------VSLNPSLIKNMT 192
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-35
Identities = 27/103 (26%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 346 SDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYE 405
+D + + F A + + L + +K++F +D D SG I +
Sbjct: 3 TDLLSAEDIKKAIGAFTAADSFDHKKFFQMV-GLKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 406 ELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
EL + L L+ E + LM A D DG+G I EF T
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFST 104
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-09
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L+ ++++ + A + D+ +F K + D + K F DKD SG
Sbjct: 2 MTDLLSAEDIKKAIGAFTAAD--SFDHKKFFQMVGL--KKKSADDVKKVFHILDKDKSG 56
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 81/346 (23%), Positives = 132/346 (38%), Gaps = 104/346 (30%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS-------KRKLVTKNDKDDIKR 128
D+ Y K LG G G+ + +N ++ A K I K L R
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----------R 57
Query: 129 EIQIMQHLSGQPNIVE--------------FKGAYEDKQSVHVVMELCAGGELFDRIIAK 174
EI+I++ L NIV+ G+ + SV++V E +L ++ +
Sbjct: 58 EIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQ 114
Query: 175 GHYSERAAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENAL 221
G E H FM V+HRDLKP N +++ E+ +
Sbjct: 115 GPLLE-------------EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLV 159
Query: 222 LKATDFGLSVFIEEGKVYRDI----VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILL 275
LK DFGL+ ++ ++ + + +Y +P +L Y K ID+W+AG I +L
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 276 SGVPPFWAETEKG---------IFDAI---LQGDIDF---------ESAPW--------- 305
+G F G I ++I + D +
Sbjct: 220 TGKTLF-----AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274
Query: 306 -PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
P IS A D + ++LT P R+T+ + L HP++ D+PI
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 91/334 (27%), Positives = 135/334 (40%), Gaps = 88/334 (26%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--------KRKLVTKNDKDDIK 127
DV Y+ +G G +G+ +N + A K IS +R L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL---------- 73
Query: 128 REIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
REI+I+ NI+ E + V++V +L +L +++ H S
Sbjct: 74 REIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDL-METDL-YKLLKTQHLSN--- 127
Query: 183 ASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGL 229
HIC+F+ V+HRDLKP N LL + LK DFGL
Sbjct: 128 ----------DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGL 174
Query: 230 SVFIEEGKVYRDI----VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWA 283
+ + + V + +Y APE++ + Y K IDIWS G IL +LS P F
Sbjct: 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 284 ETEKGIFDAIL-------QGDIDF----------ESAPW----------PTISSSAKDLV 316
+ + IL Q D++ S P P S A DL+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 294
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+MLT +P KRI Q L HP++++ + SD+PI
Sbjct: 295 DKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
D+ G+ LG+G FG T TG K + + + + +E+++
Sbjct: 8 RPSDLIH----GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKV 60
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVN 191
M+ L PN+++F G + ++ + E GG L I Y S + I +
Sbjct: 61 MRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD---------- 241
+ H M ++HRDL N L+ EN + DFGL+ + + K +
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 242 -----IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPF 281
+VG+ Y++APE++ R Y +++D++S G++L ++ V
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-34
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
+EI+ L + F +D DNSG+++ EE + L VQ++++ D DGNG +D+
Sbjct: 3 DEIKRLGKRFKKLDLDNSGSLSVEEFMS----LPELQQNPLVQRVIDIFDTDGNGEVDFK 58
Query: 442 EFITATMHRHK-LERDDHLYKAFQHFDKDNSG 472
EFI +++ L AF+ +D D G
Sbjct: 59 EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDG 90
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 5/65 (7%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARL-GSKLTEAEVQQL----MEAADVDGNGTIDYI 441
L+ F D D G I+ EL L + G+ L + ++QQ+ + AD DG+G I +
Sbjct: 77 LRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFE 136
Query: 442 EFITA 446
EF
Sbjct: 137 EFCAV 141
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 68/308 (22%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G+G FG + TG++ A K K++ +N+K+ REI+I+Q L N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLK-HENV 78
Query: 143 VEFKG--------AYEDKQSVHVVMELC----AGGELFDRIIAKGHYSERAAASICRSIV 190
V K S+++V + C AG L + ++ + + ++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQMLL 134
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-----EEGKVYRDIVGS 245
N ++ H ++HRD+K N L++ LK DFGL+ + Y + V +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 246 AYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDI- 298
+Y PE+L R YG ID+W AG I+ + + P TE+ I L G I
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ--LCGSIT 249
Query: 299 -----------DFESA--------------PWPTISSSAKDLVRRMLTQDPKKRITSAQV 333
+E A DL+ ++L DP +RI S
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 334 LEHPWIKE 341
L H +
Sbjct: 310 LNHDFFWS 317
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-34
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 4/103 (3%)
Query: 346 SDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYE 405
+D S + + ++ +A + I+ +S + LK++F +D D SG I +
Sbjct: 3 TDILSPSDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEED 61
Query: 406 ELKAGLARLGS---KLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
ELK L R S LT +E + + AAD DG+G I EF
Sbjct: 62 ELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQE 104
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-11
Identities = 10/59 (16%), Positives = 21/59 (35%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L L+ +++ + D + +F + + L + F+ D D SG
Sbjct: 2 LTDILSPSDIAAALR--DCQAPDSFSPKKFFQISGM--SKKSSSQLKEIFRILDNDQSG 56
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 66/286 (23%), Positives = 117/286 (40%), Gaps = 45/286 (15%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQ 131
+ ++ + +G G FG Y G + A K+ +++++E +
Sbjct: 5 DFAELT----LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI-- 189
+ L PNI+ +G + ++ +VME GG L +++ + I
Sbjct: 59 LFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIAR 116
Query: 190 -VNVVHICHFMGVMHRDLKPENFLLSSKDE-----NALLKATDFGLSVFIEEGKVYRDIV 243
+N +H + ++HRDLK N L+ K E N +LK TDFGL+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAA 175
Query: 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302
G+ ++APEV+R + K D+WS GV+L+ LL+G PF ID +
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------------RGIDGLA 221
Query: 303 APW--------PTISSSAKDLVRRMLTQ----DPKKRITSAQVLEH 336
+ I S+ + +++ DP R + +L+
Sbjct: 222 VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 73/365 (20%), Positives = 127/365 (34%), Gaps = 84/365 (23%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSI---SKRKLVTKNDKDDIKREI 130
E YS GK LG G FG+ + +G++FA K + + K RE+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------REL 51
Query: 131 QIMQHLSGQPNIVEFKGAY---EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR 187
IM+ L NI++ + D++ H+
Sbjct: 52 DIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 188 SIVNVV-------------------------HICHFM-------------GVMHRDLKPE 209
+NV+ I ++ G+ HRD+KP+
Sbjct: 111 KYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSA 267
N L++S ++ LK DFG + + + + S +Y APE++ Y ID+WS
Sbjct: 171 NLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 268 GVILYILLSGVPPFWAETEKGIFDAILQ-------GDIDF-------------ESAPWPT 307
G + L+ G P F ET I+Q + ++ W
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 308 I-----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
I S A DL+ ++L +P RI + + HP+ + + + + +
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQ 348
Query: 363 AMNKL 367
+ +L
Sbjct: 349 NIPQL 353
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 72/331 (21%), Positives = 124/331 (37%), Gaps = 74/331 (22%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----DKDDIK--- 127
++ Y+ + + G +G +S G A K + + D K
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 128 REIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
REI+++ H PNI+ + +++V EL +L ++I
Sbjct: 78 REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDL-AQVIHDQ------- 127
Query: 183 ASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGL 229
R +++ HI +FM GV+HRDL P N LL +N + DF L
Sbjct: 128 ----RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNL 180
Query: 230 SVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
+ V +Y APE++ + + K +D+WSAG ++ + + F T
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 288 GIFDAILQ----------GDIDFESA--------------PW----PTISSSAKDLVRRM 319
+ I++ SA W PT A DL+ +M
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 320 LTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
L +P++RI++ Q L HP+ + + D
Sbjct: 301 LEFNPQRRISTEQALRHPYFESLFDPLDLTE 331
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 69/323 (21%), Positives = 118/323 (36%), Gaps = 89/323 (27%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
++ Y +G G +G + +G + A K +S KR
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--------- 71
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+ +++H+ N++ + + ++VM +L +I+
Sbjct: 72 -RELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDL-QKIM-------- 119
Query: 181 AAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDF 227
+ I + + GV+HRDLKP N + +E+ LK DF
Sbjct: 120 ------GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDF 170
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAET 285
GL+ + V + +Y APEV+ Y + +DIWS G I+ +L+G F +
Sbjct: 171 GLARHADAEMT--GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228
Query: 286 EKGIFDAILQ-------GDIDF----------------ESAPW----PTISSSAKDLVRR 318
IL+ + + P S A DL+ +
Sbjct: 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288
Query: 319 MLTQDPKKRITSAQVLEHPWIKE 341
ML D KR+T+AQ L HP+ +
Sbjct: 289 MLELDVDKRLTAAQALTHPFFEP 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 87/338 (25%), Positives = 128/338 (37%), Gaps = 106/338 (31%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--------KRKLVTKNDKDDIK 127
++ + LG G +GV T TG A K I R L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------- 57
Query: 128 REIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
REI+I++H NI+ ++E+ V+++ EL +L R+I+ S+
Sbjct: 58 REIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDL-HRVISTQMLSD--- 111
Query: 183 ASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGL 229
HI +F+ V+HRDLKP N L+ + N LK DFGL
Sbjct: 112 ----------DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGL 158
Query: 230 SVFIEEGKVYRDIVGSA-----------YYVAPEVL--RRRYGKEIDIWSAGVILYILLS 276
+ I+E +Y APEV+ +Y + +D+WS G IL L
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 277 GVPPFWAETEKG---------IFDAI----LQGDIDF---ESA-------------PW-- 305
P F G IF I D+ A P
Sbjct: 219 RRPIF-----PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK 273
Query: 306 --PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P ++ DL++RML DP KRIT+ + LEHP+++
Sbjct: 274 MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 74/324 (22%), Positives = 116/324 (35%), Gaps = 76/324 (23%)
Query: 84 GKELGRGQFGVTY--LCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLS 137
G ++GRG +G Y + + +A K + + I REI +++ L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALK---------QIEGTGISMSACREIALLRELK 76
Query: 138 GQPNIVEFKGAYEDKQ--SVHVVME--------LCAGGELFDRIIAKGHYSERAAASICR 187
PN++ + + V ++ + + S+
Sbjct: 77 -HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGLS-VFIEEGKVYRDIVGS 245
I++ +H H V+HRDLKP N L+ + E +K D G + +F K D+
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 246 A---YYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--- 297
+Y APE+L R Y K IDIW+ G I LL+ P F E D
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 298 -I-------------DFESAPW--------------------------PTISSSAKDLVR 317
I D + P S A L++
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315
Query: 318 RMLTQDPKKRITSAQVLEHPWIKE 341
++LT DP KRITS Q ++ P+ E
Sbjct: 316 KLLTMDPIKRITSEQAMQDPYFLE 339
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P+E ++ G+ +G+G+FG Y + A + I + ++ KRE+
Sbjct: 31 PFEQLE----IGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKREVMA 82
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVN 191
+ N+V F GA + ++ LC G L+ + AK I + IV
Sbjct: 83 YRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS------VFIEEGKVYRDIVGS 245
+ H G++H+DLK +N +N + TDFGL R G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 246 AYYVAPEVLRRR----------YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
++APE++R+ + K D+++ G I Y L + PF + + I +
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 296 G---DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
G ++ + D++ + ++R T ++++
Sbjct: 258 GMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 23/106 (21%), Positives = 45/106 (42%), Gaps = 3/106 (2%)
Query: 368 KKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQL 426
++ + + T+E + F + SG T E K L G ++ + Q+
Sbjct: 5 NGKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62
Query: 427 MEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
D + +G +D++EFI A + + + L F+ +D D +G
Sbjct: 63 YNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNG 108
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 21/91 (23%), Positives = 33/91 (36%), Gaps = 13/91 (14%)
Query: 387 LKQMFTNIDTDNSGTITYEELKA------GLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
LK F D D +G+I EL L + E + + D++ +G +
Sbjct: 95 LKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTL 154
Query: 441 IEFITATMHRHKLERDDHLYKAFQH-FDKDN 470
EFI + +D L + FD N
Sbjct: 155 EEFING------MAKDQDLLEIVYKSFDFSN 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 62/319 (19%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
+V Y +G G +G + TG + A K +S KR
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--------- 76
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+++++H+ N++ + E+ V++V L G +L + I+ ++
Sbjct: 77 -RELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDD 132
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ I+ + H ++HRDLKP N + +E+ LK DFGL+ +
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADEMT-- 187
Query: 241 DIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--- 295
V + +Y APE++ Y + +DIWS G I+ LL+G F IL+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 296 ----GDIDF----------ESAPW----------PTISSSAKDLVRRMLTQDPKKRITSA 331
+ +S + A DL+ +ML D KRIT+A
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 332 QVLEHPWIKEGGEASDKPI 350
Q L H + + + D+P+
Sbjct: 308 QALAHAYFAQYHDPDDEPV 326
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 68/332 (20%), Positives = 124/332 (37%), Gaps = 88/332 (26%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
+V+ Y + +G G +G + TG + A K + KR
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--------- 72
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+++++H+ N++ +D ++VM G +L +++ E
Sbjct: 73 -RELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDL-GKLMKHEKLGE- 127
Query: 181 AAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDF 227
I + G++HRDLKP N + +E+ LK DF
Sbjct: 128 ------------DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF 172
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAET 285
GL+ + V + +Y APEV+ RY + +DIWS G I+ +++G F
Sbjct: 173 GLARQADSEMT--GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230
Query: 286 EKGIFDAILQ-------GDIDF----------------ESAPW----PTISSSAKDLVRR 318
I++ + E + S A +L+ +
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
ML D ++R+T+ + L HP+ + + D+P
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 66/326 (20%), Positives = 116/326 (35%), Gaps = 78/326 (23%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK---REIQIMQHLS---- 137
++LG G F +L + A K + + DK + EI+++Q ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-------IVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 138 ------GQPNIVEFKGA--YEDKQSVHV--VMELCAGGELFDRIIAKGH--YSERAAASI 185
G +I++ ++ VHV V E+ G L I H I
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 186 CRSIVNVVHICH-FMGVMHRDLKPENFLLSSKDENAL---LKATDFGLSVFIEEGKVYRD 241
+ ++ + H G++H D+KPEN L+ D +K D G + + +E
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNS 195
Query: 242 IVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG------------ 288
I + Y +PEV L +G DIWS +++ L++G F +
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 289 -------------------IFDAILQGDIDFESAPWPTISSSAK-------------DLV 316
F++ + WP + D +
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342
ML DP+KR + ++ HPW+K+
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 31/305 (10%)
Query: 37 QAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY 96
+HH P T G Y + +GRG G Y
Sbjct: 3 SSHHHHHHSSG---LVPRGSHMDGTAESREGTQFG--------PYRLRRLVGRGGMGDVY 51
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLSGQPNIVEFKGAYEDKQ 153
+ R A K + L +D R E + L +P++V E
Sbjct: 52 EAEDTVRERIVALK-LMSETLS--SDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDG 107
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
++V M L G +L + +G + A +I R I + + H G HRD+KPEN L+
Sbjct: 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167
Query: 214 SSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLRRRYGKEI----DIWSA 267
S+ D DFG++ + K+ + + VG+ YY+APE DI++
Sbjct: 168 SADDF---AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS---ESHATYRADIYAL 221
Query: 268 GVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327
+LY L+G PP+ + + A + I S P I + ++ R + ++P+ R
Sbjct: 222 TCVLYECLTGSPPYQGDQL-SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
Query: 328 ITSAQ 332
+
Sbjct: 281 YVTCG 285
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 23/104 (22%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
A + L ++IQ +K+ F+ ID D G ++ E++KA +LG + E+ +++
Sbjct: 4 AASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK-- 61
Query: 431 DVDGNGTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
+ G +++ F++ D + + AF FD+ +
Sbjct: 62 --EAPGPLNFTMFLSI-FSDKLSGTDSEETIRNAFAMFDEQETK 102
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 6e-15
Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 30/148 (20%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
S +D+ + L + P ++ +KE P++ F ++ K
Sbjct: 36 SKEDIKAISEQLGRAPDD----KELTAM--LKEA----PGPLN------FTMFLSIFSDK 79
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
++ S E I + F D + + E +K L +G + E++ +
Sbjct: 80 ------LSGTDSEETI---RNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFK 130
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERD 456
A V+G G DY++F M + E +
Sbjct: 131 EAPVEG-GKFDYVKFT--AMIKGSGEEE 155
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-32
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 351 DSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAG 410
+ + +++ + + + LS +K +F ID D SG + +ELK
Sbjct: 8 AEDIAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYF 66
Query: 411 LARLGS---KLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
L + S +LTE+E + LM+AAD DG+G I EF
Sbjct: 67 LQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQE 104
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-09
Identities = 10/59 (16%), Positives = 21/59 (35%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L+ ++ ++ T + +F T K+ + F+ D D SG
Sbjct: 2 ITDILSAEDIAAALQE--CQDPDTFEPQKFF-QTSGLSKMSASQ-VKDIFRFIDNDQSG 56
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 76/320 (23%), Positives = 120/320 (37%), Gaps = 71/320 (22%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
V Y K +G G G+ + R A K +S KR
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--------- 109
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+ +M+ + NI+ E+ Q V++VMEL L ++I +
Sbjct: 110 -RELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANL-CQVI-QMELDHE 164
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ + ++ + H G++HRDLKP N ++ + LK DFGL+ +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMT 221
Query: 241 DIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPF------------------ 281
V + YY APEV L Y + +DIWS G I+ ++ F
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 282 -WAETEKGI------------------FDAILQGDIDF-ESAPWPTISSSAKDLVRRMLT 321
E K + F + + +S +S A+DL+ +ML
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 322 QDPKKRITSAQVLEHPWIKE 341
DP KRI+ L+HP+I
Sbjct: 342 IDPAKRISVDDALQHPYINV 361
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 43/287 (14%), Positives = 96/287 (33%), Gaps = 53/287 (18%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
++ + F +L G + G K + R + D E
Sbjct: 8 DFKQLN----FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPR 60
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVH--VVMELCAGGELFDRIIAKGHY--SERAAASICRS 188
++ S PN++ GA + + H ++ G L++ + ++ + A
Sbjct: 61 LRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 189 I---VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
+ + +H + + L + ++ DE+ + + + + + +
Sbjct: 120 MARGMAFLHTLEPL-IPRHALNSRSVMI---DEDMTARISMADVKFSFQSPGR----MYA 171
Query: 246 AYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
+VAPE L+++ + D+WS V+L+ L++ PF D+
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF--------------ADLSNM 217
Query: 302 SAPW------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
P IS L++ + +DP KR ++
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 79/320 (24%), Positives = 125/320 (39%), Gaps = 71/320 (22%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
V Y K +G G G+ + R A K +S KR
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--------- 72
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+ +M+ + NI+ + E+ Q V++VMEL L ++I ER
Sbjct: 73 -RELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANL-CQVIQMELDHER 128
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ + + + + H+ H G++HRDLKP N ++ + LK DFGL+ +
Sbjct: 129 MSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMT 184
Query: 241 DIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPF------------------ 281
V + YY APEV L Y + +DIWS G I+ ++ G F
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244
Query: 282 -WAETEKGI------------------FDAILQG-DIDFESAPWPTISSSAKDLVRRMLT 321
E K + F+ + +S +S A+DL+ +ML
Sbjct: 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304
Query: 322 QDPKKRITSAQVLEHPWIKE 341
D KRI+ + L+HP+I
Sbjct: 305 IDASKRISVDEALQHPYINV 324
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 28/141 (19%), Positives = 55/141 (39%), Gaps = 4/141 (2%)
Query: 333 VLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFT 392
VL +++ G + ++ +V ++ ++ + L L + +E+Q L + F
Sbjct: 16 VLFVKLLEQFG-LIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFK 74
Query: 393 NIDTDNSGTITYEELKAGLARLGSKLTEAE-VQQLMEAADVDGNGTIDYIEFITATMHRH 451
N SG + E K ++ + L A D D NG + + +FI
Sbjct: 75 NEC--PSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILL 132
Query: 452 KLERDDHLYKAFQHFDKDNSG 472
+ + L AF +D + G
Sbjct: 133 RGTVQEKLNWAFNLYDINKDG 153
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 20/93 (21%), Positives = 37/93 (39%), Gaps = 18/93 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLTEAE--------VQQLMEAADVDG 434
L F D + G IT EE+ KA +G V+ + D +
Sbjct: 140 LNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNK 199
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
+G + EFI + ++D+++ ++ Q F+
Sbjct: 200 DGVVTIDEFIES------CQKDENIMRSMQLFE 226
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 21/109 (19%), Positives = 46/109 (42%), Gaps = 2/109 (1%)
Query: 365 NKLKKLALKVIAENLSTEEIQGLKQMFTN-IDTDNSGTITYEELKAGLARLGSKLTEAEV 423
+ + + + L++ + ++ SGT+ E K ++ V
Sbjct: 3 QQFSWEEAEEN-GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 61
Query: 424 QQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + A D +G+ TID++E++ A + + L F+ +DKD +G
Sbjct: 62 EAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNG 110
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 20/95 (21%), Positives = 31/95 (32%), Gaps = 23/95 (24%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLT-----------------EAEVQQLMEA 429
LK F D D +G I +EL + + E V ++
Sbjct: 97 LKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLL 156
Query: 430 ADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
D +G+G + EF+ RD + K Q
Sbjct: 157 VDENGDGQLSLNEFVEGAR------RDKWVMKMLQ 185
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 71/266 (26%), Positives = 116/266 (43%), Gaps = 24/266 (9%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLS 137
Y +LG G YL + + A K ++ +KR E+ LS
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPR--EKEETLKRFEREVHNSSQLS 69
Query: 138 GQPNIVEFKGAY---EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV E+ ++VME G L + I + G S A + I++ +
Sbjct: 70 -HQNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPE 252
H M ++HRD+KP+N L+ D N LK DFG++ + E + + ++G+ Y +PE
Sbjct: 126 HAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 253 VLRRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAPW-PTI 308
+ + DI+S G++LY +L G PPF ET I AI +Q + + I
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKDI 240
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVL 334
S +++ R +D R + Q +
Sbjct: 241 PQSLSNVILRATEKDKANRYKTIQEM 266
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 33/192 (17%), Positives = 58/192 (30%), Gaps = 16/192 (8%)
Query: 282 WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
E K G++ + P + R T+ R WI
Sbjct: 4 TKEAVKASD-----GNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCL-----IKWILS 53
Query: 342 GGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGT 401
+ L L +L + + +E+Q L + F N +G
Sbjct: 54 SAAPQGSDSSDSELELSTVRHQPEGLDQLQAQ---TKFTKKELQSLYRGFKNEC--PTGL 108
Query: 402 ITYEELKAGLARLGSKLTEAE-VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460
+ + K ++ + L A D DGNG I + +F+ + + L
Sbjct: 109 VDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLK 168
Query: 461 KAFQHFDKDNSG 472
AF +D + G
Sbjct: 169 WAFNLYDINKDG 180
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 18/93 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLT--------EAEVQQLMEAADVDG 434
LK F D + G IT EE+ K+ +G V++ + D +
Sbjct: 167 LKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQ 226
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
+G + EF+ ++D+++ + Q F+
Sbjct: 227 DGVVTIDEFLET------CQKDENIMNSMQLFE 253
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-30
Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
LS E+ Q +K+ F DT+ +G+I Y ELK + LG + + E+ +LM D +GNG I
Sbjct: 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYI 60
Query: 439 DYIEFITATMHRHKLERD 456
+ +F+ M RD
Sbjct: 61 GFDDFLDI-MTEKIKNRD 77
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 80/376 (21%), Positives = 129/376 (34%), Gaps = 129/376 (34%)
Query: 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKN 121
G+ V Y K+LG+G +G+ + + TG A K I +R
Sbjct: 1 GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF---- 56
Query: 122 DKDDIKREIQIMQHLSGQPNIVEFKGAY--EDKQSVHVVMELCAGGELFDRIIAKGHYSE 179
REI I+ LSG NIV ++ + V++V + +L +I
Sbjct: 57 ------REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL-HAVIRANILEP 108
Query: 180 RAAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATD 226
VH + + G++HRD+KP N LL + +K D
Sbjct: 109 -------------VHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVAD 152
Query: 227 FGLSVFIEEGKVYRDIVGSA----------------------YYVAPEVL--RRRYGKEI 262
FGLS + + + + +Y APE+L +Y K I
Sbjct: 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212
Query: 263 DIWSAGVILYILLSGVPPFWAETEKG---------IFDAI---LQGDIDF---------- 300
D+WS G IL +L G P F G I I D++
Sbjct: 213 DMWSLGCILGEILCGKPIF-----PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMI 267
Query: 301 --------------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+ P + A DL+ ++L +P KRI++ L
Sbjct: 268 ESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327
Query: 335 EHPWIKEGGEASDKPI 350
+HP++ +++P
Sbjct: 328 KHPFVSIFHNPNEEPN 343
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 23/274 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P + + G+ +G G FG Y + A K + T K E+ +
Sbjct: 22 PDGQITV----GQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGV 73
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVN 191
++ NI+ F G + +V + C G L+ + ++ + + I R
Sbjct: 74 LRKTR-HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS---VFIEEGKVYRDIVGSAYY 248
+ H ++HRDLK N L E+ +K DFGL+ + + GS +
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 249 VAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESA 303
+APEV+R Y + D+++ G++LY L++G P+ + I + + +G + + +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 304 PWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
K L+ L + +R + ++L
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT 437
+ Q L + F +DTD SG I+ EL A L+ G + A ++L+ D + +G
Sbjct: 20 ARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGE 79
Query: 438 IDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I + EF +H L + + F+ D G
Sbjct: 80 ITFDEFK--DLHHFILS----MREGFRKRDSSGDG 108
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 17/89 (19%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
I +++ F D+ G + E++A L G +++E Q LM D G++ + ++
Sbjct: 92 ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDY 151
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ ++ ++ F +D++ +G
Sbjct: 152 VELSIFVCRVR------NVFAFYDRERTG 174
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 11/80 (13%), Positives = 26/80 (32%), Gaps = 11/80 (13%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
AL +S + Q + D G++ +++ + ++
Sbjct: 118 ALLSSGYQVSEQTFQ---ALMRKFDRQRRGSLGFDDYVELSIFV-CRVRNV-----FAFY 168
Query: 431 DVDGNG--TIDYIEFITATM 448
D + G T + FI ++
Sbjct: 169 DRERTGQVTFTFDTFIGGSV 188
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 70/340 (20%), Positives = 113/340 (33%), Gaps = 80/340 (23%)
Query: 87 LGRGQFGVTYLCTENSTGRQF-ACKSISKRKLVTKNDK---DDIKREIQIMQHL-----S 137
LG G FG C +++ G+ A K + +N + + EI +++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALK-------IIRNVGKYREAARLEINVLKKIKEKDKE 79
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY---SERAAASICRSIVNVVH 194
+ V + + + EL G F+ + + ++ + + + +
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 195 ICHFMGVMHRDLKPENFLLSSKD----------------ENALLKATDFGLSVFIEEGKV 238
H + H DLKPEN L + + +N ++ DFG + F E
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-HH 196
Query: 239 YRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE----------K 287
IV + +Y PEV L + + D+WS G IL+ G F
Sbjct: 197 TT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255
Query: 288 GIFD------AILQGDIDFESAPWPTISSSAK------------------------DLVR 317
G Q W SS + DL+R
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
RML DP +RIT A+ L HP+ S SR
Sbjct: 316 RMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 23/268 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLS 137
Y G+ LG G +L + R A K + + L D R E Q L+
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLA--RDPSFYLRFRREAQNAAALN 70
Query: 138 GQPNIVEF--KGAYEDKQSVHV--VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
P IV G E VME G L D + +G + + A + +
Sbjct: 71 -HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY----RDIVGSAYYV 249
+ H G++HRD+KP N ++S +K DFG++ I + ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 250 APEVLRRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAPWP 306
+PE R D++S G +LY +L+G PPF ++ + A ++ D SA
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPPSARHE 244
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVL 334
+S+ +V + L ++P+ R +A +
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 63/300 (21%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ-----HLS 137
+ +G+G++G + + G A K S R D+ RE ++ H
Sbjct: 12 LLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR------DEKSWFRETELYNTVMLRH-- 61
Query: 138 GQPNIVEFKGAYEDKQSVH----VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-- 191
NI+ F + + ++ G L+D + + I SI +
Sbjct: 62 --ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGL 118
Query: 192 ------VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--- 242
+ + HRDLK +N L+ +N D GL+V + D+
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 243 --VGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDA 292
VG+ Y+APEVL K +DIW+ G++L+ + + + F
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 293 ILQGDIDFESAPW--------PTISSSA---------KDLVRRMLTQDPKKRITSAQVLE 335
++ D FE P I + L++ Q+P R+T+ ++ +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 71/313 (22%), Positives = 113/313 (36%), Gaps = 44/313 (14%)
Query: 31 PAPAQQQAHHRPEKPGPTPAAAPVSG-LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGR 89
+ E G + P G +P+ + I+ YE +
Sbjct: 38 WNCGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQYE-------VKGCIAH 90
Query: 90 GQFGVTYLCT-ENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLSGQPNIVE- 144
G G YL N GR K LV D + E Q + + P+IV+
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEVV-HPSIVQI 144
Query: 145 --FKGAYEDKQSVHV---VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
F + D+ V VME G L A + I+ + H +
Sbjct: 145 FNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYG 259
G+++ DLKPEN +L+ +++ LK D G I + + G+ + APE++R
Sbjct: 202 GLVYNDLKPENIMLT-EEQ---LKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGPT 254
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
DI++ G L L +P G+ E P S L+RR
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRA 304
Query: 320 LTQDPKKRITSAQ 332
+ DP++R T+A+
Sbjct: 305 IDPDPRQRFTTAE 317
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 67/334 (20%), Positives = 114/334 (34%), Gaps = 84/334 (25%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK---DDIKREIQIMQHLS 137
+ +++G G FG LC + +A K V +N K K E I++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-------VVRNIKKYTRSAKIEADILKKIQ 89
Query: 138 GQP----NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVN 191
NIV++ G + + ++ E G L++ I + + C I+
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKD----------------------ENALLKATDFGL 229
++ M + H DLKPEN LL ++ +K DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 230 SVFIEEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-- 286
+ F + I + Y APEV L + D+WS G +L L +G F
Sbjct: 209 ATFKSD-YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
Query: 287 --------KGIFDA--ILQG---------DIDFESAPWPTISSSAK-------------- 313
+ + + D WP +SS
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326
Query: 314 -------DLVRRMLTQDPKKRITSAQVLEHPWIK 340
D + +L DP R + A++L+H +++
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 6/100 (6%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+ EI+ K+ FT ID + G I ++L+ A +G + E M +
Sbjct: 15 VFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAM---IKEA 71
Query: 435 NGTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
+G I++ F+T D D + AF+ D D G
Sbjct: 72 SGPINFTVFLTM-FGEKLKGADPEDVIMGAFKVLDPDGKG 110
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 17/70 (24%), Positives = 27/70 (38%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ F +D D G+I L+ L G + T E++ + A D G +DY
Sbjct: 97 IMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYV 156
Query: 447 TMHRHKLERD 456
H E +
Sbjct: 157 ITHGEDAEGE 166
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-28
Identities = 19/85 (22%), Positives = 35/85 (41%), Gaps = 2/85 (2%)
Query: 361 FRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTE 420
+ + L + EE+ L+ +F D + SG + EE +A L +
Sbjct: 3 HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRP 60
Query: 421 AEVQQLMEAADVDGNGTIDYIEFIT 445
A+ + + + D D +G I + EF
Sbjct: 61 ADAEAVFQRLDADRDGAITFQEFAR 85
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 76/328 (23%), Positives = 115/328 (35%), Gaps = 78/328 (23%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQF-ACKSISKRKLVTKNDK---DDIKREIQIMQHL 136
Y LG G FG C ++ G + A K + KN + + EIQ+++HL
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-------IVKNVDRYCEAARSEIQVLEHL 68
Query: 137 -----SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSI 189
+ V+ +E + +V EL G +D I G + + I
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKD----------------ENALLKATDFGLSVFI 233
V+ H + H DLKPEN L D N +K DFG + +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 234 EEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE------ 286
+E +V + +Y APEV L + + D+WS G IL G F
Sbjct: 188 DE-HHST-LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 287 ----KGIFD------AILQGDIDFESAPWPTISSSAK----------------------- 313
G + + W SS+ +
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305
Query: 314 -DLVRRMLTQDPKKRITSAQVLEHPWIK 340
DL+++ML DP KRIT + L+HP+
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 17/120 (14%), Positives = 37/120 (30%), Gaps = 20/120 (16%)
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKL---------TEAEV 423
+ E+L + + L + F D D+ G + +E+ R+ + V
Sbjct: 24 QFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAV 83
Query: 424 QQLMEAADVDGNGTIDYIEFITATMHRHKLERDDH-----------LYKAFQHFDKDNSG 472
+ V+ + +++ A + ER+ + D D G
Sbjct: 84 RVFFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDG 143
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 3/95 (3%)
Query: 363 AMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
A + + + + +D D GT+ +ELK + + +
Sbjct: 106 ANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEA 163
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457
E AD D +G ++ E + + +E D
Sbjct: 164 AYTFFEKADTDKSGKLERTELVHL-FRKFWMEPYD 197
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 18/100 (18%), Positives = 33/100 (33%), Gaps = 13/100 (13%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL-------GSKLTEAEVQQLMEAA----DV 432
++ F + + + E+ + + + L + D
Sbjct: 80 RDAVRVFFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDD 139
Query: 433 DGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
DG+GT+D E T M + + Y F+ D D SG
Sbjct: 140 DGDGTVDVDELKTM-MKAFDVP-QEAAYTFFEKADTDKSG 177
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 3/98 (3%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE-VQQLMEAADVDG 434
E LS E + F + SG +T E K + + V+Q+ E D +
Sbjct: 8 VEELSATECHQWYKKF--MTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNK 65
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+G ID++E++ A K + D L F+ +D D +G
Sbjct: 66 DGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNG 103
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 7/93 (7%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF--- 443
++QMF D + G I + E A L+ + + +++ + DVDGNG ID E
Sbjct: 54 VEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNI 113
Query: 444 ITATMHRHKLERD----DHLYKAFQHFDKDNSG 472
I A ++ + F D + G
Sbjct: 114 IKAIRAINRCNEAMTAEEFTNMVFDKIDINGDG 146
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-08
Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 15/94 (15%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKA------GLARLGSKLT-EAEVQQLMEAA 430
++ L+ F D D +G I EL + R +T E + +
Sbjct: 83 KGKVDQK--LRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKI 140
Query: 431 DVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
D++G+G + EF+ +++D+ L
Sbjct: 141 DINGDGELSLEEFMEG------VQKDEVLLDILT 168
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 63/328 (19%), Positives = 113/328 (34%), Gaps = 71/328 (21%)
Query: 55 SGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISK 114
SG +P TI + L + +G+G+FG + G + A K S
Sbjct: 26 SGSGSGLPLLVQRTIA----RTIVL----QESIGKGRFGEVWRGKWR--GEEVAVKIFSS 75
Query: 115 RKLVTKNDKDDIKREIQI-----MQHLSGQPNIVEFKGAYEDKQSVH----VVMELCAGG 165
R ++ RE +I ++H NI+ F A +V + G
Sbjct: 76 R------EERSWFREAEIYQTVMLRH----ENILGFIAADNKDNGTWTQLWLVSDYHEHG 125
Query: 166 ELFDRIIAKGHYSERAAASICRSIVN--------VVHICHFMGVMHRDLKPENFLLSSKD 217
LFD + + + + S + +V + HRDLK +N L+
Sbjct: 126 SLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---K 181
Query: 218 ENALLKATDFGLSVFIEEGKVYRDI-----VGSAYYVAPEVLR-------RRYGKEIDIW 265
+N D GL+V + DI VG+ Y+APEVL K DI+
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241
Query: 266 SAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPW--------PTISSSA---- 312
+ G++ + + + + + ++ D E P I +
Sbjct: 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE 301
Query: 313 -----KDLVRRMLTQDPKKRITSAQVLE 335
++R + R+T+ ++ +
Sbjct: 302 ALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 76/343 (22%), Positives = 125/343 (36%), Gaps = 86/343 (25%)
Query: 67 NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--- 123
+ + YE +K+ +G+G FG ++ + A K + +N+K
Sbjct: 92 HDHVAYRYEVLKV-------IGKGSFGQVVKAYDHKVHQHVALK-------MVRNEKRFH 137
Query: 124 DDIKREIQIMQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY- 177
EI+I++HL N++ + + + + EL L++ +I K +
Sbjct: 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQ 195
Query: 178 --SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
S SI+ + H ++H DLKPEN LL + + + K DFG S + +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFGSSCYEHQ 254
Query: 236 GKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-------- 286
+VY I S +Y APEV L RYG ID+WS G IL LL+G P E E
Sbjct: 255 -RVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312
Query: 287 --KGIFDAIL-----QGDIDFESAP------------WPTISSSAKDLVRRMLTQDPKK- 326
G+ L + S + + + ++ +
Sbjct: 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372
Query: 327 ---------------------------RITSAQVLEHPWIKEG 342
R+T Q L HPW++
Sbjct: 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 3e-28
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+IQ K+ F ID + G I E+L LA +G T+ ++ +M + G I
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMS----EAPGPI 56
Query: 439 DYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
++ F+T D D + AF FD++ SG
Sbjct: 57 NFTMFLTM-FGEKLNGTDPEDVIRNAFACFDEEASG 91
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-16
Identities = 28/141 (19%), Positives = 50/141 (35%), Gaps = 27/141 (19%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
+DL + + ++P + + E PI+ F M K
Sbjct: 25 DKEDLHDMLASMGKNPTD----EYLEGM--MSEA----PGPIN------FTMFLTMFGEK 68
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+ + I+ F D + SG I + L+ L +G + T+ EV ++
Sbjct: 69 ------LNGTDPEDVIRNAFACF---DEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYR 119
Query: 429 AADVDGNGTIDYIEFITATMH 449
A +D G +Y+EF H
Sbjct: 120 EAPIDKKGNFNYVEFTRILKH 140
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 20/94 (21%), Positives = 40/94 (42%), Gaps = 7/94 (7%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTI 438
+ + L +F +D D SG I+ EL+ L+ + V+ ++ D + +
Sbjct: 2 ALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGV 61
Query: 439 DYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
++ EF + + F+ +D+DNSG
Sbjct: 62 NFSEFTGVWKYITDWQ------NVFRTYDRDNSG 89
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-22
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
I + +F D DNSG I ELK L+ G +L++ L+ D G G I + +F
Sbjct: 73 ITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDF 132
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I + L+R L F+ +D D G
Sbjct: 133 IQGCIV---LQR---LTDIFRRYDTDQDG 155
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 16/82 (19%), Positives = 29/82 (35%), Gaps = 11/82 (13%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
K AL LS + + D G I +++ G L +LT+
Sbjct: 97 KQALSGFGYRLSDQFHD---ILIRKFDRQGRGQIAFDDFIQGCIVL-QRLTDI-----FR 147
Query: 429 AADVDGNG--TIDYIEFITATM 448
D D +G + Y ++++
Sbjct: 148 RYDTDQDGWIQVSYEQYLSMVF 169
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-28
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 3/89 (3%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+A + ++I +++F DT+ G I+ EL L LG +T EV+++M D DG
Sbjct: 1 MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDG 59
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAF 463
+G I + EF R + K F
Sbjct: 60 DGFISFDEFT--DFARANRGLVKDVSKIF 86
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 23/109 (21%), Positives = 38/109 (34%), Gaps = 16/109 (14%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG--SKLTEAEVQQLMEA-------- 429
S +Q +K F ID D G IT + ++ R S++ + LM++
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60
Query: 430 -ADVDGNGTIDYIEFITATMHRHKLERDDHLYK-----AFQHFDKDNSG 472
V G ID FI + K + + F+ D +
Sbjct: 61 LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDN 109
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-13
Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 370 LALKVIAENLSTEEIQG-LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+++ + ++G L F +DT+ I+ +E LG L + +
Sbjct: 78 SMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFD 135
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463
A D + +G + EF+ A + D K F
Sbjct: 136 AIDTNNDGLLSLEEFVIA-GSDFFMNDGDSTNKVF 169
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-10
Identities = 15/118 (12%), Positives = 36/118 (30%), Gaps = 14/118 (11%)
Query: 367 LKKLALKVIAE-NLSTEEIQGLKQMFTNI------DTDNSGTITYEE-LKAGLARLGSKL 418
+ +A + E + E + L T + I + + + +
Sbjct: 28 FESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEMVKNPE 87
Query: 419 TEAEVQQLMEAA----DVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
++ V+ + D + + I E+ L++ +F D +N G
Sbjct: 88 AKSVVEGPLPLFFRAVDTNEDNNISRDEYGIF-FGMLGLDKTM-APASFDAIDTNNDG 143
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 20/92 (21%), Positives = 42/92 (45%), Gaps = 3/92 (3%)
Query: 357 RMKQFRAMNKLKKLAL---KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR 413
+ +Q ++++ K L K ++ +++G K+ + D + +G I LK L +
Sbjct: 1 KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
LG T E+++L+ T Y +F+
Sbjct: 61 LGVPKTHLELKKLIGEVSSGSGETFSYPDFLR 92
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 79/383 (20%), Positives = 129/383 (33%), Gaps = 137/383 (35%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
V +Y +GRG +G YL + +T + A K ++ KR L
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--------- 73
Query: 127 KREIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SER 180
REI I+ L I+ +++V+E+ A +L ++ + +E
Sbjct: 74 -REITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDL-KKLFKTPIFLTE- 128
Query: 181 AAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDF 227
HI + G++HRDLKP N LL +++ +K DF
Sbjct: 129 ------------EHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDF 173
Query: 228 GLSVFIEEGKVYRDIVGSA-----------------------YYVAPEVL--RRRYGKEI 262
GL+ I K + +Y APE++ + Y K I
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
Query: 263 DIWSAGVILYILLSGVPPFWAETEKG--------------------------------IF 290
DIWS G I LL+ + + IF
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293
Query: 291 DAI---LQGDIDF----------------ESAPW----PTISSSAKDLVRRMLTQDPKKR 327
+ I + D+ + P+IS +L+ ML +P KR
Sbjct: 294 NIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKR 353
Query: 328 ITSAQVLEHPWIKEGGEASDKPI 350
IT Q L+HP++K+ + +
Sbjct: 354 ITIDQALDHPYLKDVRKKKLENF 376
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 84/427 (19%), Positives = 145/427 (33%), Gaps = 126/427 (29%)
Query: 27 VAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKE 86
A+ Q ++ G S ++PRP ++ + YE
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-------L 60
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDIKREIQIMQHLS 137
+G G +G + R A K I KR L REI I+ L+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----------REIAILNRLN 110
Query: 138 GQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVN 191
++V+ E ++VV+E+ A + ++ Y +E ++ +++
Sbjct: 111 -HDHVVKVLDIVIPKDVEKFDELYVVLEI-ADSDF-KKLFRTPVYLTELHIKTLLYNLLV 167
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA----- 246
V H G++HRDLKP N L+ +++ +K DFGL+ ++ + + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 247 -----------------------YYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPF 281
+Y APE++ + Y + ID+WS G I LL+ +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 282 WAETEKG-----------------------------------IFDAI---LQGDIDF--- 300
A IF+ + + DI+
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 301 -------------ESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
E S+ A L++RML +P KRIT + L HP+ KE
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
Query: 344 EASDKPI 350
A +
Sbjct: 405 IAEVETN 411
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-27
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 15/109 (13%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA------EVQQLMEAADV 432
S +++ + D D SG + +EL+ + L +A E++ ++
Sbjct: 10 SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQ 69
Query: 433 DGNGTIDYIEFIT---------ATMHRHKLERDDHLYKAFQHFDKDNSG 472
+G I +E +L+ + K ++ +D D+SG
Sbjct: 70 RDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSG 118
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 6e-22
Identities = 34/173 (19%), Positives = 60/173 (34%), Gaps = 27/173 (15%)
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM--NKLKKLALKVI 375
+ L Q KK ++ + G+ D I + + + + L L
Sbjct: 43 QELLQARKKAGLELSPEMKTFVDQYGQRDDGKIG------IVELAHVLPTEENFLLLFRC 96
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA--------EVQQLM 427
+ S EE + + DTD+SG I EELK L L K + ++
Sbjct: 97 QQLKSCEE---FMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLML 153
Query: 428 EAADVDGNGTIDYIEFIT--------ATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ D + +G ++ E + KAF+ +D+D +G
Sbjct: 154 KLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNG 206
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 16/87 (18%), Positives = 27/87 (31%), Gaps = 8/87 (9%)
Query: 362 RAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA 421
R + + LK + +E + F D D +G I EL A L L K +
Sbjct: 171 RLLPVQENFLLKFQGIKMCGKE---FNKAFELYDQDGNGYIDENELDALLKDLCEKNKQE 227
Query: 422 EVQQLMEA-----ADVDGNGTIDYIEF 443
+ + G + +
Sbjct: 228 LDINNISTYKKNIMALSDGGKLYRTDL 254
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-26
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ +F ID + G ++YEE+KA +++ + E +Q + ++ D DGNG ID EF
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-10
Identities = 12/50 (24%), Positives = 23/50 (46%)
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L + DV+G+G + Y E + ++ + L F+ D D +G
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNG 51
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 3e-05
Identities = 8/46 (17%), Positives = 17/46 (36%), Gaps = 3/46 (6%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL 414
K + + + + + +F +ID D +G I E +
Sbjct: 23 KAFVSKKRAIKNEQLL---QLIFKSIDADGNGEIDQNEFAKFYGSI 65
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 63/300 (21%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-----MQHLS 137
K++G+G++G ++ G + A K ++ RE +I M+H
Sbjct: 41 MVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRH-- 90
Query: 138 GQPNIVEFKGAYEDKQSVH----VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-- 191
NI+ F A ++ + G L+D + ++ + S V+
Sbjct: 91 --ENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGL 147
Query: 192 ------VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--- 242
+ + HRDLK +N L+ +N D GL+V DI
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 243 --VGSAYYVAPEVL-------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDA 292
VG+ Y+ PEVL + D++S G+IL+ + E + +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 293 ILQGDIDFESAPW--------PTISSSA---------KDLVRRMLTQDPKKRITSAQVLE 335
++ D +E P+ + L+ +P R+T+ +V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 24/220 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK---DDIKREIQIMQHL 136
Y +G+G FG + A K + KN K + + E+++++ +
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-------IIKNKKAFLNQAQIEVRLLELM 107
Query: 137 S-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSI 189
+ + IV K + + + +V E+ L+D + S + +
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 190 VNVVHICHF--MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
+ + ++H DLKPEN LL + +A+ K DFG S + + ++Y+ I S +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAI-KIVDFGSSCQLGQ-RIYQYIQ-SRF 223
Query: 248 YVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE 286
Y +PEV L Y ID+WS G IL + +G P F E
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 14/29 (48%), Positives = 18/29 (62%)
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
KDL+ RML DPK RI L+H + K+
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 23/123 (18%), Positives = 44/123 (35%), Gaps = 21/123 (17%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQ 425
K+ ++ + I K MF +D +++G I+ +E+ + LG+ +A+ +
Sbjct: 2 NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61
Query: 426 LMEAADVDGNGT-----IDYIEFITATMHRHKLERDDH-----------LYKAFQHFDKD 469
A G G D+ +I E + + F DKD
Sbjct: 62 DAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKD 121
Query: 470 NSG 472
+G
Sbjct: 122 QNG 124
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-20
Identities = 37/192 (19%), Positives = 62/192 (32%), Gaps = 22/192 (11%)
Query: 280 PFWAETEKGIFDAILQ---GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
P W K +F+ + G I + + A D+V L P++ +
Sbjct: 12 PRWIGRHKHMFNFLDVNHNGKISLD-----EMVYKASDIVINNLGATPEQA-KRHKDAVE 65
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQF-RAMNKLKKLALKVIAENLSTEEIQGLKQMFTNID 395
+ G D + KL L+ A+N T +F +D
Sbjct: 66 AFFGGAGMKYGVETD------WPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVD 119
Query: 396 TDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL-- 453
D +G IT +E KA G + + ++ D+D +G +D E H
Sbjct: 120 KDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT--RQHLGFWYT 177
Query: 454 --ERDDHLYKAF 463
+ LY
Sbjct: 178 MDPACEKLYGGA 189
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 22/116 (18%), Positives = 38/116 (32%), Gaps = 23/116 (19%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL----GSKLTEAEVQQLMEA------ 429
+ LK+ F D D +G + + + + G AEVQ L A
Sbjct: 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFD 61
Query: 430 -----ADVDGNGTIDYIEFITATMHRHKLERDDH--------LYKAFQHFDKDNSG 472
A V +G++ +FI T + + + + DK+ G
Sbjct: 62 YLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADG 117
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-14
Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 3/81 (3%)
Query: 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNG 436
+ + +K + D + G I +E A L LG +++AE + D +GNG
Sbjct: 94 ASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNG 151
Query: 437 TIDYIEFITATMHRHKLERDD 457
+ E +TA + R D
Sbjct: 152 ELSLDELLTA-VRDFHFGRLD 171
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 19/131 (14%), Positives = 40/131 (30%), Gaps = 11/131 (8%)
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKA 409
++ A + Q K A + L + + G++T E+
Sbjct: 24 LERADFEKEAQ-HIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIR 82
Query: 410 GLARL----GSKLTEAEVQQLMEAA----DVDGNGTIDYIEFITATMHRHKLERDDHLYK 461
L G + +++ D + +G I+ EF + + +
Sbjct: 83 VTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAW-LTALGMS-KAEAAE 140
Query: 462 AFQHFDKDNSG 472
AF D + +G
Sbjct: 141 AFNQVDTNGNG 151
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-24
Identities = 24/121 (19%), Positives = 50/121 (41%), Gaps = 8/121 (6%)
Query: 355 LSRMKQFRAMNKLKKLAL---KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL 411
+ + +Q R + ++ + L K E E++ K+ + D +N G I LK +
Sbjct: 17 ILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSLKRMM 76
Query: 412 ARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNS 471
+LG T E+++++ + TI Y +F+ M + + K F+ +
Sbjct: 77 EKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNM-MLGKRSA----VLKLVMMFEGKAN 131
Query: 472 G 472
Sbjct: 132 E 132
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-24
Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 15/99 (15%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA--------EVQQLMEAADVD 433
EE++ +++F + D+ ++ EL L ++ ++ + + ++ D D
Sbjct: 1 EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 59
Query: 434 GNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
G + + EF + K ++ FD D SG
Sbjct: 60 TTGKLGFEEFKYLWNNIKK------WQAIYKQFDVDRSG 92
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-22
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 7/92 (7%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
I+ + ++ D D SGTI EL G L E + ++ D G +D+
Sbjct: 73 WNNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNE-HLYSMIIRRYSDEGGNMDF 131
Query: 441 IEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
FI+ + R D +++AF+ DKD +G
Sbjct: 132 DNFISCLV------RLDAMFRAFKSLDKDGTG 157
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 28/111 (25%), Positives = 51/111 (45%), Gaps = 5/111 (4%)
Query: 365 NKLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
+KL+ ++ + E + + EIQ + F + SG ++ EE K ++
Sbjct: 6 SKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASK 63
Query: 423 -VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + D +G+GTID+ EFI A + + + L AF +D D +G
Sbjct: 64 FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNG 114
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 18/90 (20%)
Query: 387 LKQMFTNIDTDNSGTITYEELK------AGLARLGSKLTEAE------VQQLMEAADVDG 434
LK F+ D D +G I+ E+ + K+ E E +++ D +
Sbjct: 101 LKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNR 160
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
+G + EFI + D + + Q
Sbjct: 161 DGKLSLEEFIRG------AKSDPSIVRLLQ 184
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 26/129 (20%), Positives = 51/129 (39%), Gaps = 22/129 (17%)
Query: 362 RAMNKLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT 419
RA L+ L+ I + S +I L FT++D +GT++ E+ + + L
Sbjct: 4 RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPL- 62
Query: 420 EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLE----------------RDDHLYKAF 463
+++ A +G +++ F+ H +E R + L+ AF
Sbjct: 63 ---GDRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAF 119
Query: 464 QHFDKDNSG 472
+ +D D
Sbjct: 120 RLYDLDKDD 128
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 6/94 (6%)
Query: 358 MKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGL-ARLGS 416
+ FR + +K E L++ L F D D I+ +EL L +G
Sbjct: 87 LAHFRPIEDNEKSKDVNGPEPLNSRS-NKLHFAFRLYDLDKDDKISRDELLQVLRMMVGV 145
Query: 417 KLTEAEVQQL----MEAADVDGNGTIDYIEFITA 446
+++ ++ + ++ AD DG+ I + EF+
Sbjct: 146 NISDEQLGSIADRTIQEADQDGDSAISFTEFVKV 179
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 14/86 (16%), Positives = 34/86 (39%), Gaps = 17/86 (19%)
Query: 367 LKKLALKVIAENLSTEEIQGL-KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQ 425
L ++ ++ N+S E++ + + D D I++ E +
Sbjct: 135 LLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFV----------------K 178
Query: 426 LMEAADVDGNGTIDYIEFITATMHRH 451
++E DV+ +I ++ + A + H
Sbjct: 179 VLEKVDVEQKMSIRFLHKLAAALEHH 204
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-24
Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 5/114 (4%)
Query: 362 RAMNKLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT 419
++ +KL + L+ + +E+Q + F SG + E + +
Sbjct: 3 KSQSKLSQDQLQDLVRSTRFDKKELQQWYKGF--FKDCPSGHLNKSEFQKIYKQFFPFGD 60
Query: 420 EAE-VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + + D D NG ID+ EFI A + E +D L AFQ +D DN+G
Sbjct: 61 PSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNG 114
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 18/94 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLTEAE--------VQQLMEAADVDG 434
L F D DN+G I+Y+E+ A +GS + E V ++ D +
Sbjct: 101 LIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNK 160
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDK 468
+G + EF +RD + A +D
Sbjct: 161 DGQLTLEEFCEG------SKRDPTIVSALSLYDG 188
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 21/116 (18%), Positives = 40/116 (34%), Gaps = 21/116 (18%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE----------VQQLM 427
+ + G Q++ + D D++G I +EL + KL + + M
Sbjct: 4 AFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFM 63
Query: 428 EAADVDGNGTIDYIEF-----------ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
A D +G + E + L+ K ++ +D D+SG
Sbjct: 64 SAYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSG 119
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 29/187 (15%), Positives = 60/187 (32%), Gaps = 23/187 (12%)
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF-RAMN 365
I D R + + + + K A D D + ++++ +
Sbjct: 27 YIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRL--QIEELANMIL 84
Query: 366 KLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-------- 417
++ L + + +++ D D+SG I+ ELK L L +
Sbjct: 85 PQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPN 144
Query: 418 LTEAEVQQLMEAADVDGNGTIDYIEFIT------------ATMHRHKLERDDHLYKAFQH 465
+ +M+ D + +G +D + ++ER K F H
Sbjct: 145 KLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLLQFKMDASSQVERKRDFEKIFAH 204
Query: 466 FDKDNSG 472
+D +G
Sbjct: 205 YDVSRTG 211
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 16/113 (14%), Positives = 45/113 (39%), Gaps = 12/113 (10%)
Query: 339 IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDN 398
+K + D +D L+R+ + N L + + ++ + +++F + D
Sbjct: 154 MKIFDKNKDGRLDLNDLARILALQE-NFLLQFKMDASSQVERKRD---FEKIFAHYDVSR 209
Query: 399 SGTITYEELKAGLARLGSK----LTEAEVQQ----LMEAADVDGNGTIDYIEF 443
+G + E+ + + ++ ++ + L+ D++ +G I E
Sbjct: 210 TGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSEL 262
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-24
Identities = 26/113 (23%), Positives = 39/113 (34%), Gaps = 22/113 (19%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKL---------------TEAEVQQL 426
E + + FT D D +G I + + ++ EA Q L
Sbjct: 1 EYERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGL 60
Query: 427 MEAADVDGNGTIDYIEFITATMHRHKLERDD-------HLYKAFQHFDKDNSG 472
AD DG+ I EF+T + R + + D L+ A D D G
Sbjct: 61 AGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDG 113
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-13
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L DTD G +T + L G + E +Q A D DG+G + E + A
Sbjct: 100 LHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIVPA 157
Query: 447 TMHRH 451
R+
Sbjct: 158 -FARY 161
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-10
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 10/130 (7%)
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKA 409
ID + S + + + A + L + + D D IT EE
Sbjct: 21 IDRSDFSGAAK-AMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVT 79
Query: 410 GLARLGSKLTEAE---VQQLMEAA----DVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462
G + + + + AA D DG+G + + A + + +D +A
Sbjct: 80 GAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARA-LTAFGVP-EDLARQA 137
Query: 463 FQHFDKDNSG 472
D D G
Sbjct: 138 AAALDTDGDG 147
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 43/299 (14%), Positives = 73/299 (24%), Gaps = 46/299 (15%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
A +P +A P V I Y G +
Sbjct: 2 AFDALREPDRESSAPP-----DDVQLVPGARIANGRYR-------LLIFHGGVPPLQFWQ 49
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
+ + RQ A + + ++ + + + + +P + + V
Sbjct: 50 ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLV 108
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217
V E GG L + +A S A +S+ H GV P +S
Sbjct: 109 VAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS--- 163
Query: 218 ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSG 277
+G V + + + DI G LY LL
Sbjct: 164 ----------------IDGDVV---LAYPATMPDANPQD------DIRGIGASLYALLVN 198
Query: 278 VPPFWAETEKGIFDAILQGDIDFESAPW---PTISSSAKDLVRRMLTQDPKKRITSAQV 333
P + + P I + R + D R S +
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-24
Identities = 15/96 (15%), Positives = 37/96 (38%), Gaps = 7/96 (7%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
E++ + + G I+ + +LG + + +++ E +
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKE----LYGDNL 64
Query: 439 DYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
Y +++ + ++D + L K F HFD + +G
Sbjct: 65 TYEQYLEY-LSICVHDKDNVEELIKMFAHFDNNCTG 99
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-14
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L +MF + D + +G +T ++K L G LT+ E + A + N IDY F
Sbjct: 86 LIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAFSSEDN--IDYKLFCED 143
Query: 447 TMH 449
+
Sbjct: 144 ILQ 146
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 65/321 (20%), Positives = 112/321 (34%), Gaps = 66/321 (20%)
Query: 65 DTNTILGKPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN 121
++ + E++ + RG+FG + A K +
Sbjct: 7 HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------ 58
Query: 122 DKDDIKREIQI-----MQHLSGQPNIVEFKGAYEDKQSVHV----VMELCAGGELFDRII 172
DK + E ++ M+H NI++F GA + SV V + G L D +
Sbjct: 59 DKQSWQNEYEVYSLPGMKH----ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FL 113
Query: 173 AKGHYSERAAASICRSI----------VNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222
S I ++ + + H + HRD+K +N LL N
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTA 170
Query: 223 KATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLR------RRYGKEIDIWSAGVILYI 273
DFGL++ E GK D VG+ Y+APEVL R ID+++ G++L+
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 274 LLSGVPPFWAETEKGI--FDAILQGDIDFES---------------APWPTISSSAK--D 314
L S ++ + F+ + E W + A +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 315 LVRRMLTQDPKKRITSAQVLE 335
+ D + R+++ V E
Sbjct: 291 TIEECWDHDAEARLSAGCVGE 311
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-23
Identities = 19/66 (28%), Positives = 31/66 (46%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
T + Q F N DT + TI+ EE +A R LT+ + +L V+ G + Y
Sbjct: 20 TSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKY 79
Query: 441 IEFITA 446
+F++
Sbjct: 80 PDFLSR 85
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-05
Identities = 6/29 (20%), Positives = 13/29 (44%)
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I A +H+ + + F++FD +
Sbjct: 11 ILARLHKAVTSHYHAITQEFENFDTMKTN 39
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALK 373
+ + + ++ K ID K+ + K
Sbjct: 254 TIFFKDDGNYK-----TRAEVKFEGDTLVNRIELKGID------FKEDGNILGHKLE--Y 300
Query: 374 VIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD 433
+ L+ E+I K+ F+ D D GTIT +EL + LG TEAE+Q ++ D D
Sbjct: 301 NTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD 360
Query: 434 GNGTIDYIEFITATMHRHKLERDDH--LYKAFQHFDKDNSG 472
GNGTID+ EF+T M R + D + +AF+ FDKD +G
Sbjct: 361 GNGTIDFPEFLT-MMARKMKDTDSEEEIREAFRVFDKDGNG 400
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
+ K+L V R L Q+P + A++ + I E + ID +F M K
Sbjct: 330 TTKELGTVMRSLGQNPTE----AELQDM--INEVDADGNGTID------FPEFLTMMARK 377
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+ + S EEI ++ F D D +G I+ EL+ + LG KLT+ EV +++
Sbjct: 378 ------MKDTDSEEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIR 428
Query: 429 AADVDGNGTIDYIEFITATMHR 450
AD+DG+G ++Y EF+ +
Sbjct: 429 EADIDGDGQVNYEEFVQMMTAK 450
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 7/94 (7%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+ +G Q T D+ T E+K L +++ + D +G I
Sbjct: 241 FKSAMPEGYIQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGI-------DFKEDGNI 293
Query: 439 DYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ T + E+ +AF FDKD G
Sbjct: 294 LGHKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDG 327
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-23
Identities = 16/114 (14%), Positives = 31/114 (27%), Gaps = 16/114 (14%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS---------KLTEAEVQQ 425
I E+ ++ +K +D G I+ E+ + R+ + T E +
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLR 63
Query: 426 LMEAADVDGNGTIDYIEFITATMHRH-------KLERDDHLYKAFQHFDKDNSG 472
+ + + I E K + D D G
Sbjct: 64 VADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDG 117
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 8e-17
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 2/83 (2%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
+ M+ IDTD G ++ E KA L +G LT+ + D + NG I
Sbjct: 99 MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRD 158
Query: 442 EFITATMHRHKL-ERDDHLYKAF 463
EF+ ++ + L AF
Sbjct: 159 EFLVT-VNDFLFGLEETALANAF 180
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-08
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 9/99 (9%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-------LTEAEVQQLMEAADVDG 434
E Q ++ + I+ EE K + + + + D D
Sbjct: 56 ETRQEFLRVADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDK 115
Query: 435 NGTIDYIEFITATMHRHKLE-RDDHLYKAFQHFDKDNSG 472
+G + EF A + + DD F D + +G
Sbjct: 116 DGYVSLPEF-KAFLQAVGPDLTDDKAITCFNTLDFNKNG 153
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 22/112 (19%), Positives = 44/112 (39%), Gaps = 21/112 (18%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT 437
S + L F +D + G ++ +L+ ++G+ +++E+ DG+
Sbjct: 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQ----QIGALAVNPLGDRIIESFFPDGSQR 77
Query: 438 IDYIEFITATMHRHKLE-----------------RDDHLYKAFQHFDKDNSG 472
+D+ F+ H +E R + L+ AFQ +D D G
Sbjct: 78 VDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDG 129
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 21/107 (19%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 358 MKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL-GS 416
+ FR + L F D D G I+ E+ L + G
Sbjct: 87 LAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGV 146
Query: 417 KLTEAEVQQL----MEAADVDGNGTIDYIEFITATMHRHKLERDDHL 459
++TE +++ + ++ AD DG+G + ++EF + + + +E+ +
Sbjct: 147 QVTEEQLENIADRTVQEADEDGDGAVSFVEFTKS-LEKMDVEQKMSI 192
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-22
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD--GNG 436
S K+ F D IT ++ LG T AE+ +++ +
Sbjct: 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAA 61
Query: 437 TIDYIEFITATMHRHKLERDDH----LYKAFQHFDKDNSG 472
I + EF+ + +D + + FDK+ +G
Sbjct: 62 AITFEEFLPM-LQAAANNKDQGTFEDFVEGLRVFDKEGNG 100
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 2e-14
Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 28/140 (20%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGG--EASDKPIDSAVLSRMKQFRAMNK 366
+A + + R L Q+P A++ + + E + I ++F M
Sbjct: 26 TASQVGDIARALGQNPTN----AEINKI--LGNPSKEEMNAAAIT------FEEFLPM-- 71
Query: 367 LKKLALKVIAENLSTEE--IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQ 424
L ++ T E ++GL+ +F D + +GT+ EL+ LA LG K+TE EV+
Sbjct: 72 ---LQAAANNKDQGTFEDFVEGLR-VF---DKEGNGTVMGAELRHVLATLGEKMTEEEVE 124
Query: 425 QLMEAADVDGNGTIDYIEFI 444
+LM+ + D NG I+Y F+
Sbjct: 125 ELMKGQE-DSNGCINYEAFV 143
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-22
Identities = 21/100 (21%), Positives = 41/100 (41%), Gaps = 7/100 (7%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD--GNG 436
+ ++++ K+ F D G I Y + + LG T AEV +++ D +
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSR 63
Query: 437 TIDYIEFITATMHRHKLERDDH----LYKAFQHFDKDNSG 472
+D+ F+ + R + F+ FDK+ +G
Sbjct: 64 RVDFETFLPM-LQAVAKNRGQGTYEDYLEGFRVFDKEGNG 102
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-14
Identities = 32/142 (22%), Positives = 54/142 (38%), Gaps = 32/142 (22%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGG--EASDKPID----SAVLSRMKQFR 362
V R L Q+P A+VL+ + E + +D +L + + R
Sbjct: 28 LYSQCGDVMRALGQNPTN----AEVLKV--LGNPKSDELKSRRVDFETFLPMLQAVAKNR 81
Query: 363 AMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
+ E+ + F D + +G + EL+ L LG K+TE E
Sbjct: 82 GQG--------------TYEDY---LEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEE 124
Query: 423 VQQLMEAADVDGNGTIDYIEFI 444
V+ ++ D NG I+Y F+
Sbjct: 125 VETVLA-GHEDSNGCINYEAFL 145
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-22
Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
K++F D + G ++ +E + T+ ++ + E DVDGNG ++ EF
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFT-- 60
Query: 447 TMHRHKL 453
+ L
Sbjct: 61 SCIEKML 67
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-22
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
T +++ F D DN G ++ EEL + L LG T AE+ + + D
Sbjct: 1 TASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQLNAKE---FDL 57
Query: 441 IEFITATMHRHKLERDDH---LYKAFQHFDKDNSG 472
F T + + + AF+ DK+ +G
Sbjct: 58 ATFKTV-YRKPIKTPTEQSKEMLDAFRALDKEGNG 91
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 7e-18
Identities = 23/84 (27%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 370 LALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
+ ++E+ + D + +GTI EL+ L LG LT +EV++LM+
Sbjct: 64 YRKPIKTPTEQSKEMLDAFRAL---DKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKE 120
Query: 430 ADVDGNGTIDYIEFITATMHRHKL 453
V G+G I+Y F+ + + L
Sbjct: 121 VSVSGDGAINYESFVDMLVTGYPL 144
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-22
Identities = 29/78 (37%), Positives = 39/78 (50%), Gaps = 1/78 (1%)
Query: 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNG 436
LS E I K F D D G I+ +EL + LG T+ E+ ++E D DG+G
Sbjct: 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 71
Query: 437 TIDYIEFITATMHRHKLE 454
TID+ EF+ M R E
Sbjct: 72 TIDFEEFLVM-MVRQMKE 88
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 55/265 (20%), Positives = 104/265 (39%), Gaps = 33/265 (12%)
Query: 50 AAAPVSGLKQAVPRPDTNTILGKPYEDVKL-----HYSFGKELGRGQFGVTYLCTENSTG 104
A ++ L P+ + TI G K + +LG GQ+G Y
Sbjct: 186 ADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS 245
Query: 105 RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164
A K++ + + ++ +E +M+ + PN+V+ G + +++ E
Sbjct: 246 LTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTY 300
Query: 165 GELFD--RIIAKGHYSERAAASICRSIVNVVHIC------HFMGVMHRDLKPENFLLSSK 216
G L D R + S + I +HR+L N L+
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMAT------QISSAMEYLEKKNFIHRNLAARNCLVG-- 352
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILY 272
EN L+K DFGLS + Y G+ + + APE L ++ + D+W+ GV+L+
Sbjct: 353 -ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 410
Query: 273 ILLS-GVPPFWAETEKGIFDAILQG 296
+ + G+ P+ +++ + +
Sbjct: 411 EIATYGMSPYPGIDLSQVYELLEKD 435
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-22
Identities = 21/113 (18%), Positives = 44/113 (38%), Gaps = 2/113 (1%)
Query: 357 RMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS 416
+ ++ +NK K + +++ K + D + +G I LK L +LG
Sbjct: 20 QEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV 79
Query: 417 KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKD 469
T E+++L+ T Y +F+ M K + ++ +K+
Sbjct: 80 PKTHLELKRLIREVSSGSEETFSYSDFL--RMMLGKRSAILRMILMYEEKNKE 130
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
+ED+ L G+++GRG FG + + A KS R+ + + K +E +I
Sbjct: 112 NHEDLVL----GEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARI 165
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIV 190
++ S PNIV G KQ +++VMEL GG+ + +E A + +
Sbjct: 166 LKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-------FLRTEGARLRVKTLLQ 217
Query: 191 NVVHIC------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
V +HRDL N L++ E +LK +DFG+S +G
Sbjct: 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGL 274
Query: 245 SAYYV---APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
V APE L RY E D+WS G++L+ G P+ + + + + +G
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-22
Identities = 23/98 (23%), Positives = 38/98 (38%), Gaps = 5/98 (5%)
Query: 379 LSTEEIQGLKQMFTNID--TDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNG 436
LS +EI LK +F D G + +L LG +V + G
Sbjct: 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGT-HKMGEK 61
Query: 437 TIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
++ + EF+ A E+ +AF+ FD++ G
Sbjct: 62 SLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQG 99
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-14
Identities = 26/138 (18%), Positives = 53/138 (38%), Gaps = 25/138 (18%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
A L V R L +P+ V + + +K + ++F
Sbjct: 29 DAFKLGDVCRCLGINPRN----EDVFA---VGGTHKMGEKSLP------FEEFLPA---- 71
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+ E + + + F D + G I+ EL+ L LG +L++ +V ++++
Sbjct: 72 -YEGLMDCEQGTFADYMEAFKTF---DREGQGFISGAELRHVLTALGERLSDEDVDEIIK 127
Query: 429 AADV--DGNGTIDYIEFI 444
D+ D G + Y +F+
Sbjct: 128 LTDLQEDLEGNVKYEDFV 145
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 65/263 (24%), Positives = 102/263 (38%), Gaps = 51/263 (19%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH + PT G + T +K ++LG+G FG +C
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSAFEDRDPTQF--EERHLKF----LQQLGKGNFGSVEMC 60
Query: 99 T----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA--YEDK 152
+++TG A K + + T+ D +REI+I++ L NIV++KG +
Sbjct: 61 RYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 116
Query: 153 QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM------GVMHRD 205
+++ ++ME G L D + K IC M +HRD
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEYLGTKRYIHRD 170
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-----------APEVL 254
L N L+ +K DFGL+ + + K Y Y V APE L
Sbjct: 171 LATRNILVE---NENRVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESL 220
Query: 255 R-RRYGKEIDIWSAGVILYILLS 276
++ D+WS GV+LY L +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ +LG GQ+G Y A K++ + + ++ +E +M+ + PN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPN 70
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM 199
+V+ G + +++ E G L D R + S + I M
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT------QISSAM 124
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---A 250
+HRDL N L+ EN L+K DFGLS + Y G+ + + A
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTA 180
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
PE L ++ + D+W+ GV+L+ + + G+ P+ +++ + +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 73/327 (22%), Positives = 119/327 (36%), Gaps = 63/327 (19%)
Query: 7 KSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDT 66
+ P R SS + + P + R TP A VS + +P
Sbjct: 21 TKRIPLRRQVTVSAESSSSMNSNTPL---VRITTRLSSTADTPMLAGVSEYE--LPEDPK 75
Query: 67 NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCT-------ENSTGRQFACKSISKRKLVT 119
P + + L GK LG G FG + + A K + + T
Sbjct: 76 WEF---PRDKLTL----GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDAT 126
Query: 120 KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE 179
+ D D+ E+++M+ + NI+ GA ++V++E + G L + + A+
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 180 RAAASICRSIVNVVHICHFMGVM----------------HRDLKPENFLLSSKDENALLK 223
+ I R + + HRDL N L++ EN ++K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMK 243
Query: 224 ATDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVI 270
DFGL+ RDI YY APE L R Y + D+WS GV+
Sbjct: 244 IADFGLA---------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 271 LY-ILLSGVPPFWAETEKGIFDAILQG 296
++ I G P+ + +F + +G
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFKLLKEG 321
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 62/370 (16%), Positives = 115/370 (31%), Gaps = 120/370 (32%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-- 137
Y ++LG G F +L + + A K + K ++ + EI++++ +
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS---AEHYTETALDEIRLLKSVRNS 93
Query: 138 -----GQPNIV------EFKGAYEDKQSVHV--VMELCAGGELFDRIIAKGH--YSERAA 182
+ +V + G H+ V E+ G L II +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVN----GTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCV 148
Query: 183 ASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKD------------------------ 217
I + ++ + H ++H D+KPEN LLS +
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 218 ----------------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-L 254
E +K D G + ++ + + + + + Y + EV +
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLI 266
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD---------AIL----------- 294
Y DIWS + + L +G F + + +L
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326
Query: 295 ---------QGDIDFESAPWPTISSS---------------AKDLVRRMLTQDPKKRITS 330
+GD+ + P D + ML P+KR T+
Sbjct: 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386
Query: 331 AQVLEHPWIK 340
A+ L HPW+
Sbjct: 387 AECLRHPWLN 396
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 52/236 (22%), Positives = 86/236 (36%), Gaps = 54/236 (22%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P + GK LG G FG T ++ A K + + +++ +
Sbjct: 21 PRNRLSF----GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALM 74
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--------RIIAKGHYSE 179
E++++ +L NIV GA V+ E C G+L + I +K +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 180 RAAASICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGL 229
+ + +++ + +HRDL N LL+ + K DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGL 191
Query: 230 SVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY 272
+ RDI + YV APE + Y E D+WS G+ L+
Sbjct: 192 A---------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 17/225 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K LG G FG Y G + A K + R+ + +I E +M +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
P++ G +V ++ +L G L D + K + + + C I ++
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEV 253
++HRDL N L+ + +K TDFGL+ + + G + A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 254 LR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R Y + D+WS GV ++ L++ G P+ I + +G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 58/313 (18%), Positives = 106/313 (33%), Gaps = 76/313 (24%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-----MQHL 136
+ +GRG++G Y + + R A K S ++ + E I M+H
Sbjct: 16 KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA------NRQNFINEKNIYRVPLMEH- 66
Query: 137 SGQPNIVEFKGAYEDKQSVH------VVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
NI F +++ + +VME G L ++ ++ + S+
Sbjct: 67 ---DNIARFIVG-DERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVT 121
Query: 191 N---------VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+ + HRDL N L+ + +DFGLS+ + ++ R
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 242 ---------IVGSAYYVAPEVLR--------RRYGKEIDIWSAGVILYILLSGV------ 278
VG+ Y+APEVL K++D+++ G+I + +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 279 -------PPFWAETEKGIFDAILQGDIDFE------SAPWPTISSSA---KDLVRRMLTQ 322
F E +Q + E W S + K+ + Q
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 323 DPKKRITSAQVLE 335
D + R+T+ E
Sbjct: 299 DAEARLTAQXAEE 311
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 9/98 (9%)
Query: 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA-ADVDGNGTIDYI 441
+ K +FT D G I + L L +G T VQ ++ A + + ++
Sbjct: 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLD 61
Query: 442 EFITATMHRHKLERDDH-------LYKAFQHFDKDNSG 472
+ + ++ E D KAFQ FDK+++G
Sbjct: 62 QITGL-IEVNEKELDATTKAKTEDFVKAFQVFDKESTG 98
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 9e-16
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 17/136 (12%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
+ L R + +P V + + + + Q + +
Sbjct: 22 AKDSLGDYLRAIGYNPTN----QLVQDI-INADSSLRDASSLT------LDQITGLIE-V 69
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
TE+ Q+F D +++G ++ +L+ L LG KLT+AEV +L++
Sbjct: 70 NEKELDATTKAKTEDFVKAFQVF---DKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLK 126
Query: 429 AADVDGNGTIDYIEFI 444
+VD NG IDY +FI
Sbjct: 127 GVEVDSNGEIDYKKFI 142
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 48/243 (19%), Positives = 95/243 (39%), Gaps = 44/243 (18%)
Query: 83 FGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ELG+G FG+ Y ++ + A K++ + + ++ + E +M+
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEF- 85
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
++V G Q V+MEL G+L + + S+ ++ +
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 198 ----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
+HRDL N +++ E+ +K DFG++ RDI + Y
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------RDIYETDY 193
Query: 248 YV------------APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAI 293
Y +PE L+ + D+WS GV+L+ I P+ + + + +
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 294 LQG 296
++G
Sbjct: 254 MEG 256
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-20
Identities = 20/91 (21%), Positives = 33/91 (36%), Gaps = 12/91 (13%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA-----EVQQLMEAADVDGNGTIDYI 441
L F ++ G I +EL+ L + G + ++ D D +GT+ +
Sbjct: 4 LYGYFASV-AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFN 62
Query: 442 EFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
EF + + F FD D SG
Sbjct: 63 EFKELWAVLN------GWRQHFISFDSDRSG 87
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-16
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
+ G +Q F + D+D SGT+ +EL+ L +G +L V + +G I + ++
Sbjct: 71 LNGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIA--KRYSTSGKITFDDY 128
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I + KL L +F+ D G
Sbjct: 129 IACCV---KLRA---LTDSFRRRDSAQQG 151
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 50/232 (21%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P +++ GK LG G FG T + + A K + + ++K+ +
Sbjct: 44 PRNNLQF----GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALM 97
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD----RIIAKGHYSERAAA 183
E++IM HL NIV GA V V+ E C G+L + + A A
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 184 SICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
+ S +++H +HRD+ N LL+ + K DFGL+
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA--- 211
Query: 234 EEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY 272
RDI+ + Y+ APE + Y + D+WS G++L+
Sbjct: 212 ------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 29/244 (11%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
P + L G+ LG+G+FG E+ + + A K + K ++ +D ++ RE
Sbjct: 21 PEQQFTL----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLRE 75
Query: 130 IQIMQHLSGQPNIVEFKGA------YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA 183
M+ P++ + G V++ G+L ++A
Sbjct: 76 AACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 184 SICRSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
+ + +V I M +HRDL N +L+ E+ + DFGLS I G
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGD 191
Query: 238 VYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292
YR S V A E L Y D+W+ GV ++ +++ G P+ I++
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 293 ILQG 296
++ G
Sbjct: 252 LIGG 255
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 83 FGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
F ++LG+G FG +C +++TG A K + + T+ D +REI+I++ L
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ- 69
Query: 139 QPNIVEFKGA--YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHI 195
NIV++KG ++++ ++ME G L D + K I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 196 CHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
C M +HRDL N L+ +K DFGL+ + + K + + V
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEF-------FKV 173
Query: 250 -----------APEVLR-RRYGKEIDIWSAGVILYILLS 276
APE L ++ D+WS GV+LY L +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 2e-20
Identities = 70/306 (22%), Positives = 110/306 (35%), Gaps = 41/306 (13%)
Query: 11 PKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTIL 70
P + +T+ + P+KP P P V P D +
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVF----ESPFSDPEELK 326
Query: 71 GKPYEDVKLHYSFGK-ELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDI 126
K + + ELG G FG A K + ++ K D +++
Sbjct: 327 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVL--KQGTEKADTEEM 383
Query: 127 KREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
RE QIM L P IV G + +++ +VME+ GG L ++ K
Sbjct: 384 MREAQIMHQLD-NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-------- 433
Query: 187 RSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
+ NV + H +HR+L N LL ++ K +DFGLS +
Sbjct: 434 -PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALGAD 489
Query: 237 K-VYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF 290
Y + + APE + R++ D+WS GV ++ LS G P+ +
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 291 DAILQG 296
I QG
Sbjct: 550 AFIEQG 555
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-20
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 9/96 (9%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
+ + KQ F+ D +G I + L G T AE+ ++ + +D
Sbjct: 1 STDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEI----ESTLPAEVDM 56
Query: 441 IEFITATMHRHKLERDDH----LYKAFQHFDKDNSG 472
+F+ ++R K FQ FDKD +G
Sbjct: 57 EQFLQV-LNRPNGFDMPGDPEEFVKGFQVFDKDATG 91
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 5e-14
Identities = 29/136 (21%), Positives = 51/136 (37%), Gaps = 26/136 (19%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
+ + R Q+P A++ E +D M+QF +
Sbjct: 23 PKTSIGDLLRACGQNPTL----AEITEI--ESTL----PAEVD------MEQFLQV---- 62
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
L + E + F D D +G I EL+ L LG KL+ E+ +L++
Sbjct: 63 -LNRPNGFDMPGDPE--EFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLK 119
Query: 429 AADVDGNGTIDYIEFI 444
V +G ++Y +F+
Sbjct: 120 GVPVK-DGMVNYHDFV 134
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-20
Identities = 31/105 (29%), Positives = 45/105 (42%), Gaps = 6/105 (5%)
Query: 345 ASDKPIDSAVLSRMKQFRAMNKLKKLA-LKVIAENLSTEEIQGLKQMFTNIDTDNSGTIT 403
A D + + +A ++ + +K++F ID D SG I
Sbjct: 3 AKDLLKADDIKKALDAVKAEGSFNHKKFFALVGLKAMSAN--DVKKVFKAIDADASGFIE 60
Query: 404 YEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
EELK L G LT+AE + ++AAD DG+G I EF T
Sbjct: 61 EEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFET 105
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-18
Identities = 13/59 (22%), Positives = 28/59 (47%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L ++++ ++A V G+ ++ +F A + + +D + K F+ D D SG
Sbjct: 3 AKDLLKADDIKKALDA--VKAEGSFNHKKFF-ALVGLKAMSAND-VKKVFKAIDADASG 57
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 26/136 (19%), Positives = 55/136 (40%), Gaps = 7/136 (5%)
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDT 396
K +A ++ D+ + + + + + + + ++Q K+ F ID
Sbjct: 9 KKKKSKKKAEEEGGDAPAAPPAPKPPSQKRRAQRSGSNVFAMFTQHQVQEFKEAFQLIDQ 68
Query: 397 DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456
D G I+ +++A LG TE E+ ++ + G I++ F+T D
Sbjct: 69 DKDGFISKNDIRATFDSLGRLCTEQELDSMVA----EAPGPINFTMFLTI-FGDRIAGTD 123
Query: 457 DH--LYKAFQHFDKDN 470
+ + AF FD+ +
Sbjct: 124 EEDVIVNAFNLFDEGD 139
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 30/149 (20%), Positives = 49/149 (32%), Gaps = 30/149 (20%)
Query: 311 SAKDL--VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
S D+ L + + ++ + E PI+ F + +
Sbjct: 75 SKNDIRATFDSLGRLCTE----QELDSM--VAEA----PGPIN------FTMFLTIFGDR 118
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
IA + I F D + G E LK L G K ++ EV Q +
Sbjct: 119 ------IAGTDEEDVI---VNAFNLFD-EGDGKCKEETLKRSLTTWGEKFSQDEVDQALS 168
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERDD 457
A +DGNG ID +F + + +
Sbjct: 169 EAPIDGNGLIDIKKFA--QILTKGAKEEG 195
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 28/243 (11%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ L GK LG G+FG E+ T + A K++ K ++ + ++ E
Sbjct: 32 DRNLLIL----GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSE 86
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVH-----VVMELCAGGELFDRIIAKGHYSERAAAS 184
M+ S PN++ G + S V++ G+L ++ +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 185 ICRSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
+ + +V I M +HRDL N +L ++ + DFGLS I G
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDY 202
Query: 239 YRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293
YR + V A E L R Y + D+W+ GV ++ + + G+ P+ ++D +
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 294 LQG 296
L G
Sbjct: 263 LHG 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 41/252 (16%), Positives = 74/252 (29%), Gaps = 51/252 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---KR-KLVTKNDKDDIKR 128
ED+ + LG+G F + G K +N +
Sbjct: 6 RNEDLIF----NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
+M LS ++V G +V E G L Y ++ I +
Sbjct: 62 AASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDT-------YLKKNKNCI--N 111
Query: 189 IVNVVHICH----------FMGVMHRDLKPENFLLSSKD-----ENALLKATDFGLSVFI 233
I+ + + ++H ++ +N LL ++ +K +D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--- 168
Query: 234 EEGKVYRDIVGSAYY------VAPEVL--RRRYGKEIDIWSAGVILYILLS-GVPPFWAE 284
++ V PE + + D WS G L+ + S G P A
Sbjct: 169 ------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
Query: 285 TEKGIFDAILQG 296
+
Sbjct: 223 DSQRKLQFYEDR 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 56/316 (17%), Positives = 111/316 (35%), Gaps = 50/316 (15%)
Query: 15 HYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPY 74
+Y H + + Q + P + + P+
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLR-TSTIMTDYNPNYCFAGKTSS 61
Query: 75 EDVKLHY-----SFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKD 124
+ + LG G FG Y + + Q A K++ ++ ++ D+
Sbjct: 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDEL 119
Query: 125 DIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
D E I+ + NIV G +++EL AGG+L + + ++
Sbjct: 120 DFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 185 ICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
++++++H+ +HRD+ N LL+ + K DFG++
Sbjct: 179 ---AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---- 231
Query: 235 EGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPP 280
RDI + YY PE + + D WS GV+L+ + S G P
Sbjct: 232 -----RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 281 FWAETEKGIFDAILQG 296
+ +++ + + + + G
Sbjct: 287 YPSKSNQEVLEFVTSG 302
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 83 FGKELGRGQFGVTYLC----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
++LG G FG L T + TG A K++ + + K+EI I++ L
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLY- 91
Query: 139 QPNIVEFKGA--YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
+I+++KG S+ +VME G L D Y R + + + ++ IC
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQIC 144
Query: 197 HFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV- 249
M +HRDL N LL + L+K DFGL+ + EG Y Y V
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEY-------YRVR 194
Query: 250 ----------APEVLR-RRYGKEIDIWSAGVILYILLS 276
APE L+ ++ D+WS GV LY LL+
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-20
Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT 437
++ T+ + LK+ F D D +G I+ EL+ + LG KLT+ EV+Q+++ AD+DG+G
Sbjct: 2 HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQ 61
Query: 438 IDYIEFITATMHRHKLERDDH---LYKAF 463
++Y EF+ M + L + F
Sbjct: 62 VNYEEFVKMMMTVRGGGGGNGWSRLRRKF 90
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-20
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 3/77 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
++++F DT+ G I+ EL L LGS + EVQ++M D DG+G ID+ EFI
Sbjct: 5 MERIFKRFDTNGDGKISLSELTDALRTLGSTSAD-EVQRMMAEIDTDGDGFIDFNEFI-- 61
Query: 447 TMHRHKLERDDHLYKAF 463
+ + K F
Sbjct: 62 SFCNANPGLMKDVAKVF 78
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 51/244 (20%), Positives = 98/244 (40%), Gaps = 44/244 (18%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF-----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ + LG G FG Y + A K++ ++ ++ D+ D E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 90
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
+ NIV G ++MEL AGG+L + + ++ ++++++H+
Sbjct: 91 N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL---AMLDLLHVA 146
Query: 197 H----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
+HRD+ N LL+ + K DFG++ RDI ++
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRAS 197
Query: 247 YYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292
YY PE + + D WS GV+L+ + S G P+ +++ + + +
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 293 ILQG 296
+ G
Sbjct: 258 VTSG 261
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 47/242 (19%)
Query: 60 AVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKR 115
+ +P T P K ++LG G FG LC ++TG Q A KS+ +
Sbjct: 5 SEKKPATEV---DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--K 59
Query: 116 KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA--YEDKQSVHVVMELCAGGELFDRIIA 173
N D+K+EI+I+++L NIV++KG + + ++ME G L + +
Sbjct: 60 PESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118
Query: 174 -KGHYSERAAASICRSIVNVVHIC------HFMGVMHRDLKPENFLLSSKDENALLKATD 226
K + + IC +HRDL N L+ +K D
Sbjct: 119 NKNKINLKQQLKYAV------QICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGD 169
Query: 227 FGLSVFIEEGKVYRDIVGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYIL 274
FGL+ IE K Y Y V APE L ++ D+WS GV L+ L
Sbjct: 170 FGLTKAIETDKEY-------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 275 LS 276
L+
Sbjct: 223 LT 224
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 7e-20
Identities = 24/128 (18%), Positives = 46/128 (35%), Gaps = 3/128 (2%)
Query: 346 SDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYE 405
+P + ++ ++ + L N + E+Q L + F N SG + E
Sbjct: 15 QRRPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNEC--PSGVVNEE 72
Query: 406 ELKAGLARLGSKLTEAE-VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
K A+ + L A D G++ + +F+TA + + L F
Sbjct: 73 TFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFN 132
Query: 465 HFDKDNSG 472
+D + G
Sbjct: 133 LYDINKDG 140
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 18/94 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLTEAE--------VQQLMEAADVDG 434
L+ F D + G I EE+ KA +G V + D +
Sbjct: 127 LRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNK 186
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDK 468
+G + EF+ + + DD++ ++ Q F
Sbjct: 187 DGIVTLDEFLES------CQEDDNIMRSLQLFQN 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 63/247 (25%), Positives = 94/247 (38%), Gaps = 49/247 (19%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
EDV L + LG G FG Y A K+ +K T ++K+ E
Sbjct: 10 AREDVVL----NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSE 63
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRS 188
IM++L P+IV+ G E ++ ++MEL GEL + K
Sbjct: 64 AVIMKNLD-HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL- 120
Query: 189 IVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
IC M +HRD+ N L++ +K DFGLS R I
Sbjct: 121 -----QICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---------RYI 163
Query: 243 VGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGI 289
YY +PE + RR+ D+W V ++ +LS G PF+ K +
Sbjct: 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
Query: 290 FDAILQG 296
+ +G
Sbjct: 224 IGVLEKG 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+F +E+G GQFG+ +L + + A K+I + ++D E ++M LS P
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIRE----GAMSEEDFIEEAEVMMKLS-HPK 64
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM- 199
+V+ G ++ + +V E G L D + +G ++ +C +C M
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMA 118
Query: 200 -----GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---AP 251
V+HRDL N L+ EN ++K +DFG++ F+ + Y G+ + V +P
Sbjct: 119 YLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASP 174
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
EV RY + D+WS GV+++ + S G P+ + + + I G
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 57/238 (23%), Positives = 90/238 (37%), Gaps = 29/238 (12%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREI 130
+ + L KELG G FG A K + K + KD++ E
Sbjct: 14 DRKLLTL---EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEA 69
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
+MQ L P IV G E +S +VME+ G L + H ++ +
Sbjct: 70 NVMQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--- 124
Query: 191 NVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIV 243
+ M +HRDL N LL K +DFGLS + + Y+
Sbjct: 125 ---QVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQT 178
Query: 244 GSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ V APE + ++ + D+WS GV+++ S G P+ + + +G
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 13/125 (10%), Positives = 37/125 (29%), Gaps = 27/125 (21%)
Query: 374 VIAENLSTEEIQGLKQMFTNI-DTDNSGTITYEELKAGLARLGS---------------K 417
+ A LS + + ++F D ++ G I +++ + + ++ +
Sbjct: 1 MAAHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARA 60
Query: 418 LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDH----------LYKAFQHFD 467
+ L + AD + + + E++ + + F D
Sbjct: 61 TLKLIWDGLRKYADENEDEQVTKEEWLKM-WAECVKSVEKGESLPEWLTKYMNFMFDVND 119
Query: 468 KDNSG 472
Sbjct: 120 TSGDN 124
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 9e-13
Identities = 12/87 (13%), Positives = 25/87 (28%), Gaps = 3/87 (3%)
Query: 360 QFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT 419
++ M + + E+L + + MF DT I E G +
Sbjct: 85 EWLKMWA-ECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IP 141
Query: 420 EAEVQQLMEAADVDGNGTIDYIEFITA 446
+++ + G + F
Sbjct: 142 KSDCDAAFDTLSDGGKTMVTREIFARL 168
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 14/106 (13%), Positives = 26/106 (24%), Gaps = 11/106 (10%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE---------VQQL 426
+ D + +T EE A + + E + +
Sbjct: 55 HNEARATLKLIWDGLRKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFM 114
Query: 427 MEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ D G+ ID E+ T + + AF
Sbjct: 115 FDVNDTSGDNIIDKHEYSTV-YMSYGIP-KSDCDAAFDTLSDGGKT 158
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 18/227 (7%)
Query: 82 SFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
F + +GRG FG Y L + A KS+ ++ + E IM+ S
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 84
Query: 139 QPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
PN++ G + S VV+ G+L + I + + + + +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-----AP 251
+HRDL N +L E +K DFGL+ + + + Y + + A
Sbjct: 145 ASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
E L+ +++ + D+WS GV+L+ L++ G PP+ I +LQG
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V Y G+++G G FG YL T+ + G + A K K + E +I + +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMM 61
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-RIIAKGHYSERAAASICRSIVNVVHI 195
G I + + +VMEL G L D +S + + +++ +
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-------------- 241
H +HRD+KP+NFL+ + L+ DFGL+ K YRD
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA------KKYRDARTHQHIPYRENKN 174
Query: 242 IVGSAYYVAPEVLRRRYGKEI----DIWSAG-VILYILLSGVPPFW----AETEKGIFDA 292
+ G+A Y + + G E D+ S G V++Y L +P W A T++ ++
Sbjct: 175 LTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYER 229
Query: 293 ILQ 295
I +
Sbjct: 230 ISE 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 60/294 (20%)
Query: 40 HRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCT 99
H P A VS + +P P + + L GK LG G FG +
Sbjct: 5 HHHHHHSQDPMLAGVSEYE--LPEDPKWEF---PRDKLTL----GKPLGEGAFGQVVMAE 55
Query: 100 ENSTGRQF-------ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152
+ A K + + T+ D D+ E+++M+ + NI+ GA
Sbjct: 56 AVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113
Query: 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-------------- 198
++V++E + G L + + A+ + I R +
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173
Query: 199 --MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------- 249
+HRDL N L++ EN ++K DFGL+ RDI YY
Sbjct: 174 ASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---------RDINNIDYYKKTTNGRL 221
Query: 250 -----APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
APE L R Y + D+WS GV+++ I G P+ + +F + +G
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 61/244 (25%), Positives = 96/244 (39%), Gaps = 43/244 (17%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V + G+++G G FG YL T T + A K + K + E +I + L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRIL 59
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG---GELFDRIIAKGHYSERAAASICRSIVNVV 193
G I + + +VM+L G +LF+ S + + ++N V
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD------------ 241
H +HRD+KP+NFL+ + DFGL+ K YRD
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA------KKYRDTSTHQHIPYREN 170
Query: 242 --IVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFW----AETEKGIFD 291
+ G+A Y + + G E D+ S G +L L G P W A T+K ++
Sbjct: 171 KNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYE 226
Query: 292 AILQ 295
I +
Sbjct: 227 KISE 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 66/329 (20%), Positives = 113/329 (34%), Gaps = 69/329 (20%)
Query: 15 HYAHGYRSSPN----TVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTIL 70
+Y H + + HH + PT + +
Sbjct: 3 YYHHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPT------TENLYFQGMLAGVSEY 56
Query: 71 GKPYEDV------KLHYSFGKELGRGQFGVTYLCT-------ENSTGRQFACKSISKRKL 117
P + +L GK LG G FG L + + + A K + +
Sbjct: 57 ELPEDPRWELPRDRL--VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSD 112
Query: 118 VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD---RIIAK 174
T+ D D+ E+++M+ + NI+ GA ++V++E + G L +
Sbjct: 113 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 172
Query: 175 GHYSERAAASICRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENAL 221
G + ++ + +HRDL N L++ E+ +
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNV 229
Query: 222 LKATDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAG 268
+K DFGL+ RDI YY APE L R Y + D+WS G
Sbjct: 230 MKIADFGLA---------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 269 VILY-ILLSGVPPFWAETEKGIFDAILQG 296
V+L+ I G P+ + +F + +G
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFKLLKEG 309
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 46/242 (19%)
Query: 83 FGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
+ +LG+G FG LC ++TG A K + + + + D +REIQI++ L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH- 82
Query: 139 QPNIVEFKG--AYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHI 195
IV+++G +QS+ +VME G L D + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 196 CHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
C M +HRDL N L+ A +K DFGL+ + K Y Y V
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDY-------YVV 186
Query: 250 -----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE L + ++ D+WS GV+LY L + E +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 297 DI 298
Sbjct: 247 VP 248
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-19
Identities = 15/55 (27%), Positives = 22/55 (40%), Gaps = 4/55 (7%)
Query: 418 LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L +A+V + A + + EF K D + KAF D+D SG
Sbjct: 6 LKDADVAAALAACS--AADSFKHKEFFAKVGLASK--SLDDVKKAFYVIDQDKSG 56
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-16
Identities = 24/70 (34%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGN 435
L+++ + +K+ F ID D SG I +ELK L LT+AE + + D DG+
Sbjct: 35 LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGD 94
Query: 436 GTIDYIEFIT 445
G I EF
Sbjct: 95 GMIGVDEFAA 104
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 44/235 (18%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+F KELG GQFGV A K I ++ +D+ E ++M +LS
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMI--KEGSM--SEDEFIEEAKVMMNLS-HEK 80
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM- 199
+V+ G ++ + ++ E A G L + + + + + +C+ +C M
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK------DVCEAME 134
Query: 200 -----GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV----- 249
+HRDL N L++ + ++K +DFGLS R ++ Y
Sbjct: 135 YLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---------RYVLDDEYTSSVGSK 182
Query: 250 ------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
PEVL ++ + DIW+ GV+++ + S G P+ T + I QG
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 17/225 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K LG G FG Y G + A K + R+ + +I E +M +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
P++ G +V ++ +L G L D + K + + + C I ++
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEV 253
++HRDL N L+ + +K TDFGL+ + + G + A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 254 LR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R Y + D+WS GV ++ L++ G P+ I + +G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 59/241 (24%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P E+++ GK LG G FG T + Q A K + ++ ++++ +
Sbjct: 43 PRENLEF----GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALM 96
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL----------FDRIIAKGHY 177
E+++M L NIV GA ++++ E C G+L F +
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 178 SERAAASICRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLKA 224
+R +++ + F +HRDL N L++ ++K
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKI 213
Query: 225 TDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVIL 271
DFGL+ RDI+ + YV APE L Y + D+WS G++L
Sbjct: 214 CDFGLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 272 Y 272
+
Sbjct: 265 W 265
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 43/245 (17%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V +HY G+ +G G FGV + T +Q A K ++D ++ E + + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLL 62
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-RIIAKGHYSERAAASICRSIVNVVHI 195
+G I ++ +V++L G L D + +S + A + ++ V
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 196 CHFMGVMHRDLKPENFLL---SSKDENALLKATDFGLSVFIEEGKVYRD----------- 241
H +++RD+KP+NFL+ +SK+ N ++ DFG+ K YRD
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMV------KFYRDPVTKQHIPYRE 174
Query: 242 ---IVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFW----AETEKGIF 290
+ G+A Y++ + G+E D+ + G + L G P W A T K +
Sbjct: 175 KKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQKY 230
Query: 291 DAILQ 295
+ I +
Sbjct: 231 ERIGE 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 46/236 (19%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ KELG GQFGV L A K I + +D+ +E Q M LS P
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKE----GSMSEDEFFQEAQTMMKLS-HPK 64
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIVNVVHICHFM 199
+V+F G + +++V E + G L + Y S + + +C M
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLN-------YLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---- 249
+HRDL N L+ + +K +DFG++ R ++ Y
Sbjct: 118 AFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---------RYVLDDQYVSSVGT 165
Query: 250 -------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APEV +Y + D+W+ G++++ + S G P+ T + + QG
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 50/249 (20%)
Query: 82 SFGKELGRGQFGVTYLCT-ENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
ELG G FG +L N Q A K++ K +++ + D +RE +++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML 100
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-----RIIAKGHYSERAAASICRSIVN 191
+IV F G + + + +V E G+L AK A +
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 192 VVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
++ + + +HRDL N L+ + ++K DFG+S RD
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------RD 207
Query: 242 IVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEK 287
I + YY PE + R++ E D+WS GV+L+ + + G P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 288 GIFDAILQG 296
D I QG
Sbjct: 268 EAIDCITQG 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 66/328 (20%), Positives = 114/328 (34%), Gaps = 68/328 (20%)
Query: 2 GGCLTKSKDPK--PRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQ 59
G C + + + ++ K +Q T A +
Sbjct: 316 GYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEI----- 370
Query: 60 AVPRPDTNTILGK-----PYEDVKLHYSFGKELGRGQFGVTY---LCTENSTGRQFACKS 111
+ DT T+ E ++L G+ +G GQFG + + + A K+
Sbjct: 371 -IDEEDTYTMPSTRDYEIQRERIEL----GRCIGEGQFGDVHQGIYMSPENPAMAVAIKT 425
Query: 112 ISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI 171
+ + + ++ +E M+ P+IV+ G + V ++MELC GEL +
Sbjct: 426 C--KNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL 481
Query: 172 IAKGHYSERAAASICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENAL 221
+ + +++ + +HRD+ N L+S N
Sbjct: 482 QVRKFSL---------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDC 529
Query: 222 LKATDFGLSVFIEEGKVYRDIVGSAYYV-----------APEVLR-RRYGKEIDIWSAGV 269
+K DFGLS R + S YY APE + RR+ D+W GV
Sbjct: 530 VKLGDFGLS---------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580
Query: 270 ILYILLS-GVPPFWAETEKGIFDAILQG 296
++ +L GV PF + I G
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIENG 608
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 62/256 (24%), Positives = 98/256 (38%), Gaps = 53/256 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREI 130
+ D+K +G G FG G + A K + ++ +K+D D E+
Sbjct: 23 DWNDIKF----QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 76
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD---RIIAKGHYSERAAASICR 187
+++ L PNI+ GA E + +++ +E G L D + A A+
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 188 SIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
S ++ + HF +HRDL N L+ EN + K DFGLS
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---- 189
Query: 235 EGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPP 280
R YV A E L Y D+WS GV+L+ I+ G P
Sbjct: 190 -----RG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 281 FWAETEKGIFDAILQG 296
+ T +++ + QG
Sbjct: 242 YCGMTCAELYEKLPQG 257
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 44/230 (19%), Positives = 80/230 (34%), Gaps = 29/230 (12%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
K LG G FG + G K I + + + + L
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD- 73
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICH 197
+IV G S+ +V + G L D + +G + + I
Sbjct: 74 HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAK 126
Query: 198 FM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-- 249
M G++HR+L N LL + ++ DFG++ + + +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 250 -APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
A E + +Y + D+WS GV ++ L++ G P+ + D + +G
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 64/306 (20%), Positives = 109/306 (35%), Gaps = 63/306 (20%)
Query: 14 RHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKP 73
H++ G R + K P P H E+PG + +
Sbjct: 5 HHHSSG-RENLYFQGKLPEPQFYAEPHTYEEPG-----RAGRSFTREIEA---------- 48
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF---ACKSISKRKLVTKNDKDDIKREI 130
+ + K +G G G G++ A K++ + T+ + D E
Sbjct: 49 -SRIHI----EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEA 101
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSI 189
IM PNI+ +G + +V E G L + G ++ + R
Sbjct: 102 SIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR-- 158
Query: 190 VNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ M G +HRDL N L+ N + K +DFGLS +E+
Sbjct: 159 ----GVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDA---- 207
Query: 244 GSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF 290
Y APE + R + D+WS GV+++ +L+ G P+W T + +
Sbjct: 208 ---AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 291 DAILQG 296
++ +G
Sbjct: 265 SSVEEG 270
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P + +KL GK LGRG FG + +T R A K + ++ T ++ +
Sbjct: 25 PRDRLKL----GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALM 78
Query: 128 REIQIMQHLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
E++I+ H+ N+V GA + + V++E C G L + +K + +
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 187 RSIVNVVHICHF----------------MGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
+ + + H +HRDL N LLS E ++K DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA 195
Query: 231 VFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY 272
RDI YV APE + R Y + D+WS GV+L+
Sbjct: 196 ---------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 9e-19
Identities = 50/250 (20%), Positives = 97/250 (38%), Gaps = 50/250 (20%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF-----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
F +ELG +FG Y A K++ + +++ + E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL 69
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR------SIV 190
PN+V G Q + ++ C+ G+L + ++ + +S+ + R
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 191 NVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ VH+ V+H+DL N L+ + +K +D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---------R 176
Query: 241 DIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETE 286
++ + YY APE + ++ + DIWS GV+L+ + S G+ P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 287 KGIFDAILQG 296
+ + + I
Sbjct: 237 QDVVEMIRNR 246
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-19
Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L ++ + + GT DY F + K D + + F+ DKD SG
Sbjct: 2 MTKVLKADDINKAIS--AFKDPGTFDYKRFFHLVGLKGK--TDAQVKEVFEILDKDQSG 56
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-15
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEELK---AGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
+K++F +D D SG I EELK G + G L + E + L+ A D D +G I EF
Sbjct: 43 VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEF 102
Query: 444 IT 445
Sbjct: 103 AK 104
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 61/264 (23%), Positives = 93/264 (35%), Gaps = 43/264 (16%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY---LCTENS 102
G P+ L + +D++L ++LG G FGV +
Sbjct: 1 GSAGEG-PLQSLTCLIGE-----------KDLRL----LEKLGDGSFGVVRRGEWDAPSG 44
Query: 103 TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162
A K + L DD RE+ M L N++ G + +V EL
Sbjct: 45 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELA 102
Query: 163 AGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM------GVMHRDLKPENFLLSS 215
G L DR+ +GH+ + + M +HRDL N LL++
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYLESKRFIHRDLAARNLLLAT 156
Query: 216 KDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVI 270
+D L+K DFGL + + Y APE L+ R + D W GV
Sbjct: 157 RD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 271 LYILLS-GVPPFWAETEKGIFDAI 293
L+ + + G P+ I I
Sbjct: 214 LWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-18
Identities = 15/59 (25%), Positives = 24/59 (40%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L +A+V ++A + + +Y F K D + KAF D+D SG
Sbjct: 3 FSGILADADVAAALKA--CEAADSFNYKAFFAKVGLTAKSA--DDIKKAFFVIDQDKSG 57
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-16
Identities = 24/70 (34%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGN 435
L+ + +K+ F ID D SG I +ELK L LT+AE + ++A D DG+
Sbjct: 36 LTAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGD 95
Query: 436 GTIDYIEFIT 445
G I E+
Sbjct: 96 GAIGVDEWAA 105
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 45/276 (16%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGK-----PYEDVKLHYSFGKELGRGQFG 93
H++ G L K P E +KL K+LG GQFG
Sbjct: 153 HYKKGNDGLC------QKLSVPCMSSKPQKPWEKDAWEIPRESLKL----EKKLGAGQFG 202
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153
++ T N + A K++ + E +M+ L +V+ K+
Sbjct: 203 EVWMATYNKHTK-VAVKTMKP----GSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KE 255
Query: 154 SVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM------GVMHRD 205
++++ E A G L D + I M +HRD
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA------QIAEGMAFIEQRNYIHRD 309
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-RRYGKE 261
L+ N L+S + + K DFGL+ IE+ + Y G+ + + APE + + +
Sbjct: 310 LRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 262 IDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
D+WS G++L +++ G P+ + + A+ +G
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 63/285 (22%), Positives = 103/285 (36%), Gaps = 52/285 (18%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVP----RPDTNTILGKPYEDVKLHYSFGKELGRGQFGV 94
HH + PT G + P T I V K +G G+FG
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEI---HPSCVTR----QKVIGAGEFGE 59
Query: 95 ----TYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
+ A K++ + T+ + D E IM S NI+ +G
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS 116
Query: 151 DKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM------GVMH 203
+ + ++ E G L + G +S + R I M +H
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR------GIAAGMKYLANMNYVH 170
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV----------APEV 253
RDL N L++ N + K +DFGLS +E D + Y APE
Sbjct: 171 RDLAARNILVN---SNLVCKVSDFGLSRVLE------DDPEATYTTSGGKIPIRWTAPEA 221
Query: 254 LR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R++ D+WS G++++ +++ G P+W + + AI G
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 49/247 (19%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
E ++L G+ +G GQFG + + + A K+ + + + ++ +E
Sbjct: 13 QRERIEL----GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQE 66
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRS 188
M+ P+IV+ G + V ++MELC GEL + K +
Sbjct: 67 ALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY- 123
Query: 189 IVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ + +HRD+ N L+S N +K DFGLS R +
Sbjct: 124 -----QLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---------RYM 166
Query: 243 VGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGI 289
S YY APE + RR+ D+W GV ++ +L GV PF +
Sbjct: 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
Query: 290 FDAILQG 296
I G
Sbjct: 227 IGRIENG 233
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 62/283 (21%), Positives = 103/283 (36%), Gaps = 58/283 (20%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDV----KLHYSFGKELGRGQFG 93
H+ + G + L + T + Y + +G+G+FG
Sbjct: 154 EHYTTDADGL------CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFG 207
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQPNIVEFKGA-YE 150
L G + A K I KND E +M L N+V+ G E
Sbjct: 208 DVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE 257
Query: 151 DKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM------GVM 202
+K +++V E A G L D R + +C M +
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL------DVCEAMEYLEGNNFV 311
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-------APEVLR 255
HRDL N L+S E+ + K +DFGL+ ++ + APE LR
Sbjct: 312 HRDLAARNVLVS---EDNVAKVSDFGLT---------KEASSTQDTGKLPVKWTAPEALR 359
Query: 256 -RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+++ + D+WS G++L+ + S G P+ K + + +G
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 51/250 (20%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF-----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ELG G FG +L + A K++ K T + D +RE +++ +L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNL 74
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR------SIV 190
+IV+F G D + +V E G+L + A G + R +
Sbjct: 75 Q-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 191 NVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
++HI +HRDL N L+ N L+K DFG+S R
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---------R 181
Query: 241 DIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETE 286
D+ + YY PE + R++ E D+WS GVIL+ + + G P++ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 287 KGIFDAILQG 296
+ + I QG
Sbjct: 242 TEVIECITQG 251
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 4e-18
Identities = 22/66 (33%), Positives = 36/66 (54%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
+ ++ L+ F D D G IT +EL+ +A LG L + E+ ++ ADVD +G ++
Sbjct: 1 ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVN 60
Query: 440 YIEFIT 445
Y EF
Sbjct: 61 YEEFAR 66
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-18
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 12/91 (13%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE-----VQQLMEAADVDGNGTIDYI 441
+ F+ + G + EEL+ L + G T + + ++ D D G + +
Sbjct: 2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFN 60
Query: 442 EFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
F + + + F D+D SG
Sbjct: 61 AFK--ELWAAL----NAWKENFMTVDQDGSG 85
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-17
Identities = 20/89 (22%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
+ K+ F +D D SGT+ + EL+ + +G +L+ + +++ NG I + ++
Sbjct: 69 LNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDY 126
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + KL L F+ D G
Sbjct: 127 VACCV---KLRA---LTDFFRKRDHLQQG 149
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 40/222 (18%), Positives = 72/222 (32%), Gaps = 36/222 (16%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
HH G + P + + GK++G G FG+ YL
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDM------EGNQWVLGKKIGSGGFGLIYL 55
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI--------------- 142
+ + A + V + + E++ Q ++ + I
Sbjct: 56 AFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111
Query: 143 -VEFKGAYEDKQSVH--VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
G E K + +VME G +L G + + + +++V+ H
Sbjct: 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN 170
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+H D+K N LL K+ + + D+GLS Y
Sbjct: 171 EYVHGDIKAANLLLGYKNPD-QVYLADYGLS------YRYCP 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 60/252 (23%), Positives = 101/252 (40%), Gaps = 52/252 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF---ACKSISKRKLVTKNDKDDIKRE 129
P+E V H + +G+G FGV Y + A KS+ ++ + RE
Sbjct: 17 PHERVVTH--SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLRE 72
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVH-VVMELCAGGELFDRIIAKGHY--SERAAASIC 186
+M+ L+ PN++ G + + V++ G+L + S + ++
Sbjct: 73 GLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-------FIRSPQRNPTVK 124
Query: 187 RSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
I + + M +HRDL N +L E+ +K DFGL+ R
Sbjct: 125 DLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------R 172
Query: 241 DIVGSAYYV--------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAE 284
DI+ YY A E L+ R+ + D+WS GV+L+ LL+ G PP+
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232
Query: 285 TEKGIFDAILQG 296
+ + QG
Sbjct: 233 DPFDLTHFLAQG 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 82 SFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
F + +GRG FG Y L + A KS+ ++ + E IM+ S
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 148
Query: 139 QPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
PN++ G + S VV+ G+L + I + + + + +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------- 249
+HRDL N +L DE +K DFGL+ RD+ +
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---------RDMYDKEFDSVHNKTGA 256
Query: 250 -------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
A E L+ +++ + D+WS GV+L+ L++ G PP+ I +LQG
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF---ACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
S K +G G+FG ++ A K++ + T+ + D E IM
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFD- 104
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICH 197
PNI+ +G + V +V E G L + ++ + R I
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR------GIAS 158
Query: 198 FM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYV- 249
M G +HRDL N L++ N + K +DFGL +E+ G +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 250 --APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+PE + R++ D+WS G++L+ ++S G P+W + + + A+ +G
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-18
Identities = 48/236 (20%), Positives = 86/236 (36%), Gaps = 46/236 (19%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ LG GQFG ++ N + A KS+ + D E +M+ L
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ----GSMSPDAFLAEANLMKQLQ-HQR 69
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM 199
+V ++ ++++ E G L D + + + + I M
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA------QIAEGM 122
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---- 249
+HRDL+ N L+S + K DFGL+ R I + Y
Sbjct: 123 AFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA---------RLIEDNEYTAREGA 170
Query: 250 -------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE + + + D+WS G++L +++ G P+ T + + +G
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 34/229 (14%)
Query: 86 ELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
ELG G FG +Q A K + ++ K D +++ RE QIM L P IV
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYIV 73
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH------ 197
G + +++ +VME+ GG L ++ K + NV + H
Sbjct: 74 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI---------PVSNVAELLHQVSMGM 123
Query: 198 ----FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYV--- 249
+HRDL N LL ++ K +DFGLS + Y + +
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE + R++ D+WS GV ++ LS G P+ + I QG
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-17
Identities = 24/80 (30%), Positives = 45/80 (56%), Gaps = 2/80 (2%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGT 437
+ ++ + + + F D + G I ++E K + ++G + LT+AEV++ M+ AD DGNG
Sbjct: 2 VRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGV 61
Query: 438 IDYIEFITATMHRHKLERDD 457
ID EF+ + + K +
Sbjct: 62 IDIPEFM-DLIKKSKNALKE 80
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 3e-04
Identities = 5/21 (23%), Positives = 13/21 (61%)
Query: 452 KLERDDHLYKAFQHFDKDNSG 472
+ + ++ + +AF+ FD + G
Sbjct: 3 RQDDEEEILRAFKVFDANGDG 23
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 55/267 (20%), Positives = 103/267 (38%), Gaps = 62/267 (23%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P +++ L GK LG G+FG T + A K + ++ + ++ D+
Sbjct: 21 PRKNLVL----GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLL 74
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL-----------FDRIIAKGH 176
E +++ + P++++ GA + +++E G L + + G
Sbjct: 75 SEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 177 YSERAAASICRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLK 223
+ + + + + F M ++HRDL N L++ E +K
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMK 190
Query: 224 ATDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVI 270
+DFGLS RD+ YV A E L Y + D+WS GV+
Sbjct: 191 ISDFGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 271 LY-ILLSGVPPFWAETEKGIFDAILQG 296
L+ I+ G P+ + +F+ + G
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTG 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 57/235 (24%), Positives = 93/235 (39%), Gaps = 48/235 (20%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQ 139
+ +G+G+FG L G + A K I KND E +M L
Sbjct: 24 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLR-H 73
Query: 140 PNIVEFKGA-YEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHIC 196
N+V+ G E+K +++V E A G L D R + +C
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL------DVC 127
Query: 197 HFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV- 249
M +HRDL N L+S E+ + K +DFGL+ ++ +
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---------KEASSTQDTGK 175
Query: 250 ------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE LR +++ + D+WS G++L+ + S G P+ K + + +G
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 52/258 (20%), Positives = 94/258 (36%), Gaps = 58/258 (22%)
Query: 82 SFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ +++G G FG + A K + ++ + + + D +RE +M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF 107
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGEL-----------FDRIIAKGHYSERAAASI 185
PNIV+ G + + ++ E A G+L + + +S
Sbjct: 108 D-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 186 CRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
++ +HRDL N L+ EN ++K DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS-- 221
Query: 233 IEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GV 278
R+I + YY PE + RY E D+W+ GV+L+ + S G+
Sbjct: 222 -------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 279 PPFWAETEKGIFDAILQG 296
P++ + + + G
Sbjct: 275 QPYYGMAHEEVIYYVRDG 292
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 46/256 (17%)
Query: 62 PRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN 121
+P T + +E + +LG+G FG ++ T N T R A K++
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTM 221
Query: 122 DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA 181
+ +E Q+M+ L +V+ ++ +++V E + G L D + + R
Sbjct: 222 SPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 182 AA--SICRSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
+ I M +HRDL+ N L+ EN + K DFGL+
Sbjct: 280 PQLVDMAA------QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA--- 327
Query: 234 EEGKVYRDIVGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPP 280
R I + Y APE R+ + D+WS G++L L + G P
Sbjct: 328 ------RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
Query: 281 FWAETEKGIFDAILQG 296
+ + + D + +G
Sbjct: 382 YPGMVNREVLDQVERG 397
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 54/282 (19%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPR--PDTNTILGKPYEDVKLHYSFGKELGRGQFGVT 95
A++ G L P P T + +E + +LG+G FG
Sbjct: 230 AYYSKHADGLC------HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV 283
Query: 96 YLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155
++ T N T R A K++ + +E Q+M+ L +V+ ++ +
Sbjct: 284 WMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPI 336
Query: 156 HVVMELCAGGELFDRIIAKGHYSERAAA--SICRSIVNVVHICHFM------GVMHRDLK 207
++V E + G L D + + R + I M +HRDL+
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIASGMAYVERMNYVHRDLR 390
Query: 208 PENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-----------APEVLR- 255
N L+ EN + K DFGL+ R I + Y APE
Sbjct: 391 AANILVG---ENLVCKVADFGLA---------RLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
R+ + D+WS G++L L + G P+ + + D + +G
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-17
Identities = 20/96 (20%), Positives = 32/96 (33%), Gaps = 12/96 (12%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA-----EVQQLMEAADVDGNG 436
+ L F G I +EL+ L + G + ++ D D +G
Sbjct: 30 QTQDPLYGYF-AAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSG 88
Query: 437 TIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
T+ + EF + + F FD D SG
Sbjct: 89 TMGFNEFKELWAVLNG------WRQHFISFDTDRSG 118
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-16
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 8/89 (8%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
+ G +Q F + DTD SGT+ +EL+ L +G +L+ V + + NG I + ++
Sbjct: 102 LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDY 159
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I + + L +F+ D G
Sbjct: 160 IACCV------KLRALTDSFRRRDTAQQG 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 43/245 (17%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V ++ GK++G G FG L T A K + K + + E + + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQL 61
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-RIIAKGHYSERAAASICRSIVNVVHI 195
I + + +V+EL G L D + +S + I +++ +
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 196 CHFMGVMHRDLKPENFLL---SSKDENALLKATDFGLSVFIEEGKVYRD----------- 241
H +++RD+KPENFL+ +K + ++ DF L+ K Y D
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQ-VIHIIDFALA------KEYIDPETKKHIPYRE 173
Query: 242 ---IVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFW----AETEKGIF 290
+ G+A Y++ + GKE D+ + G + L G P W A+T K +
Sbjct: 174 HKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERY 229
Query: 291 DAILQ 295
I
Sbjct: 230 QKIGD 234
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-16
Identities = 26/70 (37%), Positives = 37/70 (52%), Gaps = 3/70 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK---LTEAEVQQLMEAADVDGN 435
LS++ +K++F +D D SG I EEL+ L S LT AE + + A D DG+
Sbjct: 36 LSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGD 95
Query: 436 GTIDYIEFIT 445
G I EF +
Sbjct: 96 GKIGVEEFQS 105
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-16
Identities = 11/60 (18%), Positives = 23/60 (38%), Gaps = 4/60 (6%)
Query: 413 RLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L+ +++ + + + +Y F + K D + K F D+D SG
Sbjct: 2 AITDILSAKDIESALSS--CQAADSFNYKSFFSTVGLSSKTP--DQIKKVFGILDQDKSG 57
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-16
Identities = 25/71 (35%), Positives = 43/71 (60%), Gaps = 3/71 (4%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+ + S EE +++ F D D +G I+ EL+ + LG KLT+ EV +++ AD+DG
Sbjct: 22 MKDTDSEEE---IREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDG 78
Query: 435 NGTIDYIEFIT 445
+G ++Y EF+
Sbjct: 79 DGQVNYEEFVQ 89
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-15
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
++ E+ + F ++ D S I+ K + SKL+ E+ + E +D D +G +
Sbjct: 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK--SKLSIPELSYIWELSDADCDGAL 73
Query: 439 DYIEFITATMH 449
EF A H
Sbjct: 74 TLPEFCAA-FH 83
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 6e-15
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE-VQQLMEAADVDGNG 436
N + E+Q L + F N SG + E K A+ + L A D G
Sbjct: 14 NFTKRELQVLYRGFKNEX--PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTG 71
Query: 437 TIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
++ + +F+TA + + L F +D + G
Sbjct: 72 SVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDG 107
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 18/93 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEEL----KAGLARLGSKLTEAE--------VQQLMEAADVDG 434
L+ F D + G I EE+ KA +G V + D +
Sbjct: 94 LRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNK 153
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
+G + EF+ + + DD++ ++ Q F
Sbjct: 154 DGIVTLDEFLES------XQEDDNIMRSLQLFQ 180
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
+F DT +G++ +E+ L+ L +++ D++ +G I+ E +
Sbjct: 60 YLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVK 119
Query: 449 HRHKLER------------DDHLYKAFQHFDKDNSG 472
+ + H+ FQ DK+ G
Sbjct: 120 AIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDG 155
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-15
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+S E ++F D D G ++ E++ + + L + + D G +
Sbjct: 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK--TGLPSTLLAHIWSLCDTKDCGKL 61
Query: 439 DYIEFITATMH 449
+F A H
Sbjct: 62 SKDQFALA-FH 71
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-15
Identities = 15/73 (20%), Positives = 32/73 (43%), Gaps = 6/73 (8%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKL------TEAEVQQLMEAADV 432
++ + L+ F +D + G +T EL+ + L + + +L++ AD
Sbjct: 1 MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADK 60
Query: 433 DGNGTIDYIEFIT 445
+ +G I EF+
Sbjct: 61 NSDGKISKEEFLN 73
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 5/110 (4%)
Query: 366 KLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE- 422
KL K L + + EIQ + F SG + E+ + + +
Sbjct: 7 KLSKDDLTCLKQSTYFDRREIQQWHKGFLRDC--PSGQLAREDFVKIYKQFFPFGSPEDF 64
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L D D NG I + EFIT + ++ L AF+ +D ++ G
Sbjct: 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDG 114
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 18/94 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGS------------KLTEAEVQQLMEAADVDG 434
L F D ++ G IT++E+ +A + E V+++ + D +
Sbjct: 101 LSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNE 160
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDK 468
+G I EF + D + A +D
Sbjct: 161 DGYITLDEFR------EGSKVDPSIIGALNLYDG 188
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 8e-06
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 12/98 (12%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI-- 444
+FT D DN+G I +EE L+ E ++ E D++ +G I + E +
Sbjct: 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124
Query: 445 ----------TATMHRHKLERDDHLYKAFQHFDKDNSG 472
T++ + + + K F+ DK+ G
Sbjct: 125 VASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDG 162
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-14
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 372 LKVIAENLS-TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-KLTEAEVQQLMEA 429
L V+AE + E + L + F+ + IT E L+ LG +++ + Q ++
Sbjct: 26 LPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVRE 85
Query: 430 ADVDGNGTIDYIEFITATMHR----HKLERDDHLYKAFQHFDKDNS 471
D+DG+G ++ EF M R + + L KA +++
Sbjct: 86 GDLDGDGALNQTEFC-VLMVRLSPEMMEDAETWLEKALTQELCNHN 130
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-14
Identities = 6/55 (10%), Positives = 12/55 (21%), Gaps = 3/55 (5%)
Query: 420 EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD--DHLYKAFQHFDKDNSG 472
E + ++ Y + + M + L K F
Sbjct: 2 EPTEKSMLLETTSTTKMETKYEDMLPV-MAEKMDVEEFVSELCKGFSLLADPERH 55
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 10/89 (11%), Positives = 23/89 (25%), Gaps = 4/89 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEE-LKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF-- 443
K M + YE+ L ++ + +E+ + I
Sbjct: 5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRR 64
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + + + + D D G
Sbjct: 65 NSGILGIEGM-SKEDAQGMVREGDLDGDG 92
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-05
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 3/67 (4%)
Query: 367 LKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQL 426
L++ + + E +S E+ Q M D D G + E + RL ++ E L
Sbjct: 62 LRRNSGILGIEGMSKEDAQ---GMVREGDLDGDGALNQTEFCVLMVRLSPEMMEDAETWL 118
Query: 427 MEAADVD 433
+A +
Sbjct: 119 EKALTQE 125
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A Length = 190 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 366 KLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE- 422
KLK ++ + + +E+Q + F SG + + + +
Sbjct: 7 KLKPEVVEELTRKTYFTEKEVQQWYKGFIKDC--PSGQLDAAGFQKIYKQFFPFGDPTKF 64
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ D + +G I++ EFI A + D+ L AF+ +D DN G
Sbjct: 65 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDG 114
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A Length = 190 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 18/93 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLT------------EAEVQQLMEAADVDG 434
L+ F D DN G IT E+ + + + E V ++ D +
Sbjct: 101 LRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNA 160
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
+G + EF + D + +A +D
Sbjct: 161 DGKLTLQEFQ------EGSKADPSIVQALSLYD 187
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A Length = 190 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 19/131 (14%), Positives = 42/131 (32%), Gaps = 17/131 (12%)
Query: 359 KQFRAMNK---LKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR 413
K F L + I + + + +F D + G I + E L+
Sbjct: 32 KGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSV 91
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLER------------DDHLYK 461
+ +++ + D+D +G I E + +++ + + +
Sbjct: 92 TSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDR 151
Query: 462 AFQHFDKDNSG 472
F DK+ G
Sbjct: 152 IFAMMDKNADG 162
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 25/111 (22%), Positives = 47/111 (42%), Gaps = 5/111 (4%)
Query: 365 NKLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE 422
L K L+ + S EE+ Q F + +G IT ++ ++ A+
Sbjct: 14 GALSKEILEELQLNTKFSEEELCSWYQSF--LKDCPTGRITQQQFQSIYAKFFPDTDPKA 71
Query: 423 -VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
Q + + D + +GT+D+ E++ A + + L AF +D D +G
Sbjct: 72 YAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNG 122
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 21/100 (21%), Positives = 41/100 (41%), Gaps = 14/100 (14%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ +F + D++ GT+ ++E L + T +++ DVDGNGTI E +
Sbjct: 73 AQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEI 132
Query: 447 TMHRHKLER--------------DDHLYKAFQHFDKDNSG 472
M K+ + K +++F K++
Sbjct: 133 VMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDD 172
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 13/92 (14%), Positives = 32/92 (34%), Gaps = 20/92 (21%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE--------------VQQLMEAADV 432
L+ F+ D D +GTI+ E+ + + +T + +++ +
Sbjct: 109 LEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGK 168
Query: 433 DGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
+ + + EFI + + + Q
Sbjct: 169 NDDDKLTEKEFIEG------TLANKEILRLIQ 194
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-14
Identities = 20/71 (28%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
++ E+ Q F I D +G I K + SKL E+ + E +D D +G +
Sbjct: 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELSDFDKDGAL 60
Query: 439 DYIEFITATMH 449
EF A H
Sbjct: 61 TLDEFCAA-FH 70
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 33/222 (14%), Positives = 76/222 (34%), Gaps = 39/222 (17%)
Query: 41 RPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTE 100
R + ++ L + + T + + G +G+G FG YL +
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA------AWKVGLPIGQGGFGCIYLA-D 55
Query: 101 NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI----------------VE 144
++ + K V +D + E++ Q + I
Sbjct: 56 MNSSESVGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114
Query: 145 FKGAYEDKQSVH--VVMELCAG---GELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
G ++ + ++M+ G ++++ +S + + I++++ H
Sbjct: 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH 171
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+H D+K N LL+ K+ + + D+GL+ Y
Sbjct: 172 EYVHGDIKASNLLLNYKNPD-QVYLVDYGLA------YRYCP 206
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+ +Q+F + D SG +T + + L + S L +A++ + +D+D +G +
Sbjct: 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ--SSLPQAQLASIWNLSDIDQDGKL 65
Query: 439 DYIEFITATMH 449
EFI A MH
Sbjct: 66 TAEEFILA-MH 75
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-13
Identities = 20/68 (29%), Positives = 37/68 (54%), Gaps = 3/68 (4%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT--EAEVQQLMEAADVDGNGT 437
S EEI+G ++F + + I+ EELK + LG L + + +++E D +G+G
Sbjct: 3 SPEEIKGAFEVFAAKE-GDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGE 61
Query: 438 IDYIEFIT 445
+ + EF+
Sbjct: 62 VSFEEFLV 69
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 6e-13
Identities = 31/177 (17%), Positives = 56/177 (31%), Gaps = 20/177 (11%)
Query: 277 GVPPFWAETEKGIFDAIL----QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQ 332
G+ F + K FD L G I + + + K++ + L+ K +
Sbjct: 1 GLNDFQKQKIKFTFDFFLDMNHDGSIQDND--FEDMMTRYKEVNKGSLSDADYKSMQ--A 56
Query: 333 VLEHPW---IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQ 389
LE W D + +++ AM + K +A +L +
Sbjct: 57 SLEDEWRDLKGRADINKDDVVS------WEEYLAMWE-KTIATCKSVADLPAWCQNRIPF 109
Query: 390 MFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+F +D G + EE + L A+V + G T D +
Sbjct: 110 LFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKEL 164
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 12/93 (12%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLAR----LGSKLTEAEVQQLMEAADVDGNGTID 439
+ + +F + + G + +L + G ++ E+ L+ D G +
Sbjct: 75 LVHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISR-ELLHLVTLRYSDSVGRVS 132
Query: 440 YIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + M R + + K F++ KD G
Sbjct: 133 FPSLVCFLM------RLEAMAKTFRNLSKDGKG 159
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-07
Identities = 12/94 (12%), Positives = 25/94 (26%), Gaps = 14/94 (14%)
Query: 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE------VQQLMEAADVDGNGTI 438
+ + I +L+ L + + + L+ ++ NG +
Sbjct: 5 HHHHHHSSGL-VPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRL 63
Query: 439 DYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
D EF + FQ + G
Sbjct: 64 DQEEFARLWKRLVHYQ------HVFQKVQ-TSPG 90
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 35/227 (15%), Positives = 71/227 (31%), Gaps = 35/227 (15%)
Query: 35 QQQAHHR--PEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQF 92
HH + ++ +A+P T T+L + R
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMTTSLEALP---TGTVLTDK---SGRQWKLKSFQTRDNQ 55
Query: 93 GVTYLCTENSTGRQFACKSISK--RKLVTKNDKDDI----------KREIQIMQHLSGQP 140
G+ Y ST + K KL K+ + ++ + L P
Sbjct: 56 GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115
Query: 141 NI----VEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVH 194
+ G ++DK +V+ G L + K SER+ + +++ +
Sbjct: 116 LLAIPTCMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALE 173
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
H +H ++ EN + +D++ + +G + Y
Sbjct: 174 FLHENEYVHGNVTAENIFVDPEDQS-QVTLAGYGFA------FRYCP 213
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A Length = 121 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 8e-12
Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 4/71 (5%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
++ EE Q F ++ SG IT ++ + + S L + + Q+ AD++ +G +
Sbjct: 27 ITVEERAKHDQQFHSLK-PISGFITGDQARNFFFQ--SGLPQPVLAQIWALADMNNDGRM 83
Query: 439 DYIEFITATMH 449
D +EF A M
Sbjct: 84 DQVEFSIA-MK 93
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 1e-10
Identities = 72/496 (14%), Positives = 141/496 (28%), Gaps = 156/496 (31%)
Query: 57 LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGV----------TY------LCTE 100
K + + + + I+ F L + + V Y + TE
Sbjct: 42 PKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 101 NSTGRQFACKSISKR-KLVTKND---KDDIKRE---IQIMQHLSGQPNIVEFKGAYEDKQ 153
I +R +L N K ++ R +++ Q L E +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL------------LELRP 149
Query: 154 SVHVV---MELCAG-GE--LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV----MH 203
+ +V+ + G G+ + A +C S V + +
Sbjct: 150 AKNVLIDGV---LGSGKTWV--------------ALDVCLS--YKVQCKMDFKIFWLNLK 190
Query: 204 RDLKPENFL-----LSSKDENALLKATDFGLSVF--IEEGKVY-RDIVGSAYYVAPE--- 252
PE L L + + +D ++ I + R ++ S Y
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENCLL 248
Query: 253 VLRRRYGKEIDIWSAGVILY------ILLSGVPPFWAET-EKGIFDAI---LQGDIDFES 302
VL ++ +A ILL+ T K + D + I +
Sbjct: 249 VLL-------NVQNAKAWNAFNLSCKILLT--------TRFKQVTDFLSAATTTHISLDH 293
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE-HPW----IKEGGEASDKPIDSAVLSR 357
K L+ + L P+ +VL +P I E D +
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQD--LPREVLTTNPRRLSIIAE--SIRDGL------AT 343
Query: 358 MKQFRAMN--KLKKLALKVIAENLSTEEIQGLKQMFTNI-----DTDNSGTITYEELKAG 410
++ +N KL ++ L E ++MF + I L
Sbjct: 344 WDNWKHVNCDKLTT-IIESSLNVLEPAE---YRKMFDRLSVFPPSAH----IP-TIL--- 391
Query: 411 LARLGSKLTEAEVQQLME------AADVDGNGTIDYIEFIT----------ATMHRHKLE 454
L+ + + +++V ++ + + I I +HR ++
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 455 RDDHLYKAFQHFDKDN 470
Y + FD D+
Sbjct: 452 H----YNIPKTFDSDD 463
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 16/154 (10%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P + +KL GK LGRG FG + +T R A K + ++ T ++ +
Sbjct: 20 PRDRLKL----GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALM 73
Query: 128 REIQIMQHLSGQPNIVEFKGAY-EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
E++I+ H+ N+V GA + + V++E C G L + +K +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYK 129
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220
++G + DLK ++S +A
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR 255
+HRDL N LLS E ++K DFGL+ I + Y + + APE +
Sbjct: 212 RKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268
Query: 256 -RRYGKEIDIWSAGVILY-ILLSGVPP 280
R Y + D+WS GV+L+ I G P
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C Length = 143 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 4e-10
Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 13/81 (16%)
Query: 405 EELKAGLARLGSKLTEAEVQ-QLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY--- 460
E L+ + + ++++ E+Q + D DGN +D +E TA H HK E +
Sbjct: 51 EHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMS 110
Query: 461 ---------KAFQHFDKDNSG 472
+ DK+N G
Sbjct: 111 EDELINIIDGVLRDDDKNNDG 131
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C Length = 143 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 3e-07
Identities = 17/87 (19%), Positives = 33/87 (37%), Gaps = 14/87 (16%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL--------GSKLTEAEV 423
+ +S +E+Q F D D + + EL + + ++E E+
Sbjct: 57 INKPEAEMSPQELQ--LHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDEL 114
Query: 424 QQL----MEAADVDGNGTIDYIEFITA 446
+ + D + +G IDY EF +
Sbjct: 115 INIIDGVLRDDDKNNDGYIDYAEFAKS 141
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 Length = 99 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 8e-10
Identities = 14/75 (18%), Positives = 33/75 (44%), Gaps = 3/75 (4%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
++ + ++ + ++ N+G + + A L + S L + + ++ + AD DG
Sbjct: 1 LSLTQLSSGNPVYEKYYRQVEAGNTGRVLALDAAAFLKK--SGLPDLILGKIWDLADTDG 58
Query: 435 NGTIDYIEFITATMH 449
G + EF A +
Sbjct: 59 KGVLSKQEFFVA-LR 72
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 Length = 863 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 1e-09
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 362 RAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA 421
R +N+++ L A+ +S E++ + F + D +G + E+ +A L +G + EA
Sbjct: 702 RTINEVENQILTRDAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEA 761
Query: 422 EVQQLMEAADVDGNGTIDYIEFITATMHRH--KLERDDHLYKAFQ 464
E ++M D + G + + FI M R + D + +F+
Sbjct: 762 EFARIMSIVDPNRMGVVTFQAFI-DFMSRETADTDTADQVMASFK 805
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 24/89 (26%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
I+ +F D D SG+++ E++ + G KL ++ Q++ A D ID+ F
Sbjct: 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPC-QLHQVIVARFADDELIIDFDNF 664
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + +LE L+K F+ D +N+G
Sbjct: 665 VRCLV---RLEI---LFKIFKQLDPENTG 687
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 5e-09
Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
I+ + ++ +TD SGTI EL G L + + ++ D G +D+ F
Sbjct: 803 IKKWQGIYKRFETDRSGTIGSNELPGAFEAAGFHLNQ-HIYSMIIRRYSDETGNMDFDNF 861
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
I+ + +L+ +++AF+ DK+ +G
Sbjct: 862 ISCLV---RLDA---MFRAFRSLDKNGTG 884
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 16/101 (15%), Positives = 41/101 (40%), Gaps = 17/101 (16%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA--------EVQQLMEAADV 432
+EE + +++F + + ++ EL L ++ ++ + + ++ D
Sbjct: 727 SEEERQFRKLFVQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDS 785
Query: 433 DGNGTIDYIEFITATMHRHKLERDDHLYK-AFQHFDKDNSG 472
D G + + EF L + ++ ++ F+ D SG
Sbjct: 786 DTTGKLGFEEF-------KYLWNNIKKWQGIYKRFETDRSG 819
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L Length = 714 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 9e-09
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
IQ ++++ ID D SGT+ E++ L G KL ++ Q++ A D ID+ F
Sbjct: 604 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPC-QLHQVIVARFADDELIIDFDNF 662
Query: 444 ITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + +LE L+K F+ D +N+G
Sbjct: 663 VRCLV---RLEI---LFKIFKQLDPENTG 685
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 2e-08
Identities = 37/243 (15%), Positives = 64/243 (26%), Gaps = 60/243 (24%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK-----DDIKREIQIMQH 135
+++G G FG + + A K I+ N ++I EI I +
Sbjct: 22 LQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 136 LSGQ--------PNIVEFKGAY------------------------------EDKQSVHV 157
LS + + + +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSS- 215
V+E GG +++ K S A SI + + + + HRDL N LL
Sbjct: 140 VLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 216 -------KDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA-----PEVLRRRYGKEID 263
GL V I + + R ++ + D
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFD 258
Query: 264 IWS 266
I+
Sbjct: 259 IYR 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 26/130 (20%)
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGK--VYRDIVGSAYYVAPEV 253
H ++HRD+K N LL DEN + K TDFG+S E + + + G+ Y+ PE
Sbjct: 156 HTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 254 LRRRYGKE-IDIWSAGVILYILLSGVPPF-------------WAET--EKGIFDAI---- 293
+ E D++S GV+L+ +L WA G + I
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 294 LQGDIDFESA 303
L I ES
Sbjct: 273 LADKIRPESL 282
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A Length = 106 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 6e-08
Identities = 16/71 (22%), Positives = 34/71 (47%), Gaps = 4/71 (5%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+ E+ +F ++ +G ++ +++K L SKL + ++ E +D+D +G +
Sbjct: 9 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLN--SKLPVDILGRVWELSDIDHDGML 65
Query: 439 DYIEFITATMH 449
D EF M
Sbjct: 66 DRDEFAV-AMF 75
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A Length = 624 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 1e-07
Identities = 12/80 (15%), Positives = 30/80 (37%), Gaps = 3/80 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ D + + ++ELK L L ++ + +++ D +++ E T
Sbjct: 13 IHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETF 72
Query: 447 TMHRHKLERDDHLYKAFQHF 466
L + + +AF+
Sbjct: 73 Y---KMLTQRAEIDRAFEEA 89
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 37/160 (23%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGK--VYRDIVGSAYYVAPEVLRRR 257
+HRD+K N LL DE K +DFGL+ + + + IVG+ Y+APE LR
Sbjct: 154 HIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210
Query: 258 YGKEIDIWSAGVILYILLSGVPPF-----------WAE---TEKGIFDAILQGDIDFESA 303
+ DI+S GV+L +++G+P E E+ + ID
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY----ID---- 262
Query: 304 PWPTISSSAKDLVRRM-------LTQDPKKRITSAQVLEH 336
++ + V M L + KR +V +
Sbjct: 263 --KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 15/87 (17%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARL-----GSKLTEAEVQQL----MEAADVDGNGT 437
F D D+ GT+ E+L + L ++L+ +E++QL +E +D+D +GT
Sbjct: 100 SHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGT 159
Query: 438 IDYIEFITATMHRHKLERDDHLYKAFQ 464
I+ EF + R +F+
Sbjct: 160 INLSEFQHV------ISRSPDFASSFK 180
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 12/104 (11%)
Query: 378 NLSTEEIQGLKQMFTNI--------DTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA 429
L+ +EI + F + ++ + +E++ + L L + + + ++
Sbjct: 13 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKERICRVFST 71
Query: 430 ADVDGNGTIDYIEFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
+ ++ + +F+ ++ D + AF+ FD D+ G
Sbjct: 72 SP--AKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDG 113
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 15/87 (17%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARL-----GSKLTEAEVQQL----MEAADVDGNGT 437
F D D+ GT+ E+L + L ++L+ +E++QL +E +D+D +GT
Sbjct: 131 SHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGT 190
Query: 438 IDYIEFITATMHRHKLERDDHLYKAFQ 464
I+ EF + R +F+
Sbjct: 191 INLSEFQHV------ISRSPDFASSFK 211
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 16/119 (13%), Positives = 42/119 (35%), Gaps = 16/119 (13%)
Query: 366 KLKKLALKVIAE--NLSTEEIQGLKQMFT--------NIDTDNSGTITYEELKAGLARLG 415
+L K L + L+ +EI + F ++++ + +E++ +
Sbjct: 30 RLSKELLAEYQDLTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKA 89
Query: 416 SKLTEAEVQQLMEAADVD-GNGTIDYIEFITATMHRHKL-ERDDHLYKAFQHFDKDNSG 472
+ +++ ++ + +F+ D + AF+ FD D+ G
Sbjct: 90 NPF----KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDG 144
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 27/127 (21%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRRRY 258
++HRD+K N LL DE DFGL+ ++ V + G+ ++APE L
Sbjct: 155 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 259 GKE-IDIWSAGVILYILLSGVPPF---------------WAET--EKG----IFDAILQG 296
E D++ GV+L L++G F W + ++ + D LQG
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271
Query: 297 DIDFESA 303
+ E
Sbjct: 272 NYKDEEV 278
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A Length = 139 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-05
Identities = 17/70 (24%), Positives = 31/70 (44%), Gaps = 4/70 (5%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
++ ++F + +G IT K + + SKL + ++ + ADVD +G +D
Sbjct: 46 VGKDKPTYDEIFYTLS-PVNGKITGANAKKEMVK--SKLPNTVLGKIWKLADVDKDGLLD 102
Query: 440 YIEFITATMH 449
EF H
Sbjct: 103 DEEFAL-ANH 111
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A Length = 100 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-05
Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 5/62 (8%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEF 443
+ + + I+ + L + L +L++ D + +G I + E+
Sbjct: 18 YKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEY 77
Query: 444 IT 445
T
Sbjct: 78 WT 79
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A Length = 93 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-05
Identities = 8/50 (16%), Positives = 21/50 (42%), Gaps = 1/50 (2%)
Query: 397 DNSGTITYEELKAGLAR-LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
N + ++LK L + + + D++ +G +++ EF+
Sbjct: 24 GNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLI 73
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 Length = 78 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-05
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 5/71 (7%)
Query: 380 STEE-IQGLKQMFTNIDTD--NSGTITYEELKAGLAR-LGSKLT-EAEVQQLMEAADVDG 434
S ++ LK +F + ++ EELK + S L + L + D +G
Sbjct: 1 SAQKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNG 60
Query: 435 NGTIDYIEFIT 445
+G + + EF
Sbjct: 61 DGEVSFEEFQV 71
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 Length = 103 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 5e-05
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 16/77 (20%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE----------------VQQLMEAA 430
K F D ++ G + +EL+A + K+ + + + +M+
Sbjct: 22 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNV 81
Query: 431 DVDGNGTIDYIEFITAT 447
D + + + EF+ +T
Sbjct: 82 DTNQDRLVTLEEFLAST 98
|
| >2qpt_A EH domain-containing protein-2; protein-nucleotide complex, membrane protein, endocytosis; HET: ANP; 3.10A {Mus musculus} Length = 550 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 25/145 (17%), Positives = 57/145 (39%), Gaps = 4/145 (2%)
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM 364
+ ++ + + ML QD K + + E ++ G +
Sbjct: 378 FHSLKPKLLEALDDMLAQDIAKLMPLLRQEELESVEAGVAGGAFEGTRMGPFVERGPDEA 437
Query: 365 NKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQ 424
+ + + AE + T++ ++F N+ G ++ + K + +KL + +
Sbjct: 438 IEDGEEGSEDDAEWVVTKDKSKYDEIFYNLA-PADGKLSGSKAKTWMVG--TKLPNSVLG 494
Query: 425 QLMEAADVDGNGTIDYIEFITATMH 449
++ + +DVD +G +D EF A H
Sbjct: 495 RIWKLSDVDRDGMLDDEEFALA-SH 518
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A Length = 113 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 1e-04
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 7/69 (10%)
Query: 384 IQGLKQMFTN--IDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNG 436
+ + F + + ELK L R LG + EA Q+LM D + +
Sbjct: 21 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDN 80
Query: 437 TIDYIEFIT 445
+D+ E+
Sbjct: 81 EVDFQEYCV 89
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A Length = 96 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 2e-04
Identities = 13/69 (18%), Positives = 29/69 (42%), Gaps = 10/69 (14%)
Query: 387 LKQMFTNIDT-----DNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNG 436
M T + T + G +T E+L+ + + L ++ V ++M+ D +G
Sbjct: 5 EHAMETMMFTFHKFAGDKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDG 64
Query: 437 TIDYIEFIT 445
+ + F +
Sbjct: 65 KVGFQSFFS 73
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* Length = 93 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 3e-04
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 7/69 (10%)
Query: 384 IQGLKQMFTN--IDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNG 436
+ + F + + ELK L R LG + EA Q+LM D + +
Sbjct: 9 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDN 68
Query: 437 TIDYIEFIT 445
+D+ E+
Sbjct: 69 EVDFQEYCV 77
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} Length = 104 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 4e-04
Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 5/54 (9%)
Query: 397 DNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
+ + ELK L R LG + EA Q+LM D + + +D+ E+
Sbjct: 27 GDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCV 80
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A Length = 90 | Back alignment and structure |
|---|
Score = 37.8 bits (88), Expect = 8e-04
Identities = 16/52 (30%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 397 DNSGTITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
+ T++ +ELK + + +GSKL +AE+ +LME D + + +++ E++T
Sbjct: 24 GDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVT 75
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.78 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.65 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.64 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.62 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.61 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.6 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.58 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.57 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 99.54 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.53 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.53 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 99.52 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.52 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 99.5 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.49 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 99.49 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.49 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.49 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.48 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.48 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.47 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 99.47 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.47 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.46 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.46 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.45 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.44 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.43 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.43 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 99.43 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.42 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.42 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 99.41 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.41 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.4 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 99.38 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 99.38 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 99.38 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 99.37 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.36 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.36 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.35 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.35 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.35 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 99.34 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 99.34 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 99.34 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 99.33 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.33 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 99.33 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.33 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 99.33 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 99.33 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 99.32 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.32 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 99.32 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 99.32 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 99.32 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 99.32 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.32 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 99.31 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 99.31 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 99.31 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 99.3 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 99.3 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.29 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 99.29 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.29 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.29 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 99.28 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 99.28 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.28 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 99.28 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 99.27 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.26 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 99.26 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 99.26 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 99.25 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 99.25 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 99.25 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 99.25 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.25 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.25 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.25 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.25 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 99.25 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.25 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 99.25 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 99.25 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 99.25 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 99.25 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 99.24 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.24 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 99.24 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 99.24 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.24 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.23 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.23 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 99.23 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.23 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.22 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.22 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.22 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 99.21 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.2 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 99.2 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.19 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 99.19 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.19 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.18 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 99.18 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.18 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 99.18 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 99.17 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.17 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 99.17 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 99.17 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.16 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 99.15 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.15 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.15 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.15 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.15 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.14 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 99.13 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 99.13 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 99.13 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 99.13 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 99.12 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.12 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.11 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.11 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.11 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 99.1 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.1 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 99.09 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 99.09 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 99.09 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 99.09 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.09 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 99.08 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.08 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.08 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.08 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.07 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.07 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 99.06 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.06 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 99.06 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.06 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 99.05 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.05 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.05 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 99.04 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.04 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.03 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.03 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.03 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.02 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.02 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.01 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.01 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 99.01 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.0 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 98.99 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.99 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.98 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.97 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 98.97 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 98.97 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 98.95 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 98.95 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 98.94 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.94 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.93 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.93 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.93 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.93 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 98.93 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.92 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 98.92 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 98.92 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 98.92 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 98.91 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.91 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.9 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.9 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.9 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 98.9 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 98.89 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 98.89 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.89 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 98.89 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.88 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.88 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 98.88 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.88 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.87 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.87 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 98.87 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 98.87 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 98.87 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.86 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.86 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.84 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 98.84 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 98.83 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 98.83 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.82 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.82 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 98.8 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.8 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 98.79 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 98.79 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.79 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 98.79 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 98.79 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 98.78 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 98.77 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.76 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.76 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.75 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 98.74 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.73 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 98.71 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 98.7 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 98.7 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.68 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.66 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.65 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.64 |
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-72 Score=577.19 Aligned_cols=400 Identities=36% Similarity=0.624 Sum_probs=354.8
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc----------ccHHHHHHHHHHHHhccCCCC
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK----------NDKDDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~hp~ 141 (472)
.....+..+|.++++||+|+||+||+|+++.+++.||+|++.+...... .....+.+|+.+++++. |||
T Consensus 29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 3445678899999999999999999999999999999999976543211 34577899999999995 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCc
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~ 221 (472)
|+++++++.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++....
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999976555567
Q ss_pred EEEeecCCceeccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC
Q 012039 222 LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
+||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+++..+..+.+.+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999999998877666667789999999999988899999999999999999999999999999999999999988888
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCC---CCchHHHHHHHHHHhhhHhHHHHHHHHHhh
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK---PIDSAVLSRMKQFRAMNKLKKLALKVIAEN 378 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 378 (472)
...|..+|+++++||++||+.||.+|||+.++|+||||+........ ......+.++++|...+++++.++..+...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~ 347 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK 347 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 77788999999999999999999999999999999999876543221 122456778889999999999999988877
Q ss_pred c-hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc--------CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 379 L-STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL--------GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 379 ~-~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~--------~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+ +.+++.+++++|..+|.|++|.|+.+||..+++.+ |...++++++.+|..+|.|++|.|+|+||+.++..
T Consensus 348 ~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~ 427 (504)
T 3q5i_A 348 LTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMD 427 (504)
T ss_dssp TSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSC
T ss_pred CCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 6 88899999999999999999999999999999988 55778899999999999999999999999998876
Q ss_pred cccCCcHHHHHHHHHhhcCCCCC
Q 012039 450 RHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 450 ~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
......++.++.+|+.||+|+||
T Consensus 428 ~~~~~~~~~~~~~F~~~D~d~dG 450 (504)
T 3q5i_A 428 KQILFSEERLRRAFNLFDTDKSG 450 (504)
T ss_dssp HHHHTCHHHHHHHHHHHCTTCCS
T ss_pred hhcccCHHHHHHHHHHhcCCCCC
Confidence 65556678999999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-73 Score=578.19 Aligned_cols=401 Identities=39% Similarity=0.684 Sum_probs=355.3
Q ss_pred ccccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 70 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
.......+..+|++++.||+|+||+||+|+++.++..||+|++.+.... ......+.+|+.+++.+. ||||+++++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 105 (494)
T 3lij_A 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLYDFF 105 (494)
T ss_dssp CCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred eecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 3344456788999999999999999999999999999999999765432 334677899999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.+...+|+|||||.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+...+....+||+|||+
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 99999999999999999999998888999999999999999999999999999999999999997666677899999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
+............+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+++..+..+...+....|..+|
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred CeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 99887766666778999999999998889999999999999999999999999999999999999999998888889999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC----CCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHhhc-hhhHH
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE----ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENL-STEEI 384 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~ 384 (472)
+++++||++||+.||.+|||+.++|+||||+.... ....+.....+.++++|...++++++++..+...+ +.+++
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~ 345 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEET 345 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHH
Confidence 99999999999999999999999999999986421 12233445678889999999999999999988776 78889
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCC--------CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGS--------KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~--------~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.+++++|+.+|.|++|.|+.+||..+++.+|. ..+.++++.+|..+|.|++|.|+|+||+.++........+
T Consensus 346 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~ 425 (494)
T 3lij_A 346 KELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSK 425 (494)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCH
T ss_pred HHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccccH
Confidence 99999999999999999999999999999864 4457889999999999999999999999988766555677
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.||+|+||
T Consensus 426 ~~~~~~F~~~D~d~~G 441 (494)
T 3lij_A 426 DKLESAFQKFDQDGNG 441 (494)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHCCCCCC
Confidence 8999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-72 Score=574.50 Aligned_cols=397 Identities=41% Similarity=0.693 Sum_probs=355.2
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++++. ||||+++++++.+.+.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence 456789999999999999999999999999999999998766544556788999999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+|||||.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++....
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999999999988899999999999999999999999999999999999999766667889999999998877
Q ss_pred CCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+++..+..+.+.+..+.|..+|+++++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 66655667899999999999889999999999999999999999999999999999999999988888888899999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCCC---CCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHhhc-hhhHHhhhhhh
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGE---ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENL-STEEIQGLKQM 390 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~ 390 (472)
||++||+.||.+|||+.++|+||||+.... ....+.....+.++++|...+++++.++..+...+ +.+++++++++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~ 340 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAI 340 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHHH
Confidence 999999999999999999999999986543 22334456778899999999999999999988766 78889999999
Q ss_pred hccccCCCCCcccHHHHHHH----HHHcCCCCC-------HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHH
Q 012039 391 FTNIDTDNSGTITYEELKAG----LARLGSKLT-------EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHL 459 (472)
Q Consensus 391 F~~~D~~~~G~i~~~el~~~----l~~~~~~~~-------~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l 459 (472)
|..+|.|++|.|+.+||..+ ++.+|...+ +++++.+|..+|.|++|.|+|+||+.++........++.+
T Consensus 341 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~ 420 (484)
T 3nyv_A 341 FHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERL 420 (484)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCcHHHH
Confidence 99999999999999999554 455577777 7899999999999999999999999988765444566889
Q ss_pred HHHHHhhcCCCCC
Q 012039 460 YKAFQHFDKDNSG 472 (472)
Q Consensus 460 ~~~F~~~D~d~~G 472 (472)
+.+|+.||+|+||
T Consensus 421 ~~~F~~~D~d~dG 433 (484)
T 3nyv_A 421 ERAFRMFDSDNSG 433 (484)
T ss_dssp HHHHHHHCTTCCS
T ss_pred HHHHHHHCCCCCC
Confidence 9999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-72 Score=570.83 Aligned_cols=395 Identities=40% Similarity=0.700 Sum_probs=352.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+++++. ||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence 467899999999999999999999999999999999976443 2334678899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|+|||||.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+...+....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888999999999999999999999999999999999999998766777899999999987766
Q ss_pred CcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
.......+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+++..+..+.+.+..+.|..+|+++++|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999999889999999999999999999999999999999999999999888888888999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccCCCCCCC----CCchHHHHHHHHHHhhhHhHHHHHHHHHhhc-hhhHHhhhhhh
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK----PIDSAVLSRMKQFRAMNKLKKLALKVIAENL-STEEIQGLKQM 390 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~ 390 (472)
|.+||+.||.+|||+.++|+||||+........ +.....+.++++|...+++++.++.++...+ +.+++++++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~ 336 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI 336 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence 999999999999999999999999876443322 1224456788999999999999999888776 78889999999
Q ss_pred hccccCCCCCcccHHHHHHHHH----HcCCCCC----------HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 391 FTNIDTDNSGTITYEELKAGLA----RLGSKLT----------EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 391 F~~~D~~~~G~i~~~el~~~l~----~~~~~~~----------~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
|..+|.|+||.|+.+||..++. .+|...+ .++++.+|..+|.|++|.|+|+||+.++........+
T Consensus 337 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~ 416 (486)
T 3mwu_A 337 FRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSR 416 (486)
T ss_dssp HHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTTTCCH
T ss_pred HHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhccchH
Confidence 9999999999999999965554 4566655 8889999999999999999999999988776666678
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.||+|+||
T Consensus 417 ~~~~~~F~~~D~d~dG 432 (486)
T 3mwu_A 417 ERMERAFKMFDKDGSG 432 (486)
T ss_dssp HHHHHHHHHHCSSCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 8999999999999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-66 Score=486.30 Aligned_cols=256 Identities=33% Similarity=0.579 Sum_probs=234.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence 47999999999999999999999999999999998766544556788999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999 566789999999999875432
Q ss_pred --ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 238 --VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 238 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
...+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|.++.+.++ ..+|+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHH
Confidence 3456789999999999975 599999999999999999999999999999999999999887665 368999999
Q ss_pred HHHHhcccCCCCCCCHHH------HhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQ------VLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~------~l~h~~~~~~ 342 (472)
||++||++||++|||++| +++||||+..
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999987 5899999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-65 Score=492.36 Aligned_cols=259 Identities=29% Similarity=0.559 Sum_probs=231.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+....|++.++||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++|+ |||||+++++|.+++.+
T Consensus 71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL 146 (346)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 345689999999999999999999999999999999976542 34566889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||||+||+|.+++.+ +++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCC
Confidence 999999999999998865 579999999999999999999999999999999999999 5667899999999998754
Q ss_pred C-cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 G-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
. ......+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|..... .....+..+|++++
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK 301 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHH
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHH
Confidence 4 34556799999999999874 699999999999999999999999999999888888876532 33344567999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+||.+||+.||++|||++|+|+||||++..
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-64 Score=472.52 Aligned_cols=254 Identities=37% Similarity=0.654 Sum_probs=215.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|++|+ |||||++++++++++.+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence 58999999999999999999999999999999998776655556778999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
|||| +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 9999 78999999999999999999999999999999999999999999999999 5667799999999998776666
Q ss_pred eeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
..+.+||+.|+|||++.+. | +.++|||||||++|+|++|+.||.+.+..+++..+..+...++ ..+|+++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 6678999999999999754 4 6899999999999999999999999999999999998876654 46899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.+||+.||++|||++|+|+||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-63 Score=490.15 Aligned_cols=260 Identities=29% Similarity=0.559 Sum_probs=232.0
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+....|++.++||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+ |||||+++++|.+++.
T Consensus 147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 222 (423)
T ss_dssp SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence 345678999999999999999999999999999999997643 234567889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|||||||+||+|.+++.. +++++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECC
Confidence 9999999999999998864 579999999999999999999999999999999999999 566789999999999875
Q ss_pred CC-cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EG-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.. ......+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..|..... .....+..+|+++
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~ 377 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSL 377 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHH
T ss_pred CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHH
Confidence 44 34456789999999999874 699999999999999999999999999999888888877532 3334567899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
++||.+||+.||++|||++|+|+||||++..
T Consensus 378 ~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 378 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-64 Score=481.45 Aligned_cols=256 Identities=27% Similarity=0.546 Sum_probs=224.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|+ |||||+++++|++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999987654 3345678999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||+||+|.++|...+ .+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence 99999999999997543 47999999999999999999999999999999999999 56677999999999876543
Q ss_pred c-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..|..+.+.. .+..+|+++++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence 2 2345689999999999975 59999999999999999999999999999999999999886542 23578999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
||.+||+.||++|||++|+|+||||++.
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=462.26 Aligned_cols=255 Identities=24% Similarity=0.450 Sum_probs=220.6
Q ss_pred ce-EEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CCe
Q 012039 80 HY-SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQS 154 (472)
Q Consensus 80 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 154 (472)
+| ++.++||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|++|+ |||||+++++|.+ +..
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcE
Confidence 44 788899999999999999999999999999976543 3445678999999999995 9999999999875 356
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +.++.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEe
Confidence 8999999999999999999899999999999999999999999998 99999999999995 2356799999999986
Q ss_pred ccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 233 IEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
... ......+||+.|||||++.++|+.++|||||||++|+|+||+.||.+... ..++..+..+.... .....++++
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~ 258 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPE 258 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCHH
T ss_pred CCC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--CCCccCCHH
Confidence 443 34456799999999999998899999999999999999999999976544 44555555543322 223467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+++||.+||+.||++|||++|+|+||||++
T Consensus 259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-63 Score=466.61 Aligned_cols=255 Identities=28% Similarity=0.504 Sum_probs=221.6
Q ss_pred cceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
++|++++.||+|+||+||+|++. .+++.||+|++.+.... ......+.+|+.+|++|+ |||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 47999999999999999999984 46789999999876542 223456889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence 9999999999999999999999999999999999999999999999999999999999 5667899999999986543
Q ss_pred C-cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 G-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
. ......+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+..+++..|.++...++ ..+|++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence 3 33456789999999999874 599999999999999999999999999999999999998876654 46899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCccccC
Q 012039 314 DLVRRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
+||++||++||++||| ++|+++||||+..
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999999998 5799999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-62 Score=465.83 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=222.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|++.++||+|+||+||+|+++.+|+.||||++++... ..+|+.++++|+ |||||++++++.+++.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 3579999999999999999999999999999999975432 146999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC-cEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~-~~kl~Dfg~~~~~~~~ 236 (472)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+|+.+...
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC---
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCC
Confidence 999999999999999989999999999999999999999999999999999999994 443 5999999999977543
Q ss_pred cc------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 KV------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~~------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.. ....+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+..+++..|......+. ..++.+|
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCC
Confidence 21 123579999999999875 599999999999999999999999999888888888887765433 2346799
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHH-------------hcCCccccCCCC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQV-------------LEHPWIKEGGEA 345 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~-------------l~h~~~~~~~~~ 345 (472)
+++.+||.+||++||++|||+.|+ |+|||+.+...+
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 999999999999999999999997 679999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=469.59 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=224.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 151 (472)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++|+ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccc
Confidence 45689999999999999999999999999999999976432 2334567889999999995 9999999998763
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
.+.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeeccee
Confidence 467999999995 6899999988999999999999999999999999999999999999999 56778999999999
Q ss_pred eeccCC-----cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 231 VFIEEG-----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 231 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
+.+... ......+||+.|+|||++.+ .++.++||||+|||+|+|++|++||.+.+..+.+..|......+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 23345789999999998864 47999999999999999999999999999988888886533222111
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 304 ---------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 304 ---------------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.++.+|+++.+||.+||++||++|||++|+|+||||++...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 12467999999999999999999999999999999997643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=445.57 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=212.1
Q ss_pred ccccceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
.+.++|+++++||+|+||+||+|+++ .+++.||+|++.+. .....+.+|+++|+.+.+|||||+++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 46678999999999999999999875 46789999988643 23567889999999997799999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+++|||||||+||+|.+++ +.+++.+++.++.||+.||.|||++||+||||||+|||++. ..+.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCcc
Confidence 9999999999999999988 36999999999999999999999999999999999999953 336799999999986
Q ss_pred ccCCc-----------------------------ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCC
Q 012039 233 IEEGK-----------------------------VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPF 281 (472)
Q Consensus 233 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 281 (472)
..... .....+||+.|+|||++.+ .|+.++||||+|||+|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 54321 1234579999999999864 4899999999999999999999999
Q ss_pred CCC-ChHHHHHHHHcC--------------------------------------C------------ccCCCCCCCCCCH
Q 012039 282 WAE-TEKGIFDAILQG--------------------------------------D------------IDFESAPWPTISS 310 (472)
Q Consensus 282 ~~~-~~~~~~~~i~~~--------------------------------------~------------~~~~~~~~~~~s~ 310 (472)
... ++.+.+..|..- . .......|..+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 654 343444333210 0 0011234677999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++++||++||+.||++|||++|+|+||||++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=471.46 Aligned_cols=265 Identities=35% Similarity=0.637 Sum_probs=242.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+.+.++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|+.|+ |||||+++++|.+++.
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNE 228 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 445678999999999999999999999999999999997543 234677899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+++.+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEEC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEc
Confidence 9999999999999999864 4679999999999999999999999999999999999999642 3467999999999998
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|......++...|..+|+++
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 88777778899999999999875 59999999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
++||++||+.||.+|||+.|+|+||||+....
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999997543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-58 Score=434.70 Aligned_cols=253 Identities=25% Similarity=0.454 Sum_probs=200.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ----- 153 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 153 (472)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence 46999999999999999999999999999999997543 2344577899999999995 999999999987544
Q ss_pred -------eEEEEEeccCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEE
Q 012039 154 -------SVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 154 -------~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
.+|||||||+||+|.+++..... ..+..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence 47999999999999999987655 3456788999999999999999999999999999999 5566799
Q ss_pred EeecCCceeccCCcc-------------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH-H
Q 012039 224 ATDFGLSVFIEEGKV-------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK-G 288 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 288 (472)
|+|||+|+....... ....+||+.|||||++.+ .|+.++|||||||++|+|++ ||.+.... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987654321 223579999999999875 59999999999999999996 78654322 2
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+..+.....+ +.+...++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 33344433221 12234567889999999999999999999999999998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=460.31 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=222.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHH---HHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE---IQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E---~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
-++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+| +.+++.+ +|||||+++++|++.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence 3579999999999999999999999999999999987655434444555555 4555556 59999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|||||||+||+|.++|.+.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999 567789999999999876
Q ss_pred CCcceeeccCCCCCCchhhhh-c-ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR-R-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
... ..+.+||+.|||||++. + .|+.++||||||||+|+|++|.+||.+.+ ..++...+......++ ..+|
T Consensus 344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S 418 (689)
T 3v5w_A 344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFS 418 (689)
T ss_dssp SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCC
Confidence 543 34579999999999985 3 59999999999999999999999997643 3345566666655443 4689
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
+++++||.+||+.||.+|++ ++||++||||+..
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999999999998 7999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-57 Score=426.51 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=216.1
Q ss_pred ccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
+.+|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+.+|++|+ |||||++++++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 568999999999999999999875 35788999998643 2345678999999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC
Q 012039 153 QSVHVVMELCAGGELFDRIIAK-------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 219 (472)
+.+|||||||+||+|.++|... ..+++..+..|+.||+.||.|||+++|+||||||+|||+ +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 9999999999999999999754 369999999999999999999999999999999999999 566
Q ss_pred CcEEEeecCCceeccCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 012039 220 ALLKATDFGLSVFIEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 294 (472)
+.+||+|||+|+......... ...||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 789999999998765443322 246899999999986 569999999999999999998 899999999999999998
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
++..... ...+|+++.+|+.+||+.||++|||+.+++ +|++
T Consensus 245 ~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 245 QGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred cCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 8764322 246899999999999999999999999984 4554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=425.30 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=207.3
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
|+.-.+++.++++||+|+||+||+|++.. .||||+++.... .....+.|.+|+.+|++|+ |||||++++++.+ +
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-D 104 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-S
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-C
Confidence 34456688999999999999999998653 599999865432 3445678999999999995 9999999998765 5
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+|||||||+||+|.++|... .++++..+..|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCcee
Confidence 689999999999999999754 579999999999999999999999999999999999999 5677899999999987
Q ss_pred ccCCc---ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC--CC
Q 012039 233 IEEGK---VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE--SA 303 (472)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--~~ 303 (472)
..... .....+||+.|||||++.. .|+.++|||||||+||||+||+.||.+.+....+..+.......+ ..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 65322 2345689999999999853 489999999999999999999999988766555544444333222 23
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+..+|+++.+||.+||+.||++|||+.++++
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 34678999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=449.58 Aligned_cols=300 Identities=39% Similarity=0.726 Sum_probs=265.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.++|++++.||+|+||+||+|.++.+|+.||+|++.+... .......+.+|+.+++++. ||||+++++++.+.+.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH 84 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence 3467799999999999999999999999999999999976543 2334567899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999998999999999999999999999999999999999999999766567889999999998765
Q ss_pred CCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+..+...++...|..+|+++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 433 3345689999999999875 59999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHH
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIA 376 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 376 (472)
++||.+||+.||++|||+.++|+||||+..............+..+++|...++++.+++..+.
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~ 308 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVML 308 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEEC
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998654433344456778899999999999888776553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=428.04 Aligned_cols=249 Identities=21% Similarity=0.362 Sum_probs=209.6
Q ss_pred ccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+|.+.++||+|+||+||+|+++ .+++.||||+++.. .....+.|.+|+.+|++|+ |||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 457899999999999999999865 36789999999643 3345678999999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 153 QSVHVVMELCAGGELFDRIIAK---------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
+.+|||||||+||+|.+++... +++++..+..|+.||+.||.|||+++|+||||||+|||+ +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 9999999999999999998653 358999999999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.+..+||+|||+++....... ....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+.+..+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 677899999999987654332 234679999999999874 69999999999999999999 8999999999899888
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+.++... .....+|+++.+|+.+||+.||++|||+.|++++
T Consensus 273 i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8876432 1224689999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-56 Score=434.01 Aligned_cols=300 Identities=38% Similarity=0.714 Sum_probs=267.1
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++++|. ||||+++++++.+.+.
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF 102 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence 4567799999999999999999999999999999999976543 2344577899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+|||||.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+..++....+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999999999888889999999999999999999999999999999999999766666779999999998877
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+..+...++...|..++++++
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 6655566789999999999875 589999999999999999999999999999999999999998888888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHH
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIA 376 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 376 (472)
+||.+||+.||++|||+.++|+||||...............+..+++|...++++..++..+.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 325 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999998644333333456677888999999999888766554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-56 Score=421.24 Aligned_cols=250 Identities=19% Similarity=0.328 Sum_probs=216.0
Q ss_pred ccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
...+++.++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.++++|+ |||||++++++.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 457899999999999999999864 467889999986543 3345678999999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC
Q 012039 153 QSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~ 216 (472)
+.++||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++|+||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 9999999999999999999642 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCceeccCCc---ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHH
Q 012039 217 DENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFD 291 (472)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 291 (472)
+.++.+||+|||+++...... .....+||+.|+|||++. +.|+.++|||||||++|||+| |..||.+.+..+++.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 566789999999998765432 223457999999999886 569999999999999999998 899999999999999
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+..+.... ....+|+++.+|+.+||+.||++|||+.+|+++
T Consensus 259 ~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888765432 235789999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=426.74 Aligned_cols=267 Identities=38% Similarity=0.677 Sum_probs=241.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..+.++|++++.||+|+||+||+|+++.+|+.||+|++.+...... ...+.+.+|+.+++++. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence 4567899999999999999999999999999999999987553221 23578999999999995 9999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC-CCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~~~kl~Dfg~~ 230 (472)
...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999964321 237999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+.+.++...|..+|
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 98877666667789999999999875 68999999999999999999999999999999999999988888777778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+++++||.+||..||.+|||+.++|+||||+..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=425.03 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=214.5
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCC-----CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
.++...++|++++.||+|+||+||+|++..+ ++.||||++.... .......+.+|+.+|.++.+|||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4566778999999999999999999997654 3579999986543 23446779999999999976799999999
Q ss_pred EEEe-CCeEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 148 AYED-KQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 148 ~~~~-~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
++.+ ++.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9866 46789999999999999999753 348999999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
||+ +.++.+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+
T Consensus 216 ILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 216 ILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp EEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 999 5667899999999987654432 22357899999999886 469999999999999999998 999998865
Q ss_pred h-HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 286 E-KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 286 ~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
. ..+...+..+.. ... ...+|+++.+||.+||+.||++|||+.++++|
T Consensus 293 ~~~~~~~~i~~g~~-~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTR-MRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCC-CCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4 444455555432 222 24689999999999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=428.45 Aligned_cols=261 Identities=36% Similarity=0.644 Sum_probs=220.5
Q ss_pred ccccceEEc-ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe---
Q 012039 76 DVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (472)
Q Consensus 76 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 151 (472)
.+.++|.+. +.||+|+||+||+|+++.+++.||||++.. ...+.+|+.++.++.+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 455678776 689999999999999999999999999852 24577899998776679999999999876
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
...+|||||||+||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667999999999999999998653 59999999999999999999999999999999999999765557889999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCccCCCC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK----GIFDAILQGDIDFESA 303 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~ 303 (472)
++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .....+..+.+.++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 999876655556678999999999986 46899999999999999999999999875432 3567777888888888
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.|..+|+++.+||++||+.||++|||+.++|+||||.....
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 88899999999999999999999999999999999986543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=421.32 Aligned_cols=299 Identities=36% Similarity=0.644 Sum_probs=246.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC--cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+.++|++.+.||+|+||+||+|+++.+++.||||++....... ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 45678999999999999999999999999999999986543221 224678999999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 154 SVHVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.+|+|||||+|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999998877543 3589999999999999999999999999999999999997666667799999999
Q ss_pred ceeccCCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 230 SVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 230 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
+........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ....+..+..+...+....|..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 988765432 345689999999999864 5899999999999999999999999875 4567777888777766666678
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHH
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIA 376 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 376 (472)
+|+++++||.+||..||++|||+.++|+||||+..............+..+++|...++++..+...+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 327 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVS 327 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----------
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998654322222334566778888888888777665543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=413.92 Aligned_cols=295 Identities=40% Similarity=0.701 Sum_probs=239.3
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+.+.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++++. ||||+++++++.+.+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPT 121 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecCC
Confidence 3456788999999999999999999999999999999987532 3456889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999999988888999999999999999999999999999999999999976555788999999999877
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+....+..++.+
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 65555556789999999999875 58999999999999999999999998765544 67778887777777777889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHH
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIA 376 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 376 (472)
+.+||.+||..||++|||+.++|+||||+....... ........+++|....++++.+....+
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV--HMDTAQKKLQEFNARRKLKAAVKAVVA 344 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS--CCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh--hhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999986543222 235566778888888888887766554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=415.08 Aligned_cols=263 Identities=29% Similarity=0.588 Sum_probs=238.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++++.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence 3567999999999999999999999999999999998643 234567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 9999999999999999765 369999999999999999999999999999999999999642 25679999999999887
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...+....|+.+|.++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 7766677789999999999875 479999999999999999999999999999999999999988887777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
+||.+||..||.+|||+.++|+||||+....
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=409.24 Aligned_cols=258 Identities=36% Similarity=0.628 Sum_probs=233.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence 35689999999999999999999999999999999976543 3345677889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 999999999999999988899999999999999999999999999999999999999 56677999999999887766
Q ss_pred cceeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+..+...++. .+|+++.+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 243 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCEN 243 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence 666677899999999998753 4 57899999999999999999999999999999999888766553 57999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||++||..||.+|||++++|+||||+...
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=413.17 Aligned_cols=258 Identities=29% Similarity=0.532 Sum_probs=228.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 35899999999999999999999999999999999865443445567788999999998779999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-C
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-G 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~ 236 (472)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999 5667899999999986432 2
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..|..+...++. .+++++.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 33455689999999999864 5999999999999999999999999999999999999998776653 489999999
Q ss_pred HHHhcccCCCCCCCH------HHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITS------AQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~------~~~l~h~~~~~~ 342 (472)
|++||+.||.+||++ +++++||||+..
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999999 899999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=412.37 Aligned_cols=258 Identities=34% Similarity=0.550 Sum_probs=209.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++++.||+|+||+||+|++..+++.||+|++.+.. .....+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEE
Confidence 3458999999999999999999999999999999997543 23467889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCcccccccc
Confidence 999999999999999888899999999999999999999999999999999999999532 2335999999999865544
Q ss_pred cceeeccCCCCCCchhhhhc-ccCC-ccchhhHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCCCCCH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGK-EIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.......||+.|+|||++.+ .+.. ++|||||||++|+|++|..||.+... ...+..+......++. ...+++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~ 249 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISP 249 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCH
Confidence 44456689999999998864 4544 48999999999999999999987543 3455555555544433 346899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++.+||.+||+.||.+|||+.++++||||...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=409.99 Aligned_cols=267 Identities=40% Similarity=0.714 Sum_probs=238.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++.+...... .....+.+|+.+++++. ||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 4567799999999999999999999999999999999976543221 24678999999999995 9999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC-CCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~~~kl~Dfg~~ 230 (472)
...+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999996433 2337999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+..++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 9876655556678999999999987 468999999999999999999999999999888888888877776666667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=404.40 Aligned_cols=256 Identities=32% Similarity=0.589 Sum_probs=230.7
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEE
Confidence 358999999999999999999999999999999997654433445678899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~ 236 (472)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+......++ ..+|+++.+|
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 235 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSL 235 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence 34456789999999999864 589999999999999999999999999998888888888766654 3589999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 316 i~~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
|.+||+.||.+|| +++++++||||+.
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999999 9999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=395.08 Aligned_cols=265 Identities=42% Similarity=0.763 Sum_probs=242.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.++|++.+.||+|+||.||+|.+..++..||+|++.+... ...+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD 80 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence 4567899999999999999999999999999999999875432 34678999999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++..++.+..+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999888899999999999999999999999999999999999999766677889999999999877
Q ss_pred CCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+...++...+..+++++.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 66666677899999999999888999999999999999999999999999999999999988877776666789999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||.+||+.||.+|||+.++|+||||+...
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=391.63 Aligned_cols=267 Identities=40% Similarity=0.771 Sum_probs=243.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence 356799999999999999999999999999999999976543 3344577889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||++..++....+||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999999998888999999999999999999999999999999999999997666667799999999988776
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 666666789999999999865 5899999999999999999999999999999999999999888888888899999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
||.+||+.||++|||+.++|+||||+....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=406.87 Aligned_cols=267 Identities=34% Similarity=0.618 Sum_probs=238.9
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.+++++. ||||+++++++.+...
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE 122 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCE
Confidence 345678999999999999999999999999999999986532 234567889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++|||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceec
Confidence 999999999999999887553 69999999999999999999999999999999999999532 3457999999999988
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....+..+++++
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 76666666789999999999864 58999999999999999999999999999888999999888888877788999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
.+||.+||+.||.+|||+.++|+||||+......
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 315 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCcccc
Confidence 9999999999999999999999999998754433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=409.01 Aligned_cols=258 Identities=27% Similarity=0.513 Sum_probs=225.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++++.+|||||++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 45899999999999999999999999999999999877655555566788999999988679999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee-ccCC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-IEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~-~~~~ 236 (472)
|||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++. ....
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999 5667899999999986 3334
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCC
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ....+...+......++ .
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~ 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----T
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----C
Confidence 44566789999999999875 5899999999999999999999999642 23446667777666554 3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITS------AQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~------~~~l~h~~~~~~ 342 (472)
.+|+++++||++||+.||.+||++ +++++||||+..
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 589999999999999999999985 799999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=402.75 Aligned_cols=261 Identities=38% Similarity=0.647 Sum_probs=232.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++.+.||+|+||.||+|+++.+++.||+|++.+... ...+|+.++.++.+||||+++++++.+.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 467799999999999999999999999999999999975432 2346889999986799999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC-CCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~~~kl~Dfg~~~~~~ 234 (472)
|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999999888999999999999999999999999999999999999986433 33569999999998765
Q ss_pred CCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCC---CChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA---ETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..+.+.+....|..+|
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 432 3445689999999999875 489999999999999999999999986 45677888899998888888888999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+++++||++||..||++|||+.++|+||||....
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 9999999999999999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=403.65 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=230.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|.+.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 45899999999999999999999999999999999765433344567788999999987569999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-C
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-G 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~ 236 (472)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCC
Confidence 99999999999999988899999999999999999999999999999999999999 5667899999999986432 2
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+...++ ..+|+++++|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHH
Confidence 33456789999999999865 589999999999999999999999999999999999988766554 3589999999
Q ss_pred HHHhcccCCCCCCCHH-HHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITSA-QVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~-~~l~h~~~~~~ 342 (472)
|.+||..||++||++. ++++||||+..
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999998 99999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=396.16 Aligned_cols=255 Identities=30% Similarity=0.599 Sum_probs=230.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEE
Confidence 358999999999999999999999999999999997654433345677889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc-
Confidence 99999999999999988899999999999999999999999999999999999999 56678999999999876543
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++ ..+++++.+||
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 234 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLL 234 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence 345689999999999864 589999999999999999999999999998889999988876654 35899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 317 RRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 317 ~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
.+||..||.+|| +++++++||||+..
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999999999 99999999999853
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=411.88 Aligned_cols=261 Identities=31% Similarity=0.514 Sum_probs=230.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.+. |||||++++++.+.+.+|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence 3468999999999999999999999999999999997644333334456889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence 99999999999998865 579999999999999999999999999999999999999 56778999999999877654
Q ss_pred cc--eeeccCCCCCCchhhhhcc-----cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 KV--YRDIVGSAYYVAPEVLRRR-----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~~--~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.. ....+||+.|+|||++... ++.++|||||||++|+|++|..||.+.+..+.+..|..+...+..+.+..+|
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 42 2356899999999998632 7899999999999999999999999999999999998876545555556899
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~~ 342 (472)
+++++||++||+.+|.+ ||+++++++||||+..
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999988 9999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=388.78 Aligned_cols=262 Identities=34% Similarity=0.623 Sum_probs=226.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|.+.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++++++ ||||+++++++.+...+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence 46679999999999999999999999999999999987654 2345688999999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 156 HVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
++||||++|++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++...+..+.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 3679999999999999999999999999999999999999766667789999999998
Q ss_pred eccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......+... ...++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence 776665556678999999999998889999999999999999999999999988887777776655544332 2357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+.+||.+||+.||++|||+.|+|+||||++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=398.08 Aligned_cols=269 Identities=38% Similarity=0.679 Sum_probs=216.5
Q ss_pred cccceEEc---ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 77 VKLHYSFG---KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 77 ~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
+..+|.+. +.||+|+||+||+|.++.+++.||||++.+. ....+.+|+.+++.+.+||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34578875 7899999999999999999999999998642 35678899999999977999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++....+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999889999999999999999999999999999999999999976555668999999999876
Q ss_pred cCCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHcCCccCCCCC
Q 012039 234 EEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-------EKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 234 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~ 304 (472)
.... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. ..+.+..+..+...+....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 5432 3345678999999999864 58999999999999999999999997643 3567788888887777777
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~ 351 (472)
|..+|+++++||.+||+.||.+|||+.++++||||+........+..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~ 286 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 286 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCC
Confidence 77899999999999999999999999999999999986655544443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=402.72 Aligned_cols=257 Identities=26% Similarity=0.511 Sum_probs=231.0
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++..+.+||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 45899999999999999999999999999999999865443344567788999999988679999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~ 236 (472)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 23
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..|......++ ..+|+++.+|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 34456789999999999864 689999999999999999999999999999999999998876655 3689999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCCcccc
Q 012039 316 VRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 316 i~~~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
|++||..||.+||+ ++++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999994 699999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=398.76 Aligned_cols=258 Identities=27% Similarity=0.504 Sum_probs=226.6
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++++.+||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35899999999999999999999999999999999876654555567788999999998669999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~ 236 (472)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCC---------CChHHHHHHHHcCCccCCCCCCC
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA---------ETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .....+...+......++ .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~ 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence 34456789999999999865 589999999999999999999999965 233456666777665544 3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITS------AQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~------~~~l~h~~~~~~ 342 (472)
.+|.++++||++||+.||.+||++ +++++||||+..
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 689999999999999999999995 899999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=404.65 Aligned_cols=257 Identities=34% Similarity=0.612 Sum_probs=224.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence 3468999999999999999999999999999999997654333344568899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence 999999 78999999988899999999999999999999999999999999999999 56677999999999987776
Q ss_pred cceeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+..+...++ ..+|+++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHH
Confidence 666677899999999998754 3 7899999999999999999999987665544433333332222 458999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
||++||+.||.+|||++|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=399.08 Aligned_cols=254 Identities=31% Similarity=0.579 Sum_probs=230.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 46899999999999999999999999999999999765543344567889999999999 59999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC-
Confidence 99999999999999988899999999999999999999999999999999999999 56678999999999876543
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+...++ ..+++++.+||
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 235689999999998864 589999999999999999999999999999999999998876654 35899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
.+||+.||.+||+ ++++++||||+.
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999998 999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=403.86 Aligned_cols=260 Identities=34% Similarity=0.612 Sum_probs=227.2
Q ss_pred cccceEE--cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 77 VKLHYSF--GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 77 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+...|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 3445655 678999999999999999999999999987543 234677899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
++|||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence 99999999999999988654 46999999999999999999999999999999999999953 23467999999999988
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
..........||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+..+.+..+......+....+..+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 76666666789999999998864 58899999999999999999999999999999999999888877777778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.+||.+||+.||.+|||+.++|+||||+.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=402.19 Aligned_cols=257 Identities=28% Similarity=0.538 Sum_probs=219.7
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHH-HhccCCCCeeEEEEEEEeCCeEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM-QHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l-~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
.++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEEE
Confidence 45899999999999999999999999999999999877654445556677787774 556 5999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-C
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-E 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~ 235 (472)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccC
Confidence 999999999999999988899999999999999999999999999999999999999 566789999999998643 2
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..|......++ +.++.++++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Confidence 334456789999999999865 589999999999999999999999999999999999988766554 468999999
Q ss_pred HHHHhcccCCCCCCCH----HHHhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITS----AQVLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~----~~~l~h~~~~~~ 342 (472)
||.+||+.||.+||++ .++++||||+..
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999999987 699999999853
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=401.10 Aligned_cols=258 Identities=26% Similarity=0.512 Sum_probs=229.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+. |||||++++++.+.+.+|
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEE
Confidence 3568999999999999999999999999999999997665444456778899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCC
Confidence 999999999999999988899999999999999999999999999999999999999 56678999999999988766
Q ss_pred cceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 KVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAE---TEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
......+||+.|+|||++.. .++.++|||||||++|+|++|..||... .....+..+......++ ..+|
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s 244 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWS 244 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCC
Confidence 66677899999999999852 4899999999999999999999999753 34455566665554444 3589
Q ss_pred HHHHHHHHHhcccCCCCCCC-HHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRIT-SAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps-~~~~l~h~~~~~~ 342 (472)
+++.+||.+||+.||.+||+ ++++++||||+..
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 99999999999999999998 8999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=386.60 Aligned_cols=259 Identities=30% Similarity=0.517 Sum_probs=224.3
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.....+|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCE
Confidence 345678999999999999999999999999999999986543 234677889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecC
Confidence 99999999999999988664 69999999999999999999999999999999999999 556679999999998765
Q ss_pred CCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....... ......+++.+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 246 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIF 246 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHH
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHH
Confidence 443 2345689999999999864 58999999999999999999999999888776666555433221 11235689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+||.+||+.||++|||+.++|+||||+..
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=392.63 Aligned_cols=264 Identities=33% Similarity=0.610 Sum_probs=224.0
Q ss_pred ccccceEEc-ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 76 DVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 76 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
.+.++|.+. +.||+|+||.||+|++..+++.||||++.+.. ......+.+|+.+++++.+||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 356789995 78999999999999999999999999997542 34467889999999996579999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988899999999999999999999999999999999999999765555569999999987654
Q ss_pred CCc--------ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCC---------------
Q 012039 235 EGK--------VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAET--------------- 285 (472)
Q Consensus 235 ~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------- 285 (472)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 221 122356999999999985 348999999999999999999999997754
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...+...+..+...++...+..+++++++||.+||..||.+|||+.++|+||||+..
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 244667777777766655566789999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=410.13 Aligned_cols=263 Identities=26% Similarity=0.474 Sum_probs=228.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
...++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence 3457899999999999999999999999999999999764432233344588999999999 599999999999999999
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 999999999999999987 5689999999999999999999999999999999999999 567789999999998765
Q ss_pred CCcce--eeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-CC
Q 012039 235 EGKVY--RDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PW 305 (472)
Q Consensus 235 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~ 305 (472)
..... ...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..|......+..+ .+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 44332 3368999999999885 358999999999999999999999999999999998887654333222 23
Q ss_pred CCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCccccC
Q 012039 306 PTISSSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~--Rps~~~~l~h~~~~~~ 342 (472)
..+|+++++||++||..+|++ |++++++++||||+..
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 568999999999999998888 9999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=392.84 Aligned_cols=272 Identities=31% Similarity=0.563 Sum_probs=237.9
Q ss_pred cccccccccceEEc-ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 71 GKPYEDVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 71 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
-...+.+..+|.+. +.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.+.+||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34456778899998 889999999999999999999999999976543 3345678999999999998789999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
.+.+.+++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++......+.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999988543 67999999999999999999999999999999999999975444678999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
|++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+......+....+.
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 9999877665556678999999999986 458999999999999999999999999999988888888888888888788
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 9999999999999999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=392.03 Aligned_cols=267 Identities=37% Similarity=0.670 Sum_probs=236.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..+.++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++++. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 3467789999999999999999999999999999999976543221 24678999999999995 9999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC-CCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~~~kl~Dfg~~ 230 (472)
.+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++..++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999988888999999999999999999999999999999999999964321 126999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+......++...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 98776655566789999999999864 58999999999999999999999999999888888888877666555556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..+.+||.+||..||++|||+.++|+||||+..
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=390.59 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=192.6
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~---- 153 (472)
..+|.+.++||+|+||+||+|++ +|+.||||++.... ........|+..+.+++ |||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence 45799999999999999999987 48899999986432 11223345666667885 999999999997653
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeecCCCCceeeccCCCCCcEEEe
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------GVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
.+|||||||+||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence 68999999999999999865 4699999999999999999999987 99999999999999 667789999
Q ss_pred ecCCceeccCCcce-----eeccCCCCCCchhhhhc-------ccCCccchhhHHHHHHHHhhCCCCCCCC---------
Q 012039 226 DFGLSVFIEEGKVY-----RDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAE--------- 284 (472)
Q Consensus 226 Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~--------- 284 (472)
|||+++........ ...+||+.|+|||++.+ .++.++|||||||++|||+||.+||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 99999877654322 23579999999999864 3678999999999999999998765321
Q ss_pred ------ChHHHHHHHHcCCccCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 285 ------TEKGIFDAILQGDIDFESAP-W--PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 285 ------~~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
....+...+.........+. + ...+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 12233344444433222111 1 113357889999999999999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=410.64 Aligned_cols=258 Identities=38% Similarity=0.636 Sum_probs=232.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 4568999999999999999999999999999999997654333344678899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccc
Confidence 999999999999999888889999999999999999999999999999999999999 55677999999999987766
Q ss_pred cceeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+......+..+..+....+ ..+++++.+
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 245 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVIS 245 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHH
Confidence 666677899999999998754 3 6899999999999999999999999888888888888765443 357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
||++||+.||.+|||+.++++||||+..
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=403.77 Aligned_cols=261 Identities=25% Similarity=0.453 Sum_probs=225.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..++..+. ||||+++++++.+.+.+|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEE
Confidence 4578999999999999999999999999999999997644323334456889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence 9999999999999998754 79999999999999999999999999999999999999 5677899999999987765
Q ss_pred Ccce--eeccCCCCCCchhhhh--------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-C
Q 012039 236 GKVY--RDIVGSAYYVAPEVLR--------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-P 304 (472)
Q Consensus 236 ~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~ 304 (472)
.... ...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+++..|......+..+ .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 4432 2458999999999986 358999999999999999999999999999988888887644222222 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCccccC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKR---ITSAQVLEHPWIKEG 342 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~R---ps~~~~l~h~~~~~~ 342 (472)
...+|+++++||++||. +|.+| |+++++++||||+..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 24789999999999999 99998 599999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=396.18 Aligned_cols=264 Identities=37% Similarity=0.711 Sum_probs=235.9
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC-----cccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----KNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
..+..+|++.+.||+|+||.||+|++..+|+.||||++....... ......+.+|+.+++++.+||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 345578999999999999999999999999999999986543211 112456789999999996699999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
......|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCc
Confidence 9999999999999999999999888889999999999999999999999999999999999999 5667899999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (472)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+..+...+..
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 998876666667789999999998853 4788999999999999999999999998888888888888877776
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+.|..++..+.+||.+||+.||++|||+.++|+||||++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 667789999999999999999999999999999999973
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=382.49 Aligned_cols=258 Identities=25% Similarity=0.449 Sum_probs=215.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence 479999999999999999999999999999999976543 3334577889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~- 236 (472)
|||+.+ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence 999975 55555544 6789999999999999999999999999999999999999 55677999999999876533
Q ss_pred cceeeccCCCCCCchhhhhc-c-cCCccchhhHHHHHHHHhhCCCC-CCCCChHHHHHHHHcCCccCCC-----------
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPP-FWAETEKGIFDAILQGDIDFES----------- 302 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~----------- 302 (472)
.......||+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+.+..+.+..+.........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 23345678999999999864 3 79999999999999999988777 4555666666665442111111
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 303 --------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 303 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...+.+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1123578999999999999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=390.09 Aligned_cols=260 Identities=32% Similarity=0.511 Sum_probs=231.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|.+++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 4568999999999999999999999999999999998765544456678899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecccC
Confidence 999999999999999888889999999999999999999999999999999999999 45667999999999876532
Q ss_pred -cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+......++ ..+++++.+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 270 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS 270 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence 23345679999999999864 589999999999999999999999998888888888877665543 357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
||.+||+.||++|||+.++|+||||+....
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=385.24 Aligned_cols=266 Identities=43% Similarity=0.753 Sum_probs=241.0
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+.+..+|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence 4566799999999999999999999999999999999976543 2345678999999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888899999999999999999999999999999999999999766666789999999998766
Q ss_pred CCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+..+...+....+..+++++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55544555789999999999888999999999999999999999999999988888889888877777667789999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
||.+||..||++|||+.++|+||||++.
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=385.76 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=215.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+.+.++|++++.||+|+||+||+|++. +++.||+|++..... .......+.+|+.++++++ ||||+++++++.+++.
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCE
Confidence 456779999999999999999999985 589999999865432 2334567889999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEET
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceec
Confidence 9999999974 888877654 459999999999999999999999999999999999999 45667999999999876
Q ss_pred cCC-cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC-------
Q 012039 234 EEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA------- 303 (472)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------- 303 (472)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 533 23345678999999999864 48999999999999999999999998887766666654311111110
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 304 -------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 304 -------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 123578899999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=385.00 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=218.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--CcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYED 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~ 151 (472)
.+.++|++++.||+|+||+||+|++..+++.||+|++...... .......+.+|+.+++++. +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3567999999999999999999999999999999998754321 1222456778888888774 49999999999987
Q ss_pred CC-----eEEEEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 152 KQ-----SVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 152 ~~-----~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
.. .+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence 65 5899999996 599999987654 9999999999999999999999999999999999999 55667999
Q ss_pred eecCCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 225 TDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999998776655556678999999999885 468999999999999999999999999998888777776532221111
Q ss_pred C-----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 304 P-----------------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 304 ~-----------------------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
. .+.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1 136789999999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=392.13 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=214.2
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence 45689999999999999999999999999999999975432 2233556789999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC--CCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--DENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~--~~~~~~kl~Dfg~~~~~~ 234 (472)
+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+..+ +....+||+|||++....
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999996 5999999988899999999999999999999999999999999999999643 245569999999998765
Q ss_pred CC-cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCC-----
Q 012039 235 EG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP----- 306 (472)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 306 (472)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........|+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 33 23345578999999999864 48999999999999999999999999988877777765432111111111
Q ss_pred ---------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 307 ---------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 307 ---------------------~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 168999999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=384.73 Aligned_cols=263 Identities=40% Similarity=0.740 Sum_probs=234.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+..+|.+.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++++. ||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIK-HENIVTLEDIYESTTHY 81 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCC-CCCeeehhhhcccCCEE
Confidence 46779999999999999999999999999999999997543 223457889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++...+.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999999998888999999999999999999999999999999999999996656677899999999976543
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...+....+..+++++.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred C-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 2 2234579999999999864 5899999999999999999999999999998899999998888777777889999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||.+||..||++|||+.++|+||||+...
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=382.59 Aligned_cols=264 Identities=36% Similarity=0.689 Sum_probs=236.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC------cccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT------KNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999999999999999997543211 122456789999999997799999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.+.+.+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 9999999999999999999999988889999999999999999999999999999999999999 5566799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhh-------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (472)
+.............|++.|+|||++. ..++.++||||||+++|+|++|..||...+.......+..+...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98877665556678999999999874 24788999999999999999999999999888888888888888777
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
..+..++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 7777899999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=388.94 Aligned_cols=259 Identities=30% Similarity=0.543 Sum_probs=218.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++++.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 45689999999999999999999999999999999865432 223466889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+|||||+|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence 999999999999999888889999999999999999999999999999999999999 55667999999999876433
Q ss_pred c---ceeeccCCCCCCchhhhhcc--cCCccchhhHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCH
Q 012039 237 K---VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ..+..+...... ...+..+++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS 236 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccccCCH
Confidence 2 22356799999999998643 377899999999999999999999876553 233333333222 233567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
++.+||.+||..||.+|||+.|+++||||+...
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=407.55 Aligned_cols=258 Identities=32% Similarity=0.572 Sum_probs=220.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence 3468999999999999999999999999999999997655444455667889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||++|++|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++.....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence 999999999999999988899999999999999999999998 999999999999999 5567899999999986432
Q ss_pred -CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 -GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ ..+++++.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 377 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAK 377 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 333456789999999999864 689999999999999999999999999999889999888776655 35899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 314 DLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 314 ~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+||.+||+.||.+|| +++++|+||||+..
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999999999 99999999999853
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=409.27 Aligned_cols=262 Identities=27% Similarity=0.401 Sum_probs=200.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 151 (472)
.+.++|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|++++ |||||++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence 34578999999999999999999999999999999986532 23345677899999999995 9999999999843
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
...+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence 36799999998 67999999888889999999999999999999999999999999999999 56678999999999
Q ss_pred eeccCCc----------------------------ceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhh----
Q 012039 231 VFIEEGK----------------------------VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLS---- 276 (472)
Q Consensus 231 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~---- 276 (472)
+...... .....+||+.|+|||++. ..++.++||||||||+|+|++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 8764221 234467899999999763 459999999999999999999
Q ss_pred -------CCCCCCCCCh--------------------HHHHHHHHcC----------------------Cc-----cCCC
Q 012039 277 -------GVPPFWAETE--------------------KGIFDAILQG----------------------DI-----DFES 302 (472)
Q Consensus 277 -------g~~pf~~~~~--------------------~~~~~~i~~~----------------------~~-----~~~~ 302 (472)
|+++|.+.+. ...+..|... .. ....
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6777765431 1222222110 00 0001
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..++.+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 12456799999999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=405.65 Aligned_cols=264 Identities=38% Similarity=0.678 Sum_probs=221.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----ccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
.+.++|.+.+.||+|+||+||+|.+..+++.||+|++.+...... .....+.+|+.+|+++. ||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 456789999999999999999999999999999999976543211 12235789999999995 999999999986
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
. +.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4 558999999999999999988889999999999999999999999999999999999999986666678999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 305 (472)
............+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......+..+...+....|
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 9877665556778999999999874 3578899999999999999999999976543 3455667777766666666
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..+++.+.+||.+||+.||++|||++++|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 789999999999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.10 Aligned_cols=258 Identities=30% Similarity=0.550 Sum_probs=216.9
Q ss_pred cccceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccCC-cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVT-KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
...+|++.+.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence 3468999999999999999999985 689999999997654321 234556789999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCcccc
Confidence 9999999999999999999988899999999999999999999999999999999999999 5567899999999976
Q ss_pred ccCC-cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 233 IEEG-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 233 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+....+..+......++ +.+++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~ 246 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCH
Confidence 4332 23345679999999999864 589999999999999999999999999998888888888766544 35899
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
++.+||.+||..||.+|| ++.++++||||+..
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999999 89999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=412.23 Aligned_cols=258 Identities=30% Similarity=0.542 Sum_probs=227.2
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+++. |||||++++++.+.+.+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence 3467999999999999999999999999999999997655433445677889999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence 99999999999999876543 9999999999999999999999999999999999999 566789999999999887
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ...+...+......++ ..+|
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s 413 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS 413 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence 6666667799999999999875 68999999999999999999999998753 3445555655544333 4689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+++++||++||+.||.+|| +++++++||||+..
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999999999 89999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=382.81 Aligned_cols=257 Identities=30% Similarity=0.585 Sum_probs=217.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC-----------------------cccHHHHHHHHHHHH
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----------------------KNDKDDIKREIQIMQ 134 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 134 (472)
..+|++.+.||+|+||.||+|++..+++.||+|++.+..... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 458999999999999999999999999999999997654211 112356889999999
Q ss_pred hccCCCCeeEEEEEEEe--CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCcee
Q 012039 135 HLSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212 (472)
Q Consensus 135 ~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 212 (472)
+++ ||||+++++++.+ ...+|+||||+++++|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 995 9999999999987 57899999999999998754 3457999999999999999999999999999999999999
Q ss_pred eccCCCCCcEEEeecCCceeccCCc-ceeeccCCCCCCchhhhhcc----cCCccchhhHHHHHHHHhhCCCCCCCCChH
Q 012039 213 LSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (472)
Q Consensus 213 i~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 287 (472)
+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 170 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 V---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp E---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred E---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9 556679999999998765443 33456899999999998643 377899999999999999999999988887
Q ss_pred HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.....+......++. .+.+++++.+||.+||+.||++|||+.++|+||||++
T Consensus 247 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777777776555443 3578999999999999999999999999999999963
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=379.70 Aligned_cols=256 Identities=32% Similarity=0.475 Sum_probs=213.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|++ .+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence 4799999999999999999998 6789999999865432 2234577889999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~- 236 (472)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence 999965 998888754 679999999999999999999999999999999999999 55677999999999876432
Q ss_pred cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC------------
Q 012039 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------------ 302 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 302 (472)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23344578999999999864 4899999999999999999999999988877766666431110000
Q ss_pred -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 303 -------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 303 -------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..+..+++++.+||.+||+.||++|||++++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012457899999999999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=421.69 Aligned_cols=258 Identities=26% Similarity=0.508 Sum_probs=233.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|..++..+.+||+|+++++++.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 45799999999999999999999999999999999865443445567888999999998779999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc-CC
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~-~~ 236 (472)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ..
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred cceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+++..|......++. .+|+++.+|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Confidence 3445678999999999987 46999999999999999999999999999999999999998776653 689999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITS-----AQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~-----~~~l~h~~~~~~ 342 (472)
|++||+.||.+||++ +++++||||+..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999999997 999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=384.41 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=207.6
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++++.||+|+||.||+|+++.+++.||+|++.... .......+.+|+.++++++ ||||+++++++.+++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEE
Confidence 357999999999999999999999999999999987543 2334577889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 158 VMELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence 999997 5999888653 358999999999999999999999999999999999999 556679999999998
Q ss_pred eccCC-cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC------
Q 012039 232 FIEEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------ 302 (472)
Q Consensus 232 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 302 (472)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 76533 23345689999999999864 4899999999999999999999999998887777766542111000
Q ss_pred ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 303 ------------------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 303 ------------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.....++.++.+||.+||+.||++|||+.++|+||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 011257899999999999999999999999999999997544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=378.53 Aligned_cols=265 Identities=41% Similarity=0.737 Sum_probs=230.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
+.++|++++.||+|+||.||+|++..+++.||+|++........ ...+.+.+|+.+++++. ||||+++++++.+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence 45689999999999999999999999999999999976543222 24678999999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC-CCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~~~kl~Dfg~~~~ 232 (472)
.+++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++..++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999996433 234799999999988
Q ss_pred ccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
...........||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+......+....+..++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76655555678999999999986 45899999999999999999999999999888888888877666655555678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+||.+||..||++|||+.++|+||||+..
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=395.09 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=211.1
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ- 153 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 153 (472)
..+..+|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++++.+||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 345679999999999999999999999999999999986532 234456778899999999977999999999997544
Q ss_pred -eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 -SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 -~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+|+|||||. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence 7999999996 689888765 579999999999999999999999999999999999999 5667899999999986
Q ss_pred ccC----------------------CcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHH
Q 012039 233 IEE----------------------GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKG 288 (472)
Q Consensus 233 ~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 288 (472)
... .......+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 532 112334689999999998864 58999999999999999999999999988877
Q ss_pred HHHHHHcCCccCCC--------------------------------------------CCCCCCCHHHHHHHHHhcccCC
Q 012039 289 IFDAILQGDIDFES--------------------------------------------APWPTISSSAKDLVRRMLTQDP 324 (472)
Q Consensus 289 ~~~~i~~~~~~~~~--------------------------------------------~~~~~~s~~~~~li~~~L~~dp 324 (472)
.+..+.... ..+. .....+++++.+||.+||+.||
T Consensus 239 ~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 239 QLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 777665311 1100 0123678999999999999999
Q ss_pred CCCCCHHHHhcCCccccCC
Q 012039 325 KKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 325 ~~Rps~~~~l~h~~~~~~~ 343 (472)
++|||++|+|+||||+...
T Consensus 318 ~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIFH 336 (388)
T ss_dssp GGSCCHHHHTTSTTTTTTC
T ss_pred ccCCCHHHHhCCHHHHHhc
Confidence 9999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=377.45 Aligned_cols=259 Identities=32% Similarity=0.614 Sum_probs=226.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++++.||+|+||.||+|.+..++..||+|++.+...........+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEE
Confidence 3468999999999999999999999999999999987654433344677899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc
Confidence 999999999999999888899999999999999999999999999999999999999 56677999999998655433
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
. .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++ ..+++++.+|
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l 237 (279)
T 3fdn_A 163 R-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred c-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence 2 345679999999999875 478999999999999999999999999988888888877665544 3578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
|.+||+.||.+|||+.++|+||||+....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=387.76 Aligned_cols=264 Identities=38% Similarity=0.684 Sum_probs=224.1
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC-----CcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
.+.++|.+.+.||+|+||.||+|++..+++.||||++.+.... .......+.+|+.+++++. ||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence 4567899999999999999999999999999999999764321 1122345789999999995 999999999997
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
.+. +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 765 8999999999999999988888999999999999999999999999999999999999976666667999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCccCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPW 305 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 305 (472)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+..+...+....+
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8876655445567999999999873 35889999999999999999999999765433 455566666655544445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..+++++.+||.+||..||++|||+.++|+||||+.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 678999999999999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=393.54 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=216.7
Q ss_pred ccceEEcceeeec--CCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 78 KLHYSFGKELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.++|++++.||+| +||+||+|+++.+++.||||++..... .......+.+|+.++++++ |||||++++++.+.+.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEE
Confidence 4589999999999 999999999999999999999976543 3345677889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999999999999875 679999999999999999999999999999999999999 56668999999998754
Q ss_pred cCCc--------ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC--
Q 012039 234 EEGK--------VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF-- 300 (472)
Q Consensus 234 ~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-- 300 (472)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 3221 1122478999999999865 58999999999999999999999998876655544443322110
Q ss_pred ----------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 301 ----------------------------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 301 ----------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
....+..+++++.+||.+||+.||++|||+.++|+||||+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 0112345789999999999999999999999999999998
Q ss_pred cCC
Q 012039 341 EGG 343 (472)
Q Consensus 341 ~~~ 343 (472)
...
T Consensus 339 ~~~ 341 (389)
T 3gni_B 339 QIK 341 (389)
T ss_dssp GC-
T ss_pred HHh
Confidence 754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=391.80 Aligned_cols=267 Identities=35% Similarity=0.615 Sum_probs=229.1
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC--CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
..+..+|++.+.||+|+||+||+|++..+++.||+|++.+.... .......+.+|+.++++++ ||||+++++++.+.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 100 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccC
Confidence 45678999999999999999999999999999999998765321 2345678999999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 012039 153 QSVHVVMELCAGGELFDRIIA----------------------------------------KGHYSERAAASICRSIVNV 192 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~ 192 (472)
+.+++|||||+|++|.+++.. ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999988742 1123677889999999999
Q ss_pred HHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-----ceeeccCCCCCCchhhhh---cccCCccch
Q 012039 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-----VYRDIVGSAYYVAPEVLR---RRYGKEIDI 264 (472)
Q Consensus 193 l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~Di 264 (472)
|.|||++||+||||||+||+++.+ ....+||+|||++....... ......||+.|+|||++. ..++.++||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999999999999999999999532 23379999999998764322 124567999999999986 458899999
Q ss_pred hhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 265 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||||+++|+|++|..||.+....+....+......+....+..+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999999999889999988888777777777999999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=380.07 Aligned_cols=261 Identities=29% Similarity=0.525 Sum_probs=216.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence 3589999999999999999999999999999999865432 2233567889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 99999999999888888889999999999999999999999999999999999999 556789999999998765332
Q ss_pred -ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------------
Q 012039 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------------- 297 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------------- 297 (472)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 3345679999999998864 57999999999999999999999999888766655543210
Q ss_pred --ccCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 298 --IDFESA--------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 298 --~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
...+.. .++.+++++.+||.+||+.||.+|||++++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 001110 1256899999999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=378.79 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=212.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+.+..+|++.++||+|+||+||+|++..+++.||||++..... ..........|+..+.++.+||||+++++++.+.+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 4456799999999999999999999999999999998765332 223344556677777776569999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeec
Confidence 99999999 67998888764 459999999999999999999999999999999999999 45667999999999887
Q ss_pred cCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
..........||+.|+|||++.+.++.++|||||||++|+|++|..|+.+.. ....+..+... ......+++++.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~l~ 282 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLP--PEFTAGLSSELR 282 (311)
T ss_dssp C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCC--HHHHTTSCHHHH
T ss_pred ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCC--cccccCCCHHHH
Confidence 6655555667999999999998889999999999999999999977775432 23344443221 112346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+||.+||+.||++|||+.++|+||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=389.52 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=212.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|++..+++.||+|++..... ......+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence 479999999999999999999999999999999864432 111223457999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-
Q 012039 159 MELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~- 236 (472)
|||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence 99996 58988887654 59999999999999999999999999999999999999 55667999999999865433
Q ss_pred cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC----------
Q 012039 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP---------- 304 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 304 (472)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345578999999998864 589999999999999999999999999888877777655222211111
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 305 ----------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 305 ----------------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
++.+++++.+||.+||+.||.+|||++|+|+||||.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 235789999999999999999999999999999998765433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=373.39 Aligned_cols=258 Identities=32% Similarity=0.650 Sum_probs=228.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEE
Confidence 458999999999999999999999999999999987654333334577899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSSC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCcccc
Confidence 99999999999999988889999999999999999999999999999999999999 456679999999997665432
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
.....|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++ ..++.++++||
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 243 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 243 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHH
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHH
Confidence 245679999999999875 589999999999999999999999998888888888877665443 45899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 317 RRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.+||..||.+|||+.++++||||+....
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=383.78 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=220.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 151 (472)
...+|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY 92 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence 45689999999999999999999999999999999866543 2334567789999999995 9999999999887
Q ss_pred ---CCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 152 ---KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 152 ---~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
.+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Df 168 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADF 168 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccc
Confidence 4578999999965 777777653 579999999999999999999999999999999999999 55668999999
Q ss_pred CCceeccCC-----cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC
Q 012039 228 GLSVFIEEG-----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (472)
Q Consensus 228 g~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 300 (472)
|++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876422 22345678999999998864 47999999999999999999999999998888777776544444
Q ss_pred CCCCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 301 ESAPWPT----------------------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 301 ~~~~~~~----------------------------~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
....|+. .++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 4333333 2778999999999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=402.21 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=210.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|++++.||+|+||+||+|++..+++.||||++.+.. ........+.+|+.+++.+. ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 45678999999999999999999999999999999997543 23345677889999999995 99999999999654
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+||||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEe
Confidence 467999999965 5666664 359999999999999999999999999999999999999 5667899999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc---------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID--------- 299 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 299 (472)
++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..|....-.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 998776655667789999999998864 6999999999999999999999999998877777666542110
Q ss_pred -------------CCCCCC----CC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 -------------FESAPW----PT------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 -------------~~~~~~----~~------------~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+....+ +. .++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000000 00 15679999999999999999999999999999854
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=372.48 Aligned_cols=262 Identities=31% Similarity=0.509 Sum_probs=232.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|.+++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence 4568999999999999999999999999999999997765444455678899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecccC
Confidence 999999999999999888899999999999999999999999999999999999999 55667999999999876532
Q ss_pred -cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+......++ ..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 244 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS 244 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHH
Confidence 23344679999999999865 589999999999999999999999999888888888777655443 367899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
||.+||+.||++|||+.++++||||.......
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99999999999999999999999998764433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=397.63 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=211.3
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+....+|++.+.||+|+||+||+|++..++. ||+|.+..... ...+|+.+++.++ ||||+++++++...+
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEecC
Confidence 34456789999999999999999999987665 88887754321 1237999999995 999999999985433
Q ss_pred ------eEEEEEeccCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEE
Q 012039 154 ------SVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 154 ------~~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
.+++||||++++ +.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEE
T ss_pred CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEE
Confidence 388999999764 444332 356799999999999999999999999999999999999994 2566899
Q ss_pred EeecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----
Q 012039 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---- 297 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---- 297 (472)
|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999998766666667789999999998854 48999999999999999999999999988776666654310
Q ss_pred -------------ccCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 298 -------------IDFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 298 -------------~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
..++. ...+.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 01111 012348899999999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=389.04 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=216.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC-CCCeeEEEEEEEeCCeEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-QPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~~~~~ 156 (472)
..+|++++.||+|+||+||+|.+.. ++.||||++..... .......+.+|+.++++|.+ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3469999999999999999999865 89999999976443 33456788999999999974 699999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCC
Confidence 9999 56889999999888999999999999999999999999999999999999993 356999999999876543
Q ss_pred cc---eeeccCCCCCCchhhhhc------------ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccC
Q 012039 237 KV---YRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDF 300 (472)
Q Consensus 237 ~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~ 300 (472)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+......+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 22 235679999999999854 588899999999999999999999987543 34556666655444
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..+ ...+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 333 34588999999999999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=372.19 Aligned_cols=259 Identities=39% Similarity=0.622 Sum_probs=220.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
...++|.+++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeE
Confidence 34568999999999999999999999999999999987654333345678899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCC
Confidence 9999999999999999888899999999999999999999999999999999999999 5566799999999987766
Q ss_pred CcceeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+..+....+ ..++.++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 239 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVA 239 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHH
Confidence 5555566899999999998754 3 6799999999999999999999998888888888877655433 35789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++|.+||+.||.+|||+.++++||||+..
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 99999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=400.62 Aligned_cols=256 Identities=28% Similarity=0.512 Sum_probs=225.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+...+|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEE
Confidence 468999999999999999999999999999999997655433445678899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 158 VMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeeec
Confidence 99999999999998763 369999999999999999999999999999999999999 56678999999999887
Q ss_pred cCCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..++...+......++ ..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence 65443 334589999999999875 58999999999999999999999998753 4566777777655544 46
Q ss_pred CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCcccc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
+|+++++||++||+.||.+||+ ++++++||||+.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 8999999999999999999996 589999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=386.40 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=220.5
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc----CCCCeeEEE
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS----GQPNIVEFK 146 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~ 146 (472)
..+...+.++|+++++||+|+||+||+|++..+++.||||++... ......+..|+.+++.+. +||||++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345566778999999999999999999999999999999998632 234566788999999996 499999999
Q ss_pred EEEEeCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC--------
Q 012039 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-------- 216 (472)
Q Consensus 147 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-------- 216 (472)
+++...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 999999998654 49999999999999999999999999999999999999531
Q ss_pred --------------CCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCC
Q 012039 217 --------------DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPF 281 (472)
Q Consensus 217 --------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 281 (472)
.....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 12667999999999875443 245689999999998864 6899999999999999999999999
Q ss_pred CCCChHHHHHHHHcCCccCCC---------------------CCCC---------------------CCCHHHHHHHHHh
Q 012039 282 WAETEKGIFDAILQGDIDFES---------------------APWP---------------------TISSSAKDLVRRM 319 (472)
Q Consensus 282 ~~~~~~~~~~~i~~~~~~~~~---------------------~~~~---------------------~~s~~~~~li~~~ 319 (472)
.+.+..+.+..+......++. ..|+ ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988877766665442211110 0010 1247788999999
Q ss_pred cccCCCCCCCHHHHhcCCccc
Q 012039 320 LTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 320 L~~dp~~Rps~~~~l~h~~~~ 340 (472)
|+.||.+|||+.++|+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999995
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=384.89 Aligned_cols=259 Identities=24% Similarity=0.429 Sum_probs=214.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+..+|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.++++++ ||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 99 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence 45678999999999999999999999999999999986532 23334567889999999995 99999999999765
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL 174 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeec
Confidence 3469999999 8899988865 579999999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc--------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-------- 299 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 299 (472)
++..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 175 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9876542 345689999999998864 5899999999999999999999999988877766665431110
Q ss_pred ---------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 300 ---------------FE----SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 300 ---------------~~----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.. ...++.+++++.+||.+||..||.+|||++++|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00 112356799999999999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=380.79 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=222.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|.+.+.||+|+||+||+|++..+++.||||++.............+.+|+.++++++ ||||+++++++.+.+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence 34567999999999999999999999999999999997654333334567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+. |+|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecC
Confidence 99999996 68888775 45679999999999999999999999999999999999999 456789999999998764
Q ss_pred CCcceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.. ....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+....+..+........ ....+++
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 280 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSE 280 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCH
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCH
Confidence 43 3457999999999874 4589999999999999999999999998887777766666543322 2246799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+.+||.+||+.||++|||++++|+||||...
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=384.83 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=221.3
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ- 153 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 153 (472)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++. ||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence 346679999999999999999999999999999999997655444445667899999999995 999999999987654
Q ss_pred ---eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 154 ---SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 154 ---~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccCc
Confidence 3599999999999999999888999999999999999999999999999999999999994 5567999999999
Q ss_pred eeccCCc----ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 231 VFIEEGK----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 231 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+...........+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8765432 1233568999999998865 5899999999999999999999999998887777777666554444445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..+++++.+||.+||+.||.+||++.++|.|+|++.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 678999999999999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=373.80 Aligned_cols=256 Identities=29% Similarity=0.556 Sum_probs=222.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
...|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEE
Confidence 345888899999999999999999999999999986543 344677899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 120 v~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSS
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCc
Confidence 9999999999988754 579999999999999999999999999999999999999 456679999999998765432
Q ss_pred -ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||........+..+........ .....+++++.+|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHH
Confidence 2345689999999999864 589999999999999999999999998888777777766533221 1234688999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
|.+||+.||++|||+.++|+||||...
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcChhhccC
Confidence 999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=371.00 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=199.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEE
Confidence 457999999999999999999999999999999997554333334578899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence 99999999999998865 569999999999999999999999999999999999999 55667999999999876532
Q ss_pred c-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........+..+....... ...++.++.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHHHHH
Confidence 2 2234578999999998864 58899999999999999999999998776655555444333222 2457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||.+||..||++|||+.++|+||||....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=382.76 Aligned_cols=253 Identities=30% Similarity=0.537 Sum_probs=218.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc-----ccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
.+..+|++.+.||+|+||+||+|++..+++.||+|++.+...... .....+.+|+.++++++ ||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 466799999999999999999999999999999999976543221 13345778999999995 999999999999
Q ss_pred eCCeEEEEEeccCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 151 DKQSVHVVMELCAGG-ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 999999999999766 999999888899999999999999999999999999999999999999 5567899999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhcc-c-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
+.............||+.|+|||++.+. + +.++||||||+++|+|++|..||..... ...... .....
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI----HPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC----CCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc----CCCcc
Confidence 9988776666677899999999998653 4 7899999999999999999999975322 111111 12235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 89999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=388.56 Aligned_cols=262 Identities=29% Similarity=0.457 Sum_probs=210.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+.++|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.+|++++ ||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCC
Confidence 45679999999999999999999999999999999996532 23345678899999999995 99999999999766
Q ss_pred --CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCc
Confidence 67999999995 6999999888889999999999999999999999999999999999999 56678999999999
Q ss_pred eeccCCc-----------------------ceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhC--------
Q 012039 231 VFIEEGK-----------------------VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSG-------- 277 (472)
Q Consensus 231 ~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g-------- 277 (472)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 8765432 235678999999999863 4599999999999999999984
Q ss_pred ---CCCCCCCCh-----------------HHHHHHHHc------------------------CCccCCC---CCCCCCCH
Q 012039 278 ---VPPFWAETE-----------------KGIFDAILQ------------------------GDIDFES---APWPTISS 310 (472)
Q Consensus 278 ---~~pf~~~~~-----------------~~~~~~i~~------------------------~~~~~~~---~~~~~~s~ 310 (472)
.++|.+.+. ...+..|.. ....... ..++.+++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 444433320 112222111 0000000 01356899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=369.16 Aligned_cols=257 Identities=23% Similarity=0.435 Sum_probs=219.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~ 153 (472)
...|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.++++++ ||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence 3469999999999999999999999999999999875443 3445678899999999995 9999999999875 46
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ +.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 68999999999999999998889999999999999999999999999 99999999999995 245679999999997
Q ss_pred eccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCH
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|..||..... ......+..+.... ......++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIP 257 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--ccCCCCCH
Confidence 65443 3345679999999999988899999999999999999999999987544 44444444432221 11245679
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
++.+||.+||+.||.+|||+.++|+||||++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=375.92 Aligned_cols=254 Identities=27% Similarity=0.495 Sum_probs=213.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 155 (472)
.++|++++.||+|+||+||+|++..+++.||+|++.. .....+.+|+.+++++.+||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4689999999999999999999999999999999853 3357789999999999779999999999988 6789
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++. ....+||+|||++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECCT
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEcCC
Confidence 99999999999988774 4899999999999999999999999999999999999952 233799999999998776
Q ss_pred CcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCC-ChHHHHHHH-------------HcCCcc
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAI-------------LQGDID 299 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i-------------~~~~~~ 299 (472)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||... ...+.+..+ ......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 666666789999999998864 5899999999999999999999999543 222222221 111111
Q ss_pred C--------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 F--------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ~--------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
. .......+++++.+||.+||+.||.+|||++++|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 1 011112379999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=370.21 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=220.5
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.++++++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCe
Confidence 456779999999999999999999999999999999987655444455678899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccccc
Confidence 99999999999999999988899999999999999999999999999999999999999 556679999999998765
Q ss_pred CCc--ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-CCCCCCCCCH
Q 012039 235 EGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF-ESAPWPTISS 310 (472)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s~ 310 (472)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+............... .....+.+++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 432 2234579999999998865 58899999999999999999999999888776665555543322 1223467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.+.++|.+||..||.+||+..+.+.+.|..-
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 9999999999999999997777777666553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=384.75 Aligned_cols=258 Identities=31% Similarity=0.561 Sum_probs=217.7
Q ss_pred ccceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..+|++.+.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+++++.+||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 48899999998754321 12234567789999999977999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeec
Confidence 999999999999999999988899999999999999999999999999999999999999 56678999999999865
Q ss_pred cCCc--ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCccCCCCC
Q 012039 234 EEGK--VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 234 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 304 (472)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ...+...+......+
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 285 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---- 285 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC----
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC----
Confidence 4322 2234579999999999864 37899999999999999999999997543 233444444443332
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
...++..+.+||.+||..||.+|| |++++++||||+..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 246899999999999999999999 99999999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=365.38 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=215.2
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+..+|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++..+.+||||+++++++.+.+.++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 56789999999999999999999999999999999876433 23346678899999999956999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC---------------
Q 012039 157 VVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--------------- 217 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--------------- 217 (472)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999764 6799999999999999999999999999999999999996443
Q ss_pred -CCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhcc--cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 012039 218 -ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 218 -~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 294 (472)
....+||+|||++....... ...||+.|+|||++.+. ++.++||||||+++|+|++|.+|+... .....+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHH
T ss_pred CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHH
Confidence 45579999999998775433 34689999999998754 557999999999999999999877544 2344555
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+..... ...+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 242 ~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 242 QGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred cCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 5543222 24689999999999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=377.81 Aligned_cols=260 Identities=27% Similarity=0.463 Sum_probs=216.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEE
Confidence 45689999999999999999999999999999999865432 2334566789999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence 999999999998887777889999999999999999999999999999999999999 55668999999999876543
Q ss_pred -cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----------------
Q 012039 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---------------- 297 (472)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------------- 297 (472)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 23345679999999999865 58999999999999999999999999888766655543210
Q ss_pred ---ccCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 298 ---IDFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 298 ---~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
...+. ..++.+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00000 012467999999999999999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=379.25 Aligned_cols=263 Identities=27% Similarity=0.391 Sum_probs=214.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC--cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
...+|++++.||+|+||.||+|++..+|+.||+|++....... ......+.+|+.+++++. ||||+++++++.+.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence 4568999999999999999999999999999999987543211 112346789999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence 9999999975 888888654 358999999999999999999999999999999999999 55677999999999876
Q ss_pred cCCc-ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC------
Q 012039 234 EEGK-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP------ 304 (472)
Q Consensus 234 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 304 (472)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+...........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 4432 3345689999999999854 478999999999999999999999999888877777765321111111
Q ss_pred ------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 305 ------------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 305 ------------------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
+..+++++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 1456799999999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=363.94 Aligned_cols=259 Identities=30% Similarity=0.537 Sum_probs=221.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence 34689999999999999999999999999999999865432 234678899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence 999999999999998877789999999999999999999999999999999999999 45667999999999876433
Q ss_pred c---ceeeccCCCCCCchhhhhc-c-cCCccchhhHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCH
Q 012039 237 K---VYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||...... ..+..+...... ...+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence 2 2334679999999999864 3 367899999999999999999999876543 233444443222 223457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+.+||.+||..||.+|||+.++++||||+...
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=384.75 Aligned_cols=256 Identities=28% Similarity=0.442 Sum_probs=211.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
...+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.|+ |||||++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence 3458999999999999999999999999999999986432 12347999999995 99999999988532
Q ss_pred --CeEEEEEeccCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 153 --QSVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. ....+||+|
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEECC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEecc
Confidence 247799999975 6665554 3467999999999999999999999999999999999999952 345689999
Q ss_pred cCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--------
Q 012039 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-------- 296 (472)
Q Consensus 227 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------- 296 (472)
||+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999998766555566789999999998854 5899999999999999999999999998876666555431
Q ss_pred ---------CccCCC---C-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 297 ---------DIDFES---A-----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 297 ---------~~~~~~---~-----~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+.++. . ..+.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 111111 0 1135689999999999999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=368.64 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=216.2
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe---
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 151 (472)
....++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++++.+||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 345678999999999999999999999999999999986432 3457889999999999669999999999987
Q ss_pred ---CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 152 ---KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 152 ---~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEee
Confidence 56899999999999999999764 569999999999999999999999999999999999999 4566799999
Q ss_pred cCCceeccCCc-ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc
Q 012039 227 FGLSVFIEEGK-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299 (472)
Q Consensus 227 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 299 (472)
||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 99998765332 233457999999999984 35889999999999999999999999888777666666554332
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
......++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 253 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 --RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp --CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred --cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 22235689999999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=387.09 Aligned_cols=265 Identities=28% Similarity=0.430 Sum_probs=217.6
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc-----CCCCeeEE
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-----GQPNIVEF 145 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~ 145 (472)
..+.+.+..+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ +|+||+++
T Consensus 89 ~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp CCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 344566778999999999999999999999999999999998642 233467788999998884 47799999
Q ss_pred EEEEEeCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEE
Q 012039 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
++++...+.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+|
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vk 242 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIK 242 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEE
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceE
Confidence 999999999999999995 69999887654 499999999999999999999999999999999999995322 12399
Q ss_pred EeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC-
Q 012039 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE- 301 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~- 301 (472)
|+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+....-...
T Consensus 243 L~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 243 VIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9999999765432 345689999999998864 599999999999999999999999999888777666543100000
Q ss_pred -------------------------------------------------CCC-----CCCCCHHHHHHHHHhcccCCCCC
Q 012039 302 -------------------------------------------------SAP-----WPTISSSAKDLVRRMLTQDPKKR 327 (472)
Q Consensus 302 -------------------------------------------------~~~-----~~~~s~~~~~li~~~L~~dp~~R 327 (472)
... ....++++.+||++||++||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 000 01247889999999999999999
Q ss_pred CCHHHHhcCCccccCC
Q 012039 328 ITSAQVLEHPWIKEGG 343 (472)
Q Consensus 328 ps~~~~l~h~~~~~~~ 343 (472)
||++|+|+||||+...
T Consensus 401 pta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCHHHHHTSTTTC---
T ss_pred CCHHHHhCChhhccCC
Confidence 9999999999998743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=363.67 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=224.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
....|++++.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++++. ||||+++++++.+...++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 45679999999999999999999999999999999975542 345678999999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCcc
Confidence 99999999999998754 579999999999999999999999999999999999999 55667999999999876544
Q ss_pred c-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ....++..+.+
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 249 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKE 249 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCHHHHH
Confidence 3 2234579999999999864 58999999999999999999999998888777776666554322 22468999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
||.+||..||.+|||+.++++||||....
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=381.94 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=205.9
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
.+..+|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.+. ||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 356789999999999999999999999999999999875432 3344567889999999995 999999999997665
Q ss_pred ----eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 154 ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 154 ----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.+|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence 7899999996 57888775 469999999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC-------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------- 301 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 301 (472)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 987765544556789999999999864 589999999999999999999999999888777777655321100
Q ss_pred ----------CCCC--------------C-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 302 ----------SAPW--------------P-------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 302 ----------~~~~--------------~-------~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
...+ + ..+.++++||.+||+.||++|||++++|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 0 01568999999999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=382.06 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=212.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 151 (472)
....+|++++.||+|+||+||+|++..+|+.||+|++..... ...+|+.+++.+. ||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCcc
Confidence 345689999999999999999999999999999999864321 2237999999995 9999999999843
Q ss_pred ----------------------------------CCeEEEEEeccCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 012039 152 ----------------------------------KQSVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVV 193 (472)
Q Consensus 152 ----------------------------------~~~~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~i~~qi~~~l 193 (472)
...+++||||++ ++|.+.+. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 345899999997 57766654 356799999999999999999
Q ss_pred HHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHH
Q 012039 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVIL 271 (472)
Q Consensus 194 ~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il 271 (472)
.|||++||+||||||+|||++. .++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999999999999999952 456799999999998776666667789999999998864 489999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHcC-----------------CccCCCC--------CCCCCCHHHHHHHHHhcccCCCC
Q 012039 272 YILLSGVPPFWAETEKGIFDAILQG-----------------DIDFESA--------PWPTISSSAKDLVRRMLTQDPKK 326 (472)
Q Consensus 272 ~~ll~g~~pf~~~~~~~~~~~i~~~-----------------~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~ 326 (472)
|+|++|..||.+.+..+.+..+... ...++.. ....+++++.+||.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998887777666531 0111110 11347899999999999999999
Q ss_pred CCCHHHHhcCCccccC
Q 012039 327 RITSAQVLEHPWIKEG 342 (472)
Q Consensus 327 Rps~~~~l~h~~~~~~ 342 (472)
|||+.|+|+||||+..
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 9999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=374.57 Aligned_cols=265 Identities=38% Similarity=0.680 Sum_probs=194.9
Q ss_pred ccccceEEcc-eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe---
Q 012039 76 DVKLHYSFGK-ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (472)
Q Consensus 76 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 151 (472)
.+.++|.+.+ .||+|+||+||+|+++.+++.||+|++... ....+|+..+.++.+||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 3567899965 599999999999999999999999998542 2233444443333369999999999876
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
...+++|||||+|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998654 69999999999999999999999999999999999999876667789999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHH----HHHHHcCCccCCCC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI----FDAILQGDIDFESA 303 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~ 303 (472)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+......++..
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 99876533 234567899999999885 4588999999999999999999999977655433 33444555566666
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 349 (472)
.+..+++++.+||.+||+.||.+|||+.++|+||||+........+
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~ 301 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCB
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCc
Confidence 7788999999999999999999999999999999998765444333
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=373.34 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=211.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-CCeeEEEEEEEeCCeE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQSV 155 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~iv~~~~~~~~~~~~ 155 (472)
...+|++++.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++.+| |||+++++++.+.+.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3557999999999999999999884 688999999875432 233457789999999999632 9999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|+|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+. ++.+||+|||++.....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence 999995 5889999999988999999999999999999999999999999999999994 35699999999987654
Q ss_pred Ccc---eeeccCCCCCCchhhhh------------cccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCcc
Q 012039 236 GKV---YRDIVGSAYYVAPEVLR------------RRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDID 299 (472)
Q Consensus 236 ~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~ 299 (472)
... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+..+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 332 23467999999999885 3578899999999999999999999976443 2344444443333
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
...+ ...+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 240 IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 2222 35678999999999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=372.61 Aligned_cols=259 Identities=22% Similarity=0.404 Sum_probs=215.7
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
....+|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.++++++ ||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence 356789999999999999999999999999999999975442 234677889999999995 999999999998765
Q ss_pred eEEEEEeccCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeec-cCCCCCcEEEeecCC
Q 012039 154 SVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLS-SKDENALLKATDFGL 229 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~~~kl~Dfg~ 229 (472)
.+++||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+. .++....+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999976433 99999999999999999999999999999999999974 334556799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhh---------cccCCccchhhHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLR---------RRYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQG 296 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~ 296 (472)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+.+..+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 99887766666678999999999875 458899999999999999999999996432 24455555543
Q ss_pred Ccc---------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 012039 297 DID---------------------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (472)
Q Consensus 297 ~~~---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~ 337 (472)
... ........++..+.+||.+||+.||++|||++|+|+||
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 221 00111123456889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=377.86 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=216.6
Q ss_pred cccccceEEcceeeecCCeEEEEEEEC-------CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTEN-------STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
+...++|++++.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++++.+||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345678999999999999999999875 345679999986542 23346678999999999955999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
++.+.+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999997643 478999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 286 (472)
|+ +.++.+||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus 235 ll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 235 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99 5667899999999987654332 223457789999998864 58999999999999999999 9999999888
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+++..+..+.... ....++.++.+||.+||+.||.+|||+.+++++
T Consensus 312 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888777764322 224689999999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=375.62 Aligned_cols=254 Identities=24% Similarity=0.426 Sum_probs=207.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--- 153 (472)
+..+|++++.||+|+||.||+|+++.+++.||||++.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence 4568999999999999999999999999999999997543 3345678999999999995 999999999986543
Q ss_pred ------------------------------------------------------eEEEEEeccCCcchHHHHHhcCC---
Q 012039 154 ------------------------------------------------------SVHVVMELCAGGELFDRIIAKGH--- 176 (472)
Q Consensus 154 ------------------------------------------------------~~~lv~e~~~g~sL~~~l~~~~~--- 176 (472)
.+++|||||+|++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-------------ceeecc
Q 012039 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-------------VYRDIV 243 (472)
Q Consensus 177 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~ 243 (472)
.++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5566789999999999999999999999999999999 456689999999998776542 123357
Q ss_pred CCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 012039 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (472)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (472)
||+.|+|||++.+ .++.++||||||+++|+|++|..|+.. .......+...... ..+...++++.+||.+||+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP---LLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHHCS
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC---cccccCChhHHHHHHHHccC
Confidence 9999999999865 589999999999999999998776521 12233333333221 11234578899999999999
Q ss_pred CCCCCCCHHHHhcCCcccc
Q 012039 323 DPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 323 dp~~Rps~~~~l~h~~~~~ 341 (472)
||++|||+.++|+||||+.
T Consensus 313 ~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCC
T ss_pred CCCcCCCHHHHhhchhhhc
Confidence 9999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=381.93 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=202.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-- 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 152 (472)
..+..+|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCc
Confidence 345679999999999999999999999999999999986532 23344667889999999995 99999999998654
Q ss_pred ----CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 153 ----QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 153 ----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
..+|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG 177 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 177 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC--
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecc
Confidence 6689999999 7899888765 679999999999999999999999999999999999999 566779999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc--------
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-------- 298 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 298 (472)
++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+....-
T Consensus 178 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 178 LARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99875432 345689999999998864 589999999999999999999999999887776666543110
Q ss_pred ---------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 299 ---------------DFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 299 ---------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
..+.. .++.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 00111 12467899999999999999999999999999999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=389.18 Aligned_cols=252 Identities=17% Similarity=0.199 Sum_probs=205.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEE------
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFK------ 146 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~------ 146 (472)
.....+|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.+. +|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 344578999999999999999999999999999999998655445556788999995554443 599999988
Q ss_pred -EEEEeCCe-----------------EEEEEeccCCcchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCc
Q 012039 147 -GAYEDKQS-----------------VHVVMELCAGGELFDRIIAKGHYSE-------RAAASICRSIVNVVHICHFMGV 201 (472)
Q Consensus 147 -~~~~~~~~-----------------~~lv~e~~~g~sL~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~lH~~~i 201 (472)
+++.+.+. .|+||||+ +|+|.+++...+.+++ ..++.|+.||+.||.|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77766543 89999999 6899999987655655 7888899999999999999999
Q ss_pred EeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc------------ccCCccchhhHHH
Q 012039 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGV 269 (472)
Q Consensus 202 ~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~ 269 (472)
+||||||+|||+ +.++.+||+|||++..... .....+| +.|+|||++.+ .++.++|||||||
T Consensus 228 vHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999 4566899999999986433 3455678 99999998864 5899999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 270 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
++|+|++|+.||.+.........+. ..+..+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999997655433222222 123578999999999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=376.76 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=218.3
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++++. ||||+++++++.+++.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCE
Confidence 344678999999999999999999999999999999987542 2344677899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++||||++|++|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence 999999999999999999888999999999999999999999996 99999999999999 45667999999999765
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHH--------------------
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA-------------------- 292 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------------------- 292 (472)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 432 2234589999999999875 589999999999999999999999987665443222
Q ss_pred ----------------------HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 293 ----------------------ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 293 ----------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+..... .......++.++.+||.+||+.||.+|||++++|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 112111 111223578999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=363.42 Aligned_cols=259 Identities=25% Similarity=0.318 Sum_probs=198.9
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
...++|++.+.||+|+||+||+|++..+++.||+|++..... .......+..+...++.+ +||||+++++++.+.+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCE
Confidence 446789999999999999999999999999999999865421 111223334444456666 599999999999999999
Q ss_pred EEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 156 HVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
++||||++ ++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCc
Confidence 99999996 588776643 56799999999999999999999998 99999999999999 55667999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh-----cccCCccchhhHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCccCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR-----RRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~ 304 (472)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.. ......+......... ...
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 235 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLP 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCC
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Ccc
Confidence 8776655555568999999999962 3588899999999999999999999976 3333444444333222 122
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 24689999999999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.83 Aligned_cols=259 Identities=30% Similarity=0.430 Sum_probs=217.2
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 152 (472)
+..+|++++.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccc
Confidence 4568999999999999999999999999999999986432 2334577889999999995 99999999999754
Q ss_pred -CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 -~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceE
Confidence 47899999996 599888865 579999999999999999999999999999999999999 556679999999998
Q ss_pred eccCCcc----eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-----
Q 012039 232 FIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----- 300 (472)
Q Consensus 232 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----- 300 (472)
....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7654322 234589999999998653 48999999999999999999999999888777666654311000
Q ss_pred ---------------C---C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 301 ---------------E---S----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 301 ---------------~---~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+ . ..++.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 0 0 01246789999999999999999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=384.77 Aligned_cols=263 Identities=28% Similarity=0.466 Sum_probs=199.3
Q ss_pred cccccceEE-cceeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSF-GKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
+.+.+.|.+ +++||+|+||+||+|+++ .+++.||+|++.... ....+.+|+.+|++|+ ||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 456678888 558999999999999976 578899999986432 2356889999999995 9999999999954
Q ss_pred --CCeEEEEEeccCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC-CCC
Q 012039 152 --KQSVHVVMELCAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DEN 219 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~ 219 (472)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 778999999995 5888877532 249999999999999999999999999999999999999644 456
Q ss_pred CcEEEeecCCceeccCC----cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCCh-------
Q 012039 220 ALLKATDFGLSVFIEEG----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE------- 286 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~------- 286 (472)
+.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 78999999999876542 22345689999999998864 489999999999999999999999976543
Q ss_pred --HHHHHHHHcCCccCCCCCCC----------------------------------CCCHHHHHHHHHhcccCCCCCCCH
Q 012039 287 --KGIFDAILQGDIDFESAPWP----------------------------------TISSSAKDLVRRMLTQDPKKRITS 330 (472)
Q Consensus 287 --~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dp~~Rps~ 330 (472)
.+.+..+....-......|. ..++++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 23444443211111111121 237889999999999999999999
Q ss_pred HHHhcCCccccCCC
Q 012039 331 AQVLEHPWIKEGGE 344 (472)
Q Consensus 331 ~~~l~h~~~~~~~~ 344 (472)
+|+|+||||+....
T Consensus 329 ~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 329 EQAMQDPYFLEDPL 342 (405)
T ss_dssp HHHHTSGGGTSSSC
T ss_pred HHHhcChhhccCCC
Confidence 99999999987543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.98 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=211.3
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
...+....+|++.+.||+|+||+||+|++ +++.||+|++..... .......+.+|+.++++++ ||||+++++++.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 105 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQ 105 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE
Confidence 34455677999999999999999999987 478999999875443 2334567889999999995 9999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEee
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
...+++||||++|++|.+++...+. +++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~D 182 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCD 182 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECC
Confidence 9999999999999999999976543 999999999999999999999999 9999999999999 5667899999
Q ss_pred cCCceeccCCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 227 FGLSVFIEEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 227 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.........
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-- 260 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI-- 260 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--
Confidence 99998654432 2334679999999999875 5899999999999999999999999998888777776544333322
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCcccc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~--h~~~~~ 341 (472)
...+++++.+||.+||+.||.+|||+.++++ +++++.
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2468999999999999999999999999987 455543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=377.90 Aligned_cols=260 Identities=26% Similarity=0.482 Sum_probs=223.7
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccH--------------HHHHHHHHHHHhccCCCC
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--------------DDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~--------------~~~~~E~~~l~~l~~hp~ 141 (472)
....+|++++.||+|+||.||+|.+ +++.||+|++........... ..+.+|+.++++++ |||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence 3457899999999999999999998 799999999976543322221 78999999999995 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCcchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCcee
Q 012039 142 IVEFKGAYEDKQSVHVVMELCAGGELFDR------IIA--KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFL 212 (472)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil 212 (472)
|+++++++.+.+.+++||||++|++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999988 655 5679999999999999999999999 99999999999999
Q ss_pred eccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhcc--cCC-ccchhhHHHHHHHHhhCCCCCCCCCh-HH
Q 012039 213 LSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YGK-EIDIWSAGVILYILLSGVPPFWAETE-KG 288 (472)
Q Consensus 213 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwslG~il~~ll~g~~pf~~~~~-~~ 288 (472)
+ +.++.+||+|||++...... ......||+.|+|||++.+. ++. ++||||||+++|+|++|..||..... .+
T Consensus 185 ~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 M---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp E---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred E---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9 55667999999999876544 34556899999999998653 555 99999999999999999999988776 77
Q ss_pred HHHHHHcCCccCCCCC---------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 289 IFDAILQGDIDFESAP---------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 289 ~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
....+..+...++... ...++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 7788877765554321 14689999999999999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=375.53 Aligned_cols=263 Identities=26% Similarity=0.388 Sum_probs=217.1
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC-----eeEEE
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-----IVEFK 146 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-----iv~~~ 146 (472)
...+.+.++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.+..|++ |++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 34456778999999999999999999999999999999998642 2335677889999999865664 99999
Q ss_pred EEEEeCCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCcEeecCCCCceeeccCCCCCcE
Q 012039 147 GAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICH--FMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 147 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
+++...+.+|+||||+. ++|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||+.. +..+.+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcE
Confidence 99999999999999995 5999998765 45999999999999999999999 579999999999999953 235679
Q ss_pred EEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC
Q 012039 223 KATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 201 kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999999876543 345689999999999865 589999999999999999999999999888777766654211000
Q ss_pred ------------------CCCC-----------------CC-------------------------CCHHHHHHHHHhcc
Q 012039 302 ------------------SAPW-----------------PT-------------------------ISSSAKDLVRRMLT 321 (472)
Q Consensus 302 ------------------~~~~-----------------~~-------------------------~s~~~~~li~~~L~ 321 (472)
...| .. .++++.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 0000 00 01378999999999
Q ss_pred cCCCCCCCHHHHhcCCccccC
Q 012039 322 QDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 322 ~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.||++|||++|+|+||||+..
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=363.87 Aligned_cols=259 Identities=27% Similarity=0.488 Sum_probs=219.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEE--EeCC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAY--EDKQ 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~ 153 (472)
+.++|++++.||+|+||.||+|.+..+++.||+|++.+.... .......+.+|+.++++++ ||||+++++++ .+..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence 456899999999999999999999999999999999754321 1234678899999999995 99999999998 4556
Q ss_pred eEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 SVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.+++||||+.++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence 899999999765 7777765 4569999999999999999999999999999999999999 456679999999998
Q ss_pred eccCC---cceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 232 FIEEG---KVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 232 ~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+...++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP---- 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence 76432 23345579999999999864 247799999999999999999999999888888888887765443
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
..+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 367899999999999999999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=365.33 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=218.5
Q ss_pred cccceEEcceeeecCCeEEEEEEEC-CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEE---
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTEN-STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYE--- 150 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~--- 150 (472)
...+|++.+.||+|+||.||+|++. .+++.||+|++...... ......+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999999995 67889999998754421 222345667888887773 5999999999987
Q ss_pred --eCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEee
Q 012039 151 --DKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 151 --~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEec
Confidence 5678999999997 59999987653 49999999999999999999999999999999999999 5566799999
Q ss_pred cCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc-----cC
Q 012039 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-----DF 300 (472)
Q Consensus 227 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~~ 300 (472)
||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......+..+..... .+
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 999987665444556789999999998864 589999999999999999999999999888777766653110 00
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 301 ------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 301 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
....+..++..+.+||.+||..||++|||+.++|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 00123568999999999999999999999999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=362.00 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=217.5
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeE
Confidence 45678999999999999999999999999999999986542 345678899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcccc
Confidence 999999999999988875 4669999999999999999999999999999999999999 456679999999876432
Q ss_pred CC-cceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 235 EG-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
.. .......||+.|+|||++. ..++.++||||||+++|+|++|..||...+....+..+........ .....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 247 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSK 247 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGG
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccc
Confidence 21 1223457899999999873 3578899999999999999999999998888777777666543221 12246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 78999999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=380.79 Aligned_cols=258 Identities=15% Similarity=0.192 Sum_probs=197.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc-CCCCeeEEE-------EEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQPNIVEFK-------GAY 149 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~-------~~~ 149 (472)
...|++.+.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.|+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346999999999999999999999999999999998765433445667888876666664 499988865 455
Q ss_pred EeC-----------------CeEEEEEeccCCcchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCcEeec
Q 012039 150 EDK-----------------QSVHVVMELCAGGELFDRIIAK-GHYSERAA------ASICRSIVNVVHICHFMGVMHRD 205 (472)
Q Consensus 150 ~~~-----------------~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~lH~~~i~H~d 205 (472)
... ..+|||||||+ ++|.+++... ..+.+... ..++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 34899999997 8999999764 33444445 57779999999999999999999
Q ss_pred CCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCC
Q 012039 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFW 282 (472)
Q Consensus 206 lkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~ 282 (472)
|||+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus 220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999 55677999999999876432 224567799999999864 58999999999999999999999998
Q ss_pred CCChHHH--HHH---HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 283 AETEKGI--FDA---ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 283 ~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+...... +.. .......+....+..+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 7643210 000 1111222333344688999999999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=360.84 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=215.2
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+|+.+++++. ||||+++++++...+.+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence 3456899999999999999999999999999999998643 23567899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence 99999999999999986 45679999999999999999999999999999999999999 456679999999998765
Q ss_pred CCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......++..+
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 255 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNF 255 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHH
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHH
Confidence 432 2334579999999999864 5899999999999999999999999887776655555443221 111123578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+||.+||..||.+|||+.++|+||||+..
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=365.78 Aligned_cols=263 Identities=29% Similarity=0.473 Sum_probs=199.1
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
+.....+|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++++. ||||+++++++...+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecC
Confidence 34456789999999999999999999998999999998865432 234567889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 154 SVHVVMELCAGGELFDRIIA--------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEE
Confidence 99999999999999998864 4569999999999999999999999999999999999999 456679999
Q ss_pred ecCCceeccCCc------ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 012039 226 DFGLSVFIEEGK------VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297 (472)
Q Consensus 226 Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 297 (472)
|||++....... ......||+.|+|||++.. .++.++||||||+++|+|++|..||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999987654321 1234579999999999864 58999999999999999999999998877766665555443
Q ss_pred ccCC------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 298 IDFE------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 298 ~~~~------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.... ...+..++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 2211 12235688999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=358.64 Aligned_cols=257 Identities=29% Similarity=0.509 Sum_probs=220.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 155 (472)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+ ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence 4589999999999999999999999999999999976443 2344677899999999995 9999999998754 6789
Q ss_pred EEEEeccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----cEeecCCCCceeeccCCCCCcEEEee
Q 012039 156 HVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMG-----VMHRDLKPENFLLSSKDENALLKATD 226 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~~~kl~D 226 (472)
++||||++|++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence 9999999999999998753 34999999999999999999999999 9999999999999 5567799999
Q ss_pred cCCceeccCCcc-eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 227 FGLSVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 227 fg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..++...+..+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--- 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence 999987654322 234578999999999865 588999999999999999999999999888888888877755322
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
...+++++.+||.+||+.||.+|||+.++|+|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 23689999999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=374.43 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=221.0
Q ss_pred cccccceEEcceeeecCCeEEEEEE-----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
+....+|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.++++++ ||||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 3456789999999999999999999 44577899999986432 3344567889999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcE
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKG-------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
.+....++|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++....+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997653 48999999999999999999999999999999999999765566779
Q ss_pred EEeecCCceeccCC---cceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 012039 223 KATDFGLSVFIEEG---KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGD 297 (472)
Q Consensus 223 kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 297 (472)
||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+..+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999755322 2223456899999999885 468999999999999999998 999999999888888887765
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 298 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.... ...++..+.+||.+||+.||.+|||+.+++++.|+.
T Consensus 304 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3322 246899999999999999999999999999987664
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.08 Aligned_cols=262 Identities=29% Similarity=0.458 Sum_probs=215.9
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-- 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 152 (472)
..+.++|.+.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDSF 83 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCS
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccccc
Confidence 346679999999999999999999999999999999986432 2334567889999999995 99999999987654
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
...++||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGL 158 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTT
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccc
Confidence 67999999996 689888765 579999999999999999999999999999999999999 5566799999999
Q ss_pred ceeccCCcc-----------eeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 012039 230 SVFIEEGKV-----------YRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (472)
Q Consensus 230 ~~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 296 (472)
+........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 987653221 12357899999999875 45899999999999999999999999988776655544321
Q ss_pred Cc------------------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 297 DI------------------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 297 ~~------------------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.- .... ..++.+++++.+||.+||..||++|||+.++|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00 0000 012468999999999999999999999999999999987544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.09 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=216.8
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEE-CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCC------CeeE
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTE-NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP------NIVE 144 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp------~iv~ 144 (472)
.+.+.+..+|++.+.||+|+||.||+|.+ ..+++.||+|++... ......+.+|+.+++.+. |+ +|++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence 34456778999999999999999999998 567899999998642 234567889999999985 54 5999
Q ss_pred EEEEEEeCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC----
Q 012039 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE---- 218 (472)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---- 218 (472)
+++++.+.+.+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+...+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998765 6899999999999999999999999999999999999964321
Q ss_pred ------------CCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC
Q 012039 219 ------------NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET 285 (472)
Q Consensus 219 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 285 (472)
+..+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 567999999999875443 345689999999999865 68999999999999999999999999887
Q ss_pred hHHHHHHHHcCCccCC----------------CCCC------------------------CCCCHHHHHHHHHhcccCCC
Q 012039 286 EKGIFDAILQGDIDFE----------------SAPW------------------------PTISSSAKDLVRRMLTQDPK 325 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~----------------~~~~------------------------~~~s~~~~~li~~~L~~dp~ 325 (472)
..+....+.......+ ...| ...++++.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 7665544432111100 0011 12356789999999999999
Q ss_pred CCCCHHHHhcCCccccC
Q 012039 326 KRITSAQVLEHPWIKEG 342 (472)
Q Consensus 326 ~Rps~~~~l~h~~~~~~ 342 (472)
+|||+.|+|+||||+..
T Consensus 319 ~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 319 KRITLREALKHPFFDLL 335 (339)
T ss_dssp TSCCHHHHTTSGGGGGG
T ss_pred cccCHHHHhcCHHHHHH
Confidence 99999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=372.45 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=212.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+..+|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSS
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCc
Confidence 466799999999999999999999999999999999875432 2334577889999999995 99999999999877654
Q ss_pred ------EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 156 ------HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 156 ------~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL 190 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTC
T ss_pred ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCc
Confidence 99999996 68877663 459999999999999999999999999999999999999 5667799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc--------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-------- 299 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 299 (472)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 9865432 345688999999998864 5899999999999999999999999988877666665431100
Q ss_pred ---------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 300 ---------------FES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 300 ---------------~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
... ..++.+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 0124679999999999999999999999999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=361.80 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=214.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
....+|++.+.||+|+||.||+|.+..++. .||||++.... .......+.+|+.++++++ ||||+++++++.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRG 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 346789999999999999999999986655 49999986532 3344677899999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
+.+|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccc
Confidence 9999999999999999999654 579999999999999999999999999999999999999 566789999999998
Q ss_pred eccCCcc----eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 232 FIEEGKV----YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 232 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.... ..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 276 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---AP 276 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CC
Confidence 7654321 12234677899999987 468999999999999999999 999999999888888887763222 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+++++.+||.+||..||.+|||+.++++
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 478999999999999999999999999886
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=370.25 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=203.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe--
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS-- 154 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-- 154 (472)
..++|++.+.||+|+||+||+|++..+++.||||++.... .......+|+..+..+. ||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccc
Confidence 3468999999999999999999999999999999885432 22345667888888885 9999999999865433
Q ss_pred -----EEEEEeccCCcchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCcEeecCCCCceeeccCCCCCcEE
Q 012039 155 -----VHVVMELCAGGELFDRI----IAKGHYSERAAASICRSIVNVVHICH--FMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 155 -----~~lv~e~~~g~sL~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
+++||||+.+ +|.+.+ .....+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcEE
Confidence 8899999976 554433 34567999999999999999999999 999999999999999952 356899
Q ss_pred EeecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccC-
Q 012039 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF- 300 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~- 300 (472)
|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999999998776666666789999999998853 38999999999999999999999999988877776665411000
Q ss_pred -------------------C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 301 -------------------E--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 301 -------------------~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
. .......++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 0011235789999999999999999999999999999987644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=370.96 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=213.0
Q ss_pred ccccccccceEEcceeeecCCeEEEEEE-----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEE
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 146 (472)
..++...++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++++.+||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3455667899999999999999999999 55677899999996542 2334567899999999997799999999
Q ss_pred EEEEeCC-eEEEEEeccCCcchHHHHHhcCC-------------------------------------------------
Q 012039 147 GAYEDKQ-SVHVVMELCAGGELFDRIIAKGH------------------------------------------------- 176 (472)
Q Consensus 147 ~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~------------------------------------------------- 176 (472)
+++.+.+ .+++|||||+||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 48999999999999999976533
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc-
Q 012039 177 -----------------YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (472)
Q Consensus 177 -----------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~- 238 (472)
+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc
Confidence 8999999999999999999999999999999999999 4566799999999987644322
Q ss_pred --eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 239 --YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 239 --~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+.+............ ...+++++.+
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 327 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQ 327 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHH
Confidence 23456889999999886 468999999999999999998 99999887654444333332222222 2468999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h 336 (472)
+|.+||+.||.+|||+.++++|
T Consensus 328 li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=364.16 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=212.3
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE----
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE---- 150 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---- 150 (472)
..+..+|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++. ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGS 82 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccc
Confidence 45678999999999999999999999999999999998643 2344677889999999995 999999999873
Q ss_pred ----------eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 151 ----------DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 151 ----------~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+...+++||||+. ++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++. .+.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~ 158 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDL 158 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTT
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCC
Confidence 4478999999997 69988875 467999999999999999999999999999999999999952 346
Q ss_pred cEEEeecCCceeccCCc----ceeeccCCCCCCchhhhh--cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 012039 221 LLKATDFGLSVFIEEGK----VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 294 (472)
.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++|+.||.+....+.+..+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 79999999998764321 223346799999999875 458999999999999999999999999888777666665
Q ss_pred cCCccC----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 295 QGDIDF----------------------ES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 295 ~~~~~~----------------------~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
...... .. ..++.++.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 432110 00 012468999999999999999999999999999999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=368.15 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=208.0
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc--------ccHHHHHHHHHHHHhccCCCCeeEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK--------NDKDDIKREIQIMQHLSGQPNIVEF 145 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~iv~~ 145 (472)
...+.++|++++.||+|+||.||+|.+.. ++.||||++........ ...+.+.+|+.++++++ ||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccce
Confidence 34567899999999999999999999865 89999999865432211 12377899999999995 9999999
Q ss_pred EEEEEe-----CCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC
Q 012039 146 KGAYED-----KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 146 ~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 219 (472)
++++.. ...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||++ +.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADN 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCC
Confidence 999853 347899999996 6888877654 369999999999999999999999999999999999999 556
Q ss_pred CcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 012039 220 ALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 297 (472)
+.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 6799999999987665555556789999999998864 58999999999999999999999999888777666654311
Q ss_pred c------------------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 298 I------------------------DFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 298 ~------------------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
. ..+.. ..+.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 01111 124568999999999999999999999999999999865
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=357.96 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=210.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 151 (472)
+.++|++++.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++++. ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence 456899999999999999999999999999999998542 234577889999999995 9999999998865
Q ss_pred --------CCeEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcE
Q 012039 152 --------KQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (472)
Q Consensus 152 --------~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~ 222 (472)
...+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence 457899999999999999997543 57889999999999999999999999999999999999 556679
Q ss_pred EEeecCCceeccCC---------------cceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCC-C
Q 012039 223 KATDFGLSVFIEEG---------------KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWA-E 284 (472)
Q Consensus 223 kl~Dfg~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~-~ 284 (472)
||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++ ||.. .
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999865422 12234578999999999864 58999999999999999998 5543 3
Q ss_pred ChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
........+......++.......+..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 334556666666666665555678899999999999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=364.36 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=212.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe-
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS- 154 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~- 154 (472)
.+..+|.+.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++++++ ||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence 356789999999999999999999999999999999865432 2334567889999999995 9999999999987654
Q ss_pred -----EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 155 -----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 155 -----~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence 599999996 68887764 359999999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---------- 297 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 297 (472)
+...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+....
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9865432 335678999999998864 58999999999999999999999999888766665554310
Q ss_pred -----------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 298 -----------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 298 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.......++.+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000112235689999999999999999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=353.28 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=207.2
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
|.....||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.+.+.+++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence 333448999999999999999999999999986542 334577899999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 161 LCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|+++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++. .++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence 999999999987652 4678999999999999999999999999999999999953 25679999999998765432
Q ss_pred -ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHH
Q 012039 238 -VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....... ..........+++++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPEIPESMSAEA 255 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCCCCTTSCHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccccccccccCCHHH
Confidence 2334579999999999864 27899999999999999999999997644322 1111111 111222235689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.+||.+||+.||++|||+.++|+||||+...
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=364.17 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=215.8
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCC-CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC------ee
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTG-RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN------IV 143 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~------iv 143 (472)
....+.+.++|++.+.||+|+||+||+|++..++ +.||+|++... ......+.+|+.+++++. |++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 3445567789999999999999999999998877 68999998642 234567889999999996 554 99
Q ss_pred EEEEEEEeCCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC-----
Q 012039 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK----- 216 (472)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~----- 216 (472)
.+++++...+.+++||||+ +++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 667777776653 69999999999999999999999999999999999999543
Q ss_pred -----------CCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC
Q 012039 217 -----------DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE 284 (472)
Q Consensus 217 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 284 (472)
+....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 24677999999999875443 245689999999999864 6899999999999999999999999988
Q ss_pred ChHHHHHHHHcCCccCCC----------------CCC------------------------CCCCHHHHHHHHHhcccCC
Q 012039 285 TEKGIFDAILQGDIDFES----------------APW------------------------PTISSSAKDLVRRMLTQDP 324 (472)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dp 324 (472)
...+.+..+.......+. ..| ...+.++.+||++||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 776655444321111000 001 1124578899999999999
Q ss_pred CCCCCHHHHhcCCccccC
Q 012039 325 KKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 325 ~~Rps~~~~l~h~~~~~~ 342 (472)
++|||+.++|+||||+..
T Consensus 323 ~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSCCHHHHTTSGGGGGC
T ss_pred hhCcCHHHHhcChhhcCC
Confidence 999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=374.84 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=208.2
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc-------CCCCeeEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-------GQPNIVEFK 146 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~hp~iv~~~ 146 (472)
.+.+.++|++.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.++++++ +||||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 345668999999999999999999999999999999998643 234567889999999995 278899999
Q ss_pred EEEE----eCCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCC--
Q 012039 147 GAYE----DKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKD-- 217 (472)
Q Consensus 147 ~~~~----~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-- 217 (472)
+++. +...+++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||+..++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 556899999999 66777777654 4699999999999999999999998 999999999999996432
Q ss_pred --------------------------------------------CCCcEEEeecCCceeccCCcceeeccCCCCCCchhh
Q 012039 218 --------------------------------------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253 (472)
Q Consensus 218 --------------------------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~ 253 (472)
....+||+|||++...... .....||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence 1137999999999876543 345689999999998
Q ss_pred hhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh------HHHHHHHHc------------CCcc---CC---------C
Q 012039 254 LRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE------KGIFDAILQ------------GDID---FE---------S 302 (472)
Q Consensus 254 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~------------~~~~---~~---------~ 302 (472)
+.+ .++.++|||||||++|+|++|..||.+.+. ...+..+.. +... +. .
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 865 589999999999999999999999976542 222222211 0000 00 0
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 303 --------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 303 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
......++++.+||.+||+.||++|||++++|+||||+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00012346788999999999999999999999999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.01 Aligned_cols=256 Identities=29% Similarity=0.543 Sum_probs=216.4
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhcc-CCCCeeEEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLS-GQPNIVEFKGAY 149 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~ 149 (472)
.+.+..+|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++++. +||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34567799999999999999999999999999999999976543221 12345678999999996 369999999999
Q ss_pred EeCCeEEEEEeccCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 150 EDKQSVHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.+.+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEeeCc
Confidence 999999999999976 899999998889999999999999999999999999999999999999952 45679999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhhc-c-cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
++....... .....||+.|+|||++.. . ++.++||||||+++|+|++|..||.... .+......+. .
T Consensus 196 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----~ 264 (320)
T 3a99_A 196 SGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----Q 264 (320)
T ss_dssp TCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----S
T ss_pred ccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----c
Confidence 998775432 345679999999998864 3 3678999999999999999999996532 2333333222 4
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+++++.+||.+||..||++|||++++++||||+..
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 689999999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=365.76 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=217.9
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCC-------CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENST-------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
+...++|.+++.||+|+||+||+|++..+ +..||+|++.... .......+.+|+.+++++.+||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45567999999999999999999997543 3579999986542 33445778999999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
++.+.+.+++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998653 499999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 286 (472)
|+ +.++.+||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus 223 ll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 223 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99 5567799999999987654322 223457889999998864 58999999999999999999 9999999888
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+....+..+..... ...+++++.+||.+||+.||++|||+.+++++
T Consensus 300 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 EELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888888777643222 24689999999999999999999999999885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.68 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=215.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
...++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCce
Confidence 34578999999999999999999876 46789999986533 23567899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecc
Confidence 99999999999999997654 49999999999999999999999999999999999999 566779999999998765
Q ss_pred CCccee--eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKVYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
...... ...+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+...... ..+++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASD 232 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChH
Confidence 543322 2345678999999875 68999999999999999999 99999998888888877776543332 35789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+.+||.+||+.||.+|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=360.61 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=199.0
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
.....+|++++.||+|+||.||+|++..++. .||+|++..... .......+.+|+.++++++ ||||+++++++..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeec
Confidence 3445689999999999999999999887765 899999875433 2344678999999999994 9999999999987
Q ss_pred CCeE------EEEEeccCCcchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC
Q 012039 152 KQSV------HVVMELCAGGELFDRIIAKG------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 152 ~~~~------~lv~e~~~g~sL~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 219 (472)
.... ++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCC
Confidence 7655 99999999999999886533 59999999999999999999999999999999999999 556
Q ss_pred CcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 012039 220 ALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 294 (472)
+.+||+|||++......... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 78999999999876544322 23456788999998865 58999999999999999999 999999988888888887
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCccccCC
Q 012039 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT-------SAQVLEHPWIKEGG 343 (472)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps-------~~~~l~h~~~~~~~ 343 (472)
.+..... ...+++++.+||.+||+.||++||| .+++++|+|+....
T Consensus 254 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 254 GGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred cCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 7653222 2468999999999999999999999 67788999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=356.20 Aligned_cols=260 Identities=25% Similarity=0.438 Sum_probs=212.4
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC-CCCeeEEEEEEEeCC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-QPNIVEFKGAYEDKQ 153 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~~ 153 (472)
.....+|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++.+ ||||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 344568999999999999999999986 488999999865432 23446788999999999973 699999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+++||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++. ++.+||+|||++...
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC-
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccc
Confidence 9999999 55889999999888999999999999999999999999999999999999994 267999999999876
Q ss_pred cCCcc---eeeccCCCCCCchhhhhc------------ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCC
Q 012039 234 EEGKV---YRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGD 297 (472)
Q Consensus 234 ~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~ 297 (472)
..... .....||+.|+|||++.. .++.++||||||+++|+|++|..||..... ...+..+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 54322 234578999999999853 578899999999999999999999976543 33444444443
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 298 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
...... ...+.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 257 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 257 HEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp SCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 332222 35689999999999999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=360.83 Aligned_cols=256 Identities=28% Similarity=0.552 Sum_probs=205.6
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhcc---CCCCeeEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLS---GQPNIVEFKGA 148 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~hp~iv~~~~~ 148 (472)
+.+..+|++.+.||+|+||.||+|++..+++.||+|++........ .....+.+|+.+++++. +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4567799999999999999999999999999999999976543211 12234567999999983 49999999999
Q ss_pred EEeCCeEEEEEec-cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 149 YEDKQSVHVVMEL-CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 149 ~~~~~~~~lv~e~-~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
+.+.+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~df 184 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLIDF 184 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEECCC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEEEc
Confidence 9999999999999 789999999998888999999999999999999999999999999999999952 4567999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhhc-cc-CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
|++....... .....||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||.... .+......++
T Consensus 185 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~---- 253 (312)
T 2iwi_A 185 GSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP---- 253 (312)
T ss_dssp SSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC----
T ss_pred chhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc----
Confidence 9998776543 345679999999998864 34 458999999999999999999996532 2333333322
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 46899999999999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=361.84 Aligned_cols=252 Identities=18% Similarity=0.218 Sum_probs=208.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+..+|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++++|.+||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 4568999999999999999999999999999999986432 23458899999999966999999999999999999
Q ss_pred EEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC--CCcEEEeecCCceec
Q 012039 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE--NALLKATDFGLSVFI 233 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~~~kl~Dfg~~~~~ 233 (472)
+||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999876 467999999999999999999999999999999999999953321 223999999999876
Q ss_pred cCCcc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCccCC
Q 012039 234 EEGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFE 301 (472)
Q Consensus 234 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 301 (472)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 54332 235689999999999875 58999999999999999999999998743 3444555544433332
Q ss_pred CCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 302 SAP-WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 302 ~~~-~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
... ...++ ++.+||..||..||.+||++.++++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 211 12344 9999999999999999999998865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=350.26 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=212.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
....+|++++.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++++. ||||+++++++.+.+.+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCe
Confidence 34568999999999999999999876 57789999987543 23567899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccc
Confidence 999999999999999976 5679999999999999999999999999999999999999 566679999999998664
Q ss_pred CCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 012039 235 EGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (472)
Q Consensus 235 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (472)
.... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+...... ..+++
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 248 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASE 248 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCH
Confidence 3321 12335678899999886 468999999999999999998 99999998888888888776433322 45789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 311 SAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 311 ~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+.+||.+||+.||.+|||+.++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=347.31 Aligned_cols=248 Identities=24% Similarity=0.427 Sum_probs=214.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++ ||||+++++++.+.+.++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceE
Confidence 4568999999999999999999987 47789999987543 23567899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccc
Confidence 999999999999999654 458999999999999999999999999999999999999 4556799999999986543
Q ss_pred Ccc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 236 GKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 236 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+..... ...++++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 235 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTH 235 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHH
Confidence 321 12345677899999986 468999999999999999999 9999999988888888877633322 2457999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+.++|.+||+.||.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999886
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.01 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=216.6
Q ss_pred cccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
+....+|.+.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEE
Confidence 445678999999999999999999983 455889999986432 3344677899999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeec
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKGH------------------------YSERAAASICRSIVNVVHICHFMGVMHRD 205 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 205 (472)
.+.+.+++||||++|++|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986543 89999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCC
Q 012039 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPP 280 (472)
Q Consensus 206 lkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~p 280 (472)
|||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..|
T Consensus 176 ikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999994 5667999999999876544322 23457788999998864 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 281 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
|.+.........+..+... .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp STTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9998888888777765432 2225789999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=353.92 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=206.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+++.+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence 458999999999999999999999999999999997654433444578899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccccc
Confidence 99999999999999988889999999999999999999999999999999999999 456679999999998765432
Q ss_pred --ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 238 --VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 238 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+. ..........+.+|+++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHHHHH
Confidence 2234579999999998864 58899999999999999999999998776654444443 3333333344678999999
Q ss_pred HHHHhcccCCCCCC-CHHHHhc
Q 012039 315 LVRRMLTQDPKKRI-TSAQVLE 335 (472)
Q Consensus 315 li~~~L~~dp~~Rp-s~~~~l~ 335 (472)
||.+||..||++|| +++++++
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999 7777765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.09 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=199.7
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..+.....+|++.+.||+|+||.||+|++..+++.||||++..... .......+..+..+++.+ +||||+++++++.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT 95 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEec
Confidence 3444556789999999999999999999999999999999875432 111223344445567777 59999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 KQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.+.+++||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGI 171 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCC
Confidence 99999999999 5555555443 46799999999999999999999995 99999999999999 5567799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCccCCC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFES 302 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 302 (472)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.. ....+.+..+..+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 250 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL- 250 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-
Confidence 98776555555568999999999984 3578999999999999999999999986 345556666666543322
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.....+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 2234689999999999999999999999999999999853
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=360.40 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=212.8
Q ss_pred ccccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++....+|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++.+||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4455679999999999999999999973 456789999997543 234467899999999999559999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeec
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAKG-----------------------HYSERAAASICRSIVNVVHICHFMGVMHRD 205 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 205 (472)
+...+.+++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997643 278999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCC
Q 012039 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPP 280 (472)
Q Consensus 206 lkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 280 (472)
|||+||++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..|
T Consensus 198 ikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999 4566899999999987654332 12345788999999885 468999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 281 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
|.+......+..+.......... ..+++++.+||.+||..||.+|||+.++++|
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 98877655555555544333322 4679999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=358.04 Aligned_cols=245 Identities=24% Similarity=0.411 Sum_probs=206.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|.+++.||+|+||+||+|.+..+++.||+|++... .......+.+|+.++++++ ||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence 46899999999999999999999999999999988542 3445678899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence 9999999999999987 5679999999999999999999999999999999999999 56677999999999876443
Q ss_pred cce---------------eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHH-----HHHHHHc
Q 012039 237 KVY---------------RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-----IFDAILQ 295 (472)
Q Consensus 237 ~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~ 295 (472)
... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 221 14579999999999875 58999999999999999999999986532210 0111111
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.. ..+.+++++.+||.+||+.||++|||+.++++
T Consensus 242 ~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 10 12467889999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.54 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=203.5
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC-cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..+|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence 458999999999999999999975 7899999987543322 234577899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---cEeecCCCCceeeccCC-----CCCcEEEeecC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG---VMHRDLKPENFLLSSKD-----ENALLKATDFG 228 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~-----~~~~~kl~Dfg 228 (472)
+||||++|++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+||++.... ..+.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999988774 567999999999999999999999999 89999999999996422 25679999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.......... ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--ST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cc
Confidence 9987654432 34579999999998864 58999999999999999999999999888877777776665544332 57
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+++.+.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=360.58 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=217.6
Q ss_pred ccccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
.+....+|++++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.++++++ ||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence 3455679999999999999999999987 345889999987543 2334677899999999995 9999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEee
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAK------------------------GHYSERAAASICRSIVNVVHICHFMGVMHR 204 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 204 (472)
+.+.+.+++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999763 568999999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCcEEEeecCCceeccCCc---ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCC
Q 012039 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVP 279 (472)
Q Consensus 205 dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 279 (472)
||||+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..
T Consensus 199 Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 999999999 456679999999998654332 223456889999999886 468999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
||.+....+....+..+..... ...+++++.+||++||+.||.+|||+.+++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999988888888877654322 24689999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=351.65 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=212.9
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.+|+||+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 345678999999999999999999999999999999986432 234578899999999779999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC--CCCcEEEeecCCce
Q 012039 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLSV 231 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~~~kl~Dfg~~~ 231 (472)
.++||||+ |++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998654 599999999999999999999999999999999999996432 23459999999998
Q ss_pred eccCCcc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCcc
Q 012039 232 FIEEGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDID 299 (472)
Q Consensus 232 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~ 299 (472)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.. ....+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654322 234579999999999865 58999999999999999999999998743 34444444433222
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 300 FE-SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 300 ~~-~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+ ......+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 21 1122468999999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.26 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=214.5
Q ss_pred ccccccceEEcceeeecCCeEEEEEEE-----CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++....+|++++.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 445567999999999999999999985 4567899999987543 233457889999999999569999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAKG------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
+.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999997654 48999999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
|++ +.++.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+..
T Consensus 176 il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999 45677999999999877554322 2345678899999876 468999999999999999999 999998876
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.......+........ ....++.++.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5554444443333222 224689999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=364.63 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=214.7
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
+.....+|.+++.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++++. ||||+++++++.+.+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCC
Confidence 3445678999999999999999999999999999999986432 2233456889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSRE 262 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCcee
Confidence 9999999999999999997654 59999999999999999999999999999999999999 5567899999999987
Q ss_pred ccCCccee---eccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 233 IEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 233 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
........ ...+++.|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+..+... + ....
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~ 339 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-P--CPEL 339 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-C--CCTT
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCC
Confidence 54432211 123467899999986 468999999999999999998 99999988887777777665322 2 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+++++.+||.+||+.||++|||+.++++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=348.42 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=203.8
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
++....+|++++.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence 455677999999999999999999998754 4569999886432 2344667899999999995 999999999985
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
++..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 162 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccc
Confidence 456889999999999999997654 699999999999999999999999999999999999995 456799999999
Q ss_pred ceeccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 230 SVFIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 230 ~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
+......... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~ 239 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MP 239 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CC
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CC
Confidence 9876543322 2345678899999986 468999999999999999996 999999988888888887764322 23
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+++++.+||.+||..||++|||+.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5789999999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=353.46 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=215.8
Q ss_pred cccccceEEcceeeecCCeEEEEEEEC-------CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTEN-------STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
+...++|++++.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++++.+||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 344679999999999999999999976 456789999986542 23446778999999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
++.+.+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997653 389999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 286 (472)
++ +.++.+||+|||++......... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus 189 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 189 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99 55677999999999877654322 2345678899999886 458999999999999999999 9999999888
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+....+..+.... ....++.++.+||.+||..||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88887777664322 224689999999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=358.47 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=192.3
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+. +++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREG 94 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSS
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCC
Confidence 334568999999999999999999999999999999997542 2233455666776 55555 6999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 154 SVHVVMELCAGGELFDRIIA-----KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
..++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||++ +.++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccC
Confidence 99999999975 88777753 56799999999999999999999999 99999999999999 45667999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhh-----cccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCC-ccC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLR-----RRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGD-IDF 300 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~ 300 (472)
|++.............||+.|+|||++. ..++.++||||||+++|+|++|..||..... .+.+..+..+. ..+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9998776554444557999999999973 3589999999999999999999999976432 12222222221 122
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
....+..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 223335689999999999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.85 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=210.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEE--EEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
.+|++.+.||+|+||.||+|++..++..+ |+|.+.... .......+.+|+.+++++.+||||+++++++.+.+.+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 58999999999999999999999888865 899886432 23345678899999999956999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 157 VVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence 9999999999999997654 69999999999999999999999999999999999999 4556
Q ss_pred cEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCc
Q 012039 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 298 (472)
.+||+|||++.............+++.|+|||++.. .++.++||||||+++|+|++ |..||.+....+....+..+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 799999999875433222334467889999999864 58999999999999999998 9999999888887777766532
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
. .....+++++.+||.+||..||.+|||+.+++++
T Consensus 260 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 2224689999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=357.96 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=216.7
Q ss_pred ccccceEEcceeeecCCeEEEEEE-----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
....+|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc
Confidence 456789999999999999999999 55678899999986432 3344567889999999994 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEE
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAKG-------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
+....|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 489999999999999999999999999999999999997655667899
Q ss_pred EeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCc
Q 012039 224 ATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 298 (472)
|+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999999876543322 22346789999999886 468999999999999999998 9999998888888887777643
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
... ...++..+.+||.+||+.||.+|||+.++++|.|+.
T Consensus 264 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 322 246899999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=367.60 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=212.6
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
....+|.+.+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.++++++ ||||+++++++.+..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence 456789999999999999999999999999999999975432 234677889999999995 999999999998755
Q ss_pred eEEEEEeccCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeec-cCCCCCcEEEeecCC
Q 012039 154 SVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLS-SKDENALLKATDFGL 229 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~~~kl~Dfg~ 229 (472)
..++|||||+|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+. .++....+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 78999999999999999875433 99999999999999999999999999999999999984 234556799999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhh---------cccCCccchhhHHHHHHHHhhCCCCCCC----CChHHHHHHHHcC
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLR---------RRYGKEIDIWSAGVILYILLSGVPPFWA----ETEKGIFDAILQG 296 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~----~~~~~~~~~i~~~ 296 (472)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. ....+.+..+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 99877666666678999999999875 3578899999999999999999999964 2334555566554
Q ss_pred CccC---------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 297 DIDF---------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 297 ~~~~---------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.... .......++..+.+||++||+.||++|||+.++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 3211 00011234567889999999999999999998854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=349.09 Aligned_cols=254 Identities=27% Similarity=0.480 Sum_probs=202.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++ ||||+++++++...+.++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence 3458999999999999999999999999999999997654444455678899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 157 VVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence 99999999999998864 4569999999999999999999999999999999999999 5566799999999987
Q ss_pred ccCCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCccCCCCCCCCC
Q 012039 233 IEEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 233 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
..... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .......+...... ......+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 263 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHY 263 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTS
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCccccc
Confidence 65432 2234578999999998864 58999999999999999999999997653 33445555554332 2233578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
++++.+||.+||..||.+|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999998873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.76 Aligned_cols=248 Identities=35% Similarity=0.643 Sum_probs=200.7
Q ss_pred cccccceEEc-ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--
Q 012039 75 EDVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-- 151 (472)
Q Consensus 75 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 151 (472)
..+..+|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++.++.+||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3455678887 779999999999999999999999999853 24677899998666579999999999987
Q ss_pred --CCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 152 --KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
...+++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999999999999998754 6999999999999999999999999999999999999976555778999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHH----HcCCccCCCC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI----LQGDIDFESA 303 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~~~~~~~~~ 303 (472)
|++..... ..++.++|||||||++|+|++|..||.+.........+ ......++..
T Consensus 165 g~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 165 GFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp TTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred cccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 99875432 34678899999999999999999999776543322111 1122222222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~ 350 (472)
.+..+++++.+||.+||+.||.+|||+.++|+||||+........+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 23568999999999999999999999999999999987655444333
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=380.43 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=207.6
Q ss_pred cceEEc-ceeeecCCeEEEEEEE--CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFG-KELGRGQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
..+.+. +.||+|+||.||+|.+ +.+++.||||+++.... .......+.+|+.++++|+ |||||++++++.. +.+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESW 444 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCE
Confidence 344543 4799999999999954 45678999999875432 3345678999999999995 9999999999875 458
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++|||||++|+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCcccccc
Confidence 89999999999999999888899999999999999999999999999999999999995 556799999999987654
Q ss_pred Ccc----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 236 GKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 236 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
... .....+|+.|+|||++.. .++.++|||||||++|+|++ |..||.+....++...+..+..... ...++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~ 598 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCP 598 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 332 122346788999999875 68999999999999999998 9999999998888888877653322 24689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+++.+||.+||..||++|||+.++++
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=345.53 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=217.7
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
.++....+|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 81 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 3445677899999999999999999999999999999998643 334678899999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+.+++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence 9999999999999999999864 349999999999999999999999999999999999999 45567999999999
Q ss_pred eeccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 231 VFIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 231 ~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
......... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCC
Confidence 876544322 2245678899999886 468999999999999999999 99999988887777777664322 2235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+++++.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 78999999999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=345.68 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=207.7
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc----cHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN----DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..+|++.+.||+|+||+||+|++..+++.||+|++......... ..+.+.+|+.++++++ ||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCCC
Confidence 45899999999999999999999999999999998654432221 1267899999999995 999999999997765
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCC--CCCcEEEeecC
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKD--ENALLKATDFG 228 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~--~~~~~kl~Dfg 228 (472)
++||||+++++|.+.+... ..+++..++.++.||+.||.|||++| |+||||||+||++..++ ....+||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999998888654 46999999999999999999999999 99999999999996432 12348999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh---cccCCccchhhHHHHHHHHhhCCCCCCCCChHHH--HHHHHcCCccCCCC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR---RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI--FDAILQGDIDFESA 303 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 303 (472)
++..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+....... .
T Consensus 175 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 250 (287)
T 4f0f_A 175 LSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP--T 250 (287)
T ss_dssp TCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC--C
T ss_pred ccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC--C
Confidence 9985443 344568999999999983 3478999999999999999999999987654333 34444433322 2
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 23578999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.80 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=207.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC----------CCCeeEEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG----------QPNIVEFKG 147 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~----------hp~iv~~~~ 147 (472)
..+|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+++++.+ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 45899999999999999999999999999999998643 2345678899999998852 789999999
Q ss_pred EEEeCC----eEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceeeccC---C
Q 012039 148 AYEDKQ----SVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSK---D 217 (472)
Q Consensus 148 ~~~~~~----~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~---~ 217 (472)
++...+ .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+..+ +
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 988654 789999999 89999998763 4599999999999999999999998 99999999999999643 2
Q ss_pred CCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh------HHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE------KGIF 290 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~ 290 (472)
....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 3457999999999876543 334589999999999865 589999999999999999999999976542 2222
Q ss_pred HHHHcCCccCC--------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 012039 291 DAILQGDIDFE--------------------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQ 332 (472)
Q Consensus 291 ~~i~~~~~~~~--------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~ 332 (472)
..+....-..+ ......++.++.+||.+||+.||++|||+++
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 22221000000 0000134578899999999999999999999
Q ss_pred HhcCCccccCCC
Q 012039 333 VLEHPWIKEGGE 344 (472)
Q Consensus 333 ~l~h~~~~~~~~ 344 (472)
+|+||||+....
T Consensus 331 ll~hp~f~~~~~ 342 (373)
T 1q8y_A 331 LVNHPWLKDTLG 342 (373)
T ss_dssp HHTCGGGTTCTT
T ss_pred HhhChhhhcccC
Confidence 999999997543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=351.48 Aligned_cols=255 Identities=20% Similarity=0.348 Sum_probs=217.6
Q ss_pred cccccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
.++....+|++.+.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.+++++. ||||+++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~ 95 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLG 95 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEE
Confidence 44556789999999999999999999877 457889999986432 2334567889999999995 999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAK----------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
++.+.+..++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---A 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---C
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---c
Confidence 999999999999999999999988653 357999999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 292 (472)
.++.+||+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 5667999999999866543322 22356889999999864 58999999999999999999 8999999888888888
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+..+..... ...++..+.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 877654322 24689999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=352.67 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=204.1
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEE----EEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..+|++.+.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.++++++ ||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 458999999999999999999998887755 667664322 2345678999999999995 999999999998765
Q ss_pred eEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeE
Confidence 7899999999999999976 45699999999999999999999999999999999999994 556799999999987
Q ss_pred ccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 233 IEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 233 ~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
....... ....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.....+...+..+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence 6543322 23456889999998864 58999999999999999999 999999888877777776654322 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
++.++.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=354.68 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=207.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCE----EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQ----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..+|++.+.||+|+||+||+|++..+++. ||+|.+.... .......+.+|+.+++++. ||||+++++++.+ .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB-S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-C
Confidence 45899999999999999999999888876 6667664322 2233456778999999995 9999999999874 5
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 689999999999999998764 579999999999999999999999999999999999999 4566799999999987
Q ss_pred ccCCc---ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 233 IEEGK---VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
..... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+...... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 65433 223456788999999986 468999999999999999999 99999988887777777765433222 35
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
++.++.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78889999999999999999999999886
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=364.69 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=200.5
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+...|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+++++.+|||||++++++.+.+.+|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 4557888899999999999875 4457999999998542 24567899999998756999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccC----------CCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYS-------ERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK----------DEN 219 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~-------~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~----------~~~ 219 (472)
||||||. |+|.+++....... +..++.++.||+.||.|||++||+||||||+|||++.. +..
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999995 69999997654332 23457899999999999999999999999999999643 245
Q ss_pred CcEEEeecCCceeccCCcc-----eeeccCCCCCCchhhhhc--------ccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 220 ALLKATDFGLSVFIEEGKV-----YRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
..+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 6899999999988765332 234579999999999853 48899999999999999999 999997654
Q ss_pred hHHHHHHHHcCCccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 286 EKGIFDAILQGDIDFESAP---WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
... ..+..+........ ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 433 34445444433221 1234688999999999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=347.32 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=201.9
Q ss_pred cccccceEEcceeeecCCeEEEEEE----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
.....+|++++.||+|+||+||+|+ +..+++.||+|++... .......+.+|+.++++++ ||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 3456799999999999999999998 5678999999998643 2344577899999999995 999999999985
Q ss_pred e--CCeEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 151 D--KQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 151 ~--~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
. ...+++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Df 158 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDF 158 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccC
Confidence 4 456899999999999999997654 499999999999999999999999999999999999994 4567999999
Q ss_pred CCceeccCCcc----eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChH---------------
Q 012039 228 GLSVFIEEGKV----YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK--------------- 287 (472)
Q Consensus 228 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------------- 287 (472)
|++........ .....++..|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99987654322 22345777899999886 46899999999999999999999998643211
Q ss_pred -HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 288 -GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 288 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.....+.... .. .....+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccC-cC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1222222221 11 223578999999999999999999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=352.46 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=213.6
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCC-----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGR-----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++....+|++.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++++.+||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34456789999999999999999999987664 79999986533 233467789999999999559999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeec
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAK--------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLS 214 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 214 (472)
+.+.+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998653 3589999999999999999999999999999999999994
Q ss_pred cCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHH
Q 012039 215 SKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGI 289 (472)
Q Consensus 215 ~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 289 (472)
.++.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+......
T Consensus 199 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 ---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp ---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred ---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 5567999999999876543321 2345678999999876 468999999999999999998 9999988766555
Q ss_pred HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 290 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+..+......... ...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 276 FYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 5555444333322 24578999999999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.07 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=211.0
Q ss_pred cccceEEcc-eeeecCCeEEEEEE--ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 77 VKLHYSFGK-ELGRGQFGVTYLCT--ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 77 ~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
...+|.+.+ .||+|+||.||+|. +..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++ ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 356899998 99999999999995 456778999999875432 2334678999999999995 99999999999 566
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceee
Confidence 7899999999999999999888899999999999999999999999999999999999995 4567999999999877
Q ss_pred cCCccee----eccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKVYR----DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~~~----~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
....... ...+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+.... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAG 244 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCC
Confidence 5543321 2346788999998864 58899999999999999999 999999988888777777654321 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+++++.++|.+||+.||.+|||+.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=358.43 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=202.7
Q ss_pred cccceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
...+|.+.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+++++. ||||+++++++.+.+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCC
Confidence 4568999999999999999999987 467789999986532 2344677999999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 9999999999999999997654 69999999999999999999999999999999999999 5667899999999987
Q ss_pred ccCCcc----eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 233 IEEGKV----YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 233 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
...... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+... + ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-P--PPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-C--CCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCc
Confidence 654321 11224567899999886 468999999999999999998 99999998888888777765322 1 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.++..+.+||.+||+.||.+||++.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 68899999999999999999999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=351.40 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=210.9
Q ss_pred ccccccceEEcceeeecCCeEEEEEEE-----CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
+....++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++++.+||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 344567999999999999999999985 3567899999986543 233456789999999999769999999999
Q ss_pred EEeCC-eEEEEEeccCCcchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 149 YEDKQ-SVHVVMELCAGGELFDRIIAKGH----------------YSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 149 ~~~~~-~~~lv~e~~~g~sL~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
+...+ .+++||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87754 59999999999999999986543 89999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 286 (472)
++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+...
T Consensus 180 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99 4556799999999987654332 123457889999998864 58999999999999999998 9999987654
Q ss_pred HH-HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 287 KG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 287 ~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.. ....+..+.. ... ...+++++.++|.+||+.||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~-~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTR-MRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCcc-CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33 4444444322 121 24578999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=347.15 Aligned_cols=249 Identities=16% Similarity=0.243 Sum_probs=205.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCC-------CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTG-------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
..++|.+.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.++++++ ||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence 3568999999999999999999998877 479999986532 345678999999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC-----CcEE
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN-----ALLK 223 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~-----~~~k 223 (472)
.+.+..++||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.. ..+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 9999999999999999999999999999999999999643321 2399
Q ss_pred EeecCCceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC
Q 012039 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (472)
|+|||++...... ....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...........+.......+
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence 9999998765432 23468899999999864 589999999999999999996555444433333333333333222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...++++.+||.+||+.||.+|||+.++++|
T Consensus 239 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 ----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3457889999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=345.76 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=208.4
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.+|+++..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 35678999999999999999999999999999999986432 2346889999999997444455565566788899
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 9999999874 4579999999999999999999999999999999999999644466789999999998766
Q ss_pred CCcc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCccCCC
Q 012039 235 EGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFES 302 (472)
Q Consensus 235 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 302 (472)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.. ....+..+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 5432 234579999999999875 58999999999999999999999997633 23344444443333221
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 303 -APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 303 -~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.....+|+++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 112468899999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=358.33 Aligned_cols=256 Identities=15% Similarity=0.173 Sum_probs=195.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCC-----CCEEEEEEecccccCCc--------ccHHHHHHHHHHHHhccCCCCee
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTK--------NDKDDIKREIQIMQHLSGQPNIV 143 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~va~K~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~iv 143 (472)
...+|++++.||+|+||.||+|.+..+ ++.||+|++........ .....+..|+..++.+ +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 455899999999999999999998764 57899999864321000 0011223344455555 399999
Q ss_pred EEEEEEEeC----CeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCC
Q 012039 144 EFKGAYEDK----QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (472)
Q Consensus 144 ~~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 218 (472)
++++++... ...||||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 999998764 5689999999 99999999775 67999999999999999999999999999999999999963 14
Q ss_pred CCcEEEeecCCceeccCCcce--------eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHH
Q 012039 219 NALLKATDFGLSVFIEEGKVY--------RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289 (472)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 289 (472)
.+.+||+|||++..+...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 567999999999876433211 23459999999999875 489999999999999999999999986433222
Q ss_pred HHHHHcCCc-----cCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 290 FDAILQGDI-----DFE--SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 290 ~~~i~~~~~-----~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
......... .+. ......+++++.+||..||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 211111000 000 0011467899999999999999999999998875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=348.35 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=208.1
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCC----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
+....+|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++++. ||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence 445568999999999999999999987653 359999986432 2334567889999999995 999999999999
Q ss_pred eCCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCc
Confidence 999999999999999999999764 579999999999999999999999999999999999999 5567899999999
Q ss_pred ceeccCCcc----eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCC
Q 012039 230 SVFIEEGKV----YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (472)
Q Consensus 230 ~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (472)
+........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+... .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~ 270 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---P 270 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---C
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---C
Confidence 987654321 12234678899999986 458999999999999999999 99999988888888887765322 1
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
....+++.+.++|.+||+.||.+||++.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 224689999999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=342.21 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=204.0
Q ss_pred cccceEEcceeeecCCeEEEEEE----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
...+|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.++++++ ||||+++++++.+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTED 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence 35679999999999999999999 56789999999987543 3345678999999999995 99999999999876
Q ss_pred --CeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 --QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccc
Confidence 679999999999999999954 45799999999999999999999999999999999999994 456799999999
Q ss_pred ceeccCCcc----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCC--------------Ch-HHH
Q 012039 230 SVFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE--------------TE-KGI 289 (472)
Q Consensus 230 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------------~~-~~~ 289 (472)
+........ .....||..|+|||++.+ .++.++||||||+++|+|++|..|+... .. ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 988765432 223567888999998864 5889999999999999999999876322 11 122
Q ss_pred HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 290 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+..+. .. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGK-RL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTC-CC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccC-CC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22333322 22 223578999999999999999999999999886
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.17 Aligned_cols=251 Identities=20% Similarity=0.353 Sum_probs=216.8
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
++....+|++.+.||+|+||.||+|+++.++..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+..
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 289 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 4455678999999999999999999999999999999986532 34678999999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 SVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.+||||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSR 366 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEE
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccce
Confidence 999999999999999999764 458999999999999999999999999999999999999 456779999999998
Q ss_pred eccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 232 FIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 232 ~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
........ ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.+..++...+..+.. ......
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 443 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEG 443 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCC
Confidence 76543221 1234567899999986 468999999999999999999 9999998888777777765432 222357
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+++++.+||.+||+.||.+|||+.++++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=343.55 Aligned_cols=247 Identities=23% Similarity=0.451 Sum_probs=211.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 151 (472)
.+..+|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+|+.+++++. ||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccC
Confidence 35678999999999999999999999999999999986432 35678999999995 9999999998864
Q ss_pred ------------CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 152 ------------KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 152 ------------~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++.
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--- 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---
Confidence 45689999999999999999754 5799999999999999999999999999999999999995
Q ss_pred CCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 012039 218 ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 296 (472)
.++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||... ......+..+
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~ 234 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG 234 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT
T ss_pred CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc
Confidence 456799999999988766555556689999999999864 5899999999999999999999987532 2333444443
Q ss_pred CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 297 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
.. ...++..+.+||.+||..||.+|||+.++++|.|.-.
T Consensus 235 ~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 II------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 22 1457899999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.47 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=213.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEE
Confidence 468999999999999999999986 57789999987543 23567899999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence 99999999999999765 468999999999999999999999999999999999999 45667999999999865432
Q ss_pred cc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 237 KV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 237 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.. .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+..... ...++..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l 234 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV 234 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHH
Confidence 21 12345678899999986 468999999999999999999 8999999888888888877643222 24578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.++|.+||+.||.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=366.22 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=198.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|.+.+.||+|+||+||. ....+++.||||++..... ..+.+|+.+++.+.+|||||++++++.+...+||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 34799999999999999764 3446789999999864321 2356899999999669999999999999999999
Q ss_pred EEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC--CCCcEEEeecCCceecc
Q 012039 158 VMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLSVFIE 234 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~~~kl~Dfg~~~~~~ 234 (472)
|||||. |+|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++....
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999995 69999987654 456667789999999999999999999999999999996432 33468899999998765
Q ss_pred CCc----ceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 235 EGK----VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||...........+....... ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 253 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT-SCTT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc-cCcc
Confidence 432 233467999999999985 347789999999999999999 999996654443322222111111 1112
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
...+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 234567899999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=340.20 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=212.2
Q ss_pred cccceEEcc-eeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 77 VKLHYSFGK-ELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 77 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++ ||||+++++++ ..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 456788877 9999999999999864 467789999987542 3345678899999999995 99999999999 456
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceee
Confidence 689999999999999998654 4599999999999999999999999999999999999995 456799999999987
Q ss_pred ccCCcce----eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 233 IEEGKVY----RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 233 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
....... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCC
Confidence 7544322 2234678999999986 468999999999999999998 999999888888888777764322 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~ 337 (472)
.+++++.++|.+||..||.+|||+.+++++.
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7899999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.67 Aligned_cols=253 Identities=23% Similarity=0.433 Sum_probs=198.6
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
++...++|++.+.||+|+||+||+|++.. .||+|++..... .....+.+.+|+.++++++ ||||++++++. ...
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP 92 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence 35566789999999999999999998653 599999865432 3344677899999999995 99999999965 556
Q ss_pred eEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATE 169 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC----
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccc
Confidence 68999999999999998854 45699999999999999999999999999999999999994 556799999999986
Q ss_pred ccCC---cceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCccCCC-C
Q 012039 233 IEEG---KVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFES-A 303 (472)
Q Consensus 233 ~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~-~ 303 (472)
.... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+..+...... .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 5432 2234467999999999885 34788999999999999999999999875554 444445554443322 2
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23578999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=359.99 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=210.2
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
++....+|++.+.||+|+||.||+|.+. ++.||||+++.. ...+.+.+|+.++++++ ||||+++++++.+..
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEK 259 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC-----TTSHHHHHHHHHHHTCC-CTTBCCEEEEEECTT
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc-----hHHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCC
Confidence 3445678999999999999999999876 779999998643 24578999999999995 999999999987654
Q ss_pred -eEEEEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 154 -SVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 154 -~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
.+||||||+++|+|.+++...+. +++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT 336 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCc
Confidence 79999999999999999987654 7999999999999999999999999999999999999 55678999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
+...... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.+..+....+..+... .....+
T Consensus 337 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~~ 411 (450)
T 1k9a_A 337 KEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGC 411 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTTC
T ss_pred ccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence 8654322 2336788999999986 468999999999999999998 99999988888888887765321 223578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++++.+||.+||..||.+|||+.++++
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=340.38 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=209.0
Q ss_pred cccccceEEcceeeecCCeEEEEEEECC---CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
.....+|++.+.||+|+||+||+|++.. ++..||+|++.... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC
Confidence 3445789999999999999999998654 33469999987542 2345678899999999995 9999999999876
Q ss_pred CCeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+ ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS 160 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGG
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCC
Confidence 5 468999999999999999765 4599999999999999999999999999999999999995 4567999999999
Q ss_pred eeccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 231 VFIEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
........ .....+++.|+|||++. ..++.++||||||+++|+|++ |+.||...........+..+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 237 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PD 237 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CT
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CC
Confidence 87654332 22345788999999986 468999999999999999998 9999988877777777766543221 24
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+++.+.++|.+||..||++|||+.+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 689999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=336.75 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=213.6
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..++....+|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC
Confidence 345566789999999999999999999976 46789999986532 34678899999999995 9999999999875
Q ss_pred CCeEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+..++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 80 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGL 155 (279)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred -CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcc
Confidence 45899999999999999886543 69999999999999999999999999999999999999 5667799999999
Q ss_pred ceeccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 230 SVFIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 230 ~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
+......... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 232 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RP 232 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CC
T ss_pred cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Cc
Confidence 9877554322 2235678899999986 468999999999999999999 999999988888888877653322 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+++++.+||.+||..||++|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 468999999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=373.14 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=207.0
Q ss_pred ccccceEEcc-eeeecCCeEEEEEEECC--CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 76 DVKLHYSFGK-ELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 76 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
....++.+.+ .||+|+||.||+|.++. ++..||||+++... .....+.+.+|+.+|++++ |||||++++++.+
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~- 407 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA- 407 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-
Confidence 3445666666 89999999999998763 45679999987542 3345788999999999995 9999999999976
Q ss_pred CeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
+.++||||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcc
Confidence 5689999999999999998754 4599999999999999999999999999999999999994 55679999999998
Q ss_pred eccCCcce----eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 232 FIEEGKVY----RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 232 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
........ ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.+..++...+..+.... ..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p 561 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CP 561 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CC
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 76433221 1234568899999986 568999999999999999998 999999988888888888764321 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+++++.+||.+||..||++||++.++++
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 468999999999999999999999999854
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=337.51 Aligned_cols=246 Identities=17% Similarity=0.264 Sum_probs=210.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--Ce
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QS 154 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 154 (472)
..++|++.+.||+|+||.||+|++. ++.||+|++..... .......+.+|+.++++++ ||||+++++++.+. +.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence 4568999999999999999999985 88999999876432 2344567899999999995 99999999999887 78
Q ss_pred EEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 155 VHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+++||||++|++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence 899999999999999998765 4899999999999999999999999 9999999999999 55667899988887
Q ss_pred eeccCCcceeeccCCCCCCchhhhhcc-c---CCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y---GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
..... ....||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+......... ..
T Consensus 161 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 234 (271)
T 3kmu_A 161 FSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--PP 234 (271)
T ss_dssp CTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--CT
T ss_pred eeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--CC
Confidence 65332 234789999999998643 3 33799999999999999999999988887777776665443332 35
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+++++.++|.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=344.32 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=203.3
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.+|++|..+..++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4578999999999999999999999999999999875433 22357889999999974555556666668889999
Q ss_pred EEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999999874 45799999999999999999999999999999999999996445667799999999987655
Q ss_pred Ccc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCccCCC-
Q 012039 236 GKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDIDFES- 302 (472)
Q Consensus 236 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~- 302 (472)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ...+..+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 432 224579999999999865 589999999999999999999999976432 2333333333222221
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.....+|+++.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 112467899999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=350.27 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=198.6
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~---- 153 (472)
..+|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence 458999999999999999999876 7899999986432 23445667999999995 999999999998743
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CcEeecCCCCceeeccCCCCCcEE
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM----------GVMHRDLKPENFLLSSKDENALLK 223 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------~i~H~dlkp~Nili~~~~~~~~~k 223 (472)
.+++|||||++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEE
Confidence 47999999999999999866 4699999999999999999999999 99999999999999 5667899
Q ss_pred EeecCCceeccCCcc---eeeccCCCCCCchhhhhc------ccCCccchhhHHHHHHHHhhCCCCCCCCCh--------
Q 012039 224 ATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETE-------- 286 (472)
Q Consensus 224 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------- 286 (472)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654332 223579999999999864 467789999999999999999999975422
Q ss_pred --------HHHHHHHHcCCccCCCC-CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 287 --------KGIFDAILQGDIDFESA-PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 287 --------~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
......+.......... .| ...++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222232222211111 01 112456999999999999999999999886
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.13 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=190.9
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
+...+....+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++++.+||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 334444566899999999999999999999999999999988543 23345678899999999977999999999984
Q ss_pred --------eCCeEEEEEeccCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCC
Q 012039 151 --------DKQSVHVVMELCAGGELFDRIIA---KGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKD 217 (472)
Q Consensus 151 --------~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~ 217 (472)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||+ +
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~ 172 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---S 172 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---C
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---C
Confidence 3456899999995 799888764 456999999999999999999999999 9999999999999 4
Q ss_pred CCCcEEEeecCCceeccCCcce-------------eeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCC
Q 012039 218 ENALLKATDFGLSVFIEEGKVY-------------RDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPP 280 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~p 280 (472)
.++.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 5667999999999876543221 1346899999999873 3478899999999999999999999
Q ss_pred CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 012039 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (472)
Q Consensus 281 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~ 337 (472)
|........ ........ .....+..+.+||.+||+.||.+|||+.++++|-
T Consensus 253 ~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 253 FEDGAKLRI----VNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp C----------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CcchhHHHh----hcCcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 976544332 22222222 2346778899999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=356.46 Aligned_cols=256 Identities=17% Similarity=0.185 Sum_probs=197.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECC---CCCEEEEEEecccccCC--------cccHHHHHHHHHHHHhccCCCCeeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVT--------KNDKDDIKREIQIMQHLSGQPNIVEF 145 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp~iv~~ 145 (472)
...+|++++.||+|+||.||+|.+.. ++..||+|++....... ......+.+|+.+++.+. ||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence 35689999999999999999999987 78899999987542100 011234667888899995 9999999
Q ss_pred EEEEEe----CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCc
Q 012039 146 KGAYED----KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 146 ~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~ 221 (472)
++++.. ...+|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCc
Confidence 999987 78899999999 999999998777899999999999999999999999999999999999996432 237
Q ss_pred EEEeecCCceeccCCc--------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCC--hHHHH
Q 012039 222 LKATDFGLSVFIEEGK--------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIF 290 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~ 290 (472)
+||+|||++..+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998764322 1134579999999999875 48999999999999999999999996532 22221
Q ss_pred HHHHcCCccCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 291 DAILQGDIDFES-----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 291 ~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..........+. .....+++++.+||.+||..||++|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111111111 011268899999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=352.60 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=206.2
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+....+|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCe
Confidence 445678999999999999999999964 6899999987653 2345678999999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 155 VHVVMELCAGGELFDRIIAKG----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence 999999999999999886543 58999999999999999999999999999999999999 56678999999999
Q ss_pred eeccCCc---ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHH-------HHHcCCcc
Q 012039 231 VFIEEGK---VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD-------AILQGDID 299 (472)
Q Consensus 231 ~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~ 299 (472)
....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.+....+... ....+...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8754322 223346899999999885 568999999999999999999999997654322111 11111111
Q ss_pred ------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 300 ------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 300 ------~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
......+..+..+.+++.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011112345678999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=360.31 Aligned_cols=250 Identities=21% Similarity=0.346 Sum_probs=213.7
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
.++....+|++.+.||+|+||.||+|.+. .+..||||++.... ...+.+.+|+.++++++ ||||+++++++. .
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 34566789999999999999999999986 46789999987532 34678999999999995 999999999986 5
Q ss_pred CeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence 6789999999999999999754 368999999999999999999999999999999999999 55678999999999
Q ss_pred eeccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 231 VFIEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
+....... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+....+..+... ....
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 87643221 12234677899999986 568999999999999999999 99999998888888888765322 2235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+++++.+||.+||..||++|||+.++++
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 78999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=343.66 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=203.3
Q ss_pred ccccceEEcceeeecCCeEEEEEEECC---CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
....+|.+++.||+|+||.||+|.+.. ++..||+|++..... .......+.+|+.++++++ ||||+++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeec
Confidence 345689999999999999999998765 456899999865432 2334567899999999995 99999999998765
Q ss_pred C-----eEEEEEeccCCcchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCc
Q 012039 153 Q-----SVHVVMELCAGGELFDRIIA------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 153 ~-----~~~lv~e~~~g~sL~~~l~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~ 221 (472)
. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCc
Confidence 4 45999999999999998843 3569999999999999999999999999999999999999 55667
Q ss_pred EEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 012039 222 LKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 296 (472)
+||+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999999987654322 123457889999999864 58999999999999999999 99999988888888877776
Q ss_pred CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 297 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.... ....+++++.+||.+||..||.+|||+.+++++
T Consensus 266 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 HRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4322 225689999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=345.54 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=203.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEE----EEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..+|++++.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 458999999999999999999999888766 555554322 3345678999999999995 999999999998765
Q ss_pred eEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.++|+||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence 7899999999999999876 45699999999999999999999999999999999999994 456799999999987
Q ss_pred ccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 233 IEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 233 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
...... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+..... ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 654322 223456788999998864 58999999999999999999 9999999888887777766543222 246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.++.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=341.48 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=204.0
Q ss_pred ccceEEcceeeecCCeEEEEEEECC-CCC--EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENS-TGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
..+|++.+.||+|+||+||+|++.. +++ .||+|++...........+.+.+|+.+++++. ||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 4589999999999999999998653 333 68999987654434455678899999999995 999999999998765
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccccc
Confidence 88999999999999998764 5699999999999999999999999999999999999994 4567999999999877
Q ss_pred cCCcce----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
...... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+.+..+.......+. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 544321 23457788999998864 58899999999999999999 99999999888888888776544433 357
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.++.++|.+||..||.+|||+.++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=345.42 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=206.1
Q ss_pred ccceEEcceeeecCCeEEEEEE----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE--e
Q 012039 78 KLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--D 151 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~ 151 (472)
..+|++.+.||+|+||.||+|+ +..+++.||+|++... .......+.+|+.+++++. ||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 3589999999999999999999 5678899999998653 2344567899999999995 999999999886 5
Q ss_pred CCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
...+++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence 5779999999999999999976 45699999999999999999999999999999999999994 5567999999999
Q ss_pred eeccCCcce----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH---------------HHH
Q 012039 231 VFIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------------GIF 290 (472)
Q Consensus 231 ~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------------~~~ 290 (472)
......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 877544322 23457888999998864 5899999999999999999999998654321 222
Q ss_pred HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+..+. .. .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQ-RL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhccc-CC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233322 11 2235789999999999999999999999999654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=351.62 Aligned_cols=248 Identities=19% Similarity=0.244 Sum_probs=199.3
Q ss_pred cccccceEEcceeeecCCeEEEEE-----EECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccC--CCCeeEEEE
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLC-----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG--QPNIVEFKG 147 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~ 147 (472)
.....+|.+.+.||+|+||+||+| .+..+++.||+|++... ....+.+|+.+++.+.. |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 344578999999999999999999 46778999999998542 35678889999988842 899999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeecc-------
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIA-----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS------- 215 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~------- 215 (472)
++...+..|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 456999999999999999999999999999999999999954
Q ss_pred -CCCCCcEEEeecCCceecc---CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHH
Q 012039 216 -KDENALLKATDFGLSVFIE---EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290 (472)
Q Consensus 216 -~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 290 (472)
++..+.+||+|||++..+. ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 2226789999999997654 3334456789999999999875 589999999999999999999999965432110
Q ss_pred HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.....+.. ...++.+.+++..||+.+|.+|++..+.|.+
T Consensus 294 ----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 ----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00001111 1246789999999999999999766555554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.32 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=211.6
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
.++....+|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE- 250 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-
Confidence 345567789999999999999999999875 4679999987533 23578999999999995 9999999999876
Q ss_pred CeEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 QSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
+.++|||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccc
Confidence 678999999999999999964 3569999999999999999999999999999999999999 45667999999999
Q ss_pred eeccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 231 VFIEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
........ .....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+... ....
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~ 404 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPP 404 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 87654321 12345678899999886 568999999999999999999 99999998888888888765322 1224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCcccc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~--h~~~~~ 341 (472)
.+++.+.+||.+||+.||++|||++++++ ..++..
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 78999999999999999999999999986 355543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=360.69 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=210.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.|.++++|+.+..++...+..+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 55789999999999999999999999999999998764332 2357899999999986688888888888999999
Q ss_pred EEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||+...+..+.+||+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 56799999999999999999999999999999999999996545677899999999987765
Q ss_pred Ccce--------eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCccCCC-
Q 012039 236 GKVY--------RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDIDFES- 302 (472)
Q Consensus 236 ~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~- 302 (472)
.... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 4321 25679999999999865 589999999999999999999999987543 3344444333222111
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.....++.++.+||.+||..||++||++.+|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112467899999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=339.41 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=196.8
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHh--ccCCCCeeEEEEEEEe--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKGAYED-- 151 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hp~iv~~~~~~~~-- 151 (472)
.+..+|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. + +||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeecccc
Confidence 4567999999999999999999987 5889999998532 34566778888777 6 59999999998654
Q ss_pred --CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEeecCCCCceeeccCCCCCc
Q 012039 152 --KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH--------FMGVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~i~H~dlkp~Nili~~~~~~~~ 221 (472)
...+++||||+++|+|.+++. ...+++..++.++.||+.||.||| +++|+||||||+|||+ +.++.
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~ 151 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQ 151 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCC
Confidence 356899999999999999885 457999999999999999999999 9999999999999999 56678
Q ss_pred EEEeecCCceeccCCcce-----eeccCCCCCCchhhhhc-------ccCCccchhhHHHHHHHHhhC----------CC
Q 012039 222 LKATDFGLSVFIEEGKVY-----RDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSG----------VP 279 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g----------~~ 279 (472)
+||+|||++......... ....||+.|+|||++.+ .++.++|||||||++|+|++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999876554332 23479999999999864 345789999999999999999 88
Q ss_pred CCCCCCh----HHHHHHHHcCCccCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 280 PFWAETE----KGIFDAILQGDIDFESAP----WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 280 pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
||..... ...+..+.......+... ...+++++.+||.+||+.||++|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 8865321 222333322211111111 0124578999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=334.77 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=201.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-CeE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-QSV 155 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~ 155 (472)
...+|++.+.||+|+||.||+|.+. |+.||+|++... ...+.+.+|+.++++++ ||||+++++++.+. +.+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCce
Confidence 4568999999999999999999875 889999998642 24577899999999995 99999999987544 578
Q ss_pred EEEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 156 HVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
++||||+++++|.+++...+. +++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccc
Confidence 999999999999999976543 8999999999999999999999999999999999999 55677999999998865
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
.... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+.. ......+++.
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 242 (278)
T 1byg_A 168 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA 242 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHH
T ss_pred cccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHH
Confidence 4432 23467889999999864 58999999999999999998 9999998888777777765532 2223578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++|.+||..||.+|||+.++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.30 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=206.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCC---CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE-EeCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY-EDKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~ 153 (472)
..+|++.+.||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.++++++ ||||+++++++ ..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 457999999999999999999976443 358999886432 3344677899999999995 99999999985 5567
Q ss_pred eEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence 88999999999999999975 4458999999999999999999999999999999999999 5667899999999987
Q ss_pred ccCCcc-----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 233 IEEGKV-----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 233 ~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++ |.+||......+....+..+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 644321 223467889999998864 58999999999999999999 67777777777777777766544332
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+++.+.++|.+||..||.+|||+.++++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 457899999999999999999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=379.50 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=211.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe------
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------ 151 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------ 151 (472)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++++. ||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccC
Confidence 358999999999999999999999999999999986532 3345677899999999995 9999999998765
Q ss_pred CCeEEEEEeccCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.+..++|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 677899999999999999997644 58999999999999999999999999999999999999866666679999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHH---------H-----H
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD---------A-----I 293 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------~-----i 293 (472)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+......+. . .
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 999877666666678999999999886 468999999999999999999999997653321110 0 0
Q ss_pred HcCCccCC------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 294 LQGDIDFE------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 294 ~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
..+...+. ......+++.+.+||.+||..||++|||+.++|+||||+.
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 11111111 1112346789999999999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=343.41 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=203.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----C
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----K 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~ 152 (472)
...+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.+. ||||+++++++.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCC
Confidence 356899999999999999999999999999999988643 2345677899999999995 9999999999863 3
Q ss_pred CeEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 153 QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
...++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecC
Confidence 578999999999999998875 4679999999999999999999999999999999999999 556679999999
Q ss_pred CceeccCCc----------ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCC--hHHHHHH
Q 012039 229 LSVFIEEGK----------VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDA 292 (472)
Q Consensus 229 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~ 292 (472)
++....... ......||+.|+|||++.. .++.++||||||+++|+|++|..||.... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 987653211 0123457999999999853 36899999999999999999999995421 1122222
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+.. ...++ ....++.++.+||.+||+.||.+|||+.+++++
T Consensus 260 ~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQN-QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHC-C--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhc-cCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222 22222 235789999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=336.08 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=206.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
...|.+.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEG 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCC
Confidence 3468888999999999999999765554 79999986432 3344678889999999995 9999999999987655
Q ss_pred E-EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 155 V-HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 155 ~-~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
. ++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccc
Confidence 5 999999999999999976 4568999999999999999999999999999999999999 5666899999999986
Q ss_pred ccCCc-----ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 233 IEEGK-----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 233 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++ |.+||...........+..+..... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~ 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---P 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---C
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---C
Confidence 54322 2233567889999999865 58999999999999999999 5555666666666666666543222 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
..+++.+.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 468899999999999999999999999886
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.68 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=202.6
Q ss_pred cccce-EEcceeeecCCeEEEEEEE----CCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 77 VKLHY-SFGKELGRGQFGVTYLCTE----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 77 ~~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
+..+| ++++.||+|+||+||++.. ..+++.||+|++.... .......+.+|+.++++++ ||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence 34455 9999999999999988754 4578899999997542 2344677899999999996 9999999999987
Q ss_pred --CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 --KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
...+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL 180 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence 46899999999999999988654 59999999999999999999999999999999999999 5567799999999
Q ss_pred ceeccCCcc----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH---------------HH
Q 012039 230 SVFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------------GI 289 (472)
Q Consensus 230 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------------~~ 289 (472)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 988765432 223467888999999865 6889999999999999999999999654221 11
Q ss_pred HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 290 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+..+ .. ......+++++.+||++||+.||.+|||+.++++
T Consensus 261 ~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERG-ER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcc-cC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222222 22 2223578999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=344.31 Aligned_cols=259 Identities=19% Similarity=0.252 Sum_probs=204.7
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
......++|++.+.||+|+||.||+|++. +++.||+|++..... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEEecC
Confidence 34456678999999999999999999854 689999999875432 222346889999999995 99999999999999
Q ss_pred CeEEEEEeccCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CcEeecCCCCceeeccCCCCCcEEEe
Q 012039 153 QSVHVVMELCAGGELFDRIIAKG----HYSERAAASICRSIVNVVHICHFM---GVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 153 ~~~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~ 176 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVG 176 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEEC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEec
Confidence 99999999999999999997543 399999999999999999999999 99999999999999 556779999
Q ss_pred ecCCceeccCCc--ceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCC----ChHHHHHHHHcCCc
Q 012039 226 DFGLSVFIEEGK--VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAE----TEKGIFDAILQGDI 298 (472)
Q Consensus 226 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~ 298 (472)
|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||... ..............
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998765332 233456999999999885 46899999999999999999999999521 11111111111111
Q ss_pred cCC-----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 012039 299 DFE-----------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (472)
Q Consensus 299 ~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~ 338 (472)
... .......+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 100 0011123467999999999999999999999998744
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=347.68 Aligned_cols=245 Identities=15% Similarity=0.193 Sum_probs=200.3
Q ss_pred ccceEEcceeeecCCeEEEEEEECCC--------CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeE-----
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENST--------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE----- 144 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~----- 144 (472)
..+|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.++++++ ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 46899999999999999999999874 889999998643 35789999999995 998887
Q ss_pred ----------EEEEEEe-CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 145 ----------FKGAYED-KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 145 ----------~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
+++++.. +..+|+||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777766 78899999999 99999999875 7899999999999999999999999999999999999
Q ss_pred eeccCCCCC--cEEEeecCCceeccCCcc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCC
Q 012039 212 LLSSKDENA--LLKATDFGLSVFIEEGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPP 280 (472)
Q Consensus 212 li~~~~~~~--~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 280 (472)
|++ .++ .+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 995 444 799999999987643221 123479999999999875 689999999999999999999999
Q ss_pred CCCCC--hHHHHHHHH---cCCccC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 281 FWAET--EKGIFDAIL---QGDIDF--ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 281 f~~~~--~~~~~~~i~---~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
|.... ...+..... .....+ ....+..+++++.+||.+||..||++|||+.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 98764 222222222 111111 12223467999999999999999999999999876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=349.46 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=199.7
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCC---CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE-eCC
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE-DKQ 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~ 153 (472)
...|++.+.||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.++++++ ||||+++++++. .++
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 164 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCC
Confidence 346899999999999999999976443 358999886422 3345678999999999995 999999999864 456
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 241 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccc
Confidence 889999999999999999764 458999999999999999999999999999999999999 5667899999999986
Q ss_pred ccCCcc-----eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 233 IEEGKV-----YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 233 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |.+||...+..+....+..+..... .
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p 318 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P 318 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---C
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 643321 12345778899999886 458999999999999999999 7888887777777777776654322 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
..+++.+.++|.+||..||++|||+.+++++
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4689999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.42 Aligned_cols=250 Identities=27% Similarity=0.362 Sum_probs=203.2
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEeccccc-CCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 159 (472)
|..++.||+|+||.||+|.+ +++.||+|++..... ........+.+|+.++++++ ||||+++++++.+.+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence 45568999999999999986 588999999875432 22334678999999999995 999999999999999999999
Q ss_pred eccCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 160 ELCAGGELFDRIIA---KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 160 e~~~g~sL~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 99999999998864 3469999999999999999999999999999999999999 56678999999999876543
Q ss_pred cc---eeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHH----HHHHHHcCCccC-------CC
Q 012039 237 KV---YRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDF-------ES 302 (472)
Q Consensus 237 ~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~-------~~ 302 (472)
.. .....||+.|+|||++.+.++.++||||||+++|+|++|..||....... +...+......+ ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 22 22357999999999998889999999999999999999999997654322 222222211110 00
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
......+..+.+++.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1112345778999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=360.14 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=215.7
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..++....+|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++|+ ||||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee
Confidence 3455667889999999999999999999875 4679999987533 23578999999999995 9999999999876
Q ss_pred CCeEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 KQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+.+||||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGL 409 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTS
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEccccc
Confidence 678999999999999999964 3569999999999999999999999999999999999999 4566799999999
Q ss_pred ceeccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 230 SVFIEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 230 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
+........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+++..+..+... ...
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~ 486 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCP 486 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCC
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 986643211 12335678899999876 468999999999999999999 99999998888888888765322 122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--Cccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH--PWIK 340 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h--~~~~ 340 (472)
..++.++.+||.+||..||++|||+.++++. .++.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 4789999999999999999999999999863 4554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=334.57 Aligned_cols=241 Identities=28% Similarity=0.456 Sum_probs=194.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
..+|++.+.||+|+||+||+|++. ++.||+|++.. ....+.+.+|+.++++++ ||||+++++++.+ ..++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEE
Confidence 358999999999999999999875 78899999853 234678899999999995 9999999998864 4789
Q ss_pred EEeccCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 158 VMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHF---MGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
||||++|++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+||++.. ....+||+|||++.
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFGTAC 154 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCCCC--
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEccccccc
Confidence 999999999999998654 37899999999999999999999 89999999999999953 22348999999997
Q ss_pred eccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCC
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+..+.. ......+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNL 229 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTC
T ss_pred ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCccccc
Confidence 65432 234579999999999875 589999999999999999999999975432 233333433322 2223578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.+.+||.+||+.||.+|||+.++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=342.31 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=209.9
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
..++...++|++.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 3445556789999999999999999999864 499999875432 2333456778999999995 9999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
...+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCc
Confidence 999999999999999999987654 699999999999999999999999999999999999994 357999999998
Q ss_pred eeccCC------cceeeccCCCCCCchhhhhc----------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 012039 231 VFIEEG------KVYRDIVGSAYYVAPEVLRR----------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (472)
Q Consensus 231 ~~~~~~------~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 294 (472)
...... .......||+.|+|||++.. .++.++||||||+++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 764321 12233468999999999853 36889999999999999999999999988888877777
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
.+...... ...++.++.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 257 TGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 66443222 2367899999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=361.93 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=210.9
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECCC---CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 149 (472)
.++....+|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++++. ||||+++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~ 460 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVI 460 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 4455667899999999999999999998654 4579999876432 2334577899999999995 99999999998
Q ss_pred EeCCeEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 150 EDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 150 ~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
.+ +.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG 536 (656)
T 2j0j_A 461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG 536 (656)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecC
Confidence 54 56899999999999999997654 699999999999999999999999999999999999995 45679999999
Q ss_pred CceeccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 229 LSVFIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 229 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
++......... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+.+..+..+.... .
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~ 613 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---M 613 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---C
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence 99876544322 2345678999999886 458999999999999999997 999999988888888887764322 2
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...+++.+.+||.+||..||.+|||+.++++
T Consensus 614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2468999999999999999999999999886
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=346.85 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=199.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccC-----CcccHHHHHHHHHHHHhcc--------CCCCeeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----TKNDKDDIKREIQIMQHLS--------GQPNIVE 144 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~hp~iv~ 144 (472)
..+|++++.||+|+||+||+|++ +|+.||||++...... .......+.+|+.+++.++ +|||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 6899999999765431 2334578999999999996 4888888
Q ss_pred EEEEEE------------------------------eCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 012039 145 FKGAYE------------------------------DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194 (472)
Q Consensus 145 ~~~~~~------------------------------~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~ 194 (472)
+.+.+. +.+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 888753 26789999999999987777644 57899999999999999999
Q ss_pred HHH-HcCcEeecCCCCceeeccCC-----------------CCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhhc
Q 012039 195 ICH-FMGVMHRDLKPENFLLSSKD-----------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR 256 (472)
Q Consensus 195 ~lH-~~~i~H~dlkp~Nili~~~~-----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 256 (472)
||| ++||+||||||+|||+..++ ....+||+|||+++..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999997543 1237999999999977653 3479999999999987
Q ss_pred ccCCccchhhHHHH-HHHHhhCCCCCCCCCh-HHHHHHHHcC-Ccc--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 012039 257 RYGKEIDIWSAGVI-LYILLSGVPPFWAETE-KGIFDAILQG-DID--FESAPWPTISSSAKDLVRRMLTQDPKKRITSA 331 (472)
Q Consensus 257 ~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~~~i~~~-~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~ 331 (472)
..+.++||||||++ .+++++|..||..... ......+... ... .....++.+|+++++||++||+.| |++
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 77889999998766 7789999999843211 1223333322 111 111123357899999999999976 999
Q ss_pred HHh-cCCccc
Q 012039 332 QVL-EHPWIK 340 (472)
Q Consensus 332 ~~l-~h~~~~ 340 (472)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.17 Aligned_cols=249 Identities=22% Similarity=0.385 Sum_probs=203.2
Q ss_pred cccceEEcceeeecCCeEEEEEE----ECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
...+|++++.||+|+||.||+|+ +..+++.||+|++... .......+.+|+.++++++ ||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 45689999999999999999998 4668999999998653 2344678899999999995 99999999998654
Q ss_pred --CeEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 153 --QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
..+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence 3789999999999999999875 4599999999999999999999999999999999999994 456799999999
Q ss_pred ceeccCCcce----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChH----------------H
Q 012039 230 SVFIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK----------------G 288 (472)
Q Consensus 230 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~ 288 (472)
+......... ....++..|+|||++.+ .++.++||||||+++|+|++|..||...... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9887654322 12356778999998864 5889999999999999999999998543110 1
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+...+..+. .. .....+++++.+||.+||..||++|||+.++++
T Consensus 272 ~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCC-CC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112222221 11 123568999999999999999999999999886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.68 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=202.9
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHh--ccCCCCeeEEEEEEEeC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hp~iv~~~~~~~~~ 152 (472)
..+..+|++.+.||+|+||.||+|++ +++.||+|++.. .....+.+|+.+++. + +||||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~------~~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS------REERSWFREAEIYQTVML-RHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG------GGHHHHHHHHHHHHHSCC-CCTTBCCEEEEEECC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc------hhHHHHHHHHHHHHHhhc-CCCcEEEEEeeeccc
Confidence 34567999999999999999999997 488999999853 235677889999988 5 599999999999887
Q ss_pred C----eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEeecCCCCceeeccCCCCC
Q 012039 153 Q----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH--------FMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 153 ~----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
. .+++||||+++++|.+++.. ..+++..++.++.||+.||.||| +++|+||||||+||++ +.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCC
Confidence 6 89999999999999999865 47999999999999999999999 8999999999999999 5566
Q ss_pred cEEEeecCCceeccCCcc-----eeeccCCCCCCchhhhhcc-------cCCccchhhHHHHHHHHhhC----------C
Q 012039 221 LLKATDFGLSVFIEEGKV-----YRDIVGSAYYVAPEVLRRR-------YGKEIDIWSAGVILYILLSG----------V 278 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~~ll~g----------~ 278 (472)
.+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 799999999987765442 2345799999999998653 34689999999999999999 7
Q ss_pred CCCCCCC-----hHHHHHHHHcCCccCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 279 PPFWAET-----EKGIFDAILQGDIDFESAP-W--PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 279 ~pf~~~~-----~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.||.... .......+........... + ..+++.+.+||.+||+.||++|||+.++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8886542 2334444433333222110 1 1234679999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=351.88 Aligned_cols=248 Identities=17% Similarity=0.193 Sum_probs=193.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-CC---------------
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PN--------------- 141 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~--------------- 141 (472)
...|.+++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.+. | +|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchh
Confidence 346889999999999999999999999999999987544434445778999999999996 4 22
Q ss_pred ------eeEEEEEEEe-----CCeEEEEEeccCCcchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEe
Q 012039 142 ------IVEFKGAYED-----KQSVHVVMELCAGGELFDRIIA-------KGHYSERAAASICRSIVNVVHICHFMGVMH 203 (472)
Q Consensus 142 ------iv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 203 (472)
...+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111122222 23577888877 6899888741 234778889999999999999999999999
Q ss_pred ecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCCCchhhhh----------c-ccCCccchhhHHHHHH
Q 012039 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR----------R-RYGKEIDIWSAGVILY 272 (472)
Q Consensus 204 ~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~-~~~~~~DiwslG~il~ 272 (472)
|||||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++. . .++.++|||||||++|
T Consensus 235 rDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999 55666999999998875433 445678 9999999883 2 3788999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 273 ILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 273 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+|++|+.||...+..+....+.. .+..+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999987655433322222 23468999999999999999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=331.49 Aligned_cols=227 Identities=15% Similarity=0.089 Sum_probs=186.9
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.++.++. ||||+++++++.+.+.+|
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcEE
Confidence 4568999999999999999999999999999999997655433444578899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
+||||++|++|.+++.. ......+..++.||+.||.|||++||+||||||+|||++ .++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc--------
Confidence 99999999999999854 246667899999999999999999999999999999994 55668887443
Q ss_pred cceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHH---HHHcCCccCCCCCCCCCCHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD---AILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
|++| ++.++|||||||++|+|++|+.||.+.+....+. ....+...........+++++.
T Consensus 175 -----------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 -----------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp -----------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred -----------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 3332 6889999999999999999999998765432110 1111111111122357899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+||.+||+.||++| |+.++++
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHH
Confidence 99999999999999 9999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.32 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=194.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc-CCCCeeEEEEEEEeC-
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQPNIVEFKGAYEDK- 152 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~- 152 (472)
..+.++|++.+.||+|+||.||+|++. ++.||||++... ......+|..++..+. +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 456779999999999999999999976 889999998532 2344555666665541 599999999999887
Q ss_pred ---CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeecCCCCceeeccCCCCCc
Q 012039 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------GVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 153 ---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~~~ 221 (472)
..+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCC
Confidence 789999999999999999865 4799999999999999999999998 99999999999999 55668
Q ss_pred EEEeecCCceeccCCcce-----eeccCCCCCCchhhhhcc-cCCc------cchhhHHHHHHHHhhC----------CC
Q 012039 222 LKATDFGLSVFIEEGKVY-----RDIVGSAYYVAPEVLRRR-YGKE------IDIWSAGVILYILLSG----------VP 279 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~DiwslG~il~~ll~g----------~~ 279 (472)
+||+|||++......... ....||+.|+|||++.+. ++.. +|||||||++|+|++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999876543321 245799999999998753 3333 8999999999999999 77
Q ss_pred CCCCCC----hHHHHHHHH-cCCccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 280 PFWAET----EKGIFDAIL-QGDIDFESAP---WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 280 pf~~~~----~~~~~~~i~-~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
||.... ......... .......... ...+++++.+||.+||+.||.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 775432 122222222 2222111110 12456789999999999999999999999885
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=369.23 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=202.7
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECC-CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 152 (472)
.+.+.++|++.+.||+|+||+||+|.+.. +++.||||++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT 151 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence 34566899999999999999999999976 78999999886432 2334567889999999995 99999999999876
Q ss_pred Ce-----EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeec
Q 012039 153 QS-----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 153 ~~-----~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
+. .||||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~DF 225 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLIDL 225 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEECCC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEEec
Confidence 55 7999999999999887654 7999999999999999999999999999999999999953 26999999
Q ss_pred CCceeccCCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 228 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
|++...... ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+..... .. .......
T Consensus 226 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~-~~~~~~~ 292 (681)
T 2pzi_A 226 GAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LP-EDDPVLK 292 (681)
T ss_dssp TTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CC-TTCHHHH
T ss_pred ccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc---------cc-ccccccc
Confidence 999876543 3457999999999998878999999999999999999999886532110 00 0111112
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.++.+.+||.+||+.||.+||++.+++.|+|+.
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 467899999999999999999999999888874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=338.42 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=189.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHH--HHhccCCCCeeEEEEEEEe----
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI--MQHLSGQPNIVEFKGAYED---- 151 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~--l~~l~~hp~iv~~~~~~~~---- 151 (472)
.++|++++.||+|+||.||+|++ +++.||||++... ....+..|..+ +..+ +||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhc-cCcchhhheecccccccC
Confidence 45899999999999999999976 5889999998643 23444445444 4446 59999999986542
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEeecCCCCceeeccCCCCCc
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---------GVMHRDLKPENFLLSSKDENAL 221 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~i~H~dlkp~Nili~~~~~~~~ 221 (472)
...+++|||||++|+|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCc
Confidence 34678999999999999998654 468999999999999999999999 99999999999999 45678
Q ss_pred EEEeecCCceeccCCc---------ceeeccCCCCCCchhhhhc--------ccCCccchhhHHHHHHHHhhCCCCCCCC
Q 012039 222 LKATDFGLSVFIEEGK---------VYRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLSGVPPFWAE 284 (472)
Q Consensus 222 ~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~ 284 (472)
+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998765322 1224579999999999864 4678899999999999999997776432
Q ss_pred Ch-----------------HHHHHH-HHcCCccCC-CCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc------C
Q 012039 285 TE-----------------KGIFDA-ILQGDIDFE-SAPW---PTISSSAKDLVRRMLTQDPKKRITSAQVLE------H 336 (472)
Q Consensus 285 ~~-----------------~~~~~~-i~~~~~~~~-~~~~---~~~s~~~~~li~~~L~~dp~~Rps~~~~l~------h 336 (472)
.. ...... +........ ...| ..+++++.+||.+||+.||++|||+.++++ +
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 111111 111111111 1111 124568999999999999999999999954 6
Q ss_pred CccccC
Q 012039 337 PWIKEG 342 (472)
Q Consensus 337 ~~~~~~ 342 (472)
+|-+..
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 666653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.09 Aligned_cols=232 Identities=18% Similarity=0.138 Sum_probs=160.1
Q ss_pred eeeecCCeEEEEEEECCCCCEEEEEEecccccCC-------cccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-------KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
.++.|+.|.+..++....|..|+||++.+..... ....+.+.+|+.+|+++.+|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4677888888888888889999999997653221 123467899999999998899999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-c
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~-~ 237 (472)
||||+|++|.++|.+.+++++. .|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999998888875 478999999999999999999999999999 56678999999999876543 2
Q ss_pred ceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....+||+.|+|||++.+.+..++|+||+|+++|.+.++..++ ...+... +.. ...+..++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-----~~~~~~l~~ 457 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-----RWNFVLLLA 457 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS----CGG-----GCSHHHHHH
T ss_pred cccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC----CCC-----CCcHHHHHH
Confidence 33456899999999999988889999999999999887765443 1111111 110 112456677
Q ss_pred HhcccCCCCCCCHHHHhcCCccc
Q 012039 318 RMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 318 ~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.++..+|..|+.......++|..
T Consensus 458 ~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 458 LFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHhCCCCCCCCChhhhccchhHH
Confidence 77777787777766655565543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-29 Score=253.66 Aligned_cols=184 Identities=18% Similarity=0.151 Sum_probs=142.1
Q ss_pred EEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc-----cHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+.||+|+||.||+|. ..++.+++|........... ..+.+.+|+.++++++ ||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence 446689999999999995 45788999986543322111 2345789999999995 999995555555677779
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||||+|++|.+++.. +..++.||+.+|.|||++||+||||||+|||++ . .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence 99999999999998865 668999999999999999999999999999995 3 7999999999987653
Q ss_pred cc--------eeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCC
Q 012039 237 KV--------YRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPF 281 (472)
Q Consensus 237 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf 281 (472)
.. .....||+.|+|||++.. .|+..+|+||..+-..+-..++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32 135689999999999864 5888999999988888777776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=210.79 Aligned_cols=159 Identities=25% Similarity=0.253 Sum_probs=123.0
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---------------ccHHHHHHHHHHHHhccCCCCeeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---------------NDKDDIKREIQIMQHLSGQPNIVE 144 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~hp~iv~ 144 (472)
.|.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+++++. |++++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~ 168 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK 168 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe
Confidence 456669999999999999999 7899999999864322111 13456889999999996 444444
Q ss_pred EEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEE
Q 012039 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (472)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl 224 (472)
++.. +..|+||||++|++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 169 ---~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl 233 (282)
T 1zar_A 169 ---VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 233 (282)
T ss_dssp ---EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred ---EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEE
Confidence 4443 44699999999999987 41 233557999999999999999999999999999995 667999
Q ss_pred eecCCceeccCCcceeeccCCCCCCchhhhh-----------cccCCccchhhH
Q 012039 225 TDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-----------RRYGKEIDIWSA 267 (472)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-----------~~~~~~~Diwsl 267 (472)
+|||+++. +..+.|||.+. ..|+..+|+|.+
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999864 34578999874 246677777764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=182.03 Aligned_cols=142 Identities=14% Similarity=0.114 Sum_probs=108.1
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCE--EEEEEecccccCCc---------------------ccHHHHHHHHHHHHhc
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTK---------------------NDKDDIKREIQIMQHL 136 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--va~K~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l 136 (472)
-|.+.+.||+|+||.||+|.+..+|+. ||||++........ .....+.+|+.++++|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778999 99998754321100 0123678999999999
Q ss_pred cCCCCe--eEEEEEEEeCCeEEEEEeccCC-c----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEeecCCC
Q 012039 137 SGQPNI--VEFKGAYEDKQSVHVVMELCAG-G----ELFDRIIAKGHYSERAAASICRSIVNVVHICH-FMGVMHRDLKP 208 (472)
Q Consensus 137 ~~hp~i--v~~~~~~~~~~~~~lv~e~~~g-~----sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp 208 (472)
. |++| +.+++. +..+|||||+.+ | +|.+.... .++..+..++.||+.+|.||| ++||+||||||
T Consensus 128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 6 6653 444442 246899999942 3 66554332 235578899999999999999 99999999999
Q ss_pred CceeeccCCCCCcEEEeecCCceecc
Q 012039 209 ENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 209 ~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+|||+. . .++|+|||+|....
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEETT
T ss_pred HHEEEc---C--cEEEEECcccccCC
Confidence 999994 3 69999999997653
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-19 Score=158.89 Aligned_cols=137 Identities=29% Similarity=0.531 Sum_probs=108.8
Q ss_pred cCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc
Q 012039 335 EHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL 414 (472)
Q Consensus 335 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~ 414 (472)
.|||.+... ....++...++.++++|...+++++.++..+...++.+++..++++|..+|.|++|.|+.+||..++..+
T Consensus 8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~ 86 (197)
T 3pm8_A 8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI 86 (197)
T ss_dssp ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 489998654 4456778899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 415 GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 415 ~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
|..++..+++.++..+|.|++|.|+|+||+.++........++.++.+|+.||.|++|
T Consensus 87 g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 144 (197)
T 3pm8_A 87 GYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGNG 144 (197)
T ss_dssp C----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCSS
T ss_pred CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999999999887665566788999999999999998
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=152.73 Aligned_cols=135 Identities=36% Similarity=0.540 Sum_probs=114.9
Q ss_pred cCCccccCCCCCCCCCchHHHHHHHHHHhhhHhHHHHHHHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc
Q 012039 335 EHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL 414 (472)
Q Consensus 335 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~ 414 (472)
.|||+.... ....++...++.++++|...+++++.++..+...++.+++..++++|..+|.|++|.|+.+||..+++.+
T Consensus 3 ~~~~~~~~~-~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSGR-ENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCCc-cccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 477776533 3345667889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 415 GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 415 ~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
|...+ .+++.++..+|.|++|.|+|+||+.++.... ...++.+..+|+.||.|++|
T Consensus 82 g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~-~~~~~~l~~~F~~~D~d~~G 137 (191)
T 3k21_A 82 GLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRK-QLSKKLIYCAFRVFDVDNDG 137 (191)
T ss_dssp TCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGG-GCCHHHHHHHHHHHSTTCSS
T ss_pred CCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhh-hccHHHHHHHHHHhCCCCCC
Confidence 99888 8899999999999999999999999886554 35678999999999999998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=166.25 Aligned_cols=141 Identities=18% Similarity=0.220 Sum_probs=101.8
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC-----------cccH--------HHHHHHHHHHHhccCCCC
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----------KNDK--------DDIKREIQIMQHLSGQPN 141 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----------~~~~--------~~~~~E~~~l~~l~~hp~ 141 (472)
|.+++.||+|++|.||+|.+. +|+.||||+++.....- .... -...+|...|.+|. +.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 899999999999999999975 69999999976432110 0001 11246778888884 444
Q ss_pred e--eEEEEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCC
Q 012039 142 I--VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (472)
Q Consensus 142 i--v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 219 (472)
+ ...++. .. .+|||||++|++|.++. ....+..++.||+.+|.+||++|||||||||.|||+..++..
T Consensus 175 v~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 3 223322 22 36999999998886532 223456789999999999999999999999999999754321
Q ss_pred -------CcEEEeecCCceec
Q 012039 220 -------ALLKATDFGLSVFI 233 (472)
Q Consensus 220 -------~~~kl~Dfg~~~~~ 233 (472)
..+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 13789999987754
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.2e-16 Score=135.16 Aligned_cols=119 Identities=26% Similarity=0.550 Sum_probs=106.8
Q ss_pred chHHHHHHHHHHhhhHhHHHHHHHHHhhch--hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHH
Q 012039 351 DSAVLSRMKQFRAMNKLKKLALKVIAENLS--TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428 (472)
Q Consensus 351 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~ 428 (472)
...++.++++|...+++++.++..+...++ .+++..++++|..+|.|++|.|+.+||..+++.+|.. ..+++.+|.
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~--~~~~~~~~~ 80 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK--KWDINRILQ 80 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC--HHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC--HHHHHHHHH
Confidence 467889999999999999999999998887 8889999999999999999999999999999999854 688999999
Q ss_pred HhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 429 AADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 429 ~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.+|.|++|.|+|+||+.++..... ..++.++.+|+.||+|++|
T Consensus 81 ~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~F~~~D~d~~G 123 (180)
T 3mse_B 81 ALDINDRGNITYTEFMAGCYRWKN-IESTFLKAAFNKIDKDEDG 123 (180)
T ss_dssp HHCTTCCSEECHHHHHHHHSCCTT-C--CHHHHHHHHHCTTCSS
T ss_pred HhCCCCCCcCcHHHHHHHHHhccc-CCHHHHHHHHHHHCCCCCC
Confidence 999999999999999998865433 2347899999999999998
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=140.56 Aligned_cols=124 Identities=35% Similarity=0.597 Sum_probs=112.6
Q ss_pred CCchHHHHHHHHHHhhhHhHHHHHHHHHhhc-hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc-----------CC
Q 012039 349 PIDSAVLSRMKQFRAMNKLKKLALKVIAENL-STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL-----------GS 416 (472)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-----------~~ 416 (472)
++...++.++++|...+.+++.++..+...+ +.+++..++++|..+|.|++|.|+.+||..++..+ +.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 3456788999999999999999999999888 88889999999999999999999999999999987 66
Q ss_pred CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 417 KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 417 ~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
..+.+++..++..+|.|++|.|+|+||+.++........++.+..+|+.+|.|++|
T Consensus 83 ~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 138 (191)
T 3khe_A 83 SQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSG 138 (191)
T ss_dssp HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCCHHHHHHHHHHHCTTCSS
T ss_pred hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccchHHHHHHHHHHHCCCCcC
Confidence 67788999999999999999999999999887665556778999999999999998
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=131.33 Aligned_cols=114 Identities=67% Similarity=1.016 Sum_probs=100.4
Q ss_pred HHHHhhhHhHHHHHHHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcce
Q 012039 359 KQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438 (472)
Q Consensus 359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i 438 (472)
++|...+.+++.++..+...++.+++..++++|..+|.|++|.|+.+||..++..+|..++..++..++..+|.|++|.|
T Consensus 1 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i 80 (166)
T 2aao_A 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTI 80 (166)
T ss_dssp -----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSB
T ss_pred CchhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeE
Confidence 35677888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 439 DYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 439 ~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+|+||+..+.........+.+..+|+.+|.|++|
T Consensus 81 ~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 114 (166)
T 2aao_A 81 DYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSG 114 (166)
T ss_dssp CHHHHHHHHTTCHHHHTTHHHHHHHHHHCTTCSS
T ss_pred cHHHHHHHHHHHhhcccHHHHHHHHHHhCCCCCC
Confidence 9999999886544334457899999999999998
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=145.74 Aligned_cols=98 Identities=38% Similarity=0.657 Sum_probs=87.4
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-C
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-L 453 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~ 453 (472)
..+.++++++++++++|+.||.|++|+|+.+||+.+|+.+|..+++++++.+|..+|.|++|.|+|+||+.++..... .
T Consensus 292 s~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~ 371 (440)
T 3u0k_A 292 TRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDT 371 (440)
T ss_dssp BCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC----
T ss_pred hHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCC
Confidence 345678999999999999999999999999999999999999999999999999999999999999999998865433 4
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
..++.|+.+|+.||+|++|
T Consensus 372 d~eeeLreAFk~fDkDgdG 390 (440)
T 3u0k_A 372 DSEEEIREAFRVFDKDGNG 390 (440)
T ss_dssp --CHHHHHHHHHHCTTCSS
T ss_pred ChHHHHHHHHHHHCCCCcC
Confidence 4568899999999999998
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=9.6e-16 Score=133.24 Aligned_cols=96 Identities=39% Similarity=0.629 Sum_probs=88.1
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LER 455 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~ 455 (472)
..++++++++++++|..||.|++|+|+.+||..+++.+|..+++.++..++..+|.|++|.|+|.||+..+..... ...
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~ 82 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS 82 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCc
Confidence 4578899999999999999999999999999999999999999999999999999999999999999998865543 335
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
++.++.+|+.||+|++|
T Consensus 83 ~~~l~~aF~~fD~d~~G 99 (176)
T 2lhi_A 83 EQELLEAFKVFDKNGDG 99 (176)
T ss_dssp HHHHHHHHHHHCSSCSS
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 67899999999999998
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.9e-15 Score=125.55 Aligned_cols=92 Identities=28% Similarity=0.592 Sum_probs=82.1
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDDHL 459 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~~l 459 (472)
++++.+++++|..||.|++|.|+.+||..+++.+|..++.++++.++..+|.|++|.|+|+||+.++..... ....+.+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l 81 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI 81 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHH
Confidence 456788999999999999999999999999999999999999999999999999999999999998754321 2235689
Q ss_pred HHHHHhhcCCCCC
Q 012039 460 YKAFQHFDKDNSG 472 (472)
Q Consensus 460 ~~~F~~~D~d~~G 472 (472)
+.+|+.||+|++|
T Consensus 82 ~~~F~~~D~d~~G 94 (143)
T 2obh_A 82 LKAFKLFDDDETG 94 (143)
T ss_dssp HHHHHHHCTTCSS
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999998
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.4e-15 Score=125.26 Aligned_cols=95 Identities=31% Similarity=0.582 Sum_probs=87.5
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~ 456 (472)
.++++++++++++|..+|.|++|.|+.+||..+++.+|..++.+++..++..+|.+++|.|+|.||+..+..... ...+
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~ 82 (148)
T 2lmt_A 3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTE 82 (148)
T ss_dssp SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcH
Confidence 467889999999999999999999999999999999999999999999999999999999999999998765433 4567
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||+|++|
T Consensus 83 ~~l~~aF~~~D~d~~G 98 (148)
T 2lmt_A 83 EEMREAFKIFDRDGDG 98 (148)
T ss_dssp HHHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHHCCCCcC
Confidence 8999999999999998
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=99.54 E-value=3.4e-15 Score=127.43 Aligned_cols=94 Identities=23% Similarity=0.349 Sum_probs=83.0
Q ss_pred hchhhHHhhhhhhhccccC--CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---c
Q 012039 378 NLSTEEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---K 452 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~--~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---~ 452 (472)
+++++++++++++|..||. |++|+|+..||+.+|+.+|..+++++++.++. .|.+++|.|+|+||+.++.... .
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~~ 80 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKDT 80 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCCT
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhcccc
Confidence 4678899999999999995 89999999999999999999999999999874 4788899999999999876433 2
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
...++.++.||+.||+|++|
T Consensus 81 ~~~~~~l~~aF~~fD~d~~G 100 (159)
T 3i5g_C 81 GTAADEFMEAFKTFDREGQG 100 (159)
T ss_dssp TCCHHHHHHHHHHHCTTSSS
T ss_pred cchHHHHHHHHHHHhcCCCC
Confidence 34578899999999999998
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.8e-15 Score=114.20 Aligned_cols=71 Identities=28% Similarity=0.583 Sum_probs=66.8
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.++.+++++++++|+.||.|++|+|+.+||+.+|+.+|..+++++++.+++.+|.|++|.|+|+||+.+|.
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence 35678888999999999999999999999999999999999999999999999999999999999998763
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=121.69 Aligned_cols=95 Identities=40% Similarity=0.685 Sum_probs=84.6
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~ 456 (472)
.++.+++.+++++|..+|.|++|.|+.+||..+++.+|..++..+++.++..+|.|++|.|+|+||+.++..... ....
T Consensus 3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 82 (148)
T 1exr_A 3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE 82 (148)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcH
Confidence 356778889999999999999999999999999999999999999999999999999999999999998764321 2345
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.||+|++|
T Consensus 83 ~~l~~~F~~~D~d~~G 98 (148)
T 1exr_A 83 EELIEAFKVFDRDGNG 98 (148)
T ss_dssp HHHHHHHHHHSTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 7899999999999998
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.6e-14 Score=120.24 Aligned_cols=87 Identities=18% Similarity=0.400 Sum_probs=78.1
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
.+++.+++++|..+|.|++|+|+.+||+.+++.+|..+++++++.++..+|.|++|.|+|+||+.++... .+.+.
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~-----~~~~~ 118 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRMMLGK-----RSAIL 118 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSS-----GGGGG
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh-----HHHHH
Confidence 5677889999999999999999999999999999999999999999999999999999999999988643 45788
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.||.|++|
T Consensus 119 ~aF~~~D~d~~g 130 (147)
T 1wy9_A 119 RMILMYEEKNKE 130 (147)
T ss_dssp GGGGGCCCC---
T ss_pred HHHHHHccCCCC
Confidence 999999999987
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.5e-14 Score=117.89 Aligned_cols=92 Identities=29% Similarity=0.578 Sum_probs=83.9
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc-ccCCcHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR-HKLERDDHL 459 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~-~~~~~~~~l 459 (472)
++++.+++++|..+|.|++|.|+.+||..+++.+|..++..+++.++..+|.|++|.|+|+||+.++... ......+.+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 81 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDIL 81 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHH
Confidence 4577889999999999999999999999999999999999999999999999999999999999988753 234567899
Q ss_pred HHHHHhhcCCCCC
Q 012039 460 YKAFQHFDKDNSG 472 (472)
Q Consensus 460 ~~~F~~~D~d~~G 472 (472)
+.+|+.+|+|++|
T Consensus 82 ~~~F~~~D~d~~G 94 (142)
T 2bl0_C 82 RQAFRTFDPEGTG 94 (142)
T ss_dssp HHHHHHTCCSSCS
T ss_pred HHHHHHHCCCCCC
Confidence 9999999999998
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.9e-14 Score=120.40 Aligned_cols=87 Identities=21% Similarity=0.393 Sum_probs=73.7
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
.++..+++++|..||.|++|+|+.+||+.+++.+|..+++++++.++..+|.|++|.|+|+||+.++... ...+.
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~-----~~~i~ 120 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGK-----RSAVL 120 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSS-----SCCHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh-----HHHHH
Confidence 4567789999999999999999999999999999999999999999999999999999999999988754 34689
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.||.|++|
T Consensus 121 ~aF~~~D~d~~G 132 (150)
T 2jjz_A 121 KLVMMFEGKANE 132 (150)
T ss_dssp HHHHC-------
T ss_pred HHHHHHcCCCCC
Confidence 999999999987
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.49 E-value=6.4e-14 Score=119.57 Aligned_cols=98 Identities=30% Similarity=0.502 Sum_probs=87.4
Q ss_pred HHhhchhhHHhhhhhhhccccCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc--
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDN-SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-- 451 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-- 451 (472)
+...++.+++..++++|..+|.|+ +|.|+.+||..++..+|..++.++++.++..+|.|++|.|+|+||+.++....
T Consensus 8 ~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 87 (161)
T 1dtl_A 8 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKD 87 (161)
T ss_dssp GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-
T ss_pred HHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcc
Confidence 345577888999999999999999 99999999999999999999999999999999999999999999999886543
Q ss_pred --cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 --KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 --~~~~~~~l~~~F~~~D~d~~G 472 (472)
.....+.+..+|+.+|.|++|
T Consensus 88 ~~~~~~~~~~~~~F~~~D~d~~G 110 (161)
T 1dtl_A 88 DSKGKSEEELSDLFRMFDKNADG 110 (161)
T ss_dssp ----CHHHHHHHHHHHHCTTCSS
T ss_pred cccchHHHHHHHHHHHhCCCCCC
Confidence 234567899999999999998
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=119.43 Aligned_cols=91 Identities=32% Similarity=0.551 Sum_probs=81.3
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~ 456 (472)
.++++++++++++|..||.|++|.|+..||+.+|+.+|..++.+++..++. +.+|.|+|.||+.++..... ..++
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~----~~~~~i~f~ef~~~~~~~~~~~~~~ 84 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLK----ECPGQLNFTAFLTLFGEKVSGTDPE 84 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHH----TSSSCCCSHHHHHTTTTTTTTCCCH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHH----hccCCccHHHHHHHHHhhhcccccH
Confidence 478899999999999999999999999999999999999999999888775 45778999999998876543 4567
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.|+.+|+.||+|++|
T Consensus 85 ~~l~~aF~~fD~d~~G 100 (153)
T 3i5g_B 85 DALRNAFSMFDEDGQG 100 (153)
T ss_dssp HHHHHHHHTTCSSCSS
T ss_pred HHHHHHHhccccCCCC
Confidence 8999999999999998
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-14 Score=114.89 Aligned_cols=90 Identities=14% Similarity=0.308 Sum_probs=72.7
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc----
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---- 451 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---- 451 (472)
+..++.+..+|+.||.| +|+|+.+||+.+|++ ++...+++++++||+.+|.|+||.|+|+||+.++....
T Consensus 11 E~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~~~h 89 (121)
T 4drw_A 11 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIACN 89 (121)
T ss_dssp HHHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHH
Confidence 34578899999999988 899999999999987 78888999999999999999999999999999765321
Q ss_pred ----------c--CCcHHHHHHHHHhhcCCCC
Q 012039 452 ----------K--LERDDHLYKAFQHFDKDNS 471 (472)
Q Consensus 452 ----------~--~~~~~~l~~~F~~~D~d~~ 471 (472)
. ...+..+.++|+.+|.|||
T Consensus 90 e~f~~~~k~~~~~~~~d~~~~e~~~~~d~~gd 121 (121)
T 4drw_A 90 DYFVVHMKQENLYFQGDSTVHEILSKLSLEGD 121 (121)
T ss_dssp HHHTTSCC---------CCHHHHHHHCCC---
T ss_pred HHHHHHHHHhccCCCCchHHHHHHHHhcccCC
Confidence 0 1223459999999999986
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.49 E-value=5e-14 Score=118.16 Aligned_cols=98 Identities=39% Similarity=0.636 Sum_probs=86.3
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-C
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-L 453 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~ 453 (472)
|+..++.+++..++++|..+|.|++|.|+.+||..++..+|..++..++..++..+|.|++|.|+|+||+..+..... .
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~ 80 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCN 80 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTH
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCC
Confidence 345678889999999999999999999999999999999999999999999999999999999999999998865422 2
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
..++.+..+|+.+|+|++|
T Consensus 81 ~~~~~~~~~F~~~D~d~~G 99 (147)
T 4ds7_A 81 DSEQELLEAFKVFDKNGDG 99 (147)
T ss_dssp HHHHHHHHHHHHHCTTCSS
T ss_pred CcHHHHHHHHHHhCCCCCC
Confidence 3457899999999999998
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.48 E-value=4.7e-14 Score=119.16 Aligned_cols=97 Identities=27% Similarity=0.460 Sum_probs=86.5
Q ss_pred HhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCC-
Q 012039 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLE- 454 (472)
Q Consensus 376 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~- 454 (472)
...++.+++..++++|..+|.|++|.|+.+||..++..+|..++..++..++..+|.|++|.|+|+||+..+.......
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 81 (153)
T 3ox6_A 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAET 81 (153)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCC
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccc
Confidence 3457788899999999999999999999999999999999999999999999999999999999999999886443222
Q ss_pred ----cHHHHHHHHHhhcCCCCC
Q 012039 455 ----RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ----~~~~l~~~F~~~D~d~~G 472 (472)
..+.++.+|+.+|.|++|
T Consensus 82 ~~~~~~~~~~~~F~~~D~d~~G 103 (153)
T 3ox6_A 82 ADMIGVKELRDAFREFDTNGDG 103 (153)
T ss_dssp HHHHCHHHHHHHHHHHCTTCSS
T ss_pred cccccHHHHHHHHHHhCCCCCC
Confidence 247899999999999998
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.48 E-value=8.1e-14 Score=118.60 Aligned_cols=95 Identities=26% Similarity=0.459 Sum_probs=85.5
Q ss_pred hchhhHHhhhhhhhcccc-CCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC---
Q 012039 378 NLSTEEIQGLKQMFTNID-TDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL--- 453 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D-~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~--- 453 (472)
.++.+++..++++|..+| .|++|+|+.+||..+++.+|..++..+++.++..+|.|++|.|+|+||+..+......
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 85 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVN 85 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCC
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccc
Confidence 456778889999999999 9999999999999999999999999999999999999999999999999988654322
Q ss_pred --CcHHHHHHHHHhhcCCCCC
Q 012039 454 --ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 --~~~~~l~~~F~~~D~d~~G 472 (472)
.....++.+|+.||+|++|
T Consensus 86 ~~~~~~~~~~~F~~~D~d~~G 106 (158)
T 2jnf_A 86 PEQMQQELREAFRLYDKEGNG 106 (158)
T ss_dssp TTTTSSTHHHHHHHHCSSSSS
T ss_pred hhhHHHHHHHHHHHhCCCCCC
Confidence 4456799999999999998
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.47 E-value=2.7e-14 Score=125.59 Aligned_cols=95 Identities=63% Similarity=0.970 Sum_probs=86.0
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~ 457 (472)
.++.+++..++++|..+|.|++|.|+.+||..++..+|..++.+++..++..+|.|++|.|+|+||+..+........++
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~ 82 (188)
T 1s6i_A 3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREE 82 (188)
T ss_dssp SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCC
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHH
Confidence 45677888999999999999999999999999999999999999999999999999999999999999887654444556
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.++.+|+.||+|++|
T Consensus 83 ~l~~~F~~~D~d~dG 97 (188)
T 1s6i_A 83 NLVSAFSYFDKDGSG 97 (188)
T ss_dssp STHHHHHHTTTTCSS
T ss_pred HHHHHHHHHCCCCCC
Confidence 789999999999998
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=99.47 E-value=4.1e-14 Score=119.00 Aligned_cols=90 Identities=23% Similarity=0.359 Sum_probs=79.2
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHh-cCCCCcceeHHHHHHHHhcc------ccCCc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA-DVDGNGTIDYIEFITATMHR------HKLER 455 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~-d~d~~g~i~~~eF~~~~~~~------~~~~~ 455 (472)
++.+++++|..+|.|++|.|+.+||..+++.+|..++.++++.++..+ |.|++|.|+|+||+.++... .....
T Consensus 2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 81 (148)
T 1m45_A 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAK 81 (148)
T ss_dssp -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCC
T ss_pred hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhcccccccc
Confidence 456789999999999999999999999999999999999999999999 99999999999999988765 34456
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
.+.++.+|+.||+|++|
T Consensus 82 ~~~~~~~F~~~D~d~~G 98 (148)
T 1m45_A 82 TEDFVKAFQVFDKESTG 98 (148)
T ss_dssp THHHHHHHHTTCSSSSS
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 68999999999999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5e-13 Score=124.04 Aligned_cols=141 Identities=16% Similarity=0.153 Sum_probs=112.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|++...++.|+.+.||++... +..+++|+...... .....+.+|+.+++.|..+..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 46888889999999999998744 67899998864321 12345889999999997677889999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF---------------------------------------- 198 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------- 198 (472)
|||++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 222345788899999999998
Q ss_pred -------------------cCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 199 -------------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 199 -------------------~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++|+|++|.||++. ....+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999994 344567999998754
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-13 Score=117.47 Aligned_cols=96 Identities=29% Similarity=0.499 Sum_probs=87.1
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LER 455 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~ 455 (472)
..++.+++..++++|..+|.|++|.|+.+||..+++.+|..++.++++.++..+|.|++|.|+|+||+..+..... ...
T Consensus 15 ~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 94 (161)
T 3fwb_A 15 SELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDP 94 (161)
T ss_dssp TTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCH
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCc
Confidence 4567888999999999999999999999999999999999999999999999999999999999999998875432 345
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
.+.+..+|+.||.|++|
T Consensus 95 ~~~~~~~F~~~D~d~~G 111 (161)
T 3fwb_A 95 LDEIKRAFQLFDDDHTG 111 (161)
T ss_dssp HHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHHcCCCCC
Confidence 68899999999999998
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.46 E-value=8.2e-14 Score=121.28 Aligned_cols=96 Identities=41% Similarity=0.691 Sum_probs=83.9
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LER 455 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~ 455 (472)
..++.+++..++++|..+|.|++|.|+.+||..++..+|..++..+++.++..+|.|++|.|+|+||+..+..... ...
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~ 82 (179)
T 2f2o_A 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDS 82 (179)
T ss_dssp ---CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCccc
Confidence 4567788899999999999999999999999999999999999999999999999999999999999998765422 234
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
.+.+..+|+.||.|++|
T Consensus 83 ~~~~~~~F~~~D~d~~G 99 (179)
T 2f2o_A 83 EEEIREAFRVFDKDGNG 99 (179)
T ss_dssp HHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 56799999999999998
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=125.11 Aligned_cols=108 Identities=22% Similarity=0.329 Sum_probs=96.7
Q ss_pred HHHHhhhHhHHHHHHHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcce
Q 012039 359 KQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438 (472)
Q Consensus 359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i 438 (472)
..+...+.+++..+..+...++.+++.+++++|..+|.|++|.|+.+||..+++.+|..++.++++.++..+|.|++|.|
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I 104 (220)
T 3sjs_A 25 CIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHI 104 (220)
T ss_dssp HHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSCB
T ss_pred hccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcC
Confidence 44555666666666677788899999999999999999999999999999999999999999999999999999999999
Q ss_pred eHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 439 DYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 439 ~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+|+||+.++... +.++.+|+.||+|++|
T Consensus 105 ~~~EF~~~~~~~------~~l~~~F~~~D~d~~G 132 (220)
T 3sjs_A 105 SFYEFMAMYKFM------ELAYNLFVMNARARSG 132 (220)
T ss_dssp CHHHHHHHHHHH------HHHHHHHHHHCCSSTT
T ss_pred CHHHHHHHHHHH------HHHHHHHHHHCCCCCC
Confidence 999999987653 6799999999999998
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=118.53 Aligned_cols=95 Identities=38% Similarity=0.635 Sum_probs=84.9
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~ 456 (472)
.++.+++..++++|..+|.|++|.|+.+||..++..+|..++..++..++..+|.|++|.|+|+||+..+..... ....
T Consensus 21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 100 (169)
T 3qrx_A 21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSR 100 (169)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcH
Confidence 457788899999999999999999999999999999999999999999999999999999999999998765322 2235
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.+|+|++|
T Consensus 101 ~~~~~~F~~~D~d~~G 116 (169)
T 3qrx_A 101 EEILKAFRLFDDDNSG 116 (169)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 6889999999999998
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-15 Score=144.70 Aligned_cols=156 Identities=18% Similarity=0.324 Sum_probs=108.6
Q ss_pred CCCCHHHHHHHHHhc---ccCCCCCCCHHHHhcC------CccccCCCCCCCC----------------C-------chH
Q 012039 306 PTISSSAKDLVRRML---TQDPKKRITSAQVLEH------PWIKEGGEASDKP----------------I-------DSA 353 (472)
Q Consensus 306 ~~~s~~~~~li~~~L---~~dp~~Rps~~~~l~h------~~~~~~~~~~~~~----------------~-------~~~ 353 (472)
..++.++.+|.++++ ..+|++|.+.++.+.| +|+.++.+....+ . -..
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 345678899999998 8899999999999988 8887663221000 0 012
Q ss_pred HHHHHH-HHHhhhHhHHHHHHHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Q 012039 354 VLSRMK-QFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV 432 (472)
Q Consensus 354 ~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 432 (472)
++.+++ +|..++.+++ +...++.+++..++.+|..+|.|++|.|+.+||..+|..+|..++..++..++..+|.
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~ 169 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVEN 169 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Confidence 233333 3444444443 3456788889999999999999999999999999999999999999999999999999
Q ss_pred CCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 433 DGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 433 d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
|++|.|+|.+|+.++. ....+..+|+.||.|++|
T Consensus 170 d~~G~I~f~ef~~l~~------~~~~l~~~F~~~D~d~dG 203 (323)
T 1ij5_A 170 DTKGRMSYITLVAVAN------DLAALVADFRKIDTNSNG 203 (323)
T ss_dssp CCSSTHHHHHHTTSHH------HHHTSCCCHHHHCTTCCS
T ss_pred CCCCcCcHHHHHhhhh------HHHHHHHHHHHHCCCCCC
Confidence 9999999998876431 234566778888888776
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=103.16 Aligned_cols=85 Identities=29% Similarity=0.476 Sum_probs=72.3
Q ss_pred HhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCc
Q 012039 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLER 455 (472)
Q Consensus 376 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~ 455 (472)
...++.++...++++|..+|.|++|+|+.+||+.+++.+| .++.++++.++..+|.|++|.|+|+||+.++..... .
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~--~ 78 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRG--L 78 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTT--T
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCcc--H
Confidence 3456777888999999999999999999999999999999 999999999999999999999999999998876532 2
Q ss_pred HHHHHHHH
Q 012039 456 DDHLYKAF 463 (472)
Q Consensus 456 ~~~l~~~F 463 (472)
.+.+.+||
T Consensus 79 ~~~~~~aF 86 (86)
T 2opo_A 79 VKDVSKIF 86 (86)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhC
Confidence 35566665
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-13 Score=117.43 Aligned_cols=93 Identities=24% Similarity=0.338 Sum_probs=84.3
Q ss_pred chhhHHhhhhhhhccccC--CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc--CC
Q 012039 379 LSTEEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK--LE 454 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~--~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~--~~ 454 (472)
++.+++.+++++|..+|. |++|.|+.+||..+++.+|..++..++..+ ..+|.|++|.|+|+||+.++..... ..
T Consensus 3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 81 (156)
T 1wdc_C 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQG 81 (156)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCC
T ss_pred CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCC
Confidence 567788899999999999 999999999999999999999999999999 9999999999999999998876543 45
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
..+.++.+|+.||+|++|
T Consensus 82 ~~~~l~~~F~~~D~d~~G 99 (156)
T 1wdc_C 82 TFADYMEAFKTFDREGQG 99 (156)
T ss_dssp CHHHHHHHHHTTCSSSSS
T ss_pred hHHHHHHHHHHhCCCCCC
Confidence 678999999999999998
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=99.43 E-value=2.8e-13 Score=115.64 Aligned_cols=98 Identities=34% Similarity=0.541 Sum_probs=87.0
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-C
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-L 453 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~ 453 (472)
+...++.+++..++++|..+|.|++|.|+..||..++..+|..++.+++..++..+|.|++|.|+|+||+..+..... .
T Consensus 10 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~ 89 (162)
T 1top_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKED 89 (162)
T ss_dssp HHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHH
T ss_pred hhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHhccc
Confidence 445678889999999999999999999999999999999999999999999999999999999999999998764321 1
Q ss_pred C---cHHHHHHHHHhhcCCCCC
Q 012039 454 E---RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~---~~~~l~~~F~~~D~d~~G 472 (472)
. ..+.+..+|+.+|.|++|
T Consensus 90 ~~~~~~~~~~~~F~~~D~d~~G 111 (162)
T 1top_A 90 AKGKSEEELANCFRIFDKNADG 111 (162)
T ss_dssp HHHHHHHHHHHHHHHHCTTCSS
T ss_pred cccccHHHHHHHHHHhCCCCCC
Confidence 1 356799999999999998
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-13 Score=117.56 Aligned_cols=80 Identities=15% Similarity=0.334 Sum_probs=74.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHc----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARL----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
..++++|+.|| |++|+|+.+||+.+++.+ |..+++++++.|+..+| |++|.|+|+||+.++... +.+.
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~------~~~~ 147 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRL------EAMA 147 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHH------HHHH
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHH------HHHH
Confidence 46889999999 999999999999999999 99999999999999999 999999999999988643 5789
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.+|+|++|
T Consensus 148 ~~F~~~D~d~~G 159 (174)
T 2i7a_A 148 KTFRNLSKDGKG 159 (174)
T ss_dssp HHHHHHCSSSSC
T ss_pred HHHHHhCCCCCC
Confidence 999999999998
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.7e-13 Score=111.94 Aligned_cols=93 Identities=19% Similarity=0.357 Sum_probs=84.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHh---cCCCCcceeHHHHHHHHhcc---cc
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA---DVDGNGTIDYIEFITATMHR---HK 452 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~---d~d~~g~i~~~eF~~~~~~~---~~ 452 (472)
++++++.+++++|..+|.|++|.|+..||..+++.+|..++.+++..++..+ |.|+ |.|+|+||+..+... ..
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~ 80 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKD 80 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCC
Confidence 4567888999999999999999999999999999999999999999999999 9999 999999999988764 22
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
......++.+|+.||+|++|
T Consensus 81 ~~~~~~~~~~F~~~D~d~~G 100 (149)
T 2mys_C 81 QGTFEDFVEGLRVFDKEGNG 100 (149)
T ss_pred cchHHHHHHHHHHhCCCCCc
Confidence 34567899999999999998
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.3e-13 Score=102.03 Aligned_cols=85 Identities=34% Similarity=0.556 Sum_probs=74.9
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCC---cH
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLE---RD 456 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~---~~ 456 (472)
..++...++++|..+|.|++|+|+.+||+.+++.+|..++.++++.++..+|.|++|.|+|+||+.++....... ..
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~~~~ 83 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGNGW 83 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTTCCCHHH
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCCCCCchH
Confidence 455677899999999999999999999999999999999999999999999999999999999999887654322 34
Q ss_pred HHHHHHHH
Q 012039 457 DHLYKAFQ 464 (472)
Q Consensus 457 ~~l~~~F~ 464 (472)
+.++.||+
T Consensus 84 ~~l~~aF~ 91 (92)
T 2kn2_A 84 SRLRRKFS 91 (92)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhc
Confidence 67888885
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.6e-13 Score=120.77 Aligned_cols=92 Identities=33% Similarity=0.555 Sum_probs=78.8
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
.+++..++++|..+|.|++|.|+.+||..+++.+|..++.++++.++..+|.|++|.|+|+||+..+........++.+.
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~ 112 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIA 112 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHH
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHH
Confidence 45678899999999999999999999999999999999999999999999999999999999999886554434567899
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.+|.|++|
T Consensus 113 ~~F~~~D~d~~G 124 (204)
T 3e3r_A 113 AAFAKLDRSGDG 124 (204)
T ss_dssp HHHHHHCTTCSS
T ss_pred HHHHHhCcCCCC
Confidence 999999999998
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.40 E-value=6.7e-13 Score=114.92 Aligned_cols=93 Identities=23% Similarity=0.272 Sum_probs=81.0
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHH----HHHHcCCCCCHHHHH-----------HHHHHhcCCCCcceeHHHHH
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKA----GLARLGSKLTEAEVQ-----------QLMEAADVDGNGTIDYIEFI 444 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~----~l~~~~~~~~~~~~~-----------~~~~~~d~d~~g~i~~~eF~ 444 (472)
+++++.+++++|..+|.|++|.|+.+||.. +++.+|..++..++. .++..+|.|++|.|+|+||+
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~ 81 (176)
T 1nya_A 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFI 81 (176)
T ss_dssp CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHH
T ss_pred cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 456788999999999999999999999999 688899999988877 78899999999999999999
Q ss_pred HHHhccccCCc--------HHHHHHHHHhhcCCCCC
Q 012039 445 TATMHRHKLER--------DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 445 ~~~~~~~~~~~--------~~~l~~~F~~~D~d~~G 472 (472)
.++........ ...++.+|+.+|.|++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 117 (176)
T 1nya_A 82 RVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADG 117 (176)
T ss_dssp HHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCS
T ss_pred HHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCC
Confidence 98765433222 36799999999999998
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=99.38 E-value=5.5e-13 Score=103.30 Aligned_cols=69 Identities=14% Similarity=0.307 Sum_probs=61.8
Q ss_pred hhHHhhhhhhhcccc-CCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDNS-GTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+..+.++|+.|| .|++ |+|+.+||+.+++. +|...+++++++|++.+|.|+||.|+|+||+.++..
T Consensus 6 e~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~ 81 (101)
T 3nso_A 6 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLAC 81 (101)
T ss_dssp HHHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 345678999999998 8987 99999999999996 467889999999999999999999999999987753
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.8e-13 Score=110.77 Aligned_cols=89 Identities=29% Similarity=0.503 Sum_probs=79.4
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHHH
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDDH 458 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~~ 458 (472)
+.+++.+++++|..+|.|++|.|+.+||..+++.+|..++.+++..++.. ++|.|+|+||+.++..... ....+.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~~~~ 77 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTDPEDV 77 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSCCHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCCcHHH
Confidence 56788899999999999999999999999999999999999999888865 8899999999998875433 456789
Q ss_pred HHHHHHhhcCCCCC
Q 012039 459 LYKAFQHFDKDNSG 472 (472)
Q Consensus 459 l~~~F~~~D~d~~G 472 (472)
+..+|+.||+|++|
T Consensus 78 l~~~F~~~D~d~~G 91 (143)
T 3j04_B 78 IRNAFACFDEEASG 91 (143)
T ss_dssp HHHHHTTSCSSSCC
T ss_pred HHHHHHHHCCCCCC
Confidence 99999999999998
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-13 Score=116.25 Aligned_cols=94 Identities=22% Similarity=0.412 Sum_probs=76.6
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCC--CCcceeHHHHHHHHhcccc---C
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD--GNGTIDYIEFITATMHRHK---L 453 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d--~~g~i~~~eF~~~~~~~~~---~ 453 (472)
++++++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..++..+|.| ++|.|+|+||+.++..... .
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~ 83 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQ 83 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC----
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCC
Confidence 5677888999999999999999999999999999999999999999999999999 9999999999998865432 1
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
...+.+..+|+.||.|++|
T Consensus 84 ~~~~~l~~~F~~~D~d~~G 102 (151)
T 1w7j_B 84 GTYEDYLEGFRVFDKEGNG 102 (151)
T ss_dssp ----CCHHHHHTTCTTSSS
T ss_pred CcHHHHHHHHHHhCCCCCC
Confidence 2346788999999999998
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.36 E-value=5e-12 Score=109.31 Aligned_cols=81 Identities=28% Similarity=0.544 Sum_probs=75.9
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++.+|+.+|.|++|+|+.+||+.++..+|..++.++++.++..+| |++|.|+|+||+.++... ..+..+|+
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~------~~~~~~F~ 149 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRL------DAMFRAFK 149 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH------HHHHHHHH
Confidence 56888999999999999999999999999999999999999999999 999999999999988643 68899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 150 ~~D~d~~G 157 (173)
T 1alv_A 150 SLDKDGTG 157 (173)
T ss_dssp HHSSSCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=111.70 Aligned_cols=91 Identities=26% Similarity=0.518 Sum_probs=79.7
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCCc
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLER 455 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~~ 455 (472)
.++.+++..++++|..+|.|++|.|+.+||..+++.+|. .++..++..++... +|.|+|+||+.++.... ....
T Consensus 18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~~~~ 93 (166)
T 2mys_B 18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMFGEKLKGADP 93 (166)
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhccCCc
Confidence 567788899999999999999999999999999999999 99999999998764 78999999998876542 2345
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
.+.++.+|+.||.|++|
T Consensus 94 ~~~l~~~F~~~D~d~~G 110 (166)
T 2mys_B 94 EDVIMGAFKVLDPDGKG 110 (166)
T ss_pred HHHHHHHHHHhCCCCCc
Confidence 67899999999999988
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.4e-12 Score=111.22 Aligned_cols=82 Identities=30% Similarity=0.540 Sum_probs=77.0
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++.+|+.+|.|++|+|+.+||..++..+|..++.++++.++..+|.|++|.|+|+||+.++... +.+..+|+
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~------~~~~~~F~ 147 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL------QRLTDIFR 147 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH------HHHHHHHH
Confidence 568889999999999999999999999999999999999999999999999999999999988643 68899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 148 ~~D~d~dG 155 (172)
T 2znd_A 148 RYDTDQDG 155 (172)
T ss_dssp HHCTTSSS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=107.75 Aligned_cols=86 Identities=28% Similarity=0.424 Sum_probs=74.1
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc---cccCCcHHHHHHHH
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH---RHKLERDDHLYKAF 463 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~---~~~~~~~~~l~~~F 463 (472)
++++|..+|.|++|.|+.+||..++..++..++.++++.++..+|.|++|.|+++||+.++.. .........++.+|
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f 81 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLY 81 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHH
Confidence 567899999999999999999999999998889999999999999999999999999988752 22222345699999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|.|++|
T Consensus 82 ~~~D~d~~G 90 (134)
T 1jfj_A 82 KLMDVDGDG 90 (134)
T ss_dssp HHHCCSSSS
T ss_pred HHHCCCCCC
Confidence 999999987
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=109.50 Aligned_cols=93 Identities=23% Similarity=0.479 Sum_probs=80.5
Q ss_pred HhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCC
Q 012039 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLE 454 (472)
Q Consensus 376 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~ 454 (472)
...++.+++..++++|..+|.|++|.|+.+||..+++.+|..++..++..++. +++|.|+|+||+.++.... ...
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~ 84 (156)
T 1wdc_B 9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTD 84 (156)
T ss_dssp ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCC
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhcCCC
Confidence 34567788899999999999999999999999999999999999999999885 5789999999999886542 345
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
..+.++.+|+.||+|++|
T Consensus 85 ~~~~l~~~F~~~D~d~~G 102 (156)
T 1wdc_B 85 SEETIRNAFAMFDEQETK 102 (156)
T ss_dssp CHHHHHHHHHTTCTTCCS
T ss_pred hHHHHHHHHHHHCcCCCC
Confidence 678999999999999998
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-12 Score=98.06 Aligned_cols=75 Identities=35% Similarity=0.536 Sum_probs=69.3
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+...++.+++..++.+|..+|.|++|+|+.+||..+++.+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~ 84 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR 84 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 344567788899999999999999999999999999999999999999999999999999999999999998764
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.2e-13 Score=118.40 Aligned_cols=98 Identities=21% Similarity=0.309 Sum_probs=76.9
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHH-----HHHHHcCCCCCHH-----HHHHHHHHhcCCCCcceeHHHHH
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELK-----AGLARLGSKLTEA-----EVQQLMEAADVDGNGTIDYIEFI 444 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~-----~~l~~~~~~~~~~-----~~~~~~~~~d~d~~g~i~~~eF~ 444 (472)
+...++++++.+++++|..+|.|++|+|+.+||. .+++.+|..++.. +++.++..+|.|++|.|+|+||+
T Consensus 10 ~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~ 89 (195)
T 1qv0_A 10 KTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFL 89 (195)
T ss_dssp SCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHH
T ss_pred CcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHHHH
Confidence 3344578889999999999999999999999999 7888999888776 68999999999999999999999
Q ss_pred HHHhcccc-------CCcHHHHH----HHHHhhcCCCCC
Q 012039 445 TATMHRHK-------LERDDHLY----KAFQHFDKDNSG 472 (472)
Q Consensus 445 ~~~~~~~~-------~~~~~~l~----~~F~~~D~d~~G 472 (472)
.++..... ....+.++ .+|+.||+|++|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 128 (195)
T 1qv0_A 90 DGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSG 128 (195)
T ss_dssp HHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----C
T ss_pred HHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCC
Confidence 97654321 11112344 999999999998
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=114.67 Aligned_cols=95 Identities=13% Similarity=0.183 Sum_probs=82.4
Q ss_pred hchhhHHhhhhhhhccc-cCCCCCcccHHHHHHHHHHc----CCCCCHHHHHHHH-----------HHhcCCCCcceeHH
Q 012039 378 NLSTEEIQGLKQMFTNI-DTDNSGTITYEELKAGLARL----GSKLTEAEVQQLM-----------EAADVDGNGTIDYI 441 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~-D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~~~-----------~~~d~d~~g~i~~~ 441 (472)
.++.++..+++++|..+ |.|++|+|+.+||..++..+ |...+..+++.++ ..+|.|++|.|+|+
T Consensus 5 ~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~~ 84 (191)
T 2ccm_A 5 QLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTKE 84 (191)
T ss_dssp CCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHH
T ss_pred hccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECHH
Confidence 45677788899999999 99999999999999999998 9888989999988 99999999999999
Q ss_pred HHHHHHhcccc---------CCcHHHHHHHHHhhcCCCCC
Q 012039 442 EFITATMHRHK---------LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 442 eF~~~~~~~~~---------~~~~~~l~~~F~~~D~d~~G 472 (472)
||+.++..... ...+..+..+|+.+|+|++|
T Consensus 85 Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG 124 (191)
T 2ccm_A 85 EWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDN 124 (191)
T ss_dssp HHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCC
Confidence 99998765311 12246799999999999998
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=99.33 E-value=8e-13 Score=118.06 Aligned_cols=96 Identities=18% Similarity=0.260 Sum_probs=77.5
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCC--CCCHHHHHHHH-------HHhcCCCCcceeHHHHHHHH
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS--KLTEAEVQQLM-------EAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~--~~~~~~~~~~~-------~~~d~d~~g~i~~~eF~~~~ 447 (472)
..++.+++.+++++|..+|.|++|.|+.+||..++..+|. .++.+++..++ ..+|.|++|.|+|+||+.++
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~ 107 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEAN 107 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 4456777889999999999999999999999999999987 89999999999 99999999999999999987
Q ss_pred h---------ccc-cCCcHHH-HHHHHHhhcCCCCC
Q 012039 448 M---------HRH-KLERDDH-LYKAFQHFDKDNSG 472 (472)
Q Consensus 448 ~---------~~~-~~~~~~~-l~~~F~~~D~d~~G 472 (472)
. ... .....+. ++.+|+.||+|++|
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 143 (208)
T 2hpk_A 108 RVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDG 143 (208)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSS
T ss_pred HHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCC
Confidence 5 221 2222334 89999999999998
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-12 Score=114.49 Aligned_cols=90 Identities=23% Similarity=0.379 Sum_probs=81.7
Q ss_pred HHhhhhhhhccccCC-CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHH
Q 012039 383 EIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYK 461 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~ 461 (472)
+.++++++|..||.| ++|.|+.+||..+++.+|...+.++++.+|..+|.|++|.|+|+||+.++........++.+..
T Consensus 20 ~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~ 99 (204)
T 1jba_A 20 DAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKW 99 (204)
T ss_dssp HHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHH
T ss_pred CHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHH
Confidence 445678899999999 8999999999999999999888999999999999999999999999998876555556789999
Q ss_pred HHHhhcCCCCC
Q 012039 462 AFQHFDKDNSG 472 (472)
Q Consensus 462 ~F~~~D~d~~G 472 (472)
+|+.||.|++|
T Consensus 100 ~F~~~D~d~~G 110 (204)
T 1jba_A 100 TFKIYDKDRNG 110 (204)
T ss_dssp HHHHHCSSCSS
T ss_pred HHHHhCCCCCC
Confidence 99999999998
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.9e-12 Score=98.15 Aligned_cols=67 Identities=25% Similarity=0.290 Sum_probs=62.2
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+.++..+++++|+.||.|++|+|+.+|++.+++.+| ++.+++++|+..+|.|++|.|+|+||+.++.
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~ 70 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 566788899999999999999999999999999987 6789999999999999999999999999875
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-12 Score=106.92 Aligned_cols=85 Identities=25% Similarity=0.329 Sum_probs=75.5
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc---CCcHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK---LERDDHLY 460 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~---~~~~~~l~ 460 (472)
+.+++++|..+|.|++|.|+.+||..+++.+|..++.+++..++. |++|.|+|+||+.++..... ....+.++
T Consensus 4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 79 (140)
T 1ggw_A 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMPGDPEEFV 79 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSSCCHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCcccHHHHH
Confidence 467889999999999999999999999999999999999999886 88999999999998876532 22358899
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.||+|++|
T Consensus 80 ~~F~~~D~d~~G 91 (140)
T 1ggw_A 80 KGFQVFDKDATG 91 (140)
T ss_dssp HHHHTTCSSCSS
T ss_pred HHHHHhCCCCCC
Confidence 999999999998
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-12 Score=112.32 Aligned_cols=82 Identities=20% Similarity=0.455 Sum_probs=76.7
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+.++|+.+|.|++|.|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++... ..++.+|+
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~------~~~~~~F~ 166 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV------CRVRNVFA 166 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH------HHHHHHHH
Confidence 457889999999999999999999999999999999999999999999999999999999988643 68899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 167 ~~D~d~dG 174 (191)
T 1y1x_A 167 FYDRERTG 174 (191)
T ss_dssp HHCTTCCS
T ss_pred HhCcCCCc
Confidence 99999998
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-12 Score=101.73 Aligned_cols=69 Identities=23% Similarity=0.380 Sum_probs=62.8
Q ss_pred hhHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++++.++++|..|| .|++| +|+.+||+.+|+. +|..+++++++.|+..+|.|+||.|+|+||+.++..
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~ 93 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 93 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 456778999999999 89997 9999999999987 777889999999999999999999999999998764
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-12 Score=114.12 Aligned_cols=94 Identities=21% Similarity=0.307 Sum_probs=79.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHH-----HHHHHcCCCCCHH-----HHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELK-----AGLARLGSKLTEA-----EVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~-----~~l~~~~~~~~~~-----~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.+++.+++++|..+|.|++|.|+.+||. .+++.+|..++.. +++.++..+|.|++|.|+|+||+..+.
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~ 89 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWK 89 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHHH
Confidence 467788899999999999999999999999 8899999888877 689999999999999999999999765
Q ss_pred cccc-------CCcHHHHH----HHHHhhcCCCCC
Q 012039 449 HRHK-------LERDDHLY----KAFQHFDKDNSG 472 (472)
Q Consensus 449 ~~~~-------~~~~~~l~----~~F~~~D~d~~G 472 (472)
.... ....+.++ .+|+.+|+|++|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 124 (191)
T 1uhk_A 90 KLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNG 124 (191)
T ss_dssp HHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSS
T ss_pred HHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCC
Confidence 4321 11112344 999999999998
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-12 Score=95.00 Aligned_cols=70 Identities=34% Similarity=0.603 Sum_probs=65.5
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.++...++++|..+|.|++|+|+.+||+.+++.+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 71 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTE 71 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 4567788999999999999999999999999999999999999999999999999999999999998764
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=107.21 Aligned_cols=83 Identities=28% Similarity=0.446 Sum_probs=75.3
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc--cCCcHHHHHHHHH
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH--KLERDDHLYKAFQ 464 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~--~~~~~~~l~~~F~ 464 (472)
++++|..+|.|++|.|+.+||..+++.+|..++.+++..++.. |++|.|+|+||+.++.... .......++.+|+
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~ 83 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFR 83 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHH
Confidence 8899999999999999999999999999999999999999987 8899999999999887652 3345688999999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.||+|++|
T Consensus 84 ~~D~d~~G 91 (145)
T 2bl0_B 84 ALDKEGNG 91 (145)
T ss_dssp HHCSSSSS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=111.76 Aligned_cols=83 Identities=18% Similarity=0.346 Sum_probs=76.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc-C-------CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCC
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL-G-------SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLE 454 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~-------~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~ 454 (472)
++.+++++|..+| |++|.|+.+||..+++.+ | ..++.++++.++..+|.|++|.|+|+||+..+..
T Consensus 2 ~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~----- 75 (173)
T 1alv_A 2 EVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN----- 75 (173)
T ss_dssp HHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH-----
T ss_pred chhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHH-----
Confidence 5678999999999 999999999999999998 6 6788999999999999999999999999988764
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.+.++.+|+.+|+|++|
T Consensus 76 -~~~~~~~F~~~D~d~~G 92 (173)
T 1alv_A 76 -IKKWQAIYKQFDVDRSG 92 (173)
T ss_dssp -HHHHHHHHHHHCTTCCS
T ss_pred -HHHHHHHHHHHCCCCCC
Confidence 36799999999999998
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=99.31 E-value=4.1e-12 Score=124.60 Aligned_cols=95 Identities=41% Similarity=0.689 Sum_probs=83.9
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~ 456 (472)
.++.+++++++++|..+|.|++|.|+.+||..+|..++..++.++++.++..+|.|++|.|+|+||+.++..... ...+
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~~ 384 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSE 384 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------CH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccchh
Confidence 456677889999999999999999999999999999999999999999999999999999999999998875432 4456
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||+|++|
T Consensus 385 e~l~~aFk~fD~D~dG 400 (450)
T 3sg6_A 385 EEIREAFRVFDKDGNG 400 (450)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred hHHHHHHHHhCCCCCC
Confidence 7899999999999998
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.4e-12 Score=102.64 Aligned_cols=86 Identities=17% Similarity=0.233 Sum_probs=64.8
Q ss_pred hhHHhhhhhhhccccC-CCCC-cccHHHHHHHHH-HcCCC-----CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc
Q 012039 381 TEEIQGLKQMFTNIDT-DNSG-TITYEELKAGLA-RLGSK-----LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK 452 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~-~~~G-~i~~~el~~~l~-~~~~~-----~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~ 452 (472)
.+++..++++|..||. |++| +|+.+||+.+|+ .+|.. .++++++.+|..+|.|+||.|+|+||+.++....
T Consensus 8 ~~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~- 86 (113)
T 1xk4_C 8 ERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLT- 86 (113)
T ss_dssp HHHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHH-
Confidence 3456789999999995 9999 999999999999 78753 5789999999999999999999999999886432
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
......|...| +++|
T Consensus 87 ----~~~~~~f~~~~-~~~g 101 (113)
T 1xk4_C 87 ----WASHEKMHEGD-EGPG 101 (113)
T ss_dssp ----HHHHC-----------
T ss_pred ----HHHHHHHhhCC-CCCc
Confidence 34566788888 7776
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.1e-12 Score=113.10 Aligned_cols=91 Identities=27% Similarity=0.490 Sum_probs=81.6
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~~~ 456 (472)
.++.+++..++++|..+|.|++|.|+..||..+|+.+|..++..++..++..+ +|.|+|+||+.++.... .....
T Consensus 50 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~~~~ 125 (196)
T 3dtp_E 50 MFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGTDEE 125 (196)
T ss_dssp SSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSSCCH
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCCCcH
Confidence 46777888999999999999999999999999999999999999999999877 89999999999887543 34567
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.||.|++|
T Consensus 126 ~~l~~~F~~~D~d~~G 141 (196)
T 3dtp_E 126 DVIVNAFNLFDEGDGK 141 (196)
T ss_dssp HHHHHHHHTTCSSSSC
T ss_pred HHHHHHHHHHCCCCCC
Confidence 8999999999999998
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.8e-12 Score=115.13 Aligned_cols=91 Identities=23% Similarity=0.367 Sum_probs=80.3
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------ 451 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------ 451 (472)
.++.+++..++++|..+|.|++|.|+.+||..+ ..+|...+ ++.++..+|.|++|.|+|+||+.++....
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~ 97 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDED 97 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhc
Confidence 467788899999999999999999999999999 88886655 89999999999999999999999887654
Q ss_pred -----------cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 -----------KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 -----------~~~~~~~l~~~F~~~D~d~~G 472 (472)
.....+.++.+|+.||.|++|
T Consensus 98 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG 129 (202)
T 2bec_A 98 TETQDPKKPEPLNSRRNKLHYAFQLYDLDRDG 129 (202)
T ss_dssp HC-----CCCCTTSHHHHHHHHHHHHCTTCSS
T ss_pred ccccccccccccccHHHHHHHHHHHhCCCCCC
Confidence 234467899999999999998
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-12 Score=99.35 Aligned_cols=70 Identities=21% Similarity=0.310 Sum_probs=60.9
Q ss_pred hhHHhhhhhhhcccc-CCCC-CcccHHHHHHHHHH-cC----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNID-TDNS-GTITYEELKAGLAR-LG----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+..+..++++|..|| .|++ |+|+.+||+.+|+. +| ...+++++++||+.+|.|+||.|+|+||+.++...
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~ 85 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSI 85 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 445678999999998 7785 89999999999996 54 45689999999999999999999999999987643
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.6e-12 Score=111.18 Aligned_cols=94 Identities=17% Similarity=0.302 Sum_probs=80.8
Q ss_pred chhhHHhhhhhhhccc-cCCCCCcccHHHHHHHHHHcC----CCCCHHHHHHH-----------HHHhcCCCCcceeHHH
Q 012039 379 LSTEEIQGLKQMFTNI-DTDNSGTITYEELKAGLARLG----SKLTEAEVQQL-----------MEAADVDGNGTIDYIE 442 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~-D~~~~G~i~~~el~~~l~~~~----~~~~~~~~~~~-----------~~~~d~d~~g~i~~~e 442 (472)
++.++..+++++|..+ |.|++|.|+.+||..++..++ ..++..+++.+ +..+|.|++|.|+|+|
T Consensus 2 ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~E 81 (185)
T 2sas_A 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHH
Confidence 3456778899999999 999999999999999999988 78888888765 9999999999999999
Q ss_pred HHHHHhcccc---------CCcHHHHHHHHHhhcCCCCC
Q 012039 443 FITATMHRHK---------LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 443 F~~~~~~~~~---------~~~~~~l~~~F~~~D~d~~G 472 (472)
|+.++..... ...+..++.+|+.+|.|++|
T Consensus 82 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG 120 (185)
T 2sas_A 82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDG 120 (185)
T ss_dssp HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSS
T ss_pred HHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCC
Confidence 9998764421 12347899999999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=8.2e-12 Score=115.49 Aligned_cols=135 Identities=11% Similarity=0.113 Sum_probs=97.8
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC-eeEEEEEEEeCCeEEEE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-iv~~~~~~~~~~~~~lv 158 (472)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.|..+.- +++++.+....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 455544445666799999864 45778999986532 22457889999999974422 66788888888889999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG-------------------------------------- 200 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------------------------------------- 200 (472)
|||++|.+|. .. ... ...++.++...|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998883 21 112 2256677777777777643
Q ss_pred --------------------cEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 201 --------------------VMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 201 --------------------i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
++|+|++|.||++. ....+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999994 344567999998764
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.4e-12 Score=107.94 Aligned_cols=88 Identities=34% Similarity=0.587 Sum_probs=77.0
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDDHL 459 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~~l 459 (472)
++++..++++|..+|.|++|.|+.+|| ..+..++... +++.++..+|.|++|.|+|+||+.++..... ....+.+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~~~---~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 77 (155)
T 3ll8_B 2 ADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQNP---LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKL 77 (155)
T ss_dssp CHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTTCT---THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhccccch---HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHH
Confidence 467889999999999999999999999 6777777544 7889999999999999999999998876543 3556899
Q ss_pred HHHHHhhcCCCCC
Q 012039 460 YKAFQHFDKDNSG 472 (472)
Q Consensus 460 ~~~F~~~D~d~~G 472 (472)
+.+|+.+|.|++|
T Consensus 78 ~~~F~~~D~d~~G 90 (155)
T 3ll8_B 78 RFAFRIYDMDKDG 90 (155)
T ss_dssp HHHHHHHCTTCSS
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999998
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=4.6e-12 Score=96.93 Aligned_cols=69 Identities=22% Similarity=0.321 Sum_probs=59.2
Q ss_pred hhHHhhhhhhhcccc-CCCC-CcccHHHHHHHHHH-cC----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDNS-GTITYEELKAGLAR-LG----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+..++++|+.|| .|++ |+|+.+||+.+++. +| ...+++++++|++.+|.|+||.|+|+||+.++..
T Consensus 6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~ 81 (93)
T 4eto_A 6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 81 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence 345678999999998 6885 89999999999986 65 4568999999999999999999999999998764
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.29 E-value=2.9e-12 Score=110.63 Aligned_cols=84 Identities=24% Similarity=0.396 Sum_probs=75.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHH
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYK 461 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~ 461 (472)
+..+++++|..+|.|++|.|+.+||..+++.+| ..++.++++.++..+|.|++|.|+|+||+..+.. ...++.
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~------~~~~~~ 78 (172)
T 2znd_A 5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY------ITDWQN 78 (172)
T ss_dssp -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHH------HHHHHH
T ss_pred chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH------HHHHHH
Confidence 446788999999999999999999999999998 7789999999999999999999999999987753 267889
Q ss_pred HHHhhcCCCCC
Q 012039 462 AFQHFDKDNSG 472 (472)
Q Consensus 462 ~F~~~D~d~~G 472 (472)
+|+.+|+|++|
T Consensus 79 ~F~~~D~d~~G 89 (172)
T 2znd_A 79 VFRTYDRDNSG 89 (172)
T ss_dssp HHHHHCTTCSS
T ss_pred HHHHHCCCCCC
Confidence 99999999987
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.29 E-value=3.2e-12 Score=113.22 Aligned_cols=87 Identities=22% Similarity=0.297 Sum_probs=78.8
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-----KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL 453 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~ 453 (472)
.+.++++++++ |..+|.|++|.|+.+||..+++.+|. .++.++++.++..+|.|++|.|+|+||+..+...
T Consensus 27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~--- 102 (198)
T 1juo_A 27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL--- 102 (198)
T ss_dssp CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH---
T ss_pred CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH---
Confidence 44557788999 99999999999999999999999986 6789999999999999999999999999987643
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.+|+|++|
T Consensus 103 ---~~~~~~F~~~D~d~~G 118 (198)
T 1juo_A 103 ---NGWRQHFISFDTDRSG 118 (198)
T ss_dssp ---HHHHHHHHTTCTTCCS
T ss_pred ---HHHHHHHHHhCCCCCC
Confidence 6899999999999998
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=99.28 E-value=6.8e-13 Score=120.19 Aligned_cols=98 Identities=21% Similarity=0.295 Sum_probs=81.9
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHH-HHHHcCCCCCHHHHHHHHHHh---------cCCCCcceeHHHHH
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKA-GLARLGSKLTEAEVQQLMEAA---------DVDGNGTIDYIEFI 444 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~-~l~~~~~~~~~~~~~~~~~~~---------d~d~~g~i~~~eF~ 444 (472)
+...++.+++..++++|..+|.|++|.|+.+||.. +++.+|..++..++..++..+ |.|++|.|+|+||+
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~ 120 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL 120 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence 44566888899999999999999999999999998 556678887777777777777 99999999999999
Q ss_pred HHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 445 TATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 445 ~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.++........++.+..+|+.||+|++|
T Consensus 121 ~~~~~~~~~~~~~~l~~~F~~~D~d~dG 148 (226)
T 2lvv_A 121 EFRLMLCYIYDIFELTVMFDTMDKDGSL 148 (226)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSCSSCC
T ss_pred HHHHHHHhccCHHHHHHHHHHHcCCCCC
Confidence 9654333333457899999999999998
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=3.2e-12 Score=98.56 Aligned_cols=67 Identities=19% Similarity=0.274 Sum_probs=62.1
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+.++.++++++|+.||.|++|+|+.+|++.+++.+| ++++++++++..+|.|++|.|+|+||+.++.
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~ 71 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 456788899999999999999999999999999986 6789999999999999999999999998874
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.28 E-value=4.7e-12 Score=111.45 Aligned_cols=83 Identities=29% Similarity=0.417 Sum_probs=70.5
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
..+++++|..+|.|++|.|+.+||..++..+|..++.++++.++..+|.|++|.|+|+||+..+.. ...++.+|
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~------~~~~~~~F 99 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF------ILSMREGF 99 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH------HHHHHHHH
Confidence 356788899999999999999999999977778888899999999999999999999999887653 25778888
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|.|++|
T Consensus 100 ~~~D~d~~G 108 (191)
T 1y1x_A 100 RKRDSSGDG 108 (191)
T ss_dssp HHHCTTSSS
T ss_pred HHhCCCCCC
Confidence 888888887
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.6e-12 Score=97.04 Aligned_cols=70 Identities=21% Similarity=0.331 Sum_probs=62.7
Q ss_pred hhHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
.+++..++++|+.|| .|++| +|+.+||+.+++. +|..+++++++.++..+|.|+||.|+|+||+.++...
T Consensus 6 ~~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~ 82 (99)
T 2y5i_A 6 EGAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAAL 82 (99)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence 345678999999997 89998 9999999999987 6778899999999999999999999999999987643
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=99.27 E-value=3.4e-12 Score=96.55 Aligned_cols=73 Identities=18% Similarity=0.208 Sum_probs=67.3
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHH---HHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE---VQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~---~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
..++.+++.+++++|..||.|++|+|+..||..+++.+|..++.++ ++.++..+|.|++|.|+| ||+.++...
T Consensus 6 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~~ 81 (86)
T 1j7q_A 6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSKW 81 (86)
T ss_dssp CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHHH
Confidence 4466778889999999999999999999999999999999999999 999999999999999999 999887643
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=106.10 Aligned_cols=80 Identities=23% Similarity=0.428 Sum_probs=74.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++.+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+ |++|.|+|+||+.++... +.+..+|+
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~------~~~~~~F~ 141 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVKL------RALTDFFR 141 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH------HHHHHHHH
Confidence 4678899999999999999999999999999999999999999999 899999999999988654 68899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 142 ~~D~d~~G 149 (165)
T 1k94_A 142 KRDHLQQG 149 (165)
T ss_dssp TTCTTCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.26 E-value=7.9e-12 Score=89.42 Aligned_cols=64 Identities=23% Similarity=0.501 Sum_probs=60.3
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+++++|..+|.|++|.|+.+||..++..+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 65 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999999999999999987753
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=97.04 Aligned_cols=67 Identities=21% Similarity=0.342 Sum_probs=62.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++..+++++|+.||. ++|+|+.+|++.+|+.+| ++++++++|+..+|.|+||.|+|+||+.++.
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~id~~EF~~~m~ 75 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMF 75 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 356778889999999999 999999999999999987 6799999999999999999999999999875
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=99.25 E-value=6.6e-12 Score=96.71 Aligned_cols=69 Identities=23% Similarity=0.412 Sum_probs=56.7
Q ss_pred hhHHhhhhhhhcccc-CCC-CCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDN-SGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~-~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++++..++++|+.|| .|+ +|+|+.+||+.+++. +|..+++++++.|+..+|.|+||.|+|+||+.++..
T Consensus 5 ~~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~ 80 (95)
T 1j55_A 5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA 80 (95)
T ss_dssp HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 345678999999999 798 589999999999987 566778899999999999999999999999998764
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=8.5e-12 Score=95.44 Aligned_cols=72 Identities=25% Similarity=0.447 Sum_probs=65.1
Q ss_pred HhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 376 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...++.++...++++|..+|.|++|+|+.+||..+++.+| ++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 18 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~ 89 (91)
T 2pmy_A 18 GADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDADRDGAITFQEFARGFLG 89 (91)
T ss_dssp -CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEECHHHHTHHHHH
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence 3456677888999999999999999999999999999998 68999999999999999999999999987753
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.25 E-value=1e-11 Score=95.56 Aligned_cols=67 Identities=33% Similarity=0.643 Sum_probs=62.7
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+..++++++|..+|.|++|+|+.+||+.+++.+|..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~ 92 (94)
T 2kz2_A 26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 92 (94)
T ss_dssp SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 3456788999999999999999999999999999999999999999999999999999999998775
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=99.25 E-value=3.5e-12 Score=94.48 Aligned_cols=65 Identities=35% Similarity=0.634 Sum_probs=60.9
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
++++.+|..+|.|++|+|+.+||..+++.+| .++.++++.++..+|.|++|.|+|+||+.++...
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~ 67 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTDGDGFIDFNEFISFCNAN 67 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHC
Confidence 3578899999999999999999999999999 9999999999999999999999999999988754
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=109.08 Aligned_cols=94 Identities=23% Similarity=0.424 Sum_probs=81.3
Q ss_pred hchhhHHhhhhhhhccccCC--CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CC
Q 012039 378 NLSTEEIQGLKQMFTNIDTD--NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LE 454 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~ 454 (472)
.++.+++..++++|..+|.| ++|.|+.+||..++.. .....+..++.+|..+|.|++|.|+|+||+.++..... ..
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~ 108 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAP 108 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSC
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCC
Confidence 46788899999999999999 9999999999999987 33344566888999999999999999999998876543 34
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.++.++.+|+.||.|++|
T Consensus 109 ~~~~l~~~F~~~D~d~~G 126 (207)
T 2ehb_A 109 VHEKVKFAFKLYDLRQTG 126 (207)
T ss_dssp HHHHHHHHHHHHCTTCCS
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 577899999999999998
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=103.34 Aligned_cols=65 Identities=32% Similarity=0.612 Sum_probs=61.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.++++|+.||.|++|+|+.+||+.++..+|..++.++++.++..+|.|+||.|+|+||+.++..
T Consensus 83 ~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~ 147 (148)
T 2lmt_A 83 EEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ 147 (148)
T ss_dssp HHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred HHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 46889999999999999999999999999999999999999999999999999999999998764
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.25 E-value=8.4e-12 Score=106.74 Aligned_cols=90 Identities=27% Similarity=0.353 Sum_probs=74.1
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHH----HHcCCCCCHHHHHHH-----------HHHhcCCCCcceeHHHHHHHH
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGL----ARLGSKLTEAEVQQL-----------MEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l----~~~~~~~~~~~~~~~-----------~~~~d~d~~g~i~~~eF~~~~ 447 (472)
++++++++|..+|.|++|.|+.+||..++ +.+|..++..+++.+ |..+|.|++|.|+|+||+.++
T Consensus 2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~ 81 (166)
T 3akb_A 2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGA 81 (166)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTH
T ss_pred HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 35678899999999999999999999975 556988888887755 699999999999999999877
Q ss_pred hccccCCc-------HHHHHHHHHhhcCCCCC
Q 012039 448 MHRHKLER-------DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 448 ~~~~~~~~-------~~~l~~~F~~~D~d~~G 472 (472)
........ ...+..+|+.+|.|++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 113 (166)
T 3akb_A 82 VKRLRDKPDRFAEMARPFLHAALGVADTDGDG 113 (166)
T ss_dssp HHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSS
T ss_pred HHHhccCccchHHHHHHHHHHHHHHhCCCCCC
Confidence 64422111 24589999999999998
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=105.91 Aligned_cols=78 Identities=23% Similarity=0.299 Sum_probs=71.9
Q ss_pred hhhccccCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 389 QMFTNIDTDNSGTITYEELKAGLARLGS-----KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 389 ~~F~~~D~~~~G~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
+.|..+|.|++|.|+.+||..+++.+|. .++.++++.++..+|.|++|.|+|+||+..+... +.++.+|
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F 78 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQHF 78 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHH------HHHHHHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHH
Confidence 4688999999999999999999999986 6789999999999999999999999999987643 6899999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|.|++|
T Consensus 79 ~~~D~d~~G 87 (167)
T 1gjy_A 79 ISFDSDRSG 87 (167)
T ss_dssp HHHCTTCCS
T ss_pred HHhCCCCCC
Confidence 999999998
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=94.97 Aligned_cols=68 Identities=24% Similarity=0.410 Sum_probs=61.9
Q ss_pred hhHHhhhhhhhccccCCCCC---cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDTDNSG---TITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G---~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+..++++|..|| +++| +|+.+||+.+++. +|...+.++++++++.+|.|+||.|+|+||+.++..
T Consensus 5 e~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~ 80 (92)
T 3rm1_A 5 EKAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAM 80 (92)
T ss_dssp HHHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence 345678999999999 7777 9999999999999 899999999999999999999999999999998764
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=105.72 Aligned_cols=80 Identities=26% Similarity=0.500 Sum_probs=74.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+..+|+.+|.|++|.|+.+||+.++..+|..++.++++.++..+ |++|.|+|+||+.++... ..+..+|+
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~------~~~~~~F~ 143 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVKL------RALTDSFR 143 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHHH------HHHHHHHH
Confidence 4678899999999999999999999999999999999999999999 899999999999988653 68899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 144 ~~D~d~~G 151 (167)
T 1gjy_A 144 RRDSAQQG 151 (167)
T ss_dssp HHCTTCCS
T ss_pred HhCCCCCe
Confidence 99999998
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=99.25 E-value=6e-12 Score=105.41 Aligned_cols=89 Identities=17% Similarity=0.279 Sum_probs=79.3
Q ss_pred hhhHHhhhhhhhccccCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCCcHH
Q 012039 380 STEEIQGLKQMFTNIDTDN-SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLERDD 457 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~~~~ 457 (472)
..+++.+++++|..+|.|+ +|.|+.+||..+++.+|..++..++..++..+|.| |+|+||+.++.... .....+
T Consensus 9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~~~ 84 (146)
T 2qac_A 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKDNVE 84 (146)
T ss_dssp HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTCCHH
T ss_pred HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcchHH
Confidence 3456778999999999999 99999999999999999999999999999999987 99999999887543 344578
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.++.+|+.||+|++|
T Consensus 85 ~l~~~F~~~D~d~~G 99 (146)
T 2qac_A 85 ELIKMFAHFDNNCTG 99 (146)
T ss_dssp HHHHHHHTTCTTCSS
T ss_pred HHHHHHHHhCCCCCC
Confidence 999999999999998
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=99.25 E-value=9.9e-13 Score=118.50 Aligned_cols=98 Identities=19% Similarity=0.335 Sum_probs=78.9
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHH-cCCCCCHHHHHHHHHHh---------cCCCCcceeHHHHH
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-LGSKLTEAEVQQLMEAA---------DVDGNGTIDYIEFI 444 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~---------d~d~~g~i~~~eF~ 444 (472)
+...++.+++..++++|..+|.|++|.|+.+||..++.. +|..++.+++..++..+ |.|++|.|+|+||+
T Consensus 38 ~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF~ 117 (219)
T 3cs1_A 38 IPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFL 117 (219)
T ss_dssp SCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCHH
T ss_pred hcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHHH
Confidence 445677888999999999999999999999999999988 78777776776665433 34889999999999
Q ss_pred HHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 445 TATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 445 ~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
..+.........+.++.+|+.||+|++|
T Consensus 118 ~~~~~~~~~~~~~~l~~~F~~~D~d~~G 145 (219)
T 3cs1_A 118 EFRLMLCYIYDFFELTVMFDEIDASGNM 145 (219)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSSSSS
T ss_pred HHHHHHhccchHHHHHHHHHHHCCCCCC
Confidence 8764433233457899999999999988
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=99.25 E-value=5.1e-12 Score=109.16 Aligned_cols=90 Identities=24% Similarity=0.322 Sum_probs=76.4
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcC----CCCCHHH-H--------HHHHHHhcCCCCcceeHHHHHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG----SKLTEAE-V--------QQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~----~~~~~~~-~--------~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
++++.+++++|..+|.|++|.|+.+||..++..++ ..++..+ + +.++..+| ++|.|+|+||+.++
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~~~ 79 (174)
T 1q80_A 2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFINSM 79 (174)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHHHH
Confidence 45678899999999999999999999999999988 8888877 6 35778888 89999999999987
Q ss_pred hccccC-----CcHHHHHHHHHhhcCCCCC
Q 012039 448 MHRHKL-----ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 448 ~~~~~~-----~~~~~l~~~F~~~D~d~~G 472 (472)
...... .....++.+|+.+|+|++|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 109 (174)
T 1q80_A 80 KEMVKNPEAKSVVEGPLPLFFRAVDTNEDN 109 (174)
T ss_dssp HHHTTSTTCHHHHHTHHHHHHHHHCTTSSS
T ss_pred HHHcCcccHHHHHHHHHHHHHHHhCCCCCC
Confidence 655331 1246799999999999998
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=6.6e-12 Score=91.02 Aligned_cols=66 Identities=33% Similarity=0.615 Sum_probs=61.9
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+.++++|..+|.|++|+|+.+||..++..+|..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 69 (71)
T 2b1u_A 4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLA 69 (71)
T ss_dssp THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHT
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 346788999999999999999999999999999999999999999999999999999999998774
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=97.49 Aligned_cols=68 Identities=25% Similarity=0.365 Sum_probs=62.3
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++.++++++|..||.|++|+|+.+||+.+++ +..++.++++.|+..+|.|+||.|+|+||+.++.
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~ 75 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMH 75 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 3556778899999999999999999999999998 6678999999999999999999999999999875
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=111.75 Aligned_cols=81 Identities=19% Similarity=0.165 Sum_probs=73.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+| |++|.|+|+||+.++... ..++.+|+
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~l------~~~~~~F~ 189 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWIAICAFA------AQTRSAYQ 189 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH------HHHHHHHH
Confidence 56889999999999999999999999999999999999999999999 999999999999988754 47899999
Q ss_pred hh-cCCCCC
Q 012039 465 HF-DKDNSG 472 (472)
Q Consensus 465 ~~-D~d~~G 472 (472)
.+ |.+++|
T Consensus 190 ~~~D~~~~G 198 (220)
T 3sjs_A 190 MIFMNPYYG 198 (220)
T ss_dssp HHHTSGGGC
T ss_pred HhcccCCCC
Confidence 99 999987
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2.7e-12 Score=100.62 Aligned_cols=70 Identities=16% Similarity=0.279 Sum_probs=60.4
Q ss_pred hhHHhhhhhhhcccc-CCCC-CcccHHHHHHHHHH-cCCCC-CHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNID-TDNS-GTITYEELKAGLAR-LGSKL-TEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-~~~~~-~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
.+++..++++|+.|| .|++ |+|+.+||+.+|+. +|... ++++++.|+..+|.|+||.|+|+||+.++...
T Consensus 18 e~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~ 91 (106)
T 2h2k_A 18 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 91 (106)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHH
Confidence 445678999999999 7987 79999999999986 77554 35789999999999999999999999987654
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=99.24 E-value=5.1e-12 Score=97.33 Aligned_cols=69 Identities=20% Similarity=0.392 Sum_probs=62.2
Q ss_pred hhHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++++..++++|+.|| .|++| +|+.+||+.+++. +|..+++++++.++..+|.|+||.|+|+||+.++..
T Consensus 8 e~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~ 83 (95)
T 2wcb_A 8 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAI 83 (95)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 445678999999999 89998 9999999999987 667789999999999999999999999999998753
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=111.10 Aligned_cols=94 Identities=27% Similarity=0.405 Sum_probs=81.2
Q ss_pred hchhhHHhhhhhhhccccCC--CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CC
Q 012039 378 NLSTEEIQGLKQMFTNIDTD--NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LE 454 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~ 454 (472)
.++.+++.+++++|..+|.| ++|.|+.+||..++.. .....+..++.+|..+|.|++|.|+|+||+.++..... ..
T Consensus 41 ~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~ 119 (226)
T 2zfd_A 41 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAP 119 (226)
T ss_dssp SCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSC
T ss_pred CCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCC
Confidence 56788899999999999999 9999999999999987 33334556788999999999999999999998876542 34
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.++.++.+|+.||.|++|
T Consensus 120 ~~~~l~~~F~~~D~d~~G 137 (226)
T 2zfd_A 120 IDDKIHFSFQLYDLKQQG 137 (226)
T ss_dssp HHHHHHHHHHHHCTTSSS
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 577899999999999998
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=106.28 Aligned_cols=78 Identities=19% Similarity=0.296 Sum_probs=71.5
Q ss_pred hhhccccCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 389 QMFTNIDTDNSGTITYEELKAGLARLGS-----KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 389 ~~F~~~D~~~~G~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
+.|..+|.|++|.|+.+||..+++.+|. .++.++++.++..+|.|++|.|+|+||+.++... +.++.+|
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F 76 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENF 76 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHH
Confidence 4688999999999999999999999986 6789999999999999999999999999877543 6899999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|+|++|
T Consensus 77 ~~~D~d~~G 85 (165)
T 1k94_A 77 MTVDQDGSG 85 (165)
T ss_dssp HHHCTTCCS
T ss_pred HHhCCCCCc
Confidence 999999998
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.23 E-value=2.6e-11 Score=107.26 Aligned_cols=80 Identities=29% Similarity=0.521 Sum_probs=74.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++++|+.+|.|++|.|+.+||+.++..+|..++.++++.++..+ |++|.|+|+||+..+... +.+..+|+
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~------~~~~~~F~ 174 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKL------RALTDSFR 174 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH------HHHHHHHH
Confidence 4688999999999999999999999999999999999999999999 899999999999988654 67899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 175 ~~D~d~~G 182 (198)
T 1juo_A 175 RRDTAQQG 182 (198)
T ss_dssp HTCTTCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=99.23 E-value=1.8e-11 Score=104.14 Aligned_cols=68 Identities=24% Similarity=0.480 Sum_probs=62.6
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcC--CCCcceeHHHHHHHHhcc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV--DGNGTIDYIEFITATMHR 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~--d~~g~i~~~eF~~~~~~~ 450 (472)
..+.++++|+.||.|++|+|+.+||+.+|+.+|..+++++++.|++.+|. |++|.|+|+||+.+++..
T Consensus 83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~~ 152 (159)
T 3i5g_C 83 AADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMAG 152 (159)
T ss_dssp CHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHCC
Confidence 34568899999999999999999999999999999999999999999995 889999999999988754
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=105.82 Aligned_cols=93 Identities=24% Similarity=0.315 Sum_probs=78.6
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++.+++..+.++|..+ |++|.|+.+||..++..++.. .+..+++.+|..+|.|++|.|+|+||+.++........+
T Consensus 14 ~~s~~~i~~l~~~fd~~--d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~ 91 (183)
T 1s6c_A 14 NFTKRELQVLYRGFKNE--XPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVH 91 (183)
T ss_dssp SCCHHHHHHHHHHHHHH--CTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHH
T ss_pred CCCHHHHHHHHHHHHHh--CCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHH
Confidence 45666666655555443 799999999999999999865 789999999999999999999999999988765445567
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.+|.|++|
T Consensus 92 ~~~~~~f~~~D~d~~G 107 (183)
T 1s6c_A 92 EKLRWTFNLYDINKDG 107 (183)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 8999999999999998
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.22 E-value=4.7e-12 Score=117.24 Aligned_cols=95 Identities=19% Similarity=0.334 Sum_probs=82.7
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCH------HHHHHHHHHhcCCCCcceeHHHHHHHHhcc-
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTE------AEVQQLMEAADVDGNGTIDYIEFITATMHR- 450 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~------~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~- 450 (472)
.++..+..+++++|..+|.|++|.|+.+||..+++.+|..++. .+++.++..+|.|++|.|+|+||+..+...
T Consensus 9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~~~ 88 (263)
T 2f33_A 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPTEE 88 (263)
T ss_dssp TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTTSCT
T ss_pred hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhhh
Confidence 4566677889999999999999999999999999998765554 789999999999999999999999987543
Q ss_pred --------ccCCcHHHHHHHHHhhcCCCCC
Q 012039 451 --------HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 451 --------~~~~~~~~l~~~F~~~D~d~~G 472 (472)
......+.++.+|+.||.|++|
T Consensus 89 ~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 118 (263)
T 2f33_A 89 NFLLLFRCQQLKSCEEFMKTWRKYDTDHSG 118 (263)
T ss_dssp THHHHHGGGTSSCHHHHHHHHTTSSTTTCS
T ss_pred hHHHHHHHhhccHHHHHHHHHHHHCCCCCC
Confidence 3355678899999999999998
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.9e-12 Score=96.41 Aligned_cols=72 Identities=67% Similarity=0.994 Sum_probs=65.4
Q ss_pred HhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 376 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
...++.+++..++++|..+|.|++|+|+..||+.+++.+|..++.++++.++..+|.|++|.|+|+||+.++
T Consensus 14 ~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~ 85 (87)
T 1s6j_A 14 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAAT 85 (87)
T ss_dssp SSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred HHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 334556667789999999999999999999999999999999999999999999999999999999998654
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.6e-11 Score=106.48 Aligned_cols=68 Identities=32% Similarity=0.500 Sum_probs=63.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH 451 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~ 451 (472)
..+.++++|+.||.|++|+|+.+||+.+|..+|..+++++++.|++.+| |+||.|+|+||+.++....
T Consensus 82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k~~ 149 (176)
T 2lhi_A 82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSKGS 149 (176)
T ss_dssp HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTCCS
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHhcC
Confidence 3457889999999999999999999999999999999999999999999 9999999999999987543
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=8.4e-12 Score=96.79 Aligned_cols=65 Identities=22% Similarity=0.360 Sum_probs=60.2
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++++++|+.+|.|++|+|+.+|++.+++.+| ++++++++|+..+|.|++|.|+|+||+.++.
T Consensus 8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~ 72 (99)
T 1qjt_A 8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 4567789999999999999999999999999986 6799999999999999999999999999875
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-12 Score=101.26 Aligned_cols=68 Identities=22% Similarity=0.273 Sum_probs=61.8
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++..+++++|+.||.|++|+|+.+||+.+++.+| ++++++++|+..+|.|++|.|+|+||+.++.
T Consensus 16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~I~~~EF~~~m~ 83 (110)
T 1iq3_A 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 3566778899999999999999999999999998886 5678899999999999999999999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=5.3e-11 Score=115.62 Aligned_cols=142 Identities=22% Similarity=0.375 Sum_probs=104.9
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEec--ccccCCcccHHHHHHHHHHHHhccC-CCCeeEEEEEEEeC---CeEEE
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSIS--KRKLVTKNDKDDIKREIQIMQHLSG-QPNIVEFKGAYEDK---QSVHV 157 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~---~~~~l 157 (472)
.+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+++++.++.+. +..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 567899999999998754 4688899765 3221 1224568899999999963 34578888888776 45899
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF--------------------------------------- 198 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 198 (472)
||||++|.++.+.. ...++......++.++...|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998875421 2346788888999999999999997
Q ss_pred -------------------cCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 199 -------------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 199 -------------------~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
..++|||+++.||++..++. ..+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 35899999999999964322 3468999998764
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.20 E-value=3e-11 Score=106.01 Aligned_cols=88 Identities=31% Similarity=0.376 Sum_probs=77.8
Q ss_pred hhhhhhhccccCC-CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 385 QGLKQMFTNIDTD-NSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 385 ~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
.++.++|..+|.| ++|.|+.+||..++..++.. .+.++++.+|..+|.|++|.|+++||+.++........++.+..+
T Consensus 25 ~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~ 104 (190)
T 2l2e_A 25 KELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWA 104 (190)
T ss_dssp HHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHH
Confidence 3567789999999 89999999999999998654 566789999999999999999999999988766555678899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 105 f~~~D~d~~G 114 (190)
T 2l2e_A 105 FQLYDLDNNG 114 (190)
T ss_dssp HHHHCTTSCS
T ss_pred HhHccCCCCC
Confidence 9999999998
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=99.20 E-value=3.2e-11 Score=93.49 Aligned_cols=70 Identities=16% Similarity=0.202 Sum_probs=59.5
Q ss_pred hhHHhhhhhhhccccCCC---CCcccHHHHHHHHHHcC-CCCC----HHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNIDTDN---SGTITYEELKAGLARLG-SKLT----EAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~---~G~i~~~el~~~l~~~~-~~~~----~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+..+..++++|..||.++ +|+|+.+||+.+|+.++ ..++ +++++.|++.+|.|+||.|+|+||+.++...
T Consensus 7 e~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~ 84 (100)
T 3nxa_A 7 EKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGI 84 (100)
T ss_dssp HHHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 345678999999999964 79999999999998753 3333 6889999999999999999999999988654
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-11 Score=109.68 Aligned_cols=88 Identities=26% Similarity=0.355 Sum_probs=77.3
Q ss_pred hhhhhhhccccCC-CCCcccHHHHHHHHHHcCCCCCH-HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 385 QGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTE-AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 385 ~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
++++++|..||.+ ++|.|+.+||..+++.+|...+. ++++.+|..+|.|++|.|+|+||+.++........++.++.+
T Consensus 14 ~el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~ 93 (198)
T 2r2i_A 14 TECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWY 93 (198)
T ss_dssp SCHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHH
Confidence 4567889999988 89999999999999999876654 559999999999999999999999988765555567899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.||.|++|
T Consensus 94 F~~~D~d~~G 103 (198)
T 2r2i_A 94 FKLYDVDGNG 103 (198)
T ss_dssp HHHHCTTCSS
T ss_pred HHHhcCCCCC
Confidence 9999999998
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=5.3e-11 Score=93.99 Aligned_cols=70 Identities=23% Similarity=0.458 Sum_probs=65.9
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
.++...++.+|..+|.|++|+|+.+||..+++.+|..++.++++.++..+|.|++|.|+|+||+.++...
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~~~~~~~ 97 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSSGSGETFSYPDFLRMMLGK 97 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHc
Confidence 5677889999999999999999999999999999999999999999999999999999999999988654
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-11 Score=110.99 Aligned_cols=88 Identities=24% Similarity=0.357 Sum_probs=73.8
Q ss_pred hhhhhhhccccCC-CCCcccHHHHHHHHHHcCCCCCH-HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 385 QGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTE-AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 385 ~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
++++++|..||.+ ++|.|+.+||..+++.++...+. ++++.+|..+|.|++|.|+|+||+.++........++.++.+
T Consensus 19 ~ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~ 98 (211)
T 2ggz_A 19 QETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWY 98 (211)
T ss_dssp -----CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHH
Confidence 4567899999998 89999999999999999876544 569999999999999999999999988765445567899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.||.|++|
T Consensus 99 F~~~D~d~~G 108 (211)
T 2ggz_A 99 FKLYDADGNG 108 (211)
T ss_dssp HHHHCTTCSS
T ss_pred HHHhcCCCCC
Confidence 9999999998
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.2e-11 Score=113.32 Aligned_cols=94 Identities=26% Similarity=0.444 Sum_probs=80.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHH----HcCC--CCCHHHHHHHH----HHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLA----RLGS--KLTEAEVQQLM----EAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~----~~~~--~~~~~~~~~~~----~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++..+..+++++|..+|.|++|.|+.+||..+++ .+|. .++.+++..++ ..+|.|++|.|+|+||+.++.
T Consensus 5 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~ 84 (272)
T 2be4_A 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMIL 84 (272)
T ss_dssp CCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHHS
T ss_pred HHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHHh
Confidence 3455667899999999999999999999999999 8998 89998887754 778999999999999999843
Q ss_pred -----------ccccCCcHHHHHHHHHhhcCCCCC
Q 012039 449 -----------HRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 449 -----------~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
........+.++.+|+.||.|++|
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 119 (272)
T 2be4_A 85 PQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSG 119 (272)
T ss_dssp CHHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCCS
T ss_pred hhhHHHHHHHhhccCcccHHHHHHHHHHhCCCCCC
Confidence 222245678899999999999998
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.8e-11 Score=98.10 Aligned_cols=64 Identities=23% Similarity=0.350 Sum_probs=59.5
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++..+++++|+.|| |++|+|+.+|++.+|++++ ++++++++|+..+|.|+||.|+|+||+.++.
T Consensus 48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~d~dG~Ld~~EF~~am~ 111 (139)
T 2jq6_A 48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADVDKDGLLDDEEFALANH 111 (139)
T ss_dssp GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCSSCCSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 45678999999999 9999999999999999977 7899999999999999999999999999875
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.5e-11 Score=104.65 Aligned_cols=90 Identities=23% Similarity=0.359 Sum_probs=79.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-------cCCc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-------KLER 455 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-------~~~~ 455 (472)
....+..+|..+|.|++|.|+..||..++..++...+.+++..+|..+|.|++|.|+++||..++.... ....
T Consensus 50 ~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~ 129 (198)
T 2r2i_A 50 ANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTA 129 (198)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCH
T ss_pred hHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhH
Confidence 345588899999999999999999999999999888889999999999999999999999999887542 2334
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
++.+..+|+.+|.|++|
T Consensus 130 ~~~~~~~f~~~D~d~dG 146 (198)
T 2r2i_A 130 EEFTNMVFDKIDINGDG 146 (198)
T ss_dssp HHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 56699999999999998
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.7e-12 Score=88.97 Aligned_cols=63 Identities=32% Similarity=0.495 Sum_probs=58.9
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++++|..+|.|++|+|+.+||..+++.+|...+.++++.++..+|.|++|.|+|+||+.++..
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 64 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGS 64 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 567899999999999999999999999998888999999999999999999999999988754
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-11 Score=109.09 Aligned_cols=91 Identities=22% Similarity=0.392 Sum_probs=77.1
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC----
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL---- 453 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~---- 453 (472)
.++.+++..++++|..+|.|++|+|+.+||..++ .+|...+. +.++..+|.|++|.|+|+||+..+......
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~---~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~~ 97 (208)
T 2ct9_A 22 GFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLG---DRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDNE 97 (208)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTH---HHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC---
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcH---HHHHHHHcCCCCCcCcHHHHHHHHHhhccccchh
Confidence 4677888999999999999999999999999864 67766654 467888999999999999999988754321
Q ss_pred ------------CcHHHHHHHHHhhcCCCCC
Q 012039 454 ------------ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ------------~~~~~l~~~F~~~D~d~~G 472 (472)
...+.++.+|+.||+|++|
T Consensus 98 ~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG 128 (208)
T 2ct9_A 98 KSKDVNGPEPLNSRSNKLHFAFRLYDLDKDD 128 (208)
T ss_dssp --------CCTTSHHHHHHHHHHHHCTTCSS
T ss_pred hhcccccccccccHHHHHHHHHHHHCCCCCC
Confidence 1567899999999999998
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=99.17 E-value=1.8e-11 Score=103.46 Aligned_cols=66 Identities=21% Similarity=0.394 Sum_probs=61.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
.+.++++|+.||.|++|+|+.+||+.+|..+|..+++++++.|+..+|.| ||.|+|+||+.++...
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~~ 149 (153)
T 3i5g_B 84 EDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGKA 149 (153)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHCS
T ss_pred HHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcCC
Confidence 35788999999999999999999999999999999999999999999988 9999999999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=7.3e-11 Score=111.88 Aligned_cols=182 Identities=15% Similarity=0.222 Sum_probs=123.9
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCC--eeEEEEEEEeCC---eEEEE
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN--IVEFKGAYEDKQ---SVHVV 158 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~--iv~~~~~~~~~~---~~~lv 158 (472)
++.++.|.+..||++. ..+++|+.... .....+.+|+.+++.|..+.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999863 46889975421 235678999999999853433 445555543333 34789
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF---------------------------------------- 198 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------- 198 (472)
|++++|.+|.+... ..++..+...++.++...|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998875433 346777888888888888888886
Q ss_pred ------------------cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcceeeccCCCCC---Cchhhhh--
Q 012039 199 ------------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY---VAPEVLR-- 255 (472)
Q Consensus 199 ------------------~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y---~aPE~~~-- 255 (472)
..++|+|++|.||++..+ ....+.|+||+.+..-...... .....+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHHH
Confidence 136999999999999632 1456789999998764332111 111111 3343321
Q ss_pred -cccCC------------ccchhhHHHHHHHHhhCCCCC
Q 012039 256 -RRYGK------------EIDIWSAGVILYILLSGVPPF 281 (472)
Q Consensus 256 -~~~~~------------~~DiwslG~il~~ll~g~~pf 281 (472)
..|.. ..+.|++|.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12222 258999999999999998776
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.5e-11 Score=105.54 Aligned_cols=88 Identities=22% Similarity=0.283 Sum_probs=75.3
Q ss_pred hhhhhhhccccCC-CCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 385 QGLKQMFTNIDTD-NSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 385 ~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
.++.++|..||.+ ++|.|+.+||..++..++ ...+..+++.+|..+|.|++|.|+++||+.++........++.++.+
T Consensus 25 ~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 104 (190)
T 1g8i_A 25 KEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWA 104 (190)
T ss_dssp HHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHH
Confidence 3456678888887 899999999999999983 34567889999999999999999999999988765444567899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 105 f~~~D~d~~G 114 (190)
T 1g8i_A 105 FKLYDLDNDG 114 (190)
T ss_dssp HHHHCTTCSS
T ss_pred HHhhcCCCCC
Confidence 9999999998
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.5e-11 Score=91.67 Aligned_cols=68 Identities=37% Similarity=0.607 Sum_probs=62.6
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+....++ +|..+|.|++|+|+.+||..+++.+| ..++.++++.++..+|.|++|.|+|+||+.++...
T Consensus 6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 74 (81)
T 1c7v_A 6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKS 74 (81)
T ss_dssp -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC
T ss_pred cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhh
Confidence 4456788 99999999999999999999999999 99999999999999999999999999999988654
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2.4e-11 Score=92.99 Aligned_cols=68 Identities=22% Similarity=0.418 Sum_probs=60.6
Q ss_pred hhHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH---cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+++..++++|..|| .|++| +|+.+||+.+++. +|. +++++++.++..+|.|++|.|+|+||+.++..
T Consensus 6 ~~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~~~ 78 (92)
T 2kax_A 6 EKALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKNSDQEIDFKEYSVFLTM 78 (92)
T ss_dssp HHHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 345678999999999 99999 9999999999997 334 78889999999999999999999999998754
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.16 E-value=9.2e-11 Score=102.79 Aligned_cols=87 Identities=25% Similarity=0.366 Sum_probs=77.8
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------cC
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------KL 453 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------~~ 453 (472)
.+..+|..+|.|++|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++.... ..
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~ 143 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEA 143 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCC
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccc
Confidence 477899999999999999999999999999888899999999999999999999999999886521 12
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
..++.+..+|+.+|.|++|
T Consensus 144 ~~~~~~~~~f~~~D~d~dG 162 (190)
T 1fpw_A 144 TPEMRVKKIFKLMDKNEDG 162 (190)
T ss_dssp CHHHHHHHHHHHHTTTCSS
T ss_pred hHHHHHHHHHHHhCCCCCC
Confidence 4567899999999999998
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.15 E-value=9.7e-11 Score=101.74 Aligned_cols=96 Identities=13% Similarity=0.184 Sum_probs=78.5
Q ss_pred HHHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhc---CCCCcceeHHHHHHHHh
Q 012039 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD---VDGNGTIDYIEFITATM 448 (472)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d---~d~~g~i~~~eF~~~~~ 448 (472)
+.++......+++.+++++|..+| ++|.|+.+||..++ |...+.++++.++..+| .+++|.|+|+||+.++.
T Consensus 15 l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~~~ 89 (179)
T 3a8r_A 15 LQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GMDGSDEFAVQMFDSLARKRGIVKQVLTKDELKDFYE 89 (179)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TCCSCHHHHHHHHHHHHHHHTCCSSEECHHHHHHHHH
T ss_pred HHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CCCCcHHHHHHHHHHHHHhccCCCCCcCHHHHHHHHH
Confidence 445555545566788999999999 89999999999864 77788888999998887 57789999999998765
Q ss_pred ccccCCcHHHHHHHHHhhcCCCCC
Q 012039 449 HRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 449 ~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.......++.++.+|+.||+|++|
T Consensus 90 ~~~~~~~~~~l~~~F~~~D~d~dG 113 (179)
T 3a8r_A 90 QLTDQGFDNRLRTFFDMVDKNADG 113 (179)
T ss_dssp HHHCCCHHHHHHHHHHHHCTTCSS
T ss_pred HHcCCCHHHHHHHHHHHHCCCCCC
Confidence 543345678999999999999998
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.15 E-value=9.2e-11 Score=108.44 Aligned_cols=90 Identities=23% Similarity=0.384 Sum_probs=78.6
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc----CCCCCHHHHHH----HHHHhcCCCCcceeHHHHHHHHhcc----
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL----GSKLTEAEVQQ----LMEAADVDGNGTIDYIEFITATMHR---- 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~----~~~~~d~d~~g~i~~~eF~~~~~~~---- 450 (472)
....++++|..+|.|++|+|+.+||..++..+ |..++.+++.. ++..+|.|++|.|+|+||+.++...
T Consensus 101 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~ 180 (263)
T 2f33_A 101 SCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFL 180 (263)
T ss_dssp CHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCSH
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999988 88999988877 9999999999999999999877531
Q ss_pred ----ccCCcHHHHHHHHHhhcCCCCC
Q 012039 451 ----HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 451 ----~~~~~~~~l~~~F~~~D~d~~G 472 (472)
......+.+..+|+.||+|++|
T Consensus 181 ~~~~~~~~~~~~~~~~F~~~D~d~~G 206 (263)
T 2f33_A 181 LKFQGIKMCGKEFNKAFELYDQDGNG 206 (263)
T ss_dssp HHHHHTCCCHHHHHHHHHHHCCSSSS
T ss_pred HHhcCcchHHHHHHHHHHHhCCCCCC
Confidence 1235568899999999999998
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=8e-11 Score=101.67 Aligned_cols=72 Identities=21% Similarity=0.245 Sum_probs=56.9
Q ss_pred ccCCCCCcccHHHHHHHHHHc------CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhc
Q 012039 394 IDTDNSGTITYEELKAGLARL------GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467 (472)
Q Consensus 394 ~D~~~~G~i~~~el~~~l~~~------~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D 467 (472)
-+.|++|+|+.+||+.+|+.+ |..++.++++.++..+|.|++|.|+|+||+.++... ..++.+|+.||
T Consensus 13 ~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~l~~aF~~fD 86 (174)
T 2i7a_A 13 GLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRL------VHYQHVFQKVQ 86 (174)
T ss_dssp CSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHHH------HHHHHHHHHHC
T ss_pred ccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHhc
Confidence 467888888888888888887 567788888888888888888888888888776532 56888888888
Q ss_pred CCCCC
Q 012039 468 KDNSG 472 (472)
Q Consensus 468 ~d~~G 472 (472)
|++|
T Consensus 87 -d~~G 90 (174)
T 2i7a_A 87 -TSPG 90 (174)
T ss_dssp -SBTT
T ss_pred -CCCC
Confidence 8887
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4e-11 Score=106.77 Aligned_cols=88 Identities=23% Similarity=0.340 Sum_probs=77.0
Q ss_pred hhhhhhhccccCC-CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 385 QGLKQMFTNIDTD-NSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 385 ~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
.++.++|..||.+ ++|.|+.+||..++..++.. .+..++..+|..+|.|++|.|+|+||+.++........++.++.+
T Consensus 33 ~~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~ 112 (207)
T 2d8n_A 33 EELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWA 112 (207)
T ss_dssp HHHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHH
T ss_pred HHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHH
Confidence 3566778888888 79999999999999999864 788999999999999999999999999988765444566789999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 113 f~~~D~d~~G 122 (207)
T 2d8n_A 113 FSLYDVDGNG 122 (207)
T ss_dssp HHHHCTTCSS
T ss_pred HHHhcCCCCC
Confidence 9999999998
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.15 E-value=4.8e-11 Score=104.90 Aligned_cols=87 Identities=25% Similarity=0.383 Sum_probs=76.0
Q ss_pred hhhhhhccccCC-CCCcccHHHHHHHHHHcCCCC-CHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 386 GLKQMFTNIDTD-NSGTITYEELKAGLARLGSKL-TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 386 ~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
++.++|..||.+ ++|.|+.+||..++..++... +..+++.+|..+|.|++|.|+|.||+.++........++.+..+|
T Consensus 26 ~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f 105 (193)
T 1bjf_A 26 EIQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAF 105 (193)
T ss_dssp HHHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHH
Confidence 456678888988 899999999999999988654 467799999999999999999999999887655556678999999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|.|++|
T Consensus 106 ~~~D~d~~G 114 (193)
T 1bjf_A 106 SMYDLDGNG 114 (193)
T ss_dssp HHHCTTCSS
T ss_pred hhcCCCCCC
Confidence 999999998
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.14 E-value=1e-10 Score=105.54 Aligned_cols=92 Identities=23% Similarity=0.291 Sum_probs=76.9
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHH
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~ 457 (472)
++.+++..+.+.|... |++|.|+.+||..++..++.. .+..+++.+|+.+|.|++|.|+|+||+.++........++
T Consensus 48 ~s~~ei~~l~~~Fd~~--d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~ 125 (224)
T 1s1e_A 48 FTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHE 125 (224)
T ss_dssp CCHHHHHHHHHHHHHH--CTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHH
T ss_pred CCHHHHHHHHHHHHhh--CCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHH
Confidence 5666665555554433 489999999999999999854 7899999999999999999999999999887654455678
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.++.+|+.||.|++|
T Consensus 126 ~l~~~F~~~D~d~dG 140 (224)
T 1s1e_A 126 KLRWTFNLYDINKDG 140 (224)
T ss_dssp HHHHHHHHHCTTCCS
T ss_pred HHHHHHHHHcCCCCC
Confidence 999999999999998
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=99.13 E-value=8.5e-11 Score=92.41 Aligned_cols=68 Identities=26% Similarity=0.407 Sum_probs=62.5
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
....++++|..||.|++|+|+..||+.+++.+|..++.++++.++..+|.|++|.|+|+||+.++...
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~~eF~~~~~~~ 89 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRFSSE 89 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHHC--
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcc
Confidence 34678899999999999999999999999999999999999999999999999999999999988643
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=6.4e-11 Score=103.25 Aligned_cols=91 Identities=18% Similarity=0.245 Sum_probs=78.2
Q ss_pred hchhhHHhhhhhhhccccC-----CC-C--CcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcc-eeHHHHHHHHh
Q 012039 378 NLSTEEIQGLKQMFTNIDT-----DN-S--GTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT-IDYIEFITATM 448 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~-----~~-~--G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~-i~~~eF~~~~~ 448 (472)
.++.+++..++++|..+|. |+ + |.|+.+||.. +..+|..++.+ .++..+|.|++|. |+|+||+.++.
T Consensus 13 ~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~~~~~---~l~~~~D~d~~G~~I~~~EF~~~~~ 88 (183)
T 1dgu_A 13 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKE---RICRVFSTSPAKDSLSFEDFLDLLS 88 (183)
T ss_dssp SCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSCTTHH---HHHHHHSCSSSSCCCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcCcHHH---HHHHHhCCCCCCCEecHHHHHHHHH
Confidence 3567788899999999999 68 8 9999999999 99999887765 5777789999999 99999999887
Q ss_pred ccccC-CcHHHHHHHHHhhcCCCCC
Q 012039 449 HRHKL-ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 449 ~~~~~-~~~~~l~~~F~~~D~d~~G 472 (472)
..... ..++.++.+|+.||.|++|
T Consensus 89 ~~~~~~~~~~~l~~~F~~~D~d~~G 113 (183)
T 1dgu_A 89 VFSDTATPDIKSHYAFRIFDFDDDG 113 (183)
T ss_dssp HHSTTCCHHHHHHHHHHHHCTTCSS
T ss_pred HhcCCCCHHHHHHHHHHHhCCCCCC
Confidence 55433 3456899999999999998
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=99.13 E-value=5.2e-11 Score=91.38 Aligned_cols=69 Identities=22% Similarity=0.412 Sum_probs=63.4
Q ss_pred hhHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+++..++++|..+| .|++| +|+.+||+.+++. +|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 5 ~~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 80 (93)
T 1k2h_A 5 ETAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (93)
T ss_dssp HHHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 345678999999999 79999 9999999999998 999999999999999999999999999999998754
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2.3e-11 Score=89.38 Aligned_cols=66 Identities=24% Similarity=0.466 Sum_probs=61.5
Q ss_pred Hhhhhhhhccc-cCCCC-CcccHHHHHHHHHHcCCCC--CHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNI-DTDNS-GTITYEELKAGLARLGSKL--TEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~~~~~~--~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+.++++|..+ |.|++ |+|+..||..+++.+|..+ +.++++.++..+|.|++|.|+|+||+.++..
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~ 73 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK 73 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 45688999999 99999 9999999999999999888 8999999999999999999999999988754
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.9e-11 Score=91.64 Aligned_cols=67 Identities=27% Similarity=0.448 Sum_probs=61.2
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcC--CCCCHHHHHH----HHHHhcCCCCcceeHHHHHHHHh
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG--SKLTEAEVQQ----LMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~--~~~~~~~~~~----~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.+.+..+|..+|.|++|+|+.+||..++..+| ..++.++++. ++..+|.|++|.|+|+||+..+.
T Consensus 4 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~eF~~~~~ 76 (83)
T 1yx7_A 4 KVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKISKEEFLNANA 76 (83)
T ss_dssp CSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHHHHHHHHH
T ss_pred cHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHHHHHHhhH
Confidence 4456789999999999999999999999999999 8888889999 99999999999999999997654
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.12 E-value=2e-10 Score=95.83 Aligned_cols=65 Identities=31% Similarity=0.574 Sum_probs=61.2
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+.++|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~ 142 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMK 142 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 45688999999999999999999999999999999999999999999999999999999998763
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.5e-10 Score=103.38 Aligned_cols=90 Identities=23% Similarity=0.425 Sum_probs=78.8
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------cCCcH
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------KLERD 456 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------~~~~~ 456 (472)
....+.++|..+|.|++|.|+.+||..++..++...+.+++..+|+.+|.|++|.|+++||..++.... ....+
T Consensus 55 ~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~ 134 (211)
T 2ggz_A 55 ANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPE 134 (211)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHH
T ss_pred hHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHH
Confidence 345678899999999999999999999999998878889999999999999999999999999887542 23345
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.+|.|++|
T Consensus 135 ~~~~~~f~~~D~d~dG 150 (211)
T 2ggz_A 135 EFINLVFHKIDINNDG 150 (211)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 6799999999999998
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.11 E-value=8.9e-11 Score=92.97 Aligned_cols=66 Identities=35% Similarity=0.486 Sum_probs=61.6
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+.++.+|+.+|.|++|+|+.+||+.++..+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (109)
T 5pal_A 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVA 107 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 34568899999999999999999999999999 8999999999999999999999999999998775
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.8e-10 Score=101.00 Aligned_cols=88 Identities=22% Similarity=0.326 Sum_probs=78.4
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc------------cc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR------------HK 452 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~------------~~ 452 (472)
..+..+|..+|.|++|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++... ..
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~ 142 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDE 142 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCccccc
Confidence 457789999999999999999999999999988899999999999999999999999999987652 11
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
...++.+..+|+.+|.|++|
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG 162 (190)
T 2l2e_A 143 DTPEKRVNKIFNMMDKNKDG 162 (190)
T ss_dssp CCTHHHHHHHHHHHTCCSSC
T ss_pred ccHHHHHHHHHHHhCCCCCC
Confidence 24578899999999999998
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=99.10 E-value=2.1e-11 Score=94.86 Aligned_cols=68 Identities=21% Similarity=0.313 Sum_probs=60.1
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHH-----cCC--CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-----LGS--KLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-----~~~--~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+++..++++|+.||.+ +|+|+.+||+.+++. +|. .+++++++.|++.+|.|+||.|+|+||+.++..
T Consensus 6 ~~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~~ 80 (100)
T 1psr_A 6 ERSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGD 80 (100)
T ss_dssp HHHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 45677899999999976 799999999999987 555 677889999999999999999999999998764
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.6e-10 Score=104.63 Aligned_cols=93 Identities=24% Similarity=0.321 Sum_probs=79.4
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL-GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++.+++..+++.|.. .|++|.|+.+||..++..+ +...+...++.+|..+|.|++|.|+|+||+.++........+
T Consensus 60 ~~s~~ei~~l~~~F~~--~d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~ 137 (229)
T 3dd4_A 60 KFTKKELQILYRGFKN--ECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQ 137 (229)
T ss_dssp HHHHHHHHHHHHHHHT--TCCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHH
T ss_pred CCCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChH
Confidence 3566778888888866 5788999999999999996 455667889999999999999999999999988765555667
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||+|++|
T Consensus 138 ~~l~~~F~~~D~d~dG 153 (229)
T 3dd4_A 138 EKLNWAFNLYDINKDG 153 (229)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 8999999999999998
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=99.09 E-value=4.6e-11 Score=92.11 Aligned_cols=68 Identities=16% Similarity=0.333 Sum_probs=59.8
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+++..++++|..||. ++|+|+.+||+.+++. +|..+++++++.|+..+|.|+||.|+|+||+.++..
T Consensus 5 ~~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~~ 77 (96)
T 1a4p_A 5 EHAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAG 77 (96)
T ss_dssp HHHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 3456789999999993 5679999999999987 566788899999999999999999999999998764
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=102.00 Aligned_cols=95 Identities=19% Similarity=0.285 Sum_probs=62.1
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc------CCCCCHHHHHHH-------------------------
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL------GSKLTEAEVQQL------------------------- 426 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~------~~~~~~~~~~~~------------------------- 426 (472)
.++.+++.+++++|..+|.|++|+|+.+||..+++.+ |..++.++++.+
T Consensus 7 ~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~~E 86 (186)
T 2hps_A 7 SERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAVNAT 86 (186)
T ss_dssp HHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHHHH
T ss_pred cccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccHHH
Confidence 3455566677777777777777777777777777654 433333333322
Q ss_pred ---------------------HHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 427 ---------------------MEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 427 ---------------------~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
...+|.|++|.|+++||..++.......+++.+..+|+.+|.|++|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG 153 (186)
T 2hps_A 87 DSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNG 153 (186)
T ss_dssp HHHHHCCTHHHHHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSS
T ss_pred HHHHHhcCChHHHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCC
Confidence 2455777778888888877765544345667778888888887776
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=91.55 Aligned_cols=67 Identities=34% Similarity=0.498 Sum_probs=62.0
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.....++++|+.+|.|++|+|+.+||+.++..+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (109)
T 1rwy_A 38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107 (109)
T ss_dssp SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 345678899999999999999999999999999 7889999999999999999999999999998764
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=99.09 E-value=3.3e-11 Score=92.54 Aligned_cols=68 Identities=10% Similarity=0.299 Sum_probs=61.0
Q ss_pred hHHhhhhhhhccccC-CCCC-cccHHHHHHHH-HHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDT-DNSG-TITYEELKAGL-ARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~-~~~G-~i~~~el~~~l-~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.+..++++|..||. |++| +|+.+||+.++ +.+|..++..+++.++..+|.|++|.|+|+||+.++..
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~ 77 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIK 77 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 456678999999999 9999 99999999999 78886666678999999999999999999999988754
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-10 Score=92.06 Aligned_cols=66 Identities=35% Similarity=0.486 Sum_probs=61.4
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....++.+|+.+|.|++|+|+.+||+.+++.+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 108 (109)
T 1bu3_A 40 SADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEWAALVK 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 45678899999999999999999999999999 7889999999999999999999999999998763
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8.1e-11 Score=89.62 Aligned_cols=68 Identities=28% Similarity=0.463 Sum_probs=62.2
Q ss_pred hHHhhhhhhhcccc-CCCCC-cccHHHHHHHHHH---cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNID-TDNSG-TITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.+..++.+|..+| +|++| .|+.+||+.+++. +|..++..+++.++..+|.|++|.|+|+||+.++..
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 79 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGA 79 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 34567899999999 69999 9999999999998 998889999999999999999999999999988753
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-10 Score=95.42 Aligned_cols=68 Identities=22% Similarity=0.375 Sum_probs=63.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
....++.+|+.||.|++|+|+.+||+.++..+| ..++.++++.++..+|.|++|.|+|+||+.++...
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 106 (135)
T 3h4s_E 38 FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLDGDGALNQTEFCVLMVRL 106 (135)
T ss_dssp HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCSSCSSSBCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Confidence 346788999999999999999999999999999 49999999999999999999999999999988654
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.1e-10 Score=102.30 Aligned_cols=91 Identities=24% Similarity=0.332 Sum_probs=75.5
Q ss_pred chhhHHhhhhhhhccccCC-CCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 379 LSTEEIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
++.++ +.++|..||.+ ++|.|+.+||..++..++. ..+.++++.+|..+|.|++|.|+++||+.++........+
T Consensus 22 ~~~~~---i~~~~~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~ 98 (190)
T 1fpw_A 22 FDRRE---IQQWHKGFLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLE 98 (190)
T ss_dssp STHHH---HHHHHHHHHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCST
T ss_pred CCHHH---HHHHHHHHHHHCCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcH
Confidence 44444 45566667766 8999999999999999864 3456779999999999999999999999988765545567
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.+..+|+.+|.|++|
T Consensus 99 ~~~~~~f~~~D~d~~G 114 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDG 114 (190)
T ss_dssp HHHHHHHHHHCSSCSS
T ss_pred HHHHHHHHHhcCCCCC
Confidence 8999999999999998
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8.5e-11 Score=93.06 Aligned_cols=66 Identities=35% Similarity=0.483 Sum_probs=61.3
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+.++.+|+.+|.|++|+|+.+||+.++..+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~~ 108 (109)
T 3fs7_A 40 TPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGVEEFQSLVK 108 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred cHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 44578899999999999999999999999999 8899999999999999999999999999998764
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=100.85 Aligned_cols=88 Identities=17% Similarity=0.283 Sum_probs=77.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc------------cc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR------------HK 452 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~------------~~ 452 (472)
..+..+|..+|.|++|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++... ..
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~ 142 (190)
T 1g8i_A 63 KFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEE 142 (190)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGG
T ss_pred HHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCcccc
Confidence 347789999999999999999999999998877788899999999999999999999999987652 12
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
...++.+..+|+.+|.|++|
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG 162 (190)
T 1g8i_A 143 NTPEKRVDRIFAMMDKNADG 162 (190)
T ss_dssp SSHHHHHHHHHHHHCSSCSS
T ss_pred ccHHHHHHHHHHHhcCCCCC
Confidence 34567899999999999998
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.1e-10 Score=92.13 Aligned_cols=66 Identities=35% Similarity=0.499 Sum_probs=61.3
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....++.+|+.+|.|++|+|+.+||..++..+ |..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 2pvb_A 39 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIK 107 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 45678899999999999999999999999999 7889999999999999999999999999998764
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=99.06 E-value=8.5e-11 Score=105.30 Aligned_cols=91 Identities=18% Similarity=0.245 Sum_probs=78.1
Q ss_pred hchhhHHhhhhhhhccccC-----CC-C--CcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcc-eeHHHHHHHHh
Q 012039 378 NLSTEEIQGLKQMFTNIDT-----DN-S--GTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT-IDYIEFITATM 448 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~-----~~-~--G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~-i~~~eF~~~~~ 448 (472)
.++.+++..+.+.|..+|. |+ + |.|+.+||.. +..+|..++.+ .++..+|.|++|. |+|+||+.++.
T Consensus 44 ~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~~~~~---~lf~~~D~d~dG~~I~f~EF~~~~~ 119 (214)
T 2l4h_A 44 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKE---RICRVFSTSPAKDSLSFEDFLDLLS 119 (214)
T ss_dssp SCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTSTTHH---HHHHHHCCSSSCCSEEHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCChHHH---HHHHHhCcCCCCCEecHHHHHHHHH
Confidence 4678889999999999998 56 6 9999999999 88898877754 5788889999999 99999999887
Q ss_pred ccccC-CcHHHHHHHHHhhcCCCCC
Q 012039 449 HRHKL-ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 449 ~~~~~-~~~~~l~~~F~~~D~d~~G 472 (472)
..... ..++.++.+|+.||.|++|
T Consensus 120 ~~~~~~~~~~~l~~~F~~~D~d~dG 144 (214)
T 2l4h_A 120 VFSDTATPDIKSHYAFRIFDFDDDG 144 (214)
T ss_dssp HTSSCSCHHHHHHHHHHHHCTTCSS
T ss_pred HHcCCCCHHHHHHHHHHHhCCCCCC
Confidence 65432 3467999999999999998
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.06 E-value=5.2e-10 Score=99.27 Aligned_cols=89 Identities=25% Similarity=0.308 Sum_probs=78.2
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------ 451 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------ 451 (472)
...+..+|..+|.|++|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++....
T Consensus 58 ~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~ 137 (204)
T 1jba_A 58 TQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEA 137 (204)
T ss_dssp HHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTS
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccc
Confidence 34567889999999999999999999999998888889999999999999999999999999876541
Q ss_pred -----cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 -----KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 -----~~~~~~~l~~~F~~~D~d~~G 472 (472)
....++.+..+|+.+|.|++|
T Consensus 138 ~~~g~~~~~~~~~~~~f~~~D~d~dG 163 (204)
T 1jba_A 138 EQQGKLLTPEEVVDRIFLLVDENGDG 163 (204)
T ss_dssp STTTCCCCHHHHHHHHHHHHCCSCCS
T ss_pred cccCchhhHHHHHHHHHHHhCCCCCC
Confidence 114567899999999999998
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=99.06 E-value=4.6e-11 Score=88.25 Aligned_cols=68 Identities=22% Similarity=0.374 Sum_probs=61.3
Q ss_pred hHHhhhhhhhccccC-CCCC-cccHHHHHHHHHH-cCCCC-CHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDT-DNSG-TITYEELKAGLAR-LGSKL-TEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~-~~~G-~i~~~el~~~l~~-~~~~~-~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++...++.+|..+|. |++| .|+.+||+.+++. +|... +.++++.++..+|.|++|.|+|+||+.++..
T Consensus 4 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 75 (78)
T 1cb1_A 4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKK 75 (78)
T ss_dssp CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCCcHHHHHHHHHH
Confidence 345678999999999 9999 9999999999986 88777 8888999999999999999999999987753
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.06 E-value=3.6e-10 Score=99.26 Aligned_cols=88 Identities=23% Similarity=0.378 Sum_probs=76.3
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-------cC----
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-------KL---- 453 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-------~~---- 453 (472)
..+..+|..+|.|++|.|+..||..++..++...+.+++..+|..+|.|++|.|+++||..++.... .+
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~ 142 (193)
T 1bjf_A 63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDE 142 (193)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGG
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCccc
Confidence 3467899999999999999999999999998888889999999999999999999999999875421 11
Q ss_pred -CcHHHHHHHHHhhcCCCCC
Q 012039 454 -ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 -~~~~~l~~~F~~~D~d~~G 472 (472)
..+..+..+|+.+|.|++|
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG 162 (193)
T 1bjf_A 143 STPEKRTEKIFRQMDTNRDG 162 (193)
T ss_dssp SSHHHHHHHHHHHSCTTCSS
T ss_pred ccHHHHHHHHHHHhCCCCCC
Confidence 2246799999999999998
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=91.98 Aligned_cols=67 Identities=42% Similarity=0.566 Sum_probs=61.9
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.....++.+|+.+|.|++|+|+.+||+.++..+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 108 (110)
T 1pva_A 39 MSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVH 108 (110)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred chHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 345678899999999999999999999999999 7889999999999999999999999999998764
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.7e-10 Score=109.98 Aligned_cols=83 Identities=24% Similarity=0.403 Sum_probs=75.5
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHH-HHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQ-LMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~-~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
.....+..+|..+|.|++|+|+.+||..++ +|..++..++.. ++..+|.|++|.|+|+||+.++.... .+.
T Consensus 185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~------~l~ 256 (323)
T 1ij5_A 185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL------VLR 256 (323)
T ss_dssp HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH------HHH
T ss_pred hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCCCCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH------HHH
Confidence 456678999999999999999999999999 888889999999 99999999999999999999886542 788
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.||.|++|
T Consensus 257 ~~F~~~D~d~dG 268 (323)
T 1ij5_A 257 ILYAFADFDKSG 268 (323)
T ss_dssp HHHHHTCSSSCS
T ss_pred HHHHHhCCCCCC
Confidence 999999999998
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.05 E-value=6e-10 Score=93.35 Aligned_cols=65 Identities=37% Similarity=0.663 Sum_probs=61.4
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+.++|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 82 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~ 146 (148)
T 1exr_A 82 EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV 146 (148)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 45678899999999999999999999999999999999999999999999999999999998875
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=99.04 E-value=1.6e-10 Score=91.22 Aligned_cols=66 Identities=39% Similarity=0.540 Sum_probs=60.8
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....++.+|+.+|.|++|+|+.+||+.++..+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 1rro_A 39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 45678899999999999999999999999999 6789999999999999999999999999998763
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.04 E-value=3.1e-10 Score=98.75 Aligned_cols=89 Identities=19% Similarity=0.305 Sum_probs=76.2
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------ 451 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------ 451 (472)
...+..+|..+|.|++|.|+.+||..++..++...+.+++..+|+.+|.|++|.|+++||..++....
T Consensus 55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~ 134 (183)
T 1s6c_A 55 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLK 134 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC--------
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCcc
Confidence 34567889999999999999999999999888777889999999999999999999999999876531
Q ss_pred cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 ~~~~~~~l~~~F~~~D~d~~G 472 (472)
....++.+..+|+.+|.|++|
T Consensus 135 ~~~~~~~~~~~f~~~D~d~dG 155 (183)
T 1s6c_A 135 EDTPRQHVDVFFQKMDKNKDG 155 (183)
T ss_dssp ---CHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHHHHHhCCCCCC
Confidence 011247899999999999998
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.4e-10 Score=107.69 Aligned_cols=89 Identities=25% Similarity=0.431 Sum_probs=75.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHc----CCCCCHHHHHH----HHHHhcCCCCcceeHHHHHHHHhccc----
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL----GSKLTEAEVQQ----LMEAADVDGNGTIDYIEFITATMHRH---- 451 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~----~~~~~d~d~~g~i~~~eF~~~~~~~~---- 451 (472)
...++.+|..+|.|++|.|+.+||..++..+ |..++.++++. ++..+|.|++|.|+|+||+..+....
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~~ 182 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLL 182 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSST
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHHh
Confidence 4568899999999999999999999999988 88889888754 99999999999999999998764310
Q ss_pred --------cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 --------KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 --------~~~~~~~l~~~F~~~D~d~~G 472 (472)
.....+.+..+|+.+|+|++|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 211 (272)
T 2be4_A 183 QFKMDASSQVERKRDFEKIFAHYDVSRTG 211 (272)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHCTTCCS
T ss_pred hhhhhhccccccHHHHHHHHHHhCCCCCC
Confidence 112346899999999999998
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.03 E-value=1e-09 Score=94.68 Aligned_cols=82 Identities=17% Similarity=0.203 Sum_probs=38.4
Q ss_pred hhhccccCCCCCcccHHHHHHHHHHcCCCCC--------HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLT--------EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 389 ~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~--------~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
.+|..+|.|++|.|+.+||..++........ ...+..+|..+|.|++|.|+++||..++.... .+++.+.
T Consensus 62 ~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~ 139 (176)
T 1nya_A 62 YLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAA 139 (176)
T ss_dssp HHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHH
T ss_pred HHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHH
Confidence 4444555555555555555554444332222 13344455555555555555555554443322 3344455
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.+|.|++|
T Consensus 140 ~~~~~~D~d~dg 151 (176)
T 1nya_A 140 EAFNQVDTNGNG 151 (176)
T ss_dssp HHHHHHCTTCSS
T ss_pred HHHHHhCCCCCC
Confidence 555555555544
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.03 E-value=4e-10 Score=101.67 Aligned_cols=89 Identities=19% Similarity=0.305 Sum_probs=76.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------ 451 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------ 451 (472)
...+..+|+.+|.|++|.|+.+||..++..++...+.++++.+|+.+|.|++|.|+++||..++....
T Consensus 88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~ 167 (224)
T 1s1e_A 88 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLK 167 (224)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGC
T ss_pred HHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCC
Confidence 34567889999999999999999999999887777888999999999999999999999999876431
Q ss_pred cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 ~~~~~~~l~~~F~~~D~d~~G 472 (472)
....++.+..+|+.+|.|+||
T Consensus 168 ~~~~~~~~~~~f~~~D~d~dG 188 (224)
T 1s1e_A 168 EDTPRQHVDVFFQKMDKNKDG 188 (224)
T ss_dssp SSSHHHHHHHHHHHHCTTCSS
T ss_pred HhHHHHHHHHHHHHhCCCCCC
Confidence 112357899999999999998
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.2e-10 Score=107.83 Aligned_cols=66 Identities=33% Similarity=0.653 Sum_probs=61.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+.++++|+.||.|++|+|+.+||+.+|..+|..+++++++.||+.+|.|+||.|+|+||+.+|..
T Consensus 374 eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMtS 439 (440)
T 3u0k_A 374 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 439 (440)
T ss_dssp CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC-
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhCC
Confidence 356889999999999999999999999999999999999999999999999999999999998764
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.02 E-value=3e-10 Score=119.61 Aligned_cols=87 Identities=22% Similarity=0.392 Sum_probs=79.8
Q ss_pred chhhH-HhhhhhhhccccCCCCCcccHHHHHHHHHHc--------CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 379 LSTEE-IQGLKQMFTNIDTDNSGTITYEELKAGLARL--------GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 379 ~~~~~-~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~--------~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+++++ +++++++|..+| |++|.|+.+||+.+|+.+ +..++.++++.|+..+|.|++|.|+|+||+.++..
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~ 603 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK 603 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHHH
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 55666 788999999999 999999999999999997 77899999999999999999999999999998864
Q ss_pred cccCCcHHHHHHHHHhhcCCCCC
Q 012039 450 RHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 450 ~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
. +.++.+|+.||+|++|
T Consensus 604 ~------~~l~~~F~~~D~d~dG 620 (714)
T 3bow_A 604 I------QKYQKIYREIDVDRSG 620 (714)
T ss_dssp H------HHHHHHHHHHCTTCCS
T ss_pred H------HHHHHHHHHhCCCCCC
Confidence 3 6899999999999998
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.01 E-value=3e-10 Score=104.75 Aligned_cols=91 Identities=21% Similarity=0.337 Sum_probs=76.2
Q ss_pred chhhHHhhhhhhhccccC-CCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 379 LSTEEIQGLKQMFTNIDT-DNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~-~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
++.+++..+ |..||. +++|.|+.+||..++..++ ...+..+++.+|..+|.|++|.|+|+||+.++........+
T Consensus 88 ~s~~ei~~l---~~~fd~~~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~ 164 (256)
T 2jul_A 88 FTKKELQSL---YRGFKNECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVH 164 (256)
T ss_dssp SCHHHHHHH---HHHHHHHCTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHH
T ss_pred CCHHHHHHH---HHHHHhhCCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChH
Confidence 455555555 444554 4899999999999999986 46678899999999999999999999999988765555667
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.+|.|++|
T Consensus 165 ~~l~~~F~~~D~d~dG 180 (256)
T 2jul_A 165 EKLKWAFNLYDINKDG 180 (256)
T ss_dssp HHHHHHHHHTCCSSSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 8999999999999998
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.01 E-value=4.2e-10 Score=100.11 Aligned_cols=88 Identities=24% Similarity=0.355 Sum_probs=77.3
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---------ccC--
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---------HKL-- 453 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---------~~~-- 453 (472)
..+..+|..+|.|++|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++... ..+
T Consensus 71 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~ 150 (207)
T 2d8n_A 71 AYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPD 150 (207)
T ss_dssp HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCccc
Confidence 467889999999999999999999999999888888899999999999999999999999987653 111
Q ss_pred ---CcHHHHHHHHHhhcCCCCC
Q 012039 454 ---ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ---~~~~~l~~~F~~~D~d~~G 472 (472)
..++.+..+|+.+|.|++|
T Consensus 151 ~~~~~~~~~~~~f~~~D~d~dG 172 (207)
T 2d8n_A 151 DENTPEKRAEKIWKYFGKNDDD 172 (207)
T ss_dssp TTSSHHHHHHHHHHHTTCCTTC
T ss_pred ccccHHHHHHHHHHHcCCCCCC
Confidence 2246799999999999998
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=99.01 E-value=2.7e-10 Score=123.55 Aligned_cols=95 Identities=20% Similarity=0.443 Sum_probs=84.4
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LER 455 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~ 455 (472)
..++.+++..++++|..||.|++|+|+.+||+.+++.+|..+++++++.+|..+|.|++|.|+|+||+.++..... ...
T Consensus 717 ~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~ 796 (863)
T 1sjj_A 717 KGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETADTDT 796 (863)
T ss_dssp CCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTTCSS
T ss_pred cCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCC
Confidence 3455677889999999999999999999999999999999999999999999999999999999999998765432 345
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
.+.+..+|+.| .|++|
T Consensus 797 ~~~l~~aF~~~-~d~~G 812 (863)
T 1sjj_A 797 ADQVMASFKIL-AGDKN 812 (863)
T ss_dssp SHHHHHHHHGG-GTSSS
T ss_pred HHHHHHHHHHH-hCCCC
Confidence 67899999999 79887
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.8e-10 Score=103.36 Aligned_cols=88 Identities=20% Similarity=0.348 Sum_probs=77.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------c
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------K 452 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------~ 452 (472)
..+..+|..+|.|++|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++.... .
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~ 208 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILRE 208 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCC
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccch
Confidence 4577899999999999999999999999988778889999999999999999999999999876431 1
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
...++.+..+|+.+|.|+||
T Consensus 209 ~~~~~~~~~~f~~~D~d~dG 228 (256)
T 2jul_A 209 DAPLEHVERFFQKMDRNQDG 228 (256)
T ss_dssp CCHHHHHHHHHHHSCCSTTC
T ss_pred hhHHHHHHHHHHHHCCCCCC
Confidence 23568899999999999998
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=98.99 E-value=4.6e-10 Score=118.23 Aligned_cols=81 Identities=28% Similarity=0.484 Sum_probs=76.1
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
+.++.+|+.+|.|++|+|+.+||+.+|+.+|..+++++++.++..+| |+||.|+|+||+.++... +.+..+|+
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~------~~l~~~F~ 677 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL------EILFKIFK 677 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHH------HHHHHHHS
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH------HHHHHHHH
Confidence 56889999999999999999999999999999999999999999999 999999999999988643 68899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 678 ~~D~d~dG 685 (714)
T 3bow_A 678 QLDPENTG 685 (714)
T ss_dssp SSCSSCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.98 E-value=6.5e-10 Score=95.07 Aligned_cols=67 Identities=24% Similarity=0.330 Sum_probs=62.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
...+..+|+.+|.|++|+|+.+||..++..+|..+++++++.+|..+|.|++|.|+|+||+.++...
T Consensus 94 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~ 160 (166)
T 2mys_B 94 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHG 160 (166)
T ss_pred HHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhc
Confidence 3567889999999999999999999999999999999999999999999999999999999988754
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.97 E-value=6.6e-10 Score=92.36 Aligned_cols=66 Identities=27% Similarity=0.540 Sum_probs=62.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++..
T Consensus 75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 140 (143)
T 3j04_B 75 EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKH 140 (143)
T ss_dssp HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHS
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 356889999999999999999999999999999999999999999999999999999999998864
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=98.97 E-value=6.4e-10 Score=100.71 Aligned_cols=87 Identities=22% Similarity=0.364 Sum_probs=74.7
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc------------ccC
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR------------HKL 453 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~------------~~~ 453 (472)
.+..+|+.+|.|++|.|+.+||..++..+....+.+++..+|+.+|.|++|.|+++||..++... ...
T Consensus 103 ~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~ 182 (229)
T 3dd4_A 103 YAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKED 182 (229)
T ss_dssp HHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC----------
T ss_pred HHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchh
Confidence 46678999999999999999999999988766678889999999999999999999999988653 122
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
..++.+..+|+.+|.|+||
T Consensus 183 ~~~~~~~~~f~~~D~d~dG 201 (229)
T 3dd4_A 183 APRQHVETFFQKMDKNKDG 201 (229)
T ss_dssp -CCTHHHHHHHHHCSSCSS
T ss_pred hHHHHHHHHHHHhcCCCCC
Confidence 3457899999999999998
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=98.97 E-value=9.8e-10 Score=86.85 Aligned_cols=67 Identities=27% Similarity=0.388 Sum_probs=61.3
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++..++.++|+.+|. ++|+|+.+|++.++.+.| ++++++.+|+..+|.|+||.|+|+||+.+|.
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~d~dG~Ld~~EF~~aM~ 93 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADMNNDGRMDQVEFSIAMK 93 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCCHHHHHHHHH
Confidence 356788899999999998 899999999999999875 5799999999999999999999999999764
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=5.3e-10 Score=86.77 Aligned_cols=68 Identities=21% Similarity=0.369 Sum_probs=60.4
Q ss_pred hHHhhhhhhhcccc-CCCCC-cccHHHHHHHHH-HcC----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNID-TDNSG-TITYEELKAGLA-RLG----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~-~~~----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+....+..+|..+| .|++| +|+.+||+.+++ .++ ..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I~~~EF~~~~~~ 84 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGG 84 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 34567899999998 99999 999999999998 443 6788899999999999999999999999988754
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=98.95 E-value=9.3e-11 Score=120.79 Aligned_cols=84 Identities=13% Similarity=0.223 Sum_probs=21.1
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++++|..||.|++|+|+.+||+.+|+.+|..+++++++.+|+.+|.|++|.|+|+||+.++.... .+++++.+|+
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~---~~~el~~aF~ 87 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLT---QRAEIDRAFE 87 (624)
T ss_dssp ---------------------------------------------------------CTTHHHHHHT---CCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhc---cHHHHHHHHH
Confidence 3578999999999999999999999999999999999999999999999999999999999886542 3478999999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.||++ +|
T Consensus 88 ~fD~~-~G 94 (624)
T 1djx_A 88 EAAGS-AE 94 (624)
T ss_dssp HHHTT-SS
T ss_pred HhcCC-CC
Confidence 99985 65
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.94 E-value=7.9e-10 Score=95.94 Aligned_cols=68 Identities=22% Similarity=0.311 Sum_probs=61.2
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHH-HcCCC-C------CHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLA-RLGSK-L------TEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~-~~~~~-~------~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.....++.+|+.||.|++|+|+.+||+.+++ .+|.. + ++++++.+|..+|.|+||.|+|+||+.++..
T Consensus 95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~ 170 (179)
T 3a8r_A 95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALLLQ 170 (179)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHHHHHHHC-
T ss_pred CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHh
Confidence 3456789999999999999999999999999 88876 5 7889999999999999999999999998864
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.2e-09 Score=90.86 Aligned_cols=67 Identities=33% Similarity=0.591 Sum_probs=62.8
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
....+..+|+.+|.|++|+|+.+||+.++..+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 74 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 140 (145)
T 2bl0_B 74 QSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVT 140 (145)
T ss_dssp GHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHh
Confidence 4457889999999999999999999999999999999999999999999999999999999998864
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.93 E-value=2.3e-09 Score=92.82 Aligned_cols=84 Identities=27% Similarity=0.550 Sum_probs=65.5
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc----CCcHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK----LERDDHL 459 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~----~~~~~~l 459 (472)
...+..+|..+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|++|.|+|+||+.++..... ......+
T Consensus 83 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~~~~~~~~~~~~ 162 (179)
T 2f2o_A 83 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAKGGGGGAAARKEVI 162 (179)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC-------------C
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCchHHHHHHHH
Confidence 356788999999999999999999999999999999999999999999999999999999998875432 1223445
Q ss_pred HHHHHhhc
Q 012039 460 YKAFQHFD 467 (472)
Q Consensus 460 ~~~F~~~D 467 (472)
+++|..+.
T Consensus 163 ~~~~~~~~ 170 (179)
T 2f2o_A 163 RNKIRAIG 170 (179)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 66666543
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.93 E-value=2.1e-09 Score=91.08 Aligned_cols=65 Identities=32% Similarity=0.595 Sum_probs=61.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 95 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 159 (161)
T 3fwb_A 95 LDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICT 159 (161)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 45688899999999999999999999999999999999999999999999999999999998775
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.93 E-value=9.4e-10 Score=92.35 Aligned_cols=65 Identities=29% Similarity=0.532 Sum_probs=59.3
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+| |++|.|+|+||+.++.
T Consensus 85 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~ 149 (151)
T 1w7j_B 85 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHIL 149 (151)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHh
Confidence 3457888999999999999999999999999999999999999999999 9999999999998764
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.93 E-value=2.1e-09 Score=90.80 Aligned_cols=68 Identities=24% Similarity=0.483 Sum_probs=63.1
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHH--hcCCCCcceeHHHHHHHHhcc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA--ADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~--~d~d~~g~i~~~eF~~~~~~~ 450 (472)
....+..+|+.+|.|++|+|+.+||+.++..+|..++.++++.++.. +|.|++|.|+|+||+.++...
T Consensus 82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 151 (156)
T 1wdc_C 82 TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAG 151 (156)
T ss_dssp CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHC
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcC
Confidence 34568899999999999999999999999999999999999999999 999999999999999988653
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.92 E-value=3.2e-09 Score=90.87 Aligned_cols=66 Identities=36% Similarity=0.514 Sum_probs=61.5
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++..
T Consensus 100 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 165 (169)
T 3qrx_A 100 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK 165 (169)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC-
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 456788999999999999999999999999999999999999999999999999999999998754
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.92 E-value=6.5e-10 Score=91.67 Aligned_cols=86 Identities=12% Similarity=0.010 Sum_probs=52.9
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cCCcHHHHHHHHH
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARL-GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KLERDDHLYKAFQ 464 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~~~~~~l~~~F~ 464 (472)
.+++|..+|.|++|.|+.+||..++... ......+++..+|..+|.|++|.|+.+||..++.... ...+++.+..+|+
T Consensus 5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~ 84 (135)
T 3h4s_E 5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVR 84 (135)
T ss_dssp --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHH
Confidence 4678999999999999999999888753 2223457799999999999999999999999887665 2567889999999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|.|++|
T Consensus 85 ~~D~d~dG 92 (135)
T 3h4s_E 85 EGDLDGDG 92 (135)
T ss_dssp HHCSSCSS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=98.92 E-value=2.7e-09 Score=84.28 Aligned_cols=84 Identities=13% Similarity=0.194 Sum_probs=70.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYK 461 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~ 461 (472)
.++.++|..+| ++|.|+.+||..++.. .....+++..+|..+|.|++|.|+.+||..++... ....+++.+..
T Consensus 10 ~ei~~~~~~~D--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~ 85 (109)
T 3fs7_A 10 KDIESALSSCQ--AADSFNYKSFFSTVGL--SSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKA 85 (109)
T ss_dssp HHHHHHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHH
T ss_pred HHHHHHHHhcC--CCCcCcHHHHHHHHhc--CCCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHH
Confidence 34566777777 8999999999988865 23467889999999999999999999999887665 34567889999
Q ss_pred HHHhhcCCCCC
Q 012039 462 AFQHFDKDNSG 472 (472)
Q Consensus 462 ~F~~~D~d~~G 472 (472)
+|+.+|.|++|
T Consensus 86 ~~~~~D~~~dg 96 (109)
T 3fs7_A 86 FLAAGDTDGDG 96 (109)
T ss_dssp HHHHHCTTCSS
T ss_pred HHHHhCCCCCC
Confidence 99999999998
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.92 E-value=4.4e-09 Score=87.19 Aligned_cols=61 Identities=28% Similarity=0.514 Sum_probs=35.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~ 446 (472)
..+..+|+.+|.|++|+|+.+||+.++..+|..++.++++.++..+| |++|.|+|+||+.+
T Consensus 79 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~ 139 (142)
T 2bl0_C 79 DILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINT 139 (142)
T ss_dssp HHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTT
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHH
Confidence 34555566666666666666666666655555555555666666666 66666666666543
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.8e-09 Score=90.82 Aligned_cols=60 Identities=28% Similarity=0.433 Sum_probs=40.1
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+..+|+.+|.|++|+|+.+||+.++..+| ++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 100 ~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 159 (166)
T 3akb_A 100 LHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIVPAFA 159 (166)
T ss_dssp HHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSBCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 56666666666666666666666666666 5666666666666666666666666666554
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=2.6e-09 Score=93.85 Aligned_cols=61 Identities=28% Similarity=0.375 Sum_probs=54.6
Q ss_pred hhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 389 ~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|++|.|+|+||+.++..
T Consensus 117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 177 (195)
T 1qv0_A 117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 177 (195)
T ss_dssp HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999999999999999999988764
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.7e-09 Score=94.62 Aligned_cols=62 Identities=24% Similarity=0.411 Sum_probs=58.9
Q ss_pred hhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 388 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+|+.+|.|++|+|+.+||+.++..+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 112 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~~~~~~ 173 (191)
T 1uhk_A 112 DALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG 173 (191)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 38999999999999999999999999999999999999999999999999999999988764
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.90 E-value=5.4e-09 Score=88.67 Aligned_cols=67 Identities=30% Similarity=0.478 Sum_probs=62.3
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
....+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+..+..
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 160 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG 160 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHS
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 3456789999999999999999999999999999999999999999999999999999999998754
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=98.90 E-value=4.6e-09 Score=87.45 Aligned_cols=64 Identities=34% Similarity=0.537 Sum_probs=59.6
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|.|+.+||+.++..+|..+++++++.++..+| |++|.|+|+||+.++.
T Consensus 83 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~ 146 (147)
T 4ds7_A 83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLS 146 (147)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHh
Confidence 356788999999999999999999999999999999999999999999 9999999999998764
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=98.89 E-value=1.2e-09 Score=90.92 Aligned_cols=86 Identities=23% Similarity=0.259 Sum_probs=41.3
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCC----C-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc--------cC
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGS----K-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH--------KL 453 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~----~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~--------~~ 453 (472)
-...|..+|.|++|.|+.+||..++..+.. . ...+++..+|+.+|.|++|.|+++||..++.... ..
T Consensus 29 ~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~ 108 (143)
T 3a4u_B 29 SFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPL 108 (143)
T ss_dssp ----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------
T ss_pred CHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCC
Confidence 446899999999999999999998877622 1 3456799999999999999999999998776542 12
Q ss_pred CcHHHH----HHHHHhhcCCCCC
Q 012039 454 ERDDHL----YKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l----~~~F~~~D~d~~G 472 (472)
.+++++ ..+|+.+|.|+||
T Consensus 109 ~s~~e~~~~~~~~f~~~D~d~dG 131 (143)
T 3a4u_B 109 MSEDELINIIDGVLRDDDKNNDG 131 (143)
T ss_dssp CCHHHHHHHHHHHHHHHCTTCSS
T ss_pred CCHHHHHHHHHHHHHHcCCCCCC
Confidence 333433 6778999999998
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.89 E-value=2e-09 Score=93.50 Aligned_cols=83 Identities=14% Similarity=0.226 Sum_probs=62.9
Q ss_pred hhhhccccCCCCCcccHHHHHHHHHHcCC---------CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHH
Q 012039 388 KQMFTNIDTDNSGTITYEELKAGLARLGS---------KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDH 458 (472)
Q Consensus 388 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~---------~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~ 458 (472)
..+|..+|.|++|.|+.+||..++..... ......+..+|..+|.|++|.|+++||..++.... .+++.
T Consensus 63 ~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~ 140 (185)
T 2sas_A 63 RDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCAD 140 (185)
T ss_dssp HHHHHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSS
T ss_pred HHHHHhcCCCCCCeEcHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHH
Confidence 35688888888888888888888776521 12346788888888888888888888888775432 34567
Q ss_pred HHHHHHhhcCCCCC
Q 012039 459 LYKAFQHFDKDNSG 472 (472)
Q Consensus 459 l~~~F~~~D~d~~G 472 (472)
+..+|+.+|.|++|
T Consensus 141 ~~~~~~~~D~d~dG 154 (185)
T 2sas_A 141 VPAVYNVITDGGKV 154 (185)
T ss_dssp HHHHHHHHHTTTTS
T ss_pred HHHHHHHhcCCCCC
Confidence 88888888888887
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.89 E-value=3.7e-09 Score=88.27 Aligned_cols=66 Identities=35% Similarity=0.658 Sum_probs=58.3
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 81 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~ 146 (148)
T 1m45_A 81 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL 146 (148)
T ss_dssp CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 346688899999999999999999999999999888999999999999999999999999988775
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-09 Score=90.06 Aligned_cols=65 Identities=25% Similarity=0.638 Sum_probs=60.9
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHH-cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLAR-LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|+|+.+||+.++.. +|..+++++++.++..+|.|++|.|+|+||+.++.
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 152 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS 152 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 456888999999999999999999999999 89999999999999999999999999999998763
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.88 E-value=2.6e-09 Score=90.64 Aligned_cols=65 Identities=34% Similarity=0.564 Sum_probs=43.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 94 ~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 158 (161)
T 1dtl_A 94 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 158 (161)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 34566677777777777777777777777666666777777777777777777777777766554
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.1e-09 Score=94.11 Aligned_cols=85 Identities=22% Similarity=0.293 Sum_probs=54.9
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHh
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQH 465 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~ 465 (472)
.+..+|..+|.|++|.|+.+||..++.......+.+++..+|..+|.|++|.|+++||..++. ....+++.+..+|+.
T Consensus 88 ~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~ 165 (191)
T 3khe_A 88 EVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQE 165 (191)
T ss_dssp HHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHH
Confidence 455566666777777777777766665444344556677777777777777777777766655 223455666777777
Q ss_pred hcCCCCC
Q 012039 466 FDKDNSG 472 (472)
Q Consensus 466 ~D~d~~G 472 (472)
+|.|++|
T Consensus 166 ~D~~~dg 172 (191)
T 3khe_A 166 CDKNNDG 172 (191)
T ss_dssp HCTTCSS
T ss_pred hCCCCCC
Confidence 7777665
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.1e-10 Score=90.62 Aligned_cols=66 Identities=38% Similarity=0.509 Sum_probs=61.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....++.+|+.+|.|++|+|+.+||+.++..+ |..++.++++.++..+|.|++|.|+|+||+.++.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 107 (108)
T 2kyc_A 39 SSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQEMVQ 107 (108)
T ss_dssp CSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCCSSSSCCCSSHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHh
Confidence 44678899999999999999999999999999 7888999999999999999999999999998763
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.2e-09 Score=94.02 Aligned_cols=62 Identities=15% Similarity=0.181 Sum_probs=47.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+..+|+.+|.|++|+|+.+||..++..+| ++.++++.+|..+|.|+||.|+|+||+.++.
T Consensus 109 ~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~ 170 (191)
T 2ccm_A 109 KYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSDGGKTMVTREIFARLWT 170 (191)
T ss_dssp HHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTTTTTSCCBHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 4567777778888888888888877777776 6777777788888888888888888877664
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.8e-09 Score=88.97 Aligned_cols=65 Identities=35% Similarity=0.577 Sum_probs=60.9
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++.. |.|++|.|+|+||+.++.
T Consensus 83 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~ 147 (149)
T 2mys_C 83 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIM 147 (149)
T ss_pred hHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHh
Confidence 45668899999999999999999999999999999999999999999 999999999999998775
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.87 E-value=2.3e-09 Score=90.56 Aligned_cols=66 Identities=20% Similarity=0.418 Sum_probs=61.6
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|.| +|.|+|+||+.++...
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~ 151 (156)
T 1wdc_B 86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGS 151 (156)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTS
T ss_pred HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcC
Confidence 35688999999999999999999999999999999999999999999999 9999999999988654
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.87 E-value=5.7e-09 Score=82.35 Aligned_cols=83 Identities=19% Similarity=0.220 Sum_probs=70.1
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYKA 462 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~~ 462 (472)
++.++|..+|. +|.|+.+||..++... ....+++..+|..+|.|++|.|+.+||..++... ....+++.+..+
T Consensus 10 ei~~~~~~~d~--~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~ 85 (109)
T 5pal_A 10 DINKAISAFKD--PGTFDYKRFFHLVGLK--GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKAL 85 (109)
T ss_dssp HHHHHHHHTCS--TTCCCHHHHHHHHTCT--TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHH
T ss_pred HHHHHHHHhCC--CCcCcHHHHHHHHhhc--cCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHH
Confidence 45667777776 8999999999888642 4467889999999999999999999999888765 445678899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 86 ~~~~D~~~dg 95 (109)
T 5pal_A 86 LAAGDSDHDG 95 (109)
T ss_dssp HHHHCTTCSS
T ss_pred HHHhCCCCCC
Confidence 9999999998
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.87 E-value=2.5e-09 Score=83.54 Aligned_cols=64 Identities=22% Similarity=0.342 Sum_probs=54.9
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHH-----cCCCCCH-----------HHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTE-----------AEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~-----~~~~~~~-----------~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++.+|..||.|++|+|+.+||..++.. +|...+. ..++.+|..+|.|+||.|+|+||+.++..
T Consensus 21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~ 100 (103)
T 1snl_A 21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQR 100 (103)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCCCCCcCCHHHHHHHHhc
Confidence 4778999999999999999999999996 4655442 34889999999999999999999987753
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2.3e-09 Score=87.71 Aligned_cols=84 Identities=21% Similarity=0.290 Sum_probs=68.3
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHH---cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYK 461 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~ 461 (472)
..+..+|..+|.|++|.|+.+|+..++.. .+...+..++..+|..+|.|++|.|+++||..++..... ..+..
T Consensus 36 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~----~~~~~ 111 (134)
T 1jfj_A 36 QLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAE 111 (134)
T ss_dssp HHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHH
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHHHHHCCCCCCccCHHHHHHHHHHhCH----HHHHH
Confidence 45677899999999999999999998863 333345677999999999999999999999998864321 12889
Q ss_pred HHHhhcCCCCC
Q 012039 462 AFQHFDKDNSG 472 (472)
Q Consensus 462 ~F~~~D~d~~G 472 (472)
+|+.+|.|++|
T Consensus 112 ~~~~~D~~~dg 122 (134)
T 1jfj_A 112 QVMKADANGDG 122 (134)
T ss_dssp HHHHHHCSSSS
T ss_pred HHHHhCCCCCC
Confidence 99999999987
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.86 E-value=4.5e-09 Score=87.62 Aligned_cols=63 Identities=27% Similarity=0.456 Sum_probs=59.1
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+ |++|.|+|+||+.++.
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~ 145 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDIL 145 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHh
Confidence 45688999999999999999999999999999999999999999999 9999999999998764
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.2e-09 Score=94.60 Aligned_cols=66 Identities=23% Similarity=0.291 Sum_probs=61.9
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
...+..+|..||.|++|+|+.+||+.+| .+|..++.++++.+|..+|.|++|.|+|+||+.++...
T Consensus 125 ~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~ 190 (196)
T 3dtp_E 125 EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKG 190 (196)
T ss_dssp HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcC
Confidence 4568899999999999999999999999 99999999999999999999999999999999988654
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.85 E-value=5.3e-09 Score=88.41 Aligned_cols=68 Identities=26% Similarity=0.513 Sum_probs=59.4
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.....+..+|+.+|.|++|+|+.+||+.++..+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 88 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 155 (158)
T 2jnf_A 88 QMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTG 155 (158)
T ss_dssp TTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSS
T ss_pred hHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 34456888999999999999999999999999998889999999999999999999999999887753
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.84 E-value=2.6e-09 Score=88.39 Aligned_cols=64 Identities=28% Similarity=0.527 Sum_probs=60.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+|. ++|.|+|+||+.++.
T Consensus 75 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~ 138 (140)
T 1ggw_A 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMIL 138 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHh
Confidence 4568899999999999999999999999999999999999999999999 999999999998775
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=98.84 E-value=9.5e-09 Score=81.05 Aligned_cols=83 Identities=14% Similarity=0.124 Sum_probs=69.7
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYKA 462 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~~ 462 (472)
++.++|..+| ++|.|+.+||..++... ....+++..+|..+|.|++|.|+.+||..++... ....+++.+..+
T Consensus 10 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~ 85 (109)
T 1rwy_A 10 DIKKAIGAFT--AADSFDHKKFFQMVGLK--KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTL 85 (109)
T ss_dssp HHHHHHHTTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHH
T ss_pred HHHHHHHHcC--CCCcEeHHHHHHHHhcC--cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHH
Confidence 4556777788 89999999999887542 3457889999999999999999999999988765 334577899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 86 ~~~~D~~~dg 95 (109)
T 1rwy_A 86 MAAGDKDGDG 95 (109)
T ss_dssp HHHHCTTCSS
T ss_pred HHHHCCCCCC
Confidence 9999999987
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=98.83 E-value=8.4e-09 Score=81.23 Aligned_cols=84 Identities=15% Similarity=0.125 Sum_probs=69.9
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYK 461 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~ 461 (472)
.++.++|..+| ++|.|+.+||..++... ....+++..+|..+|.|++|.|+.+||..++... ....+++.+..
T Consensus 9 ~e~~~l~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~ 84 (108)
T 2pvb_A 9 ADVAAALAACS--AADSFKHKEFFAKVGLA--SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKA 84 (108)
T ss_dssp HHHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHH
T ss_pred HHHHHHHHHhC--CCCcCcHHHHHHHHhCC--hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHH
Confidence 34566777787 89999999999887543 3457889999999999999999999999887655 33467889999
Q ss_pred HHHhhcCCCCC
Q 012039 462 AFQHFDKDNSG 472 (472)
Q Consensus 462 ~F~~~D~d~~G 472 (472)
+|+.+|.|++|
T Consensus 85 ~~~~~D~~~dg 95 (108)
T 2pvb_A 85 FLADGDKDGDG 95 (108)
T ss_dssp HHHHHCTTCSS
T ss_pred HHHHhCCCCCC
Confidence 99999999987
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.83 E-value=1e-08 Score=80.89 Aligned_cols=83 Identities=13% Similarity=0.141 Sum_probs=69.6
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYKA 462 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~~ 462 (472)
++.++|..+| ++|.|+.+||..++... ....+++..+|..+|.|++|.|+.+||..++... ....+++.+..+
T Consensus 11 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~ 86 (109)
T 1bu3_A 11 DVAAALKACE--AADSFNYKAFFAKVGLT--AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAF 86 (109)
T ss_dssp HHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHH
T ss_pred HHHHHHHHhC--CCCcCcHHHHHHHHHcC--hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHH
Confidence 4556777777 89999999999887543 2357889999999999999999999999988765 334678899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 87 ~~~~D~~~dg 96 (109)
T 1bu3_A 87 LKAGDSDGDG 96 (109)
T ss_dssp HHHHCTTCSS
T ss_pred HHHhCCCCCC
Confidence 9999999987
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.2e-09 Score=93.96 Aligned_cols=88 Identities=22% Similarity=0.314 Sum_probs=73.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc-------ccCCcHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR-------HKLERDD 457 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~-------~~~~~~~ 457 (472)
..+..+|..+|.|++|.|+.+||..++.........+++..+|..+|.|++|.|+++||..++... .....++
T Consensus 73 ~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~ 152 (204)
T 3e3r_A 73 AEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDE 152 (204)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHH
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHH
Confidence 346778899999999999999999988766554456789999999999999999999999987632 2234567
Q ss_pred HHHHHHHhhcC-CCCC
Q 012039 458 HLYKAFQHFDK-DNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~-d~~G 472 (472)
.+..+|+.+|. |++|
T Consensus 153 ~~~~~~~~~D~~d~dg 168 (204)
T 3e3r_A 153 VLRRFLDNFDSSEKDG 168 (204)
T ss_dssp HHHHHHHHHSCSSCCS
T ss_pred HHHHHHHHhhccCCCC
Confidence 89999999998 9998
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.82 E-value=4.7e-09 Score=93.38 Aligned_cols=68 Identities=24% Similarity=0.425 Sum_probs=61.9
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHH----HHHhcCCCCcceeHHHHHHHHhcc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARL-GSKLTEAEVQQL----MEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~----~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
....+..+|+.+|.|++|+|+.+||+.++..+ |..+++++++.+ +..+|.|+||.|+|+||+.++...
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~~~~~~ 183 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKVLEKV 183 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHHTTTTS
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhcc
Confidence 45678899999999999999999999999997 999999998888 999999999999999999987643
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=98.80 E-value=1.2e-08 Score=85.75 Aligned_cols=87 Identities=22% Similarity=0.344 Sum_probs=72.1
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc-cccCCcHHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMH-RHKLERDDHLYKAF 463 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~-~~~~~~~~~l~~~F 463 (472)
.+.++|..+|.|++|.|+.+|+..++..+... ...+.+..+|..+|.|++|.|+.+||..++.. .....+++.+..+|
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~ 118 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 118 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHH
Confidence 45568888999999999999999999887644 45578999999999999999999999998866 23345566677777
Q ss_pred Hh----hcCCCCC
Q 012039 464 QH----FDKDNSG 472 (472)
Q Consensus 464 ~~----~D~d~~G 472 (472)
+. +|.|++|
T Consensus 119 ~~~~~~~D~~~dg 131 (155)
T 3ll8_B 119 DKTIINADKDGDG 131 (155)
T ss_dssp HHHHHHHCTTSSS
T ss_pred HHHHHHhCCCCCC
Confidence 66 9999998
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.4e-08 Score=89.76 Aligned_cols=86 Identities=15% Similarity=0.208 Sum_probs=72.1
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCC-----------------CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGS-----------------KLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-----------------~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+|..+|.|++|.|+.+||..++..... ....+++..+|..+|.|++|.|+.+||..++..
T Consensus 63 ~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~ 142 (202)
T 2bec_A 63 GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRL 142 (202)
T ss_dssp HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 567899999999999999999999987653 334677999999999999999999999998876
Q ss_pred c-ccCCcHHHHHHHHHh----hcCCCCC
Q 012039 450 R-HKLERDDHLYKAFQH----FDKDNSG 472 (472)
Q Consensus 450 ~-~~~~~~~~l~~~F~~----~D~d~~G 472 (472)
. ....+++.+..+|+. +|.|++|
T Consensus 143 ~~g~~~~~~~~~~~~~~~~~~~D~d~dG 170 (202)
T 2bec_A 143 MVGVQVTEEQLENIADRTVQEADEDGDG 170 (202)
T ss_dssp SCCSCCCHHHHHHHHHHHHHHHCSSCSS
T ss_pred hcCCCCCHHHHHHHHHHHHHHcCCCCCC
Confidence 5 334566677777777 9999998
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=98.79 E-value=8.5e-09 Score=111.91 Aligned_cols=82 Identities=26% Similarity=0.455 Sum_probs=76.4
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
+..++.+|+.+|.|++|+|+.+||+.+++.+|..+++++++.++..+| |++|.|+|+||+.++... +.+..+|
T Consensus 606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~------~~l~~~F 678 (900)
T 1qxp_A 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL------EILFKIF 678 (900)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHH------HHHHHHH
T ss_pred HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH------HHHHHHH
Confidence 367899999999999999999999999999999999999999999999 999999999999988643 6789999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|+|++|
T Consensus 679 ~~~D~d~~G 687 (900)
T 1qxp_A 679 KQLDPENTG 687 (900)
T ss_dssp HHSCSSCCS
T ss_pred HhhCCCCCc
Confidence 999999987
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.2e-08 Score=80.36 Aligned_cols=83 Identities=13% Similarity=0.153 Sum_probs=68.7
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYKA 462 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~~ 462 (472)
++.++|..+| ++|.|+.+||..++... ....+++..+|..+|.|++|.|+.+||..++... ....+++.+..+
T Consensus 10 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~ 85 (108)
T 1rro_A 10 DIAAALQECQ--DPDTFEPQKFFQTSGLS--KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSL 85 (108)
T ss_dssp HHHHHHHHTC--STTCCCHHHHHHHHSGG--GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHH
T ss_pred HHHHHHHHcc--CCCCcCHHHHHHHHhcC--cccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHH
Confidence 4556777777 89999999999887432 3457889999999999999999999999887665 234577899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 86 ~~~~D~~~dg 95 (108)
T 1rro_A 86 MDAADNDGDG 95 (108)
T ss_dssp HHHHCCSSSS
T ss_pred HHHhCCCCCC
Confidence 9999999987
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.2e-09 Score=94.65 Aligned_cols=65 Identities=29% Similarity=0.461 Sum_probs=50.0
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHc--CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL--GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~--~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.+..+|+.+|.|++|+|+.+||+.++..+ |..+++++++.+|..+|.|+||.|+|+||+.++.
T Consensus 128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~ 194 (197)
T 3pm8_A 128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMS 194 (197)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 3467778888888888888888888888877 6666777888888888888888888888887764
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=98.79 E-value=2.8e-09 Score=88.77 Aligned_cols=63 Identities=22% Similarity=0.359 Sum_probs=50.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcC--------CCCCHHHHHHHH----HHhcCCCCcceeHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLG--------SKLTEAEVQQLM----EAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~--------~~~~~~~~~~~~----~~~d~d~~g~i~~~eF~~~~ 447 (472)
+.+..+|+.||.|++|+|+.+||+.++..++ ..++.++++.++ ..+|.|+||.|+|+||+.++
T Consensus 68 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 68 ELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp HHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred HHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 4677899999999999999999999998874 578888886665 99999999999999998754
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=98.79 E-value=2.1e-09 Score=86.80 Aligned_cols=64 Identities=19% Similarity=0.356 Sum_probs=55.3
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
.++..+++++|+.|| |+|+.+||+.+++.+|. ++++++.++..+|.|++|.|+|+||+.++...
T Consensus 46 ~~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~d~dG~I~~~EF~~~~~~~ 109 (123)
T 2kld_A 46 KNTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQDGDQELTEHEHQQMRDDL 109 (123)
T ss_dssp -----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSSSSCCEECSHHHHHCSCTT
T ss_pred hhHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 344567899999998 99999999999999997 99999999999999999999999999987544
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1.6e-08 Score=79.92 Aligned_cols=83 Identities=18% Similarity=0.255 Sum_probs=69.1
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc---ccCCcHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---HKLERDDHLYKA 462 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---~~~~~~~~l~~~ 462 (472)
++.++|..+| ++|.|+.+||..++.. .....+++..+|..+|.|++|.|+.+||..++... ....+++.+..+
T Consensus 11 e~~~~~~~~d--~~g~i~~~ef~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~ 86 (110)
T 1pva_A 11 DIKKALDAVK--AEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAF 86 (110)
T ss_dssp HHHHHHHHTC--STTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHH
T ss_pred HHHHHHHhcC--CCCcCcHHHHHHHHcc--CcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHH
Confidence 4556777777 8999999999988742 23467889999999999999999999999988765 234577899999
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 87 ~~~~d~~~dg 96 (110)
T 1pva_A 87 LKAADKDGDG 96 (110)
T ss_dssp HHHHCTTCSS
T ss_pred HHHhCCCCCC
Confidence 9999999987
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1.6e-08 Score=86.84 Aligned_cols=63 Identities=24% Similarity=0.369 Sum_probs=58.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
...+..+|+.+|.|++|+|+.+||+.++..+| +++++++.++..+|.|++|.|+|+||+.++.
T Consensus 93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 155 (174)
T 1q80_A 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTNNDGLLSLEEFVIAGS 155 (174)
T ss_dssp HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCceEeHHHHHHHHH
Confidence 46788999999999999999999999999996 7888999999999999999999999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=9.4e-08 Score=88.61 Aligned_cols=134 Identities=16% Similarity=0.199 Sum_probs=95.7
Q ss_pred eeeecCCe-EEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 86 ELGRGQFG-VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 86 ~lg~G~~g-~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
.+..|..| .||+......+..+++|+-.. .....+.+|...|+.|..+--+.+++.++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445555 699988777778899997642 23567889999999997555578899999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 012039 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------------------------------------------- 199 (472)
Q Consensus 165 ~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------------------------------------------- 199 (472)
.++.+..... ......+..++...|..||+.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654321 112233444555555555521
Q ss_pred -------------CcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 200 -------------GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 200 -------------~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.++|+|+.+.|||+. ....+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence 168999999999994 344567999998764
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=98.77 E-value=2e-08 Score=90.54 Aligned_cols=87 Identities=18% Similarity=0.284 Sum_probs=70.7
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc----cccCCcHH---
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGNGTIDYIEFITATMH----RHKLERDD--- 457 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~----~~~~~~~~--- 457 (472)
.+.++|..+|.|++|.|+.+||..++..++. ....+++..+|..+|.|++|.|+++||..++.. .....+++
T Consensus 86 ~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~ 165 (226)
T 2zfd_A 86 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIE 165 (226)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHH
Confidence 3566899999999999999999999998864 345677999999999999999999999998742 11122332
Q ss_pred -HHHHHHHhhcCCCCC
Q 012039 458 -HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 -~l~~~F~~~D~d~~G 472 (472)
.+..+|+.+|.|+||
T Consensus 166 ~~~~~~f~~~D~d~dG 181 (226)
T 2zfd_A 166 DIIDKTFEEADTKHDG 181 (226)
T ss_dssp HHHHHHHHHHCSSCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 357889999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=7.4e-09 Score=104.66 Aligned_cols=86 Identities=21% Similarity=0.298 Sum_probs=72.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+.++|..+|.|++|.|+.+||..++.......+.+++..+|+.+|.|+||.|+.+||..++.. ...+++++..+|+
T Consensus 382 ~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~ 459 (484)
T 3nyv_A 382 HEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLS 459 (484)
T ss_dssp HHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHH
Confidence 45778899999999999999999988877655556778999999999999999999999888764 3356788999999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|.|+||
T Consensus 460 ~~D~d~dG 467 (484)
T 3nyv_A 460 EVDKNNDG 467 (484)
T ss_dssp HHCTTCCS
T ss_pred HhcCCCCC
Confidence 99999988
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.76 E-value=4.9e-09 Score=91.71 Aligned_cols=81 Identities=27% Similarity=0.455 Sum_probs=63.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC--CcHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL--ERDDHLYKA 462 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~--~~~~~l~~~ 462 (472)
..+..+|..+|.|++|+|+.+||+.++..+| +++++++.+|..+|.|++|.|+|+||+.++...... .....+..+
T Consensus 82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~~~~~~~~~~~~~~~~ 159 (188)
T 1s6i_A 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKT 159 (188)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCCSSTTCCSCTTSSS
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHcCCCCCccHhHhccC
Confidence 5688899999999999999999999998887 567889999999999999999999999887654321 223345555
Q ss_pred HHhhc
Q 012039 463 FQHFD 467 (472)
Q Consensus 463 F~~~D 467 (472)
|+.+|
T Consensus 160 ~~~~~ 164 (188)
T 1s6i_A 160 LNLRD 164 (188)
T ss_dssp CCCCC
T ss_pred cchhh
Confidence 55443
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.75 E-value=6.1e-09 Score=93.48 Aligned_cols=66 Identities=23% Similarity=0.368 Sum_probs=61.1
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...+..+|+.+|.|++|+|+.+||+.++..+|. .++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus 129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~ 195 (219)
T 3cs1_A 129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAWASA 195 (219)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 356889999999999999999999999999987 788889999999999999999999999998864
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=98.74 E-value=2.4e-08 Score=88.54 Aligned_cols=87 Identities=20% Similarity=0.267 Sum_probs=70.9
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc----ccCCcH----
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATMHR----HKLERD---- 456 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~----~~~~~~---- 456 (472)
.+.++|..+|.|++|.|+.+||..++..++.. ...+++..+|..+|.|++|.|+++||..++... ....++
T Consensus 75 ~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~ 154 (207)
T 2ehb_A 75 FADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIE 154 (207)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHH
T ss_pred HHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHH
Confidence 35678999999999999999999999988644 456779999999999999999999999987421 112233
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
..+..+|+.+|.|++|
T Consensus 155 ~~~~~~f~~~D~d~dG 170 (207)
T 2ehb_A 155 VMVDKAFVQADRKNDG 170 (207)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 3357889999999998
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.73 E-value=2e-08 Score=88.05 Aligned_cols=87 Identities=23% Similarity=0.358 Sum_probs=72.1
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc--cCCcH---HHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH--KLERD---DHL 459 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~--~~~~~---~~l 459 (472)
..+..+|..+|.|++|.|+.+||..++.... ....+++..+|..+|.|++|.|+.+||..++.... ...++ +.+
T Consensus 87 ~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~ 165 (191)
T 3k21_A 87 YNFDLLLDQIDSDGSGKIDYTEFIAAALDRK-QLSKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRV 165 (191)
T ss_dssp TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGG-GCCHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhh-hccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHH
Confidence 4567789999999999999999998885543 35678899999999999999999999999886521 12222 469
Q ss_pred HHHHHhhcCCCCC
Q 012039 460 YKAFQHFDKDNSG 472 (472)
Q Consensus 460 ~~~F~~~D~d~~G 472 (472)
..+|+.+|.|+||
T Consensus 166 ~~~~~~~D~d~dG 178 (191)
T 3k21_A 166 KRMIRDVDKNNDG 178 (191)
T ss_dssp HHHHHHHCSSSSS
T ss_pred HHHHHHhcCCCCC
Confidence 9999999999998
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=98.72 E-value=2e-09 Score=116.85 Aligned_cols=83 Identities=25% Similarity=0.405 Sum_probs=64.8
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCC--------CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCC
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS--------KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLE 454 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~--------~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~ 454 (472)
++++++++|..+| |++|.|+.+||..+|..++. .++.++++.|+..+|.|++|.|+|+||+.++...
T Consensus 532 ~~~~l~~~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~---- 606 (900)
T 1qxp_A 532 IDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI---- 606 (900)
T ss_dssp ---------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH----
T ss_pred HHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH----
Confidence 3778999999999 99999999999999999875 7899999999999999999999999999987643
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||+|++|
T Consensus 607 --~~l~~~F~~~D~d~~G 622 (900)
T 1qxp_A 607 --RNYLTIFRKFDLDKSG 622 (900)
T ss_dssp --HHHHHHHGGGCTTCCS
T ss_pred --HHHHHHHHhhCCCCCC
Confidence 7899999999999998
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=2.1e-07 Score=87.93 Aligned_cols=136 Identities=19% Similarity=0.291 Sum_probs=92.8
Q ss_pred ceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCC--CeeEEEEEEE-eCCeEEEEEec
Q 012039 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP--NIVEFKGAYE-DKQSVHVVMEL 161 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--~iv~~~~~~~-~~~~~~lv~e~ 161 (472)
+.++.|....||+. +..+++|+.. .......+.+|..+|+.|..+- .+++++.+.. ..+..++|||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788998999987 5678899742 1223567899999999997432 3566666664 45667899999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 012039 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM------------------------------------------ 199 (472)
Q Consensus 162 ~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~------------------------------------------ 199 (472)
++|.+|.+... ..++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988865321 2344444555555555555555432
Q ss_pred ------------------CcEeecCCCCceeeccCCC-CCcEEEeecCCcee
Q 012039 200 ------------------GVMHRDLKPENFLLSSKDE-NALLKATDFGLSVF 232 (472)
Q Consensus 200 ------------------~i~H~dlkp~Nili~~~~~-~~~~kl~Dfg~~~~ 232 (472)
.++|+|++|.||++..++. ...+.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999964222 33458999998765
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=98.71 E-value=2.1e-08 Score=87.17 Aligned_cols=67 Identities=27% Similarity=0.392 Sum_probs=59.6
Q ss_pred hhhhhhh--ccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc
Q 012039 385 QGLKQMF--TNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH 451 (472)
Q Consensus 385 ~~~~~~F--~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~ 451 (472)
.++.++| ..||.|++|+|+.+||+.++..+|..++.++++.+|..+|.|++|.|+|+||+.++....
T Consensus 100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~~~~~ 168 (186)
T 2hps_A 100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTVNDFL 168 (186)
T ss_dssp TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 3445555 667999999999999999999999999999999999999999999999999999887543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=9.3e-09 Score=104.23 Aligned_cols=87 Identities=21% Similarity=0.268 Sum_probs=73.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
...+.++|..+|.|++|.|+.+||..++...+...+.+++..+|+.+|.|++|.|+++||..++.. ...+++.+..+|
T Consensus 389 ~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~ 466 (494)
T 3lij_A 389 ESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMI 466 (494)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccccHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHH
Confidence 356788999999999999999999998876655567888999999999999999999999987754 334567899999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|.|+||
T Consensus 467 ~~~D~d~dG 475 (494)
T 3lij_A 467 SGIDSNNDG 475 (494)
T ss_dssp HTTCSSSSS
T ss_pred HHhCCCCCC
Confidence 999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.1e-08 Score=103.84 Aligned_cols=86 Identities=15% Similarity=0.224 Sum_probs=71.9
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+.++|..+|.|++|.|+.+||..++.......+.+++..+|+.+|.|++|.|+.+||..++.. ...+++++..+|+
T Consensus 399 ~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~--~~~~~~~~~~~~~ 476 (504)
T 3q5i_A 399 EEVDNILKEVDFDKNGYIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANLFGL--TSISEKTWNDVLG 476 (504)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHHTTC--SCCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHhhhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh--CCCCHHHHHHHHH
Confidence 45678888999999999999999888876655567788999999999999999999999887754 2356788999999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|.|+||
T Consensus 477 ~~D~d~dG 484 (504)
T 3q5i_A 477 EADQNKDN 484 (504)
T ss_dssp TTCSSCSS
T ss_pred HhCCCCCC
Confidence 99999987
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.68 E-value=3e-08 Score=97.31 Aligned_cols=65 Identities=34% Similarity=0.667 Sum_probs=60.4
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.++.+|+.+|.|++|+|+.+||+.+|..+|..+++++++.++..+|.|+||.|+|+||+.++.
T Consensus 384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~ 448 (450)
T 3sg6_A 384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 448 (450)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC
T ss_pred hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 34678899999999999999999999999999999999999999999999999999999998875
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.66 E-value=3.3e-08 Score=85.68 Aligned_cols=84 Identities=18% Similarity=0.334 Sum_probs=69.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+..+|..+|.|++|.|+.+||..++..+.. ...+++..+|..+|.|++|.|+.+||..++.. ...+++.+..+|+
T Consensus 73 ~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~--~~~~~~~~~~~~~ 149 (180)
T 3mse_B 73 WDINRILQALDINDRGNITYTEFMAGCYRWKN-IESTFLKAAFNKIDKDEDGYISKSDIVSLVHD--KVLDNNDIDNFFL 149 (180)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHSCCTT-C--CHHHHHHHHHCTTCSSCBCHHHHHHHTTT--SSCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHhccc-CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHcC--CCCCHHHHHHHHH
Confidence 45778899999999999999999988876543 34578999999999999999999999998873 3456789999999
Q ss_pred hhcCCCC
Q 012039 465 HFDKDNS 471 (472)
Q Consensus 465 ~~D~d~~ 471 (472)
.+|.|++
T Consensus 150 ~~d~~~d 156 (180)
T 3mse_B 150 SVHSIKK 156 (180)
T ss_dssp HHHTC--
T ss_pred HhhhccC
Confidence 9999987
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.65 E-value=4.9e-08 Score=86.65 Aligned_cols=62 Identities=21% Similarity=0.384 Sum_probs=55.5
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+..+|+.+|.|++|+|+.+||+.++..+| +++++++.+|..+|.|+||.|+|+||+.++...
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 191 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADTDKSGKLERTELVHLFRKF 191 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCTTCCSSBCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 78899999999999999999999999988 788889999999999999999999999887644
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.64 E-value=4.6e-08 Score=87.36 Aligned_cols=84 Identities=12% Similarity=0.188 Sum_probs=68.0
Q ss_pred hhhccccCCCCCc-ccHHHHHHHHHHcCCCC-CHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-----CCcHHHH--
Q 012039 389 QMFTNIDTDNSGT-ITYEELKAGLARLGSKL-TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-----LERDDHL-- 459 (472)
Q Consensus 389 ~~F~~~D~~~~G~-i~~~el~~~l~~~~~~~-~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-----~~~~~~l-- 459 (472)
++|..+|.|++|. |+.+||..++..+.... ..+++..+|+.+|.|++|.|+.+||..++..... ..+++.+
T Consensus 95 ~lf~~~D~d~dG~~I~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~ 174 (214)
T 2l4h_A 95 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 174 (214)
T ss_dssp HHHHHHCCSSSCCSEEHHHHHHHHHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHH
T ss_pred HHHHHhCcCCCCCEecHHHHHHHHHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHH
Confidence 4688889999999 99999999998875443 3568999999999999999999999998764421 2233334
Q ss_pred --HHHHHhhcCCCCC
Q 012039 460 --YKAFQHFDKDNSG 472 (472)
Q Consensus 460 --~~~F~~~D~d~~G 472 (472)
..+|+.+|.|++|
T Consensus 175 ~~~~~~~~~D~d~dG 189 (214)
T 2l4h_A 175 LIDNILEESDIDRDG 189 (214)
T ss_dssp HHHHHHHHHCCSCCS
T ss_pred HHHHHHHHhCCCCCC
Confidence 4599999999998
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 472 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-96 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-89 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-87 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-87 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-87 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-83 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-81 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-81 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-78 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-78 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-78 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-76 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-72 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-72 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-71 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-70 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-70 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-66 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-63 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-62 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-61 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-60 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-60 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-42 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 8e-24 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 7e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 4e-18 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 5e-08 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 4e-06 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 7e-18 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 9e-06 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 8e-18 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 1e-17 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 3e-10 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 3e-07 | |
| d1jbaa_ | 189 | a.39.1.5 (A:) Guanylate cyclase activating protein | 1e-17 | |
| d1jbaa_ | 189 | a.39.1.5 (A:) Guanylate cyclase activating protein | 2e-05 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-17 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 4e-10 | |
| d2opoa1 | 81 | a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che | 6e-17 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 1e-16 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 7e-10 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 0.001 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 2e-16 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 6e-08 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 1e-06 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 3e-16 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 3e-06 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 6e-16 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 1e-15 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 5e-04 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 3e-15 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 4e-04 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 4e-15 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 4e-10 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 6e-15 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 1e-10 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 8e-15 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 4e-11 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 9e-15 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 5e-05 | |
| d1fpwa_ | 190 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 1e-14 | |
| d1fpwa_ | 190 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 1e-08 | |
| d1fpwa_ | 190 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 4e-08 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 3e-14 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 3e-08 | |
| d1df0a1 | 186 | a.39.1.8 (A:515-700) Calpain large subunit, C-term | 7e-14 | |
| d1df0a1 | 186 | a.39.1.8 (A:515-700) Calpain large subunit, C-term | 1e-10 | |
| d1df0a1 | 186 | a.39.1.8 (A:515-700) Calpain large subunit, C-term | 5e-04 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 7e-14 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 2e-13 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 2e-04 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 1e-13 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 5e-10 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 1e-13 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 2e-05 | |
| d1k94a_ | 165 | a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta | 2e-13 | |
| d1k94a_ | 165 | a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta | 3e-11 | |
| d1k94a_ | 165 | a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta | 1e-05 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 4e-13 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 7e-06 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 8e-13 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 6e-09 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 9e-08 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 1e-12 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 3e-07 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 9e-07 | |
| d1fw4a_ | 65 | a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: | 1e-12 | |
| d2fcea1 | 61 | a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [ | 1e-12 | |
| d5pala_ | 109 | a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis | 2e-12 | |
| d5pala_ | 109 | a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis | 5e-10 | |
| d5pala_ | 109 | a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis | 7e-09 | |
| d1juoa_ | 172 | a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: | 2e-12 | |
| d1juoa_ | 172 | a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: | 1e-10 | |
| d1fi5a_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), | 2e-12 | |
| d1fi5a_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), | 4e-05 | |
| d2pvba_ | 107 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 2e-12 | |
| d2pvba_ | 107 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 2e-07 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-12 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 5e-05 | |
| d1cb1a_ | 78 | a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax | 2e-12 | |
| d1snla_ | 99 | a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo | 3e-12 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 3e-12 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 3e-05 | |
| d1qx2a_ | 76 | a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax | 7e-12 | |
| d1omra_ | 201 | a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: | 2e-11 | |
| d1omra_ | 201 | a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: | 5e-06 | |
| d1omra_ | 201 | a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: | 9e-05 | |
| d1wlza1 | 83 | a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H | 2e-11 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 2e-11 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 1e-10 | |
| d3c1va1 | 93 | a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa | 6e-11 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 2e-10 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 5e-09 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 3e-10 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 8e-10 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 3e-10 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 2e-06 | |
| d1zfsa1 | 93 | a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus no | 6e-10 | |
| d1a4pa_ | 92 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 8e-10 | |
| d1yuta1 | 98 | a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sa | 8e-10 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 9e-10 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 2e-06 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 0.002 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 1e-09 | |
| d2jxca1 | 95 | a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [ | 1e-09 | |
| d1c07a_ | 95 | a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: | 2e-09 | |
| d1fi6a_ | 92 | a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: | 5e-09 | |
| d1xo5a_ | 180 | a.39.1.5 (A:) Calcium- and integrin-binding protei | 6e-09 | |
| d1xo5a_ | 180 | a.39.1.5 (A:) Calcium- and integrin-binding protei | 1e-06 | |
| d1ksoa_ | 93 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 2e-08 | |
| d2zkmx1 | 170 | a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human | 4e-08 | |
| d1psra_ | 100 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 6e-08 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 7e-08 | |
| d1xk4a1 | 87 | a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sa | 2e-07 | |
| d1e8aa_ | 87 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 3e-07 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 3e-07 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 1e-04 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 9e-07 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 2e-06 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 9e-07 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 1e-05 | |
| d1jfja_ | 134 | a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly | 1e-06 | |
| d1jfja_ | 134 | a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly | 4e-04 | |
| d1iq3a_ | 110 | a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9 | 2e-06 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 2e-06 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 4e-06 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 0.002 | |
| d1y1xa_ | 182 | a.39.1.8 (A:) Programmed cell death 6 protein-like | 3e-06 | |
| d1y1xa_ | 182 | a.39.1.8 (A:) Programmed cell death 6 protein-like | 1e-04 | |
| d1qjta_ | 99 | a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: | 4e-06 | |
| d1k8ua_ | 89 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 4e-06 | |
| d1ggwa_ | 140 | a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo | 3e-05 | |
| d1ggwa_ | 140 | a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo | 3e-05 | |
| d1j55a_ | 94 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 2e-04 | |
| d3cr5x1 | 90 | a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos tauru | 3e-04 | |
| d1qlsa_ | 95 | a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), | 3e-04 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 6e-04 | |
| d2hf5a1 | 33 | a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien | 0.001 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 289 bits (741), Expect = 6e-96
Identities = 121/299 (40%), Positives = 179/299 (59%), Gaps = 5/299 (1%)
Query: 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
K ED++ Y F LG G F L + T + A K I+K+ L + + ++ EI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIA 59
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
++ + PNIV YE ++++M+L +GGELFDRI+ KG Y+ER A+ + +++
Sbjct: 60 VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
V H +G++HRDLKPEN L S DE++ + +DFGLS + G V G+ YVAP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
EVL ++ Y K +D WS GVI YILL G PPF+ E + +F+ IL+ + +F+S W IS
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
SAKD +R ++ +DP+KR T Q L+HPWI G A DK I +V ++K+ A +K K+
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (696), Expect = 8e-89
Identities = 82/300 (27%), Positives = 154/300 (51%), Gaps = 12/300 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y ++LGRG+FG+ + C E S+ + + K + + D+ +K+EI I+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-H 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHF 198
NI+ ++E + + ++ E +G ++F+RI +ER S + + H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RR 257
+ H D++PEN + + ++ +K +FG + ++ G +R + + Y APEV +
Sbjct: 121 HNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
D+WS G ++Y+LLSG+ PF AET + I + I+ + F+ + IS A D V
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAE 377
R+L ++ K R+T+++ L+HPW+K+ E + + V+ +K R + L K L ++
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 270 bits (691), Expect = 1e-87
Identities = 102/349 (29%), Positives = 170/349 (48%), Gaps = 33/349 (9%)
Query: 58 KQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL 117
K+ VP+P G Y+ +Y +ELG G FGV + C E +TGR F K I+
Sbjct: 13 KKYVPQP-VEVKQGSVYD----YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 67
Query: 118 VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH- 176
+ DK +K EI IM L P ++ A+EDK + +++E +GGELFDRI A+ +
Sbjct: 68 L---DKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
SE + R + H ++H D+KPEN + +K + +K DFGL+ +
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPD 182
Query: 237 KVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
++ + +A + APE++ R G D+W+ GV+ Y+LLSG+ PF E + + +
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
Query: 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE----------- 344
D +F+ + ++S AKD ++ +L ++P+KR+T LEHPW+K
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 302
Query: 345 ----------ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEE 383
+D P + R+ F ++ K + ++ +E
Sbjct: 303 NKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 268 bits (687), Expect = 4e-87
Identities = 102/319 (31%), Positives = 155/319 (48%), Gaps = 14/319 (4%)
Query: 57 LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRK 116
KQ P+P ++ V HY +ELG G FGV + TE +TG FA K +
Sbjct: 9 WKQYYPQPVE-----IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 63
Query: 117 LVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-G 175
++DK+ +++EIQ M L P +V A+ED + ++ E +GGELF+++ +
Sbjct: 64 ---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 119
Query: 176 HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
SE A R + + H +H DLKPEN + ++ + LK DFGL+ ++
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDP 178
Query: 236 GKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294
+ + G+A + APEV + G D+WS GV+ YILLSG+ PF E + +
Sbjct: 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
D + + + + IS KD +R++L DP R+T Q LEHPW+ G
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS--QIP 296
Query: 355 LSRMKQFRAMNKLKKLALK 373
SR + R K K A
Sbjct: 297 SSRYTKIRDSIKTKYDAWP 315
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 265 bits (677), Expect = 9e-87
Identities = 96/275 (34%), Positives = 150/275 (54%), Gaps = 16/275 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT------KNDKDDIKREIQIM 133
+Y + LGRG V C T +++A K I + + ++ +E+ I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
+ +SG PNI++ K YE +V +L GELFD + K SE+ I R+++ V+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H + ++HRDLKPEN LL D++ +K TDFG S ++ G+ R++ G+ Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 254 L-------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306
+ YGKE+D+WS GVI+Y LL+G PPFW + + I+ G+ F S W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
S + KDLV R L P+KR T+ + L HP+ ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 2e-83
Identities = 108/272 (39%), Positives = 161/272 (59%), Gaps = 6/272 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KDDIKREIQ 131
E+V +Y G+ELG GQF V C E STG Q+A K I KR+ + ++DI+RE+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + PN++ YE+K V +++EL AGGELFD + K +E A + I+N
Sbjct: 66 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + + H DLKPEN +L ++ +K DFGL+ I+ G +++I G+ +VA
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ + + +FE + S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ AKD +RR+L +DPKKR+T L+HPWIK
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (650), Expect = 9e-83
Identities = 84/263 (31%), Positives = 136/263 (51%), Gaps = 10/263 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G+ LG+G+FG YL E + A K + K +L + ++RE++I HL
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 65
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNI+ G + D V++++E G ++ + + E+ A+ + N + CH
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY 258
V+HRD+KPEN LL S E LK DFG SV + + G+ Y+ PE++ R +
Sbjct: 126 RVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH 181
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+++D+WS GV+ Y L G PPF A T + + I + + F ++ A+DL+ R
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISR 237
Query: 319 MLTQDPKKRITSAQVLEHPWIKE 341
+L +P +R +VLEHPWI
Sbjct: 238 LLKHNPSQRPMLREVLEHPWITA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 251 bits (643), Expect = 4e-81
Identities = 78/323 (24%), Positives = 137/323 (42%), Gaps = 20/323 (6%)
Query: 64 PDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
PD + K +D + +S +E+G G FG Y + A K +S +
Sbjct: 2 PDVAELFFK--DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA 183
DI +E++ +Q L PN ++++G Y + + +VME C G + K E A
Sbjct: 60 QDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
++ + + H ++HRD+K N LL E L+K DFG + + + V
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---V 172
Query: 244 GSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
G+ Y++APEV+ +Y ++D+WS G+ L PP + I Q +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMK 359
S ++ V L + P+ R TS +L+H ++ + ++ R K
Sbjct: 233 AL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---RERPPTVIMDLIQRTK 287
Query: 360 QFRAMNKLKKLALKVIAENLSTE 382
A+ +L L + + + L E
Sbjct: 288 D--AVRELDNLQYRKMKKILFQE 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 5e-81
Identities = 97/313 (30%), Positives = 155/313 (49%), Gaps = 19/313 (6%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
+ LG G G T +FA K + +RE+++ S P+IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIV 68
Query: 144 EFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICH 197
YE+ ++ + +VME GGELF RI +G ++ER A+ I +SI + H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-R 256
+ + HRD+KPEN L +SK NA+LK TDFG + + YYVAPEVL
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWPTISSSA 312
+Y K D+WS GVI+YILL G PPF++ G+ I G +F + W +S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
K L+R +L +P +R+T + + HPWI + + P+ ++ + + + R + +++
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTS 308
Query: 373 KVIAENLSTEEIQ 385
+ + E+I+
Sbjct: 309 ALATMRVDYEQIK 321
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 2e-79
Identities = 83/266 (31%), Positives = 133/266 (50%), Gaps = 12/266 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ FGK LG G F L E +T R++A K + KR ++ +N + RE +M L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P V+ ++D + ++ + GEL I G + E IV+ + H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI---EEGKVYRDIVGSAYYVAPEVLR- 255
G++HRDLKPEN LL +E+ ++ TDFG + + + VG+A YV+PE+L
Sbjct: 128 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ K D+W+ G I+Y L++G+PPF A E IF I++ + DF A+DL
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDL 240
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKE 341
V ++L D KR+ ++ + +K
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 1e-78
Identities = 79/275 (28%), Positives = 138/275 (50%), Gaps = 15/275 (5%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P+ + + + LG G +G L T A K + ++ V + ++IK+EI I
Sbjct: 2 PFVE---DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI 56
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
+ L+ N+V+F G + ++ +E C+GGELFDRI E A ++
Sbjct: 57 NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 115
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI---EEGKVYRDIVGSAYYV 249
V H +G+ HRD+KPEN LL +D LK +DFGL+ ++ + G+ YV
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 250 APEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
APE+L+RR + + +D+WS G++L +L+G P+ ++ + + + + PW
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKK 231
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
I S+ L+ ++L ++P RIT + + W +
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 2e-78
Identities = 81/277 (29%), Positives = 138/277 (49%), Gaps = 11/277 (3%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D K Y+ +++G+G G Y + +TG++ A + ++ ++ + K+ I EI +M+
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMR 72
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEV 253
H V+HRD+K +N LL +K TDFG I E +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
+ R+ YG ++DIWS G++ ++ G PP+ E I E +S+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF 246
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
+D + R L D +KR ++ ++L+H ++K S
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 3e-78
Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 25/292 (8%)
Query: 74 YEDVKL------HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
YE V + ELG G FG Y T A K I + + + +D
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYM 57
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSERAAASIC 186
EI I+ PNIV+ A+ + ++ +++E CAGG + ++ + +E +C
Sbjct: 58 VEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGS 245
+ ++ ++ H ++HRDLK N L + +K DFG+S RD +G+
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173
Query: 246 AYYVAPEVL------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
Y++APEV+ R Y + D+WS G+ L + PP + I + +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ P SS+ KD +++ L ++ R T++Q+L+HP++ S+KPI
Sbjct: 234 TLAQP-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT---VDSNKPIR 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (604), Expect = 8e-76
Identities = 59/267 (22%), Positives = 118/267 (44%), Gaps = 14/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
F E+GRG F Y + T + A + RKL TK+++ K E ++++ L P
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HP 68
Query: 141 NIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
NIV F ++E K+ + +V EL G L + + S CR I+ +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 197 HFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRDLK +N ++ +K D GL+ + + ++G+ ++APE+
Sbjct: 129 HTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY 185
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPTISSSAK 313
+Y + +D+++ G+ + + + P+ + I+ + G K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK 243
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340
+++ + Q+ +R + +L H + +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 5e-74
Identities = 70/264 (26%), Positives = 127/264 (48%), Gaps = 10/264 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K LG+G FG +L T + FA K++ K ++ +D + E +++ P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ ++ K+++ VME GG+L I + + A I+ + H G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEVLR-RRY 258
+++RDLK +N L D++ +K DFG+ G G+ Y+APE+L ++Y
Sbjct: 124 IVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+D WS GV+LY +L G PF + E+ +F +I + + + AKDL+ +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLVK 236
Query: 319 MLTQDPKKRITSA-QVLEHPWIKE 341
+ ++P+KR+ + +HP +E
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 2e-73
Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +G G +G S G+ K + + T+ +K + E+ +++ L P
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HP 63
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVH 194
NIV + D+ ++++VME C GG+L I + + E + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 195 ICHFMG-----VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYY 248
CH V+HRDLKP N L D +K DFGL+ + + + VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 249 VAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
++PE + R Y ++ DIWS G +LY L + +PPF A ++K + I +G
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 237
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
S +++ RML R + ++LE+P I
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 3e-72
Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 49/304 (16%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ ELG G GV + + +G A K I ++ I RE+Q++ +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-S 63
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P IV F GA+ + + ME GG L + G E+ + +++ +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 200 -GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RR 257
+MHRD+KP N L++S+ E +K DFG+S + + VG+ Y++PE L+
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH 179
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEK---GIFDAILQGDIDFESA----------- 303
Y + DIWS G+ L + G P K +F ++GD
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 304 --------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
P S +D V + L ++P +R Q++ H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 338 WIKE 341
+IK
Sbjct: 300 FIKR 303
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 228 bits (581), Expect = 8e-72
Identities = 78/268 (29%), Positives = 132/268 (49%), Gaps = 16/268 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G FG +L GR +A K + K +V + E ++ ++
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P I+ G ++D Q + ++M+ GGELF + + A + + H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY 258
+++RDLKPEN LL D+N +K TDFG + ++ + V + G+ Y+APEV+ + Y
Sbjct: 124 DIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
K ID WS G+++Y +L+G PF+ ++ IL ++ F P + KDL+ R
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSR 234
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341
++T+D +R+ + V HPW KE
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 226 bits (576), Expect = 1e-71
Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 7/267 (2%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y G+ LG G +L + R A K + + +RE Q L+
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-H 66
Query: 140 PNIVEFKGAYEDKQS----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
P IV E + ++VME G L D + +G + + A + ++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFG-LSVFIEEGKVYRDIVGSAYYVAPEVL 254
H G++HRD+KP N ++S+ + ++ ++ ++G+A Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 255 R-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
R D++S G +LY +L+G PPF ++ + ++ D SA +S+
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340
+V + L ++P+ R +A + ++
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-70
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 20/269 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHL 136
Y G LG G FG Y S A K + K ++ + + + E+ +++ +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 137 SGQ-PNIVEFKGAYEDKQSVHVVMELCAGG-ELFDRIIAKGHYSERAAASICRSIVNVVH 194
S ++ +E S +++E +LFD I +G E A S ++ V
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
CH GV+HRD+K EN L+ LK DFG +++ Y D G+ Y PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWI 181
Query: 255 R--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
R R +G+ +WS G++LY ++ G PF + E I++G + F +SS
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 231
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ L+R L P R T ++ HPW+++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 224 bits (572), Expect = 8e-70
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-- 137
+S + +GRG FG Y C + TG+ +A K + K+++ K + E ++ +S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
P IV A+ + +++L GG+L + G +SE I+ + H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR- 256
V++RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++
Sbjct: 125 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKG 180
Query: 257 -RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
Y D +S G +L+ LL G PF K I + + + S + L
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSL 239
Query: 316 VRRMLTQDPKKRITS-----AQVLEHPWIKE 341
+ +L +D +R+ +V E P+ +
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-68
Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 15/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + K LG+G FG L E +TGR +A K + K ++ K++ E +++Q+
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P + K A++ + VME GGELF + + ++E A IV+ + H
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRR-R 257
V++RD+K EN +L D++ +K TDFGL +G + G+ Y+APEVL
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YG+ +D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLA 237
Query: 318 RMLTQDPKKRITSA-----QVLEHPWIKE 341
+L +DPK+R+ +V+EH +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-66
Identities = 90/356 (25%), Positives = 135/356 (37%), Gaps = 57/356 (16%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
DV Y+ +G G +G+ +N + A K IS + + REI+I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62
Query: 136 LSGQPNIVEFKGA-----YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
NI+ E + V++V L G +++ H S I+
Sbjct: 63 FR-HENIIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQIL 119
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSA 246
+ H V+HRDLKP N LL + LK DFGL+ + + V +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 247 YYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304
+Y APE++ Y K IDIWS G IL +LS P F + + IL
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 305 W---------------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
P S A DL+ +MLT +P KRI Q L HP
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296
Query: 338 WIKEGGEASDKPIDSAVLSRMKQFRAMNK--LKKLALKVIAENLSTEEIQGLKQMF 391
++++ + SD+PI A + + K LK+L EE + +
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF---------EETARFQPGY 343
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-65
Identities = 72/286 (25%), Positives = 110/286 (38%), Gaps = 33/286 (11%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--DDIKREIQIMQHLSGQPNI 142
LG GQF Y + +T + A K I D REI+++Q LS PNI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
+ A+ K ++ +V + + + + + H ++
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEVLR--RRYG 259
HRDLKP N LL DEN +LK DFGL+ + Y V + +Y APE+L R YG
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP------------- 306
+D+W+ G IL LL VP +++ I + WP
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 307 -----------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
DL++ + +P RIT+ Q L+ +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-65
Identities = 58/267 (21%), Positives = 103/267 (38%), Gaps = 19/267 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G+ +G G FG Y A K ++ T K E+ +++
Sbjct: 9 QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-H 63
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHICHF 198
NI+ F G Y + +V + C G L+ + I + + I R + H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLR 255
++HRDLK N L E+ +K DFGL+ + + GS ++APEV+R
Sbjct: 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 256 ----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP--WPTIS 309
Y + D+++ G++LY L++G P+ + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ K L+ L + +R Q+L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-65
Identities = 82/276 (29%), Positives = 144/276 (52%), Gaps = 17/276 (6%)
Query: 80 HYSFGKELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQH 135
++ K LG G +G +L + + TG+ +A K + K +V K + + E Q+++H
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ P +V A++ + +H++++ GGELF + + ++E IV +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE--EGKVYRDIVGSAYYVAPEV 253
H +G+++RD+K EN LL D N + TDFGLS E + D G+ Y+AP++
Sbjct: 145 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 254 LR---RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
+R + K +D WS GV++Y LL+G PF + EK I + + E +S+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 311 SAKDLVRRMLTQDPKKRITSA-----QVLEHPWIKE 341
AKDL++R+L +DPKKR+ ++ EH + ++
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-64
Identities = 73/318 (22%), Positives = 119/318 (37%), Gaps = 48/318 (15%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P+ D Y ++G+G FG + TG++ A K + + REI+I
Sbjct: 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKI 62
Query: 133 MQHLSGQPNIVEFKGAYEDKQS--------VHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+Q L N+V K S +++V + C ++
Sbjct: 63 LQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-----VY 239
+ + ++N ++ H ++HRD+K N L+ + +LK DFGL+ K Y
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 240 RDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
+ V + +Y PE+L R YG ID+W AG I+ + + P TE+ I Q
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 298 IDFESAPWPTI----------------------------SSSAKDLVRRMLTQDPKKRIT 329
WP + A DL+ ++L DP +RI
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 330 SAQVLEHPWIKEGGEASD 347
S L H + SD
Sbjct: 299 SDDALNHDFFWSDPMPSD 316
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 205 bits (522), Expect = 5e-63
Identities = 75/324 (23%), Positives = 134/324 (41%), Gaps = 58/324 (17%)
Query: 65 DTNTILGKPYEDVKLH---------YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKR 115
D NT + Y D + H Y ++LGRG++ + + + K +
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71
Query: 116 KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIA 173
K K IKREI+I+++L G PNI+ +D ++ +V E +
Sbjct: 72 K------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-- 123
Query: 174 KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
++ I+ + CH MG+MHRD+KP N ++ + L+ D+GL+ F
Sbjct: 124 -QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 180
Query: 234 EEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETE----- 286
G+ Y V S Y+ PE+L + Y +D+WS G +L ++ PF+ +
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 287 ---------KGIFDAILQGDID--------------------FESAPWPTISSSAKDLVR 317
+ ++D I + +I+ S +S A D +
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
Query: 318 RMLTQDPKKRITSAQVLEHPWIKE 341
++L D + R+T+ + +EHP+
Sbjct: 301 KLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-62
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 34/290 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +++G G +G + T A K + + REI +++ L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH-K 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV + + +V E C G S ++ + CH
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-- 257
V+HRDLKP+N L++ E K +FGL+ F + Y V + +Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 258 YGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPWPT--------- 307
Y ID+WSAG I L + P F I + WP+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 308 ----------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
++++ +DL++ +L +P +RI++ + L+HP+ +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (513), Expect = 4e-62
Identities = 84/289 (29%), Positives = 126/289 (43%), Gaps = 34/289 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +++G G +GV Y +N+ G FA K I K + REI I++ L
Sbjct: 4 YHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HS 60
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV+ K+ + +V E + +G A S ++N + CH
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLR--RR 257
V+HRDLKP+N L++ + E LK DFGL+ + Y + + +Y AP+VL ++
Sbjct: 121 VLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI--------- 308
Y IDIWS G I +++G P F +E I + S WP +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 309 ----------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
S DL+ +ML DP +RIT+ Q LEH + KE
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-61
Identities = 77/344 (22%), Positives = 126/344 (36%), Gaps = 48/344 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P ++ Y+ K +G G FGV Y +G A K + + DK RE+QI
Sbjct: 14 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQI 66
Query: 133 MQHLSGQPNIVEFKGAY------EDKQSVHVVMELCAGG---ELFDRIIAKGHYSERAAA 183
M+ L NIV + + +D+ +++V++ AK
Sbjct: 67 MRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ + H G+ HRD+KP+N LL K DFG + + G+ +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL--KLCDFGSAKQLVRGEPNVSYI 183
Query: 244 GSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG----- 296
S YY APE++ Y ID+WSAG +L LL G P F ++ I++
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 297 --------------------DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ P A L R+L P R+T + H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQF--RAMNKLKKLALKVIAEN 378
+ E + + K + + F + ++ LA +I +
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPH 347
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-61
Identities = 67/337 (19%), Positives = 134/337 (39%), Gaps = 45/337 (13%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ K +V+ Y + +G G +G + TG + A K + R ++ RE
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRE 67
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQS------VHVVMELCAGGELFDRIIAKGHYSERAAA 183
+++++H+ N++ + ++ ++VM G +++ E
Sbjct: 68 LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 124
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ ++ + H G++HRDLKP N + +E+ LK DFGL+ + V
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYV 179
Query: 244 GSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
+ +Y APEV+ RY + +DIWS G I+ +++G F I++
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 302 SAPW---------------------------PTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+ S A +L+ +ML D ++R+T+ + L
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 335 EHPWIKEGGEASDKPIDSAVLSRMKQF-RAMNKLKKL 370
HP+ + + D+P R +++ K++
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-61
Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 37/295 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTE-NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
Y E+G G +G + + + GR A K + + + RE+ +++HL
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLET 66
Query: 139 Q--PNIVEFKGAYEDKQS-----VHVVMELCAGGEL-FDRIIAKGHYSERAAASICRSIV 190
PN+V ++ + +V E + + + + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
+ H V+HRDLKP+N L++S + K DFGL+ +V + +Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 251 PEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP--- 306
PEVL + Y +D+WS G I + P F ++ IL WP
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 307 --------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
I KDL+ + LT +P KRI++ L HP+ ++
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 2e-60
Identities = 52/288 (18%), Positives = 101/288 (35%), Gaps = 22/288 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y G+++G G FG YL T+ + G + A K K + E +I + + G
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 62
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
I + + +VMEL +S + + +++ + H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--------RDIVGSAYYVAP 251
+HRD+KP+NFL+ + L+ DFGL+ + + + +++ G+A Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP----WP 306
+ D+ S G +L G P+ + S P
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 307 TISSSAKDLVRRMLTQDPKKRITSA---QVLEHPWIKEGGEASDKPID 351
S + + + + Q+ + + ++G D D
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS-YDYVFD 289
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 3e-60
Identities = 79/268 (29%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ K LG G FG L +G +A K + K+K+V + E +I+Q ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P +V+ + +++D ++++VME AGGE+F + G +SE A IV H +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY 258
+++RDLKPEN L+ D+ ++ TDFG + ++ + G+ +APE++ + Y
Sbjct: 161 DLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGY 215
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
K +D W+ GV++Y + +G PPF+A+ I++ I+ G + F SS KDL+R
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRN 271
Query: 319 MLTQDPKKRITSA-----QVLEHPWIKE 341
+L D KR + + H W
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-59
Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 34/291 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++ +++G G +GV Y TG A K I T+ REI +++ L+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-H 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCA-GGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
PNIV+ + +++V E + F A S ++ + CH
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR-- 255
V+HRDLKP+N L+ + +K DFGL+ F + Y V + +Y APE+L
Sbjct: 121 HRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW---------- 305
+ Y +DIWS G I +++ F ++E I + + W
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 306 ---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P + + L+ +ML DP KRI++ L HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-59
Identities = 57/262 (21%), Positives = 110/262 (41%), Gaps = 17/262 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+F KELG GQFGV A K I + + +D+ E ++M +LS
Sbjct: 5 DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHF 198
+V+ G ++ + ++ E A G L + + + + + +C+ + +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLR- 255
+HRDL N L+ ++ ++K +DFGLS ++ + + + PEVL
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
++ + DIW+ GV+++ + S G P+ T + I QG + S
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVYT 232
Query: 315 LVRRMLTQDPKKRITSAQVLEH 336
++ + +R T +L +
Sbjct: 233 IMYSCWHEKADERPTFKILLSN 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-58
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 40/314 (12%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
L K +V Y +G G +G + TG + A K +S+ + RE
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 67
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSV----HVVMELCAGGELFDRIIAKGHYSERAAASI 185
+++++H+ N++ + +S+ V + G + I+ ++ +
Sbjct: 68 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
I+ + H ++HRDLKP N +E+ LK DFGL+ V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHT--DDEMTGYVAT 181
Query: 246 AYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-- 301
+Y APE++ Y + +DIWS G I+ LL+G F IL+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 302 -------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ + + A DL+ +ML D KRIT+AQ L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 337 PWIKEGGEASDKPI 350
+ + + D+P+
Sbjct: 302 AYFAQYHDPDDEPV 315
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-58
Identities = 61/274 (22%), Positives = 103/274 (37%), Gaps = 24/274 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
F +G G FG G + ++ +K+D D E++++ L P
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRI----------------IAKGHYSERAAAS 184
NI+ GA E + +++ +E G L D + S +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ + +HRDL N L+ EN + K DFGLS E
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFES 302
++A E L Y D+WS GV+L+ ++S G P+ T +++ + QG +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRL 245
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
DL+R+ + P +R + AQ+L
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-58
Identities = 55/262 (20%), Positives = 102/262 (38%), Gaps = 21/262 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +G+G+FG L G + A K I E +M L
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-H 59
Query: 140 PNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHIC 196
N+V+ G E+K +++V E A G L D + ++G + +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR- 255
+HRDL N L+ E+ + K +DFGL+ + + APE LR
Sbjct: 120 EGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
+++ + D+WS G++L+ + S G P+ K + + +G ++ + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYE 231
Query: 315 LVRRMLTQDPKKRITSAQVLEH 336
+++ D R + Q+ E
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-58
Identities = 64/272 (23%), Positives = 104/272 (38%), Gaps = 23/272 (8%)
Query: 85 KELGRGQFGVTYLCT--ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
KELG G FG + A K + K + KD++ E +MQ L P I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-NPYI 70
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
V G E +S +VME+ G L + H ++ + + + +
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLR-RR 257
HRDL N LL ++ K +DFGLS + + Y + APE + +
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 258 YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+ + D+WS GV+++ S G P+ + + +G+ DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM 243
Query: 317 RRMLTQDPKKRITSAQV---LEHPW---IKEG 342
T D + R A V L + + + EG
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-58
Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 17/262 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+F +E+G GQFG+ +L + A K+I + + ++D E ++M LS
Sbjct: 6 ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-H 59
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHF 198
P +V+ G ++ + +V E G L D + + ++ +C + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLR- 255
V+HRDL N L+ EN ++K +DFG++ F+ + + + +PEV
Sbjct: 120 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
RY + D+WS GV+++ + S G P+ + + + I G F S+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQ 233
Query: 315 LVRRMLTQDPKKRITSAQVLEH 336
++ + P+ R +++L
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-57
Identities = 62/287 (21%), Positives = 119/287 (41%), Gaps = 21/287 (7%)
Query: 63 RPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND 122
+P T + +E + +LG+G FG ++ T N T R A K++ +
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----S 55
Query: 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSER 180
+ +E Q+M+ L +V+ ++ +++V E + G L D + + +
Sbjct: 56 PEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ I + + M +HRDL+ N L+ EN + K DFGL+ IE+ +
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 170
Query: 241 D--IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ APE R+ + D+WS G++L L + G P+ + + D + +G
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230
Query: 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341
+ P S DL+ + ++P++R T + +
Sbjct: 231 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 9e-57
Identities = 58/288 (20%), Positives = 104/288 (36%), Gaps = 36/288 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHL 136
+ FGK LG G FG T + ++ + L K D + + E+++M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-------------------- 176
NIV GA ++++ E C G+L + + +K
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 177 ---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
+ + + F +HRDL N L+ ++K DFGL+ I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI 214
Query: 234 EEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG 288
V + ++APE L Y + D+WS G++L+ + S GV P+
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
F ++Q + + +++ D +KR + +
Sbjct: 275 NFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-56
Identities = 56/267 (20%), Positives = 93/267 (34%), Gaps = 17/267 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
++LG G FGV + A K + L DD RE+ M L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHI 195
N++ G + +V EL G L DR+ GH+ + + +
Sbjct: 69 D-HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY----RDIVGSAYYVAP 251
+HRDL N LL+++D +K DFGL + + + + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
E L+ R + D W GV L+ + + G P+ I I +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCP 241
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336
+++ + P+ R T + +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 2e-56
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 17/267 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISK-RKLVTKNDKDDIKREIQIMQHLSG 138
+ +G G+FG G++ +I + T+ + D E IM
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD- 85
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICH 197
PN++ +G V ++ E G L + G ++ + R I +
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY------RDIVGSAYYVAP 251
M +HRDL N L+ + N + K +DFGLS F+E+ + AP
Sbjct: 146 DMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
E ++ R++ D+WS G++++ ++S G P+W T + + +AI Q D+ P
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCP 259
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336
S+ L+ +D R Q++
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-55
Identities = 67/316 (21%), Positives = 118/316 (37%), Gaps = 53/316 (16%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y K +G G G+ + R A K +S+ + RE+ +M+ ++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN-H 75
Query: 140 PNIVEFKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
NI+ + E+ Q V++VMEL + + + ++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H G++HRDLKP N ++ S K DFGL+ + V + YY APEV
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 254 LRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--------------- 297
+ Y + +DIWS G I+ ++ F ++ +++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 298 -----------------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+S +S A+DL+ +ML DP KRI+ L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 335 EHPWIKEGGEASDKPI 350
+HP+I + ++
Sbjct: 310 QHPYINVWYDPAEVEA 325
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-55
Identities = 60/266 (22%), Positives = 96/266 (36%), Gaps = 18/266 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
ELG G FG +Q ++ K D +++ RE QIM L P IV
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVR 73
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMH 203
G + +++ +VME+ GG L ++ K A + + + +H
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLR-RRY 258
RDL N LL ++ + +DFGLS + Y + APE + R++
Sbjct: 133 RDLAARNVLLVNRHYAKI---SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 259 GKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
D+WS GV ++ LS G P+ + I QG P L+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMS 246
Query: 318 RMLTQDPKKRITSAQV---LEHPWIK 340
+ R V + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 5e-55
Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 14/263 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSI-SKRKLVTKNDKDDIKREIQIMQHLSG 138
G+ +G GQFG + S +I + + + + ++ +E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICH 197
P+IV+ G + V ++MELC GEL + + + + +
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLR 255
+HRD+ N L+SS D +K DFGLS ++E+ Y+ ++APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 256 -RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
RR+ D+W GV ++ IL+ GV PF + I G+ P +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLY 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEH 336
L+ + DP +R ++
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-54
Identities = 51/262 (19%), Positives = 95/262 (36%), Gaps = 19/262 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ LG GQFG ++ N + A KS+ + + D E +M+ L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICH 197
+V + ++++ E G L D + + + I +
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLR 255
+HRDL+ N L+S K DFGL+ IE+ + + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 256 -RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
+ + D+WS G++L +++ G P+ T + + +G +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELY 240
Query: 314 DLVRRMLTQDPKKRITSAQVLE 335
L+R + P+ R T +
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRS 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 6e-54
Identities = 53/269 (19%), Positives = 103/269 (38%), Gaps = 17/269 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +LG GQ+G Y A K++ + + + ++ +E +M+ +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 72
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIVNVVHICH 197
PN+V+ G + +++ E G L D + S + I + +
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLR 255
+HRDL N L+ EN L+K DFGLS + + APE L
Sbjct: 133 KKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 256 R-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
++ + D+W+ GV+L+ + + + + +L+ D E +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPEKVYE 247
Query: 315 LVRRMLTQDPKKRITSAQVLE--HPWIKE 341
L+R +P R + A++ + +E
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-52
Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 14/263 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISK--RKLVTKNDKDDIKREIQIMQHLSG 138
+ K LG G FG Y G + K R+ + +I E +M +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
P++ G + + G L K + + + C I ++
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD---IVGSAYYVAPEVLR 255
++HRDL N L+ +K TDFGL+ + + ++A E +
Sbjct: 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 256 -RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
R Y + D+WS GV ++ L++ G P+ I + +G+ P +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVY 243
Query: 314 DLVRRMLTQDPKKRITSAQVLEH 336
++ + D R +++
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-52
Identities = 62/284 (21%), Positives = 102/284 (35%), Gaps = 35/284 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
SFGK LG G FG T ++ A K + +++ + E++++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH------------------ 176
+L NIV GA V+ E C G+L + + K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
S + + +HRDL N LL+ K DFGL+ I+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 198
Query: 237 KVYR---DIVGSAYYVAPEVLRRRY-GKEIDIWSAGVILYILLS-GVPPFWAETEKGIFD 291
Y + ++APE + E D+WS G+ L+ L S G P+ F
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+++ S + D+++ DP KR T Q+++
Sbjct: 259 KMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (445), Expect = 5e-52
Identities = 48/289 (16%), Positives = 100/289 (34%), Gaps = 22/289 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY G+ +G G FGV + T +Q A K +R +D ++ E + + L+G
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGC 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
I ++ +V++L + +S + A + ++ V H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 200 GVMHRDLKPENFLLSSKD--ENALLKATDFGLSVFIEEG--------KVYRDIVGSAYYV 249
+++RD+KP+NFL+ + ++ DFG+ F + + +++ G+A Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP---- 304
+ R + D+ + G + L G P+ + +S P
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKEGGEASDKPID 351
+ + ++ D+ D
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 7e-52
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 43/290 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ + +++G G FG + A K + + + + + D +RE +M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY----------------- 177
PNIV+ G + + ++ E A G+L + + + +
Sbjct: 72 EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 178 -------SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
S I R + + +HRDL N L+ EN ++K DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS 187
Query: 231 VFIEEGKVYR---DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285
I Y+ + ++ PE + RY E D+W+ GV+L+ + S G+ P++
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + + G+I A +L+R ++ P R + +
Sbjct: 248 HEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-51
Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 30/282 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGR-------QFACKSISKRKLVTKNDKDDIKREIQI 132
GK LG G FG L + + A K + T+ D D+ E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEM 71
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI----------------IAKGH 176
M+ + NI+ GA ++V++E + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
S + S + + +HRDL N L++ + + I+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294
K + ++APE L R Y + D+WS GV+L+ + + G P+ + +F +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+G ++ ++R P +R T Q++E
Sbjct: 252 EG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-50
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 20/267 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
+ K +G G+FG Y ++ A K++ T+ + D E IM
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQ 65
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVH 194
S NI+ +G + + ++ E G L + K G +S + R I +
Sbjct: 66 FS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR----DIVGSAYYVA 250
M +HRDL N L+ + N + K +DFGLS +E+ + A
Sbjct: 125 YLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
PE + R++ D+WS G++++ +++ G P+W + + AI G F
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDC 238
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335
S+ L+ + Q+ +R A ++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-48
Identities = 57/276 (20%), Positives = 109/276 (39%), Gaps = 23/276 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ +H F + +GRG FG Y T + A KS+++ + E
Sbjct: 23 GPSSLIVH--FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTE 78
Query: 130 IQIMQHLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICR 187
IM+ S PN++ G + S VV+ G+L + I + H + +
Sbjct: 79 GIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-----I 242
+ + +HRDL N +L DE +K DFGL+ + + +
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 243 VGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300
++A E L+ +++ + D+WS GV+L+ L++ G PP+ I +LQG
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--- 251
Query: 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+++ + + R + ++++
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 7e-48
Identities = 54/288 (18%), Positives = 116/288 (40%), Gaps = 35/288 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ +ELG+G FG+ Y ++ + A K++++ + ++ + E +M+
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH----------YSERAAAS 184
+ ++V G Q V+MEL G+L + + S
Sbjct: 79 EFNC-HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR---D 241
+ I + + + +HRDL N ++ E+ +K DFG++ I E YR
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 242 IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDAILQGDID 299
+ +++PE L+ + D+WS GV+L+ + + P+ + + + +++G +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE------HPWIKE 341
+L+R +PK R + +++ P +E
Sbjct: 255 D---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-45
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 34/284 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
GK LGRG FG + +T R A K + + T ++ + E++I+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILI 71
Query: 135 HLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRI----------------IAKGHY 177
H+ N+V GA + + V++E C G L + + K
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
+ + + +HRDL N LL E ++K DFGL+ I +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDP 188
Query: 238 VY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDA 292
Y D ++APE + R Y + D+WS GV+L+ + S P+ F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
L+ + + + + +P +R T ++++EH
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 1e-43
Identities = 58/343 (16%), Positives = 118/343 (34%), Gaps = 68/343 (19%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
G+PY+D + Y ++LG G F +L + A K + K+ + + E
Sbjct: 6 KGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDE 59
Query: 130 IQIMQHLS----------GQPNIVEFKGAYEDKQSVHVVMEL-----CAGGELFDRIIAK 174
I+++Q ++ G +I++ + K V + + +
Sbjct: 60 IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
Query: 175 GHYSERAAASICRSIVN-VVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVF 232
I + ++ + ++ G++H D+KPEN L+ D L++ L
Sbjct: 120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD 291
+ Y + + + Y +PEVL +G DIWS +++ L++G F +
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
Query: 292 AI--------------------------------------------LQGDIDFESAPWPT 307
L+ + +
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+ D + ML DP+KR + ++ HPW+K+ + +
Sbjct: 300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-42
Identities = 52/296 (17%), Positives = 96/296 (32%), Gaps = 51/296 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ +G+G+FG + G + A K S R+ + EI L
Sbjct: 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HE 57
Query: 141 NIVEFKGAYEDKQS----VHVVMELCAGGELFDRIIAKGHYSERA-------AASICRSI 189
NI+ F A + +V + G LFD + E A+ +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-----IVG 244
+ +V + HRDLK +N L+ +N D GL+V + D VG
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 245 SAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKG--------- 288
+ Y+APEVL K DI++ G++ + + +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 289 ------IFDAILQGDIDF---ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + + + ++R + R+T+ ++ +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 92.7 bits (230), Expect = 8e-24
Identities = 50/77 (64%), Positives = 64/77 (83%)
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV 432
K +AE LS EEI GLK++F IDTDNSGTIT++ELK GL R+GS+L E+E++ LM+AAD+
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70
Query: 433 DGNGTIDYIEFITATMH 449
D +GTIDY EFI AT+H
Sbjct: 71 DKSGTIDYGEFIAATVH 87
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 44.9 bits (106), Expect = 7e-07
Identities = 18/78 (23%), Positives = 29/78 (37%), Gaps = 8/78 (10%)
Query: 398 NSGTITYEELKAGLARLGSKLTEAEVQQLMEA---ADVDGNGTIDYIEFITATMHRHKLE 454
+SG I ++ + +L+E E+ L E D D +GTI + E
Sbjct: 2 SSGHIDDDDKH-----MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSEL 56
Query: 455 RDDHLYKAFQHFDKDNSG 472
+ + D D SG
Sbjct: 57 MESEIKDLMDAADIDKSG 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 1e-21
Identities = 43/209 (20%), Positives = 70/209 (33%), Gaps = 35/209 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD--------------- 125
+ GK +G G+ + C + + K K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
+ E + +Q L G + + + V+MEL EL+ +
Sbjct: 61 ARNEFRALQKLQG-LAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEV 108
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
I+ V + G++H DL N L+S + + DF SV + E +R+I+
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGEEG-WREILER 163
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYIL 274
R Y E DI S I IL
Sbjct: 164 DVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.9 bits (196), Expect = 4e-18
Identities = 28/110 (25%), Positives = 50/110 (45%), Gaps = 5/110 (4%)
Query: 366 KLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE- 422
KL+ ++ + E + + EIQ + F + SG ++ EE K ++
Sbjct: 3 KLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASKF 60
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + D +G+GTID+ EFI A + + + L AF +D D +G
Sbjct: 61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNG 110
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.6 bits (120), Expect = 5e-08
Identities = 20/164 (12%), Positives = 47/164 (28%), Gaps = 19/164 (11%)
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
++ + L P ++ + + + V + +
Sbjct: 24 QEWYKGFLRDCPSGHLSMEEFKKI-YGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFI 82
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR------------LGSKLTE 420
++ + Q LK F+ D D +G I+ E+ + E
Sbjct: 83 IALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPE 142
Query: 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
+++ D + +G + EFI + D + + Q
Sbjct: 143 KRTEKIFRQMDTNRDGKLSLEEFIRG------AKSDPSIVRLLQ 180
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.2 bits (106), Expect = 4e-06
Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 12/98 (12%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ +F D + GTI + E L+ E +++ D+DGNG I E +
Sbjct: 61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEI 120
Query: 447 TMHRHKLER------------DDHLYKAFQHFDKDNSG 472
+K+ + K F+ D + G
Sbjct: 121 VQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDG 158
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.8 bits (186), Expect = 7e-18
Identities = 32/76 (42%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
+ NL+ E+I K+ F D DN+G+I+ EL + LG +EAEV LM DVDGN
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGN 60
Query: 436 GTIDYIEFITATMHRH 451
I++ EF+ A M R
Sbjct: 61 HQIEFSEFL-ALMSRQ 75
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.5 bits (97), Expect = 9e-06
Identities = 15/60 (25%), Positives = 22/60 (36%), Gaps = 3/60 (5%)
Query: 416 SKLTEAEVQQLMEA---ADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
S LTE ++ + EA D D NG+I E T + + D D +
Sbjct: 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNH 61
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 78.9 bits (193), Expect = 8e-18
Identities = 62/97 (63%), Positives = 80/97 (82%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
AE LS EEI GLK++F IDTDNSGTIT++ELK GL R+GS+L E+E++ LM+AAD+D +
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60
Query: 436 GTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
GTIDY EFI AT+H +KLER+++L AF +FDKD SG
Sbjct: 61 GTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSG 97
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 77.6 bits (190), Expect = 1e-17
Identities = 38/97 (39%), Positives = 57/97 (58%), Gaps = 1/97 (1%)
Query: 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNG 436
E L+ E+I K+ F D D GTIT +EL + LG TEAE+Q ++ D DGNG
Sbjct: 1 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 60
Query: 437 TIDYIEFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
TID+ EF++ + + ++ L +AF+ FD+D +G
Sbjct: 61 TIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNG 97
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 56.1 bits (134), Expect = 3e-10
Identities = 24/58 (41%), Positives = 37/58 (63%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
L + F D D +G I+ EL+ + LG KLT+ EV +++ AD+DG+G I+Y EF+
Sbjct: 84 LIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFV 141
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 47.6 bits (112), Expect = 3e-07
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 1/87 (1%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLAR-LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
L+ M +D D +GTI + E + +AR + + +E E+ + + D DGNG I E
Sbjct: 47 LQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRH 106
Query: 446 ATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + DD + + + D D G
Sbjct: 107 VMTNLGEKLTDDEVDEMIREADIDGDG 133
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.7 bits (193), Expect = 1e-17
Identities = 21/97 (21%), Positives = 43/97 (44%), Gaps = 1/97 (1%)
Query: 377 ENLSTEEIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
+ + L++ + + SGT+ E K ++ V+ + A D +G+
Sbjct: 13 GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGD 72
Query: 436 GTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
TID++E++ A + + L F+ +DKD +G
Sbjct: 73 NTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNG 109
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.9 bits (100), Expect = 2e-05
Identities = 26/121 (21%), Positives = 47/121 (38%), Gaps = 20/121 (16%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
K KV +T+ ++ MF DT+ TI + E A L + E +++ +
Sbjct: 45 KRFFKVPDNEEATQYVE---AMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFK 101
Query: 429 AADVDGNGTIDYIEFITATMHRHKLER-----------------DDHLYKAFQHFDKDNS 471
D D NG ID E + +KL++ ++ + + F D++
Sbjct: 102 IYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGD 161
Query: 472 G 472
G
Sbjct: 162 G 162
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.4 bits (187), Expect = 2e-17
Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 1/98 (1%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
+ NL+ E+I K+ F D DN+G+I+ EL + LG +EAEV LM DVDGN
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGN 60
Query: 436 GTIDYIEFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
I++ EF+ + + + L +AF+ FDK+ G
Sbjct: 61 HQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDG 98
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.0 bits (134), Expect = 4e-10
Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 1/116 (0%)
Query: 330 SAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQ 389
S+ L G S+ ++ + + + + + S + Q L +
Sbjct: 28 SSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLE 87
Query: 390 MFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
F D + G I+ ELK L +G KLT+AEV ++ DG+G I+ +F
Sbjct: 88 AFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAA 142
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Score = 73.0 bits (179), Expect = 6e-17
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 3/84 (3%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
+ ++I +++F DT+ G I+ EL L L +T EV+++M D DG+G I
Sbjct: 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTL-GSVTPDEVRRMMAEIDTDGDGFIS 59
Query: 440 YIEFITATMHRHKLERDDHLYKAF 463
+ EF R + K F
Sbjct: 60 FDEFT--DFARANRGLVKDVSKIF 81
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 78.1 bits (191), Expect = 1e-16
Identities = 29/187 (15%), Positives = 64/187 (34%), Gaps = 14/187 (7%)
Query: 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQ--DPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ +++ S + K+ R+ Q ++ + ++ +A ++
Sbjct: 17 VHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAER 76
Query: 352 SAVLSRMKQFRAMNKLKKLA------------LKVIAENLSTEEIQGLKQMFTNIDTDNS 399
+R +L L L+ LS E+ L+Q+F + S
Sbjct: 77 EREAARGDAAAEKQRLASLLKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGS 136
Query: 400 GTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHL 459
G ++++LK LA+ + E +++L + D G + YI + L D
Sbjct: 137 GKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVADFRK 196
Query: 460 YKAFQHF 466
+
Sbjct: 197 IDTNSNG 203
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 57.7 bits (138), Expect = 7e-10
Identities = 13/57 (22%), Positives = 26/57 (45%), Gaps = 1/57 (1%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
++ D D SG ++ EE++ L + + + DVD + ++ Y EF+
Sbjct: 257 ILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFV 313
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 38.5 bits (88), Expect = 0.001
Identities = 21/115 (18%), Positives = 41/115 (35%), Gaps = 6/115 (5%)
Query: 357 RMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS 416
+F A + ++ + A + E Q L + +++ D SG K L S
Sbjct: 64 VQNEFDARERAERE--REAARGDAAAEKQRLASLLKDLEDDASGYNRLRPSKPML----S 117
Query: 417 KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNS 471
+ ++QL ++ V G+G + + + L K F + D
Sbjct: 118 EEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTK 172
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.3 bits (184), Expect = 2e-16
Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 5/110 (4%)
Query: 366 KLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE- 422
KLK ++ + + +E+Q + F I SG + + + +
Sbjct: 4 KLKPEVVEELTRKTYFTEKEVQQWYKGF--IKDCPSGQLDAAGFQKIYKQFFPFGDPTKF 61
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ D + +G I++ EFI A + D+ L AF+ +D DN G
Sbjct: 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDG 111
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 6e-08
Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 18/92 (19%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGS------------KLTEAEVQQLMEAADVDGNG 436
F D DN G IT E+ + + E V ++ D + +G
Sbjct: 100 WAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADG 159
Query: 437 TIDYIEFITATMHRHKLERDDHLYKAFQHFDK 468
+ EF + D + +A +D
Sbjct: 160 KLTLQEFQEG------SKADPSIVQALSLYDG 185
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 1e-06
Identities = 15/97 (15%), Positives = 34/97 (35%), Gaps = 12/97 (12%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
+F D + G I + E L+ + +++ + D+D +G I E +
Sbjct: 63 TFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIV 122
Query: 448 MHRHKL------------ERDDHLYKAFQHFDKDNSG 472
+++ + + + F DK+ G
Sbjct: 123 DAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADG 159
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 71.5 bits (175), Expect = 3e-16
Identities = 27/74 (36%), Positives = 39/74 (52%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
LS E I K F D D G I+ +EL + LG T+ E+ ++E D DG+GTI
Sbjct: 8 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 67
Query: 439 DYIEFITATMHRHK 452
D+ EF+ + + K
Sbjct: 68 DFEEFLVMMVRQMK 81
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 43.0 bits (101), Expect = 3e-06
Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 3/60 (5%)
Query: 416 SKLTEAEVQQLMEA---ADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L+E + + A D DG G I E T + + L + D+D SG
Sbjct: 6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 65
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 70.4 bits (172), Expect = 6e-16
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNS-GTITYEELKAGLARLGSKLTEAEVQQLMEAAD 431
K E L+ E+ K F G+I+ +EL + LG T E+Q++++ D
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 62
Query: 432 VDGNGTIDYIEFITATMHRH 451
DG+GT+D+ EF+ M R
Sbjct: 63 EDGSGTVDFDEFLVM-MVRS 81
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 69.1 bits (169), Expect = 1e-15
Identities = 23/60 (38%), Positives = 37/60 (61%), Gaps = 1/60 (1%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFIT 445
+ + F D + G I ++E K + ++G + LT+AEV++ M+ AD DGNG ID EF+
Sbjct: 4 ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMD 63
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 36.4 bits (84), Expect = 5e-04
Identities = 14/54 (25%), Positives = 26/54 (48%), Gaps = 1/54 (1%)
Query: 420 EAEVQQLMEAADVDGNGTIDYIEFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
E E+ + + D +G+G ID+ EF + D + +A + D+D +G
Sbjct: 1 EEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNG 54
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 68.1 bits (166), Expect = 3e-15
Identities = 31/67 (46%), Positives = 42/67 (62%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
L+ E+I K+ F+ D D GTIT +EL + LG TEAE+Q ++ D DGNGTI
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61
Query: 439 DYIEFIT 445
D+ EF+T
Sbjct: 62 DFPEFLT 68
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 36.5 bits (84), Expect = 4e-04
Identities = 17/58 (29%), Positives = 24/58 (41%), Gaps = 3/58 (5%)
Query: 418 LTEAEVQQLMEA---ADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
LTE ++ + EA D DG+GTI E T + + L D D +G
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 59
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 70.4 bits (171), Expect = 4e-15
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD 431
K E L+ E+ K F G+I+ +EL + LG T E+Q++++ D
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 61
Query: 432 VDGNGTIDYIEFITATMHRHK----LERDDHLYKAFQHFDKDNSG 472
DG+GT+D+ EF+ + K + ++ L F+ FDK+ G
Sbjct: 62 EDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADG 106
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 56.1 bits (134), Expect = 4e-10
Identities = 22/58 (37%), Positives = 33/58 (56%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
L +F D + G I EELK L G +TE ++++LM+ D + +G IDY EF+
Sbjct: 93 LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFL 150
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 70.0 bits (170), Expect = 6e-15
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
LS E I K F D D G I+ +EL + LG T+ E+ ++E D DG+GTI
Sbjct: 14 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 73
Query: 439 DYIEFITATMHRH----KLERDDHLYKAFQHFDKDNSG 472
D+ EF+ + + K + ++ L F+ FDK+ G
Sbjct: 74 DFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADG 111
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 58.0 bits (139), Expect = 1e-10
Identities = 20/58 (34%), Positives = 31/58 (53%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
L F D + G I EEL L G +TE +++ LM+ +D + +G ID+ EF+
Sbjct: 98 LANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFL 155
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.2 bits (168), Expect = 8e-15
Identities = 27/92 (29%), Positives = 53/92 (57%), Gaps = 1/92 (1%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
E+ Q +++ F D D +GTI +ELK + LG + + E+++++ D +G G +++
Sbjct: 3 EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFG 62
Query: 442 EFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
+F+T T + + + + KAF+ FD D +G
Sbjct: 63 DFLTVMTQKMSEKDTKEEILKAFKLFDDDETG 94
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (141), Expect = 4e-11
Identities = 20/57 (35%), Positives = 34/57 (59%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
+ F D D +G I+++ LK LG LT+ E+Q++++ AD DG+G + EF+
Sbjct: 82 LKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFL 138
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 66.8 bits (163), Expect = 9e-15
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 1/72 (1%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
+ + + + F D DNSGTIT ++L+ LG LTE E+Q+++ AD + + ID
Sbjct: 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDED 65
Query: 442 EFITATMHRHKL 453
EFI M + L
Sbjct: 66 EFIRI-MKKTSL 76
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.5 bits (92), Expect = 5e-05
Identities = 9/58 (15%), Positives = 22/58 (37%)
Query: 415 GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
G + + E+ + D D +GTI + + ++ L + D+++
Sbjct: 3 GERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDN 60
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.2 bits (171), Expect = 1e-14
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 366 KLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE- 422
KL K L + + EIQ + F + SG + E+ + + +
Sbjct: 7 KLSKDDLTCLKQSTYFDRREIQQWHKGF--LRDCPSGQLAREDFVKIYKQFFPFGSPEDF 64
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L D D NG I + EFIT + ++ L AF+ +D ++ G
Sbjct: 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDG 114
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.9 bits (126), Expect = 1e-08
Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 18/94 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKL------------TEAEVQQLMEAADVDG 434
L F D ++ G IT++E+ +A + + E V+++ + D +
Sbjct: 101 LSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNE 160
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDK 468
+G I EF + D + A +D
Sbjct: 161 DGYITLDEFREG------SKVDPSIIGALNLYDG 188
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.0 bits (121), Expect = 4e-08
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 12/98 (12%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+FT D DN+G I +EE L+ E ++ E D++ +G I + E +T
Sbjct: 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124
Query: 447 TMHRHKL------------ERDDHLYKAFQHFDKDNSG 472
+K+ + + K F+ DK+ G
Sbjct: 125 VASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDG 162
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 66.5 bits (162), Expect = 3e-14
Identities = 28/69 (40%), Positives = 38/69 (55%), Gaps = 3/69 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGN 435
LS +K +F ID D SG + +ELK L + +LTE+E + LM+AAD DG+
Sbjct: 35 LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGD 94
Query: 436 GTIDYIEFI 444
G I EF
Sbjct: 95 GKIGADEFQ 103
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.2 bits (117), Expect = 3e-08
Identities = 19/101 (18%), Positives = 34/101 (33%), Gaps = 10/101 (9%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
I + LS E+I Q + + T ++ SK++ ++V+ + D D
Sbjct: 2 ITDILSAEDIAAALQ-----ECQDPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQ 54
Query: 435 NGTIDYIEFITATMHRHKLER---DDHLYKAFQHFDKDNSG 472
+G +D E R + D D G
Sbjct: 55 SGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDG 95
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Score = 67.9 bits (165), Expect = 7e-14
Identities = 21/113 (18%), Positives = 43/113 (38%), Gaps = 16/113 (14%)
Query: 369 KLALKVIAENLSTEEI-QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA------ 421
++ + + E+I G +++F + I+ EL+ L R+ +K +
Sbjct: 1 EIEANIEEIEANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFS 59
Query: 422 --EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ +++ D DG+G + EF K ++ D D SG
Sbjct: 60 IETCKIMVDMLDEDGSGKLGLKEFYILWTKIQ------KYQKIYREIDVDRSG 106
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Score = 58.2 bits (140), Expect = 1e-10
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
++++ ID D SGT+ E++ L G KL ++ Q++ A D ID+ F+
Sbjct: 94 QKIYREIDVDRSGTMNSYEMRKALEEAGFKLPC-QLHQVIVARFADDELIIDFDNFVRCL 152
Query: 448 MHRHKLERDDHLYKAFQHFDKDNSG 472
+ + L+K F+ D +N+G
Sbjct: 153 VRL------EILFKIFKQLDPENTG 171
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Score = 39.0 bits (90), Expect = 5e-04
Identities = 12/79 (15%), Positives = 30/79 (37%), Gaps = 8/79 (10%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD 431
++ E + L Q+ D+ I ++ L RL + ++ + D
Sbjct: 113 MRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRL------EILFKIFKQLD 166
Query: 432 VDGNG--TIDYIEFITATM 448
+ G +D I +++ ++
Sbjct: 167 PENTGTIQLDLISWLSFSV 185
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 67.8 bits (165), Expect = 7e-14
Identities = 21/85 (24%), Positives = 39/85 (45%), Gaps = 7/85 (8%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
+F D D SG+++ E++ + G KL ++ Q++ A D ID+ F+
Sbjct: 96 LTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPC-QLHQVIVARFADDELIIDFDNFVRCL 154
Query: 448 MHRHKLERDDHLYKAFQHFDKDNSG 472
+ L+K F+ D +N+G
Sbjct: 155 VRLEI------LFKIFKQLDPENTG 173
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 66.7 bits (162), Expect = 2e-13
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 16/105 (15%)
Query: 377 ENLSTEEI-QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEA--------EVQQLM 427
+ LS EEI K +F+ + D+ I+ +EL+ L R+ SK + + ++
Sbjct: 11 KVLSEEEIDDNFKTLFSKLAGDD-MEISVKELQTILNRIISKHKDLRTNGFSLESCRSMV 69
Query: 428 EAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
D DGNG + +EF + F+ FD D SG
Sbjct: 70 NLMDRDGNGKLGLVEFNILWNRIR------NYLTIFRKFDLDKSG 108
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 13/82 (15%), Positives = 31/82 (37%), Gaps = 12/82 (14%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
++A++ L + Q + D+ I ++ L RL L + +
Sbjct: 116 RMAIEAAGFKLPCQLHQ----VIVARFADDELIIDFDNFVRCLVRL-EILFKI-----FK 165
Query: 429 AADVDGNG--TIDYIEFITATM 448
D + G +D I +++ ++
Sbjct: 166 QLDPENTGTIQLDLISWLSFSV 187
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 64.9 bits (158), Expect = 1e-13
Identities = 29/71 (40%), Positives = 37/71 (52%), Gaps = 3/71 (4%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDG 434
L +K++F ID D SG I EELK L G LT+AE + ++AAD DG
Sbjct: 34 GLKAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDG 93
Query: 435 NGTIDYIEFIT 445
+G I EF T
Sbjct: 94 DGKIGIDEFET 104
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 54.5 bits (131), Expect = 5e-10
Identities = 11/55 (20%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 418 LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L ++++ ++A V G+ ++ +F + + + K F+ D D SG
Sbjct: 6 LKADDIKKALDA--VKAEGSFNHKKFFALVGLKAMSA--NDVKKVFKAIDADASG 56
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 66.9 bits (162), Expect = 1e-13
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 4/98 (4%)
Query: 378 NLSTEEIQGLKQMFTNIDTD--NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
S EI+ L ++F I + + G I EE + L + K + ++ + D N
Sbjct: 10 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLFDTKHN 68
Query: 436 GTIDYIEFIT-ATMHRHKLERDDHLYKAFQHFDKDNSG 472
G + + EF ++ DD ++ +FQ +D G
Sbjct: 69 GILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQG 106
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 43.0 bits (100), Expect = 2e-05
Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 15/91 (16%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGS--------KLTEAEVQQLMEAADVDGNGTID 439
F D G I +E+K + + + E + + E AD +G ID
Sbjct: 94 HFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKID 153
Query: 440 YIEFITATMHRHKLERDDHLYKAFQ-HFDKD 469
E+ + + R L K + KD
Sbjct: 154 KEEWRSL------VLRHPSLLKNMTLQYLKD 178
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (161), Expect = 2e-13
Identities = 17/84 (20%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
+ F +D D SGT+ + EL+ + +G +L+ + +++ NG I + +++ +
Sbjct: 74 ENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK--RYSKNGRIFFDDYVACCV 131
Query: 449 HRHKLERDDHLYKAFQHFDKDNSG 472
+ L F+ D G
Sbjct: 132 ------KLRALTDFFRKRDHLQQG 149
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (144), Expect = 3e-11
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 12/91 (13%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE-----VQQLMEAADVDGNGTIDYI 441
+ F+ + G + EEL+ L + G T + + ++ D D G + +
Sbjct: 2 VYTYFSAVA-GQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFN 60
Query: 442 EFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
F + + F D+D SG
Sbjct: 61 AFKELWAALN------AWKENFMTVDQDGSG 85
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (102), Expect = 1e-05
Identities = 15/82 (18%), Positives = 32/82 (39%), Gaps = 13/82 (15%)
Query: 369 KLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLME 428
+ A+ ++ LS + + + + + +G I +++ A +L LT+
Sbjct: 93 RQAIGLMGYRLSPQTLTTIVKRY-----SKNGRIFFDDYVACCVKL-RALTDF-----FR 141
Query: 429 AADVDGNG--TIDYIEFITATM 448
D G Y +F+ TM
Sbjct: 142 KRDHLQQGSANFIYDDFLQGTM 163
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 62.3 bits (151), Expect = 4e-13
Identities = 15/60 (25%), Positives = 29/60 (48%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
K++F D + G ++ +E + T+ ++ + E DVDGNG ++ EF +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 41.5 bits (97), Expect = 7e-06
Identities = 10/52 (19%), Positives = 22/52 (42%)
Query: 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ +++ E D + +G + EF + + + K F+ D D +G
Sbjct: 1 SSAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNG 52
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 62.7 bits (152), Expect = 8e-13
Identities = 30/103 (29%), Positives = 43/103 (41%), Gaps = 8/103 (7%)
Query: 346 SDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYE 405
S + I A + F A + L + +K++F +D D SG I +
Sbjct: 7 SAEDIKKA----IGAFTAADSFDHKKF-FQMVGLKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 406 ELKAGLARLGS---KLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
EL + L S L+ E + LM A D DG+G I EF T
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFST 104
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 51.5 bits (123), Expect = 6e-09
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 4/59 (6%)
Query: 414 LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ L+ ++++ + A + D+ +F + K D + K F DKD SG
Sbjct: 2 MTDLLSAEDIKKAIGA--FTAADSFDHKKFFQMVGLKKK--SADDVKKVFHILDKDKSG 56
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 48.1 bits (114), Expect = 9e-08
Identities = 17/101 (16%), Positives = 35/101 (34%), Gaps = 10/101 (9%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+ + LS E+I+ F + + +++ + K + +V+++ D D
Sbjct: 2 MTDLLSAEDIKKAIGAF-----TAADSFDHKKFFQMVGL--KKKSADDVKKVFHILDKDK 54
Query: 435 NGTIDYIEFITATMHRHKLER---DDHLYKAFQHFDKDNSG 472
+G I+ E + R DKD G
Sbjct: 55 SGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDG 95
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 64.1 bits (155), Expect = 1e-12
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE-VQQLMEAADVDGNG 436
N + E+Q L + F + SG + E K A+ + L A D G
Sbjct: 9 NFTKRELQVLYRGF--KNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTG 66
Query: 437 TIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
++ + +F+TA + + L F +D + G
Sbjct: 67 SVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDG 102
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.9 bits (113), Expect = 3e-07
Identities = 17/114 (14%), Positives = 37/114 (32%), Gaps = 14/114 (12%)
Query: 371 ALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAA 430
+ +F DT +G++ +E+ L+ L +++
Sbjct: 39 IYAQFFPHGDASTY--AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLY 96
Query: 431 DVDGNGTIDYIEFITATMHRHKLER------------DDHLYKAFQHFDKDNSG 472
D++ +G I+ E + + + H+ FQ DK+ G
Sbjct: 97 DINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDG 150
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.7 bits (110), Expect = 9e-07
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 18/93 (19%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSK------------LTEAEVQQLMEAADVDG 434
L+ F D + G I EE+ + + V + D +
Sbjct: 89 LRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNK 148
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFD 467
+G + EF+ + + DD++ ++ Q F
Sbjct: 149 DGIVTLDEFLES------CQEDDNIMRSLQLFQ 175
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.8 bits (147), Expect = 1e-12
Identities = 26/66 (39%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
S EEI ++ F D D +G I+ EL+ + LG KLT+ EV +++ AD+DG+G ++
Sbjct: 1 SEEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVN 57
Query: 440 YIEFIT 445
Y EF+
Sbjct: 58 YEEFVQ 63
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.4 bits (146), Expect = 1e-12
Identities = 23/58 (39%), Positives = 37/58 (63%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
+ F D +++G ++ +L+ L LG KLT+AEV +L++ +VD NG IDY +FI
Sbjct: 3 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 60
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Score = 61.5 bits (149), Expect = 2e-12
Identities = 24/70 (34%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGN 435
L + +K++F +D D SG I EELK L G L + E + L+ A D D +
Sbjct: 35 LKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHD 94
Query: 436 GTIDYIEFIT 445
G I EF
Sbjct: 95 GKIGADEFAK 104
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Score = 54.6 bits (131), Expect = 5e-10
Identities = 15/55 (27%), Positives = 24/55 (43%), Gaps = 4/55 (7%)
Query: 418 LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
L ++ + + A GT DY F + K + D + + F+ DKD SG
Sbjct: 6 LKADDINKAISA--FKDPGTFDYKRFFH--LVGLKGKTDAQVKEVFEILDKDQSG 56
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Score = 51.1 bits (122), Expect = 7e-09
Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 10/97 (10%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
L ++I F + GT Y+ + T+A+V+++ E D D +G I
Sbjct: 6 LKADDINKAISAF-----KDPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFI 58
Query: 439 DYIEFITATMHRHKLER---DDHLYKAFQHFDKDNSG 472
+ E R D D D+ G
Sbjct: 59 EEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDG 95
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 2e-12
Identities = 20/99 (20%), Positives = 33/99 (33%), Gaps = 12/99 (12%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-----SKLTEAEVQQLMEAADVD 433
+ L F + G I +EL+ L + G + ++ D D
Sbjct: 1 FPGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRD 59
Query: 434 GNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+GT+ + EF + + F FD D SG
Sbjct: 60 MSGTMGFNEFKELWAVLN------GWRQHFISFDTDRSG 92
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (140), Expect = 1e-10
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
Q F + DTD SGT+ +EL+ L +G +L+ V + + NG I + ++I
Sbjct: 81 QHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAK--RYSTNGKITFDDYIAC-- 136
Query: 449 HRHKLERDDHLYKAFQHFDKDNSG 472
+ L +F+ D G
Sbjct: 137 ----CVKLRALTDSFRRRDTAQQG 156
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Score = 60.7 bits (147), Expect = 2e-12
Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD 431
+K ++ + EE L +F D + G I EELK L G +TE ++++LM+ D
Sbjct: 5 MKDDSKGKTEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGD 61
Query: 432 VDGNGTIDYIEFIT 445
+ +G IDY EF+
Sbjct: 62 KNNDGRIDYDEFLE 75
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Score = 39.9 bits (93), Expect = 4e-05
Identities = 14/54 (25%), Positives = 23/54 (42%)
Query: 419 TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
TE E+ L D + +G ID E + +D + + + DK+N G
Sbjct: 13 TEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDG 66
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 61.5 bits (149), Expect = 2e-12
Identities = 24/70 (34%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS---KLTEAEVQQLMEAADVDGN 435
L+++ + +K+ F ID D SG I +ELK L LT+AE + + D DG+
Sbjct: 34 LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGD 93
Query: 436 GTIDYIEFIT 445
G I EF
Sbjct: 94 GMIGVDEFAA 103
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 47.2 bits (112), Expect = 2e-07
Identities = 15/98 (15%), Positives = 30/98 (30%), Gaps = 10/98 (10%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGT 437
L ++ + + ++E A + + + +V++ D D +G
Sbjct: 4 GLKDADVAAALA-----ACSAADSFKHKEFFAKVGL--ASKSLDDVKKAFYVIDQDKSGF 56
Query: 438 IDYIEFITATMHRHKLER---DDHLYKAFQHFDKDNSG 472
I+ E + R D DKD G
Sbjct: 57 IEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDG 94
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 59.9 bits (145), Expect = 2e-12
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN 435
A+ S EE L F D + G I EEL L G + E +++ LM+ +D + +
Sbjct: 3 AKGKSEEE---LANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNND 59
Query: 436 GTIDYIEFIT 445
G ID+ EF+
Sbjct: 60 GRIDFDEFLK 69
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 39.5 bits (92), Expect = 5e-05
Identities = 11/54 (20%), Positives = 21/54 (38%)
Query: 419 TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+E E+ D + +G ID E + ++ + + DK+N G
Sbjct: 7 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDG 60
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Score = 60.2 bits (146), Expect = 2e-12
Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 4/70 (5%)
Query: 380 STEEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGSKL--TEAEVQQLMEAADVDGN 435
+ + LK +F + ++ EELK + L + L + D +G+
Sbjct: 2 AQKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGD 61
Query: 436 GTIDYIEFIT 445
G + + EF
Sbjct: 62 GEVSFEEFQV 71
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (147), Expect = 3e-12
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 16/77 (20%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE----------------VQQLMEAA 430
K F D ++ G + +EL+A + K+ + + + +M+
Sbjct: 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNV 77
Query: 431 DVDGNGTIDYIEFITAT 447
D + + + EF+ +T
Sbjct: 78 DTNQDRLVTLEEFLAST 94
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 62.8 bits (151), Expect = 3e-12
Identities = 21/107 (19%), Positives = 30/107 (28%), Gaps = 16/107 (14%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQ-----------QLME 428
S +Q +K F ID D G IT + ++ R +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60
Query: 429 AADVDGNGTIDYIEFITATMHRHKLERDDH-----LYKAFQHFDKDN 470
V G ID FI + K L F+ D +
Sbjct: 61 LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNE 107
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 42.3 bits (98), Expect = 3e-05
Identities = 17/77 (22%), Positives = 28/77 (36%), Gaps = 3/77 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
L F +DT+ I+ +E L L + +A D + +G + EF+ A
Sbjct: 96 LPLFFRAVDTNEDNNISRDEYGIFFGML--GLDKTMAPASFDAIDTNNDGLLSLEEFVIA 153
Query: 447 TMHRHKLERDDHLYKAF 463
+ D K F
Sbjct: 154 -GSDFFMNDGDSTNKVF 169
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.8 bits (142), Expect = 7e-12
Identities = 20/68 (29%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT--EAEVQQLMEAADVDGNGT 437
S EEI+G ++F + I+ EELK + LG L + + +++E D +G+G
Sbjct: 3 SPEEIKGAFEVF-AAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGE 61
Query: 438 IDYIEFIT 445
+ + EF+
Sbjct: 62 VSFEEFLV 69
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.0 bits (147), Expect = 2e-11
Identities = 26/113 (23%), Positives = 49/113 (43%), Gaps = 5/113 (4%)
Query: 363 AMNKLKKLALKVIAE--NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT- 419
L K L+ + + EE+ Q F + SG IT +E + ++ +
Sbjct: 4 KSGALSKEILEELQLNTKFTEEELSSWYQSF--LKECPSGRITRQEFQTIYSKFFPEADP 61
Query: 420 EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+A Q + + D + +GT+D+ E++ A + + L AF +D D +G
Sbjct: 62 KAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNG 114
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Score = 44.8 bits (105), Expect = 5e-06
Identities = 26/166 (15%), Positives = 53/166 (31%), Gaps = 21/166 (12%)
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
+ L + P RIT + + + K EA K V K +
Sbjct: 28 SSWYQSFLKECPSGRITRQE-FQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYV 86
Query: 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT------------- 419
+ + + Q L+ F+ D D +GTI+ E+ + + ++
Sbjct: 87 IALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENT 146
Query: 420 -EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464
E +++ + + EFI T+ + + + Q
Sbjct: 147 PEKRAEKIWGFFGKKDDDKLTEKEFIEGTL------ANKEILRLIQ 186
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.4 bits (96), Expect = 9e-05
Identities = 22/134 (16%), Positives = 44/134 (32%), Gaps = 19/134 (14%)
Query: 358 MKQFRAMNKLKKLALKVIAENLSTEEIQG-----LKQMFTNIDTDNSGTITYEELKAGLA 412
+ F ++ + S + + +F + D ++ GT+ ++E L
Sbjct: 31 YQSFLKECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALH 90
Query: 413 RLGSKLTEAEVQQLMEAADVDGNGTIDYIEF--------------ITATMHRHKLERDDH 458
+ T +++ DVDGNGTI E T + + +
Sbjct: 91 MTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKR 150
Query: 459 LYKAFQHFDKDNSG 472
K + F K +
Sbjct: 151 AEKIWGFFGKKDDD 164
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (138), Expect = 2e-11
Identities = 19/66 (28%), Positives = 31/66 (46%)
Query: 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDY 440
T + Q F N DT + TI+ EE +A R LT+ + +L V+ G + Y
Sbjct: 16 TSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKY 75
Query: 441 IEFITA 446
+F++
Sbjct: 76 PDFLSR 81
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 59.9 bits (144), Expect = 2e-11
Identities = 15/99 (15%), Positives = 35/99 (35%), Gaps = 15/99 (15%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG--------SKLTEAEVQQLMEAADVD 433
EE++ +++F + D+ ++ EL L ++ + ++ D D
Sbjct: 1 EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 59
Query: 434 GNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
G + + ++ ++ FD D SG
Sbjct: 60 TTGKLGF------EEFKYLWNNIKKWQAIYKQFDVDRSG 92
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 58.0 bits (139), Expect = 1e-10
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 7/85 (8%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
+ ++ D D SGTI EL G L E ++ D G +D+ FI+
Sbjct: 80 QAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCL 138
Query: 448 MHRHKLERDDHLYKAFQHFDKDNSG 472
+ D +++AF+ DKD +G
Sbjct: 139 VRL------DAMFRAFKSLDKDGTG 157
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Score = 56.8 bits (137), Expect = 6e-11
Identities = 14/71 (19%), Positives = 25/71 (35%), Gaps = 7/71 (9%)
Query: 382 EEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGSKL-----TEAEVQQLMEAADVDG 434
+ + + F + + ELK L R EA Q+LM D +
Sbjct: 6 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNR 65
Query: 435 NGTIDYIEFIT 445
+ +D+ E+
Sbjct: 66 DNEVDFQEYCV 76
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 57.7 bits (138), Expect = 2e-10
Identities = 22/122 (18%), Positives = 44/122 (36%), Gaps = 21/122 (17%)
Query: 372 LKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTEAEVQQL 426
+K+ + + I+ K MF +D + +G IT +E+ + + L + + + Q+
Sbjct: 1 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQV 60
Query: 427 MEAAD-----VDGNGTIDYIEFITATMHRH-----------KLERDDHLYKAFQHFDKDN 470
A ++ I + +F+ + F FDKD
Sbjct: 61 CVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDG 120
Query: 471 SG 472
SG
Sbjct: 121 SG 122
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 53.9 bits (128), Expect = 5e-09
Identities = 37/175 (21%), Positives = 54/175 (30%), Gaps = 12/175 (6%)
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
D G I + I S A D + L P++ +E + G E +
Sbjct: 22 FLDINGNGKITLDE-----IVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKE 76
Query: 349 PIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELK 408
L KQ K A N T + +F D D SGTIT +E K
Sbjct: 77 IAFPQFLDGWKQLATSELKKW------ARNEPTLIREWGDAVFDIFDKDGSGTITLDEWK 130
Query: 409 AGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463
A G ++ + + D+D G +D E D +
Sbjct: 131 AYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQ-HLGFWYTLDPEADGLY 184
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (134), Expect = 3e-10
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 1/61 (1%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
+ F D + +G + EL+ L LG K+TE EV+ ++ D NG I+Y F+
Sbjct: 80 LEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLA-GHEDSNGCINYEAFLKHI 138
Query: 448 M 448
+
Sbjct: 139 L 139
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.9 bits (131), Expect = 8e-10
Identities = 19/91 (20%), Positives = 33/91 (36%), Gaps = 5/91 (5%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGN-----GTIDYI 441
K+ F D G I Y + + LG T AEV +++ D ++
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 61
Query: 442 EFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ A + + F+ FDK+ +G
Sbjct: 62 PMLQAVAKNRGQGTYEDYLEGFRVFDKEGNG 92
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 57.0 bits (136), Expect = 3e-10
Identities = 15/115 (13%), Positives = 30/115 (26%), Gaps = 23/115 (20%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKL---------------TEAEVQ 424
+ LK+ F D D +G + + + +
Sbjct: 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFD 61
Query: 425 QLMEAADVDGNGTIDYIEFITATMHRH--------KLERDDHLYKAFQHFDKDNS 471
L + A V +G++ +FI T + + DK+
Sbjct: 62 YLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNAD 116
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 45.4 bits (106), Expect = 2e-06
Identities = 20/71 (28%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+K + D + G I +E A L LG +AE + D +GNG + E +TA
Sbjct: 104 VKGIVGMCDKNADGQINADEFAAWLTALGMS--KAEAAEAFNQVDTNGNGELSLDELLTA 161
Query: 447 TMHRHKLERDD 457
+ R D
Sbjct: 162 -VRDFHFGRLD 171
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} Length = 93 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Score = 53.8 bits (129), Expect = 6e-10
Identities = 15/71 (21%), Positives = 31/71 (43%), Gaps = 7/71 (9%)
Query: 382 EEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGS-----KLTEAEVQQLMEAADVDG 434
++ L +F + ++ +ELK L S + V ++M+ D +G
Sbjct: 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENG 65
Query: 435 NGTIDYIEFIT 445
+G +D+ EF+
Sbjct: 66 DGEVDFQEFVV 76
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Score = 53.4 bits (128), Expect = 8e-10
Identities = 11/69 (15%), Positives = 27/69 (39%), Gaps = 6/69 (8%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-----KLTEAEVQQLMEAADVDGNG 436
++ + F D G +T E+L+ + + + V ++M+ D +G
Sbjct: 6 HAMETMMFTFHKFAGDK-GYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDG 64
Query: 437 TIDYIEFIT 445
+ + F +
Sbjct: 65 KVGFQSFFS 73
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Score = 53.7 bits (129), Expect = 8e-10
Identities = 12/76 (15%), Positives = 29/76 (38%), Gaps = 6/76 (7%)
Query: 376 AENLSTEE--IQGLKQMFTNIDT--DNSGTITYEELKAGLARLG--SKLTEAEVQQLMEA 429
AE L+ E I+ + F +++ E K + + + + M++
Sbjct: 3 AEPLTELEESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKS 62
Query: 430 ADVDGNGTIDYIEFIT 445
DV+ + + + E+
Sbjct: 63 LDVNQDSELKFNEYWR 78
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 55.8 bits (133), Expect = 9e-10
Identities = 16/118 (13%), Positives = 36/118 (30%), Gaps = 25/118 (21%)
Query: 379 LSTEEIQGLKQMFTNI-DTDNSGTITYEELKAGLARLGS---------------KLTEAE 422
L+ + Q +K F D ++ G+I + + + R E E
Sbjct: 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDE 61
Query: 423 VQQLMEAADVDGNGTIDYIEFITATMHR---------HKLERDDHLYKAFQHFDKDNS 471
+ L AD++ + + + E++ + + F+ D
Sbjct: 62 WRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGD 119
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 45.8 bits (107), Expect = 2e-06
Identities = 11/60 (18%), Positives = 19/60 (31%), Gaps = 2/60 (3%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
+ +F +D G + EE + L A+V + G T D +
Sbjct: 107 IPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKEL 164
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 36.9 bits (84), Expect = 0.002
Identities = 15/120 (12%), Positives = 34/120 (28%), Gaps = 11/120 (9%)
Query: 362 RAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG------ 415
R K +++ + + D + +++EE A +
Sbjct: 37 RYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSV 96
Query: 416 ---SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + L + DV G+G +D EF +L+ + +
Sbjct: 97 ADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNY-CKNFQLQ-CADVPAVYNVITDGGKV 154
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 55.8 bits (133), Expect = 1e-09
Identities = 34/168 (20%), Positives = 59/168 (35%), Gaps = 14/168 (8%)
Query: 280 PFWAETEKGIFDAILQ---GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
P W K +F+ + G I + + A D+V L P++ +E
Sbjct: 8 PRWIGRHKHMFNFLDVNHNGKISLDE-----MVYKASDIVINNLGATPEQAKRHKDAVEA 62
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSTEEIQGLKQMFTNIDT 396
+ G + + KL L+ A+N T +F +D
Sbjct: 63 FFGGAGMKYGVE------TDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDK 116
Query: 397 DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
D +G IT +E KA G + + ++ D+D +G +D E
Sbjct: 117 DQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT 164
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (127), Expect = 1e-09
Identities = 15/80 (18%), Positives = 34/80 (42%), Gaps = 4/80 (5%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+ E+ +F ++ +G ++ +++K L L + ++ E +D+D +G +
Sbjct: 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGML 60
Query: 439 DYIEFITATMHRHKLERDDH 458
D EF A M +
Sbjct: 61 DRDEFAVA-MFLVYCALEKE 79
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (125), Expect = 2e-09
Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
+S E ++F D D G ++ E++ L + L + + D G +
Sbjct: 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREI--FLKTGLPSTLLAHIWSLCDTKDCGKL 61
Query: 439 DYIEFITATMH 449
+F A H
Sbjct: 62 SKDQFALA-FH 71
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 92 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 51.2 bits (122), Expect = 5e-09
Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 3/80 (3%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
++ E+ Q F I D +G I K + SKL E+ + E +D D +G +
Sbjct: 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELSDFDKDGAL 60
Query: 439 DYIEFITATMHRHKLERDDH 458
EF A H ++ +
Sbjct: 61 TLDEFCAA-FHLVVARKNGY 79
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} Length = 180 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (127), Expect = 6e-09
Identities = 14/101 (13%), Positives = 34/101 (33%), Gaps = 6/101 (5%)
Query: 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAE----VQQLMEAADVD 433
L+ +EI + F + ++ L E + +++
Sbjct: 10 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTS 69
Query: 434 -GNGTIDYIEFITA-TMHRHKLERDDHLYKAFQHFDKDNSG 472
++ + +F+ ++ D + AF+ FD D+ G
Sbjct: 70 PAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDG 110
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} Length = 180 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 1e-06
Identities = 18/84 (21%), Positives = 34/84 (40%), Gaps = 15/84 (17%)
Query: 390 MFTNIDTDNSGTITYEELKAGLARLGSKLT---------EAEVQQLMEAADVDGNGTIDY 440
F D D+ GT+ E+L + L + + + ++E +D+D +GTI+
Sbjct: 100 AFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINL 159
Query: 441 IEFITATMHRHKLERDDHLYKAFQ 464
EF + R +F+
Sbjct: 160 SEFQHV------ISRSPDFASSFK 177
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} Length = 93 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Score = 49.4 bits (118), Expect = 2e-08
Identities = 10/71 (14%), Positives = 26/71 (36%), Gaps = 7/71 (9%)
Query: 382 EEIQGLKQMFTN-IDTDNSG-TITYEELKAGLARLGS-----KLTEAEVQQLMEAADVDG 434
+ + + F + ELK L + + + E + + M D +
Sbjct: 6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNK 65
Query: 435 NGTIDYIEFIT 445
+ +D++E++
Sbjct: 66 DCEVDFVEYVR 76
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 170 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.8 bits (121), Expect = 4e-08
Identities = 7/90 (7%), Positives = 21/90 (23%), Gaps = 7/90 (7%)
Query: 387 LKQMFTNI--DTDNSGTITYEELKAGLARLGSKLTEA--EVQQLMEAADVDGNGTIDYIE 442
L ++ + ++ G I + ++ A D
Sbjct: 7 LDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPV 66
Query: 443 FITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + R + + + F +
Sbjct: 67 YK--SFLMSLCPRPE-IDEIFTSYHAKAKP 93
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} Length = 100 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Score = 48.4 bits (115), Expect = 6e-08
Identities = 13/71 (18%), Positives = 22/71 (30%), Gaps = 8/71 (11%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-------KLTEAEVQQLMEAADVDG 434
I G+ MF I L + K + + E D +
Sbjct: 7 RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNE 65
Query: 435 NGTIDYIEFIT 445
+ ID+ EF++
Sbjct: 66 DKKIDFSEFLS 76
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-08
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDG 434
+ + +EI+ L + F +D DNSG+++ EE + VQ++++ D DG
Sbjct: 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSL----PELQQNPLVQRVIDIFDTDG 61
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDN 470
NG +D+ EFI + + +
Sbjct: 62 NGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMD 97
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Score = 46.4 bits (110), Expect = 2e-07
Identities = 7/67 (10%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 382 EEIQGLKQMFTN-IDTDNSGTI-TYEELKAGLARL-GSKLTEAEVQQLMEAADVDGNGTI 438
+ + + ++ + ++LK L + + + D++ +G +
Sbjct: 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAV 66
Query: 439 DYIEFIT 445
++ EF+
Sbjct: 67 NFQEFLI 73
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Score = 45.9 bits (109), Expect = 3e-07
Identities = 15/83 (18%), Positives = 33/83 (39%), Gaps = 13/83 (15%)
Query: 382 EEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLG-----SKLTEAEVQQLMEAADVDG 434
E ++G+ +F + T++ ELK L + + +A + ++ + D +
Sbjct: 5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQ 64
Query: 435 NGTIDYIEF------ITATMHRH 451
+ +D+ EF H H
Sbjct: 65 DEQVDFQEFISLVAIALKAAHYH 87
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 47.3 bits (111), Expect = 3e-07
Identities = 21/95 (22%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
L ++IQ +K+ F+ ID D G ++ E++KA +LG + E+ +++ + G +
Sbjct: 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPL 56
Query: 439 DYIEFIT-ATMHRHKLERDDHLYKAFQHFDKDNSG 472
++ F++ + + ++ + AF FD+ +
Sbjct: 57 NFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETK 91
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 40.0 bits (92), Expect = 1e-04
Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 1/58 (1%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
+ F D + + E +K L +G + E++ + A V+G G DY++F
Sbjct: 79 RNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVEG-GKFDYVKFTA 135
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 46.2 bits (108), Expect = 9e-07
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 3/97 (3%)
Query: 379 LSTEEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGSKLTEAEVQQL-MEAADVDGN 435
LS +EI LK +F D G + +L LG +V + + +
Sbjct: 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGEKS 60
Query: 436 GTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+ + + +AF+ FD++ G
Sbjct: 61 LPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQG 97
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 45.4 bits (106), Expect = 2e-06
Identities = 17/63 (26%), Positives = 33/63 (52%), Gaps = 2/63 (3%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV--DGNGTIDYIEFITA 446
+ F D + G I+ EL+ L LG +L++ +V ++++ D+ D G + Y +F+
Sbjct: 86 EAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKK 145
Query: 447 TMH 449
M
Sbjct: 146 VMA 148
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.2 bits (108), Expect = 9e-07
Identities = 18/80 (22%), Positives = 31/80 (38%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITA 446
K +FT D G I + L L +G T VQ ++ A + + ++ IT
Sbjct: 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITG 63
Query: 447 TMHRHKLERDDHLYKAFQHF 466
+ ++ E D + F
Sbjct: 64 LIEVNEKELDATTKAKTEDF 83
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.8 bits (99), Expect = 1e-05
Identities = 23/69 (33%), Positives = 41/69 (59%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
+ + + F D +++G ++ +L+ L LG KLT+AEV +L++ +VD NG IDY
Sbjct: 78 AKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYK 137
Query: 442 EFITATMHR 450
+FI + +
Sbjct: 138 KFIEDVLRQ 146
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Score = 45.5 bits (106), Expect = 1e-06
Identities = 21/78 (26%), Positives = 36/78 (46%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
+F ID + G ++YEE+KA +++ + E +Q + ++ D DGNG ID EF
Sbjct: 4 ALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYG 63
Query: 449 HRHKLERDDHLYKAFQHF 466
+ D +
Sbjct: 64 SIQGQDLSDDKIGLKVLY 81
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Score = 38.2 bits (87), Expect = 4e-04
Identities = 15/60 (25%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
++ +D D G +T EE+ + + G +V + + AD +G+G I EF+ ++
Sbjct: 79 VLYKLMDVDGDGKLTKEEVTSFFKKHG----IEKVAEQVMKADANGDGYITLEEFLEFSL 134
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-06
Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTI 438
++ E+ + F ++ D S I+ K SKL+ E+ + E +D D +G +
Sbjct: 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFF--TKSKLSIPELSYIWELSDADCDGAL 73
Query: 439 DYIEFITATMH 449
EF A H
Sbjct: 74 TLPEFCAA-FH 83
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 45.9 bits (107), Expect = 2e-06
Identities = 16/92 (17%), Positives = 33/92 (35%), Gaps = 1/92 (1%)
Query: 376 AENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG-SKLTEAEVQQLMEAADVDG 434
A + + L +F +D D SG I+ EL+ L+ + V+ ++ D +
Sbjct: 10 AAGAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDREN 69
Query: 435 NGTIDYIEFITATMHRHKLERDDHLYKAFQHF 466
+++ EF + + Y
Sbjct: 70 KAGVNFSEFTGVWKYITDWQNVFRTYDRDNSG 101
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 45.1 bits (105), Expect = 4e-06
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 6/84 (7%)
Query: 389 QMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448
+F D DNSG I ELK L+ G +L++ L+ D G G I + +FI +
Sbjct: 90 NVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCI 149
Query: 449 HRHKLERDDHLYKAFQHFDKDNSG 472
L F+ +D D G
Sbjct: 150 ------VLQRLTDIFRRYDTDQDG 167
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.0 bits (84), Expect = 0.002
Identities = 11/61 (18%), Positives = 23/61 (37%), Gaps = 8/61 (13%)
Query: 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNG--TIDYIEFI 444
+ D G I +++ G L +LT+ D D +G + Y +++
Sbjct: 124 HDILIRKFDRQGRGQIAFDDFIQGCIVL-QRLTDI-----FRRYDTDQDGWIQVSYEQYL 177
Query: 445 T 445
+
Sbjct: 178 S 178
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Score = 45.4 bits (106), Expect = 3e-06
Identities = 22/89 (24%), Positives = 37/89 (41%)
Query: 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYI 441
+ Q L + F +DTD SG I+ EL A L+ G + A ++L+ D + +G I +
Sbjct: 15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFD 74
Query: 442 EFITATMHRHKLERDDHLYKAFQHFDKDN 470
EF + + D+
Sbjct: 75 EFKDLHHFILSMREGFRKRDSSGDGRLDS 103
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Score = 40.8 bits (94), Expect = 1e-04
Identities = 10/60 (16%), Positives = 27/60 (45%), Gaps = 6/60 (10%)
Query: 413 RLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
G +++E Q LM D G++ + +++ ++ ++ F +D++ +G
Sbjct: 112 SSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVR------NVFAFYDRERTG 165
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} Length = 99 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.1 bits (101), Expect = 4e-06
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447
++ + ++ N+G + + A L + G ++ + AD DG G + EF A
Sbjct: 14 EKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILG--KIWDLADTDGKGVLSKQEFFVA- 70
Query: 448 MH 449
+
Sbjct: 71 LR 72
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} Length = 89 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Score = 42.9 bits (101), Expect = 4e-06
Identities = 19/69 (27%), Positives = 38/69 (55%), Gaps = 5/69 (7%)
Query: 382 EEIQGLKQMF-TNIDTDNSG-TITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNG 436
+ I L +F + T++ +ELK + + +GSKL +AE+ +LME D + +
Sbjct: 6 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQ 65
Query: 437 TIDYIEFIT 445
+++ E++T
Sbjct: 66 EVNFQEYVT 74
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.9 bits (97), Expect = 3e-05
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 2/93 (2%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTID 439
ST++ KQ F+ D +G I + L G T AE+ ++ + +
Sbjct: 1 STDDSP-YKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTLPAEVD-MEQ 58
Query: 440 YIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472
+++ + + K FQ FDKD +G
Sbjct: 59 FLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATG 91
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.6 bits (96), Expect = 3e-05
Identities = 18/60 (30%), Positives = 32/60 (53%), Gaps = 1/60 (1%)
Query: 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFI 444
+ + F D D +G I EL+ L LG KL+ E+ +L++ V +G ++Y +F+
Sbjct: 76 EEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFV 134
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} Length = 94 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Score = 38.2 bits (89), Expect = 2e-04
Identities = 15/54 (27%), Positives = 28/54 (51%), Gaps = 5/54 (9%)
Query: 397 DNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
++ T+T ELK + + L S + V +L++ D +G+ +D+ EFI
Sbjct: 23 GSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIV 76
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} Length = 90 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Score = 37.8 bits (88), Expect = 3e-04
Identities = 14/54 (25%), Positives = 23/54 (42%), Gaps = 5/54 (9%)
Query: 397 DNSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
+ + ELK + L + V ++ME D DG+G D+ EF+
Sbjct: 23 GDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMA 76
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} Length = 95 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Score = 37.8 bits (88), Expect = 3e-04
Identities = 10/53 (18%), Positives = 24/53 (45%), Gaps = 5/53 (9%)
Query: 398 NSGTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445
N+ I+ E + ++ + ++M+ D+D +G +D+ EF+
Sbjct: 24 NNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLN 76
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 39.4 bits (91), Expect = 6e-04
Identities = 17/147 (11%), Positives = 42/147 (28%), Gaps = 4/147 (2%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLV----TKNDKDDIKREIQIMQHLSGQP 140
+E+G G + + R K V D + E +
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ + Y D + VME + ++ + + +G + I + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 201 VMHRDLKPENFLLSSKDENALLKATDF 227
+ + K ++ + + + F
Sbjct: 152 LEPKVKKQLVKQFTNPELCDITERLVF 178
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 34.1 bits (79), Expect = 0.001
Identities = 13/36 (36%), Positives = 19/36 (52%), Gaps = 3/36 (8%)
Query: 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG 415
S EEI ++ F D D +G I+ EL+ + LG
Sbjct: 1 SEEEI---REAFRVFDKDGNGYISAAELRHVMTNLG 33
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.61 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.58 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.58 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.57 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.57 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.54 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.5 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.5 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 99.48 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.46 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.46 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.46 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.46 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.45 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.44 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 99.42 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.4 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 99.38 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.38 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.38 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 99.36 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.36 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.35 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 99.34 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.33 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.31 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.3 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.3 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 99.29 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.28 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.28 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 99.27 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.26 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.26 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 99.26 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 99.26 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 99.25 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 99.25 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.24 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.24 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 99.22 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 99.22 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 99.21 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 99.21 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.21 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.19 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 99.16 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 99.16 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.16 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.15 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.15 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.14 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 99.13 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 99.12 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 99.12 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.12 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 99.11 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 99.1 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.1 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.1 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 99.1 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.1 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.09 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 99.08 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 99.08 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 99.08 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 99.08 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 99.06 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 99.05 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 99.05 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.04 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.04 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 99.03 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 99.02 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 99.02 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 99.01 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 99.01 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 99.01 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.0 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.99 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 98.98 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.98 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.95 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.95 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.94 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.93 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 98.9 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.86 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.85 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.85 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.83 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.81 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 98.8 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.79 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.79 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.77 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 98.76 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 98.71 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 98.71 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.71 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.69 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.69 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.67 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.64 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.63 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 98.63 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.62 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 98.58 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 98.57 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.57 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.56 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.55 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 98.5 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.49 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.48 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 98.44 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.44 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 98.39 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.35 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.34 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 98.33 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.3 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 98.29 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 98.23 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.22 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 98.21 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 98.16 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 98.14 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.1 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 98.03 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 97.88 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 97.85 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.73 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.67 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 97.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.49 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 97.45 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 97.44 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 97.41 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 97.2 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.2 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 97.14 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 97.13 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 97.1 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 97.1 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.05 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 96.97 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 96.86 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.77 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 96.69 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 96.63 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 96.57 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 96.43 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 96.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.16 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 96.13 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 95.4 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 95.32 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 95.19 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 92.96 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 92.26 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 91.92 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 91.85 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 91.54 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 89.01 | |
| d1dava_ | 71 | Cellulosome endoglucanase SS {Clostridium thermoce | 88.81 | |
| d2cclb1 | 59 | Endo-1,4-beta-xylanase Y {Clostridium thermocellum | 88.66 | |
| d1pula1 | 103 | Hypothetical protein c32e8.3 {Caenorhabditis elega | 88.14 | |
| d1wlma1 | 138 | Protein cgi-38 {Mouse (Mus musculus) [TaxId: 10090 | 87.62 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 81.08 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-64 Score=479.05 Aligned_cols=291 Identities=41% Similarity=0.730 Sum_probs=236.4
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
.+++.++|++++.||+|+||+||+|+++.+++.||||++.+.... .....+.+|+.+|++++ |||||++++++.+++
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGG 80 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 467888999999999999999999999999999999999865532 23456889999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
.+|||||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999998889999999999999999999999999999999999999987667788999999999987
Q ss_pred cCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
.........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....++...+..+...++...++.+|+++
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 76666667789999999999875 58999999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCCCCchHHHHHHHHHHhhhHhH
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 368 (472)
++||++||++||++|||++|+|+||||+... .........+...++++...++++
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 295 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDT-ALDKNIHQSVSEQIKKNFAKSKWK 295 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC-CCCCCCHHHHHHHHHHHSCCCTTT
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCC-ccccccchhHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999998532 222333344444455444444443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=456.80 Aligned_cols=254 Identities=32% Similarity=0.621 Sum_probs=232.2
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++++++ |||||++++++.+++.+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999997665444455778999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc-
Confidence 9999999999999988899999999999999999999999999999999999999 556679999999998765443
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++..+.+....++ ..+|+++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence 356789999999999975 489999999999999999999999999999999999988876654 358999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCcccc
Q 012039 318 RMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 318 ~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+||+.||++|||++|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-62 Score=454.41 Aligned_cols=257 Identities=30% Similarity=0.556 Sum_probs=218.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.++++++ |||||++++++.+++.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEE
Confidence 3579999999999999999999999999999999976542 233457889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 99999999999999888889999999999999999999999999999999999999 455679999999999765433
Q ss_pred ---ceeeccCCCCCCchhhhhc-cc-CCccchhhHHHHHHHHhhCCCCCCCCChHHH-HHHHHcCCccCCCCCCCCCCHH
Q 012039 238 ---VYRDIVGSAYYVAPEVLRR-RY-GKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPWPTISSS 311 (472)
Q Consensus 238 ---~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~ 311 (472)
.....+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||........ +..+..... ....+..+|++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~ 235 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSA 235 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHH
Confidence 2345689999999999875 34 6789999999999999999999987655433 333333322 23345678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 312 ~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.+||.+||+.||++|||++|+|+||||++.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=457.48 Aligned_cols=267 Identities=40% Similarity=0.711 Sum_probs=242.2
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc---ccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
+++.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 4567899999999999999999999999999999999987654322 24678999999999995 9999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC-CCCcEEEeecCCc
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLS 230 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~~~kl~Dfg~~ 230 (472)
.+.+|||||||+||+|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||+..++ ....+||+|||++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999999999888999999999999999999999999999999999999996543 2346999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++...++.+|
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 98877766667789999999999975 58999999999999999999999999999999999999988877766667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+++++||++||+.||++|||++|+|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.6e-61 Score=462.16 Aligned_cols=266 Identities=34% Similarity=0.618 Sum_probs=241.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+|+.+|++|. |||||+++++|.+++.+
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM 101 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 34568999999999999999999999999999999987543 234567889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|||||||+||+|.+++...+ ++++..++.|+.||+.||.|||++||+||||||+|||+.. ...+.+||+|||+|....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecC
Confidence 99999999999998876544 6999999999999999999999999999999999999953 245679999999999988
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...+..+|++++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 7777777899999999999875 599999999999999999999999999999999999999998888888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCCCCC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~ 346 (472)
+||++||+.||.+|||++|+|+||||+......
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~ 293 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCCcchh
Confidence 999999999999999999999999998754433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-61 Score=462.82 Aligned_cols=263 Identities=35% Similarity=0.639 Sum_probs=240.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++|+ |||||++++++.+++.+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 45578999999999999999999999999999999996543 234677899999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+..+ .++.+||+|||++..+.
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheecc
Confidence 999999999999999854 4679999999999999999999999999999999999999642 34679999999999988
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++..|......++...++.+|++++
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 7777777899999999999875 589999999999999999999999999999999999999988888777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+||++||+.||++|||++|+|+||||+...
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-61 Score=452.61 Aligned_cols=256 Identities=33% Similarity=0.579 Sum_probs=229.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.++++++ |||||++++++.+++.+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999998765444556778999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 566779999999998775332
Q ss_pred --ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 238 --VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 238 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|.++.+.++ ..+|+++++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence 2345689999999999875 589999999999999999999999999999999999998877654 368999999
Q ss_pred HHHHhcccCCCCCCCHHH------HhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQ------VLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~------~l~h~~~~~~ 342 (472)
||++||+.||++|||++| +++||||+..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999999987 5889999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-60 Score=446.16 Aligned_cols=262 Identities=37% Similarity=0.686 Sum_probs=239.2
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc------cHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN------DKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~------~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+....... ..+.+.+|+.++++|..|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999876543221 234688999999999779999999999999
Q ss_pred CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhee
Confidence 99999999999999999999999999999999999999999999999999999999999999 567789999999999
Q ss_pred eccCCcceeeccCCCCCCchhhhhc-------ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
...........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+..+...++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8877666667789999999998852 368899999999999999999999999999999999999988887777
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+..+|+++++||++||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 78999999999999999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=449.63 Aligned_cols=257 Identities=30% Similarity=0.520 Sum_probs=225.4
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
...+|++.+.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.++++++ |||||++++++.+++.+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence 45689999999999999999999999999999999976542 34678999999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence 99999999999987654 579999999999999999999999999999999999999 45667999999999987544
Q ss_pred c-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (472)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+....+..+...... ....+..+|+++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence 3 3455689999999999875 5899999999999999999999999988887776666554322 12233578999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 315 li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
||.+||+.||++|||++|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=446.31 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=225.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
.+.|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+.+.+|+++|++|+ |||||++++++.+++.+||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence 457999999999999999999999999999999997542 344677889999999995 9999999999999999999
Q ss_pred EEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 158 VMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCC
Confidence 9999999999998765 4569999999999999999999999999999999999999 55667999999999865433
Q ss_pred c-ceeeccCCCCCCchhhhh------cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 237 K-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
. .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+.+..+..+..... .....+|
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCC
Confidence 2 233568999999999983 3478999999999999999999999999998888888887754322 2235789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
+++++||++||+.||++|||++|+|+||||+.
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-60 Score=451.50 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=228.9
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
....|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++|+ |||||++++++.+++.+|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence 4567999999999999999999999999999999998765444445677899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC
Confidence 999999999998777788889999999999999999999999999999999999999 45678999999999876443
Q ss_pred cceeeccCCCCCCchhhhh----cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (472)
....||+.|+|||++. +.|+.++|||||||++|+|++|..||.+.+..+.+..+..+...... ...+|+++
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~ 243 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYF 243 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHH
Confidence 3468999999999985 34899999999999999999999999998888888888776554332 25689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 313 ~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
++||.+||+.||++|||++++|+||||...
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-60 Score=440.27 Aligned_cols=253 Identities=23% Similarity=0.440 Sum_probs=219.4
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CCeEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQSVH 156 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~~~ 156 (472)
|++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+++|++++ |||||++++++.+ +..+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence 4788899999999999999999999999999876543 3445678899999999995 9999999999875 45689
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +.++.+||+|||+++...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc
Confidence 99999999999999998889999999999999999999999998 99999999999995 245679999999998654
Q ss_pred CCcceeeccCCCCCCchhhhhcccCCccchhhHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. .....+||+.|+|||++.++++.++|||||||++|+|++|+.||.+.. ...+...+..+.... .....++++++
T Consensus 167 ~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 AS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVK 243 (270)
T ss_dssp TT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCHHHH
T ss_pred CC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCccCCHHHH
Confidence 33 345678999999999999899999999999999999999999997654 445556665543322 12246789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
+||.+||+.||++|||++|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-60 Score=452.94 Aligned_cols=255 Identities=33% Similarity=0.589 Sum_probs=233.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+++. |||||++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence 57999999999999999999999999999999998765544556788999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC-Cc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~-~~ 237 (472)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 5667899999999987644 33
Q ss_pred ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+++..+..+...++ ..+|+++++||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence 4456789999999999864 699999999999999999999999999999999999998877655 46899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCcccc
Q 012039 317 RRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (472)
Q Consensus 317 ~~~L~~dp~~Rps-----~~~~l~h~~~~~ 341 (472)
++||++||.+|++ ++++++||||+.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999994 899999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-60 Score=453.25 Aligned_cols=262 Identities=29% Similarity=0.593 Sum_probs=239.1
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
++.++|++++.||+|+||+||+|+++.+++.||||++++.. .....+.+|+.+|++++ |||||+++++|++++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 45679999999999999999999999999999999997543 23456889999999995 99999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
|||||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence 99999999999999997655 79999999999999999999999999999999999999642 34579999999999887
Q ss_pred CCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.........||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+++..|.++...++...|+.+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 7776777889999999998864 589999999999999999999999999999999999999988888777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
+||++||..||++|||++|+|+||||++..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-60 Score=439.07 Aligned_cols=253 Identities=29% Similarity=0.523 Sum_probs=212.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 156 (472)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .....+.+.+|+++++++. |||||++++++.+ ++.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence 579999999999999999999999999999999976544 3445677899999999995 9999999999865 46789
Q ss_pred EEEeccCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----cEeecCCCCceeeccCCCCCcEEEeec
Q 012039 157 VVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMG-----VMHRDLKPENFLLSSKDENALLKATDF 227 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~~~kl~Df 227 (472)
||||||+||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 99999999999998853 457999999999999999999999976 9999999999999 55678999999
Q ss_pred CCceeccCCc-ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 228 GLSVFIEEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 228 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
|+++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+..+..... .
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 9998775543 3345789999999999865 589999999999999999999999999999999999888765422 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~ 339 (472)
..+|+++++||++||+.||++|||++|+|+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4689999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-59 Score=443.67 Aligned_cols=254 Identities=30% Similarity=0.605 Sum_probs=232.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++ |||||++++++.+.+.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence 47999999999999999999999999999999997665444456788999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence 9999999999999999999999999999999999999999999999999999999 56678999999999987543
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+.++...++ +.+|++++++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 345689999999999875 589999999999999999999999999999999999998876554 468999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCccccC
Q 012039 318 RMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (472)
Q Consensus 318 ~~L~~dp~~Rp-----s~~~~l~h~~~~~~ 342 (472)
+||..||.+|+ |++++|+||||+..
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999999996 99999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-59 Score=447.58 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=217.1
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
..++|+++++||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|++++ |||||+++++|.+.+.+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 4568999999999999999999999999999999997643 3344678899999999995 999999999999999999
Q ss_pred EEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence 999999999999999988899999999999999999999997 599999999999999 5567799999999987654
Q ss_pred CcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHH----------------------
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA---------------------- 292 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---------------------- 292 (472)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+.......
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 3 2345689999999999875 699999999999999999999999987654321110
Q ss_pred --------------------HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 293 --------------------ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 293 --------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+.... .+......+|.++++||.+||+.||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000 0111112468999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=448.56 Aligned_cols=265 Identities=35% Similarity=0.619 Sum_probs=226.6
Q ss_pred ccccceEEcc-eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe---
Q 012039 76 DVKLHYSFGK-ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (472)
Q Consensus 76 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 151 (472)
.+.++|.+.. .||+|+||+||+|+++.+++.||||++.+ ...+.+|+.++.++.+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4567899875 59999999999999999999999999853 34677899998776579999999999976
Q ss_pred -CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
+..+|||||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999864 469999999999999999999999999999999999999876677889999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHH----HHcCCccCCCC
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA----ILQGDIDFESA 303 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~ 303 (472)
+++...........+||+.|+|||++.+ .|+.++|||||||++|+|+||++||.+.+....... +..+...++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 9998877666677889999999999875 599999999999999999999999987765444433 34455556655
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCCCCC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 348 (472)
.+..+|+++++||++||+.||++|||+.|+|+||||++.......
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~ 284 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCC
Confidence 566789999999999999999999999999999999865543333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-58 Score=445.10 Aligned_cols=253 Identities=31% Similarity=0.584 Sum_probs=231.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+. |||||++++++.+...+++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence 58999999999999999999999999999999997655444455678999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence 9999999999999998999999999999999999999999999999999999999 55678999999999987643
Q ss_pred eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 012039 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (472)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (472)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..|..+...++ ..+|+++.+||+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence 235689999999999875 589999999999999999999999999999999999988876554 468999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 318 RMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 318 ~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
+||+.||.+|+ |++++++||||+.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999995 9999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-58 Score=438.95 Aligned_cols=255 Identities=28% Similarity=0.504 Sum_probs=228.4
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHH-hccCCCCeeEEEEEEEeCCeEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ-HLSGQPNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~-~l~~hp~iv~~~~~~~~~~~~~l 157 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|..++. .+ +|||||++++++.+++.+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence 47999999999999999999999999999999998655434455667778888776 46 69999999999999999999
Q ss_pred EEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC-
Q 012039 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (472)
Q Consensus 158 v~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~- 236 (472)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999 56678999999999876543
Q ss_pred cceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 012039 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (472)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (472)
.......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+..+...++ ..+|+++++|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence 33345689999999999875 699999999999999999999999999999999999988766544 3689999999
Q ss_pred HHHhcccCCCCCCCHH-HHhcCCcccc
Q 012039 316 VRRMLTQDPKKRITSA-QVLEHPWIKE 341 (472)
Q Consensus 316 i~~~L~~dp~~Rps~~-~~l~h~~~~~ 341 (472)
|++||+.||++|||+. ++++||||+.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 9999999999999995 8999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-57 Score=442.19 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=218.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHH---HHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE---IQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E---~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+| +.+++.+ +|||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 479999999999999999999999999999999976554333344445555 5556666 599999999999999999
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
|||||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999 5667899999999997765
Q ss_pred CcceeeccCCCCCCchhhhh-c-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 236 GKVYRDIVGSAYYVAPEVLR-R-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
.. ....+||+.|+|||++. + .|+.++|||||||++|+|++|+.||.+.+...... +...........+..+|++++
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHH
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHH
Confidence 43 34568999999999985 3 48999999999999999999999998765443332 222222333334467999999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCccccC
Q 012039 314 DLVRRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps-----~~~~l~h~~~~~~ 342 (472)
+||.+||+.||++||| ++++++||||+..
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 7999999999853
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-57 Score=429.04 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=215.0
Q ss_pred EcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCc--ccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 012039 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK--NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (472)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 160 (472)
.++.||+|+||+||+|+++.+|+.||||++........ .....+.+|+.++++++ |||||++++++.+++.+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999976543211 12356889999999995 9999999999999999999999
Q ss_pred ccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-ce
Q 012039 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VY 239 (472)
Q Consensus 161 ~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~-~~ 239 (472)
||.|+++..+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence 99988877666667789999999999999999999999999999999999999 566789999999998765433 33
Q ss_pred eeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC--------------
Q 012039 240 RDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-------------- 303 (472)
Q Consensus 240 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------- 303 (472)
...+||+.|+|||++.. .|+.++|||||||++|+|++|.+||.+.+..+.+..|.+........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 45689999999998853 47999999999999999999999999999888887776421111110
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 304 ----------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 304 ----------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.++.+++++.+||++||+.||++|||++|+|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 02357899999999999999999999999999999987543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=419.09 Aligned_cols=253 Identities=30% Similarity=0.560 Sum_probs=216.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcc---cHHHHHHHHHHHHhcc-CCCCeeEEEEEEEeC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQIMQHLS-GQPNIVEFKGAYEDK 152 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~ 152 (472)
+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ....+.+|+.+++++. .|||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 356899999999999999999999999999999999865543322 1234678999999995 389999999999999
Q ss_pred CeEEEEEeccCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 153 QSVHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 153 ~~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
+.+|+||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccccce
Confidence 999999999976 578888888889999999999999999999999999999999999999952 34679999999998
Q ss_pred eccCCcceeeccCCCCCCchhhhhc-c-cCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+. ..+..+...++ ..+|
T Consensus 160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s 228 (273)
T d1xwsa_ 160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVS 228 (273)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCC
T ss_pred ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCC
Confidence 76543 3456789999999999864 3 467899999999999999999999653 23455544433 4689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
+++++||++||+.||++|||++|+|+||||+..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-56 Score=419.23 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=221.7
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
.+.++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.++++++ |||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence 35678999999999999999999999999999999998766545555678999999999995 999999999987654
Q ss_pred --eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 --SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 --~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.+|||||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+. .+..++|+|||.+.
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR 159 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCE
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhhh
Confidence 4899999999999999999989999999999999999999999999999999999999994 56679999999987
Q ss_pred eccCCc----ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 012039 232 FIEEGK----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (472)
Q Consensus 232 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (472)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||.+||.+.+..+.+..+......++...++
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 654332 2345689999999999875 58999999999999999999999999999888888888877766666678
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccc
Q 012039 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (472)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~ 340 (472)
.+|+++.+||++||++||.+||+..+.|.|+|.+
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 8999999999999999999999555555666654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=418.80 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=215.6
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+++|+++. |||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence 489999999999999999999999999999999975432 2344678999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCC
Q 012039 159 MELCAGGELFDRII--AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (472)
Q Consensus 159 ~e~~~g~sL~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~ 236 (472)
||||.++ +.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.+..+||+|||+|+.....
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence 9999654 444443 24569999999999999999999999999999999999999 56667999999999876543
Q ss_pred c-ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCC----------
Q 012039 237 K-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA---------- 303 (472)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 303 (472)
. ......||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.+..+.+..+..........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3 3345689999999998754 36889999999999999999999999988877766665321111111
Q ss_pred ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 304 ---------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 304 ---------------~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.++.+|+++++||++||+.||++|||++|+|+||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 12357899999999999999999999999999999987544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=417.01 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=217.4
Q ss_pred ccceEEcceeeecCCeEEEEEEECCC-CCEEEEEEecccccCCcccHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe---
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENST-GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYED--- 151 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~iv~~~~~~~~--- 151 (472)
.++|+++++||+|+||+||+|++..+ ++.||||++...... ......+.+|+.+++.|. +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999766 567999999765432 223445668888887773 59999999999853
Q ss_pred --CCeEEEEEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 152 --KQSVHVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
...++++||||.++.+..... ....+++..++.++.||+.||+|||+++|+||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 357899999998877654433 34569999999999999999999999999999999999999 566779999999
Q ss_pred CceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc-----C--
Q 012039 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-----F-- 300 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~-- 300 (472)
++.............||+.|+|||++. ..|+.++|||||||++|+|++|++||.+.+..+.+..+...... +
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998776666666789999999999886 46999999999999999999999999999888877776541100 0
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 301 ----------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 301 ----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
....+..+|+++++||++||++||++|||++|+|+||||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 00123468999999999999999999999999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-55 Score=411.28 Aligned_cols=257 Identities=32% Similarity=0.456 Sum_probs=216.1
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|+++++||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|++++ |||||++++++.+++..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence 48999999999999999999986 789999999976543 2344678999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcc
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~ 238 (472)
||++.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence 9999877777666667889999999999999999999999999999999999999 5667899999999987654332
Q ss_pred -eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC-------------
Q 012039 239 -YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------------- 302 (472)
Q Consensus 239 -~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 302 (472)
.....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 344578999999998863 4799999999999999999999999988887777766431111100
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcccc
Q 012039 303 ------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (472)
Q Consensus 303 ------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~ 341 (472)
...+.+|+++.+||++||++||++|||+.|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112457899999999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-55 Score=409.84 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=213.8
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
++...++|++.+.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+.+|++|+ |||||++++++.+++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 86 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCC-CCCEecCCccEeeCC
Confidence 455567899999999999999999999999999999998653 234678999999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 SVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.++||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEcccccee
Confidence 999999999999999998754 568999999999999999999999999999999999999 556789999999998
Q ss_pred eccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCC-CCChHHHHHHHHcCCccCCCCCCCC
Q 012039 232 FIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 232 ~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
........ ....||+.|+|||++. +.|+.++|||||||++|+|++|..||. +.+...+.+.+..+ ... .....
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~ 240 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEG 240 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTT
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCcc
Confidence 76554332 2245789999999876 569999999999999999999766655 44555555555443 222 23357
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+|+++.+||.+||+.||++|||++++++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8999999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=416.92 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=215.5
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCC-----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGR-----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++...++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+++++.+|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 34456789999999999999999999876554 69999886543 234467789999999999669999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeec
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAK-----------------------GHYSERAAASICRSIVNVVHICHFMGVMHRD 205 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~-----------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 205 (472)
+.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||+++|+|||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999754 2488999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCC
Q 012039 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPP 280 (472)
Q Consensus 206 lkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 280 (472)
|||+|||+ +.++.+||+|||+|+........ ....||+.|+|||++. +.++.++|||||||++|||+| |..|
T Consensus 190 lKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999 56678999999999876554322 2356899999999886 568999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 281 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
|.+.+....+..+......++.+ ..+|+++++||.+||+.||++|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98877766666666655544332 5789999999999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=411.23 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=215.8
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe------
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------ 151 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------ 151 (472)
.++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence 5799999999999999999999999999999999876543 3445677889999999995 9999999998754
Q ss_pred --CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 --KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 --~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
++.+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence 45689999999877776555566789999999999999999999999999999999999999 5667899999999
Q ss_pred ceeccCCc-----ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCC
Q 012039 230 SVFIEEGK-----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (472)
Q Consensus 230 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (472)
+....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98765322 2234579999999998853 5899999999999999999999999998887777776553333322
Q ss_pred CCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 303 APWPT----------------------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 303 ~~~~~----------------------------~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
..+.. .++++.+||.+||++||++|||++|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 22111 367889999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=407.09 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=208.0
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
++...++|++++.||+|+||+||+|+.. ..||||+++.... .....+.+.+|+.+|++++ |||||++++++.+ .
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-P 76 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-S
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-c
Confidence 4455678999999999999999999754 3699999875543 3445778999999999995 9999999998654 5
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.++||||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV 153 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceee
Confidence 689999999999999999754 569999999999999999999999999999999999999 4567899999999987
Q ss_pred ccCCc---ceeeccCCCCCCchhhhhc----ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHH-HHHcCCccCC-CC
Q 012039 233 IEEGK---VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD-AILQGDIDFE-SA 303 (472)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~~~~-~~ 303 (472)
..... ......||+.|+|||++.. .|+.++|||||||++|||+||+.||.+.+....+. .+..+..... ..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 65432 2345689999999999853 47899999999999999999999998876654444 4444433222 22
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
....+|+++.+||.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 345789999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=402.07 Aligned_cols=257 Identities=19% Similarity=0.303 Sum_probs=217.2
Q ss_pred ccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 012039 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (472)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 151 (472)
.+++...++|++++.||+|+||+||+|+++ +++.||||++.... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc
Confidence 445566789999999999999999999976 57789999986532 34578999999999995 9999999998765
Q ss_pred CCeEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 152 KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 152 ~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+.++||||||++|+|.+++... .++++..+..|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGL 155 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccc
Confidence 5578999999999999877543 359999999999999999999999999999999999999 5677899999999
Q ss_pred ceeccCCcce--eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 230 SVFIEEGKVY--RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 230 ~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
|+........ ....||+.|+|||++. +.++.++|||||||++|||+|| .+||...+..+.+..+..+..... .
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p 232 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---P 232 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---c
Confidence 9987654322 2356899999999987 4699999999999999999995 556666777778888877643222 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCcccc
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~--h~~~~~ 341 (472)
..+|+++.+||.+||+.||++|||++++++ |+||..
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 478999999999999999999999999998 788753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=411.96 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=211.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe------CC
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------KQ 153 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------~~ 153 (472)
+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|++|+ |||||+++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence 79999999999999999999999999999999975432 2247999999995 9999999999853 34
Q ss_pred eEEEEEeccCCcchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 154 SVHVVMELCAGGELFDR---IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~---l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
++|||||||+++.+..+ ......+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+|||++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTTC
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccch
Confidence 68999999976543322 234567999999999999999999999999999999999999953 2346999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcC------------
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG------------ 296 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------ 296 (472)
............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 98877766677899999999998753 5899999999999999999999999988877776665421
Q ss_pred -----CccCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 297 -----DIDFE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 297 -----~~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
...++ ....+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 01111 112346799999999999999999999999999999998653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-54 Score=404.74 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=205.0
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCC---EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 153 (472)
..++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKST 100 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence 34689999999999999999999987765 58888875432 3345677999999999995 999999999999999
Q ss_pred eEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+++|||||+||+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceE
Confidence 999999999999999988764 469999999999999999999999999999999999999 5677899999999987
Q ss_pred ccCCcce------eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 233 IEEGKVY------RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 233 ~~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
....... ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+++..+..+... +.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~ 254 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PP 254 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CC
Confidence 6543221 1245789999999986 468999999999999999998 89999999998888888776432 22
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...+++++.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 35789999999999999999999999998864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=401.97 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=207.2
Q ss_pred ceeeecCCeEEEEEEEC--CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 012039 85 KELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (472)
Q Consensus 85 ~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 162 (472)
++||+|+||+||+|.++ .+++.||||+++.... .....+.+.+|+.+|++|+ |||||++++++.++ .++||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence 46999999999999864 3557899999865432 3344678999999999995 99999999998654 578999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCcce---
Q 012039 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--- 239 (472)
Q Consensus 163 ~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 239 (472)
++|+|.+++.....+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence 999999999988899999999999999999999999999999999999999 45677999999999876544322
Q ss_pred -eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 012039 240 -RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (472)
Q Consensus 240 -~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (472)
....||+.|+|||++. ..++.++|||||||++|||++ |..||.+.+..++...+.++.... ....+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHH
Confidence 2346899999999886 468999999999999999998 899999988888888887764322 2256899999999
Q ss_pred HHhcccCCCCCCCHHHH---hcCCcc
Q 012039 317 RRMLTQDPKKRITSAQV---LEHPWI 339 (472)
Q Consensus 317 ~~~L~~dp~~Rps~~~~---l~h~~~ 339 (472)
.+||+.||++|||++++ |+|+|+
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999999999998 456554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=412.52 Aligned_cols=260 Identities=31% Similarity=0.549 Sum_probs=222.7
Q ss_pred cceEEcceeeecCCeEEEEEEEC---CCCCEEEEEEecccccC-CcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
++|++++.||+|+||+||+|++. .+|+.||||++.+.... .....+.+.+|+.+++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999874 47899999999765432 223456788999999999756999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
+++||||+.||+|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++..+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999 556789999999998764
Q ss_pred CCc--ceeeccCCCCCCchhhhhc---ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EGK--VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
... ......|++.|+|||.+.. .++.++|||||||+||+|++|+.||.+.+.......+.++...........+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 332 2345679999999998853 37889999999999999999999998876665555555544444444445789
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCCcccc
Q 012039 310 SSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rp-----s~~~~l~h~~~~~ 341 (472)
+++.+||.+||.+||++|| |++|+|+||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=399.82 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=214.2
Q ss_pred ccceEEcce-eeecCCeEEEEEEECCC--CCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 78 KLHYSFGKE-LGRGQFGVTYLCTENST--GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 78 ~~~y~~~~~-lg~G~~g~V~~~~~~~~--~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+++|.+.+. ||+|+||+||+|.++.+ +..||||+++... .....+.+.+|+++|++++ |||||++++++.++ .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-A 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-e
Confidence 457888884 99999999999987644 4579999987543 3445678999999999995 99999999998754 5
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+|||||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence 89999999999999987654 5799999999999999999999999999999999999994 5667999999999987
Q ss_pred cCCcce----eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKVY----RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
...... ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+++..+..+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence 654332 2346889999999986 569999999999999999998 999999988888888888765422 2257
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHH---hcCCccc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQV---LEHPWIK 340 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~---l~h~~~~ 340 (472)
+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 89999999999999999999999888 5677764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=396.97 Aligned_cols=246 Identities=24% Similarity=0.435 Sum_probs=204.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|++++.||+|+||+||+|+++ ++..||||++.+. ....+.+.+|+.++++++ |||||++++++.+++.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC----cCcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence 47999999999999999999986 5678999998653 234578999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence 9999999999988754 568999999999999999999999999999999999999 566789999999998765443
Q ss_pred c--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 V--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
. .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||...+..+++..+..+..... ...+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHH
Confidence 2 23357899999999987 469999999999999999999 5777777777788888877643322 246789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+||.+||+.||++|||++++++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999886
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=415.02 Aligned_cols=259 Identities=24% Similarity=0.437 Sum_probs=212.7
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 153 (472)
.+.++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++++ |||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence 467899999999999999999999999999999999975432 3445678899999999995 999999999997654
Q ss_pred ----eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 154 ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 154 ----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
.+|+||||| |.+|...+ ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccc
Confidence 579999999 66776655 45689999999999999999999999999999999999999 5677899999999
Q ss_pred ceeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCc---------
Q 012039 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI--------- 298 (472)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--------- 298 (472)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 9876543 345689999999998854 478999999999999999999999988877665554432111
Q ss_pred --------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCC
Q 012039 299 --------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (472)
Q Consensus 299 --------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~ 343 (472)
.... .....+++++.+||++||..||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1111 12356799999999999999999999999999999998643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-53 Score=408.84 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=212.9
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSV 155 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 155 (472)
.++|+++++||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|+++.+||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999998642 356789999999999779999999999974 4579
Q ss_pred EEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
++|||||.+++|.... +.+++..++.++.||+.||.|||++||+||||||+|||++. .+..+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceeccC
Confidence 9999999999997653 57999999999999999999999999999999999999963 334699999999998877
Q ss_pred CcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCCh-HHHHHHHHc-------------CCc-
Q 012039 236 GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQ-------------GDI- 298 (472)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~-------------~~~- 298 (472)
.......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+.. ...
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 766677889999999998764 479999999999999999999999976543 222222110 000
Q ss_pred -------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 299 -------------------DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 299 -------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.+....+..+|+++.+||++||++||++|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 01111224578999999999999999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=392.96 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=216.3
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|+++++||+|+||+||+|+++ +++.||||++++.. ...+.+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence 36899999999999999999985 67899999997643 34578999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc
Q 012039 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~ 237 (472)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence 999999999988654 4569999999999999999999999999999999999999 567789999999998765443
Q ss_pred c--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 012039 238 V--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (472)
Q Consensus 238 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (472)
. .....||+.|+|||++. ..++.++|||||||++|||+| |+.||.+.+..++...+.++.... ....+++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccHHHH
Confidence 2 22356899999999986 468999999999999999998 899999999999988888764332 2247889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 012039 314 DLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 314 ~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+||++||+.||++|||++++|+|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=397.65 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=220.0
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
++|+++++||+|+||+||+|++..+++.||||+++.... .......+.+|+.+|++++ ||||+++++++.+...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence 489999999999999999999999999999999976543 3445788999999999995 99999999999999999999
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccCCc-
Q 012039 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (472)
Q Consensus 159 ~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~- 237 (472)
+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.+..+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence 9999999998888888899999999999999999999999999999999999999 455679999999998876543
Q ss_pred ceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCC-CCChHHHHHHHHcCCccC--------------
Q 012039 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDF-------------- 300 (472)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~-------------- 300 (472)
......+++.|+|||++.. .++.++|||||||++|+|++|+.||. +.+..+.+..+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3334567889999998864 36899999999999999999999864 455555555554311111
Q ss_pred -----------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 301 -----------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 301 -----------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
.......+++++.+||++||+.||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 111224678999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=410.23 Aligned_cols=261 Identities=30% Similarity=0.434 Sum_probs=211.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--- 153 (472)
+..+|+++++||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++|+ ||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccc
Confidence 4568999999999999999999999999999999997543 2344567889999999995 999999999987543
Q ss_pred --eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 --SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 --~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.+|+++ ++.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 83 ~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 83 MKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLAR 157 (345)
T ss_dssp CCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCcee
Confidence 355554 5569999998865 479999999999999999999999999999999999999 556789999999998
Q ss_pred eccCCcc----eeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCcc------
Q 012039 232 FIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID------ 299 (472)
Q Consensus 232 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 299 (472)
....... ....+||+.|+|||++.. .++.++||||+||++|+|++|+.||.+.+..+...........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 7644322 244679999999998853 4789999999999999999999999887765555444321000
Q ss_pred --------------CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCCC
Q 012039 300 --------------FES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (472)
Q Consensus 300 --------------~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~~ 345 (472)
.+. ..++.+|+++++||.+||+.||++|||++|+|+||||+.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 000 1235788999999999999999999999999999999965443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=392.00 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=212.9
Q ss_pred cccccccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
...++.-.++|++++.||+|+||+||+|+++.+ +.||||++.... ...+.+.+|+.++++++ |||||++++++.
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEEEe
Confidence 344555567999999999999999999998765 579999986532 34578999999999995 999999999986
Q ss_pred eCCeEEEEEeccCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg 228 (472)
+ +.+++|||||++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfG 158 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFG 158 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccc
Confidence 5 557899999999999888754 4579999999999999999999999999999999999999 556789999999
Q ss_pred CceeccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCccCCCCC
Q 012039 229 LSVFIEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAP 304 (472)
Q Consensus 229 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (472)
+++....... .....||+.|+|||++. +.++.++|||||||++|+|++| .+|+......+++..+..+... +.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~ 235 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PC 235 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CC
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CC
Confidence 9987654332 23457899999999886 4689999999999999999995 5555666777778777765322 23
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCccccCC
Q 012039 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKEGG 343 (472)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~--h~~~~~~~ 343 (472)
...+|+++++||.+||+.||++|||++++++ ++||....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 3578999999999999999999999999988 88997653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=392.20 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=205.5
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCC---CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 150 (472)
++..+++|++++.||+|+||+||+|++..++ ..||||.+.... .......+.+|+.++++++ |||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 4555679999999999999999999987653 468888875432 3444677999999999995 999999999986
Q ss_pred eCCeEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCC
Q 012039 151 DKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (472)
Q Consensus 151 ~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~ 229 (472)
+ +.+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||+
T Consensus 79 ~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 E-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 154 (273)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred c-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchh
Confidence 4 678999999999999988765 45699999999999999999999999999999999999994 556799999999
Q ss_pred ceeccCCcc--eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 012039 230 SVFIEEGKV--YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (472)
Q Consensus 230 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (472)
++....... .....||+.|+|||++. +.++.++|||||||++|+|++ |.+||.+.+..+++..+.++... ..+
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~ 231 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMP 231 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCC
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 987654332 23456899999999986 468999999999999999998 89999999999999888876543 234
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+.+|+++.+||.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6799999999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-53 Score=408.80 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=202.8
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 151 (472)
+..+|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++++++ |||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence 45789999999999999999999999999999999976543 3445567899999999995 9999999999963
Q ss_pred -CCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 152 -~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
...+|+|||||.|+ +.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred cCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhh
Confidence 47899999999664 44444 3579999999999999999999999999999999999999 55667999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------ 297 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------ 297 (472)
............+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 88777666677789999999999865 58999999999999999999999999887766655553211
Q ss_pred ----------ccCCCCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccC
Q 012039 298 ----------IDFESAP----------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (472)
Q Consensus 298 ----------~~~~~~~----------------~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~ 342 (472)
....... ....|+++.+||++||..||++|||++|+|+||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1111000 01246788999999999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=405.83 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=214.0
Q ss_pred ccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 012039 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (472)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 152 (472)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+++|++|+ |||||++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSST
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccc
Confidence 345789999999999999999999999999999999976432 3344567889999999995 99999999998633
Q ss_pred --CeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCc
Q 012039 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (472)
Q Consensus 153 --~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~ 230 (472)
...+++|+|+.||+|.+++. .+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||++
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 168 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC---
T ss_pred ccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchh
Confidence 33456667777999998875 4579999999999999999999999999999999999999 56677999999999
Q ss_pred eeccCCcceeeccCCCCCCchhhhhc--ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCccCC-------
Q 012039 231 VFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------- 301 (472)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 301 (472)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+........
T Consensus 169 ~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 169 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 76543 3345679999999998654 368999999999999999999999999887777666654221111
Q ss_pred ----------------CC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccccCCC
Q 012039 302 ----------------SA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (472)
Q Consensus 302 ----------------~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h~~~~~~~~ 344 (472)
.. .+..+|+++++||++||+.||.+|||++|+|+||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 00 12468999999999999999999999999999999997644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=386.05 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=202.7
Q ss_pred cceEEcceeeecCCeEEEEEEECCCC----CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 154 (472)
+.|++.+.||+|+||+||+|.++.++ ..||||++.... .......+.+|+.++++|+ |||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence 47999999999999999999987655 469999986433 3344567899999999995 9999999999999999
Q ss_pred EEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceec
Q 012039 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (472)
Q Consensus 155 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~ 233 (472)
+++|||||.++++.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence 99999999999999877654 569999999999999999999999999999999999999 56778999999999876
Q ss_pred cCCcc----eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 012039 234 EEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (472)
Q Consensus 234 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (472)
..... .....||+.|+|||++.+ .++.++|||||||++|||++| .+|+...+..+++..+..+... + ....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~--~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-P--TPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-C--CCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-C--Cchh
Confidence 54321 223468999999998864 689999999999999999995 5555666777777777665332 2 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
++.++.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8999999999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=394.33 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=210.8
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCE--EEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
++|++.+.||+|+||+||+|+++.+|.. ||||.+.... .....+.+.+|+.+|.++.+|||||++++++.+.+.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5799999999999999999999988875 5667664332 33456679999999999956999999999999999999
Q ss_pred EEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCC
Q 012039 157 VVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 220 (472)
+|||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.+.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence 999999999999998643 569999999999999999999999999999999999999 5566
Q ss_pred cEEEeecCCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCC-CCCCCCChHHHHHHHHcCCc
Q 012039 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDAILQGDI 298 (472)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~ 298 (472)
.+||+|||+++............||..|+|||.+. +.++.++|||||||++|+|++|. +||.+.+..+++..+.++..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 79999999998765544444567999999999886 46999999999999999999965 67888888888888877532
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
...+..+++++++||.+||+.||++|||+.++++|
T Consensus 245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22335789999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=385.14 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=203.5
Q ss_pred cceEEcceeeecCCeEEEEEEECCC-C--CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENST-G--RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
.+|++.+.||+|+||.||+|++..+ + ..||||++.+.........+.+.+|+.+|++++ |||||++++++.++ .+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence 4799999999999999999986543 3 368999987766545555678999999999995 99999999999764 67
Q ss_pred EEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++|||||++|+|.+.+.. .+.+++..+..++.||+.||.|||+++|+||||||+||+++ .+..+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhcc
Confidence 899999999999987765 45699999999999999999999999999999999999995 45679999999999875
Q ss_pred CCcce----eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 012039 235 EGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 235 ~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
..... ....|+..|+|||++.+ .++.++|||||||++|||+| |..||.+.+..+.+..+......++. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence 54321 23457889999999874 58999999999999999998 89999999999999998877655443 3678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
|+++.+||.+||..||++|||+.++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=391.63 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=201.7
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
++...++|++++.||+|+||.||+|++.. +++.||||++.... .......+.+|..++.++.+|+|||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 44556799999999999999999999754 44689999986533 234456788899999998779999999998
Q ss_pred EEe-CCeEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 012039 149 YED-KQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (472)
Q Consensus 149 ~~~-~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 211 (472)
+.. +..+++|||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 765 45789999999999999998653 2488999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhC-CCCCCCCCh
Q 012039 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETE 286 (472)
Q Consensus 212 li~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~ 286 (472)
|+ +.++.+||+|||+|+....... .....||+.|+|||++.+ .++.++|||||||++|+|++| .+||.+...
T Consensus 166 Ll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 166 LL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp EE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99 5567899999999987654332 234579999999998864 589999999999999999986 567876654
Q ss_pred HHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 287 KGIF-DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 287 ~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.+.+ ..+..+. .+. ....+++++.+||.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCC-CCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444 4444432 222 224689999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=390.40 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=205.7
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCC----EEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 155 (472)
+|++++.||+|+||+||+|++..+|+ .||+|.+.... .....+.+.+|+.++++++ |||||++++++.++ ..
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-Ce
Confidence 69999999999999999999988876 47777775432 3345678999999999995 99999999999875 46
Q ss_pred EEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceecc
Q 012039 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (472)
Q Consensus 156 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~ 234 (472)
++++||+.+++|.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecc
Confidence 7888999999999887654 569999999999999999999999999999999999999 456679999999998765
Q ss_pred CCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 235 EGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 235 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
.... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..++...+..+.... ..+.++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccC
Confidence 4332 22346899999999886 468999999999999999998 899999888888888887764322 225689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+++.+||.+||+.||++|||+.++++|
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-51 Score=387.04 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=216.1
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 148 (472)
.+..+++|++++.||+|+||+||+|+++. +++.||||++.... .......+.+|+.++++++ ||||++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~ 84 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV 84 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceee
Confidence 44567789999999999999999999753 56789999986543 2344677999999999995 9999999999
Q ss_pred EEeCCeEEEEEeccCCcchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEee
Q 012039 149 YEDKQSVHVVMELCAGGELFDRIIAKG------------------------HYSERAAASICRSIVNVVHICHFMGVMHR 204 (472)
Q Consensus 149 ~~~~~~~~lv~e~~~g~sL~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 204 (472)
+.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999986432 38889999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCcEEEeecCCceeccCCc---ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCC-C
Q 012039 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGV-P 279 (472)
Q Consensus 205 dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~-~ 279 (472)
||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+ .|+.++|||||||++|||++|. +
T Consensus 165 DlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 165 DLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999 556789999999998664432 2234578899999998875 6999999999999999999985 6
Q ss_pred CCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
||.+.+..+++..+..+.... ....+++++.+||.+||+.||++|||+.||++
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899999999999988876432 23578999999999999999999999999865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=385.46 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=212.9
Q ss_pred ccccccceEEcceeeecCCeEEEEEEECCCC-------CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEE
Q 012039 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTG-------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (472)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 146 (472)
++...++|++++.||+|+||.||+|++..++ ..||||++.+.. .......+.+|+..+.++.+|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4455779999999999999999999976554 379999986543 3344677889999999996799999999
Q ss_pred EEEEeCCeEEEEEeccCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 012039 147 GAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (472)
Q Consensus 147 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 210 (472)
+++.+++.+++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999644 348999999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEeecCCceeccCCcc---eeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 012039 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 285 (472)
||+ +.++.+||+|||+++....... .....||+.|+|||++. +.|+.++|||||||++|+|++ |.+||.+.+
T Consensus 166 iLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999 5667899999999997755432 23357899999999886 569999999999999999998 799998888
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
...++..+..+... .. ...+|+++.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~i~~~~~~-~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRM-DK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCC-CC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC-CC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88888887765332 22 2578999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=378.70 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=203.7
Q ss_pred cccccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CC
Q 012039 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQ 153 (472)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~ 153 (472)
+.-.++|++++.||+|+||.||+|+++ |+.||||++++. ...+.+.+|+.++++++ ||||+++++++.+ .+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 344568999999999999999999985 779999998643 34578999999999995 9999999998854 56
Q ss_pred eEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCce
Q 012039 154 SVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~ 231 (472)
.+|+||||+++|+|.+++...+ .+++..+..|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 7899999999999999986543 48999999999999999999999999999999999999 567789999999998
Q ss_pred eccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 012039 232 FIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (472)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (472)
...... ....+|+.|+|||++. +.++.++|||||||++|||+| |++||...+..+++..+.++.... ....++
T Consensus 152 ~~~~~~--~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~ 226 (262)
T d1byga_ 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCC
T ss_pred ecCCCC--ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCC
Confidence 765432 3457899999999885 569999999999999999998 799999888888888887753322 224688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
+++++||++||..||.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999999774
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=383.82 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=215.0
Q ss_pred cccccccceEEcceeeecCCeEEEEEEEC-----CCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
.++...++|++++.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+++++.+|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34555689999999999999999999863 456789999997543 23456678999999999977999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCC
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAKG------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 209 (472)
++.+.+.+++|||||++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987543 5899999999999999999999999999999999
Q ss_pred ceeeccCCCCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhh-CCCCCCCC
Q 012039 210 NFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAE 284 (472)
Q Consensus 210 Nili~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 284 (472)
||++ +..+.+||+|||+++........ ....||+.|+|||++. +.++.++|||||||++|+|+| |.+||.+.
T Consensus 175 NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 175 NILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999 45678999999999977654322 2357899999999887 468999999999999999998 66667666
Q ss_pred ChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+..+.+..+.........+ ..+|+++.+||.+||+.||++|||++++++
T Consensus 252 ~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6656555555443333322 468999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=379.91 Aligned_cols=254 Identities=20% Similarity=0.343 Sum_probs=217.3
Q ss_pred cccccccceEEcceeeecCCeEEEEEEECC-----CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEE
Q 012039 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (472)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 147 (472)
.++...++|++++.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.+++++. |||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLG 90 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeee
Confidence 345566899999999999999999998863 35689999986533 3344567899999999995 999999999
Q ss_pred EEEeCCeEEEEEeccCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC
Q 012039 148 AYEDKQSVHVVMELCAGGELFDRIIAK----------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (472)
Q Consensus 148 ~~~~~~~~~lv~e~~~g~sL~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 217 (472)
++..+...++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d 167 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---A 167 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---C
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---c
Confidence 999999999999999999999988642 247889999999999999999999999999999999999 6
Q ss_pred CCCcEEEeecCCceeccCCcce---eeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhC-CCCCCCCChHHHHHH
Q 012039 218 ENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDA 292 (472)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~ 292 (472)
.+..+||+|||+++........ ....||+.|+|||.+.+ .++.++||||||+++|+|+|| .+||.+.+..+.+..
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 6778999999999876544322 23468999999998864 588999999999999999998 588988898889988
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
+.++..... ...+|+.+.+||.+||+.||++|||+.++++
T Consensus 248 i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 248 VMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 887654222 2468999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-50 Score=381.34 Aligned_cols=259 Identities=19% Similarity=0.284 Sum_probs=207.7
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.+|++|+.+..++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 3458999999999999999999999999999999886532 22357889999999975666777888889999999
Q ss_pred EEEeccCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+||||+ +++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||+...+.+..+||+|||+|+....
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999999 556666554 456799999999999999999999999999999999999997666677899999999998764
Q ss_pred Ccc--------eeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCChHHHHHHH---HcCCccCC-C
Q 012039 236 GKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI---LQGDIDFE-S 302 (472)
Q Consensus 236 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~-~ 302 (472)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+ .......+ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 332 234579999999999875 5899999999999999999999999876544333222 12111111 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCCcccc
Q 012039 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQ---VLEHPWIKE 341 (472)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~~---~l~h~~~~~ 341 (472)
.....+|+++.+||.+||+.||++||++.+ +|+|+|.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 123578999999999999999999999874 467777654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=368.42 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=201.4
Q ss_pred eEEcceeeecCCeEEEEEEECCCC---CEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQSVH 156 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~ 156 (472)
+.+.++||+|+||+||+|++..++ ..||||++++.. .....+.+.+|+++|++|+ |||||++++++.+ ++.++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence 344678999999999999987643 358999986432 3445678999999999995 9999999999765 56899
Q ss_pred EEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEeecCCceeccC
Q 012039 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~~~~ 235 (472)
+|||||++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+ +.+..+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccc
Confidence 999999999999988754 457788999999999999999999999999999999999 5677899999999987654
Q ss_pred Ccce-----eeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCCCC
Q 012039 236 GKVY-----RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAPWPTI 308 (472)
Q Consensus 236 ~~~~-----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 308 (472)
.... ....||+.|+|||.+. +.++.++||||||+++|||++|..||... +..+....+.++..... ...+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~ 259 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYC 259 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccC
Confidence 3221 2346899999999876 56999999999999999999977777543 44455666666643322 2468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
++++.+||.+||+.||++|||+.|+++|
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8999999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-48 Score=365.52 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=208.6
Q ss_pred cccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.|.+|+||+.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 4568999999999999999999999999999999886532 23457789999999987799999999999999999
Q ss_pred EEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCC--CCCcEEEeecCCceec
Q 012039 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLSVFI 233 (472)
Q Consensus 157 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~~~kl~Dfg~~~~~ 233 (472)
+||||+ |++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++... ..+.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 78999888765 4699999999999999999999999999999999999997432 3567999999999876
Q ss_pred cCCc--------ceeeccCCCCCCchhhhhc-ccCCccchhhHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCccCC
Q 012039 234 EEGK--------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDIDFE 301 (472)
Q Consensus 234 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~ 301 (472)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+.......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 5332 2234679999999999875 589999999999999999999999976533 333333433222111
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 012039 302 -SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (472)
Q Consensus 302 -~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l~ 335 (472)
....+.+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1123568999999999999999999999876543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=359.48 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=191.0
Q ss_pred ccceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 012039 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (472)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~---- 153 (472)
..+|.+.+.||+|+||.||+|++ +|+.||||++.... ........|+..+.+++ |||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcce
Confidence 45799999999999999999986 58899999985432 11222334555556774 999999999987653
Q ss_pred eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF--------MGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 154 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
.+|+|||||++|+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+|||+ +.++.+||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~ 150 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEE
Confidence 689999999999999999764 69999999999999999999996 599999999999999 567789999
Q ss_pred ecCCceeccCCcc-----eeeccCCCCCCchhhhhc-------ccCCccchhhHHHHHHHHhhCCCCCCCCC--------
Q 012039 226 DFGLSVFIEEGKV-----YRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAET-------- 285 (472)
Q Consensus 226 Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~-------- 285 (472)
|||++........ .....||+.|+|||++.. .++.++|||||||++|||+||..||....
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9999988755432 234679999999999864 25778999999999999999988773311
Q ss_pred -------hHHHHHHHHcCCccCCCC-CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 012039 286 -------EKGIFDAILQGDIDFESA-PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (472)
Q Consensus 286 -------~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~Rps~~~~l~h 336 (472)
.......+.........+ .+ ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122233333332221111 01 1123468899999999999999999998773
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-45 Score=356.59 Aligned_cols=259 Identities=24% Similarity=0.446 Sum_probs=196.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhcc----------CCCCeeEEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS----------GQPNIVEFKGA 148 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~hp~iv~~~~~ 148 (472)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+++.+. +|+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 47999999999999999999999999999999997532 23467788999998884 25889999988
Q ss_pred EEe--CCeEEEEEeccCCcchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceeeccCCCC---
Q 012039 149 YED--KQSVHVVMELCAGGELFDRI---IAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDEN--- 219 (472)
Q Consensus 149 ~~~--~~~~~lv~e~~~g~sL~~~l---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~--- 219 (472)
+.. ....+++|+++..+...... .....+++..++.++.||+.||.|||+ .||+||||||+|||+..++..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 45677777776655433222 234569999999999999999999998 899999999999999643322
Q ss_pred CcEEEeecCCceeccCCcceeeccCCCCCCchhhhh-cccCCccchhhHHHHHHHHhhCCCCCCCCChH------HHHHH
Q 012039 220 ALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK------GIFDA 292 (472)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~ 292 (472)
..++++|||.+...... ....+||+.|+|||++. ..++.++||||+||++++|++|+.||...... ..+..
T Consensus 169 ~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 34899999999875443 34568999999999876 46899999999999999999999999654321 11111
Q ss_pred HHc--CC--------------------c--cC--------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012039 293 ILQ--GD--------------------I--DF--------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (472)
Q Consensus 293 i~~--~~--------------------~--~~--------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~~~l 334 (472)
+.. +. . .. ....+...++++.+||.+||.+||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 00 0 00 0001123467899999999999999999999999
Q ss_pred cCCccccCC
Q 012039 335 EHPWIKEGG 343 (472)
Q Consensus 335 ~h~~~~~~~ 343 (472)
+||||++..
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 999999653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5e-26 Score=199.49 Aligned_cols=165 Identities=22% Similarity=0.188 Sum_probs=122.7
Q ss_pred eEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCC---------------cccHHHHHHHHHHHHhccCCCCeeEE
Q 012039 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT---------------KNDKDDIKREIQIMQHLSGQPNIVEF 145 (472)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~~hp~iv~~ 145 (472)
|.++++||+|+||+||+|++. +|+.||||++....... ........+|...+.++. |++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 568899999999999999985 68999999875322110 001233457899999995 8999988
Q ss_pred EEEEEeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceeeccCCCCCcEEEe
Q 012039 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (472)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~~~kl~ 225 (472)
+++. . .+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||++. ..++|+
T Consensus 80 ~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~~~li 144 (191)
T d1zara2 80 YAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EGIWII 144 (191)
T ss_dssp EEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TEEEEC
T ss_pred EEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CCEEEE
Confidence 7653 2 269999998876532 455667889999999999999999999999999999952 248999
Q ss_pred ecCCceeccCCcceeeccCCCCCCc------hhhhhcccCCccchhhHHH
Q 012039 226 DFGLSVFIEEGKVYRDIVGSAYYVA------PEVLRRRYGKEIDIWSAGV 269 (472)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~ 269 (472)
|||+|......... .|.. .+.+.+.|+.++|+||+.-
T Consensus 145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 99999876533221 1111 1334567899999999753
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.61 E-value=7e-16 Score=113.12 Aligned_cols=77 Identities=30% Similarity=0.494 Sum_probs=71.7
Q ss_pred HHHHhhchhhHHhhhhhhhccccCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 373 KVIAENLSTEEIQGLKQMFTNIDTDN-SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~F~~~D~~~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+...+.+++++++.++++|+.||.|+ +|.|+..||+.+|+.+|..+++++++.++..+|.|++|.|+|+||+.++..
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 44566789999999999999999995 799999999999999999999999999999999999999999999998864
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.58 E-value=1.5e-15 Score=111.33 Aligned_cols=81 Identities=30% Similarity=0.503 Sum_probs=69.2
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHH
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHL 459 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l 459 (472)
+++++.+++++|+.+|.|++|.|+..||+.+|+.+| .++.++++.+|..+|.|++|.|+|+||+.++.... ...+++
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~--~~~~e~ 77 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR--GLVKDV 77 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT--TTHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCc--cchHHH
Confidence 357888999999999999999999999999999999 57999999999999999999999999999876542 222344
Q ss_pred HHHH
Q 012039 460 YKAF 463 (472)
Q Consensus 460 ~~~F 463 (472)
.++|
T Consensus 78 ~~~F 81 (81)
T d2opoa1 78 SKIF 81 (81)
T ss_dssp HHHC
T ss_pred HhhC
Confidence 4444
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.58 E-value=1.5e-15 Score=110.53 Aligned_cols=74 Identities=39% Similarity=0.620 Sum_probs=69.5
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
..++++++.+++++|..||.|++|+|+..||+.+|+.+|..++++++..++..+|.|++|.|+|+||+.++...
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~~ 75 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ 75 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTTS
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 35778899999999999999999999999999999999999999999999999999999999999999987543
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.57 E-value=1.8e-15 Score=108.67 Aligned_cols=71 Identities=44% Similarity=0.682 Sum_probs=67.6
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++++++.+++++|..||.|++|+|+..||+.+++.+|..++++++..++..+|.|++|.|+|+||+.++..
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 57788999999999999999999999999999999999999999999999999999999999999998753
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.57 E-value=2.6e-15 Score=110.08 Aligned_cols=72 Identities=36% Similarity=0.565 Sum_probs=68.6
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++++++++++++|..||.|++|+|+..||+.+|+.+|..+++.+++.|+..+|.|++|.|+|+||+.++..
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 467888999999999999999999999999999999999999999999999999999999999999998864
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.54 E-value=7.8e-16 Score=114.44 Aligned_cols=76 Identities=64% Similarity=0.965 Sum_probs=70.9
Q ss_pred HHHHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 373 KVIAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..|+..++.+++..++++|..+|.|++|+|+..||+.+|+.+|..+++++++.+++.+|.|++|.|+|+||+.+++
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am~ 86 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATV 86 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCCC
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHc
Confidence 4566778888899999999999999999999999999999999999999999999999999999999999997653
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.50 E-value=1.3e-14 Score=101.36 Aligned_cols=63 Identities=35% Similarity=0.705 Sum_probs=60.0
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
++++++|+.||+|++|+|+.+||+.+++.+|..+++++++.++..+|.|++|.|+|+||+.+|
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 467899999999999999999999999999999999999999999999999999999999753
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.50 E-value=1.8e-14 Score=103.66 Aligned_cols=65 Identities=29% Similarity=0.489 Sum_probs=62.0
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++++++|+.||.|++|+|+..||+.+|+.+|..++.++++.|+..+|.|++|.|+|+||+.++..
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~ 73 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG 73 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 46889999999999999999999999999999999999999999999999999999999998754
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.48 E-value=3.9e-14 Score=116.44 Aligned_cols=90 Identities=23% Similarity=0.501 Sum_probs=80.7
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHH
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDD 457 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~ 457 (472)
++++++++++++|..+|.|++|.|+..||..+|+.+|..++.+++..++. +++|.|+|.||+.++..... ...++
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~~~~ 76 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDSEE 76 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCCHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH----hccCccccccccccccccccccchhh
Confidence 36788999999999999999999999999999999999999999998884 67899999999998875433 45678
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.++.+|+.||+|++|
T Consensus 77 ~l~~aF~~~D~d~~G 91 (142)
T d1wdcb_ 77 TIRNAFAMFDEQETK 91 (142)
T ss_dssp HHHHHHHTTCTTCCS
T ss_pred hHHHhhhhhcccCCC
Confidence 999999999999998
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.46 E-value=4.8e-14 Score=116.51 Aligned_cols=95 Identities=40% Similarity=0.685 Sum_probs=85.3
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~ 456 (472)
+++++++.+++++|..+|.|++|+|+.+||..++..++..++...+..++..+|.+++|.|+|+||+..+..... ....
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~ 81 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE 81 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChH
Confidence 467888999999999999999999999999999999999999999999999999999999999999998754332 2345
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||.|++|
T Consensus 82 ~~~~~~F~~~D~d~~G 97 (146)
T d1exra_ 82 EELIEAFKVFDRDGNG 97 (146)
T ss_dssp HHHHHHHHHHSTTCSS
T ss_pred HHHHHHHHHhCCCCCC
Confidence 7899999999999998
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.46 E-value=3.3e-14 Score=97.87 Aligned_cols=61 Identities=38% Similarity=0.695 Sum_probs=58.4
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFIT 445 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~ 445 (472)
++++++|+.||.+++|+|+..||+.+|+.+|..+++.+++.|++.+|.|++|.|+|+||+.
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 3678999999999999999999999999999999999999999999999999999999984
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.46 E-value=5.1e-14 Score=99.04 Aligned_cols=64 Identities=23% Similarity=0.501 Sum_probs=60.5
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++++|+.+|.|++|+|+..||+.+++.+|..+++++++.++..+|.|++|.|+|+||+.++..
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~ 65 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 3578999999999999999999999999999999999999999999999999999999988753
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.46 E-value=5.1e-14 Score=102.18 Aligned_cols=68 Identities=35% Similarity=0.514 Sum_probs=63.6
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..++++++|+.+|.|++|+|+..||+.+|+.+|..++.++++.+++.+|.|++|.|+|+||+.++..
T Consensus 6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k 73 (77)
T d1oqpa_ 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK 73 (77)
T ss_dssp SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence 34467899999999999999999999999999999999999999999999999999999999998764
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.45 E-value=5.5e-14 Score=102.86 Aligned_cols=65 Identities=34% Similarity=0.570 Sum_probs=61.9
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++++++|..||.|++|+|+..||+.+++.+|..++.++++.++..+|.|++|.|+|+||+.++..
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 56889999999999999999999999999999999999999999999999999999999998754
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.44 E-value=2.6e-14 Score=100.64 Aligned_cols=64 Identities=36% Similarity=0.629 Sum_probs=60.0
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++++++|+.||.|++|+|+.+||+.+|+.+|.. +++++++.|++.+|.|++|.|+|+||+.++.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 66 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIK 66 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 357899999999999999999999999999975 7999999999999999999999999998775
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.42 E-value=8.3e-14 Score=115.86 Aligned_cols=93 Identities=24% Similarity=0.328 Sum_probs=81.2
Q ss_pred chhhHHhhhhhhhccccC--CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc--CC
Q 012039 379 LSTEEIQGLKQMFTNIDT--DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK--LE 454 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~--~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~--~~ 454 (472)
++++++++++++|..||. |++|.|+..||+.+|+.+|..++++++..++ ..|.+++|.|+|+||+.++..... ..
T Consensus 1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~-~~~~~~~~~i~~~eFl~~~~~~~~~~~~ 79 (152)
T d1wdcc_ 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG-GTHKMGEKSLPFEEFLPAYEGLMDCEQG 79 (152)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTT-CCSSTTSCEECHHHHHHHHHHHTTSCCC
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhh-hhhccccccccccccccccccccccchh
Confidence 357788999999999994 8999999999999999999999999998765 568889999999999998765432 35
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
..+.+..+|+.||+|++|
T Consensus 80 ~~~~l~~aF~~~D~~~~G 97 (152)
T d1wdcc_ 80 TFADYMEAFKTFDREGQG 97 (152)
T ss_dssp CHHHHHHHHHTTCSSSSS
T ss_pred HHHhhhhhhhccccccCc
Confidence 668899999999999998
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.40 E-value=3.8e-13 Score=110.96 Aligned_cols=96 Identities=39% Similarity=0.629 Sum_probs=87.7
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCc
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LER 455 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~ 455 (472)
..++++++.+++++|+.+|.|++|+|+.+||+.++...|..+++.++..++..++.++++.++|++|+..+..... ..+
T Consensus 2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (146)
T d1lkja_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS 81 (146)
T ss_dssp CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCH
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccH
Confidence 3578899999999999999999999999999999999999999999999999999999999999999998765544 445
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
++.++.||+.||+|++|
T Consensus 82 ~~~~~~aF~~~D~d~~G 98 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDG 98 (146)
T ss_dssp HHHHHHHHHHHCSSSSC
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 78899999999999998
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.38 E-value=2e-13 Score=112.53 Aligned_cols=89 Identities=19% Similarity=0.333 Sum_probs=77.8
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCC--CCcceeHHHHHHHHhcccc---CCcHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD--GNGTIDYIEFITATMHRHK---LERDDH 458 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d--~~g~i~~~eF~~~~~~~~~---~~~~~~ 458 (472)
.++++++|..||.|++|+|+.+||..+|+.+|..++.+++..++..++.+ ++|.|+|+||+..+..... ....+.
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 82 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFED 82 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHHH
Confidence 45789999999999999999999999999999999999999999988665 6889999999988764322 235678
Q ss_pred HHHHHHhhcCCCCC
Q 012039 459 LYKAFQHFDKDNSG 472 (472)
Q Consensus 459 l~~~F~~~D~d~~G 472 (472)
+..+|+.||+|++|
T Consensus 83 l~~aF~~~D~d~~G 96 (145)
T d2mysc_ 83 FVEGLRVFDKEGNG 96 (145)
T ss_pred HHHHHHHhhcCCCC
Confidence 99999999999998
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=5.1e-13 Score=111.99 Aligned_cols=80 Identities=23% Similarity=0.426 Sum_probs=73.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++.+|+.||+|++|+|+.+||+.++..+|..+++++++.++..+|. +|.|+|+||+.++... +.+.++|+
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~--~g~i~~~eFi~~~~~l------~~~~~~F~ 141 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSK--NGRIFFDDYVACCVKL------RALTDFFR 141 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCB--TTBCBHHHHHHHHHHH------HHHHHHHH
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCC--CCcCcHHHHHHHHHHH------HHHHHHHH
Confidence 567889999999999999999999999999999999999999999975 5899999999988654 56889999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 142 ~~D~d~~G 149 (165)
T d1k94a_ 142 KRDHLQQG 149 (165)
T ss_dssp TTCTTCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.38 E-value=1.4e-13 Score=118.07 Aligned_cols=96 Identities=64% Similarity=0.973 Sum_probs=87.4
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
..++++++.+++++|+.+|.|++|+|+.+||..++..++..++..+++.++..+|.+++|.|+|.+|+.++........+
T Consensus 2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~ 81 (182)
T d1s6ia_ 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLERE 81 (182)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCC
T ss_pred CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHHHHhhcccccH
Confidence 35678889999999999999999999999999999999999999999999999999999999999999988766655666
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.+|.+++|
T Consensus 82 e~l~~aF~~~D~d~~G 97 (182)
T d1s6ia_ 82 ENLVSAFSYFDKDGSG 97 (182)
T ss_dssp CSTHHHHHHTTTTCSS
T ss_pred HHHHHHHHHHhhcCCC
Confidence 7788999999999887
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.36 E-value=5.9e-13 Score=108.88 Aligned_cols=85 Identities=25% Similarity=0.343 Sum_probs=74.2
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc---CCcHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK---LERDDHLY 460 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~---~~~~~~l~ 460 (472)
...++++|..||.|++|.|+..||..+|+.+|..++.+++..+ +.+.+|.|+|+||+.++..... ....+.++
T Consensus 4 ~~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~----~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~ 79 (140)
T d1ggwa_ 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEI----ESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFV 79 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHH----HTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHH
T ss_pred HHHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhh----hccccccccchhhhhhhhhhhhcchhhHHHHHH
Confidence 3678999999999999999999999999999999999887654 6788999999999998864432 33467899
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.||+|++|
T Consensus 80 ~aF~~~D~d~~G 91 (140)
T d1ggwa_ 80 KGFQVFDKDATG 91 (140)
T ss_dssp HHHHTTCSSCSS
T ss_pred HHHHHHhccCCC
Confidence 999999999998
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.36 E-value=8e-13 Score=107.17 Aligned_cols=85 Identities=28% Similarity=0.428 Sum_probs=75.9
Q ss_pred hhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC---CcHHHHHHHHH
Q 012039 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL---ERDDHLYKAFQ 464 (472)
Q Consensus 388 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~---~~~~~l~~~F~ 464 (472)
..+|+.+|.|++|.|+..||..++..++...++++++.++..+|.+++|.|+|+||+..+...... ..+..++.+|+
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~ 82 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYK 82 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhccccccccccccccccccccccccccccccccccc
Confidence 468999999999999999999999999999999999999999999999999999999987654332 23467899999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|.|++|
T Consensus 83 ~~D~~~~g 90 (134)
T d1jfja_ 83 LMDVDGDG 90 (134)
T ss_dssp HHCCSSSS
T ss_pred ccccccCC
Confidence 99999987
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.35 E-value=4.7e-13 Score=103.55 Aligned_cols=65 Identities=35% Similarity=0.494 Sum_probs=60.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.++++|+.||.|++|+|+.+||+.+|+.+ |..+++++++.+++.+|.|+||.|+|+||+.++.
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (109)
T d5pala_ 40 DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVA 107 (109)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 3578899999999999999999999999886 6789999999999999999999999999999875
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=8.7e-13 Score=108.02 Aligned_cols=92 Identities=28% Similarity=0.592 Sum_probs=81.9
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHHHH
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDDHL 459 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~~l 459 (472)
+++.++++++|..+|.|++|+|+..||..+++.+|..++...+..++..+|.+++|.|++.||+..+..... ....+.+
T Consensus 2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l 81 (141)
T d2obha1 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI 81 (141)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHHH
Confidence 567789999999999999999999999999999999999999999999999999999999999998754322 2345678
Q ss_pred HHHHHhhcCCCCC
Q 012039 460 YKAFQHFDKDNSG 472 (472)
Q Consensus 460 ~~~F~~~D~d~~G 472 (472)
+.+|+.+|.+++|
T Consensus 82 ~~~f~~~d~~~~G 94 (141)
T d2obha1 82 LKAFKLFDDDETG 94 (141)
T ss_dssp HHHHHHHCTTCSS
T ss_pred HHHHHHhcccCCC
Confidence 9999999999887
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.33 E-value=1.2e-12 Score=110.05 Aligned_cols=96 Identities=34% Similarity=0.559 Sum_probs=84.3
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc----c
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH----K 452 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~----~ 452 (472)
..++.+++.+++++|..+|+|++|+|+.+||+.++..++..+++.++..++..+|.+++|.++|.||+..+.... .
T Consensus 12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~ 91 (162)
T d1topa_ 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAK 91 (162)
T ss_dssp HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcc
Confidence 346788899999999999999999999999999999999999999999999999999999999999988765332 1
Q ss_pred CCcHHHHHHHHHhhcCCCCC
Q 012039 453 LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 453 ~~~~~~l~~~F~~~D~d~~G 472 (472)
....+.++.+|+.||.|++|
T Consensus 92 ~~~~~~~~~aF~~~D~d~~G 111 (162)
T d1topa_ 92 GKSEEELANCFRIFDKNADG 111 (162)
T ss_dssp HHHHHHHHHHHHHHCTTCSS
T ss_pred cCcHHHHHHHHHHHCCCCCC
Confidence 22346788999999999998
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.31 E-value=2.2e-12 Score=110.47 Aligned_cols=82 Identities=26% Similarity=0.448 Sum_probs=72.5
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
+..++.+|+.+|+|++|.|+..||+.+|..+|..++++.++.++.. |.|++|.|+|+||+.++... +.+..+|
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~~~l------~~~~~~F 164 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR-FADDELIIDFDNFVRCLVRL------EILFKIF 164 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH-TSCSSSBCCHHHHHHHHHHH------HHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH-hcCCCCcCCHHHHHHHHHHH------HHHHHHH
Confidence 3568889999999999999999999999999999998777777765 67999999999999988653 5678899
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|++++|
T Consensus 165 ~~~D~~~~G 173 (188)
T d1qxpa2 165 KQLDPENTG 173 (188)
T ss_dssp HHSCSSCCS
T ss_pred HHhCCCCCC
Confidence 999999998
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.30 E-value=1.6e-12 Score=111.81 Aligned_cols=82 Identities=30% Similarity=0.494 Sum_probs=72.9
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAF 463 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F 463 (472)
...++.+|+.+|+|++|+|+.+||+.+|+.+|..++.+.++ ++..+|.|++|.|+|+||+.++... +.+..+|
T Consensus 90 ~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~-~~~~~d~d~dg~I~f~eFi~~~~~l------~~~~~~F 162 (186)
T d1df0a1 90 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQ-VIVARFADDELIIDFDNFVRCLVRL------EILFKIF 162 (186)
T ss_dssp HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHH-HHHHHHCCSTTEECHHHHHHHHHHH------HHHHHHH
T ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHH-HHHHHHcCCCCeEeHHHHHHHHHHH------HHHHHHH
Confidence 35688999999999999999999999999999998876554 5557899999999999999988643 6889999
Q ss_pred HhhcCCCCC
Q 012039 464 QHFDKDNSG 472 (472)
Q Consensus 464 ~~~D~d~~G 472 (472)
+.+|+|++|
T Consensus 163 ~~~D~~~~G 171 (186)
T d1df0a1 163 KQLDPENTG 171 (186)
T ss_dssp HHHCTTCCS
T ss_pred HHhCCCCCC
Confidence 999999998
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.30 E-value=2.8e-12 Score=106.91 Aligned_cols=97 Identities=30% Similarity=0.513 Sum_probs=84.8
Q ss_pred HhhchhhHHhhhhhhhccccCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc----
Q 012039 376 AENLSTEEIQGLKQMFTNIDTDN-SGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR---- 450 (472)
Q Consensus 376 ~~~~~~~~~~~~~~~F~~~D~~~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~---- 450 (472)
.+.++++++++++++|..+|.|+ +|.|+..||..+|+.+|..++..++..++..++.+++|.+++++|...+...
T Consensus 5 ~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (156)
T d1dtla_ 5 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDD 84 (156)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC--
T ss_pred HHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhhhhhhhhccccc
Confidence 45678889999999999999995 8999999999999999999999999999999999999999999998765432
Q ss_pred ccCCcHHHHHHHHHhhcCCCCC
Q 012039 451 HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 451 ~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.....++.++.+|+.||.|++|
T Consensus 85 ~~~~~~~~l~~~F~~~D~d~~G 106 (156)
T d1dtla_ 85 SKGKSEEELSDLFRMFDKNADG 106 (156)
T ss_dssp ---CHHHHHHHHHHHHCTTCSS
T ss_pred ccccHHHHHHHHHHHhCcCCCC
Confidence 2235567899999999999998
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.29 E-value=1.4e-12 Score=107.33 Aligned_cols=91 Identities=27% Similarity=0.480 Sum_probs=75.3
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHH
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDD 457 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~ 457 (472)
++++++.+++++|..+|.|++|+|+..||..+|+.+|...+..+ ++..++.+.+|.|+|.||+.++..... ...++
T Consensus 1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~---~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~ 77 (145)
T d2mysb_ 1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE---ELDAMIKEASGPINFTVFLTMFGEKLKGADPED 77 (145)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHH---HHHHHHHhccCceeechhhhhhhhcccccchHH
Confidence 46778999999999999999999999999999999996655433 344555678899999999998865433 44567
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.+..+|+.||.|++|
T Consensus 78 ~l~~aF~~fD~~~~g 92 (145)
T d2mysb_ 78 VIMGAFKVLDPDGKG 92 (145)
T ss_pred HHHHHHHhhhhcccc
Confidence 899999999999987
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.28 E-value=1.3e-12 Score=101.00 Aligned_cols=64 Identities=44% Similarity=0.606 Sum_probs=59.3
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..++++|+.+|.|++|+|+.+||+.+++.+ |..+++++++.|++.+|.|+||.|+|+||+.++.
T Consensus 41 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (109)
T d1pvaa_ 41 NDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVH 107 (109)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeHHHHHHHHH
Confidence 457889999999999999999999999887 6688999999999999999999999999998775
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.28 E-value=4.5e-12 Score=108.42 Aligned_cols=82 Identities=20% Similarity=0.455 Sum_probs=75.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+.++|..+|.+++|.|+.+||+.++..+|..+++++++.+++.+|.|++|.|+|+||+.++... ..+.++|+
T Consensus 84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l------~~~~~~F~ 157 (182)
T d1y1xa_ 84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV------CRVRNVFA 157 (182)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHHH
T ss_pred cccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHH------HHHHHHHH
Confidence 456788999999999999999999999999999999999999999999999999999999988643 46789999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|.+++|
T Consensus 158 ~~D~~~~G 165 (182)
T d1y1xa_ 158 FYDRERTG 165 (182)
T ss_dssp HHCTTCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=2.9e-12 Score=94.23 Aligned_cols=64 Identities=28% Similarity=0.436 Sum_probs=60.8
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
...+.++|..+|.+++|+|+..||+.+|..+|..+++++++.++..+|.|++|.|+|.||+..+
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 4568899999999999999999999999999999999999999999999999999999999865
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.26 E-value=5e-12 Score=108.92 Aligned_cols=90 Identities=23% Similarity=0.379 Sum_probs=77.8
Q ss_pred HHhhhhhhhccccCC-CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHH
Q 012039 383 EIQGLKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYK 461 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~ 461 (472)
...+++++|+.|+.+ ++|.|+.+||++++...+...+...++.+|..+|.|++|.|+|.||+.++........++.++.
T Consensus 19 ~~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~ 98 (189)
T d1jbaa_ 19 DAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKW 98 (189)
T ss_dssp HHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHH
T ss_pred CHHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCCCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHH
Confidence 334556666666544 5899999999999999998889999999999999999999999999999887666667789999
Q ss_pred HHHhhcCCCCC
Q 012039 462 AFQHFDKDNSG 472 (472)
Q Consensus 462 ~F~~~D~d~~G 472 (472)
+|+.||.|++|
T Consensus 99 ~F~~~D~d~~g 109 (189)
T d1jbaa_ 99 TFKIYDKDRNG 109 (189)
T ss_dssp HHHHHCSSCSS
T ss_pred HHhhhccCCCC
Confidence 99999999998
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.26 E-value=2.8e-12 Score=109.75 Aligned_cols=84 Identities=29% Similarity=0.423 Sum_probs=73.8
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
+.++++++|..+|.|++|+|+.+||..+|+.+|..++.++++.++..+|.|++|.|+|.||+..+.. ...+..+
T Consensus 16 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~------~~~~~~~ 89 (182)
T d1y1xa_ 16 DNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF------ILSMREG 89 (182)
T ss_dssp TTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH------HHHHHHH
T ss_pred cHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhcccccccccccccccccccccc------ccccccc
Confidence 3457899999999999999999999999999999999999999999999999999999999987643 2456777
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|.|++|
T Consensus 90 F~~~D~~~~g 99 (182)
T d1y1xa_ 90 FRKRDSSGDG 99 (182)
T ss_dssp HHHHCTTSSS
T ss_pred hhccccccch
Confidence 7777777776
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.26 E-value=2e-12 Score=99.88 Aligned_cols=68 Identities=38% Similarity=0.515 Sum_probs=61.1
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL---GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
......++++|+.||.|++|+|+.+||+.++..+ +..+++++++.|++.+|.|+||.|+|+||+.++.
T Consensus 37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 3445678899999999999999999999999987 4568899999999999999999999999998774
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.26 E-value=1.2e-12 Score=94.47 Aligned_cols=66 Identities=24% Similarity=0.465 Sum_probs=57.0
Q ss_pred HhhhhhhhccccCC--CCCcccHHHHHHHHHHcCCCCC--HHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTD--NSGTITYEELKAGLARLGSKLT--EAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~~~~--~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++++++|+.||.+ ++|+|+.+||+.+|+.+|..++ ..+++.++..+|.|+||.|+|+||+.++..
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~ 73 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK 73 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHH
Confidence 35688899999654 5799999999999999987665 457999999999999999999999998754
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=4.1e-12 Score=106.92 Aligned_cols=94 Identities=30% Similarity=0.512 Sum_probs=79.8
Q ss_pred HHhhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-C
Q 012039 375 IAENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK-L 453 (472)
Q Consensus 375 ~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~ 453 (472)
|...++.+++.+++++|..+|.|++|+|+.+||+.++...... .++.++..+|.+++|.|+|+||+..+..... .
T Consensus 6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~~----~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~ 81 (165)
T d1auib_ 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNP----LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKG 81 (165)
T ss_dssp CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTCT----THHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTC
T ss_pred HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCCH----HHHHHHHHHccccchhhhhhhhhhhccccccch
Confidence 3456789999999999999999999999999998876554332 3678999999999999999999998877643 3
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
.....++.+|+.+|.|++|
T Consensus 82 ~~~~~~~~~f~~~d~d~~g 100 (165)
T d1auib_ 82 DKEQKLRFAFRIYDMDKDG 100 (165)
T ss_dssp CHHHHHHHHHHHHCTTCSS
T ss_pred hhHHHHHHHHHHhcccccc
Confidence 4567899999999999998
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.25 E-value=4.5e-12 Score=98.14 Aligned_cols=66 Identities=35% Similarity=0.499 Sum_probs=60.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcC---CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLG---SKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~---~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
....++++|+.||.|++|+|+.+||+.+++.++ ..+++++++.|++.+|.|+||+|+|+||+.++.
T Consensus 39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 107 (109)
T d1rwya_ 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 345678899999999999999999999999885 467899999999999999999999999998875
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.24 E-value=3.4e-12 Score=98.33 Aligned_cols=66 Identities=35% Similarity=0.499 Sum_probs=60.1
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcC---CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLG---SKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~---~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..++++++|+.+|.|++|+|+..||+.+++.++ ..+++++++.+++.+|.|+||.|+|+||+.++.
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 345688999999999999999999999999985 468999999999999999999999999998774
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.24 E-value=7.2e-12 Score=106.24 Aligned_cols=81 Identities=28% Similarity=0.531 Sum_probs=72.0
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++.+|+.+|.|++|.|+..||+.+|...|..+++++++.++ .+|.|++|.|+|+||+.++... +.+..+|+
T Consensus 77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~-~~d~d~~G~i~~~EF~~~~~~~------~~~~~~f~ 149 (173)
T d1alva_ 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMII-RRYSDEGGNMDFDNFISCLVRL------DAMFRAFK 149 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHH-HHHTCSSSCBCHHHHHHHHHHH------HHHHHHHH
T ss_pred hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhh-ccccCCCCeEeHHHHHHHHHHH------HHHHHHHH
Confidence 4577899999999999999999999999999999988887766 5566999999999999988643 67889999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.||+|++|
T Consensus 150 ~~D~d~~G 157 (173)
T d1alva_ 150 SLDKDGTG 157 (173)
T ss_dssp HHSSSCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.22 E-value=7.8e-12 Score=102.86 Aligned_cols=87 Identities=24% Similarity=0.373 Sum_probs=73.2
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHH-hcCCCCcceeHHHHHHHHhcc------ccCCcHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEA-ADVDGNGTIDYIEFITATMHR------HKLERDDH 458 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~-~d~d~~g~i~~~eF~~~~~~~------~~~~~~~~ 458 (472)
.++++|..+|.|++|+|+.+||..+|+.+|..++.++++.++.. .+.+.+|.|+|+||+..+... ......+.
T Consensus 3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 82 (146)
T d1m45a_ 3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTED 82 (146)
T ss_dssp CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHH
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHH
Confidence 47899999999999999999999999999999999999999974 556677999999999987532 12344578
Q ss_pred HHHHHHhhcCCCCC
Q 012039 459 LYKAFQHFDKDNSG 472 (472)
Q Consensus 459 l~~~F~~~D~d~~G 472 (472)
+..+|+.||.|++|
T Consensus 83 l~~~F~~~D~~~~G 96 (146)
T d1m45a_ 83 FVKAFQVFDKESTG 96 (146)
T ss_dssp HHHHHHTTCSSSSS
T ss_pred HHHHHHhhcccccc
Confidence 99999999999998
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.4e-12 Score=106.58 Aligned_cols=87 Identities=23% Similarity=0.366 Sum_probs=73.4
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcC--CCCcceeHHHHHHHHhcccc---CCcHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV--DGNGTIDYIEFITATMHRHK---LERDDHLY 460 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~--d~~g~i~~~eF~~~~~~~~~---~~~~~~l~ 460 (472)
+++++|..+|.|++|.|+.+||..+|+.+|..++++++..++..++. +++|.|+|.||+..+..... ....+.+.
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~ 80 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYL 80 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCH
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHH
Confidence 46889999999999999999999999999999999999999987764 67899999999998764332 23346689
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.||+|++|
T Consensus 81 ~aF~~~D~d~~G 92 (139)
T d1w7jb1 81 EGFRVFDKEGNG 92 (139)
T ss_dssp HHHHTTCTTSSS
T ss_pred HhhhhccCCCCC
Confidence 999999999998
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.21 E-value=1.4e-11 Score=92.18 Aligned_cols=67 Identities=25% Similarity=0.310 Sum_probs=61.9
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
++.++...++++|+.+|.|++|+|+.+|++.++.+.+ ++.+++.+|++.+|.|++|.|+|+||+.++
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~ 69 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAF 69 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHHHHH
Confidence 4677888999999999999999999999999999986 678999999999999999999999998755
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=6e-12 Score=94.76 Aligned_cols=67 Identities=19% Similarity=0.290 Sum_probs=61.6
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
++.++...+.++|+.+|+|++|+|+.+|++.++.+.+ ++.+++++|+..+|.|++|.|+|+||+.+|
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~am 70 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAF 70 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 4567788899999999999999999999999999876 678999999999999999999999998765
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.21 E-value=1.8e-11 Score=104.56 Aligned_cols=82 Identities=30% Similarity=0.540 Sum_probs=75.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..++.+|+.+|.+++|.|+.+||+.++...+..+++++++.++..+|.+++|.|+|+||+.++... +.+..+|+
T Consensus 86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l------~~l~~~F~ 159 (181)
T d1hqva_ 86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL------QRLTDIFR 159 (181)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHH------HHHHHHHH
T ss_pred cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH------HHHHHHHH
Confidence 346788999999999999999999999999999999999999999999999999999999887643 56889999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 160 ~~D~~~dG 167 (181)
T d1hqva_ 160 RYDTDQDG 167 (181)
T ss_dssp HHCTTCSS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.19 E-value=1e-11 Score=105.98 Aligned_cols=85 Identities=24% Similarity=0.380 Sum_probs=75.2
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHH
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLY 460 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~ 460 (472)
.+.+.+.++|+.+|.|++|+|+.+||+.+|+.++. ..+.++++.+++.+|.|++|.|+|+||+.++... ..++
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~------~~~~ 89 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDWQ 89 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH------HHHH
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhc------cccc
Confidence 34567899999999999999999999999998875 4688999999999999999999999999987543 5678
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|+.+|.|++|
T Consensus 90 ~~f~~~D~~~~G 101 (181)
T d1hqva_ 90 NVFRTYDRDNSG 101 (181)
T ss_dssp HHHHHHCTTCCS
T ss_pred cccccccccccc
Confidence 899999999887
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=99.16 E-value=2.4e-11 Score=91.01 Aligned_cols=68 Identities=21% Similarity=0.347 Sum_probs=59.5
Q ss_pred hHHhhhhhhhccc-cCCCC-CcccHHHHHHHHHHcC-----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNI-DTDNS-GTITYEELKAGLARLG-----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~~~-----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..++.+.++|..| |.||+ |+|+.+||+++|+.++ ...++++++.||+.+|.|+||.|+|+||+.++..
T Consensus 6 ~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~ 80 (93)
T d1zfsa1 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (93)
T ss_dssp HHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence 4467889999998 88875 9999999999999875 3457899999999999999999999999998754
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.16 E-value=4.3e-11 Score=102.37 Aligned_cols=95 Identities=26% Similarity=0.400 Sum_probs=81.9
Q ss_pred hhchhhHHhhhhhhhccccCC--CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-cC
Q 012039 377 ENLSTEEIQGLKQMFTNIDTD--NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-KL 453 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-~~ 453 (472)
..++.+++..+++.|..+|.+ ++|.|+.+||+.++...+...+. .++.++..+|.|++|.|+|.||+.++.... ..
T Consensus 9 t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~~~~~-~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~ 87 (183)
T d2zfda1 9 TVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLFDTKHNGILGFEEFARALSVFHPNA 87 (183)
T ss_dssp SSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCH-HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTS
T ss_pred CCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCCCCCH-HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccC
Confidence 467899999999999999876 69999999999999888766544 578999999999999999999999875543 34
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
..++.++.+|+.||.|++|
T Consensus 88 ~~~~~~~~~F~~~D~d~~G 106 (183)
T d2zfda1 88 PIDDKIHFSFQLYDLKQQG 106 (183)
T ss_dssp CHHHHHHHHHHHHCTTSSS
T ss_pred cHHHHHHHhhcccccCCCC
Confidence 5577899999999999998
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=2.3e-11 Score=102.90 Aligned_cols=85 Identities=24% Similarity=0.336 Sum_probs=73.1
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-----CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-----LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLER 455 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-----~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~ 455 (472)
.++...++..|..++ ++||.|+..||+.+|+++|.. ++.++++.++..+|.|++|.|+|+||+.++...
T Consensus 3 ~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~----- 76 (172)
T d1juoa_ 3 GQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL----- 76 (172)
T ss_dssp TCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH-----
T ss_pred cchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhh-----
Confidence 345567889999997 789999999999999999854 457889999999999999999999999877532
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
..+..+|+.||.|++|
T Consensus 77 -~~~~~~f~~~D~d~sG 92 (172)
T d1juoa_ 77 -NGWRQHFISFDTDRSG 92 (172)
T ss_dssp -HHHHHHHHTTCTTCCS
T ss_pred -hhhhHHHHHhCcCCCC
Confidence 5678899999999987
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=6.3e-11 Score=100.16 Aligned_cols=80 Identities=29% Similarity=0.525 Sum_probs=72.2
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQ 464 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~ 464 (472)
..+..+|+.+|.|++|+|+.+|+..+|..+|..++.++++.+++.+|. +|.|+|+||+.++... +.+..+|+
T Consensus 77 ~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d~--~g~i~~~eF~~~~~~~------~~~~~~f~ 148 (172)
T d1juoa_ 77 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYST--NGKITFDDYIACCVKL------RALTDSFR 148 (172)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCS--SSSEEHHHHHHHHHHH------HHHHHHHH
T ss_pred hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHHh--cCCcCHHHHHHHHHHH------HHHHHHHH
Confidence 346678999999999999999999999999999999999999999965 6889999999988643 57889999
Q ss_pred hhcCCCCC
Q 012039 465 HFDKDNSG 472 (472)
Q Consensus 465 ~~D~d~~G 472 (472)
.+|+|++|
T Consensus 149 ~~D~d~~G 156 (172)
T d1juoa_ 149 RRDTAQQG 156 (172)
T ss_dssp HTCTTCCS
T ss_pred HhCCCCCC
Confidence 99999998
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=2.7e-11 Score=101.26 Aligned_cols=78 Identities=21% Similarity=0.315 Sum_probs=63.7
Q ss_pred hhhhccccCCCCCcccHHHHHHHHHHcCCCC-----CHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 388 KQMFTNIDTDNSGTITYEELKAGLARLGSKL-----TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 388 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~-----~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
.+.|..+ .+.+|.|+..||+.+|..+|.+. +.+.++.|+..+|.|++|.|+|+||+.++.. ...++.+
T Consensus 3 ~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~------~~~~~~~ 75 (165)
T d1k94a_ 3 YTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAA------LNAWKEN 75 (165)
T ss_dssp HHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH------HHHHHHH
T ss_pred HHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhc------cchhHHH
Confidence 4556666 47799999999999999888644 5677899999999999999999999887653 3678889
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.||+|++|
T Consensus 76 F~~fD~d~sG 85 (165)
T d1k94a_ 76 FMTVDQDGSG 85 (165)
T ss_dssp HHHHCTTCCS
T ss_pred HHHhCCCCCC
Confidence 9999999987
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.14 E-value=2.4e-11 Score=105.70 Aligned_cols=93 Identities=25% Similarity=0.383 Sum_probs=79.1
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT-EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++..++..+.+.|. +.+++|.|+.+||+.++..++.... ...++.+|..+|.|++|.|+|.||+.++........+
T Consensus 21 ~f~~~ei~~l~~~F~--~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~ 98 (201)
T d1omra_ 21 KFTEEELSSWYQSFL--KECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTN 98 (201)
T ss_dssp SSCHHHHHHHHHHHH--HHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGG
T ss_pred CCCHHHHHHHHHHHH--HHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchH
Confidence 367788888888883 5567999999999999999986544 5567899999999999999999999988766555667
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||.|++|
T Consensus 99 ~~l~~~F~~~D~d~~G 114 (201)
T d1omra_ 99 QKLEWAFSLYDVDGNG 114 (201)
T ss_dssp GSHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHccCCCC
Confidence 8899999999999998
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.13 E-value=6e-12 Score=90.76 Aligned_cols=68 Identities=19% Similarity=0.328 Sum_probs=57.9
Q ss_pred hHHhhhhhhhccccC-C-CCCcccHHHHHHHHHHc--CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNIDT-D-NSGTITYEELKAGLARL--GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~-~-~~G~i~~~el~~~l~~~--~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...+.+..+|..||. + +.|+|+.+||+.+++.+ +...+++++++|+..+|.|+||.|+|+||+.++..
T Consensus 4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~ 75 (78)
T d1cb1a_ 4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKK 75 (78)
T ss_dssp CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 446788999999975 3 46899999999999998 44556677999999999999999999999988754
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=99.12 E-value=2.6e-11 Score=91.37 Aligned_cols=68 Identities=13% Similarity=0.231 Sum_probs=58.5
Q ss_pred hHHhhhhhhhccc-cCCCC-CcccHHHHHHHHHHcCC--CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNI-DTDNS-GTITYEELKAGLARLGS--KLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~~~~--~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.+..+.++|..| |.|++ |+|+..||+.+++.++. ..+.++++.++..+|.|+||.|+|+||+.++..
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~ 82 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGE 82 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 4567889999998 77875 99999999999998754 346677999999999999999999999998764
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=99.12 E-value=1.5e-11 Score=91.55 Aligned_cols=69 Identities=16% Similarity=0.297 Sum_probs=59.2
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHc-----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARL-----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+..++.+..+|..+|.| +|+|+.+||+.++..+ +...+.+.++.||..+|.|+||.|+|+||+.++...
T Consensus 5 E~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 5 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp HHHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 34577899999999987 8999999999999874 344567789999999999999999999999887543
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.12 E-value=3.1e-11 Score=102.20 Aligned_cols=84 Identities=19% Similarity=0.361 Sum_probs=73.0
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCC--------CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK--------LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL 453 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~--------~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~ 453 (472)
+++.+++++|..+|. .+|.|+..||+.+|.++|.. ++.+.+..++..+|.|++|.|+|+||+..+..
T Consensus 1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~---- 75 (173)
T d1alva_ 1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN---- 75 (173)
T ss_dssp CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----
T ss_pred ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhh----
Confidence 467889999999994 48999999999999987643 46788999999999999999999999987653
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
...+..+|+.||+|++|
T Consensus 76 --~~~~~~~f~~~D~d~~G 92 (173)
T d1alva_ 76 --IKKWQAIYKQFDVDRSG 92 (173)
T ss_dssp --HHHHHHHHHHHCTTCCS
T ss_pred --hhHHHHHHHHhccCCCC
Confidence 25788999999999988
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=99.11 E-value=5.4e-11 Score=88.31 Aligned_cols=69 Identities=14% Similarity=0.302 Sum_probs=59.6
Q ss_pred hhHHhhhhhhhccc-cCCCCC-cccHHHHHHHHHHcC-----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNI-DTDNSG-TITYEELKAGLARLG-----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~~~-----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
++.+..+..+|..| |.||+| +|+.+||+++|+... ...+..++++|++.+|.|+||.|+|+||+.++..
T Consensus 5 E~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~ 80 (93)
T d1ksoa_ 5 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLAC 80 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence 34567788999998 999999 599999999998853 3457889999999999999999999999987754
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=99.10 E-value=8.9e-11 Score=87.42 Aligned_cols=68 Identities=22% Similarity=0.351 Sum_probs=58.5
Q ss_pred hHHhhhhhhhccc-cCCCCC-cccHHHHHHHHHHc-----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNI-DTDNSG-TITYEELKAGLARL-----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.++.+.++|..| |.|++| +|+.+||+++|+.. +...+++++++||..+|.|+||.|+|+||+.++..
T Consensus 6 ~~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~ 80 (93)
T d3c1va1 6 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 80 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Confidence 3467788999998 667655 79999999999873 56778999999999999999999999999997753
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.10 E-value=3.4e-11 Score=103.22 Aligned_cols=81 Identities=22% Similarity=0.393 Sum_probs=71.1
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCC--------CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGS--------KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~--------~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
+.++++|..+| |++|.|+..||..+|..+|. .++.+++..++..+|.|++|.|+|+||+..+.. .
T Consensus 18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~------~ 90 (186)
T d1df0a1 18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK------I 90 (186)
T ss_dssp HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH------H
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHh------H
Confidence 45889999998 99999999999999988753 356788999999999999999999999987753 2
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
..++.+|+.||+|++|
T Consensus 91 ~~~~~~F~~~D~d~sG 106 (186)
T d1df0a1 91 QKYQKIYREIDVDRSG 106 (186)
T ss_dssp HHHHHHHHHHCTTCCS
T ss_pred HHHHHHHHhhCCCCCC
Confidence 6789999999999998
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.10 E-value=8.8e-11 Score=96.36 Aligned_cols=64 Identities=34% Similarity=0.534 Sum_probs=60.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.+.++|+.+|.|++|+|+.+||+.++..+|..+++++++.++..+| |++|+|+|+||+.++.
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~ 145 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLS 145 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhC
Confidence 456889999999999999999999999999999999999999999999 9999999999998774
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.10 E-value=7.5e-11 Score=100.62 Aligned_cols=93 Identities=27% Similarity=0.362 Sum_probs=80.4
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT-EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++.++++.+.+.|. +.+++|.|+..||..++..++...+ ...++.++..+|.+++|.|+|+||+..+........+
T Consensus 17 ~fs~~ei~~l~~~F~--~~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~ 94 (181)
T d1bjfa_ 17 DFTEHEIQEWYKGFL--RDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLE 94 (181)
T ss_dssp SCCHHHHHHHHHHHH--HHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHH
T ss_pred CCCHHHHHHHHHHHH--hhCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchH
Confidence 467888888888884 4578999999999999999875554 5568999999999999999999999998877666778
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.+|.|++|
T Consensus 95 ~~~~~~f~~~D~d~dg 110 (181)
T d1bjfa_ 95 QKLKWAFSMYDLDGNG 110 (181)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhccCCCC
Confidence 8999999999999998
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.10 E-value=5.9e-12 Score=107.77 Aligned_cols=86 Identities=30% Similarity=0.484 Sum_probs=60.3
Q ss_pred hhhHH-hhhhhhhccccCCCCCcccHHHHHHHHHHcCCC--------CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 380 STEEI-QGLKQMFTNIDTDNSGTITYEELKAGLARLGSK--------LTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 380 ~~~~~-~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~--------~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+++++ +.++++|..+| +++|.|+..||+.+|.+++.. ++.+.++.++..+|.|++|.|+|+||..++...
T Consensus 14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~~~ 92 (188)
T d1qxpa2 14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI 92 (188)
T ss_dssp -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHhhh
Confidence 44454 45899999999 558999999999998766533 456789999999999999999999999877533
Q ss_pred ccCCcHHHHHHHHHhhcCCCCC
Q 012039 451 HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 451 ~~~~~~~~l~~~F~~~D~d~~G 472 (472)
..++.+|+.||+|++|
T Consensus 93 ------~~~~~~F~~~D~d~sG 108 (188)
T d1qxpa2 93 ------RNYLTIFRKFDLDKSG 108 (188)
T ss_dssp ------HHHHHHHGGGCTTCCS
T ss_pred ------HHHHHHHHHhCCCCCC
Confidence 6789999999999998
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.09 E-value=6.8e-11 Score=101.69 Aligned_cols=93 Identities=24% Similarity=0.287 Sum_probs=78.9
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCH-HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTE-AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++..++..+.+.|. +.+++|.|+..|+..++..++...+. ..++.+|..+|.|++|.|+|.||+.++........+
T Consensus 21 ~fs~~Ei~~l~~~F~--~~~~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~ 98 (190)
T d1fpwa_ 21 YFDRREIQQWHKGFL--RDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLE 98 (190)
T ss_dssp CSTHHHHHHHHHHHH--HHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCST
T ss_pred CCCHHHHHHHHHHHH--HHCCCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHHHHHHHHHccCchH
Confidence 367788888888884 45678999999999999998765554 457899999999999999999999988766555677
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||.|++|
T Consensus 99 e~~~~~F~~~D~d~dG 114 (190)
T d1fpwa_ 99 EKLSWAFELYDLNHDG 114 (190)
T ss_dssp HHHHHHHHHHCSSCSS
T ss_pred HHHHHHHHHhccCCCC
Confidence 8999999999999998
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.08 E-value=9.2e-11 Score=95.75 Aligned_cols=65 Identities=20% Similarity=0.425 Sum_probs=60.7
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+.+.++|+.||.|++|+|+.+||+.++..+|..+++++++.+++.+|.| +|+|+|+||+.++..
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~ 139 (142)
T d1wdcb_ 75 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKG 139 (142)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHT
T ss_pred hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhc
Confidence 35688999999999999999999999999999999999999999999998 699999999998864
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.08 E-value=6.6e-11 Score=97.14 Aligned_cols=65 Identities=35% Similarity=0.668 Sum_probs=61.6
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.+.++|+.+|.+++|+|+.+||+.+|..+|..+++++++.++..+|.|++|.|+|+||+..++.
T Consensus 81 ~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~~ 145 (146)
T d1m45a_ 81 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 145 (146)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred HHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence 46888999999999999999999999999999999999999999999999999999999988763
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.08 E-value=7.8e-11 Score=88.30 Aligned_cols=67 Identities=21% Similarity=0.338 Sum_probs=60.5
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++..++.++|+.+| +++|+|+.+|++.+|.+.| ++.++++.|+..+|.|++|.|+|+||+.++.
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~ 70 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMF 70 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence 46678889999999999 8999999999999998876 5788999999999999999999999987653
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=99.08 E-value=4.9e-11 Score=87.77 Aligned_cols=69 Identities=28% Similarity=0.454 Sum_probs=60.5
Q ss_pred hhHHhhhhhhhccc-cCCCCC-cccHHHHHHHHHH---cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNI-DTDNSG-TITYEELKAGLAR---LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+..+..+|..| |+|++| +|+..||+.+++. ++...+++++++|++.+|.|+||+|+|+||+.++..
T Consensus 5 E~ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~ 78 (89)
T d1k8ua_ 5 DQAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGA 78 (89)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHH
Confidence 34567888999998 999999 6999999999998 456667889999999999999999999999998753
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.06 E-value=1.3e-10 Score=98.83 Aligned_cols=93 Identities=23% Similarity=0.302 Sum_probs=77.6
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT-EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERD 456 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~ 456 (472)
.++..+++.+.+.|. +.+++|.|+.+||..++..++...+ ...++.|+..+|.|++|.|+|+||+.++........+
T Consensus 9 ~ft~~ei~~l~~~F~--~~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~ 86 (178)
T d1s6ca_ 9 NFTKRELQVLYRGFK--NECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVH 86 (178)
T ss_dssp SCCHHHHHHHHHHHH--HHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHH
T ss_pred CCCHHHHHHHHHHHH--HHCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccchH
Confidence 457777777777774 4567899999999999999876554 4557999999999999999999999988665555667
Q ss_pred HHHHHHHHhhcCCCCC
Q 012039 457 DHLYKAFQHFDKDNSG 472 (472)
Q Consensus 457 ~~l~~~F~~~D~d~~G 472 (472)
+.++.+|+.||.|++|
T Consensus 87 ~~~~~~f~~~D~~~~g 102 (178)
T d1s6ca_ 87 EKLRWTFNLYDINKDG 102 (178)
T ss_dssp HHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHhhccCCCC
Confidence 8999999999999998
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.05 E-value=6.3e-11 Score=96.47 Aligned_cols=65 Identities=28% Similarity=0.523 Sum_probs=60.8
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+.+.++|+.+|.|++|+|+.+||+.+|..+|.++++++++.+++.+|.| +|.|+|+||+.+++.
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s 139 (140)
T d1ggwa_ 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred HHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence 45688999999999999999999999999999999999999999999988 999999999998763
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=2.2e-10 Score=98.22 Aligned_cols=92 Identities=22% Similarity=0.267 Sum_probs=78.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCH-HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHH
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTE-AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~ 457 (472)
++..++..+.+.|.. .+++|.|+..++..++..++..... ..++.++..+|.+++|.|+|.||+.++........++
T Consensus 19 fs~~Ei~~l~~~F~~--~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e 96 (187)
T d1g8ia_ 19 FTEKEVQQWYKGFIK--DCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDE 96 (187)
T ss_dssp SCHHHHHHHHHHHHH--HCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHH
T ss_pred CCHHHHHHHHHHHHH--HCCCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhh
Confidence 577788888777754 4578999999999999998866554 4468899999999999999999999887666566678
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.++.+|+.||.|++|
T Consensus 97 ~l~~~F~~~D~d~dG 111 (187)
T d1g8ia_ 97 KLRWAFKLYDLDNDG 111 (187)
T ss_dssp HHHHHHHHHCTTCSS
T ss_pred hHHHHHHHHhcCCCC
Confidence 899999999999998
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.04 E-value=8.8e-11 Score=97.54 Aligned_cols=66 Identities=33% Similarity=0.556 Sum_probs=59.9
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+.+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.+++.+|.|+||.|+|+||+.+|.
T Consensus 89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~ 154 (156)
T d1dtla_ 89 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 154 (156)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 345678899999999999999999999999999999999999999999999999999999998774
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.04 E-value=3.3e-10 Score=92.77 Aligned_cols=65 Identities=37% Similarity=0.663 Sum_probs=61.8
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.+.++|+.+|.|++|+|+.+||+..+..+|..+++++++.+++.+|.|++|.|+|+||+.+++
T Consensus 81 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~ 145 (146)
T d1exra_ 81 EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV 145 (146)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhc
Confidence 45788999999999999999999999999999999999999999999999999999999999875
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.03 E-value=2e-10 Score=94.04 Aligned_cols=66 Identities=35% Similarity=0.567 Sum_probs=60.3
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
....+.++|+.+|.|++|+|+.+||+.+|..+|..++.++++.+++. |.|++|.|+|+||+..++.
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~ll~ 144 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS 144 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHHHhc
Confidence 34568899999999999999999999999999999999999999974 8899999999999998763
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=99.02 E-value=4e-10 Score=96.45 Aligned_cols=67 Identities=22% Similarity=0.304 Sum_probs=62.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
....+..+|..+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++..
T Consensus 103 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~ 169 (187)
T d1uhka1 103 IRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG 169 (187)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence 3455788999999999999999999999999999999999999999999999999999999987753
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=99.02 E-value=3.5e-10 Score=97.01 Aligned_cols=66 Identities=26% Similarity=0.304 Sum_probs=57.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...+..+|..+|.|++|+|+.+|+..++..+|..++.++++.+|..+|.|+||.|+|+||+.++..
T Consensus 106 ~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~ 171 (189)
T d1qv0a_ 106 REWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 171 (189)
T ss_dssp HHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999999999999999988764
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.01 E-value=2.1e-10 Score=93.93 Aligned_cols=66 Identities=24% Similarity=0.340 Sum_probs=62.4
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+.+.++|+.+|.+++|+|+..||+.+|+.+|..+++++++.++..+|.|++|.|+|.||+.+++.
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~ 141 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITH 141 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhcc
Confidence 346788999999999999999999999999999999999999999999999999999999998864
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=99.01 E-value=5.9e-11 Score=87.07 Aligned_cols=68 Identities=10% Similarity=0.270 Sum_probs=58.9
Q ss_pred hHHhhhhhhhccc-cCCCCCc-ccHHHHHHHHHH-cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNI-DTDNSGT-ITYEELKAGLAR-LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~-D~~~~G~-i~~~el~~~l~~-~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..++.+..+|..+ |+||+|. ++.+||+.++.. +|...++++++++++.+|.|+||.|+|+||+.++..
T Consensus 7 ~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~ 77 (87)
T d1xk4a1 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIK 77 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 4566788899888 8999995 599999999976 676677788999999999999999999999998764
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.01 E-value=2.8e-10 Score=93.96 Aligned_cols=66 Identities=24% Similarity=0.531 Sum_probs=60.4
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCC--CCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVD--GNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d--~~g~i~~~eF~~~~~~ 449 (472)
...+.++|+.||.+++|+|+.+||+.+|..+|..+++++++.+++.+|.+ ++|.|+|+||+..++.
T Consensus 81 ~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~ 148 (152)
T d1wdcc_ 81 FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMA 148 (152)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHH
T ss_pred HHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhc
Confidence 45688999999999999999999999999999999999999999999864 5689999999998764
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.00 E-value=6.3e-10 Score=92.84 Aligned_cols=67 Identities=30% Similarity=0.478 Sum_probs=62.0
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
....+.++|+.+|.|++|+|+..||+.++...+...+.++++.+|..+|.|+||.|+|+||+.++..
T Consensus 94 ~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~ 160 (162)
T d1topa_ 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG 160 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHS
T ss_pred cHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence 3456778999999999999999999999999999999999999999999999999999999988754
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=7.3e-10 Score=90.07 Aligned_cols=64 Identities=31% Similarity=0.590 Sum_probs=60.8
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
...++.+|..+|.+++|.|+..||..++..+|..++.+++..+|+.+|.|++|.|+|+||+.++
T Consensus 78 ~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 4568899999999999999999999999999999999999999999999999999999999865
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.98 E-value=7.5e-10 Score=94.99 Aligned_cols=86 Identities=26% Similarity=0.390 Sum_probs=74.7
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------cCC
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------KLE 454 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------~~~ 454 (472)
..++|+.+|.|++|.|+..||..++..++....++.++.+|+.+|.|++|.|+++||..++.... ...
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~ 144 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEAT 144 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCC
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhh
Confidence 45789999999999999999999999998888889999999999999999999999998875321 112
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.++.+..+|+.+|.|+||
T Consensus 145 ~~~~v~~if~~~D~d~dG 162 (190)
T d1fpwa_ 145 PEMRVKKIFKLMDKNEDG 162 (190)
T ss_dssp HHHHHHHHHHHHTTTCSS
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 246789999999999998
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.98 E-value=6.7e-10 Score=80.94 Aligned_cols=68 Identities=21% Similarity=0.354 Sum_probs=56.9
Q ss_pred hHHhhhhhhhccc-cCCCCC-cccHHHHHHHHHHc-----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNI-DTDNSG-TITYEELKAGLARL-----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+..+..+|..+ +.++++ +|+.+||++++++. +...+++.++++|+.+|.|+||.|+|+||+.++..
T Consensus 5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~ 79 (87)
T d1e8aa_ 5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAI 79 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH
Confidence 4567788999998 556665 79999999999884 33456789999999999999999999999987753
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=9.2e-11 Score=90.38 Aligned_cols=68 Identities=22% Similarity=0.273 Sum_probs=60.8
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
++.++.+.+.++|..+|+|++|+|+.+|++.+|.+.| ++.+++..|++.+|.|++|.|+++||+.+|.
T Consensus 16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence 4567788899999999999999999999999998766 5667799999999999999999999997663
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=4.1e-10 Score=91.40 Aligned_cols=65 Identities=29% Similarity=0.496 Sum_probs=57.5
Q ss_pred hHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 382 EEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 382 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
...+.+.++|+.+|.|++|+|+.+||+.++..+|..+++++++.|+.. |.|++|.|+|.||+..+
T Consensus 74 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 74 GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFLKHI 138 (139)
T ss_dssp ----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred cHHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence 344568899999999999999999999999999999999999999865 88999999999999875
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=3.7e-10 Score=85.55 Aligned_cols=64 Identities=20% Similarity=0.270 Sum_probs=52.7
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCC-------C---------CHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSK-------L---------TEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-------~---------~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.++.+|..+|.|++|+|+.+||..+++.++.. . ....++.+|..+|.|+||.|+|+||+.++..
T Consensus 17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 17 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 36789999999999999999999999865311 0 1234788999999999999999999987653
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.93 E-value=1.5e-10 Score=87.66 Aligned_cols=68 Identities=18% Similarity=0.239 Sum_probs=57.5
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-------CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-------LTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-------~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+..+..+.++|..+| +++|.|+..||+.+|+..+.. .+...++.||+.+|.|+||.|+|+||+.++..
T Consensus 6 E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~ 80 (100)
T d1psra_ 6 ERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGD 80 (100)
T ss_dssp HHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence 455777888999987 789999999999999987532 34456899999999999999999999998764
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.90 E-value=2.7e-09 Score=91.37 Aligned_cols=88 Identities=25% Similarity=0.314 Sum_probs=74.3
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-------------
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------- 451 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------- 451 (472)
..+.++|+.+|.|++|.|+..||..++..+.....++.++.+|+.+|.|++|.|++.||..++....
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~ 137 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAE 137 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhh
Confidence 3467899999999999999999999999988777788899999999999999999999988654211
Q ss_pred ----cCCcHHHHHHHHHhhcCCCCC
Q 012039 452 ----KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 452 ----~~~~~~~l~~~F~~~D~d~~G 472 (472)
....++.+..+|+.+|+|+||
T Consensus 138 ~~~~~~~~e~~~~~if~~~D~d~dG 162 (189)
T d1jbaa_ 138 QQGKLLTPEEVVDRIFLLVDENGDG 162 (189)
T ss_dssp TTTCCCCHHHHHHHHHHHHCCSCCS
T ss_pred hhccccchHHHHHHHHHHhCCCCCC
Confidence 112346678999999999998
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.86 E-value=1.9e-10 Score=107.45 Aligned_cols=89 Identities=25% Similarity=0.477 Sum_probs=74.7
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHH
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDD 457 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~ 457 (472)
.++.++...++++|..+|.|++|.|+.+||+.+|..+|..++.+++..++..+|.|++|.|+|.||+..+....
T Consensus 115 ~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~------ 188 (321)
T d1ij5a_ 115 MLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLA------ 188 (321)
T ss_dssp CCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHH------
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccccchhhhhhhhhhh------
Confidence 34567778899999999999999999999999999999999999999999999999999999999987654322
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.+..+|+.+|.+++|
T Consensus 189 ~~~~~F~~~d~d~~~ 203 (321)
T d1ij5a_ 189 ALVADFRKIDTNSNG 203 (321)
T ss_dssp TSCCCHHHHCTTCCS
T ss_pred hhhHHHHHHhhcccc
Confidence 223456667766665
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.85 E-value=1.1e-09 Score=82.52 Aligned_cols=61 Identities=23% Similarity=0.403 Sum_probs=56.1
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+.++|+.+|.|++|+|+.+|++.++++.| ++.+++..|++.+|.|++|.|+++||+.++.
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence 466899999999999999999999999876 6899999999999999999999999998764
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.85 E-value=3e-09 Score=91.00 Aligned_cols=93 Identities=26% Similarity=0.368 Sum_probs=64.1
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHH-----HHcCCCCCHHH--------------------------------
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGL-----ARLGSKLTEAE-------------------------------- 422 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l-----~~~~~~~~~~~-------------------------------- 422 (472)
+++.+..++++|..+|.|++|.|+.+||..++ +.+|...+..+
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~~ 88 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQ 88 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHHH
Confidence 45677889999999999999999999987543 22232222111
Q ss_pred --------------------HHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 423 --------------------VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 --------------------~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+..+|..+|.|++|.|+.+||..++.......+++.+..+|+.+|.|+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG 158 (189)
T d1qv0a_ 89 LATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAG 158 (189)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTS
T ss_pred HHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCC
Confidence 23457777888888888888888776654456677888888888888887
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.83 E-value=4e-09 Score=89.98 Aligned_cols=93 Identities=26% Similarity=0.372 Sum_probs=69.9
Q ss_pred hhhHHhhhhhhhccccCCCCCcccHHHHHHHHHH-----cCCCCCHHH--------------------------------
Q 012039 380 STEEIQGLKQMFTNIDTDNSGTITYEELKAGLAR-----LGSKLTEAE-------------------------------- 422 (472)
Q Consensus 380 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-----~~~~~~~~~-------------------------------- 422 (472)
++..+++++++|..+|.|++|+|+.+||..++.. +|...+..+
T Consensus 7 ~p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (187)
T d1uhka1 7 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK 86 (187)
T ss_dssp CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHH
Confidence 4556788999999999999999999999765432 222222111
Q ss_pred --------------------HHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 423 --------------------VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 --------------------~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+..+|..+|.|++|.|+.+||..++.......+++.+..+|+.+|.|+||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG 156 (187)
T d1uhka1 87 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESG 156 (187)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTS
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCC
Confidence 34466778999999999999988876554446678899999999999987
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.81 E-value=1.1e-08 Score=78.45 Aligned_cols=88 Identities=20% Similarity=0.262 Sum_probs=67.0
Q ss_pred hchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---cCC
Q 012039 378 NLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---KLE 454 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---~~~ 454 (472)
.++.+++. +++..+| .+|.|+..||...+.. ...+++++..+|+.+|.|++|.|+.+|+..++.... ...
T Consensus 5 ~l~~~di~---~~~~~~~--~~G~idf~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~ 77 (109)
T d5pala_ 5 VLKADDIN---KAISAFK--DPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDL 77 (109)
T ss_dssp TSCHHHHH---HHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred HccHHHHH---HHHHhcC--CCCcCcHHHHHHHHHh--cCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcC
Confidence 34455554 4444444 5689999999876642 234678999999999999999999999988775432 235
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
+++++..+|+.+|.|+||
T Consensus 78 ~~~e~~~~~~~~D~d~dG 95 (109)
T d5pala_ 78 NDTETKALLAAGDSDHDG 95 (109)
T ss_dssp CHHHHHHHHHHHCTTCSS
T ss_pred CHHHHHHHHHHhCCCCCC
Confidence 678899999999999998
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.80 E-value=3.2e-09 Score=91.81 Aligned_cols=87 Identities=23% Similarity=0.363 Sum_probs=72.9
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC------------
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL------------ 453 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~------------ 453 (472)
....+|+.+|.|++|.|+..||..++..+......+.++.+|+.+|.|++|.|+++||...+......
T Consensus 64 ~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~ 143 (201)
T d1omra_ 64 YAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPED 143 (201)
T ss_dssp HHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGG
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhh
Confidence 34678999999999999999999999988777777889999999999999999999998876533211
Q ss_pred --CcHHHHHHHHHhhcCCCCC
Q 012039 454 --ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 --~~~~~l~~~F~~~D~d~~G 472 (472)
..++.+..+|+.+|.|+||
T Consensus 144 ~~~~~~~~~~if~~~D~d~dG 164 (201)
T d1omra_ 144 ENTPEKRAEKIWGFFGKKDDD 164 (201)
T ss_dssp GSSHHHHHHHHHHHTTCCTTC
T ss_pred hccHHHHHHHHHHHhCCCCCC
Confidence 1234568899999999998
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.79 E-value=3.7e-09 Score=89.09 Aligned_cols=66 Identities=29% Similarity=0.423 Sum_probs=60.0
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH 451 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~ 451 (472)
...+..+|..+|.|++|+|+.+||+.+++.+| +++++++.+|..+|.|++|.|+|+||+.++....
T Consensus 101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~ 166 (176)
T d1nyaa_ 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAVRDFH 166 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred HHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHHh
Confidence 44678899999999999999999999999886 5789999999999999999999999999987654
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.79 E-value=6e-09 Score=87.77 Aligned_cols=31 Identities=32% Similarity=0.468 Sum_probs=20.4
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHH
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLAR 413 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~ 413 (472)
...+++++|+.+|.|++|.|+.+||..++..
T Consensus 4 ~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~ 34 (174)
T d2scpa_ 4 WVQKMKTYFNRIDFDKDGAITRMDFESMAER 34 (174)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCCcEeHHHHHHHHHH
Confidence 3455666777777777777777777666543
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.77 E-value=1.4e-08 Score=77.73 Aligned_cols=74 Identities=19% Similarity=0.226 Sum_probs=61.1
Q ss_pred CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---cCCcHHHHHHHHHhhcCCCCC
Q 012039 397 DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 397 ~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---~~~~~~~l~~~F~~~D~d~~G 472 (472)
+++|.|+..||..++... ..+.++++.+|+.+|.|++|.|+.+|+..++.... ...+++++..+|+.+|.|+||
T Consensus 19 d~dG~idf~EF~~~~~~~--~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG 95 (109)
T d1pvaa_ 19 KAEGSFNHKKFFALVGLK--AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDG 95 (109)
T ss_dssp CSTTCCCHHHHHHHHTCT--TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCCCcHHHHHHHHHHc--cCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcC
Confidence 567889999998776432 34678899999999999999999999987775432 235678999999999999998
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=5.4e-09 Score=89.23 Aligned_cols=86 Identities=17% Similarity=0.293 Sum_probs=71.6
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------cCC
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------KLE 454 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------~~~ 454 (472)
...+|..+|.+++|.|+..||..++..+.....++.++.+|+.+|.|++|.|+.+||..++.... ...
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~ 141 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENT 141 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSS
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhcc
Confidence 35689999999999999999999998876555677899999999999999999999988764321 122
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.++.+..+|+.+|.|+||
T Consensus 142 ~~~~v~~if~~~D~d~dG 159 (187)
T d1g8ia_ 142 PEKRVDRIFAMMDKNADG 159 (187)
T ss_dssp HHHHHHHHHHHHCSSCSS
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 346788999999999998
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.71 E-value=1e-08 Score=86.77 Aligned_cols=86 Identities=20% Similarity=0.338 Sum_probs=70.4
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------cCC
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------KLE 454 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------~~~ 454 (472)
...+|..+|.|++|.|+.+|+..++..+......+.++.+++.+|.|++|.|+++||...+.... ...
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~ 132 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDT 132 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHH
Confidence 45789999999999999999999998776566778899999999999999999999987654221 112
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.++.+..+|+.+|.|+||
T Consensus 133 ~~~~~~~if~~~D~d~DG 150 (178)
T d1s6ca_ 133 PRQHVDVFFQKMDKNKDG 150 (178)
T ss_dssp CHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 245678999999999998
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=1.3e-08 Score=86.02 Aligned_cols=76 Identities=25% Similarity=0.414 Sum_probs=59.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHc-----CCCCCHHH----HHHHHHHhcCCCCcceeHHHHHHHHhccccCC
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL-----GSKLTEAE----VQQLMEAADVDGNGTIDYIEFITATMHRHKLE 454 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-----~~~~~~~~----~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~ 454 (472)
.+.++.+|+.||.|++|+|+.+|+..++..+ +..+++++ ++.+++.+|.|+||.|+|+||..++...
T Consensus 94 ~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~~~~~~~---- 169 (180)
T d1xo5a_ 94 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRS---- 169 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHC----
T ss_pred HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC----
Confidence 3567889999999999999999999999876 33444433 5668899999999999999999987643
Q ss_pred cHHHHHHHHHh
Q 012039 455 RDDHLYKAFQH 465 (472)
Q Consensus 455 ~~~~l~~~F~~ 465 (472)
.++..+|+.
T Consensus 170 --P~~~~~f~i 178 (180)
T d1xo5a_ 170 --PDFASSFKI 178 (180)
T ss_dssp --HHHHHHHHH
T ss_pred --HHHHhhCee
Confidence 356666653
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.71 E-value=4.2e-09 Score=89.65 Aligned_cols=94 Identities=18% Similarity=0.303 Sum_probs=71.0
Q ss_pred chhhHHhhhhhhhcc-ccCCCCCcccHHHHHHHHHHcCC----CCCH-----------HHHHHHHHHhcCCCCcceeHHH
Q 012039 379 LSTEEIQGLKQMFTN-IDTDNSGTITYEELKAGLARLGS----KLTE-----------AEVQQLMEAADVDGNGTIDYIE 442 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~-~D~~~~G~i~~~el~~~l~~~~~----~~~~-----------~~~~~~~~~~d~d~~g~i~~~e 442 (472)
+++.+..++..+|+. +|.|++|.|+.+||..++.+++. .... ...+.++...|.+++|.|++++
T Consensus 2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~ 81 (185)
T d2sasa_ 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence 456677889999997 59999999999999999877631 1111 1134466778999999999999
Q ss_pred HHHHHhcccc---------CCcHHHHHHHHHhhcCCCCC
Q 012039 443 FITATMHRHK---------LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 443 F~~~~~~~~~---------~~~~~~l~~~F~~~D~d~~G 472 (472)
|+.++..... ......+..+|+.+|.|++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 120 (185)
T d2sasa_ 82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDG 120 (185)
T ss_dssp HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSS
T ss_pred hhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCc
Confidence 9988753211 12235689999999999998
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.69 E-value=3.8e-08 Score=75.44 Aligned_cols=89 Identities=16% Similarity=0.125 Sum_probs=68.4
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---cC
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---KL 453 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---~~ 453 (472)
..++.+++..+.. .+ +.+|.|+..||..++.... .+.++++.+|+.+|.|++|.|+.+||..++.... ..
T Consensus 4 ~~~~~~~i~~~~~---~~--~~~~~i~f~eF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~ 76 (109)
T d1rwya_ 4 DLLSAEDIKKAIG---AF--TAADSFDHKKFFQMVGLKK--KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARD 76 (109)
T ss_dssp HHSCHHHHHHHHH---TT--CSTTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred hhcCHHHHHHHHH---hc--ccCCCcCHHHHHHHHcccc--CCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhcccccc
Confidence 3445555554444 44 4468899999988775432 3678899999999999999999999998876432 23
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
.++..+..+|+.+|.|+||
T Consensus 77 ~~~~e~~~~~~~~D~d~dG 95 (109)
T d1rwya_ 77 LSAKETKTLMAAGDKDGDG 95 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSS
T ss_pred CCHHHHHHHHHHhCCCCCC
Confidence 5678899999999999998
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.69 E-value=1.8e-08 Score=85.31 Aligned_cols=86 Identities=22% Similarity=0.375 Sum_probs=73.5
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc------------cCC
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH------------KLE 454 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~------------~~~ 454 (472)
..++|+.+|.+++|.|+..||..++..+-.....+.+..+|+.+|.|++|.|+.+||...+.... ...
T Consensus 61 ~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~ 140 (181)
T d1bjfa_ 61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDEST 140 (181)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSS
T ss_pred HHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCccccc
Confidence 45789999999999999999999998887666678899999999999999999999999876421 123
Q ss_pred cHHHHHHHHHhhcCCCCC
Q 012039 455 RDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~G 472 (472)
.++.+..+|+.+|.|+||
T Consensus 141 ~~~~~~~if~~~D~d~dG 158 (181)
T d1bjfa_ 141 PEKRTEKIFRQMDTNRDG 158 (181)
T ss_dssp HHHHHHHHHHHSCTTCSS
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 456789999999999998
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.67 E-value=1.2e-08 Score=85.93 Aligned_cols=65 Identities=23% Similarity=0.350 Sum_probs=57.9
Q ss_pred HHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
....+..+|+.+|.|++|+|+.+||..+++.++ ++.+++..+|..+|.|+||.|+++||+.++..
T Consensus 92 ~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~--~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~ 156 (174)
T d2scpa_ 92 VEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTNNDGLLSLEEFVIAGSD 156 (174)
T ss_dssp HHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCGGGHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCccccCCHHHHHHHHHHHh--hhhHHHHHHHhhcCCCCCCcEeHHHHHHHHHH
Confidence 345578899999999999999999999999887 46778999999999999999999999998754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=9.6e-08 Score=85.83 Aligned_cols=87 Identities=15% Similarity=0.101 Sum_probs=63.9
Q ss_pred cceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 012039 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (472)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 158 (472)
..|+..+..+-++.+.||+.. ..+..+++|+...... .....+.+|..+++.|..+--+.+++.+..+++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 456766665555567899876 4566788898754332 22345778999999887665578888888889999999
Q ss_pred EeccCCcchHHH
Q 012039 159 MELCAGGELFDR 170 (472)
Q Consensus 159 ~e~~~g~sL~~~ 170 (472)
|++++|.++.+.
T Consensus 89 ~~~l~G~~~~~~ 100 (263)
T d1j7la_ 89 MSEADGVLCSEE 100 (263)
T ss_dssp EECCSSEEHHHH
T ss_pred EEeccccccccc
Confidence 999999877543
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.64 E-value=5.2e-09 Score=89.04 Aligned_cols=64 Identities=17% Similarity=0.259 Sum_probs=57.6
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
...+..+|+.+|.|++|+|+.+||+.+++.+| ++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus 104 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~d~dG~i~~~EF~~~~~~ 167 (185)
T d2sasa_ 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKELYYR 167 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCCCCCCCCcHHHHHHHHHH
Confidence 34577899999999999999999999999876 56788999999999999999999999988754
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.63 E-value=4.5e-08 Score=71.24 Aligned_cols=68 Identities=24% Similarity=0.396 Sum_probs=55.3
Q ss_pred hHHhhhhhhhccc-cCCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNI-DTDNS-GTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+..+..+|..+ ..+|+ ++++..||+.++.+ ++....+..++++|+.+|.|+||.|+|+||+.++..
T Consensus 6 ~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~ 80 (90)
T d3cr5x1 6 KAVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM 80 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 3456778899988 45555 47999999999987 334445778999999999999999999999987753
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.63 E-value=2.9e-08 Score=84.19 Aligned_cols=86 Identities=19% Similarity=0.325 Sum_probs=69.6
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCC-CHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc----cCCc----HH
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKL-TEAEVQQLMEAADVDGNGTIDYIEFITATMHRH----KLER----DD 457 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~----~~~~----~~ 457 (472)
...+|+.+|.|++|.|+..|+..++..+.... ..+.++.+|+.+|.|++|.|+.+||..++.... .... ++
T Consensus 56 ~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~ 135 (183)
T d2zfda1 56 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIED 135 (183)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHH
Confidence 46789999999999999999999998875443 456699999999999999999999998764321 1112 24
Q ss_pred HHHHHHHhhcCCCCC
Q 012039 458 HLYKAFQHFDKDNSG 472 (472)
Q Consensus 458 ~l~~~F~~~D~d~~G 472 (472)
.+..+|+.+|.|++|
T Consensus 136 ~~~~if~~~D~d~dG 150 (183)
T d2zfda1 136 IIDKTFEEADTKHDG 150 (183)
T ss_dssp HHHHHHHHHCSSCSS
T ss_pred HHHHHHHHhCCCCCC
Confidence 577899999999998
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.62 E-value=5.6e-08 Score=81.58 Aligned_cols=87 Identities=18% Similarity=0.282 Sum_probs=56.2
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcC----CCCCH---------------------------------------
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLG----SKLTE--------------------------------------- 420 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~----~~~~~--------------------------------------- 420 (472)
.++++++|+.+|.|++|.|+.+||+.++..++ .....
T Consensus 6 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 85 (176)
T d1nyaa_ 6 SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTE 85 (176)
T ss_dssp HHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHHh
Confidence 34677888889999999999988887775431 11111
Q ss_pred ----------------HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 ----------------AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ----------------~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
..+..+|..+|.|++|.|+.+||..++... ..+++.+..+|+.+|.|+||
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~--~~~~~~~~~~f~~~D~d~dG 151 (176)
T d1nyaa_ 86 NLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTAL--GMSKAEAAEAFNQVDTNGNG 151 (176)
T ss_dssp HHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHT--TCCHHHHHHHHHHHCTTCSS
T ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhc--CCcHHHHHHHHHHHCCCCCC
Confidence 112335566677777777777776655432 23556677777777777776
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=6.9e-08 Score=81.46 Aligned_cols=86 Identities=13% Similarity=0.204 Sum_probs=68.7
Q ss_pred hhhhhccccCC-CCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---------cCCc
Q 012039 387 LKQMFTNIDTD-NSGTITYEELKAGLARLGS-KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---------KLER 455 (472)
Q Consensus 387 ~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---------~~~~ 455 (472)
..++|+.+|.| ++|.|+..||..++..+.. ...++.++.+|+.+|.|++|.|+.+|+..++.... ...-
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 138 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEM 138 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTH
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHH
Confidence 34688889987 7999999999999988754 34567799999999999999999999998765321 1111
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
++.+..+|+.+|.|+||
T Consensus 139 ~~~v~~~~~~~D~d~dG 155 (180)
T d1xo5a_ 139 KQLIDNILEESDIDRDG 155 (180)
T ss_dssp HHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 34567799999999998
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=98.57 E-value=8.9e-08 Score=76.42 Aligned_cols=83 Identities=20% Similarity=0.301 Sum_probs=60.1
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHcCCCCC---HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHH
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARLGSKLT---EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKA 462 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~---~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~ 462 (472)
.+..+|..+|.+++|.|+.+|+...+........ ...+..+|+.+|.|++|.|+.+||..++... ..+.+...
T Consensus 37 ~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~~~~~----~~~~~~~~ 112 (134)
T d1jfja_ 37 LLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKH----GIEKVAEQ 112 (134)
T ss_dssp HHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTTT----TCHHHHHH
T ss_pred HHHHHHHHhhhcccccccccccccccccccccccccccccccccccccccccCCcccHHHHHHHHHhc----CcHHHHHH
Confidence 4566777788888888888888887765533222 2446778888888888888888888776532 23567778
Q ss_pred HHhhcCCCCC
Q 012039 463 FQHFDKDNSG 472 (472)
Q Consensus 463 F~~~D~d~~G 472 (472)
|+.+|+|+||
T Consensus 113 ~~~~D~d~dG 122 (134)
T d1jfja_ 113 VMKADANGDG 122 (134)
T ss_dssp HHHHHCSSSS
T ss_pred HHHHCCCCCC
Confidence 8888888887
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.57 E-value=1e-07 Score=72.80 Aligned_cols=89 Identities=19% Similarity=0.205 Sum_probs=66.9
Q ss_pred hhchhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---cC
Q 012039 377 ENLSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---KL 453 (472)
Q Consensus 377 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---~~ 453 (472)
..++.+++..+.+. . +.+|.++..++...+.. ...+.++++++|+.+|.|++|.|+++||..++.... ..
T Consensus 4 d~ls~~dI~~~l~~---~--~~~~s~~~~~F~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~ 76 (108)
T d1rroa_ 4 DILSAEDIAAALQE---C--QDPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp GTSCHHHHHHHHHH---T--CSTTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCC
T ss_pred hhCCHHHHHHHHHh---c--ccCCCccHHHHHHHHcc--CcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCC
Confidence 34455555544332 2 56778999999655432 234678899999999999999999999998876532 23
Q ss_pred CcHHHHHHHHHhhcCCCCC
Q 012039 454 ERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 454 ~~~~~l~~~F~~~D~d~~G 472 (472)
.+++.+..+|+.+|.|+||
T Consensus 77 l~~~~~~~~~~~~D~d~dG 95 (108)
T d1rroa_ 77 LTESETKSLMDAADNDGDG 95 (108)
T ss_dssp CCHHHHHHHHHHHCCSSSS
T ss_pred CCHHHHHHHHHHhCCCCCC
Confidence 5678999999999999998
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.56 E-value=8.1e-09 Score=58.97 Aligned_cols=31 Identities=29% Similarity=0.563 Sum_probs=28.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcC
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLG 415 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~ 415 (472)
++++++|+.||+|++|+|+..||+.+|+.+|
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 4788999999999999999999999998876
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.55 E-value=1.3e-07 Score=71.94 Aligned_cols=87 Identities=16% Similarity=0.159 Sum_probs=67.0
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc---cCCc
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH---KLER 455 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~---~~~~ 455 (472)
++.+++.. ++...| .+|.|+..||..++...+ .+.++++.+|+.+|.|++|.|+.+||..++.... ...+
T Consensus 5 ls~~di~~---~~~~~~--~~gsi~~~eF~~~~~l~~--~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~ 77 (107)
T d2pvba_ 5 LKDADVAA---ALAACS--AADSFKHKEFFAKVGLAS--KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALT 77 (107)
T ss_dssp SCHHHHHH---HHHHTC--STTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCC
T ss_pred CCHHHHHH---HHHhcc--CCCCcCHHHHHHHHhccc--CCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCC
Confidence 34445443 444444 456799999988775432 3678899999999999999999999998876542 2357
Q ss_pred HHHHHHHHHhhcCCCCC
Q 012039 456 DDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 456 ~~~l~~~F~~~D~d~~G 472 (472)
++.++.+|+.+|.|+||
T Consensus 78 ~~~~~~l~~~~D~d~dG 94 (107)
T d2pvba_ 78 DAETKAFLADGDKDGDG 94 (107)
T ss_dssp HHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 78999999999999998
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=98.50 E-value=5e-08 Score=71.60 Aligned_cols=67 Identities=19% Similarity=0.329 Sum_probs=54.9
Q ss_pred HHhhhhhhhcccc-CCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 383 EIQGLKQMFTNID-TDNS-GTITYEELKAGLAR-----LGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 383 ~~~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
.+..+..+|..+. .+|+ ++++..||+.++.+ ++....++.++++|+.+|.|+||.|+|+||+.++..
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~ 80 (95)
T d1qlsa_ 7 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGG 80 (95)
T ss_dssp HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence 4567778898874 4565 58999999999976 444456788999999999999999999999987754
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.49 E-value=1.5e-08 Score=86.02 Aligned_cols=64 Identities=31% Similarity=0.580 Sum_probs=58.5
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhcc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHR 450 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~ 450 (472)
+.+..+|..+|.+++|+|+..||+.++..+| +++++++.||+.+|.|+||.|+|+||+.++...
T Consensus 82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~ 145 (182)
T d1s6ia_ 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKR 145 (182)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCC
T ss_pred HHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhC
Confidence 4577899999999999999999999999887 678999999999999999999999999988654
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.48 E-value=4.7e-08 Score=90.69 Aligned_cols=64 Identities=22% Similarity=0.367 Sum_probs=58.9
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSK-LTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
..+..+|..+|.|++|+|+.+||+.++..+|.. .+.+++..+|..+|.|+||.|+|+||+.+|+
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml 317 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVL 317 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHH
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 456678999999999999999999999999974 7888999999999999999999999999876
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.6e-07 Score=78.04 Aligned_cols=86 Identities=22% Similarity=0.350 Sum_probs=69.9
Q ss_pred hhhhhccccCCCCCcccHHHHHHHHHHcCCCC-CHHHHHHHHHHhcCCCCcceeHHHHHHHHhcccc--C---CcHHHHH
Q 012039 387 LKQMFTNIDTDNSGTITYEELKAGLARLGSKL-TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHK--L---ERDDHLY 460 (472)
Q Consensus 387 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~--~---~~~~~l~ 460 (472)
+.++|..+|.+++|.|+.+||...+....... ..+.+..+++.+|.|++|.|+.+|+..++..... . ..+..+.
T Consensus 50 ~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~ 129 (165)
T d1auib_ 50 VQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 129 (165)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHH
T ss_pred HHHHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHH
Confidence 34578889999999999999999998875443 4566999999999999999999999988754321 1 1245688
Q ss_pred HHHHhhcCCCCC
Q 012039 461 KAFQHFDKDNSG 472 (472)
Q Consensus 461 ~~F~~~D~d~~G 472 (472)
.+|..+|.|++|
T Consensus 130 ~~~~~~D~~~dG 141 (165)
T d1auib_ 130 KTIINADKDGDG 141 (165)
T ss_dssp HHHHHHCTTSSS
T ss_pred HHHHHcCCCCCC
Confidence 999999999998
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.7e-09 Score=90.63 Aligned_cols=76 Identities=7% Similarity=0.041 Sum_probs=53.2
Q ss_pred ccCCCCCcccHHHHHHHHHHcCCCC--CHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCC
Q 012039 394 IDTDNSGTITYEELKAGLARLGSKL--TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNS 471 (472)
Q Consensus 394 ~D~~~~G~i~~~el~~~l~~~~~~~--~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~ 471 (472)
+|.|++|.|+..||.+++...+... ..+.+..++...|.+++|.|+|+||+..+... ....++..+|+.||.|++
T Consensus 16 ~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l---~~r~ei~~~F~~~d~d~~ 92 (170)
T d2zkmx1 16 MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSL---CPRPEIDEIFTSYHAKAK 92 (170)
T ss_dssp HSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHH---SCCHHHHTTCC-------
T ss_pred cccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhcc---CCHHHHHHHHHHHcCCCC
Confidence 7999999999999999986554322 23456667888899999999999999887644 345778999999999887
Q ss_pred C
Q 012039 472 G 472 (472)
Q Consensus 472 G 472 (472)
|
T Consensus 93 ~ 93 (170)
T d2zkmx1 93 P 93 (170)
T ss_dssp -
T ss_pred C
Confidence 6
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=98.39 E-value=2.2e-07 Score=68.02 Aligned_cols=68 Identities=25% Similarity=0.422 Sum_probs=51.4
Q ss_pred hHHhhhhhhhcccc-CCCC-CcccHHHHHHHHHH-c----CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 382 EEIQGLKQMFTNID-TDNS-GTITYEELKAGLAR-L----GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 382 ~~~~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-~----~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..+..+..+|..+. .+|+ ++++..||+..+.+ + +...++..++++|+.+|.|+||.|+|+||+.++..
T Consensus 6 ~ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 80 (94)
T d1j55a_ 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA 80 (94)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 34566778898874 4554 48999999999987 3 33334567999999999999999999999987754
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.35 E-value=3.9e-07 Score=62.45 Aligned_cols=54 Identities=24% Similarity=0.348 Sum_probs=48.8
Q ss_pred CHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 419 TEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 419 ~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+++++..+|+.+|.|++|.|+.+||..++.......++.++..+|+.+|.|++|
T Consensus 1 Seeel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g 54 (65)
T d1fw4a_ 1 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDG 54 (65)
T ss_dssp CCHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSS
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCC
Confidence 357899999999999999999999999887766667889999999999999998
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.34 E-value=2.2e-07 Score=67.76 Aligned_cols=71 Identities=23% Similarity=0.358 Sum_probs=57.4
Q ss_pred CCCCcccHHHHHHHHHHcCCCCCHH---HHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 397 DNSGTITYEELKAGLARLGSKLTEA---EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 397 ~~~G~i~~~el~~~l~~~~~~~~~~---~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+++|.|+..+. .+...++++ +++.+|..+|.|++|.|+++||..++.......+++++..+|+.+|.|++|
T Consensus 1 ~~~g~id~~~~-----~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g 74 (87)
T d1s6ja_ 1 HSSGHIDDDDK-----HMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 74 (87)
T ss_dssp CCSSSSSSHHH-----HSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCccCchHH-----HHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCC
Confidence 46788888773 233444443 367899999999999999999999987765567788999999999999998
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.33 E-value=5.4e-07 Score=64.10 Aligned_cols=58 Identities=16% Similarity=0.249 Sum_probs=51.5
Q ss_pred CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 415 GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 415 ~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
|..-+.+++.++|..+|.|++|.|+.+||..++.......+..++..+|+.+|.|++|
T Consensus 3 ge~d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G 60 (77)
T d1oqpa_ 3 GERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDN 60 (77)
T ss_dssp TTSSHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSS
T ss_pred CCccHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCC
Confidence 4455678899999999999999999999999988766667788999999999999998
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.30 E-value=7.1e-07 Score=60.17 Aligned_cols=52 Identities=10% Similarity=0.149 Sum_probs=47.5
Q ss_pred HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+++.+.|+.+|.|++|.|+..||..++.......++..+..+|+.+|.|++|
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg 52 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNG 52 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTS
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCC
Confidence 5788999999999999999999999988766667889999999999999998
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.29 E-value=6.7e-07 Score=61.63 Aligned_cols=51 Identities=20% Similarity=0.361 Sum_probs=46.2
Q ss_pred HHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 422 EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 422 ~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.++++|+.+|.|++|.|+..||..++.......+++++..+|+.+|.|++|
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg 52 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNG 52 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSS
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCC
Confidence 367899999999999999999999987766667889999999999999998
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=98.23 E-value=1.3e-06 Score=62.72 Aligned_cols=55 Identities=25% Similarity=0.328 Sum_probs=49.7
Q ss_pred CCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 418 LTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 418 ~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.+++++.++|..+|.|++|.|+..||..++.......+++++..+|..+|.|+||
T Consensus 12 ~~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg 66 (81)
T d1fi5a_ 12 KTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDG 66 (81)
T ss_dssp CCHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSS
T ss_pred CCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCC
Confidence 4678899999999999999999999999987765567788999999999999998
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.22 E-value=4.7e-07 Score=49.06 Aligned_cols=31 Identities=32% Similarity=0.414 Sum_probs=26.8
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcC
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLG 415 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~ 415 (472)
+++.++|+.||+|+||+|+.+||..+++.-|
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 5677899999999999999999999887643
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=98.21 E-value=1.5e-06 Score=62.36 Aligned_cols=51 Identities=22% Similarity=0.335 Sum_probs=45.2
Q ss_pred HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
++++++|..+|.|++|.|+..||..++.... ..++.++..+|+.+|.|++|
T Consensus 6 ~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G 56 (81)
T d2opoa1 6 ADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDG 56 (81)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCC
Confidence 4678899999999999999999999887654 35778999999999999998
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.21 E-value=2.1e-06 Score=60.47 Aligned_cols=56 Identities=20% Similarity=0.237 Sum_probs=50.6
Q ss_pred CCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 417 KLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 417 ~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
..+++++..+|+.+|.|++|.|+..||..++.......+++.+..+|+.+|.|++|
T Consensus 5 ~~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg 60 (75)
T d1jc2a_ 5 GKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDG 60 (75)
T ss_dssp CCCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCS
T ss_pred CCcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCC
Confidence 35788999999999999999999999999987766667888999999999999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=2.2e-06 Score=81.42 Aligned_cols=82 Identities=15% Similarity=0.122 Sum_probs=52.2
Q ss_pred cceeeecCCeEEEEEEECCCCCEEEEEEecccc-cC---CcccHHHHHHHHHHHHhccCC--CCeeEEEEEEEeCCeEEE
Q 012039 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRK-LV---TKNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDKQSVHV 157 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~---~~~~~~~~~~E~~~l~~l~~h--p~iv~~~~~~~~~~~~~l 157 (472)
.+.||.|....||++.+..+++.+++|.-.... .. ......+...|...|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999887778899999654211 10 112344566788888887543 245666644 4445578
Q ss_pred EEeccCCcch
Q 012039 158 VMELCAGGEL 167 (472)
Q Consensus 158 v~e~~~g~sL 167 (472)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=98.16 E-value=2.2e-06 Score=60.95 Aligned_cols=66 Identities=20% Similarity=0.321 Sum_probs=51.5
Q ss_pred HHhhhhhhhcccc-CCC-CCcccHHHHHHHHHH-cCCC-----CCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 383 EIQGLKQMFTNID-TDN-SGTITYEELKAGLAR-LGSK-----LTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 383 ~~~~~~~~F~~~D-~~~-~G~i~~~el~~~l~~-~~~~-----~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
.+..+..+|..+- .+| .++++..||+..+.+ ++.- ..+..++++|+.+|.|+||.|+|.||+.++.
T Consensus 8 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~ 81 (83)
T d1xk4c1 8 NIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA 81 (83)
T ss_dssp HHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHh
Confidence 3556778888885 344 358999999999987 4322 2345689999999999999999999998764
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=98.14 E-value=1.9e-06 Score=60.36 Aligned_cols=51 Identities=25% Similarity=0.322 Sum_probs=45.3
Q ss_pred HHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 422 EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 422 ~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+++.+|..+|.|++|.|++.||..++.......+++.+..+|+.+|.|++|
T Consensus 9 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g 59 (73)
T d2pq3a1 9 EFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 59 (73)
T ss_dssp HHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCC
Confidence 456779999999999999999999887765567789999999999999998
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.10 E-value=3.9e-06 Score=59.42 Aligned_cols=56 Identities=21% Similarity=0.262 Sum_probs=47.8
Q ss_pred CCCHHH---HHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 417 KLTEAE---VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 417 ~~~~~~---~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
++|+++ +..+|..+|.|++|.|+..|+..++.......+++.+..+|+.+|.|++|
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g 61 (77)
T d1f54a_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNH 61 (77)
T ss_dssp CCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCC
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCC
Confidence 455555 56679999999999999999999887665567789999999999999998
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.09 E-value=3.5e-06 Score=60.31 Aligned_cols=51 Identities=25% Similarity=0.326 Sum_probs=45.3
Q ss_pred HHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 422 EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 422 ~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
++..+|..+|.|++|.|+..||..++.......++.++..+|+.+|.|++|
T Consensus 15 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g 65 (81)
T d1avsa_ 15 EFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 65 (81)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCS
T ss_pred HHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCC
Confidence 456779999999999999999999987765567788999999999999998
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=9e-06 Score=72.04 Aligned_cols=74 Identities=8% Similarity=0.052 Sum_probs=52.1
Q ss_pred eeecC-CeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC-CCeeEEEEEEEeCCeEEEEEeccCC
Q 012039 87 LGRGQ-FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQSVHVVMELCAG 164 (472)
Q Consensus 87 lg~G~-~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~iv~~~~~~~~~~~~~lv~e~~~g 164 (472)
+..|. .+.||+.... .+..+++|..... ....+..|...++.|..+ -.+++++.+..+++..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 44444 3678988743 4666888976432 233477888888887633 2367788888888899999999998
Q ss_pred cch
Q 012039 165 GEL 167 (472)
Q Consensus 165 ~sL 167 (472)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 765
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.03 E-value=1.7e-06 Score=59.63 Aligned_cols=52 Identities=25% Similarity=0.402 Sum_probs=46.3
Q ss_pred HHHHHHHHHhcCCCCcceeHHHHHHHHhcccc-CCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHK-LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G 472 (472)
+++.++|..+|.|++|.|+.+||..++..... ..+++.+..+|+.+|.|++|
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG 54 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNG 54 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGG
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCC
Confidence 67899999999999999999999998876644 35789999999999999997
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=97.88 E-value=1.4e-05 Score=57.10 Aligned_cols=52 Identities=17% Similarity=0.222 Sum_probs=45.4
Q ss_pred HHHHHHHHHhcCCC-CcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAADVDG-NGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~d~d~-~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+++++.|..+|.|+ +|.|+..|+..++.......++.++..+|+.+|.|++|
T Consensus 15 ~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G 67 (82)
T d1wrka1 15 NEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSG 67 (82)
T ss_dssp HHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCS
T ss_pred HHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCC
Confidence 34667899999995 79999999999987766667889999999999999998
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=1.2e-05 Score=57.78 Aligned_cols=53 Identities=19% Similarity=0.240 Sum_probs=48.2
Q ss_pred HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 420 EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 420 ~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
...+.++|..+|.+++|.|+.+||..++.......+++++..+|+.+|.|++|
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g 71 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKG 71 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTS
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCC
Confidence 46688999999999999999999999988766667899999999999999998
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=3.3e-05 Score=56.87 Aligned_cols=50 Identities=16% Similarity=0.195 Sum_probs=43.6
Q ss_pred HHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+..+++|..+|.|++|.|+.+|+..++... ....+.|..+|+.+|.|++|
T Consensus 10 ~~~~~~F~~~D~d~~G~is~~e~~~~l~~~--~l~~~~l~~i~~~~D~d~dG 59 (95)
T d1c07a_ 10 AKYDEIFLKTDKDMDGFVSGLEVREIFLKT--GLPSTLLAHIWSLCDTKDCG 59 (95)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHTT--TCCHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHhc--CCCHHHHHHHHHHhCCCCCC
Confidence 446789999999999999999999988653 24678999999999999998
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.67 E-value=6.3e-06 Score=63.32 Aligned_cols=74 Identities=11% Similarity=0.076 Sum_probs=58.8
Q ss_pred hchhhHHhhhhhhhcccc---CCCCCcccHHHHHHHHHHcCCC--CCHHHHHHHHHHhcCCCC--------cceeHHHHH
Q 012039 378 NLSTEEIQGLKQMFTNID---TDNSGTITYEELKAGLARLGSK--LTEAEVQQLMEAADVDGN--------GTIDYIEFI 444 (472)
Q Consensus 378 ~~~~~~~~~~~~~F~~~D---~~~~G~i~~~el~~~l~~~~~~--~~~~~~~~~~~~~d~d~~--------g~i~~~eF~ 444 (472)
.++..+++.+.+.|+... .+.+|.|+.++++..+..+... .++.-++.+|..+|.|++ |.|+|.||+
T Consensus 21 ~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv 100 (118)
T d1tuza_ 21 EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVS 100 (118)
T ss_dssp HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHH
T ss_pred CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHH
Confidence 357778888888886543 2578999999999999887542 346678999999999977 889999999
Q ss_pred HHHhccc
Q 012039 445 TATMHRH 451 (472)
Q Consensus 445 ~~~~~~~ 451 (472)
.++.-..
T Consensus 101 ~~LS~l~ 107 (118)
T d1tuza_ 101 CYFSLLE 107 (118)
T ss_dssp HHHHHHH
T ss_pred HHHHHHc
Confidence 9876443
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=3.9e-05 Score=57.01 Aligned_cols=50 Identities=14% Similarity=0.187 Sum_probs=39.9
Q ss_pred HHHHHHHhcCCCCcceeHHHHHHHHhcccc----------------CCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAADVDGNGTIDYIEFITATMHRHK----------------LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~----------------~~~~~~l~~~F~~~D~d~~G 472 (472)
++.+|..+|.|+||.|+.+||..++..... ...+..+..+|+.+|.|+||
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG 83 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDR 83 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSS
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCC
Confidence 678999999999999999999998753210 01134688899999999998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.49 E-value=0.0002 Score=67.57 Aligned_cols=75 Identities=13% Similarity=0.148 Sum_probs=53.1
Q ss_pred cceeeecCCeEEEEEEECC-------CCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 012039 84 GKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (472)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 156 (472)
++.|+.|-.-.+|++.... ..+.|++++.... .......+|..+++.+..+.-.+++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678889999999988653 2456777776421 2234567899999999755545678877643 5
Q ss_pred EEEeccCCcch
Q 012039 157 VVMELCAGGEL 167 (472)
Q Consensus 157 lv~e~~~g~sL 167 (472)
+|+||++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999988654
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.45 E-value=0.0001 Score=53.76 Aligned_cols=48 Identities=17% Similarity=-0.009 Sum_probs=42.2
Q ss_pred HHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.+++|..+|.|++|.|+.+|+...+... ..+...|..+++..|.|++|
T Consensus 11 y~~~F~~~D~d~~G~i~~~e~~~~l~~~--~l~~~~l~~i~~~~D~d~dG 58 (92)
T d1fi6a_ 11 YVNQFKTIQPDLNGFIPGSAAKEFFTKS--KLPILELSHIWELSDFDKDG 58 (92)
T ss_dssp HHHHHTTTCCSTTCEEEHHHHHHHHHHH--SSCHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHhCCCcccchhHHHHHHHHHHc--cCCHHHHHHHHHHhCCCCCC
Confidence 5678999999999999999999988753 34678999999999999998
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.44 E-value=3.4e-05 Score=63.65 Aligned_cols=84 Identities=10% Similarity=0.087 Sum_probs=57.2
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccccC----------C
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRHKL----------E 454 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~----------~ 454 (472)
+.+..+|...|.+++|.|+.+|+...+..+. ...++..+|..+|.|++|.|+.+||...+...... .
T Consensus 45 ~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~---~r~ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~ 121 (170)
T d2zkmx1 45 SACHLPKGKNDAINPEDFPEPVYKSFLMSLC---PRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPA 121 (170)
T ss_dssp HHTTCCCCTTCEECGGGCCHHHHHHHHHHHS---CCHHHHTTCC--------CCCHHHHHHHHHHTCC------------
T ss_pred HHHhhhhccccccCCCccCHHHHHHHHhccC---CHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccC
Confidence 4567789999999999999999999999885 35689999999999999999999999988654322 2
Q ss_pred cHHHHHHHHHhhcCCCC
Q 012039 455 RDDHLYKAFQHFDKDNS 471 (472)
Q Consensus 455 ~~~~l~~~F~~~D~d~~ 471 (472)
+.+.++.+++.++.+.+
T Consensus 122 ~~~~~~~~i~~~~~~~~ 138 (170)
T d2zkmx1 122 RPDQVQGLIDKYEPSGI 138 (170)
T ss_dssp ---CHHHHHHHHCCC--
T ss_pred CHHHHHHHHHHHccccc
Confidence 34566777777776543
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.41 E-value=8e-05 Score=52.18 Aligned_cols=54 Identities=17% Similarity=0.185 Sum_probs=43.2
Q ss_pred CHHHHHHHHHHhcCC--CCcceeHHHHHHHHhcccc--CCcHHHHHHHHHhhcCCCCC
Q 012039 419 TEAEVQQLMEAADVD--GNGTIDYIEFITATMHRHK--LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 419 ~~~~~~~~~~~~d~d--~~g~i~~~eF~~~~~~~~~--~~~~~~l~~~F~~~D~d~~G 472 (472)
+.+++..+|+.+|.+ ++|.|+.+||..++..... ...+..+..+|+.+|.|+||
T Consensus 3 s~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG 60 (76)
T d1qx2a_ 3 SPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDG 60 (76)
T ss_dssp CHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSS
T ss_pred CHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCC
Confidence 578899999999765 4699999999998865422 22345689999999999998
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=97.20 E-value=0.00064 Score=43.66 Aligned_cols=73 Identities=22% Similarity=0.293 Sum_probs=61.1
Q ss_pred chhhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcC-CCC-cceeHHHHHHHHhccc
Q 012039 379 LSTEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV-DGN-GTIDYIEFITATMHRH 451 (472)
Q Consensus 379 ~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~-d~~-g~i~~~eF~~~~~~~~ 451 (472)
+..++..+..++|..||.|....-...+-..+|.++|+..+..|.+.|+.++-. .+| ..|.-+|++..+..|.
T Consensus 8 lgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargpkgdkknigpeewltlcskwv 82 (86)
T d1j7qa_ 8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLTLCSKWV 82 (86)
T ss_dssp CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHHHHHH
T ss_pred cCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHHHHHHHH
Confidence 456677888999999999999999999999999999999999999999998743 222 3488899999887653
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.20 E-value=0.00015 Score=39.15 Aligned_cols=30 Identities=23% Similarity=0.266 Sum_probs=26.6
Q ss_pred CHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 419 TEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 419 ~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+++|+...|+.+|.|+||.|+.+||..++.
T Consensus 2 sEeELae~FRifDkNaDGyiD~eEl~~ilr 31 (34)
T d1ctda_ 2 SEEELANAFRIFDKNADGYIDIEELGEILR 31 (34)
T ss_dssp HHHHHHHHHHTTCCSSSSCBCHHHHHHHHH
T ss_pred CHHHHHHHHHHHccCCcccccHHHHHHHHH
Confidence 468899999999999999999999987653
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=97.14 E-value=0.00026 Score=39.85 Aligned_cols=30 Identities=30% Similarity=0.442 Sum_probs=26.5
Q ss_pred CHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 419 TEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 419 ~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
+++++.+.|+.+|.|++|.|+..|+-.+|.
T Consensus 1 seeel~eAF~~FDkDg~G~Is~~EL~~vm~ 30 (33)
T d2hf5a1 1 SEEEIREAFRVFDKDGNGYISAAELRHVMT 30 (33)
T ss_dssp CHHHHHHHHHHHSSSCCSCBCHHHHHHHTT
T ss_pred CHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 467899999999999999999999987764
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=97.13 E-value=0.00015 Score=52.67 Aligned_cols=51 Identities=10% Similarity=0.083 Sum_probs=41.0
Q ss_pred HHHHHHHHHhcCCCCcceeHHHHHHHHhcc-----ccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAADVDGNGTIDYIEFITATMHR-----HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~-----~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+.+..+|..+|.| +|.|+.+||..++... .....+..+..+|+.+|.|+||
T Consensus 9 e~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG 64 (92)
T d1a4pa_ 9 ETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDG 64 (92)
T ss_dssp HHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSS
T ss_pred HHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCC
Confidence 4467788899977 8999999999988642 1233556899999999999998
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=97.10 E-value=0.00051 Score=49.95 Aligned_cols=52 Identities=13% Similarity=0.213 Sum_probs=41.0
Q ss_pred HHHHHHHHHh-cCCCC-cceeHHHHHHHHhccc-----cCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAA-DVDGN-GTIDYIEFITATMHRH-----KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~-d~d~~-g~i~~~eF~~~~~~~~-----~~~~~~~l~~~F~~~D~d~~G 472 (472)
+.+..+|..+ |.|++ |.|+.+||..++.... ....++.+..+|+.+|.|+||
T Consensus 9 ~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG 67 (93)
T d1zfsa1 9 ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDG 67 (93)
T ss_dssp HHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCS
T ss_pred HHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCC
Confidence 4466777776 78875 9999999999886532 234578899999999999998
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.10 E-value=0.00032 Score=51.71 Aligned_cols=49 Identities=14% Similarity=0.108 Sum_probs=43.1
Q ss_pred HHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 422 EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 422 ~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
-.+++|+.+|.|++|.|+.+|+..++... ..+.+.+..+|+..|.|++|
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s--~L~~~~L~~i~~~~D~d~dG 60 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKS--GLPDLILGKIWDLADTDGKG 60 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTS--SSCHHHHHHHHHHHCCSSSS
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHc--CCcHHHHHHHHHHHcCCCCC
Confidence 46789999999999999999999988643 35688999999999999998
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.05 E-value=0.00059 Score=49.77 Aligned_cols=48 Identities=15% Similarity=0.160 Sum_probs=41.4
Q ss_pred HHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 422 EVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 422 ~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+.+++|..+| |++|.|+.+|....+... ....+.|..+++..|.|++|
T Consensus 11 ~y~~~F~~~D-~~~G~i~~~el~~~l~~~--gl~~~~L~~Iw~~~D~~~dG 58 (95)
T d2jxca1 11 KYDAIFDSLS-PVNGFLSGDKVKPVLLNS--KLPVDILGRVWELSDIDHDG 58 (95)
T ss_dssp HHHHHHHHTC-CBTTEEEHHHHHHHHTTS--SCCHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHhC-CCCCceeHHHHHHHHHHc--CCCHHHHHHHHHHhcCCCCC
Confidence 3678999999 899999999999887643 35678899999999999998
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=96.97 E-value=0.00079 Score=48.81 Aligned_cols=52 Identities=10% Similarity=0.155 Sum_probs=40.2
Q ss_pred HHHHHHHHHh-cCCCCc-ceeHHHHHHHHhcc-----ccCCcHHHHHHHHHhhcCCCCC
Q 012039 421 AEVQQLMEAA-DVDGNG-TIDYIEFITATMHR-----HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 421 ~~~~~~~~~~-d~d~~g-~i~~~eF~~~~~~~-----~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+.+..+|..+ |.|++| .|+.+||..++... .....++.+.++|+.+|.|+||
T Consensus 9 ~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG 67 (93)
T d3c1va1 9 DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDN 67 (93)
T ss_dssp HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCC
Confidence 3466777776 666654 79999999988652 2345678999999999999998
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=96.86 E-value=0.00028 Score=49.48 Aligned_cols=54 Identities=20% Similarity=0.296 Sum_probs=42.8
Q ss_pred CHHHHHHHHHHhcC-C-CCcceeHHHHHHHHhccc--cCCcHHHHHHHHHhhcCCCCC
Q 012039 419 TEAEVQQLMEAADV-D-GNGTIDYIEFITATMHRH--KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 419 ~~~~~~~~~~~~d~-d-~~g~i~~~eF~~~~~~~~--~~~~~~~l~~~F~~~D~d~~G 472 (472)
..+++..+|..+|. | +.|.|+.+||..++.... ....++.+..+|+.+|.|+||
T Consensus 5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG 62 (78)
T d1cb1a_ 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDG 62 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSS
T ss_pred hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCC
Confidence 56789999999975 3 458999999999887642 233445688999999999998
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.77 E-value=0.0028 Score=57.60 Aligned_cols=70 Identities=16% Similarity=0.152 Sum_probs=46.5
Q ss_pred CeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCC-CeeEEE-----EEEEeCCeEEEEEeccCCc
Q 012039 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFK-----GAYEDKQSVHVVMELCAGG 165 (472)
Q Consensus 92 ~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-~iv~~~-----~~~~~~~~~~lv~e~~~g~ 165 (472)
--.||++.. .+|..|++|+.... ....+++..|...+..|..+. -++... ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 458999875 46888999997543 234677888999998886221 111111 1234567788999999874
Q ss_pred c
Q 012039 166 E 166 (472)
Q Consensus 166 s 166 (472)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.69 E-value=0.00063 Score=51.09 Aligned_cols=51 Identities=12% Similarity=-0.059 Sum_probs=42.9
Q ss_pred HHHHHHHHHHhcCCCCcceeHHHHHHHHhccccCCcHHHHHHHHHhhcCCCCC
Q 012039 420 EAEVQQLMEAADVDGNGTIDYIEFITATMHRHKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 420 ~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G 472 (472)
.+..+++|..+|.|++|.|+.+|+...+... ....+.|..+++..|.|++|
T Consensus 21 ~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s--~L~~~~L~~Iw~l~D~d~dG 71 (110)
T d1iq3a_ 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKS--KLSIPELSYIWELSDADCDG 71 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSS--SCSSCCHHHHHHHHCSSSCS
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHhh--ccchHHHHHHHHHhccCCCC
Confidence 3557889999999999999999999877543 24556799999999999998
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.63 E-value=0.00087 Score=50.93 Aligned_cols=73 Identities=12% Similarity=0.152 Sum_probs=54.7
Q ss_pred CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhc------CCCCcceeHHHHHHHHhccccC--CcHHHHHHHHHhhcC
Q 012039 397 DNSGTITYEELKAGLARLGSKLTEAEVQQLMEAAD------VDGNGTIDYIEFITATMHRHKL--ERDDHLYKAFQHFDK 468 (472)
Q Consensus 397 ~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d------~d~~g~i~~~eF~~~~~~~~~~--~~~~~l~~~F~~~D~ 468 (472)
+..+.|+.++|.++.+... ++..||+.+.+.+. .+.+|.|++++|..++...... ....-...+|+.||+
T Consensus 3 ~~~s~l~p~~l~~L~~~T~--fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~ 80 (118)
T d1tuza_ 3 KERGLISPSDFAQLQKYME--YSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFET 80 (118)
T ss_dssp CCCSCSCHHHHHHHHHHHH--HCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCC
T ss_pred cccCCCCHHHHHHHHHHcC--CCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHcc
Confidence 4567899999988877654 45667778877773 2467999999999887644332 235678899999999
Q ss_pred CCC
Q 012039 469 DNS 471 (472)
Q Consensus 469 d~~ 471 (472)
|++
T Consensus 81 ~~d 83 (118)
T d1tuza_ 81 GHC 83 (118)
T ss_dssp CCC
T ss_pred ccc
Confidence 986
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=96.57 E-value=0.001 Score=48.65 Aligned_cols=50 Identities=14% Similarity=0.187 Sum_probs=38.1
Q ss_pred HHHHHHHh-cCCCC-cceeHHHHHHHHhcccc--CCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAA-DVDGN-GTIDYIEFITATMHRHK--LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~-d~d~~-g~i~~~eF~~~~~~~~~--~~~~~~l~~~F~~~D~d~~G 472 (472)
+..+|+.+ |.|++ |.|+..||..++..... ..+.+.+..+|+.+|.|+||
T Consensus 16 l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG 69 (98)
T d1yuta1 16 VVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDS 69 (98)
T ss_dssp HHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCS
T ss_pred HHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCC
Confidence 45566665 67775 99999999998865322 23455789999999999998
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.43 E-value=0.00024 Score=55.81 Aligned_cols=61 Identities=21% Similarity=0.192 Sum_probs=47.9
Q ss_pred hhhhhccccCC-CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 387 LKQMFTNIDTD-NSGTITYEELKAGLARLGSKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 387 ~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
+.-.|..+|.| +||.|+..||+...+.+- ..+.=+...+..+|.|+||.|++.|+...+.-
T Consensus 79 v~W~F~~LD~n~~D~~L~~~EL~~l~~~L~--~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~v 140 (151)
T d1sraa_ 79 VHWQFGQLDQHPIDGYLSHTELAPLRAPLI--PMEHCTTRFFETCDLDNDKYIALDEWAGCFGI 140 (151)
T ss_dssp HHHHHHHHCCTTCSSEECTTTTGGGGSTTS--TTGGGHHHHHHHHCTTCSSSEEHHHHHHHTTC
T ss_pred ceeehhhcCCCCCCCccCHHHHHHHHHhhc--CCchHHHHHHHHhcCCCCCcCCHHHHHHHcCC
Confidence 44569999999 599999999987654331 12222788999999999999999999987753
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=96.39 E-value=0.003 Score=45.55 Aligned_cols=50 Identities=10% Similarity=0.025 Sum_probs=39.0
Q ss_pred HHHHHHHh-cCCCCc-ceeHHHHHHHHhccc-----cCCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAA-DVDGNG-TIDYIEFITATMHRH-----KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~-d~d~~g-~i~~~eF~~~~~~~~-----~~~~~~~l~~~F~~~D~d~~G 472 (472)
+-.+|..+ |.|++| +|+.+||..++.... ....+..+..+++.+|.|+||
T Consensus 11 i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg 67 (93)
T d1ksoa_ 11 IVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDC 67 (93)
T ss_dssp HHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCC
Confidence 44566654 899998 599999999886432 123567899999999999998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.16 E-value=0.0051 Score=55.48 Aligned_cols=145 Identities=19% Similarity=0.199 Sum_probs=73.6
Q ss_pred ccceEEcc-----eeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCC----CCeeEEE--
Q 012039 78 KLHYSFGK-----ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ----PNIVEFK-- 146 (472)
Q Consensus 78 ~~~y~~~~-----~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h----p~iv~~~-- 146 (472)
-.+|.+++ .|..|.--+.|+.... +..+++|++.... ....+..|+.++..|..+ |..+...
T Consensus 12 l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g 84 (316)
T d2ppqa1 12 LTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDG 84 (316)
T ss_dssp HTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTC
T ss_pred HHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCC
Confidence 34565543 3456767788998754 3458999875421 234566677777777521 2111110
Q ss_pred -EEEEeCCeEEEEEeccCCcchHH--------------HHHh---c------CCCCHH------------------HHHH
Q 012039 147 -GAYEDKQSVHVVMELCAGGELFD--------------RIIA---K------GHYSER------------------AAAS 184 (472)
Q Consensus 147 -~~~~~~~~~~lv~e~~~g~sL~~--------------~l~~---~------~~~~~~------------------~~~~ 184 (472)
.+..-......++.++.|..... .+.. . ...... ....
T Consensus 85 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (316)
T d2ppqa1 85 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 164 (316)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHH
Confidence 01223455667777776643210 0000 0 001111 1111
Q ss_pred HHHHHHHHHHHHH----HcCcEeecCCCCceeeccCCCCCcEEEeecCCcee
Q 012039 185 ICRSIVNVVHICH----FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (472)
Q Consensus 185 i~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~~~kl~Dfg~~~~ 232 (472)
.+..+...+...+ ..|+||+|+.++||++. .+...-|+||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 165 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHHHHhhhccCccccccccccCCcchhhhhcc---cccceeEeccccccc
Confidence 2222222222222 24799999999999994 445567899998753
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=96.13 E-value=0.0038 Score=44.53 Aligned_cols=50 Identities=10% Similarity=0.214 Sum_probs=38.6
Q ss_pred HHHHHHHh-cCCCCc-ceeHHHHHHHHhcc---ccCCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAA-DVDGNG-TIDYIEFITATMHR---HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~-d~d~~g-~i~~~eF~~~~~~~---~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+-.+|..+ |.|++| .|+..||..++... ....++..+..+++.+|.|+||
T Consensus 11 ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg 65 (89)
T d1k8ua_ 11 LVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQ 65 (89)
T ss_dssp HHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCC
Confidence 44566665 899998 69999999987642 1223557899999999999998
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=95.40 E-value=0.0051 Score=43.64 Aligned_cols=50 Identities=12% Similarity=0.082 Sum_probs=36.4
Q ss_pred HHHHHHHh-cCCCCcce-eHHHHHHHHhccc-cCCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAA-DVDGNGTI-DYIEFITATMHRH-KLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~-d~d~~g~i-~~~eF~~~~~~~~-~~~~~~~l~~~F~~~D~d~~G 472 (472)
+-.+|+.+ |.|++|.+ +.+||..++.... ...+.+.+..+|+..|.|+||
T Consensus 12 ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG 64 (87)
T d1xk4a1 12 IIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDG 64 (87)
T ss_dssp HHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSS
T ss_pred HHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCC
Confidence 44555555 88999865 8899988776432 223345689999999999998
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=95.32 E-value=0.003 Score=46.33 Aligned_cols=49 Identities=14% Similarity=0.203 Sum_probs=35.4
Q ss_pred HHHHHHHhcCCCCcceeHHHHHHHHhcccc-------CCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAADVDGNGTIDYIEFITATMHRHK-------LERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~d~d~~g~i~~~eF~~~~~~~~~-------~~~~~~l~~~F~~~D~d~~G 472 (472)
+-.+|..++ +++|.|+-.||..++..... ......+..+|+.+|.|+||
T Consensus 12 l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG 67 (100)
T d1psra_ 12 MIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDK 67 (100)
T ss_dssp HHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSS
T ss_pred HHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCC
Confidence 344555554 78899999999998765321 12234688999999999998
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=95.19 E-value=0.026 Score=39.73 Aligned_cols=50 Identities=12% Similarity=0.165 Sum_probs=37.3
Q ss_pred HHHHHHHh-cCCCCc-ceeHHHHHHHHhcc-----ccCCcHHHHHHHHHhhcCCCCC
Q 012039 423 VQQLMEAA-DVDGNG-TIDYIEFITATMHR-----HKLERDDHLYKAFQHFDKDNSG 472 (472)
Q Consensus 423 ~~~~~~~~-d~d~~g-~i~~~eF~~~~~~~-----~~~~~~~~l~~~F~~~D~d~~G 472 (472)
+-.+|..+ +.++++ .|+.+||..++... ....+...+.++|+.+|.|+||
T Consensus 10 li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg 66 (87)
T d1e8aa_ 10 IVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDE 66 (87)
T ss_dssp HHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCC
Confidence 45566665 556554 69999999988642 2234567899999999999998
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=92.96 E-value=0.032 Score=39.48 Aligned_cols=31 Identities=19% Similarity=0.403 Sum_probs=26.5
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL 414 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~ 414 (472)
...+.++|+.+|.|+||.|+.+|+..++..+
T Consensus 51 ~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (90)
T d3cr5x1 51 QEVVDKVMETLDSDGDGECDFQEFMAFVAMI 81 (90)
T ss_dssp HHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3457889999999999999999998877664
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=92.26 E-value=0.065 Score=37.12 Aligned_cols=29 Identities=21% Similarity=0.486 Sum_probs=25.2
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHH
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLAR 413 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~ 413 (472)
..+.++|+.+|.|+||.|+..||...+..
T Consensus 54 ~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 54 KVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 45778999999999999999999887754
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=91.92 E-value=0.048 Score=38.84 Aligned_cols=31 Identities=10% Similarity=0.379 Sum_probs=26.1
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARL 414 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~ 414 (472)
...+.++|+.+|.|+||.|+.+|+...+..+
T Consensus 51 ~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (94)
T d1j55a_ 51 KDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (94)
T ss_dssp -CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 4457889999999999999999998887654
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=91.85 E-value=0.029 Score=40.09 Aligned_cols=30 Identities=23% Similarity=0.469 Sum_probs=26.0
Q ss_pred hhhhhhhccccCCCCCcccHHHHHHHHHHc
Q 012039 385 QGLKQMFTNIDTDNSGTITYEELKAGLARL 414 (472)
Q Consensus 385 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~ 414 (472)
..+.++|+.+|.|+||.|+.+||..++..+
T Consensus 52 ~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 52 GVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 457788999999999999999998887665
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.54 E-value=0.15 Score=36.26 Aligned_cols=65 Identities=14% Similarity=0.144 Sum_probs=50.1
Q ss_pred hhhhhhccccCCCCCcccHHHHHHHHHHc-CC-CCCHHHHHHHHHHhcCCC----CcceeHHHHHHHHhccc
Q 012039 386 GLKQMFTNIDTDNSGTITYEELKAGLARL-GS-KLTEAEVQQLMEAADVDG----NGTIDYIEFITATMHRH 451 (472)
Q Consensus 386 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~-~~~~~~~~~~~~~~d~d~----~g~i~~~eF~~~~~~~~ 451 (472)
++..+|..+-. +.+.|+.++|...|+.- +. ..+.+.+.+++..+..+. .|.+++++|+..+....
T Consensus 9 ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~~ 79 (94)
T d1qasa1 9 EIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSAD 79 (94)
T ss_dssp HHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSST
T ss_pred HHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCcc
Confidence 45667777743 44689999999999984 43 468888999999997653 36799999999887543
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.01 E-value=0.45 Score=31.42 Aligned_cols=58 Identities=21% Similarity=0.277 Sum_probs=43.3
Q ss_pred HhhhhhhhccccCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhcC----C-CCcceeHHHHHHHHhc
Q 012039 384 IQGLKQMFTNIDTDNSGTITYEELKAGLARLGSKLTEAEVQQLMEAADV----D-GNGTIDYIEFITATMH 449 (472)
Q Consensus 384 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~----d-~~g~i~~~eF~~~~~~ 449 (472)
-+++.++|+.+ .++..+|+.+||++.| +.++++-++..+-. + ..|..+|..|...+..
T Consensus 7 aEqv~~aFr~l-A~~KpyVT~~dL~~~L-------~peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~g 69 (73)
T d1h8ba_ 7 AEQVIASFRIL-ASDKPYILAEELRREL-------PPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALYG 69 (73)
T ss_dssp HHHHHHHHHHH-TTSCSSBCHHHHHHHS-------CHHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHTC
T ss_pred HHHHHHHHHHH-hCCCCeeCHHHHHhhc-------CHHHHHHHHHHCcccCCCCCCCCcccHHHHHHHHhc
Confidence 45667888888 4678899999997654 67778887777632 2 3567999999987754
|
| >d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Cellulosome endoglucanase SS species: Clostridium thermocellum [TaxId: 1515]
Probab=88.81 E-value=0.066 Score=35.90 Aligned_cols=50 Identities=14% Similarity=0.193 Sum_probs=37.5
Q ss_pred ccCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHh
Q 012039 394 IDTDNSGTITYEELKAGLARL-GSKLTEAEVQQLMEAADVDGNGTIDYIEFITATM 448 (472)
Q Consensus 394 ~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~ 448 (472)
=|.|+||.|+..++..++..+ +.. +..+ ...+|.|+||.|+..++..+..
T Consensus 7 GDvN~DG~Vd~~D~~~~~~~i~~~~-~~~~----~~~aDvn~DG~Id~~D~~~l~~ 57 (71)
T d1dava_ 7 GDVNDDGKVNSTDAVALKRYVLRSG-ISIN----TDNADLNEDGRVNSTDLGILKR 57 (71)
T ss_dssp SCSSSSSBSSGGGHHHHHHHHHCSC-SCCC----GGGTCSSSSSSCSSHHHHHHHH
T ss_pred eccCCCCCCcHHHHHHHHHHHcCCC-CcCC----CcceecCCCCCcCHHHHHHHHH
Confidence 388999999999998888765 432 2212 2257999999999999987654
|
| >d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Endo-1,4-beta-xylanase Y species: Clostridium thermocellum [TaxId: 1515]
Probab=88.66 E-value=0.38 Score=30.60 Aligned_cols=49 Identities=29% Similarity=0.407 Sum_probs=37.6
Q ss_pred cCCCCCcccHHHHHHHHHHc-CC-CCCHHHHHHHHHHhcCCCCcceeHHHHHHHH
Q 012039 395 DTDNSGTITYEELKAGLARL-GS-KLTEAEVQQLMEAADVDGNGTIDYIEFITAT 447 (472)
Q Consensus 395 D~~~~G~i~~~el~~~l~~~-~~-~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~ 447 (472)
|.|+||.|+..++..+..-+ +. .+++. -+..+|.|+||.|+..+.+.+.
T Consensus 2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~----~~~aaDvn~Dg~i~i~D~~~l~ 52 (59)
T d2cclb1 2 DVNGDGTINSTDLTMLKRSVLRAITLTDD----AKARADVDKNGSINAADVLLLS 52 (59)
T ss_dssp CTTCSSSCCHHHHHHHHHHHTTSSCCCHH----HHHHHCTTCSSCCSHHHHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCCCChh----hhhccccCCCCCCCHHHHHHHH
Confidence 78999999999998887664 43 34443 2567899999999988887654
|
| >d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: p25-alpha domain: Hypothetical protein c32e8.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=88.14 E-value=0.88 Score=32.42 Aligned_cols=68 Identities=10% Similarity=0.074 Sum_probs=51.3
Q ss_pred hhHHhhhhhhhccccCCCCCcccHHHHHHHHHHcC----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhc
Q 012039 381 TEEIQGLKQMFTNIDTDNSGTITYEELKAGLARLG----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMH 449 (472)
Q Consensus 381 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~ 449 (472)
..++....++|..|-.-..-.++...+..+++..+ ..+|..+++-+|..+-..+ .+|+|++|..++..
T Consensus 4 ~~~l~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k~k~-~ri~f~~F~~aL~~ 75 (103)
T d1pula1 4 DADVKKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVTGPK-KKATFDETKKVLAF 75 (103)
T ss_dssp HHHHHHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHTCSS-SCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhcCCC-CCcCHHHHHHHHHH
Confidence 44566667777777633223699999999998853 4689999999999985544 56999999998753
|
| >d1wlma1 a.39.1.11 (A:8-145) Protein cgi-38 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: p25-alpha domain: Protein cgi-38 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.62 E-value=1.3 Score=33.40 Aligned_cols=80 Identities=14% Similarity=0.122 Sum_probs=54.6
Q ss_pred hhhhhccccC-CCCC-cccHHHHHHHHHHcC----CCCCHHHHHHHHHHhcCCCCcceeHHHHHHHHhccc-----cCCc
Q 012039 387 LKQMFTNIDT-DNSG-TITYEELKAGLARLG----SKLTEAEVQQLMEAADVDGNGTIDYIEFITATMHRH-----KLER 455 (472)
Q Consensus 387 ~~~~F~~~D~-~~~G-~i~~~el~~~l~~~~----~~~~~~~~~~~~~~~d~d~~g~i~~~eF~~~~~~~~-----~~~~ 455 (472)
....|..|.. ..+| .|+...+..+++..+ ..++..+++-+|..+-..+...|+|++|+.++.... ....
T Consensus 13 ~F~~F~~fG~~k~~~~~m~~~~f~K~~kd~~lid~K~~T~t~~diiF~k~k~k~~r~i~f~~F~~aL~~iA~kk~~~~s~ 92 (138)
T d1wlma1 13 SFRKFAIHGDPKASGQEMNGKNWAKLCKDCKVADGKAVTGTDVDIVFSKVKAKSARVINYEEFKKALEELATKRFKGKSK 92 (138)
T ss_dssp HHHHHHTSSCSSCCSSEEEHHHHHHHHHHTSCCCSSSSCHHHHHHHHHHHSCSSCSEEEHHHHHHHHHHTHHHHSSSCCH
T ss_pred HHHHHHhcCCCCCCcccCCHHHHHHHHHHcCCCcCCccchhhHHHHHHHhhcCCCcccCHHHHHHHHHHHHHHhcCCccH
Confidence 3344444442 2333 499999999999864 358999999999998766777899999988775432 1223
Q ss_pred HHHHHHHHHhh
Q 012039 456 DDHLYKAFQHF 466 (472)
Q Consensus 456 ~~~l~~~F~~~ 466 (472)
++.+..+.+.+
T Consensus 93 ~e~~~~i~~~i 103 (138)
T d1wlma1 93 EEAFDAICQLI 103 (138)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 44556665554
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=81.08 E-value=6.5 Score=33.82 Aligned_cols=136 Identities=15% Similarity=0.177 Sum_probs=70.3
Q ss_pred ceEEcceeeecCCeEEEEEEECCCCCEEEEEEecccccCCcccHHHHHHHHHHHHhccCCCCeeEEEEE-----------
Q 012039 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA----------- 148 (472)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~----------- 148 (472)
.++-++.=-.|+-|..|. . .++..+++|.-. ....+.+-.|+...-.+. .|...-+.-.
T Consensus 70 ~~K~i~~s~~Gs~Gv~FV-~--~e~gaiVlK~s~------tta~E~y~~eLAr~LGvp-vPqmRvI~~~~~E~~~~~~~~ 139 (342)
T d1cjaa_ 70 QFKGIERSEKGTEGLFFV-E--TESGVFIVKRST------NIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNMLECL 139 (342)
T ss_dssp GEEEEEECCSTTSCEEEE-E--ESSCEEEEECCT------THHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHHHHH
T ss_pred hhhceEEeecCCceEEEE-E--cCCceEEEecCC------chHHHHHHHHHHHHhCCC-CCceEEecCCCHHHHHHHHHH
Confidence 344444444566665554 3 234567788532 233456667777766774 7777665410
Q ss_pred ------E-----EeCCeEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHH--HHHHH-HHHHc---CcEeec-CCCCc
Q 012039 149 ------Y-----EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI--VNVVH-ICHFM---GVMHRD-LKPEN 210 (472)
Q Consensus 149 ------~-----~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~i~~qi--~~~l~-~lH~~---~i~H~d-lkp~N 210 (472)
. .-....+++|||.+|.+|.+.- ....++......+.++ +-++. ++++. .+.+++ =.++|
T Consensus 140 l~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~--~~~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~N 217 (342)
T d1cjaa_ 140 AAIDKSFRVITTLANQANILLMELVRGITLNKLT--TTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCC--SSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred hcCCChhHHHHHHHhcccceeeeccCCccccccc--cccchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccc
Confidence 0 1124588999999998875421 1111111122233332 22233 33432 245553 27899
Q ss_pred eeeccCCCCCcEEEeecCC
Q 012039 211 FLLSSKDENALLKATDFGL 229 (472)
Q Consensus 211 ili~~~~~~~~~kl~Dfg~ 229 (472)
|++.. ....+..+|=|.
T Consensus 218 iml~~--n~~~~~~IDs~i 234 (342)
T d1cjaa_ 218 IMLSE--RGATVVPIDSKI 234 (342)
T ss_dssp EEEES--BTTCEEECSCCC
T ss_pred eEEec--CCcEEEEecCCc
Confidence 99963 333455666433
|